data_2jre_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jre _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.0 t . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.924 0.392 . . . . 1.26 110.908 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 85.0 mt -80.26 127.77 32.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.873 -0.603 . . . . 1.49 110.757 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -124.56 137.82 54.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.169 -0.468 . . . . 3.0899999999999999 110.882 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 80.8 p -132.58 132.19 42.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.305 -0.407 . . . . 1.79 111.096 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.9 t -118.26 157.55 19.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 1.26 110.704 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -109.72 110.01 20.89 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.816 0.341 . . . . 1.74 111.282 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.451 HD12 ' HB2' ' A' ' 60' ' ' ASP . 4.6 mm? -118.6 166.48 12.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.154 -0.475 . . . . 1.4099999999999999 110.318 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.586 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 35.0 p90 -144.14 132.33 21.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.906 0.384 . . . . 2.6600000000000001 111.638 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.508 ' HE ' ' HG ' ' A' ' 27' ' ' LEU . 15.7 tpp85 -97.22 94.75 7.28 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.04 -0.527 . . . . 3.5899999999999999 110.21 179.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -130.25 9.93 5.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.383 -0.371 . . . . 2.5800000000000001 111.168 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -110.29 151.22 27.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.435 . . . . 4.1900000000000004 110.836 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -80.68 17.16 1.19 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.068 -0.515 . . . . 2.8700000000000001 110.998 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 63.0 p -69.0 -10.99 60.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 1.74 111.157 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.2 m 59.13 20.17 8.13 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.999 -0.546 . . . . 2.79 111.194 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 90.0 p -164.26 158.55 19.01 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.956 0.408 . . . . 1.79 111.077 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.508 ' HG ' ' HE ' ' A' ' 20' ' ' ARG . 87.4 mt -102.6 -12.09 17.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.064 -0.517 . . . . 1.1299999999999999 110.614 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.495 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 100.15 24.86 9.31 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.831 -0.7 . . . . 0.52000000000000002 112.373 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 75.6 mt -102.56 115.73 45.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.822 0.344 . . . . 1.53 110.927 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.7 t -110.67 102.44 11.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 1.4099999999999999 110.666 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 25.3 pt -99.43 160.53 3.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 1.1799999999999999 111.447 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 48.1 t -150.85 145.68 25.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.918 -0.583 . . . . 1.79 110.726 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 C-N-CA 120.72 -0.752 . . . . 1.04 112.609 -179.818 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 41.8 mm . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.667 0.27 . . . . 1.28 111.094 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 52.9 p90 -147.34 147.0 29.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.978 0.418 . . . . 1.0800000000000001 111.086 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.1 t -84.27 136.64 22.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.969 -0.559 . . . . 1.0600000000000001 111.223 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -125.96 -25.96 3.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.029 -0.532 . . . . 2.8900000000000001 110.87 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 43.1 t -135.85 170.41 16.02 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.234 -0.439 . . . . 1.8700000000000001 110.89 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 69.5 mt -141.66 160.28 40.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.211 -0.45 . . . . 1.1899999999999999 110.963 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.495 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 51.0 mt -107.08 102.01 40.96 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.242 -0.435 . . . . 1.8500000000000001 110.918 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.67 136.25 64.38 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.409 2.073 . . . . 1.26 112.31 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 99.91 -12.32 60.79 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.791 -0.718 . . . . 0.52000000000000002 112.691 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 56.3 m -88.19 179.11 6.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.706 0.289 . . . . 1.73 111.023 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.48 -54.41 36.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.319 -0.401 . . . . 1.1299999999999999 111.455 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.16 -48.02 71.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 1.0900000000000001 111.744 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.53 -56.76 13.47 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.428 -0.351 . . . . 1.1100000000000001 111.656 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 81.5 mt -59.86 -20.43 57.05 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.26 -0.427 . . . . 1.29 111.527 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.451 ' HB2' HD12 ' A' ' 18' ' ' LEU . 18.2 t70 -58.96 -48.37 81.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.875 0.369 . . . . 1.8600000000000001 110.957 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.46 -48.49 1.11 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.782 -0.723 . . . . 1.4199999999999999 112.689 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -65.24 -23.7 67.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.71 0.29 . . . . 3.0499999999999998 110.921 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 39.8 mm -76.68 98.72 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.267 -0.424 . . . . 1.6299999999999999 110.792 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -107.92 156.3 38.44 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 1.98 110.632 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.96 172.79 5.57 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.448 2.099 . . . . 1.4399999999999999 112.271 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 57.88 74.54 0.42 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.187 -0.461 . . . . 2.6299999999999999 111.243 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -149.6 151.33 33.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 2.02 110.433 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -109.88 114.67 28.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.816 0.341 . . . . 1.6200000000000001 111.244 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 43.7 mm -70.31 140.03 19.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.069 -0.514 . . . . 1.1100000000000001 110.597 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 90.5 mt -116.89 -65.1 1.22 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.298 -0.41 . . . . 1.1299999999999999 111.274 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -141.2 134.91 30.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.955 0.407 . . . . 3.1499999999999999 111.625 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.527 HG13 ' H ' ' A' ' 73' ' ' ASP . 6.6 t -90.4 175.09 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.861 -0.608 . . . . 1.0900000000000001 109.596 178.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.676 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 18.6 t70 -47.55 108.97 0.18 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.693 0.283 . . . . 0.79000000000000004 111.696 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 54.24 26.26 6.61 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.244 -0.434 . . . . 2.0099999999999998 111.768 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.407 HG21 ' O ' ' A' ' 73' ' ' ASP . 58.2 t -143.02 152.04 17.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.296 -0.411 . . . . 1.1499999999999999 110.696 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.449 ' ND2' ' H ' ' A' ' 78' ' ' GLN . 5.7 t30 -121.06 130.98 54.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.368 -0.378 . . . . 2.8500000000000001 110.718 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.7 m -110.2 17.39 7.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.379 -0.373 . . . . 1.26 111.444 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.449 ' H ' ' ND2' ' A' ' 76' ' ' ASN . 14.5 mm100 -85.84 28.92 0.75 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.264 -0.426 . . . . 1.74 111.07 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -178.4 19.04 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.56 -0.829 . . . . 0.57999999999999996 112.95 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 43.8 mtm -118.4 146.07 44.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.799 0.333 . . . . 1.1200000000000001 110.711 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.42 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -62.11 155.79 23.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.1 -0.5 . . . . 1.1200000000000001 111.068 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -51.73 -57.76 8.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.425 -0.352 . . . . 1.52 111.178 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.9 t -54.56 -37.88 65.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 2.0299999999999998 111.306 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -60.94 -45.51 94.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.322 -0.399 . . . . 2.1200000000000001 110.781 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 81' ' ' ALA . 45.6 t -60.09 -34.14 55.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.159 -0.473 . . . . 1.0800000000000001 110.769 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.528 HG12 ' HE ' ' A' ' 90' ' ' ARG . 56.7 t -64.25 -43.93 97.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.111 -0.495 . . . . 1.0700000000000001 110.533 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -58.1 -41.77 84.22 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.163 -0.471 . . . . 1.51 110.647 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 49.5 t -56.86 -52.52 54.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.954 -0.566 . . . . 1.0600000000000001 111.049 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 71.2 mt -54.41 -36.07 63.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.026 -0.534 . . . . 1.1399999999999999 110.923 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.528 ' HE ' HG12 ' A' ' 86' ' ' VAL . 74.7 mtt180 -75.14 -30.12 60.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 2.5600000000000001 110.872 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -74.68 -18.01 60.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.123 -0.489 . . . . 1.8100000000000001 111.019 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.21 -83.0 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.072 -0.513 . . . . 1.1100000000000001 111.415 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 65.64 11.76 54.53 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.477 -0.868 . . . . 0.77000000000000002 112.315 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -146.7 166.33 16.87 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 110.557 -0.164 . . . . 3.3300000000000001 110.557 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.586 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 46.2 Cg_exo -57.07 105.1 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.278 1.985 . . . . 0.92000000000000004 111.366 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.7 m -107.29 154.46 8.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.224 0.535 . . . . 1.3200000000000001 111.994 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.676 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 79.6 ttt180 -103.53 143.07 33.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.549 -0.75 . . . . 3.02 109.932 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 20.5 mt -114.83 131.01 56.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.249 -0.432 . . . . 1.1599999999999999 110.972 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 62.2 tp -120.62 99.8 6.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 1.1000000000000001 110.234 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.46 153.31 48.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.053 -0.522 . . . . 1.1100000000000001 111.322 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.9 tt -100.91 138.68 24.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.069 -0.514 . . . . 1.1399999999999999 110.708 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 24.8 tpt180 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.437 . . . . 2.7000000000000002 110.885 -179.907 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 46.9 t . . . . . 0 C--O 1.233 0.192 0 CA-C-O 120.756 0.312 . . . . 1.26 110.818 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 89.6 mt -79.52 121.58 25.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.013 -0.54 . . . . 1.49 110.851 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -113.86 151.44 32.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.123 -0.49 . . . . 3.0899999999999999 110.961 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 48.5 t -150.47 135.85 17.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.245 -0.434 . . . . 1.79 111.073 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.7 t -130.29 147.17 33.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.041 -0.527 . . . . 1.26 110.806 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -99.13 118.38 35.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.917 0.389 . . . . 1.74 111.076 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.486 HD11 ' HB2' ' A' ' 60' ' ' ASP . 4.2 mm? -116.97 166.91 11.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.937 -0.574 . . . . 1.4099999999999999 110.788 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.556 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 30.4 p90 -160.49 130.5 5.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.247 -0.433 . . . . 2.6600000000000001 111.151 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.606 ' HE ' ' HA2' ' A' ' 93' ' ' GLY . 57.2 ttp180 -112.68 97.43 6.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.399 -0.364 . . . . 3.5899999999999999 110.919 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -95.65 -20.52 18.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.121 -0.491 . . . . 2.5800000000000001 110.702 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -83.75 160.51 21.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.071 -0.513 . . . . 4.1900000000000004 110.953 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -95.23 40.4 1.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.035 -0.53 . . . . 2.8700000000000001 110.902 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 82.1 p -71.93 -13.96 61.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 1.74 111.127 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.2 m 57.76 19.1 5.32 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.921 -0.582 . . . . 2.79 111.256 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.8 m -154.9 154.93 33.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.435 -0.348 . . . . 1.79 111.005 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.447 HD23 ' HB2' ' A' ' 20' ' ' ARG . 52.0 mt -114.02 -24.43 9.04 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.097 -0.501 . . . . 1.1299999999999999 111.141 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.18 -19.98 49.25 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.692 -0.766 . . . . 0.52000000000000002 112.857 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 66.2 mt -61.64 110.27 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.676 0.274 . . . . 1.53 110.979 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.6 t -112.25 106.64 15.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.445 . . . . 1.4099999999999999 110.964 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.531 ' HA ' ' HA ' ' A' ' 48' ' ' VAL . 46.3 pt -86.81 -177.88 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.015 -0.539 . . . . 1.1799999999999999 111.144 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.2 t -156.14 146.24 21.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.358 -0.383 . . . . 1.79 111.137 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.378 0 C-N-CA 120.836 -0.697 . . . . 1.04 112.191 179.653 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.1 mm . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.68 0.276 . . . . 1.28 110.929 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -157.53 142.38 16.7 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.278 -0.419 . . . . 1.0800000000000001 111.022 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.531 ' HA ' ' HA ' ' A' ' 31' ' ' ILE . 99.3 t -77.96 127.21 38.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.151 -0.477 . . . . 1.0600000000000001 110.804 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -114.63 -23.22 9.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.031 -0.531 . . . . 2.8900000000000001 111.139 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 78.1 p -146.09 161.76 39.45 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.134 0.492 . . . . 1.8700000000000001 111.645 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 91.6 mt -133.55 154.35 50.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.662 -0.699 . . . . 1.1899999999999999 110.572 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 49.0 mm -97.24 113.89 63.9 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.346 -0.388 . . . . 1.8500000000000001 110.846 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -61.58 136.2 61.5 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.414 2.076 . . . . 1.26 112.122 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 97.9 -23.29 36.68 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.864 -0.684 . . . . 0.52000000000000002 112.307 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 67.1 m -73.14 170.86 14.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.619 0.247 . . . . 1.73 111.079 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.64 -55.64 30.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.427 -0.351 . . . . 1.1299999999999999 111.463 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.61 -39.33 57.8 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.203 -0.453 . . . . 1.0900000000000001 111.333 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.69 -46.99 67.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 1.1100000000000001 111.425 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.8 mt -63.15 -19.68 64.7 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.222 -0.444 . . . . 1.29 111.184 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.486 ' HB2' HD11 ' A' ' 18' ' ' LEU . 18.4 t70 -62.5 -50.81 69.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.294 -0.412 . . . . 1.8600000000000001 110.808 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.49 -48.4 1.69 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.761 -0.733 . . . . 1.4199999999999999 113.151 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 21.7 mmm180 -59.93 -29.25 68.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.638 0.256 . . . . 3.0499999999999998 111.204 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 66.1 mt -77.19 111.73 14.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.896 0.379 . . . . 1.6299999999999999 111.254 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -95.69 140.13 22.2 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.994 -0.548 . . . . 1.98 110.293 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -74.1 44.84 1.06 Allowed 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.495 2.13 . . . . 1.4399999999999999 112.963 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -167.75 69.5 0.09 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.285 -0.416 . . . . 2.6299999999999999 110.409 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -146.17 170.85 15.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.486 . . . . 2.02 110.835 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -115.0 104.47 11.94 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.288 -0.414 . . . . 1.6200000000000001 110.986 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.488 HD11 ' HB3' ' A' ' 100' ' ' LEU . 49.5 mm -58.48 145.49 9.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.159 -0.473 . . . . 1.1100000000000001 111.054 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.463 ' HA ' ' NE2' ' A' ' 78' ' ' GLN . 92.7 mt -124.35 -67.11 0.94 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.236 -0.438 . . . . 1.1299999999999999 111.453 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 27.2 mtm180 -132.34 134.92 45.78 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.027 0.442 . . . . 3.1499999999999999 111.695 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.538 HG11 ' H ' ' A' ' 73' ' ' ASP . 3.8 t -97.97 172.88 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.761 -0.654 . . . . 1.0900000000000001 110.02 179.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.619 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 28.1 t70 -51.07 108.81 0.27 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.784 0.326 . . . . 0.79000000000000004 111.44 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 59.39 14.21 3.63 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.045 -0.525 . . . . 2.0099999999999998 111.844 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.47 ' HB ' ' HB ' ' A' ' 72' ' ' VAL . 40.9 t -135.56 157.36 39.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.532 -0.304 . . . . 1.1499999999999999 110.849 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.406 ' N ' HG11 ' A' ' 75' ' ' VAL . 3.2 p-10 -129.07 128.61 43.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.396 -0.366 . . . . 2.8500000000000001 110.575 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.0 m -105.29 24.65 2.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.805 0.336 . . . . 1.26 111.399 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.463 ' NE2' ' HA ' ' A' ' 70' ' ' LEU . 29.1 mm-40 -90.72 33.6 0.92 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.277 -0.419 . . . . 1.74 110.763 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 170.15 23.55 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.77 -0.728 . . . . 0.57999999999999996 112.815 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 43.3 mtm -119.12 140.74 49.61 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.788 0.327 . . . . 1.1200000000000001 110.668 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.408 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -58.77 156.62 10.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.165 -0.471 . . . . 1.1200000000000001 111.484 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -50.49 -57.81 7.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 1.52 111.272 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 79.3 p -53.67 -38.85 64.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.022 -0.535 . . . . 2.0299999999999998 111.369 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -61.18 -44.54 97.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.272 -0.422 . . . . 2.1200000000000001 111.024 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 81' ' ' ALA . 47.4 t -59.42 -40.99 83.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 1.0800000000000001 111.038 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.4 t -62.14 -39.14 82.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.199 -0.455 . . . . 1.0700000000000001 110.926 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -59.91 -44.79 94.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 1.51 110.778 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 53.3 t -56.92 -54.16 33.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.173 -0.467 . . . . 1.0600000000000001 111.124 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 92.9 mt -55.69 -34.29 64.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.887 -0.597 . . . . 1.1399999999999999 111.364 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 79.3 mtm180 -80.46 -17.1 52.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.299 -0.41 . . . . 2.5600000000000001 111.341 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.424 HD21 ' N ' ' A' ' 91' ' ' ASN . 0.9 OUTLIER -89.84 -15.47 32.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.42 -0.354 . . . . 1.8100000000000001 111.142 179.858 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.62 -86.64 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.299 -0.41 . . . . 1.1100000000000001 111.512 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.606 ' HA2' ' HE ' ' A' ' 20' ' ' ARG . . . 64.19 15.49 58.77 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.688 -0.768 . . . . 0.77000000000000002 112.279 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.455 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -146.92 174.07 3.69 Favored Pre-proline 0 C--N 1.327 -0.37 0 N-CA-C 110.408 -0.219 . . . . 3.3300000000000001 110.408 -179.727 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.556 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 46.2 Cg_exo -58.24 107.23 0.31 Allowed 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 121.897 1.731 . . . . 0.92000000000000004 111.477 178.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.3 m -116.6 141.54 34.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.164 0.506 . . . . 1.3200000000000001 112.173 -178.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.619 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 75.4 ttt180 -94.61 145.07 25.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.692 -0.685 . . . . 3.02 109.707 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 13.5 mt -121.75 136.12 54.94 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.845 0.355 . . . . 1.1599999999999999 111.366 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 38.5 tp -123.88 104.1 8.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.004 -0.544 . . . . 1.1000000000000001 110.495 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.488 ' HB3' HD11 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -128.87 147.03 50.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.276 -0.42 . . . . 1.1100000000000001 111.118 -179.59 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.412 ' HB ' HD13 ' A' ' 70' ' ' LEU . 16.1 tt -98.52 143.84 12.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 1.1399999999999999 111.029 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 13.7 mmm180 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 115.995 -0.548 . . . . 2.7000000000000002 111.013 179.97 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.5 t . . . . . 0 C--O 1.232 0.183 0 CA-C-O 120.883 0.373 . . . . 1.26 111.021 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 62.5 mt -81.93 122.18 27.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.919 -0.582 . . . . 1.49 110.494 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -113.35 150.73 32.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 3.0899999999999999 110.964 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 80.3 p -151.05 138.42 19.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 1.79 111.264 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.9 t -129.67 145.64 35.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.072 -0.513 . . . . 1.26 110.823 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -95.14 114.18 25.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.997 0.427 . . . . 1.74 111.376 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -117.26 166.66 12.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.861 -0.609 . . . . 1.4099999999999999 110.591 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.471 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 30.4 p90 -157.94 134.39 9.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.81 0.338 . . . . 2.6600000000000001 111.073 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.637 ' HE ' ' H ' ' A' ' 93' ' ' GLY . 12.2 ttp180 -121.75 160.27 24.92 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.344 -0.389 . . . . 3.5899999999999999 110.847 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -165.87 -32.83 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.113 -0.494 . . . . 2.5800000000000001 110.845 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -67.76 162.43 23.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.906 -0.588 . . . . 4.1900000000000004 110.939 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -86.26 22.9 1.67 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.12 -0.491 . . . . 2.8700000000000001 110.715 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 74.6 p -63.47 -23.11 67.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.119 -0.491 . . . . 1.74 111.095 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.46 ' HA ' ' NH1' ' A' ' 20' ' ' ARG . 52.5 m 56.73 26.19 11.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.822 -0.626 . . . . 2.79 111.299 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.7 m -152.24 153.68 34.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.916 0.388 . . . . 1.79 111.12 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.526 HD23 ' HB2' ' A' ' 20' ' ' ARG . 81.0 mt -119.77 -5.66 10.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.016 -0.538 . . . . 1.1299999999999999 110.879 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.428 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 89.02 16.78 57.35 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.724 -0.751 . . . . 0.52000000000000002 112.363 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.409 HG21 HG23 ' A' ' 31' ' ' ILE . 69.9 mt -97.19 115.65 37.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.7 0.286 . . . . 1.53 110.994 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.1 t -110.66 90.32 3.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.358 -0.383 . . . . 1.4099999999999999 110.734 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.409 HG23 HG21 ' A' ' 29' ' ' ILE . 41.9 pt -87.18 167.52 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.034 -0.53 . . . . 1.1799999999999999 111.197 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 47.5 t -150.6 134.42 16.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.088 -0.505 . . . . 1.79 110.792 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.267 0 C-N-CA 120.843 -0.694 . . . . 1.04 112.556 -179.863 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.8 mp . . . . . 0 CA--C 1.528 0.117 0 CA-C-O 120.735 0.302 . . . . 1.28 110.823 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -145.33 153.07 40.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.162 -0.472 . . . . 1.0800000000000001 110.94 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 95.2 t -83.89 125.79 40.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.247 -0.433 . . . . 1.0600000000000001 111.195 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -108.54 -27.34 9.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.95 -0.568 . . . . 2.8900000000000001 111.001 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 59.2 m -147.71 172.1 14.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.045 0.45 . . . . 1.8700000000000001 111.633 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 97.1 mt -132.14 165.72 23.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.669 -0.696 . . . . 1.1899999999999999 110.741 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.428 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 43.0 mm -106.36 104.48 50.5 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.186 -0.461 . . . . 1.8500000000000001 110.958 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.61 129.77 36.68 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.424 2.082 . . . . 1.26 112.407 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 98.01 0.44 58.7 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.768 -0.729 . . . . 0.52000000000000002 112.76 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.411 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 27.9 t -100.41 170.88 8.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.637 0.256 . . . . 1.73 110.999 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -51.81 -58.54 6.12 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.226 -0.443 . . . . 1.1299999999999999 111.659 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.3 -32.36 64.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.248 -0.433 . . . . 1.0900000000000001 111.514 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.91 -24.47 55.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.349 -0.387 . . . . 1.1100000000000001 111.344 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 55' ' ' SER . 90.8 mt -74.7 -37.65 62.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.277 -0.42 . . . . 1.29 111.033 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -57.18 -46.83 82.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.401 -0.363 . . . . 1.8600000000000001 110.913 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.46 -34.93 2.65 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.905 -0.664 . . . . 1.4199999999999999 112.709 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 78.0 mtm180 -65.11 -18.46 65.32 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.712 0.292 . . . . 3.0499999999999998 111.096 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 67.8 mt -87.23 108.94 18.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.888 0.375 . . . . 1.6299999999999999 110.919 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -82.67 138.25 44.05 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.011 -0.54 . . . . 1.98 110.5 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.54 53.41 3.98 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.45 2.1 . . . . 1.4399999999999999 112.524 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -174.59 72.09 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.125 -0.489 . . . . 2.6299999999999999 110.531 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -145.23 170.38 16.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.147 -0.479 . . . . 2.02 110.847 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -110.68 107.49 17.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.316 -0.402 . . . . 1.6200000000000001 111.028 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 43.7 mm -63.0 142.69 16.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.146 -0.479 . . . . 1.1100000000000001 110.732 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 94.4 mt -121.56 -59.22 1.71 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.286 -0.416 . . . . 1.1299999999999999 111.281 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.438 ' HG2' HD21 ' A' ' 76' ' ' ASN . 77.3 mtp180 -142.02 140.92 32.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.025 0.44 . . . . 3.1499999999999999 111.583 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.546 HG11 ' H ' ' A' ' 73' ' ' ASP . 3.9 t -103.41 173.99 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.86 -0.609 . . . . 1.0900000000000001 109.646 178.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.643 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 15.3 t70 -47.28 108.62 0.16 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.736 0.303 . . . . 0.79000000000000004 111.455 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 54.98 31.0 15.14 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.224 -0.444 . . . . 2.0099999999999998 111.576 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.416 ' HB ' ' HB ' ' A' ' 72' ' ' VAL . 92.7 t -145.51 148.14 17.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.354 -0.385 . . . . 1.1499999999999999 110.904 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.438 HD21 ' HG2' ' A' ' 71' ' ' ARG . 22.1 t-20 -120.2 118.33 30.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.148 -0.478 . . . . 2.8500000000000001 110.552 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.434 ' HA ' ' HE2' ' A' ' 80' ' ' MET . 26.8 m -102.21 25.24 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.871 0.367 . . . . 1.26 111.455 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -92.28 42.4 1.1 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.166 -0.47 . . . . 1.74 110.841 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 158.15 36.79 0.02 OUTLIER Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.661 -0.781 . . . . 0.57999999999999996 112.901 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.434 ' HE2' ' HA ' ' A' ' 77' ' ' VAL . 57.6 mtm -131.36 146.88 52.47 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.826 0.345 . . . . 1.1200000000000001 110.768 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.27 142.49 31.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.067 -0.515 . . . . 1.1200000000000001 111.029 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -48.07 -54.3 13.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.804 0.335 . . . . 1.52 111.03 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 56.8 m -54.15 -42.93 70.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.987 -0.551 . . . . 2.0299999999999998 110.98 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -58.1 -43.54 87.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 2.1200000000000001 110.983 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 52.5 t -58.19 -41.63 81.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 1.0800000000000001 110.702 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.3 t -61.61 -37.57 78.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.108 -0.496 . . . . 1.0700000000000001 110.758 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.446 ' HG2' HH21 ' A' ' 90' ' ' ARG . 42.4 mt-10 -58.92 -48.46 81.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.193 -0.458 . . . . 1.51 110.595 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 55.5 t -54.17 -54.1 23.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.133 -0.485 . . . . 1.0600000000000001 111.193 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 93.0 mt -59.26 -29.88 67.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.886 -0.597 . . . . 1.1399999999999999 111.456 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.446 HH21 ' HG2' ' A' ' 87' ' ' GLU . 87.3 mtm180 -85.9 -11.46 53.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.414 -0.357 . . . . 2.5600000000000001 111.154 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -100.02 -11.3 20.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.39 -0.368 . . . . 1.8100000000000001 111.178 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.33 -85.03 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.343 -0.39 . . . . 1.1100000000000001 111.571 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.637 ' H ' ' HE ' ' A' ' 20' ' ' ARG . . . 66.61 17.39 66.78 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.637 -0.792 . . . . 0.77000000000000002 112.318 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -146.9 169.62 9.13 Favored Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 110.295 -0.261 . . . . 3.3300000000000001 110.295 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.471 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 34.6 Cg_exo -58.91 104.1 0.18 Allowed 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.025 1.817 . . . . 0.92000000000000004 111.423 178.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 18.2 m -112.07 152.43 13.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.128 0.49 . . . . 1.3200000000000001 112.209 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.643 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 79.5 ttt180 -104.01 145.01 30.78 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.606 -0.724 . . . . 3.02 109.825 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 17.9 mt -115.1 114.33 25.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.197 -0.456 . . . . 1.1599999999999999 111.137 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 45.0 tp -105.63 102.21 11.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.407 -0.36 . . . . 1.1000000000000001 110.448 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.4 162.0 31.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 1.1100000000000001 111.388 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.2 tt -110.34 139.25 34.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.95 -0.568 . . . . 1.1399999999999999 110.934 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 18.8 tpt180 . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.085 -0.507 . . . . 2.7000000000000002 110.924 179.99 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 48.0 t . . . . . 0 C--O 1.233 0.203 0 CA-C-O 120.905 0.383 . . . . 1.26 110.787 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 70.9 mt -81.36 122.03 26.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.98 -0.555 . . . . 1.49 110.313 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -113.56 143.33 44.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.298 -0.41 . . . . 3.0899999999999999 111.055 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 77.7 p -142.31 127.0 18.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.447 . . . . 1.79 111.09 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 19.5 t -118.36 143.86 28.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.078 -0.51 . . . . 1.26 110.699 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -96.74 114.55 26.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.946 0.403 . . . . 1.74 111.369 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.542 HD12 ' HB2' ' A' ' 60' ' ' ASP . 4.5 mm? -115.47 166.56 11.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.812 -0.631 . . . . 1.4099999999999999 110.558 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.569 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 43.4 p90 -157.8 132.89 8.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.292 -0.413 . . . . 2.6600000000000001 110.979 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.456 ' HB2' HD22 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -112.83 127.43 56.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.452 . . . . 3.5899999999999999 110.599 179.718 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -125.29 -8.63 6.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 2.5800000000000001 110.892 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -91.99 156.71 17.24 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.105 -0.498 . . . . 4.1900000000000004 110.74 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -87.37 34.09 0.69 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 2.8700000000000001 110.748 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 72.0 p -86.07 -21.41 27.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.964 -0.562 . . . . 1.74 111.091 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 55.7 m 58.32 17.62 4.86 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.893 -0.594 . . . . 2.79 111.398 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 54.5 m -127.84 142.42 51.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.853 0.359 . . . . 1.79 111.036 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.456 HD22 ' HB2' ' A' ' 20' ' ' ARG . 95.4 mt -113.4 -13.05 12.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.086 -0.507 . . . . 1.1299999999999999 110.902 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.415 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 91.53 30.78 10.19 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.802 -0.714 . . . . 0.52000000000000002 113.188 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.43 ' HB ' HD11 ' A' ' 89' ' ' LEU . 42.2 mm -101.6 113.31 37.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.676 0.274 . . . . 1.53 111.219 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 36.7 t -109.82 97.75 7.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.262 -0.426 . . . . 1.4099999999999999 110.765 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 23.6 pt -86.23 154.0 3.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 1.1799999999999999 111.18 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 48.3 t -131.27 139.17 49.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.091 -0.504 . . . . 1.79 110.873 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 C-N-CA 120.768 -0.73 . . . . 1.04 112.538 179.924 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.467 HG23 HG11 ' A' ' 85' ' ' VAL . 42.1 mm . . . . . 0 C--O 1.233 0.187 0 CA-C-O 120.893 0.378 . . . . 1.28 110.903 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -117.98 137.06 53.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.11 -0.496 . . . . 1.0800000000000001 110.868 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.9 t -66.92 110.47 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.083 -0.508 . . . . 1.0600000000000001 110.793 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -86.57 -28.87 23.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.0 -0.545 . . . . 2.8900000000000001 110.876 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 75.9 p -153.62 168.19 27.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.003 0.43 . . . . 1.8700000000000001 111.292 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.442 HD11 HG23 ' A' ' 63' ' ' ILE . 87.8 mt -123.76 165.03 17.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.849 -0.614 . . . . 1.1899999999999999 110.865 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.415 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 43.8 mm -112.01 107.95 55.69 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.079 -0.51 . . . . 1.8500000000000001 110.971 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -60.59 132.32 42.51 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.417 2.078 . . . . 1.26 112.276 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.73 -9.44 40.68 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.813 -0.708 . . . . 0.52000000000000002 112.57 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.41 ' OG ' ' HA3' ' A' ' 28' ' ' GLY . 97.0 p -91.91 -173.2 3.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.778 0.323 . . . . 1.73 111.03 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.95 -52.41 20.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.282 -0.417 . . . . 1.1299999999999999 111.251 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.415 ' HA ' HD12 ' A' ' 18' ' ' LEU . . . -57.53 -42.74 83.48 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.161 -0.472 . . . . 1.0900000000000001 111.555 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.71 -52.93 47.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.278 -0.419 . . . . 1.1100000000000001 111.729 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.3 mt -64.03 -19.69 65.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.398 -0.365 . . . . 1.29 111.424 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.542 ' HB2' HD12 ' A' ' 18' ' ' LEU . 14.3 t70 -57.27 -48.77 78.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.406 -0.361 . . . . 1.8600000000000001 110.863 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.63 -42.15 2.26 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.8 -0.714 . . . . 1.4199999999999999 112.86 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 67.9 mtp180 -70.38 -20.98 62.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.657 0.265 . . . . 3.0499999999999998 111.18 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.442 HG23 HD11 ' A' ' 51' ' ' LEU . 41.3 mm -72.99 134.08 30.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.816 0.341 . . . . 1.6299999999999999 110.833 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -129.77 136.71 29.5 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.105 -0.498 . . . . 1.98 110.707 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.18 168.27 16.26 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.394 2.063 . . . . 1.4399999999999999 112.22 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 63.0 t30 61.89 56.45 2.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.023 -0.535 . . . . 2.6299999999999999 110.614 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -131.92 149.93 52.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.971 -0.559 . . . . 2.02 110.683 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -96.58 117.38 30.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.342 -0.39 . . . . 1.6200000000000001 111.218 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.551 HD11 ' HB3' ' A' ' 100' ' ' LEU . 46.5 mm -78.0 136.35 24.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 1.1100000000000001 110.714 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.511 HD11 ' HB ' ' A' ' 101' ' ' ILE . 82.6 mt -107.34 -60.19 1.72 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.122 -0.49 . . . . 1.1299999999999999 110.788 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -154.32 137.18 15.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.169 0.509 . . . . 3.1499999999999999 111.377 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.593 HG12 ' H ' ' A' ' 73' ' ' ASP . 2.4 t -87.4 175.85 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.606 -0.724 . . . . 1.0900000000000001 110.138 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.606 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 24.2 t70 -49.91 110.09 0.35 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.874 0.369 . . . . 0.79000000000000004 111.642 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 56.84 23.85 8.55 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.034 -0.53 . . . . 2.0099999999999998 111.801 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.6 t -142.37 144.4 24.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.437 -0.347 . . . . 1.1499999999999999 110.788 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -112.65 138.18 49.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.484 -0.325 . . . . 2.8500000000000001 110.809 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.0 m -119.91 24.62 4.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.89 0.376 . . . . 1.26 111.212 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -95.41 44.85 1.09 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.093 -0.503 . . . . 1.74 110.908 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 164.66 24.95 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.612 -0.804 . . . . 0.57999999999999996 112.672 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 38.9 mtm -124.01 142.23 51.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.714 0.292 . . . . 1.1200000000000001 110.721 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.11 163.12 15.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.268 -0.423 . . . . 1.1200000000000001 111.041 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -48.83 -52.54 23.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.205 -0.452 . . . . 1.52 111.343 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 80.1 p -54.13 -42.23 69.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.116 -0.493 . . . . 2.0299999999999998 111.534 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -62.24 -43.91 97.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.47 -0.332 . . . . 2.1200000000000001 111.471 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.467 HG11 HG23 ' A' ' 46' ' ' ILE . 21.7 t -61.48 -43.82 97.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.855 0.359 . . . . 1.0800000000000001 111.175 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 59.4 t -59.88 -41.02 84.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.069 -0.514 . . . . 1.0700000000000001 111.154 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.48 ' HG2' HH21 ' A' ' 90' ' ' ARG . 44.0 mt-10 -59.46 -44.45 92.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 1.51 110.967 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 71.8 t -57.82 -57.39 10.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 1.0600000000000001 111.574 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.43 HD11 ' HB ' ' A' ' 29' ' ' ILE . 86.8 mt -52.24 -34.93 48.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.049 -0.523 . . . . 1.1399999999999999 111.376 -179.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.48 HH21 ' HG2' ' A' ' 87' ' ' GLU . 65.1 mtm180 -78.09 -29.12 48.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.39 -0.368 . . . . 2.5600000000000001 111.011 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -71.03 -22.58 62.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 1.8100000000000001 110.852 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.06 -86.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.115 -0.493 . . . . 1.1100000000000001 111.279 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.449 ' HA2' ' HG2' ' A' ' 20' ' ' ARG . . . 60.76 17.04 48.61 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.676 -0.773 . . . . 0.77000000000000002 112.472 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.473 ' HB3' ' HD2' ' A' ' 95' ' ' PRO . 2.4 m120 -147.52 175.13 2.88 Favored Pre-proline 0 CA--C 1.533 0.297 0 C-N-CA 122.001 0.121 . . . . 3.3300000000000001 110.909 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.569 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 50.8 Cg_exo -56.28 104.93 0.15 Allowed 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 122.121 1.88 . . . . 0.92000000000000004 111.762 178.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 30.5 m -125.45 150.31 30.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.027 0.441 . . . . 1.3200000000000001 111.896 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.606 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 77.2 ttt180 -98.05 145.33 26.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.714 -0.675 . . . . 3.02 109.856 179.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 16.0 mt -119.89 125.33 48.21 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.329 -0.396 . . . . 1.1599999999999999 111.247 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 50.8 tp -112.78 100.03 8.36 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.404 -0.362 . . . . 1.1000000000000001 110.723 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.551 ' HB3' HD11 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -124.39 141.65 51.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.961 -0.563 . . . . 1.1100000000000001 111.184 -179.897 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.511 ' HB ' HD11 ' A' ' 70' ' ' LEU . 15.0 tt -97.31 141.93 15.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.469 . . . . 1.1399999999999999 111.126 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.031 -0.531 . . . . 2.7000000000000002 110.839 179.933 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 46.8 t . . . . . 0 C--O 1.233 0.217 0 CA-C-O 120.749 0.309 . . . . 1.26 110.824 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 62.2 mt -78.87 121.25 24.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.113 -0.494 . . . . 1.49 110.772 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -114.88 129.15 56.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.038 0.447 . . . . 3.0899999999999999 111.194 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 48.4 t -101.36 137.17 40.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.843 -0.617 . . . . 1.79 111.084 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.1 t -131.28 158.38 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.047 -0.524 . . . . 1.26 110.526 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -136.35 112.93 10.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.827 0.346 . . . . 1.74 111.257 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.504 HD11 ' HB2' ' A' ' 56' ' ' ALA . 4.0 mm? -122.88 166.64 14.7 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.084 -0.507 . . . . 1.4099999999999999 110.737 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.545 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 34.1 p90 -141.18 131.26 24.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.289 -0.414 . . . . 2.6600000000000001 111.019 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.514 HH21 ' HG ' ' A' ' 27' ' ' LEU . 14.5 ttm180 -102.48 93.53 5.2 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.38 -0.373 . . . . 3.5899999999999999 110.91 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -130.08 -0.08 4.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.35 -0.387 . . . . 2.5800000000000001 110.824 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -88.25 161.09 17.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.067 -0.515 . . . . 4.1900000000000004 110.881 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -84.46 39.72 0.74 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.14 -0.482 . . . . 2.8700000000000001 110.865 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 71.5 p -98.06 -19.48 17.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.281 -0.418 . . . . 1.74 111.175 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 29.3 t 56.83 17.39 3.21 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.0 -0.545 . . . . 2.79 111.194 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.8 m -151.95 153.74 34.69 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.294 -0.412 . . . . 1.79 110.947 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.514 ' HG ' HH21 ' A' ' 20' ' ' ARG . 58.2 mt -102.88 -20.65 14.2 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.134 -0.485 . . . . 1.1299999999999999 110.837 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.472 ' HA3' ' HG ' ' A' ' 55' ' ' SER . . . 101.8 3.69 52.19 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.767 -0.73 . . . . 0.52000000000000002 112.742 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 44.9 mm -76.27 109.01 9.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.729 0.299 . . . . 1.53 111.044 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 44.4 t -110.75 92.8 4.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.341 -0.391 . . . . 1.4099999999999999 110.82 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 26.7 pt -91.01 167.8 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.968 -0.56 . . . . 1.1799999999999999 111.22 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 77.8 p -137.95 142.26 40.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.02 -0.536 . . . . 1.79 110.853 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.247 0 C-N-CA 120.873 -0.679 . . . . 1.04 112.516 -179.998 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 44.3 mm . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.712 0.291 . . . . 1.28 110.804 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -148.48 144.99 27.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.337 -0.392 . . . . 1.0800000000000001 111.117 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 97.1 t -83.37 126.17 40.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.029 -0.532 . . . . 1.0600000000000001 110.649 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -107.32 -21.95 12.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 2.8900000000000001 110.912 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 76.9 p -152.39 169.64 22.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 1.8700000000000001 111.2 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 67.8 mt -134.59 165.5 25.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.941 -0.572 . . . . 1.1899999999999999 110.771 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.47 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 47.5 mm -107.6 99.21 27.79 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 1.8500000000000001 110.877 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -49.69 141.17 27.93 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.564 2.176 . . . . 1.26 112.652 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 95.66 -22.93 36.41 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.88 -0.676 . . . . 0.52000000000000002 112.562 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.472 ' HG ' ' HA3' ' A' ' 28' ' ' GLY . 83.6 p -76.3 -178.19 4.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.733 0.301 . . . . 1.73 111.059 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.504 ' HB2' HD11 ' A' ' 18' ' ' LEU . . . -66.15 -56.87 9.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.316 -0.402 . . . . 1.1299999999999999 111.229 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.11 -34.46 66.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.458 . . . . 1.0900000000000001 111.314 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.14 -43.05 71.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.28 -0.418 . . . . 1.1100000000000001 111.288 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.4 mt -67.93 -19.62 65.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.257 -0.428 . . . . 1.29 111.118 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -57.33 -46.88 82.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.444 -0.343 . . . . 1.8600000000000001 110.891 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.61 -50.32 1.81 Allowed Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.77 -0.729 . . . . 1.4199999999999999 112.87 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 66.4 mtm180 -64.08 -42.55 96.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.634 0.254 . . . . 3.0499999999999998 111.017 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 61.5 mt -63.86 114.4 2.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.369 -0.378 . . . . 1.6299999999999999 110.962 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -130.5 158.56 74.19 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 1.98 111.179 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -55.0 174.73 0.19 Allowed 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.734 2.29 . . . . 1.4399999999999999 112.211 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 17.4 m120 61.66 35.58 17.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.195 -0.457 . . . . 2.6299999999999999 111.122 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -112.96 152.71 29.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.152 -0.476 . . . . 2.02 110.649 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -116.02 105.81 13.06 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.83 0.347 . . . . 1.6200000000000001 111.138 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 44.1 mm -63.7 131.82 29.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.195 -0.457 . . . . 1.1100000000000001 110.983 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.554 ' HA ' HE21 ' A' ' 78' ' ' GLN . 66.9 mt -102.37 -65.69 0.97 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.134 -0.484 . . . . 1.1299999999999999 110.802 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -146.84 135.31 21.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.988 -0.551 . . . . 3.1499999999999999 111.296 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.55 HG11 ' H ' ' A' ' 73' ' ' ASP . 3.7 t -87.99 175.22 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.622 -0.717 . . . . 1.0900000000000001 109.983 179.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.628 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 21.3 t70 -48.63 109.28 0.23 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.803 0.335 . . . . 0.79000000000000004 111.586 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 56.15 26.37 10.16 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.113 -0.494 . . . . 2.0099999999999998 111.853 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.5 t -145.6 149.26 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.406 -0.361 . . . . 1.1499999999999999 110.777 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -119.06 131.72 55.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.32 -0.4 . . . . 2.8500000000000001 110.459 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.0 m -105.25 26.43 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.879 0.371 . . . . 1.26 111.287 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.554 HE21 ' HA ' ' A' ' 70' ' ' LEU . 84.8 mm-40 -94.93 23.79 5.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.096 -0.502 . . . . 1.74 111.114 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -172.79 17.06 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.641 -0.79 . . . . 0.57999999999999996 112.8 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 38.6 mtm -118.05 135.9 53.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.831 0.348 . . . . 1.1200000000000001 110.849 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.91 160.08 18.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.436 . . . . 1.1200000000000001 111.097 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -48.25 -54.21 14.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.374 -0.376 . . . . 1.52 111.249 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 46.1 t -53.88 -32.84 54.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.327 -0.397 . . . . 2.0299999999999998 111.244 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.408 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 10.4 t70 -73.35 -40.13 64.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.366 -0.379 . . . . 2.1200000000000001 111.0 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 25.8 t -65.12 -30.32 49.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.961 0.41 . . . . 1.0800000000000001 110.661 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 97.5 t -70.94 -49.27 51.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.985 -0.552 . . . . 1.0700000000000001 111.187 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.408 ' HG2' ' O ' ' A' ' 84' ' ' ASP . 11.4 pt-20 -60.44 -30.01 69.37 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.722 0.296 . . . . 1.51 110.752 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 50.2 t -65.27 -56.66 14.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.893 0.378 . . . . 1.0600000000000001 110.825 179.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 93.5 mt -54.93 -35.19 63.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.957 -0.565 . . . . 1.1399999999999999 111.378 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.455 ' HA ' ' NH1' ' A' ' 20' ' ' ARG . 86.9 mtm180 -76.96 -34.32 57.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.424 -0.353 . . . . 2.5600000000000001 111.17 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.29 -18.36 63.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.436 -0.347 . . . . 1.8100000000000001 110.682 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.43 -84.51 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.133 -0.485 . . . . 1.1100000000000001 111.464 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.403 ' H ' ' HD2' ' A' ' 20' ' ' ARG . . . 63.63 22.2 65.75 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.692 -0.766 . . . . 0.77000000000000002 112.186 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -147.17 169.81 8.77 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 110.39 -0.226 . . . . 3.3300000000000001 110.39 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.545 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 33.3 Cg_exo -60.79 93.02 0.1 OUTLIER 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.055 1.837 . . . . 0.92000000000000004 111.248 178.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.5 m -101.79 145.64 11.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.085 0.469 . . . . 1.3200000000000001 111.918 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.628 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 60.4 ttp180 -91.88 136.44 33.16 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.694 -0.685 . . . . 3.02 110.157 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 65.5 mt -111.65 103.74 12.06 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.975 -0.557 . . . . 1.1599999999999999 111.187 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 21.4 tp -97.51 106.77 19.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.889 0.376 . . . . 1.1000000000000001 110.158 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.96 164.93 26.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 1.1100000000000001 111.434 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 12.4 tt -110.34 133.75 54.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.031 -0.532 . . . . 1.1399999999999999 111.033 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 18.2 mmm180 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 115.968 -0.56 . . . . 2.7000000000000002 110.508 179.996 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.9 t . . . . . 0 CA--C 1.527 0.088 0 CA-C-O 120.669 0.271 . . . . 1.26 110.685 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 56.0 mt -81.65 122.56 27.77 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.293 -0.412 . . . . 1.49 111.166 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -121.15 130.58 53.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.066 -0.515 . . . . 3.0899999999999999 110.84 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 47.6 t -125.57 132.9 52.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.31 -0.405 . . . . 1.79 111.214 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 18.3 t -131.13 151.29 35.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.968 -0.56 . . . . 1.26 110.606 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -101.2 118.71 37.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.958 0.408 . . . . 1.74 111.446 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.468 HD13 ' HB2' ' A' ' 60' ' ' ASP . 4.3 mm? -122.23 166.45 14.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.945 -0.57 . . . . 1.4099999999999999 110.191 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.566 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 36.9 p90 -141.86 131.83 24.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.85 0.357 . . . . 2.6600000000000001 111.078 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.405 ' HB2' HD22 ' A' ' 27' ' ' LEU . 3.2 tmm_? -100.83 104.82 16.06 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.21 -0.45 . . . . 3.5899999999999999 110.712 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -146.43 8.88 1.05 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.311 -0.404 . . . . 2.5800000000000001 110.953 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -89.75 162.75 15.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.253 -0.431 . . . . 4.1900000000000004 110.958 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -84.05 34.13 0.5 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.108 -0.497 . . . . 2.8700000000000001 110.958 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 51.6 p -98.1 -8.96 26.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.182 -0.463 . . . . 1.74 110.881 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.7 t 58.35 15.92 3.75 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.829 -0.623 . . . . 2.79 111.098 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 57.3 m -158.04 -176.96 6.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.262 -0.426 . . . . 1.79 110.902 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.405 HD22 ' HB2' ' A' ' 20' ' ' ARG . 37.4 mt -115.28 -5.1 12.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.042 -0.526 . . . . 1.1299999999999999 110.794 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.456 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 94.82 6.27 60.71 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.779 -0.724 . . . . 0.52000000000000002 112.171 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 25.0 mm -79.61 109.24 14.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.817 0.341 . . . . 1.53 110.958 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.481 ' HB2' ' HG ' ' A' ' 50' ' ' SER . 49.7 m -113.33 93.35 4.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.176 -0.465 . . . . 1.4099999999999999 110.796 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 44.6 pt -93.03 163.3 2.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 1.1799999999999999 111.2 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 45.3 t -119.08 130.66 55.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.259 -0.428 . . . . 1.79 110.792 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.237 0 C-N-CA 120.849 -0.691 . . . . 1.04 112.623 -179.973 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 49.7 mm . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.719 0.295 . . . . 1.28 110.895 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -143.59 137.67 28.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 1.0800000000000001 111.094 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 99.4 t -68.08 127.81 30.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.113 -0.494 . . . . 1.0600000000000001 111.051 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -99.96 -30.58 11.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.912 -0.586 . . . . 2.8900000000000001 110.999 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.481 ' HG ' ' HB2' ' A' ' 30' ' ' SER . 80.1 p -157.17 171.62 20.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.894 0.378 . . . . 1.8700000000000001 111.296 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 63.6 mt -129.26 140.55 51.4 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.921 -0.582 . . . . 1.1899999999999999 110.88 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.456 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 49.5 mm -77.15 118.0 68.95 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 116.21 -0.45 . . . . 1.8500000000000001 110.899 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -68.25 109.43 1.99 Allowed 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.268 1.979 . . . . 1.26 112.255 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 126.93 -5.46 7.39 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.849 -0.691 . . . . 0.52000000000000002 112.448 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.8 m -94.07 -174.83 3.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.709 0.29 . . . . 1.73 111.086 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.441 ' HB1' HD12 ' A' ' 18' ' ' LEU . . . -72.48 -42.8 64.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.379 -0.373 . . . . 1.1299999999999999 111.348 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.98 -42.57 99.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.298 -0.41 . . . . 1.0900000000000001 111.451 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.03 -55.24 11.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 1.1100000000000001 111.317 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.3 mt -59.25 -19.67 47.75 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.3 -0.409 . . . . 1.29 111.23 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.468 ' HB2' HD13 ' A' ' 18' ' ' LEU . 18.8 t70 -59.96 -49.74 76.5 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.837 0.351 . . . . 1.8600000000000001 110.746 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 98.71 -49.73 1.27 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.905 -0.664 . . . . 1.4199999999999999 112.987 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 51.3 mtp180 -60.33 -45.09 94.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.749 0.309 . . . . 3.0499999999999998 111.134 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 71.9 mt -67.59 114.18 4.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.906 0.384 . . . . 1.6299999999999999 111.111 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -117.29 139.75 26.41 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.025 -0.534 . . . . 1.98 110.568 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -47.62 167.18 0.09 OUTLIER 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.557 2.171 . . . . 1.4399999999999999 112.73 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 63.97 60.78 0.99 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.094 -0.503 . . . . 2.6299999999999999 110.554 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -134.28 156.66 48.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.788 -0.642 . . . . 2.02 110.579 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -109.47 113.29 25.96 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.867 0.365 . . . . 1.6200000000000001 111.073 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 34.2 mm -74.05 143.36 13.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.076 -0.511 . . . . 1.1100000000000001 110.857 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 74.7 mt -116.17 -66.51 1.08 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.312 -0.404 . . . . 1.1299999999999999 111.392 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.457 ' HG2' HD21 ' A' ' 76' ' ' ASN . 76.8 mtp180 -140.22 142.45 35.83 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.041 0.448 . . . . 3.1499999999999999 111.558 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.576 HG12 ' H ' ' A' ' 73' ' ' ASP . 3.6 t -100.83 174.48 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.871 -0.604 . . . . 1.0900000000000001 109.788 179.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.688 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 12.7 t70 -49.76 108.66 0.22 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.727 0.299 . . . . 0.79000000000000004 111.191 179.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 55.21 29.7 13.23 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.198 -0.455 . . . . 2.0099999999999998 111.542 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.482 ' HB ' ' HB ' ' A' ' 72' ' ' VAL . 92.4 t -145.36 151.78 14.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.417 -0.356 . . . . 1.1499999999999999 110.947 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.457 HD21 ' HG2' ' A' ' 71' ' ' ARG . 2.7 t-20 -120.66 126.1 49.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.32 -0.4 . . . . 2.8500000000000001 110.565 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.9 m -107.56 19.84 5.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 111.708 0.262 . . . . 1.26 111.708 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.406 ' HG2' HD22 ' A' ' 76' ' ' ASN . 14.0 mm100 -94.26 21.72 6.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.92 0.39 . . . . 1.74 110.465 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -161.68 13.09 0.14 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.004 -0.617 . . . . 0.57999999999999996 112.429 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 52.9 mtm -118.83 144.65 46.22 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.859 0.361 . . . . 1.1200000000000001 110.825 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.87 168.02 18.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.12 -0.491 . . . . 1.1200000000000001 111.086 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.406 ' O ' HG23 ' A' ' 86' ' ' VAL . 63.0 tt0 -49.5 -56.43 9.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.138 -0.483 . . . . 1.52 111.447 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 54.6 m -51.38 -43.31 61.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 2.0299999999999998 111.837 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -60.68 -50.53 73.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.465 -0.334 . . . . 2.1200000000000001 111.507 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 25.7 t -57.86 -36.46 55.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.293 -0.412 . . . . 1.0800000000000001 111.327 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 82' ' ' GLN . 90.6 t -62.54 -48.95 85.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.36 -0.382 . . . . 1.0700000000000001 111.391 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -56.73 -41.46 77.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.339 -0.392 . . . . 1.51 111.143 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 75.1 t -57.33 -58.96 3.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.255 -0.43 . . . . 1.0600000000000001 111.696 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 86.5 mt -54.22 -32.16 55.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 1.1399999999999999 111.58 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 82.6 mtm180 -81.47 -23.47 37.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.503 -0.317 . . . . 2.5600000000000001 111.276 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -84.14 -14.26 50.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.34 -0.391 . . . . 1.8100000000000001 110.955 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.03 -81.61 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.162 -0.472 . . . . 1.1100000000000001 111.49 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 63.84 15.29 57.72 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 120.625 -0.797 . . . . 0.77000000000000002 112.253 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -146.85 167.94 12.57 Favored Pre-proline 0 C--N 1.329 -0.303 0 N-CA-C 110.333 -0.247 . . . . 3.3300000000000001 110.333 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.566 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 34.3 Cg_exo -61.94 98.38 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.051 1.834 . . . . 0.92000000000000004 111.338 178.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.6 m -104.44 153.67 6.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.129 0.49 . . . . 1.3200000000000001 112.108 -178.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.688 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 40.3 ttm180 -93.04 141.26 28.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.459 -0.791 . . . . 3.02 110.063 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.447 HD11 HD21 ' A' ' 18' ' ' LEU . 48.9 mt -117.37 103.58 10.28 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.149 -0.478 . . . . 1.1599999999999999 110.848 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 58.5 tp -99.29 99.63 10.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 1.1000000000000001 110.34 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.2 165.86 20.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 1.1100000000000001 111.093 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.9 tt -114.33 130.23 68.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-O 121.096 0.474 . . . . 1.1399999999999999 111.447 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 23.0 mmm180 . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 115.443 -0.799 . . . . 2.7000000000000002 110.642 179.818 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 46.6 t . . . . . 0 C--O 1.233 0.205 0 CA-C-O 120.796 0.331 . . . . 1.26 110.788 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -84.77 126.09 33.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 1.49 111.211 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -121.16 136.09 55.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.897 -0.592 . . . . 3.0899999999999999 110.586 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 49.4 m -136.75 127.57 27.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.284 -0.416 . . . . 1.79 111.205 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 28.3 t -129.86 145.98 34.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.986 -0.552 . . . . 1.26 110.61 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -107.92 117.51 34.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.949 0.404 . . . . 1.74 111.311 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.493 HD12 ' HB2' ' A' ' 60' ' ' ASP . 4.3 mm? -111.05 166.46 11.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.855 -0.611 . . . . 1.4099999999999999 110.763 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.556 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 28.6 p90 -152.95 132.47 12.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.388 -0.369 . . . . 2.6600000000000001 111.084 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.555 HH21 ' H ' ' A' ' 93' ' ' GLY . 24.2 ttp180 -122.37 156.2 34.46 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.271 -0.422 . . . . 3.5899999999999999 110.637 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -169.39 26.45 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.311 -0.404 . . . . 2.5800000000000001 110.84 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -116.78 164.7 14.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.176 -0.466 . . . . 4.1900000000000004 110.91 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -87.58 25.99 1.36 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.999 -0.546 . . . . 2.8700000000000001 111.007 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.4 p -78.26 -23.94 47.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.927 0.394 . . . . 1.74 110.902 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 59.2 m 56.59 21.75 6.05 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.683 -0.69 . . . . 2.79 111.339 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.7 m -140.03 144.69 37.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.287 -0.415 . . . . 1.79 111.058 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 41.4 mt -113.56 12.48 18.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.125 -0.489 . . . . 1.1299999999999999 110.91 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.463 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 58.29 37.54 87.49 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.833 -0.699 . . . . 0.52000000000000002 112.715 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 65.9 mt -109.51 109.48 28.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.791 0.329 . . . . 1.53 111.144 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 39.5 t -105.64 112.24 25.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.072 -0.513 . . . . 1.4099999999999999 110.633 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 37.1 pt -107.84 167.13 3.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 1.1799999999999999 111.509 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 56.8 m -141.56 134.89 29.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.965 -0.561 . . . . 1.79 110.623 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 C-N-CA 120.754 -0.736 . . . . 1.04 112.598 -179.897 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.3 mm . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.728 0.299 . . . . 1.28 110.648 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -128.48 142.36 51.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.258 -0.428 . . . . 1.0800000000000001 111.22 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 86.3 t -76.9 113.02 15.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.11 -0.496 . . . . 1.0600000000000001 110.47 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -88.35 -29.41 20.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.276 -0.42 . . . . 2.8900000000000001 111.331 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 78.4 p -153.35 176.82 11.56 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.936 0.398 . . . . 1.8700000000000001 111.377 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 69.8 mt -135.58 153.45 51.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.933 -0.576 . . . . 1.1899999999999999 110.882 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.463 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 57.7 mt -90.33 109.71 35.54 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.312 -0.404 . . . . 1.8500000000000001 110.947 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -57.73 124.95 17.23 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.426 2.084 . . . . 1.26 112.331 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.93 -3.86 31.92 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.774 -0.727 . . . . 0.52000000000000002 112.498 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.9 t -100.09 177.86 4.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.743 0.306 . . . . 1.73 110.94 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.48 -58.34 8.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.263 -0.426 . . . . 1.1299999999999999 111.755 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.46 -49.83 66.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.225 -0.443 . . . . 1.0900000000000001 111.844 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.75 -39.45 80.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.385 -0.37 . . . . 1.1100000000000001 111.876 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 81.1 mt -70.75 -23.0 62.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.503 -0.317 . . . . 1.29 111.319 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.493 ' HB2' HD12 ' A' ' 18' ' ' LEU . 15.2 t70 -60.51 -56.23 23.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.829 0.347 . . . . 1.8600000000000001 110.862 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 98.35 -46.34 1.56 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.828 -0.701 . . . . 1.4199999999999999 113.159 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 38.0 mtp180 -60.54 -26.88 67.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.63 0.252 . . . . 3.0499999999999998 111.513 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 70.7 mt -73.06 102.24 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.946 0.403 . . . . 1.6299999999999999 111.04 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -93.98 136.18 23.99 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.001 -0.545 . . . . 1.98 110.574 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.46 171.89 1.68 Allowed 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.41 2.074 . . . . 1.4399999999999999 112.34 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 58.97 29.35 18.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.992 -0.549 . . . . 2.6299999999999999 110.902 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.427 ' OD1' ' HB2' ' A' ' 100' ' ' LEU . 11.9 t0 -102.31 140.07 37.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.046 -0.524 . . . . 2.02 110.405 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -87.32 127.83 35.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.755 0.312 . . . . 1.6200000000000001 111.202 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 39.9 mm -90.56 136.56 23.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.287 -0.415 . . . . 1.1100000000000001 110.672 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 89.5 mt -107.29 -64.38 1.2 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.326 -0.397 . . . . 1.1299999999999999 111.157 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -147.75 135.12 20.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.074 0.464 . . . . 3.1499999999999999 111.704 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.59 HG12 ' H ' ' A' ' 73' ' ' ASP . 3.1 t -89.81 175.4 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.614 -0.721 . . . . 1.0900000000000001 110.084 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.642 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 16.6 t70 -47.24 109.21 0.19 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.721 0.296 . . . . 0.79000000000000004 111.688 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 54.36 28.77 9.85 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.095 -0.502 . . . . 2.0099999999999998 111.73 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.449 HG12 HG13 ' A' ' 88' ' ' VAL . 66.6 t -145.67 147.06 18.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.39 -0.368 . . . . 1.1499999999999999 110.714 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -116.44 128.6 55.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.26 -0.427 . . . . 2.8500000000000001 110.515 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.5 m -109.98 26.44 2.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.818 0.342 . . . . 1.26 111.353 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -97.05 24.48 6.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.451 . . . . 1.74 111.046 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -170.23 15.2 0.06 OUTLIER Glycine 0 C--N 1.329 0.194 0 C-N-CA 120.543 -0.837 . . . . 0.57999999999999996 112.768 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 47.2 mtm -117.56 142.46 47.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.852 0.358 . . . . 1.1200000000000001 110.98 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.29 165.13 14.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.091 -0.504 . . . . 1.1200000000000001 110.99 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -50.01 -56.72 9.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.315 -0.402 . . . . 1.52 111.369 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.3 t -51.89 -39.92 59.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.251 -0.431 . . . . 2.0299999999999998 111.456 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -64.29 -47.07 80.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.487 -0.324 . . . . 2.1200000000000001 111.129 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 54.3 t -58.06 -32.64 44.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.306 -0.406 . . . . 1.0800000000000001 110.886 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.401 HG13 ' NE ' ' A' ' 90' ' ' ARG . 75.0 t -68.72 -42.28 82.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.14 -0.482 . . . . 1.0700000000000001 110.957 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -56.74 -46.55 81.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.839 0.352 . . . . 1.51 110.801 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.449 HG13 HG12 ' A' ' 75' ' ' VAL . 53.0 t -59.09 -56.18 18.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.228 -0.442 . . . . 1.0600000000000001 111.011 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 82.3 mt -58.73 -22.11 56.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.916 -0.584 . . . . 1.1399999999999999 111.355 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.401 ' NE ' HG13 ' A' ' 86' ' ' VAL . 80.4 mtm180 -89.04 -21.96 23.19 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.596 -0.275 . . . . 2.5600000000000001 111.177 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -86.5 -15.69 39.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.496 -0.32 . . . . 1.8100000000000001 111.001 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.97 -87.73 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.256 -0.429 . . . . 1.1100000000000001 111.377 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.555 ' H ' HH21 ' A' ' 20' ' ' ARG . . . 61.68 21.45 60.65 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.809 -0.71 . . . . 0.77000000000000002 112.613 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.438 ' HB3' ' HD2' ' A' ' 95' ' ' PRO . 4.3 m120 -147.24 173.84 3.87 Favored Pre-proline 0 C--N 1.328 -0.345 0 C-N-CA 121.936 0.094 . . . . 3.3300000000000001 110.846 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.556 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 37.1 Cg_exo -59.15 90.82 0.07 OUTLIER 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.141 1.894 . . . . 0.92000000000000004 111.783 178.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 28.8 m -104.73 153.48 6.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 1.3200000000000001 111.937 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.642 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 52.1 ttp180 -99.23 145.12 27.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.689 -0.687 . . . . 3.02 110.282 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.438 HD11 HD23 ' A' ' 18' ' ' LEU . 46.5 mt -120.78 106.21 11.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.261 -0.427 . . . . 1.1599999999999999 111.26 -179.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 22.2 tp -99.3 107.45 19.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.389 -0.369 . . . . 1.1000000000000001 110.116 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.427 ' HB2' ' OD1' ' A' ' 67' ' ' ASP . 0.4 OUTLIER -135.36 163.3 30.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.954 0.406 . . . . 1.1100000000000001 111.539 -179.159 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 15.7 tt -120.9 141.03 43.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.927 -0.579 . . . . 1.1399999999999999 110.965 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 25.7 tpt180 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.11 -0.495 . . . . 2.7000000000000002 110.776 -179.924 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.1 t . . . . . 0 C--O 1.233 0.186 0 CA-C-O 120.765 0.317 . . . . 1.26 110.549 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 70.7 mt -84.66 122.93 29.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.182 -0.463 . . . . 1.49 111.049 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -116.71 149.19 40.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.044 -0.525 . . . . 3.0899999999999999 111.044 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.403 ' HG ' HH21 ' A' ' 97' ' ' ARG . 81.8 p -149.35 130.12 14.17 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.187 -0.461 . . . . 1.79 111.121 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 19.0 t -125.55 153.25 33.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 1.26 110.577 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -101.36 117.93 35.95 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.9 0.381 . . . . 1.74 111.692 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -114.14 166.27 11.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.874 -0.603 . . . . 1.4099999999999999 110.375 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.552 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 42.3 p90 -156.93 137.03 12.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.714 0.292 . . . . 2.6600000000000001 111.305 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.435 HH22 ' HA ' ' A' ' 90' ' ' ARG . 21.3 ttp180 -129.96 153.22 48.58 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.313 -0.403 . . . . 3.5899999999999999 111.1 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -155.69 -34.49 0.09 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.048 -0.523 . . . . 2.5800000000000001 111.054 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -59.92 164.18 4.08 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.09 -0.505 . . . . 4.1900000000000004 110.936 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -93.96 33.98 1.28 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 2.8700000000000001 110.994 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 74.6 p -78.6 -13.34 59.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.277 -0.419 . . . . 1.74 111.136 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 97.2 p 50.22 24.09 1.37 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.615 -0.721 . . . . 2.79 111.605 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 47.7 t -141.84 135.37 29.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.841 0.353 . . . . 1.79 111.03 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 19.0 mt -103.45 -20.64 13.98 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.136 -0.483 . . . . 1.1299999999999999 110.951 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.44 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 97.88 10.89 51.59 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.785 -0.721 . . . . 0.52000000000000002 112.579 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 67.3 mt -94.03 110.69 23.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.721 0.296 . . . . 1.53 111.139 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 46.5 t -112.42 114.21 26.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.244 -0.434 . . . . 1.4099999999999999 110.72 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 43.0 pt -100.55 177.84 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.241 -0.436 . . . . 1.1799999999999999 111.287 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 62.8 m -158.0 132.38 8.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.882 -0.599 . . . . 1.79 110.636 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 C-N-CA 120.634 -0.793 . . . . 1.04 112.446 -179.889 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 43.9 mm . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.827 0.346 . . . . 1.28 110.982 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -139.02 138.57 37.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.164 -0.471 . . . . 1.0800000000000001 111.072 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 85.5 t -74.01 120.44 23.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.297 -0.411 . . . . 1.0600000000000001 110.822 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -99.77 -22.24 15.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 2.8900000000000001 111.254 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 84.1 p -155.88 170.04 23.01 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.058 0.456 . . . . 1.8700000000000001 111.557 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 90.6 mt -128.71 170.27 13.5 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.607 -0.724 . . . . 1.1899999999999999 110.401 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.44 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 43.1 mm -109.74 98.53 33.8 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.36 -0.382 . . . . 1.8500000000000001 111.084 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.79 111.54 0.76 Allowed 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.596 2.197 . . . . 1.26 112.312 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.15 1.9 7.85 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.794 -0.717 . . . . 0.52000000000000002 112.49 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.462 ' HG ' ' H ' ' A' ' 56' ' ' ALA . 23.0 t -112.01 -176.7 2.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.692 0.282 . . . . 1.73 110.89 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.462 ' H ' ' HG ' ' A' ' 55' ' ' SER . . . -60.15 -53.1 61.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.368 -0.378 . . . . 1.1299999999999999 111.298 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.48 -46.55 70.03 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.169 -0.468 . . . . 1.0900000000000001 111.275 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.95 -37.57 88.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.076 -0.511 . . . . 1.1100000000000001 111.262 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 82.7 mt -73.87 -19.64 60.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.89 0.376 . . . . 1.29 110.894 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.413 ' OD2' ' HB2' ' A' ' 62' ' ' ARG . 26.5 t70 -66.7 -52.04 49.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.109 -0.496 . . . . 1.8600000000000001 110.843 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 89.88 -44.49 3.0 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.846 -0.692 . . . . 1.4199999999999999 113.22 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.413 ' HB2' ' OD2' ' A' ' 60' ' ' ASP . 22.2 mmm180 -59.66 -22.32 61.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.686 0.279 . . . . 3.0499999999999998 111.126 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 52.6 mt -82.53 109.98 17.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.879 0.371 . . . . 1.6299999999999999 111.003 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -101.42 135.67 19.79 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 1.98 110.57 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -57.2 172.18 0.96 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.453 2.102 . . . . 1.4399999999999999 112.44 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 59.33 26.89 15.84 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.918 -0.583 . . . . 2.6299999999999999 111.275 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -94.5 158.87 15.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.341 -0.391 . . . . 2.02 110.645 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -107.76 124.24 49.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.77 0.319 . . . . 1.6200000000000001 110.927 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.521 HD13 ' HB3' ' A' ' 100' ' ' LEU . 45.9 mm -87.33 140.31 15.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.191 -0.459 . . . . 1.1100000000000001 110.983 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 71.6 mt -115.88 -60.58 1.85 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.206 -0.452 . . . . 1.1299999999999999 110.946 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.453 ' O ' ' HB3' ' A' ' 99' ' ' LEU . 81.2 mtt180 -144.72 138.66 27.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 3.1499999999999999 111.254 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.534 HG13 ' H ' ' A' ' 73' ' ' ASP . 4.4 t -94.13 173.82 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.963 -0.562 . . . . 1.0900000000000001 109.941 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.643 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 19.1 t70 -47.67 108.81 0.17 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.703 0.287 . . . . 0.79000000000000004 111.516 179.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 54.83 29.15 11.42 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.194 -0.457 . . . . 2.0099999999999998 111.506 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.447 ' HB ' ' HB ' ' A' ' 72' ' ' VAL . 86.5 t -145.51 151.08 15.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.047 -0.524 . . . . 1.1499999999999999 110.627 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -120.75 129.34 53.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.484 -0.325 . . . . 2.8500000000000001 110.77 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.9 m -107.35 23.84 3.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-O 120.808 0.337 . . . . 1.26 111.366 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -96.71 38.31 1.23 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.293 -0.412 . . . . 1.74 110.692 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 175.94 28.43 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.721 -0.752 . . . . 0.57999999999999996 112.76 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 60.3 mtm -132.39 141.81 49.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.93 0.395 . . . . 1.1200000000000001 110.976 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.434 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -69.05 161.85 28.15 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.994 -0.548 . . . . 1.1200000000000001 110.919 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -45.73 -57.1 4.52 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.195 -0.457 . . . . 1.52 111.638 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.4 m -50.62 -43.44 56.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.178 -0.465 . . . . 2.0299999999999998 111.565 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -63.8 -42.9 97.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.359 -0.382 . . . . 2.1200000000000001 111.471 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 81' ' ' ALA . 38.9 t -59.63 -38.73 77.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 120.857 0.361 . . . . 1.0800000000000001 110.988 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 52.4 t -66.74 -36.58 77.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.11 -0.496 . . . . 1.0700000000000001 110.968 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -60.1 -49.16 78.74 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.217 -0.447 . . . . 1.51 110.714 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.406 HG12 HG12 ' A' ' 75' ' ' VAL . 53.7 t -56.75 -53.52 40.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.082 -0.508 . . . . 1.0600000000000001 111.27 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 79.2 mt -53.89 -32.62 53.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.077 -0.51 . . . . 1.1399999999999999 111.277 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.435 ' HA ' HH22 ' A' ' 20' ' ' ARG . 85.0 mtm180 -81.64 -24.06 36.58 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.256 -0.429 . . . . 2.5600000000000001 111.115 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -78.4 -17.96 55.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.276 -0.42 . . . . 1.8100000000000001 110.835 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.68 -89.62 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.091 -0.504 . . . . 1.1100000000000001 111.474 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.427 ' H ' HH21 ' A' ' 20' ' ' ARG . . . 60.48 21.86 58.12 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.702 -0.761 . . . . 0.77000000000000002 112.429 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.427 HD21 ' HA ' ' A' ' 94' ' ' ASN . 0.1 OUTLIER -147.13 174.79 3.11 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 110.461 -0.199 . . . . 3.3300000000000001 110.461 -179.7 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.552 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 38.2 Cg_exo -59.18 97.53 0.1 OUTLIER 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.021 1.814 . . . . 0.92000000000000004 111.641 178.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 28.8 m -114.53 151.56 16.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.129 0.49 . . . . 1.3200000000000001 111.893 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.643 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 75.2 ttt180 -102.1 145.24 29.62 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.673 -0.694 . . . . 3.02 110.082 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 18.3 mt -115.49 116.18 27.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.187 -0.46 . . . . 1.1599999999999999 111.378 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.453 ' HB3' ' O ' ' A' ' 71' ' ' ARG . 63.6 tp -104.46 99.89 9.58 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.16 -0.473 . . . . 1.1000000000000001 110.261 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.521 ' HB3' HD13 ' A' ' 69' ' ' ILE . 0.5 OUTLIER -129.82 158.25 39.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.197 -0.456 . . . . 1.1100000000000001 111.394 -179.519 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.0 tt -110.37 140.39 29.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 1.1399999999999999 110.949 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.081 -0.509 . . . . 2.7000000000000002 110.942 -179.927 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.3 t . . . . . 0 C--O 1.233 0.23 0 CA-C-O 120.854 0.359 . . . . 1.26 110.891 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 79.8 mt -76.11 119.19 19.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.0 -0.545 . . . . 1.49 110.739 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -120.08 132.11 55.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 3.0899999999999999 111.0 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 79.0 p -137.34 126.94 25.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.286 -0.416 . . . . 1.79 110.972 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.17 141.53 46.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.219 -0.446 . . . . 1.26 110.952 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -96.18 116.34 28.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 1.74 111.54 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.442 HD11 ' HB2' ' A' ' 60' ' ' ASP . 4.5 mm? -114.92 166.61 11.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.98 -0.555 . . . . 1.4099999999999999 110.125 179.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.528 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 15.1 p90 -147.11 123.1 10.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.769 0.319 . . . . 2.6600000000000001 111.149 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.556 ' HB2' HD22 ' A' ' 27' ' ' LEU . 14.9 ttp180 -95.61 96.84 9.3 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.325 -0.398 . . . . 3.5899999999999999 110.687 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -107.69 -19.98 13.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.985 -0.552 . . . . 2.5800000000000001 110.672 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -82.37 148.64 28.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.954 -0.566 . . . . 4.1900000000000004 110.794 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -85.96 47.59 1.48 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.188 -0.46 . . . . 2.8700000000000001 110.974 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.428 ' HG1' ' H ' ' A' ' 26' ' ' SER . 65.1 p -87.38 -10.04 53.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.484 . . . . 1.74 111.182 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.2 t 58.05 20.3 6.76 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.988 -0.551 . . . . 2.79 111.248 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.428 ' H ' ' HG1' ' A' ' 24' ' ' THR . 60.5 m -157.47 160.95 38.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.272 -0.422 . . . . 1.79 110.965 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.556 HD22 ' HB2' ' A' ' 20' ' ' ARG . 77.2 mt -113.61 -14.66 12.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.112 -0.494 . . . . 1.1299999999999999 110.78 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.495 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 93.81 29.99 9.38 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.823 -0.703 . . . . 0.52000000000000002 112.406 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.425 HD13 HD23 ' A' ' 89' ' ' LEU . 77.7 mt -109.79 109.25 27.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.737 0.303 . . . . 1.53 111.05 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 40.0 t -111.03 100.44 9.13 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.29 -0.414 . . . . 1.4099999999999999 110.844 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 40.6 pt -92.71 179.66 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.087 -0.506 . . . . 1.1799999999999999 111.175 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 82.0 p -135.42 136.83 41.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.053 -0.521 . . . . 1.79 110.929 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.254 0 C-N-CA 120.862 -0.685 . . . . 1.04 112.434 -179.943 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.3 mm . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.801 0.334 . . . . 1.28 110.787 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.401 ' HB2' ' O ' ' A' ' 67' ' ' ASP . 27.0 p90 -145.4 145.46 31.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.322 -0.399 . . . . 1.0800000000000001 111.091 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 99.7 t -82.16 129.29 37.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.089 -0.505 . . . . 1.0600000000000001 111.061 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.2 ttpp -102.02 -24.48 13.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.996 -0.547 . . . . 2.8900000000000001 110.946 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 79.6 p -155.12 156.24 35.45 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.037 0.446 . . . . 1.8700000000000001 111.36 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 77.1 mt -114.28 162.97 15.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.775 -0.648 . . . . 1.1899999999999999 110.626 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.495 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 62.4 mt -109.7 101.97 48.43 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.367 -0.378 . . . . 1.8500000000000001 111.248 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -52.11 146.44 30.44 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.586 2.191 . . . . 1.26 112.577 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.4 -22.37 30.38 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.827 -0.701 . . . . 0.52000000000000002 112.581 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 67.4 m -80.93 -177.94 6.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.784 0.325 . . . . 1.73 111.071 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.65 -55.09 16.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.218 -0.447 . . . . 1.1299999999999999 111.472 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.63 -39.86 65.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.103 -0.499 . . . . 1.0900000000000001 111.843 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.35 -42.86 71.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.401 -0.363 . . . . 1.1100000000000001 111.438 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.0 mt -70.95 -19.67 62.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.334 -0.394 . . . . 1.29 110.992 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.442 ' HB2' HD11 ' A' ' 18' ' ' LEU . 26.0 t70 -59.52 -56.13 25.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 1.8600000000000001 110.945 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.2 -48.71 1.1 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.768 -0.73 . . . . 1.4199999999999999 112.957 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -57.4 -32.05 66.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.761 0.315 . . . . 3.0499999999999998 111.153 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 68.1 mt -76.83 127.91 37.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.304 -0.407 . . . . 1.6299999999999999 111.095 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -125.49 138.16 31.29 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 116.139 -0.482 . . . . 1.98 110.81 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_exo -52.94 165.9 1.08 Allowed 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.59 2.193 . . . . 1.4399999999999999 112.441 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 18.0 m120 60.18 45.65 11.38 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.046 -0.525 . . . . 2.6299999999999999 110.755 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' A' ' 47' ' ' TYR . 27.1 t70 -118.16 159.77 22.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.935 -0.575 . . . . 2.02 110.505 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.461 ' HB3' HG22 ' A' ' 101' ' ' ILE . 87.6 tttt -105.18 128.29 53.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.843 0.354 . . . . 1.6200000000000001 111.181 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 41.6 mm -94.9 142.18 13.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.055 -0.52 . . . . 1.1100000000000001 110.727 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 56.5 mt -111.31 -73.75 0.67 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 1.1299999999999999 111.129 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.8 ptp180 -147.29 137.85 23.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.174 0.512 . . . . 3.1499999999999999 111.779 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.539 HG11 ' H ' ' A' ' 73' ' ' ASP . 3.8 t -84.68 176.01 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.528 -0.76 . . . . 1.0900000000000001 109.771 179.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.66 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 6.6 t70 -44.25 109.0 0.13 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.17 0.434 . . . . 0.79000000000000004 112.17 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 52.39 27.87 5.29 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.443 0.535 . . . . 2.0099999999999998 112.443 178.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.406 ' O ' ' N ' ' A' ' 72' ' ' VAL . 88.1 t -148.66 140.11 17.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.725 0.298 . . . . 1.1499999999999999 110.88 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.444 ' O ' ' HE2' ' A' ' 80' ' ' MET . 25.4 m-80 -100.23 141.86 32.49 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.922 -0.399 . . . . 2.8500000000000001 109.922 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.8 m -122.59 -16.23 5.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 N-CA-C 112.104 0.409 . . . . 1.26 112.104 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -87.08 25.98 1.25 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.921 0.391 . . . . 1.74 110.886 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -141.3 1.72 1.94 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.869 -0.682 . . . . 0.57999999999999996 112.557 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.444 ' HE2' ' O ' ' A' ' 76' ' ' ASN . 51.4 mtm -123.99 172.14 9.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.748 0.309 . . . . 1.1200000000000001 110.768 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.5 168.71 14.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 1.1200000000000001 111.125 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -58.97 -47.3 85.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.44 -0.345 . . . . 1.52 110.902 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.9 m -55.46 -31.72 62.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 2.0299999999999998 111.304 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -71.98 -39.27 69.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.355 -0.384 . . . . 2.1200000000000001 111.042 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.2 t -67.75 -35.99 74.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.969 0.414 . . . . 1.0800000000000001 111.021 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.475 HG13 ' NE ' ' A' ' 90' ' ' ARG . 56.5 t -70.32 -47.22 67.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.009 -0.541 . . . . 1.0700000000000001 111.598 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -58.86 -40.75 85.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.714 -0.221 . . . . 1.51 111.085 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 52.4 t -60.04 -54.88 28.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 120.924 0.392 . . . . 1.0600000000000001 111.115 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.425 HD23 HD13 ' A' ' 29' ' ' ILE . 66.8 mt -56.83 -27.89 60.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.993 -0.549 . . . . 1.1399999999999999 111.006 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.475 ' NE ' HG13 ' A' ' 86' ' ' VAL . 76.1 mtm180 -89.24 -15.09 34.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.371 -0.377 . . . . 2.5600000000000001 111.514 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -93.47 -10.04 36.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.417 -0.356 . . . . 1.8100000000000001 111.114 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -48.9 -85.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.266 -0.425 . . . . 1.1100000000000001 111.574 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.428 ' N ' ' HE ' ' A' ' 20' ' ' ARG . . . 62.25 14.59 48.23 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.695 -0.764 . . . . 0.77000000000000002 112.556 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -146.97 169.85 8.74 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 110.54 -0.17 . . . . 3.3300000000000001 110.54 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.528 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 24.4 Cg_exo -65.13 92.26 0.21 Allowed 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.223 1.948 . . . . 0.92000000000000004 111.326 178.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 33.8 m -100.15 153.46 4.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.067 -0.515 . . . . 1.3200000000000001 111.577 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.66 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 56.2 ttp180 -102.72 138.07 40.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.969 -0.559 . . . . 3.02 109.816 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 45.4 mt -107.7 109.42 21.01 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.262 -0.426 . . . . 1.1599999999999999 111.137 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 31.7 tp -99.79 100.66 11.64 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.374 -0.375 . . . . 1.1000000000000001 110.172 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -130.37 161.95 30.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.111 -0.495 . . . . 1.1100000000000001 111.373 -179.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.461 HG22 ' HB3' ' A' ' 68' ' ' LYS . 14.2 tt -114.06 135.68 52.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.917 -0.583 . . . . 1.1399999999999999 110.862 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.003 -0.544 . . . . 2.7000000000000002 110.555 179.966 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 46.6 t . . . . . 0 C--O 1.233 0.228 0 CA-C-O 120.77 0.319 . . . . 1.26 110.78 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 62.3 mt -75.09 120.9 21.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.168 -0.469 . . . . 1.49 110.749 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -114.53 124.19 51.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.089 -0.505 . . . . 3.0899999999999999 111.328 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 44.9 t -103.27 142.75 33.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 1.79 110.79 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.4 t -136.41 158.16 37.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.238 -0.437 . . . . 1.26 110.666 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -121.93 114.34 20.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.935 0.398 . . . . 1.74 111.353 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.523 HD12 ' HB2' ' A' ' 60' ' ' ASP . 4.4 mm? -119.58 166.82 12.65 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.033 -0.53 . . . . 1.4099999999999999 110.787 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.582 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 30.1 p90 -148.8 129.45 14.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.282 -0.417 . . . . 2.6600000000000001 110.964 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.476 ' HB2' HD23 ' A' ' 27' ' ' LEU . 15.1 ttp180 -106.5 107.66 18.78 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.794 0.33 . . . . 3.5899999999999999 111.006 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -131.29 -5.67 3.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.299 -0.409 . . . . 2.5800000000000001 111.036 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -81.69 170.2 16.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.396 -0.365 . . . . 4.1900000000000004 110.874 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -93.47 30.04 1.83 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.136 -0.484 . . . . 2.8700000000000001 110.959 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 71.6 p -84.25 -14.35 50.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.45 . . . . 1.74 110.863 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 35.2 t 59.17 20.63 8.65 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.849 -0.614 . . . . 2.79 111.18 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 83.0 p -160.56 175.27 12.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.941 0.4 . . . . 1.79 110.992 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.476 HD23 ' HB2' ' A' ' 20' ' ' ARG . 33.5 mt -115.0 -10.35 12.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.827 -0.624 . . . . 1.1299999999999999 110.877 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.416 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 87.86 18.33 56.44 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.782 -0.723 . . . . 0.52000000000000002 112.754 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 70.9 mt -91.36 108.5 19.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.822 0.344 . . . . 1.53 110.847 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 41.9 t -103.14 102.66 12.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.134 -0.485 . . . . 1.4099999999999999 110.958 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.5 pt -100.34 165.68 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.82 -0.627 . . . . 1.1799999999999999 111.291 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.6 m -149.04 145.19 27.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.917 -0.583 . . . . 1.79 110.474 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 C-N-CA 120.68 -0.771 . . . . 1.04 112.598 -179.846 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 37.2 mm . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.761 0.315 . . . . 1.28 110.703 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -131.38 143.31 50.38 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.218 -0.446 . . . . 1.0800000000000001 111.201 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 84.1 t -84.54 128.6 38.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.051 -0.522 . . . . 1.0600000000000001 110.837 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -107.89 -24.1 11.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.301 -0.408 . . . . 2.8900000000000001 110.952 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.6 t -150.94 170.47 19.24 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.972 0.415 . . . . 1.8700000000000001 111.44 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 91.3 mt -135.25 157.21 47.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.816 -0.629 . . . . 1.1899999999999999 110.583 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.416 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 62.8 mt -101.46 104.05 31.3 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 1.8500000000000001 111.01 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -55.16 132.5 52.67 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.429 2.086 . . . . 1.26 112.224 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 110.55 -24.13 18.34 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.801 -0.714 . . . . 0.52000000000000002 112.544 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 63.2 m -80.91 -178.45 6.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.75 0.31 . . . . 1.73 110.921 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.74 -52.35 51.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.384 -0.371 . . . . 1.1299999999999999 111.494 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.27 -34.61 64.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.25 -0.432 . . . . 1.0900000000000001 111.616 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.79 -50.02 33.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.33 -0.395 . . . . 1.1100000000000001 111.248 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 80.7 mt -64.02 -19.7 65.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.131 -0.486 . . . . 1.29 110.988 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.523 ' HB2' HD12 ' A' ' 18' ' ' LEU . 26.6 t70 -62.05 -56.13 22.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 1.8600000000000001 110.91 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 97.42 -51.24 1.4 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.698 -0.763 . . . . 1.4199999999999999 113.01 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 84.4 mtm180 -55.98 -28.07 55.51 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.743 0.306 . . . . 3.0499999999999998 111.285 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 67.0 mt -81.05 106.25 11.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.292 -0.413 . . . . 1.6299999999999999 110.746 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -108.11 137.53 19.88 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 1.98 110.546 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -53.41 175.52 0.1 Allowed 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.57 2.18 . . . . 1.4399999999999999 112.725 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.7 m120 61.77 37.58 15.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.918 -0.583 . . . . 2.6299999999999999 110.913 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -113.15 161.93 16.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.991 -0.55 . . . . 2.02 110.553 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -110.55 116.71 31.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.822 0.344 . . . . 1.6200000000000001 111.087 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.418 HD12 ' HB3' ' A' ' 100' ' ' LEU . 42.0 mm -77.17 146.22 8.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.489 . . . . 1.1100000000000001 110.834 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 55.3 mt -123.22 -61.59 1.4 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.241 -0.436 . . . . 1.1299999999999999 111.257 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 66.8 mtp180 -144.47 142.73 30.47 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.096 0.474 . . . . 3.1499999999999999 111.808 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.533 HG11 ' H ' ' A' ' 73' ' ' ASP . 9.9 t -99.89 173.92 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.611 -0.722 . . . . 1.0900000000000001 109.582 179.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.626 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 16.8 t70 -46.82 108.44 0.14 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.711 0.291 . . . . 0.79000000000000004 111.418 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 53.32 33.84 16.54 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.18 -0.464 . . . . 2.0099999999999998 111.716 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 87.9 t -147.96 147.81 16.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.409 -0.359 . . . . 1.1499999999999999 110.842 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.526 HD22 ' HB2' ' A' ' 78' ' ' GLN . 7.1 t30 -115.44 124.89 52.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.346 -0.388 . . . . 2.8500000000000001 110.405 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.6 m -106.96 24.46 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 CA-C-O 120.783 0.325 . . . . 1.26 111.52 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.526 ' HB2' HD22 ' A' ' 76' ' ' ASN . 19.2 mm-40 -96.23 34.12 1.64 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.272 -0.422 . . . . 1.74 110.734 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 175.0 22.65 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.757 -0.735 . . . . 0.57999999999999996 112.811 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 54.6 mtm -117.98 144.42 45.54 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.873 0.368 . . . . 1.1200000000000001 110.965 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.417 ' O ' HG22 ' A' ' 85' ' ' VAL . . . -61.19 158.27 14.37 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.977 -0.556 . . . . 1.1200000000000001 111.41 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -51.41 -62.14 1.81 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.141 -0.481 . . . . 1.52 111.33 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 81.6 p -52.78 -33.53 49.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.014 -0.539 . . . . 2.0299999999999998 111.389 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -63.16 -43.46 98.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.512 -0.313 . . . . 2.1200000000000001 110.925 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.417 HG22 ' O ' ' A' ' 81' ' ' ALA . 18.2 t -61.89 -38.94 81.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.297 -0.411 . . . . 1.0800000000000001 110.605 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.1 t -63.22 -36.54 76.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.983 -0.553 . . . . 1.0700000000000001 110.991 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -63.62 -47.74 80.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.15 -0.477 . . . . 1.51 110.977 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 54.4 t -53.86 -54.23 21.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.224 -0.443 . . . . 1.0600000000000001 111.107 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 79.0 mt -57.58 -32.93 67.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 1.1399999999999999 110.94 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 85.2 mtm180 -80.6 -13.5 59.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.312 -0.404 . . . . 2.5600000000000001 111.212 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -95.62 -13.88 23.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 1.8100000000000001 110.692 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.19 -83.53 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.998 -0.547 . . . . 1.1100000000000001 111.588 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.428 ' HA2' ' HE ' ' A' ' 20' ' ' ARG . . . 62.38 15.72 52.76 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.61 -0.805 . . . . 0.77000000000000002 112.152 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -147.08 169.81 8.78 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 110.6 -0.148 . . . . 3.3300000000000001 110.6 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.582 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 32.9 Cg_exo -61.59 98.27 0.16 Allowed 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.258 1.972 . . . . 0.92000000000000004 111.429 177.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 23.6 m -106.42 150.46 9.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.082 0.467 . . . . 1.3200000000000001 111.858 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.626 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 80.9 mtp180 -97.13 140.57 31.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.811 -0.632 . . . . 3.02 110.247 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 30.3 mt -115.03 111.89 21.8 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.041 -0.527 . . . . 1.1599999999999999 110.951 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 43.3 tp -102.5 104.74 15.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 1.1000000000000001 110.75 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.418 ' HB3' HD12 ' A' ' 69' ' ' ILE . 0.4 OUTLIER -134.13 156.43 48.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.212 -0.449 . . . . 1.1100000000000001 111.045 -179.797 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 12.0 tt -104.61 136.17 39.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.23 -0.441 . . . . 1.1399999999999999 111.046 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 25.4 mmm180 . . . . . 0 C--N 1.332 -0.185 0 CA-C-N 115.866 -0.606 . . . . 2.7000000000000002 110.844 -179.986 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 46.1 t . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.887 0.375 . . . . 1.26 110.795 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 75.4 mt -79.03 121.46 24.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 1.49 110.924 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -117.31 154.53 31.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.111 -0.495 . . . . 3.0899999999999999 110.877 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 84.4 p -151.2 134.82 16.33 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.344 -0.389 . . . . 1.79 111.302 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.1 t -132.23 144.96 35.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.149 -0.478 . . . . 1.26 110.675 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -94.89 115.22 27.19 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.842 0.353 . . . . 1.74 111.59 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.51 HD12 ' HB2' ' A' ' 60' ' ' ASP . 4.3 mm? -123.24 125.47 45.13 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.986 -0.552 . . . . 1.4099999999999999 110.472 179.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.567 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 39.0 p90 -103.44 132.93 49.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.404 -0.362 . . . . 2.6600000000000001 111.21 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.575 ' HE ' ' HA2' ' A' ' 93' ' ' GLY . 19.2 ttp180 -102.31 95.26 6.18 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.881 0.372 . . . . 3.5899999999999999 110.882 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -103.01 -21.37 13.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.056 0.455 . . . . 2.5800000000000001 110.425 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.4 ' HB3' HG23 ' A' ' 24' ' ' THR . 75.0 mmtt -85.16 140.8 30.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.704 -0.68 . . . . 4.1900000000000004 110.659 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -83.37 37.4 0.56 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 2.8700000000000001 111.077 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.4 HG23 ' HB3' ' A' ' 22' ' ' LYS . 57.4 p -73.0 -11.97 60.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 1.74 110.979 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 36.5 t 59.54 15.72 4.77 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.025 -0.534 . . . . 2.79 111.014 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 53.6 m -147.97 138.09 22.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.124 -0.489 . . . . 1.79 110.971 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.434 HD21 ' HB2' ' A' ' 20' ' ' ARG . 88.2 mt -97.55 -22.98 16.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.068 -0.514 . . . . 1.1299999999999999 110.852 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.492 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 110.43 3.85 28.93 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.808 -0.71 . . . . 0.52000000000000002 112.502 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.453 ' N ' HD12 ' A' ' 29' ' ' ILE . 3.0 mp -88.23 114.93 27.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.822 0.344 . . . . 1.53 111.012 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 45.0 t -111.89 93.32 4.4 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.103 -0.499 . . . . 1.4099999999999999 110.522 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.477 ' HA ' ' HA ' ' A' ' 48' ' ' VAL . 44.6 pt -87.87 164.18 2.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.101 -0.499 . . . . 1.1799999999999999 111.432 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 56.3 m -143.47 134.61 25.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.773 -0.649 . . . . 1.79 110.415 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.225 0 C-N-CA 120.614 -0.803 . . . . 1.04 112.816 -179.567 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 43.8 mm . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.779 0.323 . . . . 1.28 110.901 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -140.17 137.37 34.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 1.0800000000000001 111.104 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.477 ' HA ' ' HA ' ' A' ' 31' ' ' ILE . 58.3 t -77.63 139.26 18.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.991 -0.55 . . . . 1.0600000000000001 110.852 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -120.58 -28.46 4.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 2.8900000000000001 111.116 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 56.3 m -143.82 173.28 11.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.15 0.5 . . . . 1.8700000000000001 111.594 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 82.1 mt -137.42 161.94 34.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.603 -0.726 . . . . 1.1899999999999999 110.55 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.492 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 71.6 mt -106.74 102.14 40.44 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.485 -0.325 . . . . 1.8500000000000001 111.218 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.6 129.51 35.46 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.59 2.193 . . . . 1.26 112.42 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 110.93 -17.46 27.3 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.794 -0.717 . . . . 0.52000000000000002 112.353 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 57.7 m -85.24 -176.67 6.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.719 0.295 . . . . 1.73 110.85 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.21 -52.55 32.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.916 0.388 . . . . 1.1299999999999999 111.171 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.22 -37.9 75.75 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.045 -0.525 . . . . 1.0900000000000001 111.659 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.99 -54.59 14.45 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.341 -0.391 . . . . 1.1100000000000001 111.572 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.7 mt -60.34 -20.28 58.72 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.343 -0.39 . . . . 1.29 111.09 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.51 ' HB2' HD12 ' A' ' 18' ' ' LEU . 33.3 t70 -59.59 -49.34 78.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.252 -0.431 . . . . 1.8600000000000001 110.927 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.11 -44.9 2.98 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.864 -0.684 . . . . 1.4199999999999999 113.043 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.401 ' HB2' ' OD2' ' A' ' 60' ' ' ASP . 76.6 mtp180 -61.42 -22.13 64.73 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.688 0.28 . . . . 3.0499999999999998 111.077 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.482 ' HA ' HH22 ' A' ' 102' ' ' ARG . 63.2 mt -89.92 116.13 30.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.353 -0.385 . . . . 1.6299999999999999 111.119 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -117.59 140.02 26.98 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.041 -0.527 . . . . 1.98 110.532 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.34 -178.57 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.578 2.185 . . . . 1.4399999999999999 112.295 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.518 ' N ' HD21 ' A' ' 66' ' ' ASN . 0.9 OUTLIER 60.97 44.88 9.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.444 . . . . 2.6299999999999999 110.681 -179.689 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -126.54 177.33 6.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.084 -0.507 . . . . 2.02 110.734 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -130.72 122.48 27.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.427 -0.351 . . . . 1.6200000000000001 111.118 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 39.8 mm -75.04 143.93 12.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 1.1100000000000001 110.618 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.477 ' HA ' ' NE2' ' A' ' 78' ' ' GLN . 71.9 mt -122.54 -66.13 1.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.927 0.394 . . . . 1.1299999999999999 111.428 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.523 ' HG2' HD21 ' A' ' 76' ' ' ASN . 21.5 mtp180 -134.4 138.11 44.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 3.1499999999999999 111.609 -179.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.527 HG12 ' H ' ' A' ' 73' ' ' ASP . 7.6 t -105.32 172.34 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.773 -0.649 . . . . 1.0900000000000001 109.624 178.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.622 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 13.1 t70 -46.81 107.98 0.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.872 0.367 . . . . 0.79000000000000004 111.766 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 49.12 22.43 0.62 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.906 -0.588 . . . . 2.0099999999999998 112.208 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 98.2 t -144.49 104.78 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.775 0.321 . . . . 1.1499999999999999 111.589 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.523 HD21 ' HG2' ' A' ' 71' ' ' ARG . 12.7 m120 -70.67 144.49 51.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.314 -0.403 . . . . 2.8500000000000001 110.371 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 18.3 m -127.89 32.88 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.841 0.353 . . . . 1.26 111.464 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.477 ' NE2' ' HA ' ' A' ' 70' ' ' LEU . 27.2 mm-40 -100.32 31.64 3.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.157 -0.474 . . . . 1.74 111.109 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -178.56 40.6 0.08 OUTLIER Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.478 -0.868 . . . . 0.57999999999999996 112.848 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 68.2 mtm -138.29 145.05 40.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.852 0.358 . . . . 1.1200000000000001 110.879 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.447 ' O ' HG21 ' A' ' 85' ' ' VAL . . . -66.97 160.75 25.76 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.061 -0.518 . . . . 1.1200000000000001 111.155 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -47.81 -53.49 15.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.185 -0.461 . . . . 1.52 111.515 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.7 t -52.51 -38.47 59.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.292 -0.413 . . . . 2.0299999999999998 111.389 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -68.89 -38.5 79.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.312 -0.404 . . . . 2.1200000000000001 111.32 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.447 HG21 ' O ' ' A' ' 81' ' ' ALA . 17.5 t -62.51 -42.38 95.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.468 -0.333 . . . . 1.0800000000000001 110.933 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.0 t -65.63 -36.34 77.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.491 . . . . 1.0700000000000001 111.025 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -58.93 -49.36 78.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.213 -0.449 . . . . 1.51 110.857 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 56.0 t -57.89 -53.16 48.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.295 -0.411 . . . . 1.0600000000000001 111.369 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 83.6 mt -58.88 -31.51 68.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 1.1399999999999999 111.385 -179.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.441 ' HA ' ' NH1' ' A' ' 20' ' ' ARG . 69.7 mtm180 -85.43 -12.16 52.65 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.546 -0.297 . . . . 2.5600000000000001 111.269 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.429 ' N ' HD21 ' A' ' 91' ' ' ASN . 0.9 OUTLIER -97.61 -11.62 23.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.289 -0.414 . . . . 1.8100000000000001 110.942 179.911 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.94 -85.62 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.213 -0.448 . . . . 1.1100000000000001 111.52 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.575 ' HA2' ' HE ' ' A' ' 20' ' ' ARG . . . 63.09 19.82 61.94 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.685 -0.769 . . . . 0.77000000000000002 112.548 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.644 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 1.9 p-10 -147.21 168.59 10.99 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 110.407 -0.22 . . . . 3.3300000000000001 110.407 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.644 ' HD2' ' HB2' ' A' ' 94' ' ' ASN . 19.6 Cg_endo -60.47 89.91 0.08 OUTLIER 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.089 1.86 . . . . 0.92000000000000004 111.325 178.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.3 m -100.13 151.98 4.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.998 -0.546 . . . . 1.3200000000000001 112.087 -178.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.622 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 59.1 mtp180 -98.11 143.85 28.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.787 -0.642 . . . . 3.02 110.055 179.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.497 HD11 HD23 ' A' ' 18' ' ' LEU . 37.3 mt -118.09 104.1 10.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.04 -0.527 . . . . 1.1599999999999999 111.069 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 58.5 tp -100.28 99.87 10.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.34 -0.391 . . . . 1.1000000000000001 110.626 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.11 152.47 49.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 1.1100000000000001 111.234 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.3 tt -94.29 135.93 27.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 1.1399999999999999 110.79 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.482 HH22 ' HA ' ' A' ' 63' ' ' ILE . 18.0 tpp85 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.066 -0.515 . . . . 2.7000000000000002 110.993 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.3 m . . . . . 0 C--O 1.233 0.197 0 CA-C-O 120.772 0.32 . . . . 1.26 110.929 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 63.5 mt -79.57 122.21 26.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.988 -0.551 . . . . 1.49 110.857 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -113.71 125.53 54.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.466 . . . . 3.0899999999999999 110.983 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 47.6 t -119.81 126.8 51.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.978 -0.556 . . . . 1.79 111.053 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.5 t -124.56 154.06 31.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.01 -0.541 . . . . 1.26 110.576 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -121.83 119.83 32.79 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.95 0.405 . . . . 1.74 111.585 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -114.56 166.62 11.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.87 -0.605 . . . . 1.4099999999999999 110.318 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.528 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 89.3 m-85 -133.29 112.05 11.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.732 0.301 . . . . 2.6600000000000001 111.497 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.463 ' HB2' HD22 ' A' ' 27' ' ' LEU . 50.8 tpt85 -97.34 102.81 14.67 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.272 -0.422 . . . . 3.5899999999999999 110.571 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -160.33 20.72 0.15 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.461 . . . . 2.5800000000000001 110.804 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.459 ' N ' ' HD2' ' A' ' 22' ' ' LYS . 11.5 mptt -106.8 161.52 14.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.113 -0.494 . . . . 4.1900000000000004 110.952 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -83.07 50.17 1.68 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.028 -0.533 . . . . 2.8700000000000001 111.038 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.4 p -117.05 -24.03 7.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.216 -0.447 . . . . 1.74 111.05 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.6 m 58.34 16.65 4.19 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.86 -0.609 . . . . 2.79 111.215 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 81.9 p -144.73 153.81 42.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.288 -0.415 . . . . 1.79 110.997 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.463 HD22 ' HB2' ' A' ' 20' ' ' ARG . 92.6 mt -114.31 -20.13 10.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 1.1299999999999999 110.874 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.11 31.72 7.48 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.831 -0.7 . . . . 0.52000000000000002 112.709 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 46.4 mt -110.02 116.13 51.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.868 0.366 . . . . 1.53 111.025 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 45.8 t -113.3 106.49 14.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 1.4099999999999999 110.704 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 43.9 pt -97.36 148.08 5.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.036 -0.529 . . . . 1.1799999999999999 111.245 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 45.0 t -111.46 139.45 46.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.105 -0.498 . . . . 1.79 110.878 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 C-N-CA 120.79 -0.719 . . . . 1.04 112.464 179.954 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 43.5 mm . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.827 0.346 . . . . 1.28 110.857 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -152.83 144.0 23.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 1.0800000000000001 110.897 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 95.7 t -76.71 121.17 28.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.194 -0.457 . . . . 1.0600000000000001 110.861 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -99.72 -23.31 15.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.109 -0.496 . . . . 2.8900000000000001 110.918 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 46.7 t -154.28 165.09 37.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.966 0.412 . . . . 1.8700000000000001 111.213 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 82.9 mt -131.88 154.79 48.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.957 -0.565 . . . . 1.1899999999999999 110.671 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 42.3 mm -97.42 109.15 48.85 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.373 -0.376 . . . . 1.8500000000000001 110.844 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.96 141.13 97.94 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.347 2.031 . . . . 1.26 112.422 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.92 -15.44 63.1 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.758 -0.734 . . . . 0.52000000000000002 112.501 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 59.6 m -80.41 179.15 7.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.663 0.268 . . . . 1.73 110.966 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.49 -47.9 58.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.903 0.382 . . . . 1.1299999999999999 111.096 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.21 -40.33 81.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.097 -0.501 . . . . 1.0900000000000001 111.497 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.1 -54.16 12.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.21 -0.45 . . . . 1.1100000000000001 111.331 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.2 mt -60.83 -19.56 60.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.271 -0.422 . . . . 1.29 111.212 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -52.7 -51.25 61.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.311 -0.404 . . . . 1.8600000000000001 110.758 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 98.05 -32.31 7.02 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.881 -0.676 . . . . 1.4199999999999999 113.145 179.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 23.2 mmm180 -71.57 -46.12 60.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.767 0.318 . . . . 3.0499999999999998 111.284 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 49.5 mt -65.41 132.45 31.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.328 -0.396 . . . . 1.6299999999999999 111.303 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -126.59 138.57 32.73 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.051 -0.522 . . . . 1.98 110.603 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -48.68 157.8 1.38 Allowed 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.443 2.096 . . . . 1.4399999999999999 112.339 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 58.4 t30 58.99 67.27 0.94 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.471 . . . . 2.6299999999999999 110.693 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -133.82 154.91 50.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.974 -0.557 . . . . 2.02 110.629 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -103.79 130.69 51.36 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.562 -0.29 . . . . 1.6200000000000001 111.187 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 36.5 mm -92.54 145.43 7.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.19 -0.459 . . . . 1.1100000000000001 111.022 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 70.2 mt -114.34 -66.9 1.04 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.242 -0.435 . . . . 1.1299999999999999 111.038 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -152.0 141.32 21.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.086 0.47 . . . . 3.1499999999999999 111.41 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.612 HG12 ' H ' ' A' ' 73' ' ' ASP . 2.2 t -90.36 175.26 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.627 -0.715 . . . . 1.0900000000000001 110.033 179.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.612 ' H ' HG12 ' A' ' 72' ' ' VAL . 6.3 p-10 -55.53 114.24 1.76 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.874 0.369 . . . . 0.79000000000000004 111.126 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 60.33 18.53 8.12 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.04 -0.527 . . . . 2.0099999999999998 111.756 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 63.0 t -143.36 149.89 17.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.656 0.265 . . . . 1.1499999999999999 111.139 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -120.01 138.58 53.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.459 -0.337 . . . . 2.8500000000000001 110.587 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.2 m -117.24 28.53 2.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.822 0.344 . . . . 1.26 111.423 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -97.53 33.95 1.93 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 1.74 111.021 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 173.12 28.33 0.02 OUTLIER Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.565 -0.826 . . . . 0.57999999999999996 112.865 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 36.0 mtm -126.25 145.64 50.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.739 0.304 . . . . 1.1200000000000001 110.753 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.01 158.89 24.36 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.28 -0.418 . . . . 1.1200000000000001 111.146 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -49.93 -58.07 6.19 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.215 -0.448 . . . . 1.52 111.531 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 46.5 t -52.65 -39.95 62.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.188 -0.46 . . . . 2.0299999999999998 111.395 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -61.2 -47.9 84.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.832 0.349 . . . . 2.1200000000000001 110.987 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 55.4 t -57.46 -40.79 76.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.108 -0.497 . . . . 1.0800000000000001 111.121 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 90.9 t -63.27 -39.04 83.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 1.0700000000000001 110.928 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.423 ' HG2' HH21 ' A' ' 90' ' ' ARG . 45.8 mt-10 -58.99 -40.83 86.03 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.264 -0.425 . . . . 1.51 110.386 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 52.1 t -60.36 -52.91 55.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.905 -0.589 . . . . 1.0600000000000001 111.203 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 67.0 mt -53.93 -38.02 64.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.095 -0.502 . . . . 1.1399999999999999 111.397 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.423 HH21 ' HG2' ' A' ' 87' ' ' GLU . 76.8 mtm180 -81.28 -21.12 39.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.244 -0.434 . . . . 2.5600000000000001 111.246 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.457 HD21 ' N ' ' A' ' 91' ' ' ASN . 0.9 OUTLIER -90.82 -5.05 56.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.361 -0.381 . . . . 1.8100000000000001 111.16 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.02 -71.66 0.07 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.329 -0.396 . . . . 1.1100000000000001 111.133 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 63.14 10.55 34.58 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.697 -0.763 . . . . 0.77000000000000002 112.522 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -147.51 173.57 4.09 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 110.077 -0.342 . . . . 3.3300000000000001 110.077 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.528 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 86.8 Cg_exo -47.79 100.09 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.005 1.803 . . . . 0.92000000000000004 111.379 178.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.3 t -80.84 113.72 20.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.106 -0.497 . . . . 1.3200000000000001 111.755 -178.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.482 ' H ' ' HB3' ' A' ' 73' ' ' ASP . 80.0 ttt180 -91.38 126.51 36.49 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.532 -0.544 . . . . 3.02 109.532 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 27.7 mt -109.42 103.61 12.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.373 -0.376 . . . . 1.1599999999999999 111.721 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 32.0 tp -96.34 99.75 11.41 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.324 -0.621 . . . . 1.1000000000000001 109.324 178.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -130.14 168.19 17.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.119 -0.491 . . . . 1.1100000000000001 111.862 -178.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 17.3 tt -118.44 143.95 27.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 115.668 -0.696 . . . . 1.1399999999999999 110.782 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.39 0 CA-C-N 116.094 -0.503 . . . . 2.7000000000000002 110.384 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.6 t . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.859 0.361 . . . . 1.26 110.671 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 58.2 mt -81.07 119.1 23.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 1.49 111.252 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -118.43 151.62 37.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.005 -0.543 . . . . 3.0899999999999999 110.586 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 78.0 p -141.26 145.6 35.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.875 0.369 . . . . 1.79 111.341 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 46.6 t -135.07 139.46 47.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.009 -0.541 . . . . 1.26 110.788 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -100.2 113.09 25.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.321 -0.399 . . . . 1.74 110.848 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 33.8 mt -124.37 141.07 52.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.365 -0.379 . . . . 1.4099999999999999 111.44 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.552 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 44.3 p90 -118.7 141.2 48.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.056 -0.52 . . . . 2.6600000000000001 110.613 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.473 ' HB3' ' HA2' ' A' ' 93' ' ' GLY . 13.0 ttp180 -118.49 80.76 1.58 Allowed 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.702 -0.399 . . . . 3.5899999999999999 111.551 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -99.86 10.07 41.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.436 . . . . 2.5800000000000001 110.779 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.458 ' N ' ' HD2' ' A' ' 22' ' ' LYS . 3.2 mptp? -108.88 156.05 20.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.988 -0.551 . . . . 4.1900000000000004 110.819 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -86.25 73.56 10.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 2.8700000000000001 110.926 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 52.4 p -113.43 -22.61 10.28 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.121 -0.49 . . . . 1.74 111.079 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 51.2 m 59.26 19.89 8.01 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.842 -0.617 . . . . 2.79 111.185 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 77.6 p -158.8 137.9 11.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.307 -0.406 . . . . 1.79 111.162 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.467 HD23 ' HB2' ' A' ' 20' ' ' ARG . 75.4 mt -97.26 -10.75 25.15 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.029 -0.532 . . . . 1.1299999999999999 110.683 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.487 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 92.11 14.85 55.52 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.784 -0.722 . . . . 0.52000000000000002 112.829 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 69.6 mt -98.61 110.57 26.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.778 0.323 . . . . 1.53 111.178 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 34.2 t -111.23 101.1 9.62 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.277 -0.419 . . . . 1.4099999999999999 110.842 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 40.8 pt -92.4 166.67 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.996 -0.547 . . . . 1.1799999999999999 111.43 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 46.0 t -131.94 134.94 46.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.03 -0.532 . . . . 1.79 110.795 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 0.294 0 C-N-CA 120.844 -0.693 . . . . 1.04 112.631 -179.977 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 49.8 mm . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.88 0.372 . . . . 1.28 111.114 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -119.77 138.28 53.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.466 . . . . 1.0800000000000001 111.103 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.8 t -80.51 123.92 37.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.059 -0.519 . . . . 1.0600000000000001 110.807 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -106.43 -29.26 9.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.033 -0.531 . . . . 2.8900000000000001 111.053 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 53.3 m -137.6 167.27 22.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.031 0.443 . . . . 1.8700000000000001 111.606 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 82.4 mt -137.68 163.59 30.9 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.807 -0.633 . . . . 1.1899999999999999 110.752 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.487 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 67.6 mt -102.51 101.02 17.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 1.8500000000000001 110.786 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 52' ' ' ILE . 19.1 Cg_endo -57.56 94.81 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.475 2.116 . . . . 1.26 112.263 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 143.91 -8.09 1.95 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.838 -0.696 . . . . 0.52000000000000002 112.388 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.41 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 53.0 m -96.47 178.66 5.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.757 0.313 . . . . 1.73 110.858 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.46 -53.34 59.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.301 -0.409 . . . . 1.1299999999999999 111.706 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.86 -37.33 66.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.19 -0.459 . . . . 1.0900000000000001 111.853 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -77.98 -32.67 51.41 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.963 0.357 . . . . 1.1100000000000001 111.963 -179.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 55' ' ' SER . 55.1 mt -62.74 -55.47 26.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.727 0.299 . . . . 1.29 111.221 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -57.87 -41.78 83.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 1.8600000000000001 111.1 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 79.6 -11.66 31.6 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.81 -0.709 . . . . 1.4199999999999999 112.681 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 39.7 mtp180 -63.18 -16.83 61.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.807 0.337 . . . . 3.0499999999999998 110.828 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 76.3 mt -104.04 115.56 46.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.081 -0.509 . . . . 1.6299999999999999 110.932 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -86.85 155.46 55.74 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 1.98 111.156 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -78.3 38.19 0.68 Allowed 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.785 2.323 . . . . 1.4399999999999999 112.473 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -164.93 64.14 0.13 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.861 0.362 . . . . 2.6299999999999999 110.746 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -132.19 167.32 19.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.146 -0.479 . . . . 2.02 110.656 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -113.31 106.88 15.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.897 0.38 . . . . 1.6200000000000001 111.171 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 46.5 mm -64.07 143.73 15.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.468 . . . . 1.1100000000000001 110.833 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 57.9 mt -116.42 -58.13 2.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.28 -0.418 . . . . 1.1299999999999999 111.212 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -159.94 136.09 8.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.031 0.443 . . . . 3.1499999999999999 111.465 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.589 HG13 ' H ' ' A' ' 73' ' ' ASP . 2.6 t -88.88 175.87 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.634 -0.712 . . . . 1.0900000000000001 109.909 179.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.664 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 12.2 t70 -44.3 108.74 0.12 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.836 0.35 . . . . 0.79000000000000004 111.802 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 53.13 33.91 16.18 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.115 -0.493 . . . . 2.0099999999999998 112.11 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 92.1 t -147.56 126.39 4.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.535 -0.302 . . . . 1.1499999999999999 111.047 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -96.83 122.98 40.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.401 -0.363 . . . . 2.8500000000000001 110.423 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.7 m -108.42 26.44 2.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 CA-C-O 120.858 0.361 . . . . 1.26 111.586 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -94.4 24.82 4.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.269 -0.423 . . . . 1.74 110.779 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -169.88 16.42 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.663 -0.78 . . . . 0.57999999999999996 112.746 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 60.4 mtm -118.35 143.51 46.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.864 0.364 . . . . 1.1200000000000001 110.856 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.83 164.91 11.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.161 -0.472 . . . . 1.1200000000000001 111.295 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.407 ' O ' HG23 ' A' ' 86' ' ' VAL . 35.3 tt0 -51.74 -55.4 19.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 1.52 111.351 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.2 m -50.44 -42.7 54.44 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.192 -0.458 . . . . 2.0299999999999998 111.577 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -61.05 -49.08 78.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.381 -0.372 . . . . 2.1200000000000001 111.096 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 33.7 t -60.59 -33.44 54.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.486 . . . . 1.0800000000000001 111.276 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 82' ' ' GLN . 89.7 t -67.59 -43.55 86.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.287 -0.415 . . . . 1.0700000000000001 110.98 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -56.95 -45.78 82.57 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.363 -0.381 . . . . 1.51 110.633 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 55.3 t -56.15 -52.43 50.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.083 -0.508 . . . . 1.0600000000000001 110.893 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 82.2 mt -61.38 -25.74 67.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.883 -0.599 . . . . 1.1399999999999999 110.95 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.1 mtm180 -87.93 -11.68 46.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.196 -0.456 . . . . 2.5600000000000001 111.12 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.441 HD21 ' N ' ' A' ' 91' ' ' ASN . 0.9 OUTLIER -99.41 -12.65 20.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.316 -0.402 . . . . 1.8100000000000001 110.605 179.625 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.5 -86.22 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.998 -0.546 . . . . 1.1100000000000001 111.445 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.473 ' HA2' ' HB3' ' A' ' 20' ' ' ARG . . . 61.84 21.97 61.63 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.62 -0.8 . . . . 0.77000000000000002 112.231 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.62 ' HB3' ' HD2' ' A' ' 95' ' ' PRO . 3.7 m120 -147.46 174.54 3.32 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 110.583 -0.155 . . . . 3.3300000000000001 110.583 -179.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.62 ' HD2' ' HB3' ' A' ' 94' ' ' ASN . 36.2 Cg_endo -66.45 81.61 0.3 Allowed 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 122.106 1.871 . . . . 0.92000000000000004 112.004 178.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 22.7 m -91.29 154.21 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.95 -0.568 . . . . 1.3200000000000001 111.48 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.664 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 77.2 ttt180 -94.56 144.07 25.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.782 -0.645 . . . . 3.02 110.112 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 25.9 mt -118.53 103.89 10.16 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.221 -0.445 . . . . 1.1599999999999999 110.986 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 24.8 tp -100.76 104.2 15.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.966 0.412 . . . . 1.1000000000000001 110.781 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.85 168.03 20.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.995 -0.548 . . . . 1.1100000000000001 110.866 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 19.4 tt -114.03 134.8 55.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-O 121.015 0.436 . . . . 1.1399999999999999 111.289 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 115.584 -0.734 . . . . 2.7000000000000002 110.689 179.997 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.0 t . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.79 0.329 . . . . 1.26 110.727 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.2 mt -79.62 120.6 24.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 1.49 111.276 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -115.0 157.29 23.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.075 -0.511 . . . . 3.0899999999999999 110.656 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 41.1 t -148.91 132.24 16.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.916 0.389 . . . . 1.79 111.161 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 44.4 t -125.16 129.9 73.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.078 -0.51 . . . . 1.26 110.775 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -95.47 109.85 21.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.15 -0.477 . . . . 1.74 111.16 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.401 HD13 HD12 ' A' ' 98' ' ' LEU . 28.5 mt -115.76 166.19 12.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 1.4099999999999999 110.874 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.638 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 39.3 p90 -149.91 133.75 16.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 2.6600000000000001 111.046 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.6 tpp180 -109.49 122.24 46.97 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.001 0.429 . . . . 3.5899999999999999 110.831 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -121.77 -25.69 5.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.893 -0.594 . . . . 2.5800000000000001 110.637 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -71.65 169.71 15.0 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.841 -0.618 . . . . 4.1900000000000004 110.682 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -95.63 51.91 1.32 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.269 -0.423 . . . . 2.8700000000000001 110.788 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 79.7 p -103.36 -24.12 13.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.133 -0.485 . . . . 1.74 111.141 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.7 t 58.41 21.12 8.07 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.951 -0.568 . . . . 2.79 111.228 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 79.0 p -145.03 153.3 41.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.869 0.366 . . . . 1.79 111.122 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 81.7 mt -114.12 -8.5 12.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.008 -0.542 . . . . 1.1299999999999999 110.799 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.406 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 97.78 -12.1 64.38 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.831 -0.699 . . . . 0.52000000000000002 112.8 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 69.8 mt -63.51 108.69 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.727 0.299 . . . . 1.53 111.156 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 36.3 t -112.19 114.22 26.9 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.318 -0.401 . . . . 1.4099999999999999 110.636 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.4 pt -96.22 -178.84 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.381 -0.372 . . . . 1.1799999999999999 111.362 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 77.3 p -163.44 137.4 5.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.138 -0.483 . . . . 1.79 110.75 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.246 0 C-N-CA 120.796 -0.716 . . . . 1.04 112.561 -179.962 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 39.5 mm . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 120.699 0.285 . . . . 1.28 110.861 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 46.5 p90 -153.68 144.84 22.92 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.338 -0.392 . . . . 1.0800000000000001 111.411 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 66.4 t -79.6 132.79 31.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.031 -0.532 . . . . 1.0600000000000001 110.924 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -125.73 -26.19 3.54 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.102 -0.499 . . . . 2.8900000000000001 111.022 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 56.6 m -130.16 161.96 29.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.025 0.441 . . . . 1.8700000000000001 111.275 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 83.6 mt -141.65 129.09 21.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.814 -0.63 . . . . 1.1899999999999999 110.728 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.406 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 63.1 mt -68.26 117.95 54.51 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.28 -0.418 . . . . 1.8500000000000001 110.934 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.21 96.76 0.64 Allowed 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.191 1.927 . . . . 1.26 112.252 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 137.29 0.45 2.7 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.837 -0.697 . . . . 0.52000000000000002 112.511 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 63.6 m -101.32 172.46 6.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.62 0.247 . . . . 1.73 110.902 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.36 -53.13 61.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.431 -0.35 . . . . 1.1299999999999999 111.8 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -47.15 -40.78 16.41 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.243 -0.435 . . . . 1.0900000000000001 112.019 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.37 -38.99 29.35 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.984 0.365 . . . . 1.1100000000000001 111.984 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 60.1 mt -56.3 -56.22 23.77 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.47 -0.332 . . . . 1.29 111.634 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -56.54 -34.26 66.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.402 -0.363 . . . . 1.8600000000000001 111.236 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 78.34 -12.74 18.71 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.784 -0.722 . . . . 1.4199999999999999 112.504 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -59.72 -29.25 68.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.789 0.328 . . . . 3.0499999999999998 110.792 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.446 ' N ' HD11 ' A' ' 63' ' ' ILE . 4.0 mp -93.49 115.1 31.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.479 . . . . 1.6299999999999999 110.651 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.464 ' HB2' ' HD2' ' A' ' 65' ' ' PRO . 12.0 pt-20 -113.03 158.13 38.76 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.458 . . . . 1.98 110.696 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.464 ' HD2' ' HB2' ' A' ' 64' ' ' GLU . 21.2 Cg_endo -60.05 173.18 1.93 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.399 2.066 . . . . 1.4399999999999999 112.095 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 54.09 58.86 4.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.044 0.45 . . . . 2.6299999999999999 110.668 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -136.51 154.28 50.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.976 -0.556 . . . . 2.02 110.537 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -110.15 136.93 48.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.977 0.418 . . . . 1.6200000000000001 111.49 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.454 HD12 ' HB3' ' A' ' 100' ' ' LEU . 45.3 mm -97.79 120.58 47.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.817 -0.629 . . . . 1.1100000000000001 110.346 179.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 77.4 mt -93.25 -63.79 1.17 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.429 -0.35 . . . . 1.1299999999999999 111.33 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 62.6 mtp180 -141.7 142.09 33.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.098 0.475 . . . . 3.1499999999999999 111.664 -179.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.549 HG12 ' H ' ' A' ' 73' ' ' ASP . 4.4 t -100.47 174.04 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.724 -0.671 . . . . 1.0900000000000001 109.944 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.645 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 18.8 t70 -50.43 110.6 0.42 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.657 0.265 . . . . 0.79000000000000004 111.205 179.262 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.4 t70 56.04 26.05 9.58 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.254 -0.43 . . . . 2.0099999999999998 111.248 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.501 ' HB ' ' HB ' ' A' ' 72' ' ' VAL . 86.9 t -144.56 153.93 14.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 1.1499999999999999 110.631 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -129.59 126.56 38.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.743 0.306 . . . . 2.8500000000000001 110.746 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.428 ' HA ' ' HE2' ' A' ' 80' ' ' MET . 33.2 m -104.63 25.14 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.245 -0.434 . . . . 1.26 111.067 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -89.62 26.34 1.77 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.083 -0.508 . . . . 1.74 110.956 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 174.78 34.12 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.535 -0.84 . . . . 0.57999999999999996 112.897 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.428 ' HE2' ' HA ' ' A' ' 77' ' ' VAL . 49.8 mtm -126.62 147.35 49.91 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.834 0.35 . . . . 1.1200000000000001 110.858 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.03 156.23 18.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.1 -0.5 . . . . 1.1200000000000001 111.301 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -51.44 -58.63 5.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.325 -0.398 . . . . 1.52 111.154 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.6 t -55.94 -36.94 68.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.099 -0.5 . . . . 2.0299999999999998 111.179 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -60.15 -46.41 89.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.355 -0.384 . . . . 2.1200000000000001 110.907 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 60.7 t -59.49 -38.3 74.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.454 . . . . 1.0800000000000001 110.886 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 58.8 t -64.35 -41.57 92.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.157 -0.474 . . . . 1.0700000000000001 111.077 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.508 ' HG2' HH21 ' A' ' 90' ' ' ARG . 48.3 mt-10 -57.85 -44.51 86.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.893 0.378 . . . . 1.51 110.547 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 54.0 t -56.18 -55.55 17.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.947 -0.57 . . . . 1.0600000000000001 111.102 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 78.7 mt -57.22 -29.79 64.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.043 -0.526 . . . . 1.1399999999999999 111.259 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.508 HH21 ' HG2' ' A' ' 87' ' ' GLU . 63.5 mtm180 -83.1 -20.76 34.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.462 -0.335 . . . . 2.5600000000000001 111.097 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -86.44 -18.35 31.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 1.8100000000000001 110.825 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.44 -85.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.289 -0.414 . . . . 1.1100000000000001 110.988 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 60.48 23.01 59.88 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.739 -0.743 . . . . 0.77000000000000002 112.583 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.465 ' HB3' ' HD2' ' A' ' 95' ' ' PRO . 2.2 m120 -147.34 175.91 2.48 Favored Pre-proline 0 C--N 1.329 -0.322 0 C-N-CA 121.928 0.091 . . . . 3.3300000000000001 110.863 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.638 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 51.5 Cg_exo -56.76 103.54 0.12 Allowed 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 122.096 1.864 . . . . 0.92000000000000004 111.715 178.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 31.3 m -123.51 149.46 27.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.111 0.482 . . . . 1.3200000000000001 111.945 -179.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.645 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 42.5 ttp180 -94.34 142.96 26.81 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.61 -0.723 . . . . 3.02 109.983 179.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.401 HD12 HD13 ' A' ' 18' ' ' LEU . 52.8 mt -116.58 115.46 25.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.188 -0.46 . . . . 1.1599999999999999 111.273 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 59.3 tp -108.88 103.22 12.23 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.941 0.4 . . . . 1.1000000000000001 110.32 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.454 ' HB3' HD12 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -132.4 166.27 22.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.089 -0.505 . . . . 1.1100000000000001 111.329 -179.249 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 19.0 tt -120.6 140.38 44.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.121 -0.491 . . . . 1.1399999999999999 110.986 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.056 -0.52 . . . . 2.7000000000000002 110.396 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.2 t . . . . . 0 C--O 1.235 0.332 0 CA-C-O 121.031 0.443 . . . . 1.26 111.215 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.498 HD23 ' HB ' ' A' ' 101' ' ' ILE . 16.6 mt -96.02 106.99 19.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.614 -0.721 . . . . 1.49 110.242 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.456 ' HH ' ' HB3' ' A' ' 102' ' ' ARG . 32.7 p90 -127.97 150.47 49.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.855 0.36 . . . . 3.0899999999999999 111.06 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 80.3 p -123.84 135.55 53.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.107 -0.497 . . . . 1.79 111.268 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.9 t -110.4 144.62 18.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.94 -0.573 . . . . 1.26 110.477 179.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -88.58 122.26 31.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.872 0.368 . . . . 1.74 111.252 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -127.13 166.25 18.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.964 -0.562 . . . . 1.4099999999999999 110.787 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.53 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 27.9 p90 -152.77 130.52 11.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.25 -0.432 . . . . 2.6600000000000001 111.04 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.452 ' HB2' HD22 ' A' ' 27' ' ' LEU . 2.0 tmm_? -108.17 107.03 17.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.312 -0.403 . . . . 3.5899999999999999 110.659 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -133.06 -28.67 1.51 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.328 -0.396 . . . . 2.5800000000000001 111.33 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -64.0 161.03 16.65 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.137 -0.483 . . . . 4.1900000000000004 111.018 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -83.37 37.54 0.57 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.022 -0.535 . . . . 2.8700000000000001 111.203 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 71.2 p -88.43 -16.18 33.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 1.74 111.028 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 51.6 m 57.54 20.5 6.22 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.903 -0.589 . . . . 2.79 111.082 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 88.5 p -159.32 -176.62 5.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.345 -0.389 . . . . 1.79 110.909 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.452 HD22 ' HB2' ' A' ' 20' ' ' ARG . 68.7 mt -128.83 -0.49 5.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.023 -0.535 . . . . 1.1299999999999999 110.634 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.29 26.76 51.07 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.835 -0.698 . . . . 0.52000000000000002 112.566 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.428 HG21 HG21 ' A' ' 31' ' ' ILE . 85.0 mt -100.94 114.52 40.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.905 0.383 . . . . 1.53 111.1 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.0 m -109.03 92.82 4.21 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.113 -0.494 . . . . 1.4099999999999999 110.722 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.428 HG21 HG21 ' A' ' 29' ' ' ILE . 43.1 pt -90.46 164.99 2.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.0 -0.545 . . . . 1.1799999999999999 111.236 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.2 t -145.4 134.49 22.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 1.79 110.788 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.266 0 C-N-CA 120.839 -0.696 . . . . 1.04 112.396 179.999 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 37.6 mm . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.704 0.288 . . . . 1.28 110.713 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -149.49 145.15 26.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.338 -0.392 . . . . 1.0800000000000001 111.457 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 93.1 t -83.37 115.58 25.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.957 -0.565 . . . . 1.0600000000000001 110.64 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -89.5 -31.34 17.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.073 -0.512 . . . . 2.8900000000000001 111.351 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.0 t -151.29 169.0 23.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.96 0.409 . . . . 1.8700000000000001 111.605 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 86.1 mt -124.94 169.73 11.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.731 -0.668 . . . . 1.1899999999999999 110.514 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 50.4 mm -108.62 99.96 36.24 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.278 -0.419 . . . . 1.8500000000000001 111.047 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -51.73 116.06 2.5 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.56 2.174 . . . . 1.26 112.397 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 111.31 3.49 27.54 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.802 -0.713 . . . . 0.52000000000000002 112.33 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 55.1 m -99.78 174.15 6.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.65 0.262 . . . . 1.73 111.037 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.68 -56.65 19.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.304 -0.407 . . . . 1.1299999999999999 111.353 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.46 -33.06 58.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.256 -0.429 . . . . 1.0900000000000001 111.384 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.08 -26.06 39.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.289 -0.414 . . . . 1.1100000000000001 111.529 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 31.2 mt -70.59 -37.65 73.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.473 -0.331 . . . . 1.29 111.241 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -61.74 -40.59 95.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.41 -0.359 . . . . 1.8600000000000001 110.993 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 79.48 -13.99 19.45 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.797 -0.716 . . . . 1.4199999999999999 112.632 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 69.6 mtp180 -74.99 -23.05 58.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.788 0.327 . . . . 3.0499999999999998 110.935 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.454 ' N ' HD13 ' A' ' 63' ' ' ILE . 3.7 mp -84.19 118.9 32.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.436 . . . . 1.6299999999999999 110.715 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -106.3 136.79 19.31 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.111 -0.495 . . . . 1.98 110.614 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -56.09 163.24 6.31 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.486 2.124 . . . . 1.4399999999999999 112.316 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 62.95 45.78 5.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.065 -0.516 . . . . 2.6299999999999999 111.046 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -109.55 165.45 11.66 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.098 -0.501 . . . . 2.02 110.602 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -113.61 107.05 15.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.819 0.342 . . . . 1.6200000000000001 111.207 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.434 ' HA ' ' HB3' ' A' ' 100' ' ' LEU . 43.7 mm -66.53 136.73 26.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.12 -0.491 . . . . 1.1100000000000001 110.692 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 96.6 mt -113.03 -72.17 0.72 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.45 -0.341 . . . . 1.1299999999999999 111.318 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 -135.89 137.35 41.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.001 0.429 . . . . 3.1499999999999999 111.61 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.456 HG13 ' N ' ' A' ' 73' ' ' ASP . 9.3 t -98.91 168.59 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.872 -0.604 . . . . 1.0900000000000001 109.829 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.67 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 13.4 t70 -47.86 108.3 0.16 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.923 0.392 . . . . 0.79000000000000004 111.95 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.8 t70 58.69 6.68 0.64 Allowed 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.592 0.589 . . . . 2.0099999999999998 112.592 178.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 38.9 t -140.09 101.05 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.718 0.294 . . . . 1.1499999999999999 111.59 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -73.83 153.78 39.78 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.454 -0.339 . . . . 2.8500000000000001 110.427 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.447 ' HA ' ' HE2' ' A' ' 80' ' ' MET . 34.9 m -125.62 28.55 2.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-O 120.853 0.359 . . . . 1.26 111.554 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -94.32 42.25 1.09 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.268 -0.424 . . . . 1.74 111.011 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 165.76 33.23 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.642 -0.79 . . . . 0.57999999999999996 113.04 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.447 ' HE2' ' HA ' ' A' ' 77' ' ' VAL . 50.5 mtm -131.39 152.48 50.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.862 0.363 . . . . 1.1200000000000001 111.01 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.55 152.98 40.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.011 -0.54 . . . . 1.1200000000000001 111.179 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -52.69 -55.86 19.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.355 -0.384 . . . . 1.52 111.286 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 48.0 t -53.7 -40.06 65.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.137 -0.483 . . . . 2.0299999999999998 111.413 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -62.34 -46.24 89.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.322 -0.399 . . . . 2.1200000000000001 111.118 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 75.6 t -57.94 -36.64 56.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.122 -0.49 . . . . 1.0800000000000001 111.128 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 64.9 t -65.99 -43.3 92.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 1.0700000000000001 111.025 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -57.25 -39.41 75.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.183 -0.462 . . . . 1.51 110.612 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 52.9 t -62.3 -53.66 44.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 1.0600000000000001 111.208 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 76.5 mt -53.29 -30.06 36.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.933 -0.576 . . . . 1.1399999999999999 111.174 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -87.53 -26.64 23.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 2.5600000000000001 111.295 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -78.22 -12.17 59.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.421 -0.354 . . . . 1.8100000000000001 111.032 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -49.76 -80.26 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.272 -0.422 . . . . 1.1100000000000001 111.29 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 65.87 10.84 52.54 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.591 -0.814 . . . . 0.77000000000000002 112.379 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.536 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -146.88 168.56 11.15 Favored Pre-proline 0 C--N 1.328 -0.332 0 N-CA-C 110.44 -0.207 . . . . 3.3300000000000001 110.44 -179.827 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.536 ' HD2' ' HB2' ' A' ' 94' ' ' ASN . 19.0 Cg_endo -61.24 102.42 0.22 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.003 1.802 . . . . 0.92000000000000004 111.506 178.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 29.9 m -107.81 146.66 13.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 1.3200000000000001 112.015 -178.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.67 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 20.7 ttm180 -92.18 142.76 27.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.818 -0.628 . . . . 3.02 109.847 179.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 71.8 mt -116.09 103.4 10.52 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.071 -0.513 . . . . 1.1599999999999999 110.892 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 65.1 tp -98.99 114.26 26.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 1.1000000000000001 110.382 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.434 ' HB3' ' HA ' ' A' ' 69' ' ' ILE . 0.5 OUTLIER -147.27 167.95 22.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.475 . . . . 1.1100000000000001 111.487 -179.352 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.498 ' HB ' HD23 ' A' ' 13' ' ' LEU . 11.7 tt -116.23 139.16 44.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.828 -0.624 . . . . 1.1399999999999999 110.807 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.456 ' HB3' ' HH ' ' A' ' 14' ' ' TYR . 32.7 tpt180 . . . . . 0 C--N 1.327 -0.413 0 CA-C-N 116.206 -0.452 . . . . 2.7000000000000002 110.601 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 56.2 p . . . . . 0 C--O 1.233 0.197 0 CA-C-O 120.767 0.318 . . . . 1.26 110.655 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 76.5 mt -77.78 128.72 34.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.121 -0.491 . . . . 1.49 111.319 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -114.74 132.55 56.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.927 -0.579 . . . . 3.0899999999999999 111.058 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 84.9 p -124.56 128.55 49.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.099 -0.501 . . . . 1.79 110.929 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 23.6 t -133.04 149.38 31.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.117 -0.492 . . . . 1.26 110.919 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -111.41 120.77 43.31 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.843 0.354 . . . . 1.74 110.986 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -121.18 166.45 13.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.034 -0.53 . . . . 1.4099999999999999 111.119 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.568 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 33.8 p90 -147.86 129.19 14.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.997 -0.547 . . . . 2.6600000000000001 110.82 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.472 ' HB2' HD23 ' A' ' 27' ' ' LEU . 3.0 tmm_? -108.71 115.31 29.84 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.935 0.398 . . . . 3.5899999999999999 111.007 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -150.93 13.76 0.71 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.101 -0.5 . . . . 2.5800000000000001 110.934 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -103.78 160.52 14.71 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.197 -0.456 . . . . 4.1900000000000004 110.712 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -90.62 57.92 3.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 2.8700000000000001 110.889 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 37.5 p -118.76 -10.49 9.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 1.74 111.103 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 90.7 p 49.71 26.84 1.98 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.76 -0.655 . . . . 2.79 111.413 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 53.4 m -152.69 137.48 17.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.38 -0.373 . . . . 1.79 111.059 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.472 HD23 ' HB2' ' A' ' 20' ' ' ARG . 85.1 mt -91.53 -34.58 14.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.081 -0.509 . . . . 1.1299999999999999 110.778 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.426 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 127.26 -26.82 4.91 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.869 -0.682 . . . . 0.52000000000000002 112.444 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 70.3 mt -63.93 113.67 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.792 0.329 . . . . 1.53 110.928 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.447 ' HB3' ' HG ' ' A' ' 50' ' ' SER . 47.3 t -113.84 99.43 7.68 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.15 -0.477 . . . . 1.4099999999999999 110.997 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.8 pt -96.47 159.2 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.073 -0.512 . . . . 1.1799999999999999 111.071 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 47.4 t -115.2 146.69 41.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.237 -0.438 . . . . 1.79 110.949 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.246 0 C-N-CA 120.901 -0.666 . . . . 1.04 112.455 179.901 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 42.7 mm . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.796 0.331 . . . . 1.28 111.041 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -151.21 143.56 24.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.485 . . . . 1.0800000000000001 111.109 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 79.3 t -76.81 134.89 27.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.215 -0.448 . . . . 1.0600000000000001 110.757 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -113.39 -31.81 6.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.985 -0.552 . . . . 2.8900000000000001 111.169 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.447 ' HG ' ' HB3' ' A' ' 30' ' ' SER . 80.0 p -153.71 177.07 11.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.957 0.408 . . . . 1.8700000000000001 111.395 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 97.6 mt -133.75 149.44 51.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.765 -0.652 . . . . 1.1899999999999999 110.838 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.426 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 57.1 mt -81.16 121.35 80.41 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.289 -0.414 . . . . 1.8500000000000001 111.121 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.16 114.23 3.7 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.441 2.094 . . . . 1.26 112.265 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.82 16.36 15.75 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.63 -0.795 . . . . 0.52000000000000002 112.652 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 78.0 p -107.76 176.45 5.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.717 0.294 . . . . 1.73 110.906 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.57 -57.6 9.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.34 -0.391 . . . . 1.1299999999999999 111.206 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.13 -29.58 13.94 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.118 -0.492 . . . . 1.0900000000000001 111.591 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -77.74 -40.92 39.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.303 -0.408 . . . . 1.1100000000000001 111.455 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.6 mt -61.78 -35.96 79.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.311 -0.404 . . . . 1.29 111.273 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -61.79 -47.32 85.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.287 -0.415 . . . . 1.8600000000000001 111.101 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.06 -20.65 7.92 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.77 -0.728 . . . . 1.4199999999999999 112.477 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 12.8 mmm180 -62.22 -22.39 65.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.827 0.346 . . . . 3.0499999999999998 110.889 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.44 ' N ' HD12 ' A' ' 63' ' ' ILE . 4.1 mp -91.18 111.23 23.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.12 -0.491 . . . . 1.6299999999999999 110.899 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -98.68 134.49 21.62 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.035 -0.529 . . . . 1.98 110.531 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.94 159.9 4.72 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.488 2.125 . . . . 1.4399999999999999 112.279 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 61.13 82.98 0.15 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.992 -0.549 . . . . 2.6299999999999999 110.861 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -156.51 170.77 21.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.072 -0.513 . . . . 2.02 110.707 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -114.42 126.06 54.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.405 -0.361 . . . . 1.6200000000000001 111.096 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 41.4 mm -84.53 137.99 19.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.135 -0.484 . . . . 1.1100000000000001 110.784 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.444 ' HA ' ' NE2' ' A' ' 78' ' ' GLN . 89.1 mt -101.36 -61.51 1.37 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.28 -0.418 . . . . 1.1299999999999999 111.07 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -158.17 138.48 12.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.171 0.51 . . . . 3.1499999999999999 111.676 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.601 HG12 ' H ' ' A' ' 73' ' ' ASP . 2.9 t -86.85 175.48 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.551 -0.749 . . . . 1.0900000000000001 109.997 179.281 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.667 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 14.7 t70 -49.54 110.25 0.36 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.795 0.331 . . . . 0.79000000000000004 111.804 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.1 t70 60.69 9.91 2.39 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.044 -0.526 . . . . 2.0099999999999998 111.978 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.509 HG11 HG21 ' A' ' 88' ' ' VAL . 57.7 t -128.51 141.85 45.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.674 0.273 . . . . 1.1499999999999999 110.999 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -109.26 129.55 55.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.323 -0.399 . . . . 2.8500000000000001 110.709 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.4 m -111.92 26.6 3.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-O 120.89 0.376 . . . . 1.26 111.319 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.444 ' NE2' ' HA ' ' A' ' 70' ' ' LEU . 27.0 mm-40 -86.77 31.62 0.69 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.14 -0.482 . . . . 1.74 111.306 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 162.38 43.3 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.466 -0.873 . . . . 0.57999999999999996 112.974 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 47.7 mtm -129.68 138.34 51.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.874 0.368 . . . . 1.1200000000000001 110.905 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.4 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -60.93 156.66 17.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.107 -0.497 . . . . 1.1200000000000001 111.123 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -48.33 -49.16 35.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.331 -0.395 . . . . 1.52 111.363 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 81.0 p -53.31 -44.96 68.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.121 -0.491 . . . . 2.0299999999999998 111.444 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -61.56 -45.32 94.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.294 -0.412 . . . . 2.1200000000000001 111.426 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 81' ' ' ALA . 15.5 t -59.34 -41.38 84.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.331 -0.395 . . . . 1.0800000000000001 111.003 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 92.2 t -64.14 -37.7 80.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.046 -0.525 . . . . 1.0700000000000001 111.103 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -58.73 -47.5 84.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 1.51 110.655 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.509 HG21 HG11 ' A' ' 75' ' ' VAL . 65.1 t -56.75 -55.09 21.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.022 -0.535 . . . . 1.0600000000000001 111.256 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.429 HD21 HD13 ' A' ' 27' ' ' LEU . 84.5 mt -53.07 -36.69 60.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.82 -0.627 . . . . 1.1399999999999999 111.822 -179.096 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 81.7 mtm180 -84.48 -18.39 36.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.613 -0.267 . . . . 2.5600000000000001 111.67 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -89.98 -8.03 52.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.703 0.287 . . . . 1.8100000000000001 110.87 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -55.49 -83.74 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.251 -0.431 . . . . 1.1100000000000001 111.263 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.454 ' HA2' ' NE ' ' A' ' 20' ' ' ARG . . . 62.11 14.5 46.8 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.717 -0.754 . . . . 0.77000000000000002 112.37 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -146.9 168.51 11.25 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 110.45 -0.204 . . . . 3.3300000000000001 110.45 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.568 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 36.1 Cg_exo -62.33 96.5 0.15 Allowed 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.211 1.941 . . . . 0.92000000000000004 111.161 178.299 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.5 m -105.76 152.76 7.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.124 0.488 . . . . 1.3200000000000001 111.988 -178.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.667 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 52.5 ttp180 -102.49 144.8 30.47 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.737 -0.665 . . . . 3.02 110.048 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.9 mt -117.23 107.5 14.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.106 -0.497 . . . . 1.1599999999999999 110.838 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 53.4 tp -99.01 101.69 13.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.304 -0.407 . . . . 1.1000000000000001 110.499 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.1 162.64 27.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.063 -0.517 . . . . 1.1100000000000001 111.175 -179.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.5 tt -117.27 140.86 38.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.211 -0.45 . . . . 1.1399999999999999 111.207 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 29.4 tpt180 . . . . . 0 C--N 1.331 -0.214 0 CA-C-N 116.016 -0.538 . . . . 2.7000000000000002 110.766 179.82 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.1 t . . . . . 0 C--O 1.235 0.292 0 CA-C-O 120.825 0.345 . . . . 1.26 110.635 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 91.4 mt -84.34 121.65 27.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 1.49 110.945 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -115.6 150.24 36.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.064 -0.516 . . . . 3.0899999999999999 110.921 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 80.9 p -146.43 138.18 24.74 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.385 -0.37 . . . . 1.79 111.274 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.453 HG13 ' HB2' ' A' ' 62' ' ' ARG . 42.0 t -136.99 138.64 45.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.131 -0.486 . . . . 1.26 110.935 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -89.92 112.49 23.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 1.74 111.042 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -115.7 114.05 24.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.011 -0.541 . . . . 1.4099999999999999 110.735 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.605 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 44.2 p90 -95.8 134.42 38.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 2.6600000000000001 111.037 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.529 ' HB2' HD23 ' A' ' 27' ' ' LEU . 14.0 ttp180 -110.94 88.35 2.76 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.416 -0.357 . . . . 3.5899999999999999 111.101 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -157.75 64.19 0.47 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.977 0.418 . . . . 2.5800000000000001 110.998 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -145.64 34.52 1.04 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.303 0.573 . . . . 4.1900000000000004 110.774 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 17.7 t70 59.01 25.34 13.73 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.119 -0.946 . . . . 2.8700000000000001 110.903 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 82.7 p -92.52 -28.24 16.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.338 -0.392 . . . . 1.74 111.213 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 99.0 p 49.62 24.84 1.27 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.811 -0.631 . . . . 2.79 111.505 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 80.9 p -160.0 144.98 15.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.938 0.399 . . . . 1.79 111.075 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.529 HD23 ' HB2' ' A' ' 20' ' ' ARG . 71.7 mt -101.33 -24.41 14.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.056 -0.52 . . . . 1.1299999999999999 110.66 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.09 -9.32 75.23 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.802 -0.713 . . . . 0.52000000000000002 112.648 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.41 HD12 HD12 ' A' ' 89' ' ' LEU . 68.5 mt -58.93 108.56 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.849 0.357 . . . . 1.53 110.877 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 44.4 t -111.79 109.88 19.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.141 -0.481 . . . . 1.4099999999999999 110.79 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 38.3 pt -101.46 172.18 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.028 -0.533 . . . . 1.1799999999999999 111.205 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 57.0 m -146.35 137.92 24.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.476 . . . . 1.79 110.933 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.268 0 C-N-CA 120.842 -0.694 . . . . 1.04 112.593 -179.931 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 47.4 mm . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.832 0.349 . . . . 1.28 110.942 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 48.3 p90 -156.97 142.28 17.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.124 -0.489 . . . . 1.0800000000000001 110.969 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 89.0 t -85.78 135.03 25.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 1.0600000000000001 111.006 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -123.65 -20.96 5.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.495 . . . . 2.8900000000000001 111.081 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.7 t -140.31 161.22 38.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.988 0.423 . . . . 1.8700000000000001 111.447 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 96.5 mt -136.6 127.16 26.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.748 -0.66 . . . . 1.1899999999999999 110.569 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 50.8 mm -63.52 112.54 7.35 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.313 -0.403 . . . . 1.8500000000000001 110.899 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.47 102.1 0.39 Allowed 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.398 2.066 . . . . 1.26 112.252 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 129.65 -0.58 5.88 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.794 -0.717 . . . . 0.52000000000000002 112.489 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.9 m -98.2 174.19 6.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.678 0.275 . . . . 1.73 110.903 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -55.75 -58.59 7.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 1.1299999999999999 111.648 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.422 ' HB2' HD11 ' A' ' 63' ' ' ILE . . . -50.72 -32.23 18.91 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.357 -0.383 . . . . 1.0900000000000001 111.479 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.91 -32.79 40.2 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.308 -0.406 . . . . 1.1100000000000001 111.627 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 79.9 mt -63.52 -55.94 19.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.377 -0.374 . . . . 1.29 111.114 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -55.13 -37.06 66.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.246 -0.433 . . . . 1.8600000000000001 111.04 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 62.94 7.17 15.08 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.985 -0.626 . . . . 1.4199999999999999 112.896 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.453 ' HB2' HG13 ' A' ' 16' ' ' VAL . 34.9 mtp180 -82.86 3.28 30.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.738 0.304 . . . . 3.0499999999999998 110.926 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.422 HD11 ' HB2' ' A' ' 57' ' ' ALA . 61.7 mt -110.54 133.51 55.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 1.6299999999999999 110.982 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 20.2 tp10 -108.08 125.39 32.14 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.475 . . . . 1.98 110.787 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -54.66 174.38 0.19 Allowed 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.628 2.219 . . . . 1.4399999999999999 112.168 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.568 ' N ' HD21 ' A' ' 66' ' ' ASN . 0.8 OUTLIER 60.79 25.87 15.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.199 -0.455 . . . . 2.6299999999999999 110.549 -179.66 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -95.7 155.58 16.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.926 -0.579 . . . . 2.02 110.578 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -104.95 109.32 21.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.407 -0.36 . . . . 1.6200000000000001 110.984 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 41.1 mm -68.7 132.52 32.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.113 -0.494 . . . . 1.1100000000000001 110.952 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 76.6 mt -104.12 -63.85 1.16 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.128 -0.487 . . . . 1.1299999999999999 110.814 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -149.59 136.56 19.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.161 0.505 . . . . 3.1499999999999999 111.518 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.457 HG11 ' H ' ' A' ' 73' ' ' ASP . 9.9 t -89.88 171.14 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.593 -0.73 . . . . 1.0900000000000001 109.866 179.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.692 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 14.0 t70 -48.26 108.53 0.17 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.789 0.328 . . . . 0.79000000000000004 111.817 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.5 t70 58.48 6.99 0.64 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.919 -0.582 . . . . 2.0099999999999998 112.328 178.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.1 t -137.85 99.54 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.695 0.283 . . . . 1.1499999999999999 111.435 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -72.57 152.08 42.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.214 -0.448 . . . . 2.8500000000000001 110.769 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.4 m -119.92 26.11 3.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.36 -0.382 . . . . 1.26 111.269 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -91.22 27.58 1.86 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 1.74 111.13 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -175.18 19.91 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.532 -0.842 . . . . 0.57999999999999996 112.905 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 45.7 mtm -120.95 139.46 53.22 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.858 0.361 . . . . 1.1200000000000001 111.0 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.446 ' O ' HG21 ' A' ' 85' ' ' VAL . . . -65.16 156.56 31.32 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.976 -0.556 . . . . 1.1200000000000001 111.108 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -44.75 -44.14 9.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.369 -0.378 . . . . 1.52 111.386 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 48.2 t -58.71 -53.16 61.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.295 -0.411 . . . . 2.0299999999999998 111.404 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -54.52 -39.14 67.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 2.1200000000000001 111.429 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.446 HG21 ' O ' ' A' ' 81' ' ' ALA . 21.1 t -62.29 -41.44 91.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.426 -0.352 . . . . 1.0800000000000001 111.221 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.535 HG11 HH21 ' A' ' 90' ' ' ARG . 85.8 t -63.23 -43.31 98.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.245 -0.434 . . . . 1.0700000000000001 111.148 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -57.74 -46.63 84.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.301 -0.409 . . . . 1.51 111.207 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 71.9 t -56.37 -58.03 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.984 0.421 . . . . 1.0600000000000001 111.345 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.41 HD12 HD12 ' A' ' 29' ' ' ILE . 75.8 mt -60.01 -23.98 64.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.971 -0.558 . . . . 1.1399999999999999 111.297 -179.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.535 HH21 HG11 ' A' ' 86' ' ' VAL . 2.1 tpp180 -89.28 -12.48 40.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.242 -0.436 . . . . 2.5600000000000001 111.432 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -103.92 -9.64 18.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.612 -0.267 . . . . 1.8100000000000001 111.143 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -50.18 -78.72 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.296 -0.411 . . . . 1.1100000000000001 111.458 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.401 ' HA2' ' HE ' ' A' ' 20' ' ' ARG . . . 61.02 19.39 56.68 Favored Glycine 0 C--N 1.331 0.25 0 C-N-CA 120.712 -0.756 . . . . 0.77000000000000002 112.281 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -147.09 169.83 8.75 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 110.433 -0.21 . . . . 3.3300000000000001 110.433 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.605 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 23.0 Cg_exo -65.9 93.23 0.27 Allowed 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.196 1.931 . . . . 0.92000000000000004 111.644 178.386 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 29.8 m -101.96 153.4 5.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.043 0.449 . . . . 1.3200000000000001 111.876 -179.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.692 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 80.0 ttt180 -98.55 144.6 27.69 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.605 -0.725 . . . . 3.02 110.182 179.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 18.2 mt -118.05 103.56 10.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.091 -0.504 . . . . 1.1599999999999999 110.867 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 34.2 tp -97.96 104.59 16.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.879 0.371 . . . . 1.1000000000000001 110.519 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -133.93 158.96 42.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.092 -0.503 . . . . 1.1100000000000001 111.351 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 17.3 tt -105.32 135.33 43.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.102 -0.499 . . . . 1.1399999999999999 110.273 179.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 32.4 tpt180 . . . . . 0 C--N 1.331 -0.231 0 CA-C-O 120.869 0.366 . . . . 2.7000000000000002 111.379 -179.28 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 44.6 t . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.749 0.309 . . . . 1.26 110.547 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 88.3 mt -85.46 121.75 28.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.281 -0.418 . . . . 1.49 111.126 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -113.79 148.29 36.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.992 -0.549 . . . . 3.0899999999999999 110.893 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.3 m -144.55 136.62 26.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 1.79 111.286 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 33.2 t -135.51 132.55 51.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.027 -0.533 . . . . 1.26 110.599 179.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -93.3 124.65 37.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.292 -0.413 . . . . 1.74 111.398 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -119.63 151.8 38.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.896 -0.593 . . . . 1.4099999999999999 110.725 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.524 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 19.2 m-85 -123.14 106.52 10.84 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.108 -0.496 . . . . 2.6600000000000001 110.462 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.451 ' HE ' ' HA2' ' A' ' 93' ' ' GLY . 5.0 ttp180 -97.56 126.16 42.69 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.56 -0.456 . . . . 3.5899999999999999 110.813 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -141.61 -36.25 0.44 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.117 -0.492 . . . . 2.5800000000000001 110.957 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -68.47 154.25 42.2 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.956 -0.566 . . . . 4.1900000000000004 110.883 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -84.43 56.5 3.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 2.8700000000000001 111.017 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 65.9 p -92.59 -21.16 20.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.306 -0.406 . . . . 1.74 110.994 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.1 t 58.0 18.56 5.2 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.759 -0.655 . . . . 2.79 111.461 179.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.2 t -154.59 141.48 19.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.835 0.35 . . . . 1.79 110.928 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.8 mt -107.95 -15.03 14.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 1.1299999999999999 110.793 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.405 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 108.34 13.69 18.48 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.669 -0.776 . . . . 0.52000000000000002 112.691 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.42 HG21 HG21 ' A' ' 48' ' ' VAL . 76.8 mt -97.56 113.38 31.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.816 0.341 . . . . 1.53 111.058 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.2 t -113.3 103.41 11.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.241 -0.436 . . . . 1.4099999999999999 110.814 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 31.7 pt -101.54 147.48 8.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.247 -0.433 . . . . 1.1799999999999999 111.256 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 71.5 m -114.25 130.73 56.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.479 . . . . 1.79 110.712 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 C-N-CA 120.813 -0.708 . . . . 1.04 112.467 -179.942 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 50.4 mm . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.719 0.295 . . . . 1.28 110.967 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 25.0 p90 -152.54 135.03 15.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.891 0.377 . . . . 1.0800000000000001 111.214 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.42 HG21 HG21 ' A' ' 29' ' ' ILE . 85.3 t -70.72 112.99 6.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.123 -0.49 . . . . 1.0600000000000001 110.834 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -88.52 -29.39 20.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.866 -0.606 . . . . 2.8900000000000001 111.076 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 78.3 p -156.06 171.27 20.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.006 0.432 . . . . 1.8700000000000001 111.212 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 71.0 mt -128.89 151.7 49.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.911 -0.586 . . . . 1.1899999999999999 110.69 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.405 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 45.5 mm -84.02 113.41 47.71 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 1.8500000000000001 110.921 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -58.5 132.11 46.53 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.576 2.184 . . . . 1.26 112.506 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.56 11.17 78.13 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.9 -0.667 . . . . 0.52000000000000002 112.846 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.2 t -99.71 170.32 8.64 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.656 0.265 . . . . 1.73 111.055 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -56.52 -54.62 43.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.332 -0.395 . . . . 1.1299999999999999 111.489 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -49.18 -44.07 42.65 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.04 -0.527 . . . . 1.0900000000000001 111.533 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.79 -33.58 75.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.48 . . . . 1.1100000000000001 111.477 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 90.9 mt -65.9 -33.42 75.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.378 -0.374 . . . . 1.29 111.187 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -58.8 -46.59 87.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.954 0.407 . . . . 1.8600000000000001 110.764 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.95 -33.46 3.55 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.839 -0.696 . . . . 1.4199999999999999 112.554 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 58.5 mtp180 -67.71 -22.14 65.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.805 0.336 . . . . 3.0499999999999998 110.735 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 70.0 mt -93.84 115.41 32.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.485 . . . . 1.6299999999999999 110.924 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.448 ' HB2' ' HD2' ' A' ' 65' ' ' PRO . 13.5 pt-20 -118.71 158.6 46.99 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.111 -0.495 . . . . 1.98 110.531 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.448 ' HD2' ' HB2' ' A' ' 64' ' ' GLU . 21.2 Cg_endo -59.27 178.05 0.33 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.38 2.053 . . . . 1.4399999999999999 112.216 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 18.2 m120 55.5 34.94 24.09 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.166 -0.47 . . . . 2.6299999999999999 110.809 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.492 ' HB2' ' HD3' ' A' ' 102' ' ' ARG . 5.3 t70 -100.42 153.05 19.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.021 -0.536 . . . . 2.02 110.886 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -110.89 95.67 5.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.861 0.363 . . . . 1.6200000000000001 110.758 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.414 HD13 ' HB3' ' A' ' 100' ' ' LEU . 44.8 mm -60.42 132.58 25.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.059 -0.519 . . . . 1.1100000000000001 110.971 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 73.1 mt -100.99 -65.44 0.97 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.036 -0.529 . . . . 1.1299999999999999 110.866 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -150.54 135.18 17.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.16 0.505 . . . . 3.1499999999999999 111.827 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.472 HG12 ' N ' ' A' ' 73' ' ' ASP . 15.7 t -87.96 170.31 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.46 -0.791 . . . . 1.0900000000000001 109.822 179.025 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.649 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 11.8 t70 -46.51 117.95 1.8 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.723 0.297 . . . . 0.79000000000000004 111.593 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.5 p30 47.32 19.4 0.12 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.755 -0.657 . . . . 2.0099999999999998 112.696 179.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.5 t -147.87 100.1 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.655 0.264 . . . . 1.1499999999999999 110.969 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -76.35 144.04 40.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.36 -0.382 . . . . 2.8500000000000001 110.814 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.6 m -117.04 30.41 2.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.36 -0.382 . . . . 1.26 111.242 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -89.94 41.74 1.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 1.74 111.174 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 157.5 25.77 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.503 -0.856 . . . . 0.57999999999999996 112.982 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 37.1 mtm -117.73 138.73 51.83 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.856 0.36 . . . . 1.1200000000000001 110.742 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.401 ' O ' HG22 ' A' ' 85' ' ' VAL . . . -59.66 160.95 6.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.019 -0.537 . . . . 1.1200000000000001 111.234 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.403 ' O ' HG22 ' A' ' 86' ' ' VAL . 36.2 tt0 -54.12 -57.61 10.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.35 -0.386 . . . . 1.52 111.087 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 79.7 p -49.93 -32.9 15.9 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.209 -0.451 . . . . 2.0299999999999998 111.271 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.404 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 12.4 t70 -69.04 -46.75 67.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.379 -0.373 . . . . 2.1200000000000001 110.969 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.401 HG22 ' O ' ' A' ' 81' ' ' ALA . 15.2 t -64.6 -29.16 46.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.99 0.424 . . . . 1.0800000000000001 110.953 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.403 HG22 ' O ' ' A' ' 82' ' ' GLN . 95.9 t -66.18 -58.58 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.964 -0.562 . . . . 1.0700000000000001 111.287 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 84' ' ' ASP . 13.6 pt-20 -54.16 -36.59 63.51 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.495 -0.32 . . . . 1.51 110.975 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 51.7 t -57.11 -56.1 16.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.889 0.376 . . . . 1.0600000000000001 111.041 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 65.4 mt -57.72 -27.25 62.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.001 -0.545 . . . . 1.1399999999999999 111.192 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -86.83 -17.63 32.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.335 -0.393 . . . . 2.5600000000000001 111.302 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -91.47 -13.24 32.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.459 -0.337 . . . . 1.8100000000000001 110.923 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -50.48 -84.18 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.099 -0.5 . . . . 1.1100000000000001 111.529 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.451 ' HA2' ' HE ' ' A' ' 20' ' ' ARG . . . 62.79 17.77 58.47 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.8 -0.714 . . . . 0.77000000000000002 112.532 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.407 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -146.94 172.82 4.76 Favored Pre-proline 0 C--N 1.328 -0.354 0 C-N-CA 121.974 0.11 . . . . 3.3300000000000001 110.922 -179.734 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.524 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 32.0 Cg_exo -61.43 92.22 0.11 Allowed 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 122.233 1.955 . . . . 0.92000000000000004 111.497 178.086 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.0 m -97.0 144.97 9.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.93 0.395 . . . . 1.3200000000000001 111.855 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.649 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 75.2 ttt180 -101.64 143.2 31.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.766 -0.652 . . . . 3.02 109.711 179.121 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 36.6 mt -113.35 107.16 15.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.189 -0.46 . . . . 1.1599999999999999 111.334 -179.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 33.6 tp -100.07 99.84 10.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.411 -0.358 . . . . 1.1000000000000001 110.294 179.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.414 ' HB3' HD13 ' A' ' 69' ' ' ILE . 0.4 OUTLIER -127.99 164.42 22.38 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.224 -0.444 . . . . 1.1100000000000001 111.379 -179.507 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.3 tt -118.02 139.25 45.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 116.087 -0.506 . . . . 1.1399999999999999 111.133 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.492 ' HD3' ' HB2' ' A' ' 67' ' ' ASP . 15.5 mmm180 . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 115.738 -0.664 . . . . 2.7000000000000002 110.867 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.6 t . . . . . 0 C--O 1.233 0.228 0 CA-C-O 120.996 0.427 . . . . 1.26 111.103 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.3 mt -77.33 119.44 20.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.816 -0.629 . . . . 1.49 110.883 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -119.09 163.68 16.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.127 -0.488 . . . . 3.0899999999999999 110.859 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 84.4 p -151.63 146.88 26.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.878 0.371 . . . . 1.79 111.04 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 13.5 t -131.61 136.01 58.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.091 -0.504 . . . . 1.26 110.799 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -89.63 113.19 24.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.289 -0.414 . . . . 1.74 111.364 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -118.0 166.04 13.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.904 -0.589 . . . . 1.4099999999999999 110.64 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.516 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 30.9 p90 -158.92 128.59 5.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.276 -0.42 . . . . 2.6600000000000001 111.104 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.673 HH21 ' HG ' ' A' ' 27' ' ' LEU . 21.0 ttm180 -101.47 82.72 2.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.905 0.383 . . . . 3.5899999999999999 110.835 179.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -97.99 -18.05 18.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.05 -0.523 . . . . 2.5800000000000001 110.747 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -95.11 144.95 25.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.034 -0.53 . . . . 4.1900000000000004 110.644 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -81.06 70.93 8.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.306 -0.406 . . . . 2.8700000000000001 110.749 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 72.2 p -108.21 -9.85 15.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 1.74 111.138 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 83.3 p 51.99 22.51 1.85 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.788 -0.642 . . . . 2.79 111.211 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 56.3 m -157.09 131.78 8.73 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.306 -0.406 . . . . 1.79 110.962 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.673 ' HG ' HH21 ' A' ' 20' ' ' ARG . 49.7 mt -92.69 -25.24 18.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 1.1299999999999999 110.619 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.528 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 99.6 31.76 5.96 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.819 -0.705 . . . . 0.52000000000000002 112.759 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.413 HG23 HG21 ' A' ' 31' ' ' ILE . 45.4 mt -109.32 108.69 25.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.661 0.267 . . . . 1.53 110.926 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 46.5 m -104.14 90.22 3.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.345 -0.388 . . . . 1.4099999999999999 110.884 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.415 HG13 ' NE2' ' A' ' 82' ' ' GLN . 28.7 pt -88.3 165.98 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.0 -0.545 . . . . 1.1799999999999999 111.295 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 53.2 m -142.85 136.42 28.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.121 -0.49 . . . . 1.79 110.909 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 0.23 0 C-N-CA 120.87 -0.681 . . . . 1.04 112.769 -179.802 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 45.4 mm . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.765 0.317 . . . . 1.28 110.965 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 51.6 p90 -144.18 152.95 41.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.247 -0.433 . . . . 1.0800000000000001 111.165 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 81.3 t -86.77 123.58 39.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.077 -0.51 . . . . 1.0600000000000001 110.898 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -99.49 -26.91 13.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.072 -0.513 . . . . 2.8900000000000001 110.941 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 64.0 m -151.85 170.64 19.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.308 -0.405 . . . . 1.8700000000000001 111.122 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.5 mt -133.91 146.85 50.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.04 -0.527 . . . . 1.1899999999999999 110.77 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.528 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 44.0 mm -90.06 108.64 27.43 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.239 -0.437 . . . . 1.8500000000000001 110.892 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -60.94 138.09 76.54 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.351 2.034 . . . . 1.26 112.287 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 98.39 -11.12 63.4 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.75 -0.738 . . . . 0.52000000000000002 112.499 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.1 m -89.44 -176.25 4.98 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.699 0.285 . . . . 1.73 110.963 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.73 -58.98 3.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 1.1299999999999999 111.45 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.13 -32.13 45.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.13 -0.486 . . . . 1.0900000000000001 111.649 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.81 -49.59 17.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.44 -0.345 . . . . 1.1100000000000001 111.447 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.8 mt -63.24 -19.97 65.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.417 -0.356 . . . . 1.29 111.084 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -58.86 -55.27 37.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.357 -0.383 . . . . 1.8600000000000001 110.852 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.3 -44.46 1.61 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.74 -0.743 . . . . 1.4199999999999999 112.832 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 20.3 mtp180 -61.42 -29.28 69.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.635 0.255 . . . . 3.0499999999999998 111.2 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 55.6 mt -85.49 109.18 18.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.914 0.388 . . . . 1.6299999999999999 111.128 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.566 ' HB3' HH12 ' A' ' 102' ' ' ARG . 36.7 tt0 -111.23 139.28 21.74 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.947 -0.57 . . . . 1.98 110.296 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -47.27 165.64 0.1 Allowed 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.504 2.136 . . . . 1.4399999999999999 112.643 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 64.04 54.17 1.73 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.002 -0.545 . . . . 2.6299999999999999 110.831 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -128.42 160.99 30.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.846 -0.616 . . . . 2.02 110.269 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.464 ' HB3' HG23 ' A' ' 101' ' ' ILE . 88.0 tttt -110.35 122.56 47.99 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.828 0.347 . . . . 1.6200000000000001 111.244 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.405 HD13 ' HB3' ' A' ' 100' ' ' LEU . 36.3 mm -90.17 145.85 6.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.173 -0.467 . . . . 1.1100000000000001 110.699 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 87.2 mt -115.74 -65.8 1.15 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.257 -0.429 . . . . 1.1299999999999999 111.274 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.447 ' HG2' HD21 ' A' ' 99' ' ' LEU . 15.8 ptm180 -149.88 137.15 19.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.252 0.549 . . . . 3.1499999999999999 112.037 -179.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.542 HG11 ' H ' ' A' ' 73' ' ' ASP . 11.5 t -84.82 175.22 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.505 -0.771 . . . . 1.0900000000000001 109.409 178.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.644 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 8.8 t70 -47.69 108.07 0.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.954 0.407 . . . . 0.79000000000000004 111.684 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 52.3 19.03 1.01 Allowed 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.599 0.592 . . . . 2.0099999999999998 112.599 179.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.9 t -146.38 102.14 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.63 0.252 . . . . 1.1499999999999999 111.335 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -62.85 152.76 35.24 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.538 -0.301 . . . . 2.8500000000000001 110.663 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.1 m -143.07 49.98 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 120.791 0.329 . . . . 1.26 111.862 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -143.3 21.33 1.89 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.069 0.461 . . . . 1.74 110.561 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -142.97 -4.21 0.85 Allowed Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.731 -0.668 . . . . 0.57999999999999996 112.259 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 71.1 mtm -108.16 173.89 6.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.822 0.344 . . . . 1.1200000000000001 110.719 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.17 166.28 18.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.212 -0.449 . . . . 1.1200000000000001 111.104 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.415 ' NE2' HG13 ' A' ' 31' ' ' ILE . 7.8 tp60 -58.94 -58.39 8.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 1.52 110.948 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 45.0 t -51.75 -39.82 59.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.026 -0.534 . . . . 2.0299999999999998 111.295 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -57.28 -44.92 84.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.345 -0.389 . . . . 2.1200000000000001 110.835 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 55.6 t -61.24 -38.4 79.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.223 -0.444 . . . . 1.0800000000000001 110.926 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 17.9 t -63.93 -39.62 86.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 1.0700000000000001 110.995 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -58.62 -51.83 68.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.285 -0.416 . . . . 1.51 110.75 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 63.6 t -52.83 -53.58 20.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 1.0600000000000001 111.431 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 80.0 mt -58.44 -30.92 67.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.049 -0.523 . . . . 1.1399999999999999 111.366 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 73.2 mtm180 -85.81 -13.6 47.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.42 -0.354 . . . . 2.5600000000000001 111.175 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -93.86 -13.76 26.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.405 -0.361 . . . . 1.8100000000000001 110.917 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.15 -83.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.213 -0.449 . . . . 1.1100000000000001 111.432 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.498 ' H ' ' HD2' ' A' ' 20' ' ' ARG . . . 63.76 13.2 50.89 Favored Glycine 0 CA--C 1.517 0.216 0 C-N-CA 120.664 -0.779 . . . . 0.77000000000000002 112.419 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.414 HD21 ' C ' ' A' ' 94' ' ' ASN . 0.2 OUTLIER -146.78 170.4 7.87 Favored Pre-proline 0 C--N 1.329 -0.318 0 O-C-N 122.999 -0.118 . . . . 3.3300000000000001 110.82 -179.725 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.516 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 31.8 Cg_exo -60.55 106.27 0.35 Allowed 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.241 1.961 . . . . 0.92000000000000004 111.669 178.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 34.7 m -114.33 154.37 15.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.95 0.405 . . . . 1.3200000000000001 111.699 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.644 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 73.7 ttt180 -101.9 142.2 33.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.833 -0.621 . . . . 3.02 109.932 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 21.8 mt -116.81 109.1 16.67 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.431 -0.35 . . . . 1.1599999999999999 111.271 -179.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.447 HD21 ' HG2' ' A' ' 71' ' ' ARG . 52.4 tp -96.19 103.32 15.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.3 -0.409 . . . . 1.1000000000000001 110.396 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.405 ' HB3' HD13 ' A' ' 69' ' ' ILE . 0.4 OUTLIER -129.8 154.11 47.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.454 . . . . 1.1100000000000001 111.403 -179.557 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.464 HG23 ' HB3' ' A' ' 68' ' ' LYS . 13.9 tt -105.89 136.71 39.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-N 116.157 -0.474 . . . . 1.1399999999999999 110.773 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.566 HH12 ' HB3' ' A' ' 64' ' ' GLU . 29.1 mmm-85 . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 115.741 -0.663 . . . . 2.7000000000000002 110.429 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.0 t . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 120.732 0.301 . . . . 1.26 110.628 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 91.4 mt -76.71 121.51 23.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.244 -0.434 . . . . 1.49 110.824 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -113.38 155.18 25.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.978 -0.555 . . . . 3.0899999999999999 110.862 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 48.3 t -151.35 132.69 14.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.271 -0.422 . . . . 1.79 111.154 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.4 t -131.56 128.77 61.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.11 -0.495 . . . . 1.26 110.676 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -92.7 119.15 31.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 1.74 111.525 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.416 HD11 HD11 ' A' ' 98' ' ' LEU . 19.6 mt -119.16 113.09 20.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.093 -0.503 . . . . 1.4099999999999999 110.542 179.311 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.621 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 33.1 m-85 -79.58 114.21 18.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.092 -0.504 . . . . 2.6600000000000001 111.022 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.518 ' HG2' ' HA2' ' A' ' 93' ' ' GLY . 20.3 ttt180 -100.16 104.9 16.46 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.836 0.35 . . . . 3.5899999999999999 110.565 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -147.63 11.25 0.98 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.277 -0.42 . . . . 2.5800000000000001 111.019 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -94.7 156.44 16.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 4.1900000000000004 110.67 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -83.06 53.33 2.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.348 -0.387 . . . . 2.8700000000000001 110.69 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.2 p -120.31 -29.27 4.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 1.74 110.95 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.432 ' HA ' ' NH2' ' A' ' 20' ' ' ARG . 41.2 t 59.61 14.88 4.24 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.691 -0.686 . . . . 2.79 111.153 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 47.6 t -125.05 132.81 53.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 1.79 110.699 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.2 mt -102.27 -11.8 18.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 1.1299999999999999 110.697 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.478 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 87.02 6.67 78.83 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.812 -0.709 . . . . 0.52000000000000002 112.584 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.401 HG23 HG21 ' A' ' 48' ' ' VAL . 67.7 mt -85.1 109.0 17.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.713 0.292 . . . . 1.53 111.026 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.5 m -113.84 99.81 7.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.37 -0.377 . . . . 1.4099999999999999 110.822 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 36.7 pt -92.49 152.46 3.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.196 -0.456 . . . . 1.1799999999999999 111.343 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.9 p -108.07 133.25 52.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.033 -0.531 . . . . 1.79 110.994 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 0.303 0 C-N-CA 120.904 -0.665 . . . . 1.04 112.529 179.964 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 50.5 mm . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.758 0.313 . . . . 1.28 110.913 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -153.67 137.23 15.96 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.362 -0.381 . . . . 1.0800000000000001 111.203 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.401 HG21 HG23 ' A' ' 29' ' ' ILE . 91.1 t -63.41 119.11 6.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.15 -0.477 . . . . 1.0600000000000001 110.888 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -98.1 -26.04 14.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.81 -0.632 . . . . 2.8900000000000001 110.952 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 79.8 p -153.56 162.32 41.37 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.926 0.393 . . . . 1.8700000000000001 111.31 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.2 mt -123.84 156.03 36.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.96 -0.564 . . . . 1.1899999999999999 110.774 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.478 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 49.4 mm -99.28 114.02 65.23 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.312 -0.403 . . . . 1.8500000000000001 110.871 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -62.15 119.73 6.97 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.446 2.097 . . . . 1.26 112.196 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.34 7.76 29.93 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.893 -0.67 . . . . 0.52000000000000002 112.514 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.4 m -105.75 -174.48 2.54 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.626 0.251 . . . . 1.73 110.941 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.65 -47.38 66.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.888 0.375 . . . . 1.1299999999999999 111.14 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.523 ' HB1' HG22 ' A' ' 63' ' ' ILE . . . -57.31 -41.15 79.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.939 -0.573 . . . . 1.0900000000000001 111.533 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.49 -53.53 15.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 1.1100000000000001 111.593 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 98.5 mt -60.55 -19.78 58.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.366 -0.379 . . . . 1.29 111.295 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -62.34 -55.41 28.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.811 0.338 . . . . 1.8600000000000001 110.795 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 105.59 -49.75 0.87 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.826 -0.702 . . . . 1.4199999999999999 112.752 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -68.26 -23.41 64.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.739 0.304 . . . . 3.0499999999999998 111.126 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.523 HG22 ' HB1' ' A' ' 57' ' ' ALA . 39.5 mm -76.12 123.62 32.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.826 0.346 . . . . 1.6299999999999999 110.937 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -111.9 155.05 43.85 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.138 -0.483 . . . . 1.98 111.028 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -78.81 36.95 0.63 Allowed 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.943 2.429 . . . . 1.4399999999999999 112.259 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -169.29 75.93 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.296 -0.411 . . . . 2.6299999999999999 110.872 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -143.28 150.01 38.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 2.02 110.877 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.439 ' HB3' HG21 ' A' ' 101' ' ' ILE . 87.7 tttt -90.62 114.68 27.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.828 0.346 . . . . 1.6200000000000001 111.129 -179.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.497 HD13 ' HB3' ' A' ' 100' ' ' LEU . 41.0 mm -84.16 137.54 20.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.215 -0.448 . . . . 1.1100000000000001 110.729 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 65.8 mt -117.08 -65.04 1.23 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.434 . . . . 1.1299999999999999 111.17 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -131.07 163.7 27.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.097 -0.501 . . . . 3.1499999999999999 111.703 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.5 HG12 ' N ' ' A' ' 73' ' ' ASP . 44.8 t -127.97 167.64 22.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.566 -0.743 . . . . 1.0900000000000001 109.562 179.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.636 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 7.7 t70 -41.6 108.11 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.5 0.555 . . . . 0.79000000000000004 112.5 -179.384 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 56.66 2.76 0.1 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.468 0.914 . . . . 2.0099999999999998 113.468 178.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.444 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 84.7 t -143.57 112.79 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.679 0.276 . . . . 1.1499999999999999 111.534 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -68.75 163.26 24.43 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.005 -0.368 . . . . 2.8500000000000001 110.005 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.7 m -134.38 0.08 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.718 0.294 . . . . 1.26 111.651 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -91.5 109.32 20.61 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 120.883 0.373 . . . . 1.74 110.385 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 125.57 -12.94 7.38 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.843 -0.694 . . . . 0.57999999999999996 112.516 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 74.4 mtm -105.44 158.66 16.5 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.839 0.352 . . . . 1.1200000000000001 110.996 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.39 162.19 15.53 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.198 -0.455 . . . . 1.1200000000000001 111.328 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -56.77 -46.38 81.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.329 -0.396 . . . . 1.52 111.136 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 85.4 p -53.42 -41.24 65.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.234 -0.439 . . . . 2.0299999999999998 111.162 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -66.02 -44.04 85.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.296 -0.411 . . . . 2.1200000000000001 111.13 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 57.7 t -58.34 -39.8 75.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.154 -0.476 . . . . 1.0800000000000001 111.372 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 64.7 t -68.04 -43.52 85.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.496 -0.32 . . . . 1.0700000000000001 111.145 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -57.35 -43.67 83.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.355 -0.384 . . . . 1.51 110.944 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 57.3 t -61.16 -55.47 24.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.46 . . . . 1.0600000000000001 111.181 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 90.8 mt -52.62 -27.56 17.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.974 -0.557 . . . . 1.1399999999999999 111.301 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 74.4 mtm180 -89.17 -28.25 20.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.286 -0.415 . . . . 2.5600000000000001 111.271 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -74.07 -14.99 61.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.399 -0.364 . . . . 1.8100000000000001 110.693 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.475 ' HB3' ' HD3' ' A' ' 20' ' ' ARG . . . -54.33 -81.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.994 -0.548 . . . . 1.1100000000000001 111.364 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.518 ' HA2' ' HG2' ' A' ' 20' ' ' ARG . . . 61.1 17.42 51.93 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.655 -0.783 . . . . 0.77000000000000002 112.139 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.431 HD21 ' C ' ' A' ' 94' ' ' ASN . 0.2 OUTLIER -147.13 170.88 7.05 Favored Pre-proline 0 CA--C 1.534 0.329 0 C-N-CA 122.06 0.144 . . . . 3.3300000000000001 110.877 -179.824 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.621 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 47.4 Cg_exo -58.25 104.2 0.17 Allowed 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.081 1.854 . . . . 0.92000000000000004 111.555 178.299 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 23.6 m -112.68 155.1 14.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.041 0.448 . . . . 1.3200000000000001 112.011 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.636 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 35.3 ttp180 -111.46 145.25 39.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.695 -0.684 . . . . 3.02 109.949 179.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.416 HD11 HD11 ' A' ' 18' ' ' LEU . 25.9 mt -110.02 124.1 50.86 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.356 -0.383 . . . . 1.1599999999999999 111.255 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 32.7 tp -109.88 101.08 9.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.332 -0.395 . . . . 1.1000000000000001 110.245 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.497 ' HB3' HD13 ' A' ' 69' ' ' ILE . 0.4 OUTLIER -130.55 160.67 33.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 1.1100000000000001 111.396 -179.467 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.439 HG21 ' HB3' ' A' ' 68' ' ' LYS . 12.6 tt -116.08 141.92 31.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.873 -0.603 . . . . 1.1399999999999999 110.896 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 32.3 tpt180 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.043 -0.526 . . . . 2.7000000000000002 110.979 -179.761 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 44.2 t . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.827 0.346 . . . . 1.26 110.869 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 62.6 mt -77.55 126.37 30.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.06 -0.518 . . . . 1.49 110.824 179.826 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -123.65 130.42 52.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.12 -0.491 . . . . 3.0899999999999999 111.023 179.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 80.8 p -120.42 139.26 53.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.285 -0.416 . . . . 1.79 111.091 -179.815 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.3 t -131.58 146.4 33.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.116 -0.493 . . . . 1.26 110.743 179.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -103.0 114.04 28.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.381 -0.372 . . . . 1.74 111.386 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.41 HD12 ' HB3' ' A' ' 56' ' ' ALA . 4.6 mm? -115.5 166.1 12.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.079 -0.509 . . . . 1.4099999999999999 110.702 179.537 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.526 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 37.9 p90 -159.51 131.69 6.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.277 -0.42 . . . . 2.6600000000000001 111.053 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.671 HH21 ' HG ' ' A' ' 27' ' ' LEU . 27.8 ttm180 -109.85 130.86 55.47 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.68 -0.408 . . . . 3.5899999999999999 110.879 179.635 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -134.67 6.68 3.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.01 -0.541 . . . . 2.5800000000000001 110.73 179.777 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -112.47 162.7 15.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.007 -0.542 . . . . 4.1900000000000004 110.788 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -86.7 42.98 1.05 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.262 -0.426 . . . . 2.8700000000000001 110.958 -179.911 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 69.3 p -86.98 -13.01 45.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 1.74 111.339 -179.924 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 94.8 p 50.56 24.56 1.67 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.778 -0.646 . . . . 2.79 111.504 179.89 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 80.5 p -158.7 153.32 24.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.297 -0.41 . . . . 1.79 110.904 -179.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.671 ' HG ' HH21 ' A' ' 20' ' ' ARG . 84.0 mt -107.76 -13.17 15.07 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.012 -0.54 . . . . 1.1299999999999999 110.998 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.514 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 100.69 18.94 19.25 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.828 -0.701 . . . . 0.52000000000000002 112.741 179.748 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 78.2 mt -97.52 112.46 29.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.702 0.287 . . . . 1.53 110.694 179.751 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.9 t -110.12 101.93 10.68 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.337 -0.392 . . . . 1.4099999999999999 111.019 -179.713 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.411 ' HA ' ' HA ' ' A' ' 48' ' ' VAL . 33.2 pt -92.33 163.41 2.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.967 -0.56 . . . . 1.1799999999999999 110.914 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 47.9 t -147.33 156.69 43.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.179 -0.464 . . . . 1.79 110.782 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.247 0 C-N-CA 120.722 -0.752 . . . . 1.04 112.558 -179.953 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 42.8 mm . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.784 0.326 . . . . 1.28 110.806 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -132.52 141.17 48.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 1.0800000000000001 111.074 -179.888 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 31' ' ' ILE . 97.8 t -80.19 111.86 17.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.147 -0.479 . . . . 1.0600000000000001 110.51 179.444 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -84.39 -34.67 23.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.092 -0.503 . . . . 2.8900000000000001 111.284 -179.607 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 83.0 p -151.06 179.07 8.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.064 0.459 . . . . 1.8700000000000001 111.527 -179.718 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 66.6 mt -134.06 160.84 36.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.725 -0.67 . . . . 1.1899999999999999 110.558 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.514 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 53.2 mt -96.54 108.55 43.1 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.257 -0.429 . . . . 1.8500000000000001 111.12 179.954 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -59.34 127.54 24.29 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.348 2.032 . . . . 1.26 112.324 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 104.69 -2.68 42.1 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.763 -0.732 . . . . 0.52000000000000002 112.549 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.45 ' HG ' ' HB ' ' A' ' 52' ' ' ILE . 49.6 m -95.68 -179.03 4.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.659 0.266 . . . . 1.73 110.99 -179.998 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.41 ' HB3' HD12 ' A' ' 18' ' ' LEU . . . -65.69 -55.44 17.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.36 -0.382 . . . . 1.1299999999999999 111.189 179.937 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.72 -33.05 63.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.061 -0.518 . . . . 1.0900000000000001 111.413 -179.852 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.38 -50.47 31.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.259 -0.428 . . . . 1.1100000000000001 111.442 -179.739 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.2 mt -61.4 -21.27 63.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.312 -0.404 . . . . 1.29 111.123 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -60.66 -54.72 41.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.405 -0.361 . . . . 1.8600000000000001 110.977 -179.782 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.34 -46.85 1.79 Allowed Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.742 -0.742 . . . . 1.4199999999999999 112.927 179.458 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 66.9 mtp180 -56.45 -39.27 72.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.772 0.32 . . . . 3.0499999999999998 110.991 -179.772 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 64.6 mt -68.57 108.55 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 1.6299999999999999 110.883 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -107.29 137.41 19.6 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.038 -0.528 . . . . 1.98 110.715 -179.702 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -54.91 175.64 0.15 Allowed 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.571 2.181 . . . . 1.4399999999999999 112.278 179.855 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 59.32 44.48 15.28 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.031 0.443 . . . . 2.6299999999999999 110.285 -179.632 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -119.51 167.22 12.18 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.895 -0.593 . . . . 2.02 110.807 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -116.71 123.07 46.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.316 -0.402 . . . . 1.6200000000000001 110.962 179.911 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.448 HD12 ' HB3' ' A' ' 100' ' ' LEU . 47.5 mm -81.16 139.11 18.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.159 -0.473 . . . . 1.1100000000000001 111.202 -179.729 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 79.2 mt -105.53 -68.75 0.85 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.906 -0.588 . . . . 1.1299999999999999 110.723 179.844 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -150.24 137.42 19.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 3.1499999999999999 111.21 -179.868 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.581 HG11 ' H ' ' A' ' 73' ' ' ASP . 2.6 t -87.19 175.29 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.712 -0.676 . . . . 1.0900000000000001 110.285 179.579 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.629 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 17.7 t70 -50.49 112.7 0.73 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.773 0.321 . . . . 0.79000000000000004 111.465 179.432 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 56.69 23.23 7.61 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.079 -0.51 . . . . 2.0099999999999998 111.806 179.548 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.447 HG11 HG12 ' A' ' 88' ' ' VAL . 68.2 t -143.74 144.44 23.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.82 0.343 . . . . 1.1499999999999999 110.923 179.855 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -115.69 133.05 56.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.311 -0.404 . . . . 2.8500000000000001 110.504 179.668 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.485 HG12 HG12 ' A' ' 85' ' ' VAL . 31.2 m -121.15 35.49 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.849 0.357 . . . . 1.26 111.722 -179.39 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -97.51 41.46 1.12 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.302 -0.408 . . . . 1.74 111.051 179.948 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.19 36.18 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.449 -0.881 . . . . 0.57999999999999996 113.235 179.77 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.414 ' HE3' ' HA ' ' A' ' 77' ' ' VAL . 52.4 mtm -127.91 158.55 37.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.844 0.354 . . . . 1.1200000000000001 110.849 179.562 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.08 151.5 42.95 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.104 -0.498 . . . . 1.1200000000000001 111.149 -179.935 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -53.57 -55.0 29.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.334 -0.393 . . . . 1.52 111.308 -179.556 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 59.4 m -53.57 -37.37 62.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 2.0299999999999998 111.445 -179.512 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -64.02 -42.35 97.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.478 -0.328 . . . . 2.1200000000000001 110.926 -179.826 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.485 HG12 HG12 ' A' ' 77' ' ' VAL . 48.0 t -61.08 -41.71 90.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.218 -0.447 . . . . 1.0800000000000001 111.05 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 47.8 t -63.3 -39.89 86.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.262 -0.426 . . . . 1.0700000000000001 111.013 179.929 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.417 ' HG2' HH21 ' A' ' 90' ' ' ARG . 47.8 mt-10 -57.72 -48.05 80.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 1.51 111.072 -179.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.447 HG12 HG11 ' A' ' 75' ' ' VAL . 65.7 t -57.26 -55.86 18.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 1.0600000000000001 111.368 -179.889 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 91.4 mt -52.11 -32.64 36.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.028 -0.533 . . . . 1.1399999999999999 111.222 -179.445 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.57 ' HA ' HH22 ' A' ' 20' ' ' ARG . 80.0 mtm180 -81.04 -30.27 34.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.34 -0.391 . . . . 2.5600000000000001 111.291 -179.912 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -68.96 -22.26 64.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.443 -0.344 . . . . 1.8100000000000001 110.707 179.891 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.38 -84.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.093 -0.503 . . . . 1.1100000000000001 111.275 179.778 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.651 ' HA2' ' HD2' ' A' ' 20' ' ' ARG . . . 64.11 19.41 63.73 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.81 -0.709 . . . . 0.77000000000000002 112.555 -179.794 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -146.96 178.63 1.37 Allowed Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 110.263 -0.273 . . . . 3.3300000000000001 110.263 -179.752 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.526 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 33.2 Cg_exo -60.46 102.79 0.2 Allowed 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.07 1.847 . . . . 0.92000000000000004 111.954 178.196 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 30.1 m -121.15 156.79 24.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.062 0.458 . . . . 1.3200000000000001 111.508 -179.552 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.629 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 76.3 ttt180 -101.58 142.51 32.83 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.826 -0.625 . . . . 3.02 110.351 179.791 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 13.1 mt -118.21 111.63 19.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.191 -0.459 . . . . 1.1599999999999999 111.024 -179.6 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 45.1 tp -101.65 103.82 14.64 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.834 0.349 . . . . 1.1000000000000001 110.561 179.489 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.448 ' HB3' HD12 ' A' ' 69' ' ' ILE . 0.5 OUTLIER -132.38 155.14 48.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.125 -0.489 . . . . 1.1100000000000001 111.102 -179.548 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 15.2 tt -103.13 136.92 33.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.194 -0.457 . . . . 1.1399999999999999 111.103 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 115.702 -0.681 . . . . 2.7000000000000002 110.518 179.809 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 46.0 t . . . . . 0 C--O 1.236 0.371 0 CA-C-O 121.015 0.436 . . . . 1.26 111.276 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.475 HD22 ' HB ' ' A' ' 101' ' ' ILE . 17.8 mt -97.21 103.31 15.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.497 -0.774 . . . . 1.49 110.1 179.599 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 36.5 p90 -124.5 151.91 44.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.858 0.361 . . . . 3.0899999999999999 111.119 -179.344 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 48.4 t -120.68 155.81 33.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.024 0.44 . . . . 1.79 111.383 -179.436 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.8 t -131.66 137.69 54.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.758 -0.656 . . . . 1.26 110.416 179.801 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -88.51 114.43 25.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.947 0.403 . . . . 1.74 111.406 -179.491 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -124.95 117.67 24.57 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.892 -0.595 . . . . 1.4099999999999999 110.614 179.614 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.543 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 28.2 p90 -107.66 132.97 52.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.378 -0.374 . . . . 2.6600000000000001 111.053 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.602 ' HE ' ' HA2' ' A' ' 93' ' ' GLY . 20.7 ttp180 -107.78 102.89 12.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.853 0.359 . . . . 3.5899999999999999 110.861 179.56 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -128.08 -3.03 5.75 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.149 -0.478 . . . . 2.5800000000000001 111.113 -179.797 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.417 ' N ' ' HD2' ' A' ' 22' ' ' LYS . 0.9 OUTLIER -83.78 159.77 21.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.306 -0.407 . . . . 4.1900000000000004 110.792 179.825 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -83.32 34.65 0.47 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.468 . . . . 2.8700000000000001 110.978 -179.885 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 50.3 p -92.14 -23.22 19.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.283 -0.417 . . . . 1.74 111.127 -179.872 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.7 m 56.91 24.67 9.62 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.879 -0.601 . . . . 2.79 111.361 179.785 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 52.5 m -147.19 157.9 43.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.359 -0.382 . . . . 1.79 111.053 -179.885 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.555 HD21 ' HB2' ' A' ' 20' ' ' ARG . 86.1 mt -114.98 1.1 13.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.175 -0.466 . . . . 1.1299999999999999 110.981 179.876 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 67.87 23.44 74.22 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.795 -0.717 . . . . 0.52000000000000002 112.735 179.898 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 62.5 mt -97.61 110.01 24.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.648 0.261 . . . . 1.53 110.919 179.896 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 35.9 t -107.54 98.48 8.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.386 -0.37 . . . . 1.4099999999999999 111.01 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 40.6 pt -83.58 159.39 3.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.294 -0.412 . . . . 1.1799999999999999 111.142 -179.878 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 47.9 t -138.7 152.02 47.66 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.049 -0.523 . . . . 1.79 110.989 -179.78 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 C-N-CA 120.772 -0.727 . . . . 1.04 112.471 179.94 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 45.9 mm . . . . . 0 C--O 1.233 0.189 0 CA-C-O 120.752 0.31 . . . . 1.28 111.032 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -152.72 140.9 20.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.283 -0.417 . . . . 1.0800000000000001 110.825 179.796 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 97.0 t -74.48 116.29 16.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.078 -0.51 . . . . 1.0600000000000001 110.869 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -103.9 -25.08 13.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.22 -0.445 . . . . 2.8900000000000001 110.917 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 42.3 t -141.13 165.86 26.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 1.8700000000000001 111.216 -179.926 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.463 HD12 HG21 ' A' ' 63' ' ' ILE . 95.6 mt -136.67 163.64 30.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.913 -0.585 . . . . 1.1899999999999999 110.792 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 50.1 mm -108.02 103.52 50.31 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.321 -0.399 . . . . 1.8500000000000001 111.076 -179.853 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.93 132.1 47.99 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.426 2.084 . . . . 1.26 112.297 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 99.68 -4.9 58.14 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.789 -0.72 . . . . 0.52000000000000002 112.408 -179.779 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.8 t -93.66 167.98 11.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.614 0.245 . . . . 1.73 110.944 -179.876 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -53.91 -57.84 9.5 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.283 -0.417 . . . . 1.1299999999999999 111.704 -179.75 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.35 -43.78 61.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 1.0900000000000001 111.468 -179.638 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.7 -34.57 77.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 1.1100000000000001 111.719 -179.52 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 70.2 mt -62.94 -37.04 85.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.456 -0.338 . . . . 1.29 111.444 -179.622 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.03 -44.88 95.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.469 -0.332 . . . . 1.8600000000000001 111.017 -179.878 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.76 -27.29 4.36 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.79 -0.719 . . . . 1.4199999999999999 112.652 179.892 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 78.4 mtp180 -62.51 -19.23 63.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.837 0.351 . . . . 3.0499999999999998 111.102 -179.955 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.463 HG21 HD12 ' A' ' 51' ' ' LEU . 3.2 mp -82.5 104.55 11.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.115 -0.493 . . . . 1.6299999999999999 110.695 179.808 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -93.71 137.23 23.3 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.088 -0.506 . . . . 1.98 110.7 -179.764 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -51.47 160.8 2.24 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.38 2.053 . . . . 1.4399999999999999 112.316 179.693 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.1 m120 58.7 44.89 16.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.186 -0.461 . . . . 2.6299999999999999 110.787 -179.855 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -95.11 143.19 26.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.906 -0.588 . . . . 2.02 111.049 -179.88 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.576 ' HB3' HG21 ' A' ' 101' ' ' ILE . 25.9 tptp -91.85 101.49 14.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.108 -0.497 . . . . 1.6200000000000001 111.152 -179.948 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.427 HG22 HG23 ' A' ' 77' ' ' VAL . 40.0 mm -74.33 134.39 29.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.494 -0.321 . . . . 1.1100000000000001 110.62 179.627 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.617 ' HA ' HE21 ' A' ' 78' ' ' GLN . 88.3 mt -108.91 -57.26 2.17 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.395 -0.366 . . . . 1.1299999999999999 111.139 -179.766 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -157.87 138.95 13.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.088 0.47 . . . . 3.1499999999999999 111.623 -179.738 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.532 HG12 ' H ' ' A' ' 73' ' ' ASP . 5.3 t -88.45 174.23 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.543 -0.753 . . . . 1.0900000000000001 109.855 179.242 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.684 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 14.9 t70 -46.6 111.0 0.33 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.866 0.365 . . . . 0.79000000000000004 111.957 179.845 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 54.1 29.02 9.64 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.021 -0.536 . . . . 2.0099999999999998 112.084 179.113 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 96.2 t -147.28 137.27 16.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.419 -0.355 . . . . 1.1499999999999999 110.771 179.729 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -103.51 132.19 49.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.42 -0.355 . . . . 2.8500000000000001 110.594 179.716 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.513 ' HA ' ' HE2' ' A' ' 80' ' ' MET . 34.6 m -112.24 26.07 3.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-O 120.817 0.342 . . . . 1.26 111.423 -179.588 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.617 HE21 ' HA ' ' A' ' 70' ' ' LEU . 72.5 mm-40 -95.26 31.03 2.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 1.74 111.158 179.823 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 173.53 37.23 0.04 OUTLIER Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.575 -0.821 . . . . 0.57999999999999996 112.751 179.818 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.513 ' HE2' ' HA ' ' A' ' 77' ' ' VAL . 51.6 mtm -128.99 142.71 50.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.787 0.327 . . . . 1.1200000000000001 110.83 179.824 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.32 161.5 9.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 1.1200000000000001 111.254 -179.884 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -53.96 -60.97 2.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.256 -0.429 . . . . 1.52 110.949 -179.847 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 54.5 m -55.29 -26.74 42.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.244 -0.434 . . . . 2.0299999999999998 111.386 -179.737 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -69.64 -54.21 14.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.771 0.319 . . . . 2.1200000000000001 110.894 -179.786 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.7 t -56.1 -39.08 56.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.298 -0.41 . . . . 1.0800000000000001 110.922 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.477 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 59.7 t -58.53 -55.86 20.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.232 -0.44 . . . . 1.0700000000000001 110.628 179.586 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -47.6 -41.6 22.12 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.073 -0.512 . . . . 1.51 111.001 179.893 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 54.0 t -56.29 -51.84 58.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.164 -0.471 . . . . 1.0600000000000001 110.711 179.309 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 76.1 mt -56.28 -28.61 59.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.755 -0.657 . . . . 1.1399999999999999 110.792 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.477 ' HG2' ' O ' ' A' ' 86' ' ' VAL . 20.9 mmt180 -79.6 -30.3 41.44 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.082 -0.508 . . . . 2.5600000000000001 110.654 179.982 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -75.16 -18.41 60.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.052 -0.522 . . . . 1.8100000000000001 110.845 -179.824 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.53 -88.63 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.049 -0.523 . . . . 1.1100000000000001 111.636 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.602 ' HA2' ' HE ' ' A' ' 20' ' ' ARG . . . 60.97 16.97 49.98 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.746 -0.74 . . . . 0.77000000000000002 112.509 -179.741 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -146.99 172.9 4.66 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 110.657 -0.127 . . . . 3.3300000000000001 110.657 -179.677 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.543 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 37.5 Cg_exo -62.39 97.45 0.17 Allowed 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 122.068 1.845 . . . . 0.92000000000000004 111.625 178.338 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 29.0 m -105.64 156.41 6.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 1.3200000000000001 111.717 -179.307 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.684 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 78.5 ttt180 -103.55 142.14 34.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.713 -0.676 . . . . 3.02 110.029 179.366 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 21.3 mt -115.14 104.37 11.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 1.1599999999999999 111.35 -179.214 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 34.3 tp -95.8 111.59 23.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.82 0.343 . . . . 1.1000000000000001 110.172 179.173 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.09 166.84 23.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.086 0.469 . . . . 1.1100000000000001 111.628 -179.105 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.576 HG21 ' HB3' ' A' ' 68' ' ' LYS . 4.1 tt -121.92 138.32 52.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.684 -0.689 . . . . 1.1399999999999999 110.478 179.71 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 33.0 tpt180 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.322 -0.399 . . . . 2.7000000000000002 110.784 -179.831 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 48.3 t . . . . . 0 C--O 1.237 0.411 0 CA-C-O 121.033 0.444 . . . . 1.26 111.383 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.502 HD23 ' HB ' ' A' ' 101' ' ' ILE . 15.6 mt -93.88 101.86 13.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.468 -0.787 . . . . 1.49 110.076 179.58 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -121.88 148.08 45.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.927 0.394 . . . . 3.0899999999999999 111.117 -179.464 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 80.3 p -112.57 146.99 37.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.052 -0.522 . . . . 1.79 111.143 -179.68 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 17.2 t -120.31 135.3 61.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.096 -0.502 . . . . 1.26 110.644 179.751 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -92.09 111.53 23.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.323 -0.399 . . . . 1.74 111.614 -179.509 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.51 HD11 ' HB3' ' A' ' 56' ' ' ALA . 3.5 mm? -116.14 166.16 12.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.94 -0.573 . . . . 1.4099999999999999 110.184 179.112 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.565 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 42.2 p90 -153.61 136.93 15.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.796 0.332 . . . . 2.6600000000000001 111.433 -179.745 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.445 ' HB2' HD21 ' A' ' 27' ' ' LEU . 21.5 ttp180 -121.31 140.32 52.25 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.175 -0.466 . . . . 3.5899999999999999 110.607 179.317 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -160.63 26.15 0.15 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.388 -0.369 . . . . 2.5800000000000001 111.317 -179.947 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -123.17 165.46 16.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.33 -0.395 . . . . 4.1900000000000004 110.712 179.602 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -88.96 72.58 8.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.243 -0.435 . . . . 2.8700000000000001 110.799 -179.951 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 48.3 p -124.07 -24.89 4.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.06 -0.518 . . . . 1.74 110.987 179.935 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.0 t 58.35 23.82 10.93 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.775 -0.648 . . . . 2.79 111.189 179.687 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 56.5 m -151.18 136.08 17.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.893 0.378 . . . . 1.79 111.086 -179.918 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.445 HD21 ' HB2' ' A' ' 20' ' ' ARG . 46.7 mt -97.11 -12.29 23.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.017 -0.538 . . . . 1.1299999999999999 110.608 179.707 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.477 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 92.78 20.59 33.56 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.851 -0.69 . . . . 0.52000000000000002 112.509 179.91 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 75.9 mt -98.59 112.14 29.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.717 0.294 . . . . 1.53 111.064 179.956 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 70.4 m -113.68 98.89 7.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 1.4099999999999999 110.834 179.921 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 36.9 pt -91.34 166.7 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.186 -0.461 . . . . 1.1799999999999999 111.376 -179.854 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 44.8 t -147.4 153.59 39.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.029 -0.532 . . . . 1.79 110.654 -179.981 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 C-N-CA 120.738 -0.744 . . . . 1.04 112.529 -179.991 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 40.5 mm . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.723 0.297 . . . . 1.28 111.164 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -155.94 139.19 15.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.238 -0.437 . . . . 1.0800000000000001 110.715 179.862 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 57.5 t -76.74 127.11 37.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.222 -0.445 . . . . 1.0600000000000001 111.111 -179.84 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -116.71 -22.55 8.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.036 -0.529 . . . . 2.8900000000000001 111.165 -179.763 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 46.9 t -139.58 163.39 32.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.952 0.406 . . . . 1.8700000000000001 111.304 -179.871 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 76.0 mt -134.78 163.17 30.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.888 -0.596 . . . . 1.1899999999999999 110.807 179.984 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.477 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 48.5 mm -110.32 98.92 38.15 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.29 -0.414 . . . . 1.8500000000000001 110.96 179.67 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.07 126.88 22.92 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.404 2.069 . . . . 1.26 112.28 -179.928 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.76 -4.54 32.41 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.905 -0.664 . . . . 0.52000000000000002 112.625 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.441 ' HG ' ' HA3' ' A' ' 28' ' ' GLY . 93.1 p -99.47 -172.54 2.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.903 0.383 . . . . 1.73 111.058 -179.814 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.51 ' HB3' HD11 ' A' ' 18' ' ' LEU . . . -67.8 -58.06 5.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.052 -0.522 . . . . 1.1299999999999999 111.333 -179.951 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.81 -22.91 62.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.079 -0.51 . . . . 1.0900000000000001 111.438 -179.782 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.15 -31.62 34.06 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.511 -0.313 . . . . 1.1100000000000001 111.776 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.5 mt -83.45 -59.27 2.5 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.313 0.486 . . . . 1.29 112.313 -179.038 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -103.98 -24.53 13.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.665 0.269 . . . . 1.8600000000000001 111.331 -178.781 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.502 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -64.53 87.15 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.516 -0.85 . . . . 1.4199999999999999 112.246 179.959 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 -61.31 0.75 0.24 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.603 0.24 . . . . 3.0499999999999998 111.234 179.751 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.502 ' H ' ' C ' ' A' ' 61' ' ' GLY . 59.2 mt -48.95 125.65 2.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.276 -0.42 . . . . 1.6299999999999999 111.194 179.582 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.459 ' C ' ' H ' ' A' ' 66' ' ' ASN . 11.5 mt-10 -78.93 159.85 72.66 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 1.98 110.93 179.86 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -73.61 28.06 0.31 Allowed 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.656 2.237 . . . . 1.4399999999999999 112.443 179.654 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.459 ' H ' ' C ' ' A' ' 64' ' ' GLU . 3.1 t-20 -163.03 49.44 0.15 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.094 0.473 . . . . 2.6299999999999999 110.281 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -108.55 152.62 24.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.867 -0.606 . . . . 2.02 110.904 -179.716 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -107.09 111.21 23.56 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.41 -0.359 . . . . 1.6200000000000001 110.981 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 34.7 mm -70.43 141.55 16.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.256 -0.429 . . . . 1.1100000000000001 110.768 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 82.8 mt -117.86 -66.11 1.11 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 1.1299999999999999 111.35 -179.724 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -137.69 135.62 36.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.972 0.415 . . . . 3.1499999999999999 111.431 -179.62 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.516 HG13 ' H ' ' A' ' 73' ' ' ASP . 3.1 t -94.41 174.49 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.899 -0.591 . . . . 1.0900000000000001 110.083 179.329 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.661 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 14.2 t70 -53.49 108.79 0.37 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.839 0.352 . . . . 0.79000000000000004 111.392 179.807 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.4 t70 61.48 15.91 7.1 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.008 -0.542 . . . . 2.0099999999999998 111.699 179.434 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.407 ' HB ' ' HB ' ' A' ' 72' ' ' VAL . 26.0 t -138.42 157.18 30.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.559 -0.291 . . . . 1.1499999999999999 110.802 179.795 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 65.6 m-20 -127.71 129.59 47.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.442 -0.345 . . . . 2.8500000000000001 110.907 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.7 m -106.41 21.02 4.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.337 -0.392 . . . . 1.26 111.004 179.954 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -86.27 23.66 1.52 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.013 -0.54 . . . . 1.74 110.918 -179.958 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -177.02 18.85 0.04 OUTLIER Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.706 -0.759 . . . . 0.57999999999999996 112.828 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.426 ' HE2' HG23 ' A' ' 88' ' ' VAL . 51.6 mtm -115.12 139.16 50.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.843 0.354 . . . . 1.1200000000000001 110.876 179.809 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.432 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -65.97 156.86 32.35 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.159 -0.473 . . . . 1.1200000000000001 111.025 -179.932 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -44.04 -55.03 4.97 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.199 -0.455 . . . . 1.52 111.546 -179.568 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 79.3 p -51.29 -46.78 62.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.312 -0.404 . . . . 2.0299999999999998 111.256 -179.68 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -60.62 -40.74 93.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 2.1200000000000001 111.104 -179.915 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 81' ' ' ALA . 35.0 t -60.07 -39.69 81.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.295 -0.412 . . . . 1.0800000000000001 110.766 179.85 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.431 HG11 ' NE ' ' A' ' 90' ' ' ARG . 39.9 t -64.43 -37.06 79.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.168 -0.469 . . . . 1.0700000000000001 110.658 179.711 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -58.92 -48.62 80.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.162 -0.472 . . . . 1.51 110.808 179.798 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.426 HG23 ' HE2' ' A' ' 80' ' ' MET . 61.4 t -57.1 -55.15 22.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.205 -0.452 . . . . 1.0600000000000001 111.37 179.972 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 85.3 mt -56.33 -32.59 64.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.998 -0.546 . . . . 1.1399999999999999 111.385 -179.36 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.431 ' NE ' HG11 ' A' ' 86' ' ' VAL . 79.0 mtm180 -81.23 -20.07 41.81 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.458 -0.337 . . . . 2.5600000000000001 111.272 -179.687 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.432 ' N ' HD21 ' A' ' 91' ' ' ASN . 0.9 OUTLIER -86.05 -16.85 36.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.33 -0.395 . . . . 1.8100000000000001 111.077 -179.953 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.2 -86.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.267 -0.424 . . . . 1.1100000000000001 111.424 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.443 ' HA2' ' HE ' ' A' ' 20' ' ' ARG . . . 60.81 17.18 49.45 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.756 -0.735 . . . . 0.77000000000000002 112.578 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.38 175.56 2.66 Favored Pre-proline 0 CA--C 1.534 0.33 0 N-CA-C 110.377 -0.231 . . . . 3.3300000000000001 110.377 -179.804 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.565 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 32.9 Cg_exo -61.47 99.38 0.17 Allowed 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 122.088 1.859 . . . . 0.92000000000000004 111.604 178.247 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.6 m -116.43 155.77 17.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.265 -0.425 . . . . 1.3200000000000001 111.837 -179.191 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.661 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 44.4 ttp180 -101.71 145.38 29.2 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.881 -0.6 . . . . 3.02 110.484 179.788 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.6 mt -121.54 104.77 9.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.173 -0.467 . . . . 1.1599999999999999 111.358 -179.228 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 61.6 tp -91.81 108.1 19.68 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.777 0.322 . . . . 1.1000000000000001 110.381 179.421 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.467 HD23 HG12 ' A' ' 63' ' ' ILE . 0.5 OUTLIER -138.21 168.43 19.76 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.24 -0.436 . . . . 1.1100000000000001 111.579 -179.212 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.502 ' HB ' HD23 ' A' ' 13' ' ' LEU . 9.8 tt -119.95 141.1 41.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.862 -0.608 . . . . 1.1399999999999999 111.048 179.873 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 27.2 tpt180 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.101 -0.5 . . . . 2.7000000000000002 110.711 179.65 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.5 t . . . . . 0 C--O 1.236 0.348 0 CA-C-O 121.049 0.452 . . . . 1.26 111.263 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.497 HD22 ' HB ' ' A' ' 101' ' ' ILE . 23.8 mt -94.39 102.31 14.28 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.555 -0.748 . . . . 1.49 110.209 179.53 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.413 ' CE1' ' HB3' ' A' ' 102' ' ' ARG . 39.5 p90 -123.46 151.17 42.99 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.887 0.375 . . . . 3.0899999999999999 110.992 -179.602 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 80.2 p -122.39 161.28 23.74 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.279 -0.419 . . . . 1.79 111.465 -179.472 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 12.4 t -131.22 149.88 33.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.86 -0.609 . . . . 1.26 110.682 179.857 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -103.46 110.05 21.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.441 -0.345 . . . . 1.74 111.526 -179.47 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -126.49 123.84 38.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.179 -0.464 . . . . 1.4099999999999999 110.759 179.577 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.529 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 35.6 p90 -112.02 142.77 44.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.301 -0.409 . . . . 2.6600000000000001 110.747 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.554 ' HE ' ' HA2' ' A' ' 93' ' ' GLY . 47.5 ttp180 -125.97 160.85 28.91 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.859 -0.336 . . . . 3.5899999999999999 110.916 179.717 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -168.07 -33.06 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.139 -0.482 . . . . 2.5800000000000001 111.077 -179.891 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -59.07 160.93 5.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.949 -0.568 . . . . 4.1900000000000004 110.788 179.924 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -84.77 49.29 1.69 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.261 -0.427 . . . . 2.8700000000000001 111.069 -179.874 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 82.1 p -99.1 -24.59 14.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 1.74 111.163 -179.977 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 36.4 t 56.41 18.04 3.25 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.797 -0.638 . . . . 2.79 111.259 179.803 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 53.8 m -140.74 148.1 40.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.874 0.368 . . . . 1.79 111.206 -179.882 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 61.5 mt -113.37 -23.58 9.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.991 -0.549 . . . . 1.1299999999999999 110.833 179.905 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.484 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 110.5 -23.64 19.69 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.804 -0.713 . . . . 0.52000000000000002 112.383 -179.791 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 76.5 mt -62.41 109.0 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.805 0.336 . . . . 1.53 110.798 179.841 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 48.3 t -111.3 100.02 8.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.147 -0.479 . . . . 1.4099999999999999 110.853 -179.704 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.579 ' HA ' ' HA ' ' A' ' 48' ' ' VAL . 31.5 pt -85.19 172.75 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.825 -0.625 . . . . 1.1799999999999999 111.269 -179.928 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 43.9 t -139.67 132.12 28.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.485 . . . . 1.79 110.838 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 C-N-CA 120.806 -0.711 . . . . 1.04 112.537 -179.905 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.1 tp . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.572 0.225 . . . . 1.28 110.962 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -163.31 139.49 6.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.749 0.309 . . . . 1.0800000000000001 111.336 -179.884 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.579 ' HA ' ' HA ' ' A' ' 31' ' ' ILE . 90.5 t -71.24 105.85 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.258 -0.428 . . . . 1.0600000000000001 110.761 179.483 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -66.89 -38.08 85.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.041 -0.527 . . . . 2.8900000000000001 111.013 -179.923 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 35.9 t -168.1 175.61 6.52 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.96 0.41 . . . . 1.8700000000000001 111.252 -179.907 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 76.5 mt -115.13 155.7 26.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.842 -0.617 . . . . 1.1899999999999999 110.713 179.918 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.484 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 70.4 mt -98.93 108.51 49.53 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 1.8500000000000001 111.388 -179.62 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.05 136.12 72.96 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.432 2.088 . . . . 1.26 112.304 -179.919 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 103.99 -17.01 49.66 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.732 -0.747 . . . . 0.52000000000000002 112.645 179.92 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 95.6 p -88.54 -176.07 5.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.809 0.338 . . . . 1.73 111.118 -179.878 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.86 -54.84 13.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 1.1299999999999999 111.258 -179.853 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.64 -36.48 62.11 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.133 -0.485 . . . . 1.0900000000000001 111.522 -179.827 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.02 -46.38 62.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 1.1100000000000001 111.316 -179.887 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 97.4 mt -66.16 -19.75 65.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.364 -0.38 . . . . 1.29 110.834 179.73 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -61.24 -56.14 23.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 1.8600000000000001 110.826 179.981 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 97.3 -49.04 1.52 Allowed Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.805 -0.712 . . . . 1.4199999999999999 112.977 179.47 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -56.0 -36.25 67.71 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.727 0.299 . . . . 3.0499999999999998 111.164 -179.583 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 62.5 mt -70.27 116.18 11.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.875 0.369 . . . . 1.6299999999999999 110.713 179.776 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -102.97 131.87 21.74 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.056 -0.52 . . . . 1.98 110.786 -179.684 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -60.91 171.88 3.39 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.443 2.096 . . . . 1.4399999999999999 112.03 179.897 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 57.5 52.85 8.0 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.303 -0.408 . . . . 2.6299999999999999 110.548 -179.469 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -123.52 174.19 7.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.124 -0.489 . . . . 2.02 111.017 -179.594 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -115.01 127.0 55.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.199 -0.455 . . . . 1.6200000000000001 110.969 -179.964 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 47.9 mm -89.43 139.99 16.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.258 -0.428 . . . . 1.1100000000000001 111.014 -179.924 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 84.8 mt -110.83 -62.73 1.49 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.176 -0.465 . . . . 1.1299999999999999 111.109 -179.786 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -150.94 136.65 18.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.031 0.443 . . . . 3.1499999999999999 111.609 -179.402 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.604 HG11 ' H ' ' A' ' 73' ' ' ASP . 2.3 t -89.06 175.46 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.777 -0.647 . . . . 1.0900000000000001 110.186 179.437 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.656 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 14.5 t70 -49.15 108.66 0.2 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.725 0.298 . . . . 0.79000000000000004 111.493 179.558 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.7 t70 57.03 28.4 14.78 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.164 -0.471 . . . . 2.0099999999999998 111.544 179.306 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.7 t -145.88 144.27 20.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.334 -0.394 . . . . 1.1499999999999999 110.874 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -114.35 129.87 56.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.437 -0.347 . . . . 2.8500000000000001 110.585 179.62 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.404 ' HA ' ' HE3' ' A' ' 80' ' ' MET . 35.2 m -112.29 26.12 3.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-N 116.548 -0.296 . . . . 1.26 111.479 -179.441 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -94.25 31.64 1.67 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.92 0.39 . . . . 1.74 110.724 179.739 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 177.37 34.87 0.05 OUTLIER Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.715 -0.755 . . . . 0.57999999999999996 112.704 -179.974 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.404 ' HE3' ' HA ' ' A' ' 77' ' ' VAL . 54.9 mtm -134.62 145.28 48.47 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.905 0.383 . . . . 1.1200000000000001 110.758 179.8 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.61 150.55 40.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.063 -0.517 . . . . 1.1200000000000001 111.028 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -46.05 -51.58 13.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.298 -0.41 . . . . 1.52 111.399 -179.638 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.1 m -50.49 -47.82 57.08 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.215 -0.448 . . . . 2.0299999999999998 111.33 -179.676 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -59.4 -41.88 90.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.341 -0.39 . . . . 2.1200000000000001 111.065 -179.866 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.6 t -58.96 -38.5 73.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.275 -0.421 . . . . 1.0800000000000001 110.947 179.909 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.4 t -66.95 -38.02 80.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.173 -0.467 . . . . 1.0700000000000001 111.033 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -57.77 -46.1 85.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.305 -0.407 . . . . 1.51 110.674 179.734 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 54.8 t -59.27 -53.98 40.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.058 -0.519 . . . . 1.0600000000000001 111.073 179.747 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 78.5 mt -55.97 -26.77 49.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.996 -0.547 . . . . 1.1399999999999999 111.107 -179.612 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -89.41 -19.79 24.74 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.388 -0.369 . . . . 2.5600000000000001 111.308 179.978 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -89.68 -9.19 50.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.739 0.305 . . . . 1.8100000000000001 111.177 179.981 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.03 -87.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.439 . . . . 1.1100000000000001 111.404 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.554 ' HA2' ' HE ' ' A' ' 20' ' ' ARG . . . 60.74 20.07 56.14 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.66 -0.781 . . . . 0.77000000000000002 112.342 -179.838 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.607 ' HB3' ' HD2' ' A' ' 95' ' ' PRO . 5.9 m120 -147.17 172.63 4.97 Favored Pre-proline 0 C--N 1.33 -0.263 0 C-N-CA 122.106 0.162 . . . . 3.3300000000000001 110.775 -179.53 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.607 ' HD2' ' HB3' ' A' ' 94' ' ' ASN . 23.1 Cg_endo -62.86 89.53 0.12 Allowed 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 122.035 1.823 . . . . 0.92000000000000004 111.624 178.191 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.7 m -103.38 151.76 6.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.177 0.513 . . . . 1.3200000000000001 111.923 -179.216 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.656 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 79.4 ttt180 -101.2 143.95 30.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.566 -0.743 . . . . 3.02 110.159 179.378 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.02 105.11 10.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.432 -0.349 . . . . 1.1599999999999999 111.368 -179.525 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 51.4 tp -94.75 105.6 17.54 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.889 0.376 . . . . 1.1000000000000001 110.309 179.215 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.32 168.18 19.06 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.051 -0.522 . . . . 1.1100000000000001 111.41 -179.597 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.497 ' HB ' HD22 ' A' ' 13' ' ' LEU . 10.7 tt -122.63 142.1 40.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.916 -0.584 . . . . 1.1399999999999999 111.019 -179.962 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.413 ' HB3' ' CE1' ' A' ' 14' ' ' TYR . 31.5 tpt180 . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 115.986 -0.552 . . . . 2.7000000000000002 110.5 179.618 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 46.9 t . . . . . 0 C--O 1.235 0.297 0 CA-C-O 120.88 0.372 . . . . 1.26 111.238 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.487 HD21 ' HB ' ' A' ' 101' ' ' ILE . 45.7 mt -90.42 102.32 15.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.777 -0.647 . . . . 1.49 110.329 179.627 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.631 ' HH ' ' HB2' ' A' ' 102' ' ' ARG . 43.5 p90 -124.48 149.2 47.11 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.949 0.404 . . . . 3.0899999999999999 111.229 -179.646 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.0 m -115.3 154.57 28.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.098 -0.501 . . . . 1.79 110.883 -179.792 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.4 t -124.12 157.42 31.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 1.26 110.529 179.827 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -116.18 107.69 15.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.864 0.364 . . . . 1.74 111.398 -179.672 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.441 HD12 ' HB2' ' A' ' 60' ' ' ASP . 4.3 mm? -116.98 144.76 44.21 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.079 -0.51 . . . . 1.4099999999999999 110.546 179.696 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.679 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 21.8 p90 -118.66 117.87 30.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.936 0.398 . . . . 2.6600000000000001 110.868 179.85 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.595 ' HG2' ' HA2' ' A' ' 93' ' ' GLY . 15.0 ttt180 -110.16 153.85 24.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.002 -0.545 . . . . 3.5899999999999999 110.585 179.924 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -113.51 -70.26 0.81 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.097 0.475 . . . . 2.5800000000000001 111.131 -179.862 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -136.22 -169.85 2.53 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.712 -0.676 . . . . 4.1900000000000004 110.969 -179.812 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -55.51 -27.26 47.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.338 -0.392 . . . . 2.8700000000000001 110.869 179.775 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.3 m -66.95 -36.99 83.47 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.16 -0.473 . . . . 1.74 110.744 179.875 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.9 m -81.85 61.41 5.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.122 -0.49 . . . . 2.79 110.931 179.869 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 51.0 m -57.88 138.34 55.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.479 . . . . 1.79 110.833 179.773 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.498 HD23 ' HB2' ' A' ' 20' ' ' ARG . 75.0 mt -78.8 -35.3 44.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.033 -0.531 . . . . 1.1299999999999999 110.67 -179.845 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.75 -6.74 73.91 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.787 -0.72 . . . . 0.52000000000000002 113.219 179.212 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 74.5 mt -60.07 108.67 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.747 0.308 . . . . 1.53 111.17 -179.851 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 39.6 t -112.31 97.91 6.95 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.21 -0.45 . . . . 1.4099999999999999 110.662 179.729 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.462 ' HA ' ' HA ' ' A' ' 48' ' ' VAL . 38.6 pt -89.72 166.66 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.051 -0.522 . . . . 1.1799999999999999 111.272 -179.838 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 54.7 m -143.71 138.94 29.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.095 -0.502 . . . . 1.79 110.953 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 C-N-CA 120.825 -0.702 . . . . 1.04 112.48 179.966 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 37.5 mm . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.707 0.289 . . . . 1.28 110.822 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -131.73 142.77 49.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.287 -0.415 . . . . 1.0800000000000001 111.189 -179.726 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.462 ' HA ' ' HA ' ' A' ' 31' ' ' ILE . 46.8 t -81.54 116.64 26.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.116 -0.493 . . . . 1.0600000000000001 111.004 179.847 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -84.79 -35.71 22.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.452 . . . . 2.8900000000000001 111.22 -179.705 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 54.6 m -149.66 172.68 14.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.125 0.488 . . . . 1.8700000000000001 111.63 -179.527 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.431 HD11 HG21 ' A' ' 63' ' ' ILE . 63.0 mt -131.73 141.45 49.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.723 -0.671 . . . . 1.1899999999999999 110.538 179.835 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 43.2 mm -75.4 115.56 46.57 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.337 -0.392 . . . . 1.8500000000000001 111.074 -179.89 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -58.07 126.26 21.07 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.387 2.058 . . . . 1.26 112.391 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 98.53 -13.66 62.57 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.799 -0.715 . . . . 0.52000000000000002 112.785 179.659 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 92.8 p -72.02 -177.33 2.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.779 0.324 . . . . 1.73 110.914 -179.861 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.39 -55.29 12.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 1.1299999999999999 111.178 179.976 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.82 -33.88 67.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.108 -0.497 . . . . 1.0900000000000001 111.397 -179.804 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.78 -55.55 8.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 1.1100000000000001 111.509 -179.649 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.0 mt -59.1 -20.23 51.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 1.29 111.187 -179.835 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.441 ' HB2' HD12 ' A' ' 18' ' ' LEU . 17.4 t70 -59.05 -52.54 65.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.36 -0.382 . . . . 1.8600000000000001 110.642 -179.909 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.91 -31.7 7.36 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.707 -0.759 . . . . 1.4199999999999999 113.126 179.387 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 82.2 mtm180 -83.85 0.84 45.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.686 0.279 . . . . 3.0499999999999998 111.238 -179.571 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.431 HG21 HD11 ' A' ' 51' ' ' LEU . 53.6 mt -116.47 122.78 70.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.848 0.356 . . . . 1.6299999999999999 110.979 179.592 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -129.41 158.1 74.25 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.125 -0.489 . . . . 1.98 110.809 179.971 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -57.08 176.97 0.2 Allowed 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.587 2.191 . . . . 1.4399999999999999 112.308 179.674 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 56.38 50.08 13.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.013 -0.54 . . . . 2.6299999999999999 110.637 -179.805 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.401 ' HA ' ' HG2' ' A' ' 102' ' ' ARG . 8.3 t70 -120.81 151.85 39.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.815 -0.629 . . . . 2.02 110.83 -179.934 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -109.62 109.06 19.7 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.857 0.36 . . . . 1.6200000000000001 110.912 179.979 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 49.2 mm -71.03 142.41 15.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.143 -0.48 . . . . 1.1100000000000001 110.982 179.896 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 73.3 mt -114.97 -71.77 0.73 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.097 -0.501 . . . . 1.1299999999999999 110.98 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.41 ' O ' ' HB3' ' A' ' 99' ' ' LEU . 75.9 mtp180 -135.95 135.33 39.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 3.1499999999999999 111.406 -179.611 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.477 HG11 ' H ' ' A' ' 73' ' ' ASP . 6.6 t -93.55 170.69 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.922 -0.581 . . . . 1.0900000000000001 109.842 179.166 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.619 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 16.8 t70 -46.7 108.7 0.15 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.917 0.389 . . . . 0.79000000000000004 111.841 179.928 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 53.41 14.52 0.57 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.817 -0.629 . . . . 2.0099999999999998 112.479 179.013 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 65.2 t -144.72 99.67 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.76 0.314 . . . . 1.1499999999999999 111.388 -179.887 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -68.07 155.58 39.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.386 -0.37 . . . . 2.8500000000000001 110.355 179.462 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.424 HG13 HG11 ' A' ' 85' ' ' VAL . 17.4 m -133.44 39.84 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.846 0.355 . . . . 1.26 111.391 -179.814 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -109.8 35.84 3.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 1.74 111.048 179.795 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -179.6 26.64 0.05 OUTLIER Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.481 -0.866 . . . . 0.57999999999999996 112.927 179.962 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 65.6 mtm -130.61 153.16 49.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.853 0.358 . . . . 1.1200000000000001 110.918 179.75 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.408 ' O ' HG21 ' A' ' 85' ' ' VAL . . . -62.18 151.98 34.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.011 -0.54 . . . . 1.1200000000000001 111.333 -179.86 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -50.36 -55.75 14.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.238 -0.437 . . . . 1.52 111.249 -179.744 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.1 m -52.95 -41.03 64.12 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.07 -0.514 . . . . 2.0299999999999998 111.171 -179.813 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -59.08 -43.56 91.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.288 -0.414 . . . . 2.1200000000000001 110.89 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.424 HG11 HG13 ' A' ' 77' ' ' VAL . 22.8 t -60.16 -36.46 68.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.143 -0.48 . . . . 1.0800000000000001 110.818 179.883 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.2 t -63.76 -40.89 90.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.036 -0.529 . . . . 1.0700000000000001 111.015 179.92 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -59.1 -49.73 76.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.265 -0.425 . . . . 1.51 110.732 179.812 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 54.6 t -52.25 -53.83 17.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.95 -0.568 . . . . 1.0600000000000001 111.333 179.876 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 71.3 mt -56.71 -33.83 66.86 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.103 -0.499 . . . . 1.1399999999999999 111.329 -179.516 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 -82.2 -14.95 54.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.484 -0.325 . . . . 2.5600000000000001 111.226 -179.793 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -92.14 -15.4 27.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.365 -0.38 . . . . 1.8100000000000001 111.086 179.976 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.77 -83.51 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.287 -0.415 . . . . 1.1100000000000001 111.454 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.595 ' HA2' ' HG2' ' A' ' 20' ' ' ARG . . . 62.49 21.76 62.85 Favored Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.638 -0.791 . . . . 0.77000000000000002 112.431 -179.724 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.59 169.65 8.98 Favored Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 110.527 -0.175 . . . . 3.3300000000000001 110.527 -179.823 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.679 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 48.8 Cg_exo -57.39 92.47 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.048 1.832 . . . . 0.92000000000000004 111.427 178.349 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.9 m -103.72 148.83 8.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.133 0.492 . . . . 1.3200000000000001 111.84 -179.051 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.619 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 71.6 ttt180 -99.7 144.11 29.15 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.618 -0.719 . . . . 3.02 110.002 179.726 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 13.6 mt -118.38 103.79 10.12 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.386 -0.37 . . . . 1.1599999999999999 111.525 -179.146 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.41 ' HB3' ' O ' ' A' ' 71' ' ' ARG . 65.3 tp -90.98 109.35 20.58 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.857 -0.423 . . . . 1.1000000000000001 109.857 179.062 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -143.25 168.34 20.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.247 0.546 . . . . 1.1100000000000001 111.963 -179.115 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.487 ' HB ' HD21 ' A' ' 13' ' ' LEU . 13.0 tt -119.49 143.1 31.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.572 -0.74 . . . . 1.1399999999999999 110.556 179.838 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.631 ' HB2' ' HH ' ' A' ' 14' ' ' TYR . 0.4 OUTLIER . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.34 -0.391 . . . . 2.7000000000000002 110.751 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.188 0 N-CA-C 112.498 -0.241 . . . . 8.1300000000000008 112.498 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.0 m -106.39 -12.5 15.64 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.732 0.301 . . . . 7.25 111.062 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 45.5 m80 -61.88 121.41 12.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 6.6799999999999997 111.015 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -134.88 -60.14 0.07 OUTLIER Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.714 -0.755 . . . . 2.8900000000000001 112.619 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 56.07 46.53 21.5 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.835 0.35 . . . . 2.46 111.021 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 58.0 m -73.61 102.01 3.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 3.0099999999999998 110.845 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 58.14 86.42 0.08 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.246 -0.434 . . . . 2.6699999999999999 110.992 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -145.25 102.42 3.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.143 -0.48 . . . . 1.74 111.103 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 69.0 m 58.29 20.83 7.59 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.049 -0.523 . . . . 2.6299999999999999 111.119 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.58 40.24 8.44 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.785 -0.721 . . . . 1.8200000000000001 112.751 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -143.6 119.38 10.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.844 0.355 . . . . 1.98 110.742 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.0 t -143.38 144.36 32.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 1.26 110.908 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 85.0 mt -80.26 127.77 32.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.873 -0.603 . . . . 1.49 110.757 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -124.56 137.82 54.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.169 -0.468 . . . . 3.0899999999999999 110.882 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 80.8 p -132.58 132.19 42.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.305 -0.407 . . . . 1.79 111.096 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.9 t -118.26 157.55 19.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 1.26 110.704 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -109.72 110.01 20.89 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.816 0.341 . . . . 1.74 111.282 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.451 HD12 ' HB2' ' A' ' 60' ' ' ASP . 4.6 mm? -118.6 166.48 12.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.154 -0.475 . . . . 1.4099999999999999 110.318 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.586 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 35.0 p90 -144.14 132.33 21.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.906 0.384 . . . . 2.6600000000000001 111.638 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.508 ' HE ' ' HG ' ' A' ' 27' ' ' LEU . 15.7 tpp85 -97.22 94.75 7.28 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.04 -0.527 . . . . 3.5899999999999999 110.21 179.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -130.25 9.93 5.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.383 -0.371 . . . . 2.5800000000000001 111.168 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -110.29 151.22 27.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.435 . . . . 4.1900000000000004 110.836 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -80.68 17.16 1.19 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.068 -0.515 . . . . 2.8700000000000001 110.998 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 63.0 p -69.0 -10.99 60.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 1.74 111.157 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.2 m 59.13 20.17 8.13 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.999 -0.546 . . . . 2.79 111.194 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 90.0 p -164.26 158.55 19.01 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.956 0.408 . . . . 1.79 111.077 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.508 ' HG ' ' HE ' ' A' ' 20' ' ' ARG . 87.4 mt -102.6 -12.09 17.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.064 -0.517 . . . . 1.1299999999999999 110.614 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.495 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 100.15 24.86 9.31 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.831 -0.7 . . . . 0.52000000000000002 112.373 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 75.6 mt -102.56 115.73 45.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.822 0.344 . . . . 1.53 110.927 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.7 t -110.67 102.44 11.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 1.4099999999999999 110.666 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 25.3 pt -99.43 160.53 3.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 1.1799999999999999 111.447 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 48.1 t -150.85 145.68 25.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.918 -0.583 . . . . 1.79 110.726 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -86.1 149.13 22.79 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.72 -0.752 . . . . 1.04 112.609 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 56.7 ttm -92.89 151.41 19.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.791 0.329 . . . . 2.48 110.864 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.426 ' N ' ' HD2' ' A' ' 35' ' ' ARG . 7.7 mpt_? -106.19 94.82 5.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 6.1500000000000004 110.932 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -100.45 132.04 46.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 4.29 110.682 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -121.12 11.28 10.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.237 -0.438 . . . . 5.79 111.138 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 75.3 m -155.44 143.13 19.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.233 -0.44 . . . . 5.1799999999999997 111.012 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 50.5 p -85.91 134.31 33.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 5.54 111.13 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.3 t -154.84 23.42 0.45 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.129 -0.487 . . . . 7.3600000000000003 110.972 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 110.71 -48.33 0.95 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.956 -0.64 . . . . 5.7999999999999998 112.471 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -108.55 151.59 25.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.779 0.323 . . . . 7.2199999999999998 110.881 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -163.78 133.78 4.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.253 -0.43 . . . . 3.6000000000000001 111.006 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 63.6 p 51.39 -169.66 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.88 -0.6 . . . . 3.02 111.479 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 128.24 144.69 5.9 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.823 -0.703 . . . . 1.3600000000000001 112.456 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 41.8 mm -87.33 123.9 40.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.667 0.27 . . . . 1.28 111.094 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 52.9 p90 -147.34 147.0 29.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.978 0.418 . . . . 1.0800000000000001 111.086 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.1 t -84.27 136.64 22.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.969 -0.559 . . . . 1.0600000000000001 111.223 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -125.96 -25.96 3.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.029 -0.532 . . . . 2.8900000000000001 110.87 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 43.1 t -135.85 170.41 16.02 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.234 -0.439 . . . . 1.8700000000000001 110.89 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 69.5 mt -141.66 160.28 40.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.211 -0.45 . . . . 1.1899999999999999 110.963 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.495 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 51.0 mt -107.08 102.01 40.96 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.242 -0.435 . . . . 1.8500000000000001 110.918 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.67 136.25 64.38 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.409 2.073 . . . . 1.26 112.31 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 99.91 -12.32 60.79 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.791 -0.718 . . . . 0.52000000000000002 112.691 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 56.3 m -88.19 179.11 6.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.706 0.289 . . . . 1.73 111.023 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.48 -54.41 36.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.319 -0.401 . . . . 1.1299999999999999 111.455 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.16 -48.02 71.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 1.0900000000000001 111.744 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.53 -56.76 13.47 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.428 -0.351 . . . . 1.1100000000000001 111.656 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 81.5 mt -59.86 -20.43 57.05 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.26 -0.427 . . . . 1.29 111.527 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.451 ' HB2' HD12 ' A' ' 18' ' ' LEU . 18.2 t70 -58.96 -48.37 81.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.875 0.369 . . . . 1.8600000000000001 110.957 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.46 -48.49 1.11 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.782 -0.723 . . . . 1.4199999999999999 112.689 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -65.24 -23.7 67.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.71 0.29 . . . . 3.0499999999999998 110.921 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 39.8 mm -76.68 98.72 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.267 -0.424 . . . . 1.6299999999999999 110.792 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -107.92 156.3 38.44 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 1.98 110.632 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.96 172.79 5.57 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.448 2.099 . . . . 1.4399999999999999 112.271 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 57.88 74.54 0.42 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.187 -0.461 . . . . 2.6299999999999999 111.243 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -149.6 151.33 33.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 2.02 110.433 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -109.88 114.67 28.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.816 0.341 . . . . 1.6200000000000001 111.244 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 43.7 mm -70.31 140.03 19.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.069 -0.514 . . . . 1.1100000000000001 110.597 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 90.5 mt -116.89 -65.1 1.22 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.298 -0.41 . . . . 1.1299999999999999 111.274 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -141.2 134.91 30.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.955 0.407 . . . . 3.1499999999999999 111.625 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.527 HG13 ' H ' ' A' ' 73' ' ' ASP . 6.6 t -90.4 175.09 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.861 -0.608 . . . . 1.0900000000000001 109.596 178.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.676 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 18.6 t70 -47.55 108.97 0.18 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.693 0.283 . . . . 0.79000000000000004 111.696 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 54.24 26.26 6.61 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.244 -0.434 . . . . 2.0099999999999998 111.768 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.407 HG21 ' O ' ' A' ' 73' ' ' ASP . 58.2 t -143.02 152.04 17.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.296 -0.411 . . . . 1.1499999999999999 110.696 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.449 ' ND2' ' H ' ' A' ' 78' ' ' GLN . 5.7 t30 -121.06 130.98 54.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.368 -0.378 . . . . 2.8500000000000001 110.718 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.7 m -110.2 17.39 7.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.379 -0.373 . . . . 1.26 111.444 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.449 ' H ' ' ND2' ' A' ' 76' ' ' ASN . 14.5 mm100 -85.84 28.92 0.75 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.264 -0.426 . . . . 1.74 111.07 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -178.4 19.04 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.56 -0.829 . . . . 0.57999999999999996 112.95 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 43.8 mtm -118.4 146.07 44.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.799 0.333 . . . . 1.1200000000000001 110.711 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.42 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -62.11 155.79 23.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.1 -0.5 . . . . 1.1200000000000001 111.068 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -51.73 -57.76 8.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.425 -0.352 . . . . 1.52 111.178 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.9 t -54.56 -37.88 65.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 2.0299999999999998 111.306 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -60.94 -45.51 94.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.322 -0.399 . . . . 2.1200000000000001 110.781 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 81' ' ' ALA . 45.6 t -60.09 -34.14 55.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.159 -0.473 . . . . 1.0800000000000001 110.769 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.528 HG12 ' HE ' ' A' ' 90' ' ' ARG . 56.7 t -64.25 -43.93 97.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.111 -0.495 . . . . 1.0700000000000001 110.533 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -58.1 -41.77 84.22 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.163 -0.471 . . . . 1.51 110.647 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 49.5 t -56.86 -52.52 54.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.954 -0.566 . . . . 1.0600000000000001 111.049 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 71.2 mt -54.41 -36.07 63.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.026 -0.534 . . . . 1.1399999999999999 110.923 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.528 ' HE ' HG12 ' A' ' 86' ' ' VAL . 74.7 mtt180 -75.14 -30.12 60.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 2.5600000000000001 110.872 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -74.68 -18.01 60.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.123 -0.489 . . . . 1.8100000000000001 111.019 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.21 -83.0 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.072 -0.513 . . . . 1.1100000000000001 111.415 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 65.64 11.76 54.53 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.477 -0.868 . . . . 0.77000000000000002 112.315 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -146.7 166.33 16.87 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 110.557 -0.164 . . . . 3.3300000000000001 110.557 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.586 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 46.2 Cg_exo -57.07 105.1 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.278 1.985 . . . . 0.92000000000000004 111.366 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.7 m -107.29 154.46 8.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.224 0.535 . . . . 1.3200000000000001 111.994 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.676 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 79.6 ttt180 -103.53 143.07 33.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.549 -0.75 . . . . 3.02 109.932 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 20.5 mt -114.83 131.01 56.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.249 -0.432 . . . . 1.1599999999999999 110.972 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 62.2 tp -120.62 99.8 6.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 1.1000000000000001 110.234 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.46 153.31 48.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.053 -0.522 . . . . 1.1100000000000001 111.322 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.9 tt -100.91 138.68 24.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.069 -0.514 . . . . 1.1399999999999999 110.708 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 24.8 tpt180 -130.26 133.42 46.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.437 . . . . 2.7000000000000002 110.885 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 75.6 mtp180 -83.42 132.34 34.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.019 -0.537 . . . . 4.4000000000000004 110.969 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 59.7 mt -99.68 148.48 34.81 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.022 -0.536 . . . . 2.0 110.624 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -80.71 163.01 21.33 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.576 2.184 . . . . 2.98 112.456 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 78.2 mt -130.57 93.55 3.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.863 -0.608 . . . . 3.6699999999999999 110.669 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 72.2 mt -93.01 124.54 37.05 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.108 -0.496 . . . . 5.9699999999999998 111.261 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.139 -0.934 . . . . 6.0 111.061 -179.987 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.204 0 N-CA-C 112.514 -0.234 . . . . 8.1300000000000008 112.514 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.6 p -103.86 -65.81 0.99 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.824 0.345 . . . . 7.25 110.936 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -60.14 130.86 48.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 6.6799999999999997 110.955 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 134.17 133.72 3.35 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.874 -0.679 . . . . 2.8900000000000001 112.374 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -104.69 164.51 11.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.942 0.401 . . . . 2.46 111.144 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.1 m -134.98 83.22 2.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.911 -0.586 . . . . 3.0099999999999998 110.483 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.9 t70 57.72 76.49 0.32 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.976 -0.556 . . . . 2.6699999999999999 110.73 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -113.06 104.38 12.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.073 -0.512 . . . . 1.74 111.297 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.8 t 57.96 22.18 8.51 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.057 -0.52 . . . . 2.6299999999999999 111.186 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.48 32.31 10.49 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.706 -0.759 . . . . 1.8200000000000001 112.685 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -138.85 136.67 35.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.848 0.356 . . . . 1.98 110.762 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 46.9 t -153.77 140.38 18.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.088 -0.506 . . . . 1.26 110.818 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 89.6 mt -79.52 121.58 25.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.013 -0.54 . . . . 1.49 110.851 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.918 ' HH ' HD23 ' A' ' 104' ' ' LEU . 43.1 m-85 -113.86 151.44 32.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.123 -0.49 . . . . 3.0899999999999999 110.961 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 48.5 t -150.47 135.85 17.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.245 -0.434 . . . . 1.79 111.073 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.7 t -130.29 147.17 33.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.041 -0.527 . . . . 1.26 110.806 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -99.13 118.38 35.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.917 0.389 . . . . 1.74 111.076 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.486 HD11 ' HB2' ' A' ' 60' ' ' ASP . 4.2 mm? -116.97 166.91 11.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.937 -0.574 . . . . 1.4099999999999999 110.788 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.556 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 30.4 p90 -160.49 130.5 5.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.247 -0.433 . . . . 2.6600000000000001 111.151 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.606 ' HE ' ' HA2' ' A' ' 93' ' ' GLY . 57.2 ttp180 -112.68 97.43 6.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.399 -0.364 . . . . 3.5899999999999999 110.919 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -95.65 -20.52 18.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.121 -0.491 . . . . 2.5800000000000001 110.702 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -83.75 160.51 21.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.071 -0.513 . . . . 4.1900000000000004 110.953 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -95.23 40.4 1.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.035 -0.53 . . . . 2.8700000000000001 110.902 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 82.1 p -71.93 -13.96 61.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 1.74 111.127 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.2 m 57.76 19.1 5.32 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.921 -0.582 . . . . 2.79 111.256 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.8 m -154.9 154.93 33.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.435 -0.348 . . . . 1.79 111.005 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.447 HD23 ' HB2' ' A' ' 20' ' ' ARG . 52.0 mt -114.02 -24.43 9.04 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.097 -0.501 . . . . 1.1299999999999999 111.141 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.18 -19.98 49.25 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.692 -0.766 . . . . 0.52000000000000002 112.857 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 66.2 mt -61.64 110.27 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.676 0.274 . . . . 1.53 110.979 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.6 t -112.25 106.64 15.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.445 . . . . 1.4099999999999999 110.964 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.531 ' HA ' ' HA ' ' A' ' 48' ' ' VAL . 46.3 pt -86.81 -177.88 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.015 -0.539 . . . . 1.1799999999999999 111.144 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.2 t -156.14 146.24 21.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.358 -0.383 . . . . 1.79 111.137 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -81.53 132.13 10.94 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.836 -0.697 . . . . 1.04 112.191 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 27.2 ttt -58.12 150.72 20.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.774 0.321 . . . . 2.48 111.084 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -151.79 157.27 41.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.231 -0.441 . . . . 6.1500000000000004 111.167 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -158.07 161.87 38.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.013 -0.539 . . . . 4.29 110.59 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -93.72 24.89 3.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.392 -0.367 . . . . 5.79 111.442 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 93.1 p -165.72 102.44 0.69 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.916 0.389 . . . . 5.1799999999999997 111.051 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 69.6 p -106.41 135.64 47.55 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.001 -0.545 . . . . 5.54 111.095 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.7 t -159.24 19.41 0.18 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.146 -0.479 . . . . 7.3600000000000003 110.991 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -170.69 -6.47 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.849 -0.691 . . . . 5.7999999999999998 112.448 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 57.17 90.38 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.878 0.37 . . . . 7.2199999999999998 111.156 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -130.29 91.77 3.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.121 -0.491 . . . . 3.6000000000000001 111.015 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 81.0 p -119.73 155.29 32.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 3.02 111.015 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -146.8 173.08 27.13 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.635 -0.793 . . . . 1.3600000000000001 112.792 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.1 mm -100.2 129.55 50.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.68 0.276 . . . . 1.28 110.929 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -157.53 142.38 16.7 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.278 -0.419 . . . . 1.0800000000000001 111.022 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.531 ' HA ' ' HA ' ' A' ' 31' ' ' ILE . 99.3 t -77.96 127.21 38.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.151 -0.477 . . . . 1.0600000000000001 110.804 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -114.63 -23.22 9.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.031 -0.531 . . . . 2.8900000000000001 111.139 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 78.1 p -146.09 161.76 39.45 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.134 0.492 . . . . 1.8700000000000001 111.645 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 91.6 mt -133.55 154.35 50.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.662 -0.699 . . . . 1.1899999999999999 110.572 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 49.0 mm -97.24 113.89 63.9 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.346 -0.388 . . . . 1.8500000000000001 110.846 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -61.58 136.2 61.5 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.414 2.076 . . . . 1.26 112.122 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 97.9 -23.29 36.68 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.864 -0.684 . . . . 0.52000000000000002 112.307 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 67.1 m -73.14 170.86 14.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.619 0.247 . . . . 1.73 111.079 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.64 -55.64 30.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.427 -0.351 . . . . 1.1299999999999999 111.463 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.61 -39.33 57.8 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.203 -0.453 . . . . 1.0900000000000001 111.333 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.69 -46.99 67.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 1.1100000000000001 111.425 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.8 mt -63.15 -19.68 64.7 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.222 -0.444 . . . . 1.29 111.184 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.486 ' HB2' HD11 ' A' ' 18' ' ' LEU . 18.4 t70 -62.5 -50.81 69.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.294 -0.412 . . . . 1.8600000000000001 110.808 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.49 -48.4 1.69 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.761 -0.733 . . . . 1.4199999999999999 113.151 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 21.7 mmm180 -59.93 -29.25 68.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.638 0.256 . . . . 3.0499999999999998 111.204 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 66.1 mt -77.19 111.73 14.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.896 0.379 . . . . 1.6299999999999999 111.254 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -95.69 140.13 22.2 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.994 -0.548 . . . . 1.98 110.293 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -74.1 44.84 1.06 Allowed 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.495 2.13 . . . . 1.4399999999999999 112.963 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -167.75 69.5 0.09 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.285 -0.416 . . . . 2.6299999999999999 110.409 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -146.17 170.85 15.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.486 . . . . 2.02 110.835 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -115.0 104.47 11.94 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.288 -0.414 . . . . 1.6200000000000001 110.986 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.488 HD11 ' HB3' ' A' ' 100' ' ' LEU . 49.5 mm -58.48 145.49 9.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.159 -0.473 . . . . 1.1100000000000001 111.054 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.463 ' HA ' ' NE2' ' A' ' 78' ' ' GLN . 92.7 mt -124.35 -67.11 0.94 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.236 -0.438 . . . . 1.1299999999999999 111.453 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 27.2 mtm180 -132.34 134.92 45.78 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.027 0.442 . . . . 3.1499999999999999 111.695 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.538 HG11 ' H ' ' A' ' 73' ' ' ASP . 3.8 t -97.97 172.88 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.761 -0.654 . . . . 1.0900000000000001 110.02 179.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.619 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 28.1 t70 -51.07 108.81 0.27 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.784 0.326 . . . . 0.79000000000000004 111.44 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 59.39 14.21 3.63 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.045 -0.525 . . . . 2.0099999999999998 111.844 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.47 ' HB ' ' HB ' ' A' ' 72' ' ' VAL . 40.9 t -135.56 157.36 39.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.532 -0.304 . . . . 1.1499999999999999 110.849 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.406 ' N ' HG11 ' A' ' 75' ' ' VAL . 3.2 p-10 -129.07 128.61 43.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.396 -0.366 . . . . 2.8500000000000001 110.575 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.0 m -105.29 24.65 2.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.805 0.336 . . . . 1.26 111.399 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.463 ' NE2' ' HA ' ' A' ' 70' ' ' LEU . 29.1 mm-40 -90.72 33.6 0.92 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.277 -0.419 . . . . 1.74 110.763 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 170.15 23.55 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.77 -0.728 . . . . 0.57999999999999996 112.815 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 43.3 mtm -119.12 140.74 49.61 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.788 0.327 . . . . 1.1200000000000001 110.668 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.408 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -58.77 156.62 10.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.165 -0.471 . . . . 1.1200000000000001 111.484 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -50.49 -57.81 7.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 1.52 111.272 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 79.3 p -53.67 -38.85 64.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.022 -0.535 . . . . 2.0299999999999998 111.369 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -61.18 -44.54 97.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.272 -0.422 . . . . 2.1200000000000001 111.024 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 81' ' ' ALA . 47.4 t -59.42 -40.99 83.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 1.0800000000000001 111.038 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.4 t -62.14 -39.14 82.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.199 -0.455 . . . . 1.0700000000000001 110.926 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -59.91 -44.79 94.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 1.51 110.778 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 53.3 t -56.92 -54.16 33.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.173 -0.467 . . . . 1.0600000000000001 111.124 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 92.9 mt -55.69 -34.29 64.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.887 -0.597 . . . . 1.1399999999999999 111.364 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 79.3 mtm180 -80.46 -17.1 52.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.299 -0.41 . . . . 2.5600000000000001 111.341 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.424 HD21 ' N ' ' A' ' 91' ' ' ASN . 0.9 OUTLIER -89.84 -15.47 32.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.42 -0.354 . . . . 1.8100000000000001 111.142 179.858 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.62 -86.64 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.299 -0.41 . . . . 1.1100000000000001 111.512 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.606 ' HA2' ' HE ' ' A' ' 20' ' ' ARG . . . 64.19 15.49 58.77 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.688 -0.768 . . . . 0.77000000000000002 112.279 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.455 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -146.92 174.07 3.69 Favored Pre-proline 0 C--N 1.327 -0.37 0 N-CA-C 110.408 -0.219 . . . . 3.3300000000000001 110.408 -179.727 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.556 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 46.2 Cg_exo -58.24 107.23 0.31 Allowed 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 121.897 1.731 . . . . 0.92000000000000004 111.477 178.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.3 m -116.6 141.54 34.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.164 0.506 . . . . 1.3200000000000001 112.173 -178.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.619 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 75.4 ttt180 -94.61 145.07 25.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.692 -0.685 . . . . 3.02 109.707 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 13.5 mt -121.75 136.12 54.94 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.845 0.355 . . . . 1.1599999999999999 111.366 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 38.5 tp -123.88 104.1 8.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.004 -0.544 . . . . 1.1000000000000001 110.495 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.488 ' HB3' HD11 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -128.87 147.03 50.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.276 -0.42 . . . . 1.1100000000000001 111.118 -179.59 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.412 ' HB ' HD13 ' A' ' 70' ' ' LEU . 16.1 tt -98.52 143.84 12.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 1.1399999999999999 111.029 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 13.7 mmm180 -132.56 139.02 47.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.995 -0.548 . . . . 2.7000000000000002 111.013 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -90.18 131.41 36.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.134 -0.484 . . . . 4.4000000000000004 110.931 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.918 HD23 ' HH ' ' A' ' 14' ' ' TYR . 62.2 mt -98.49 134.37 21.87 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.25 -0.432 . . . . 2.0 110.938 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -81.89 162.4 18.47 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.473 2.115 . . . . 2.98 112.285 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 96.7 mt -128.19 98.78 5.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.484 . . . . 3.6699999999999999 110.921 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 90.2 mt -73.48 114.22 11.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.122 -0.49 . . . . 5.9699999999999998 111.043 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.257 -0.878 . . . . 6.0 110.892 -179.968 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.167 0 N-CA-C 112.576 -0.209 . . . . 8.1300000000000008 112.576 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.7 m -147.54 -53.35 0.21 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.732 0.301 . . . . 7.25 110.89 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 69.1 t60 -83.5 130.83 35.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 6.6799999999999997 110.88 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 173.07 -150.03 11.89 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.81 -0.709 . . . . 2.8900000000000001 112.359 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 56.55 48.66 16.2 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.707 0.289 . . . . 2.46 111.112 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.2 m -82.65 113.13 20.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.431 -0.35 . . . . 3.0099999999999998 110.818 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 57.0 82.87 0.11 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.174 -0.466 . . . . 2.6699999999999999 110.656 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -129.14 90.95 3.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.247 -0.433 . . . . 1.74 111.61 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 52.2 m 55.76 27.78 11.29 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.035 -0.53 . . . . 2.6299999999999999 111.512 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.06 35.4 6.73 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.684 -0.769 . . . . 1.8200000000000001 112.682 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -139.24 119.72 13.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.848 0.356 . . . . 1.98 110.703 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.5 t -139.38 145.69 39.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.096 -0.502 . . . . 1.26 111.021 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 62.5 mt -81.93 122.18 27.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.919 -0.582 . . . . 1.49 110.494 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -113.35 150.73 32.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 3.0899999999999999 110.964 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 80.3 p -151.05 138.42 19.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 1.79 111.264 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.9 t -129.67 145.64 35.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.072 -0.513 . . . . 1.26 110.823 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -95.14 114.18 25.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.997 0.427 . . . . 1.74 111.376 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -117.26 166.66 12.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.861 -0.609 . . . . 1.4099999999999999 110.591 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.471 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 30.4 p90 -157.94 134.39 9.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.81 0.338 . . . . 2.6600000000000001 111.073 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.637 ' HE ' ' H ' ' A' ' 93' ' ' GLY . 12.2 ttp180 -121.75 160.27 24.92 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.344 -0.389 . . . . 3.5899999999999999 110.847 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -165.87 -32.83 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.113 -0.494 . . . . 2.5800000000000001 110.845 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -67.76 162.43 23.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.906 -0.588 . . . . 4.1900000000000004 110.939 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -86.26 22.9 1.67 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.12 -0.491 . . . . 2.8700000000000001 110.715 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 74.6 p -63.47 -23.11 67.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.119 -0.491 . . . . 1.74 111.095 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.46 ' HA ' ' NH1' ' A' ' 20' ' ' ARG . 52.5 m 56.73 26.19 11.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.822 -0.626 . . . . 2.79 111.299 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.7 m -152.24 153.68 34.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.916 0.388 . . . . 1.79 111.12 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.526 HD23 ' HB2' ' A' ' 20' ' ' ARG . 81.0 mt -119.77 -5.66 10.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.016 -0.538 . . . . 1.1299999999999999 110.879 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.428 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 89.02 16.78 57.35 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.724 -0.751 . . . . 0.52000000000000002 112.363 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.409 HG21 HG23 ' A' ' 31' ' ' ILE . 69.9 mt -97.19 115.65 37.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.7 0.286 . . . . 1.53 110.994 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.1 t -110.66 90.32 3.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.358 -0.383 . . . . 1.4099999999999999 110.734 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.409 HG23 HG21 ' A' ' 29' ' ' ILE . 41.9 pt -87.18 167.52 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.034 -0.53 . . . . 1.1799999999999999 111.197 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 47.5 t -150.6 134.42 16.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.088 -0.505 . . . . 1.79 110.792 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.92 132.02 43.18 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.843 -0.694 . . . . 1.04 112.556 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 15.9 tpt -65.1 129.42 39.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.872 0.367 . . . . 2.48 110.751 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -62.36 162.88 9.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.003 -0.544 . . . . 6.1500000000000004 111.06 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -87.8 124.49 33.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.055 -0.52 . . . . 4.29 111.125 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -109.58 169.58 8.61 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.161 -0.472 . . . . 5.79 110.826 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.8 m -91.31 27.45 1.93 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.122 -0.49 . . . . 5.1799999999999997 111.063 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 60.8 p -114.25 135.37 54.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 5.54 111.079 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 80.4 p -85.97 -0.57 55.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.169 -0.468 . . . . 7.3600000000000003 111.241 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.42 -52.97 5.31 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.803 -0.713 . . . . 5.7999999999999998 112.445 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -117.45 144.93 44.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.699 0.285 . . . . 7.2199999999999998 110.574 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -146.88 122.16 10.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.441 -0.345 . . . . 3.6000000000000001 111.483 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 44.1 p 51.55 -172.08 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.798 -0.637 . . . . 3.02 111.739 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 141.76 146.62 4.72 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.705 -0.76 . . . . 1.3600000000000001 112.681 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.8 mp -100.64 122.31 52.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.735 0.302 . . . . 1.28 110.823 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -145.33 153.07 40.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.162 -0.472 . . . . 1.0800000000000001 110.94 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 95.2 t -83.89 125.79 40.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.247 -0.433 . . . . 1.0600000000000001 111.195 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -108.54 -27.34 9.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.95 -0.568 . . . . 2.8900000000000001 111.001 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 59.2 m -147.71 172.1 14.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.045 0.45 . . . . 1.8700000000000001 111.633 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 97.1 mt -132.14 165.72 23.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.669 -0.696 . . . . 1.1899999999999999 110.741 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.428 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 43.0 mm -106.36 104.48 50.5 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.186 -0.461 . . . . 1.8500000000000001 110.958 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.61 129.77 36.68 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.424 2.082 . . . . 1.26 112.407 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 98.01 0.44 58.7 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.768 -0.729 . . . . 0.52000000000000002 112.76 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.411 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 27.9 t -100.41 170.88 8.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.637 0.256 . . . . 1.73 110.999 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -51.81 -58.54 6.12 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.226 -0.443 . . . . 1.1299999999999999 111.659 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.3 -32.36 64.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.248 -0.433 . . . . 1.0900000000000001 111.514 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.91 -24.47 55.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.349 -0.387 . . . . 1.1100000000000001 111.344 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 55' ' ' SER . 90.8 mt -74.7 -37.65 62.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.277 -0.42 . . . . 1.29 111.033 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -57.18 -46.83 82.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.401 -0.363 . . . . 1.8600000000000001 110.913 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.46 -34.93 2.65 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.905 -0.664 . . . . 1.4199999999999999 112.709 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 78.0 mtm180 -65.11 -18.46 65.32 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.712 0.292 . . . . 3.0499999999999998 111.096 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 67.8 mt -87.23 108.94 18.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.888 0.375 . . . . 1.6299999999999999 110.919 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -82.67 138.25 44.05 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.011 -0.54 . . . . 1.98 110.5 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.54 53.41 3.98 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.45 2.1 . . . . 1.4399999999999999 112.524 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -174.59 72.09 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.125 -0.489 . . . . 2.6299999999999999 110.531 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -145.23 170.38 16.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.147 -0.479 . . . . 2.02 110.847 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -110.68 107.49 17.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.316 -0.402 . . . . 1.6200000000000001 111.028 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 43.7 mm -63.0 142.69 16.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.146 -0.479 . . . . 1.1100000000000001 110.732 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 94.4 mt -121.56 -59.22 1.71 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.286 -0.416 . . . . 1.1299999999999999 111.281 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.438 ' HG2' HD21 ' A' ' 76' ' ' ASN . 77.3 mtp180 -142.02 140.92 32.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.025 0.44 . . . . 3.1499999999999999 111.583 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.546 HG11 ' H ' ' A' ' 73' ' ' ASP . 3.9 t -103.41 173.99 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.86 -0.609 . . . . 1.0900000000000001 109.646 178.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.643 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 15.3 t70 -47.28 108.62 0.16 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.736 0.303 . . . . 0.79000000000000004 111.455 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 54.98 31.0 15.14 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.224 -0.444 . . . . 2.0099999999999998 111.576 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.416 ' HB ' ' HB ' ' A' ' 72' ' ' VAL . 92.7 t -145.51 148.14 17.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.354 -0.385 . . . . 1.1499999999999999 110.904 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.438 HD21 ' HG2' ' A' ' 71' ' ' ARG . 22.1 t-20 -120.2 118.33 30.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.148 -0.478 . . . . 2.8500000000000001 110.552 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.434 ' HA ' ' HE2' ' A' ' 80' ' ' MET . 26.8 m -102.21 25.24 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.871 0.367 . . . . 1.26 111.455 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -92.28 42.4 1.1 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.166 -0.47 . . . . 1.74 110.841 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 158.15 36.79 0.02 OUTLIER Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.661 -0.781 . . . . 0.57999999999999996 112.901 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.434 ' HE2' ' HA ' ' A' ' 77' ' ' VAL . 57.6 mtm -131.36 146.88 52.47 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.826 0.345 . . . . 1.1200000000000001 110.768 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.27 142.49 31.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.067 -0.515 . . . . 1.1200000000000001 111.029 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -48.07 -54.3 13.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.804 0.335 . . . . 1.52 111.03 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 56.8 m -54.15 -42.93 70.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.987 -0.551 . . . . 2.0299999999999998 110.98 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -58.1 -43.54 87.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 2.1200000000000001 110.983 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 52.5 t -58.19 -41.63 81.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 1.0800000000000001 110.702 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.3 t -61.61 -37.57 78.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.108 -0.496 . . . . 1.0700000000000001 110.758 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.446 ' HG2' HH21 ' A' ' 90' ' ' ARG . 42.4 mt-10 -58.92 -48.46 81.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.193 -0.458 . . . . 1.51 110.595 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 55.5 t -54.17 -54.1 23.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.133 -0.485 . . . . 1.0600000000000001 111.193 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 93.0 mt -59.26 -29.88 67.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.886 -0.597 . . . . 1.1399999999999999 111.456 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.446 HH21 ' HG2' ' A' ' 87' ' ' GLU . 87.3 mtm180 -85.9 -11.46 53.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.414 -0.357 . . . . 2.5600000000000001 111.154 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -100.02 -11.3 20.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.39 -0.368 . . . . 1.8100000000000001 111.178 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.33 -85.03 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.343 -0.39 . . . . 1.1100000000000001 111.571 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.637 ' H ' ' HE ' ' A' ' 20' ' ' ARG . . . 66.61 17.39 66.78 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.637 -0.792 . . . . 0.77000000000000002 112.318 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -146.9 169.62 9.13 Favored Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 110.295 -0.261 . . . . 3.3300000000000001 110.295 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.471 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 34.6 Cg_exo -58.91 104.1 0.18 Allowed 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.025 1.817 . . . . 0.92000000000000004 111.423 178.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 18.2 m -112.07 152.43 13.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.128 0.49 . . . . 1.3200000000000001 112.209 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.643 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 79.5 ttt180 -104.01 145.01 30.78 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.606 -0.724 . . . . 3.02 109.825 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 17.9 mt -115.1 114.33 25.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.197 -0.456 . . . . 1.1599999999999999 111.137 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 45.0 tp -105.63 102.21 11.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.407 -0.36 . . . . 1.1000000000000001 110.448 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.4 162.0 31.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 1.1100000000000001 111.388 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.2 tt -110.34 139.25 34.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.95 -0.568 . . . . 1.1399999999999999 110.934 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 18.8 tpt180 -133.99 139.1 45.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.085 -0.507 . . . . 2.7000000000000002 110.924 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -85.26 125.2 32.7 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.136 -0.483 . . . . 4.4000000000000004 110.964 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 68.9 mt -64.37 150.4 93.14 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.068 -0.515 . . . . 2.0 110.991 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -81.55 61.84 8.13 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.799 2.333 . . . . 2.98 112.61 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 93.0 mt -85.14 119.04 25.08 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.769 -0.65 . . . . 3.6699999999999999 110.842 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -87.48 165.54 15.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.202 -0.454 . . . . 5.9699999999999998 110.871 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.199 -0.905 . . . . 6.0 110.866 179.926 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 112.594 -0.203 . . . . 8.1300000000000008 112.594 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.8 m -88.28 145.93 25.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.844 0.354 . . . . 7.25 111.142 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -148.89 -24.91 0.31 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.034 -0.53 . . . . 6.6799999999999997 110.564 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -164.02 -104.95 0.19 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.837 -0.697 . . . . 2.8900000000000001 112.475 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -92.9 127.32 38.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.801 0.334 . . . . 2.46 111.071 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 72.6 p -112.38 95.07 5.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.458 . . . . 3.0099999999999998 110.785 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 20.3 t70 54.29 78.74 0.15 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.025 -0.534 . . . . 2.6699999999999999 110.894 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -123.18 107.55 11.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 1.74 111.246 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 64.3 m 55.57 25.87 8.47 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.094 -0.503 . . . . 2.6299999999999999 111.199 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.65 42.76 9.7 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.753 -0.737 . . . . 1.8200000000000001 112.654 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -143.52 112.88 6.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.944 0.402 . . . . 1.98 110.685 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 48.0 t -126.19 140.62 52.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.964 -0.562 . . . . 1.26 110.787 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 70.9 mt -81.36 122.03 26.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.98 -0.555 . . . . 1.49 110.313 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -113.56 143.33 44.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.298 -0.41 . . . . 3.0899999999999999 111.055 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 77.7 p -142.31 127.0 18.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.447 . . . . 1.79 111.09 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 19.5 t -118.36 143.86 28.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.078 -0.51 . . . . 1.26 110.699 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -96.74 114.55 26.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.946 0.403 . . . . 1.74 111.369 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.542 HD12 ' HB2' ' A' ' 60' ' ' ASP . 4.5 mm? -115.47 166.56 11.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.812 -0.631 . . . . 1.4099999999999999 110.558 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.569 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 43.4 p90 -157.8 132.89 8.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.292 -0.413 . . . . 2.6600000000000001 110.979 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.456 ' HB2' HD22 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -112.83 127.43 56.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.452 . . . . 3.5899999999999999 110.599 179.718 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -125.29 -8.63 6.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 2.5800000000000001 110.892 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -91.99 156.71 17.24 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.105 -0.498 . . . . 4.1900000000000004 110.74 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -87.37 34.09 0.69 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 2.8700000000000001 110.748 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 72.0 p -86.07 -21.41 27.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.964 -0.562 . . . . 1.74 111.091 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 55.7 m 58.32 17.62 4.86 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.893 -0.594 . . . . 2.79 111.398 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 54.5 m -127.84 142.42 51.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.853 0.359 . . . . 1.79 111.036 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.456 HD22 ' HB2' ' A' ' 20' ' ' ARG . 95.4 mt -113.4 -13.05 12.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.086 -0.507 . . . . 1.1299999999999999 110.902 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.415 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 91.53 30.78 10.19 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.802 -0.714 . . . . 0.52000000000000002 113.188 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.43 ' HB ' HD11 ' A' ' 89' ' ' LEU . 42.2 mm -101.6 113.31 37.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.676 0.274 . . . . 1.53 111.219 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 36.7 t -109.82 97.75 7.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.262 -0.426 . . . . 1.4099999999999999 110.765 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 23.6 pt -86.23 154.0 3.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 1.1799999999999999 111.18 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 48.3 t -131.27 139.17 49.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.091 -0.504 . . . . 1.79 110.873 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -73.27 143.11 32.53 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.768 -0.73 . . . . 1.04 112.538 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 27.2 ttt -98.74 107.31 19.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.818 0.342 . . . . 2.48 110.817 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.443 ' N ' ' HD2' ' A' ' 35' ' ' ARG . 6.8 mpt_? -97.23 124.52 41.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.168 -0.469 . . . . 6.1500000000000004 110.899 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -92.63 155.51 17.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 4.29 110.817 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -77.93 16.07 0.78 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.936 -0.575 . . . . 5.79 111.249 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 44.3 t -165.11 163.74 20.43 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.41 -0.359 . . . . 5.1799999999999997 110.893 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 68.0 p -122.7 139.12 54.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.163 -0.471 . . . . 5.54 111.049 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.9 t -161.16 8.97 0.08 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.082 -0.508 . . . . 7.3600000000000003 111.067 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 143.89 -109.64 0.55 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.752 -0.737 . . . . 5.7999999999999998 112.413 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -105.25 135.17 47.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.82 0.343 . . . . 7.2199999999999998 110.816 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -161.8 61.57 0.25 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.025 -0.534 . . . . 3.6000000000000001 111.102 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 82.4 p -131.4 138.9 49.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.149 -0.478 . . . . 3.02 111.007 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -132.7 126.28 4.42 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.674 -0.774 . . . . 1.3600000000000001 112.686 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.467 HG23 HG11 ' A' ' 85' ' ' VAL . 42.1 mm -88.32 83.98 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.893 0.378 . . . . 1.28 110.903 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -117.98 137.06 53.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.11 -0.496 . . . . 1.0800000000000001 110.868 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.9 t -66.92 110.47 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.083 -0.508 . . . . 1.0600000000000001 110.793 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -86.57 -28.87 23.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.0 -0.545 . . . . 2.8900000000000001 110.876 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 75.9 p -153.62 168.19 27.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.003 0.43 . . . . 1.8700000000000001 111.292 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.442 HD11 HG23 ' A' ' 63' ' ' ILE . 87.8 mt -123.76 165.03 17.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.849 -0.614 . . . . 1.1899999999999999 110.865 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.415 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 43.8 mm -112.01 107.95 55.69 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.079 -0.51 . . . . 1.8500000000000001 110.971 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -60.59 132.32 42.51 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.417 2.078 . . . . 1.26 112.276 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.73 -9.44 40.68 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.813 -0.708 . . . . 0.52000000000000002 112.57 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.41 ' OG ' ' HA3' ' A' ' 28' ' ' GLY . 97.0 p -91.91 -173.2 3.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.778 0.323 . . . . 1.73 111.03 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.95 -52.41 20.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.282 -0.417 . . . . 1.1299999999999999 111.251 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.415 ' HA ' HD12 ' A' ' 18' ' ' LEU . . . -57.53 -42.74 83.48 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.161 -0.472 . . . . 1.0900000000000001 111.555 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.71 -52.93 47.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.278 -0.419 . . . . 1.1100000000000001 111.729 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.3 mt -64.03 -19.69 65.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.398 -0.365 . . . . 1.29 111.424 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.542 ' HB2' HD12 ' A' ' 18' ' ' LEU . 14.3 t70 -57.27 -48.77 78.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.406 -0.361 . . . . 1.8600000000000001 110.863 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.63 -42.15 2.26 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.8 -0.714 . . . . 1.4199999999999999 112.86 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 67.9 mtp180 -70.38 -20.98 62.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.657 0.265 . . . . 3.0499999999999998 111.18 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.442 HG23 HD11 ' A' ' 51' ' ' LEU . 41.3 mm -72.99 134.08 30.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.816 0.341 . . . . 1.6299999999999999 110.833 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -129.77 136.71 29.5 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.105 -0.498 . . . . 1.98 110.707 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.18 168.27 16.26 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.394 2.063 . . . . 1.4399999999999999 112.22 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 63.0 t30 61.89 56.45 2.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.023 -0.535 . . . . 2.6299999999999999 110.614 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -131.92 149.93 52.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.971 -0.559 . . . . 2.02 110.683 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -96.58 117.38 30.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.342 -0.39 . . . . 1.6200000000000001 111.218 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.551 HD11 ' HB3' ' A' ' 100' ' ' LEU . 46.5 mm -78.0 136.35 24.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 1.1100000000000001 110.714 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.511 HD11 ' HB ' ' A' ' 101' ' ' ILE . 82.6 mt -107.34 -60.19 1.72 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.122 -0.49 . . . . 1.1299999999999999 110.788 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -154.32 137.18 15.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.169 0.509 . . . . 3.1499999999999999 111.377 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.593 HG12 ' H ' ' A' ' 73' ' ' ASP . 2.4 t -87.4 175.85 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.606 -0.724 . . . . 1.0900000000000001 110.138 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.606 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 24.2 t70 -49.91 110.09 0.35 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.874 0.369 . . . . 0.79000000000000004 111.642 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 56.84 23.85 8.55 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.034 -0.53 . . . . 2.0099999999999998 111.801 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.6 t -142.37 144.4 24.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.437 -0.347 . . . . 1.1499999999999999 110.788 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -112.65 138.18 49.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.484 -0.325 . . . . 2.8500000000000001 110.809 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.0 m -119.91 24.62 4.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.89 0.376 . . . . 1.26 111.212 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -95.41 44.85 1.09 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.093 -0.503 . . . . 1.74 110.908 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 164.66 24.95 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.612 -0.804 . . . . 0.57999999999999996 112.672 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 38.9 mtm -124.01 142.23 51.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.714 0.292 . . . . 1.1200000000000001 110.721 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.11 163.12 15.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.268 -0.423 . . . . 1.1200000000000001 111.041 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -48.83 -52.54 23.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.205 -0.452 . . . . 1.52 111.343 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 80.1 p -54.13 -42.23 69.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.116 -0.493 . . . . 2.0299999999999998 111.534 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -62.24 -43.91 97.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.47 -0.332 . . . . 2.1200000000000001 111.471 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.467 HG11 HG23 ' A' ' 46' ' ' ILE . 21.7 t -61.48 -43.82 97.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.855 0.359 . . . . 1.0800000000000001 111.175 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 59.4 t -59.88 -41.02 84.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.069 -0.514 . . . . 1.0700000000000001 111.154 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.48 ' HG2' HH21 ' A' ' 90' ' ' ARG . 44.0 mt-10 -59.46 -44.45 92.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 1.51 110.967 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 71.8 t -57.82 -57.39 10.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 1.0600000000000001 111.574 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.43 HD11 ' HB ' ' A' ' 29' ' ' ILE . 86.8 mt -52.24 -34.93 48.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.049 -0.523 . . . . 1.1399999999999999 111.376 -179.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.48 HH21 ' HG2' ' A' ' 87' ' ' GLU . 65.1 mtm180 -78.09 -29.12 48.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.39 -0.368 . . . . 2.5600000000000001 111.011 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -71.03 -22.58 62.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 1.8100000000000001 110.852 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.06 -86.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.115 -0.493 . . . . 1.1100000000000001 111.279 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.449 ' HA2' ' HG2' ' A' ' 20' ' ' ARG . . . 60.76 17.04 48.61 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.676 -0.773 . . . . 0.77000000000000002 112.472 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.473 ' HB3' ' HD2' ' A' ' 95' ' ' PRO . 2.4 m120 -147.52 175.13 2.88 Favored Pre-proline 0 CA--C 1.533 0.297 0 C-N-CA 122.001 0.121 . . . . 3.3300000000000001 110.909 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.569 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 50.8 Cg_exo -56.28 104.93 0.15 Allowed 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 122.121 1.88 . . . . 0.92000000000000004 111.762 178.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 30.5 m -125.45 150.31 30.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.027 0.441 . . . . 1.3200000000000001 111.896 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.606 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 77.2 ttt180 -98.05 145.33 26.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.714 -0.675 . . . . 3.02 109.856 179.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 16.0 mt -119.89 125.33 48.21 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.329 -0.396 . . . . 1.1599999999999999 111.247 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 50.8 tp -112.78 100.03 8.36 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.404 -0.362 . . . . 1.1000000000000001 110.723 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.551 ' HB3' HD11 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -124.39 141.65 51.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.961 -0.563 . . . . 1.1100000000000001 111.184 -179.897 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.511 ' HB ' HD11 ' A' ' 70' ' ' LEU . 15.0 tt -97.31 141.93 15.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.469 . . . . 1.1399999999999999 111.126 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -138.06 131.58 30.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.031 -0.531 . . . . 2.7000000000000002 110.839 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -85.96 141.95 29.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 4.4000000000000004 111.053 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 75.6 mt -84.44 147.55 50.07 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.984 -0.553 . . . . 2.0 110.914 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -81.37 60.55 7.77 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.82 2.346 . . . . 2.98 112.043 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 50.9 mt -84.97 111.72 19.95 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.449 -0.796 . . . . 3.6699999999999999 110.985 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -90.56 96.51 10.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 5.9699999999999998 110.794 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.266 -0.873 . . . . 6.0 110.899 -179.787 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.213 0 N-CA-C 112.561 -0.215 . . . . 8.1300000000000008 112.561 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 56.8 m -91.72 163.07 14.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.82 0.343 . . . . 7.25 110.966 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 54.8 m80 -137.33 26.72 2.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.168 -0.469 . . . . 6.6799999999999997 110.887 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.24 -103.92 0.18 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.725 -0.75 . . . . 2.8900000000000001 112.564 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -108.18 157.76 18.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.803 0.335 . . . . 2.46 111.017 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.8 m -119.0 94.9 4.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.495 . . . . 3.0099999999999998 110.83 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 55.71 46.82 21.79 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.136 -0.484 . . . . 2.6699999999999999 111.102 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -95.21 113.74 25.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.195 -0.457 . . . . 1.74 111.158 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 54.5 m 56.51 25.73 10.11 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.129 -0.487 . . . . 2.6299999999999999 111.173 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.71 -35.23 4.04 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.758 -0.734 . . . . 1.8200000000000001 112.657 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.405 ' HB3' HD12 ' A' ' 101' ' ' ILE . 94.0 m-85 -65.56 112.86 3.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.9 0.381 . . . . 1.98 110.961 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 46.8 t -136.01 140.83 44.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.032 -0.531 . . . . 1.26 110.824 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 62.2 mt -78.87 121.25 24.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.113 -0.494 . . . . 1.49 110.772 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.804 ' HH ' HD23 ' A' ' 104' ' ' LEU . 57.7 m-85 -114.88 129.15 56.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.038 0.447 . . . . 3.0899999999999999 111.194 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 48.4 t -101.36 137.17 40.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.843 -0.617 . . . . 1.79 111.084 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.1 t -131.28 158.38 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.047 -0.524 . . . . 1.26 110.526 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -136.35 112.93 10.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.827 0.346 . . . . 1.74 111.257 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.504 HD11 ' HB2' ' A' ' 56' ' ' ALA . 4.0 mm? -122.88 166.64 14.7 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.084 -0.507 . . . . 1.4099999999999999 110.737 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.545 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 34.1 p90 -141.18 131.26 24.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.289 -0.414 . . . . 2.6600000000000001 111.019 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.514 HH21 ' HG ' ' A' ' 27' ' ' LEU . 14.5 ttm180 -102.48 93.53 5.2 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.38 -0.373 . . . . 3.5899999999999999 110.91 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -130.08 -0.08 4.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.35 -0.387 . . . . 2.5800000000000001 110.824 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -88.25 161.09 17.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.067 -0.515 . . . . 4.1900000000000004 110.881 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -84.46 39.72 0.74 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.14 -0.482 . . . . 2.8700000000000001 110.865 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 71.5 p -98.06 -19.48 17.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.281 -0.418 . . . . 1.74 111.175 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 29.3 t 56.83 17.39 3.21 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.0 -0.545 . . . . 2.79 111.194 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.8 m -151.95 153.74 34.69 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.294 -0.412 . . . . 1.79 110.947 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.514 ' HG ' HH21 ' A' ' 20' ' ' ARG . 58.2 mt -102.88 -20.65 14.2 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.134 -0.485 . . . . 1.1299999999999999 110.837 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.472 ' HA3' ' HG ' ' A' ' 55' ' ' SER . . . 101.8 3.69 52.19 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.767 -0.73 . . . . 0.52000000000000002 112.742 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 44.9 mm -76.27 109.01 9.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.729 0.299 . . . . 1.53 111.044 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 44.4 t -110.75 92.8 4.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.341 -0.391 . . . . 1.4099999999999999 110.82 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 26.7 pt -91.01 167.8 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.968 -0.56 . . . . 1.1799999999999999 111.22 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 77.8 p -137.95 142.26 40.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.02 -0.536 . . . . 1.79 110.853 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.04 128.78 37.44 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.873 -0.679 . . . . 1.04 112.516 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 17.3 tpt -65.23 142.2 58.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.806 0.336 . . . . 2.48 110.943 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 -109.6 119.11 38.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.197 -0.456 . . . . 6.1500000000000004 110.629 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.549 ' HB3' ' HG1' ' A' ' 39' ' ' THR . 6.7 m-20 -103.53 -65.91 0.98 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.063 -0.517 . . . . 4.29 111.3 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 60.44 77.87 0.3 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.242 -0.435 . . . . 5.79 110.762 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 52.4 m 58.18 86.49 0.08 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.088 -0.505 . . . . 5.1799999999999997 111.098 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.549 ' HG1' ' HB3' ' A' ' 36' ' ' ASP . 75.3 p -135.5 136.71 41.46 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.132 -0.485 . . . . 5.54 111.207 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.7 t -109.66 19.2 19.46 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.177 -0.465 . . . . 7.3600000000000003 110.76 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -120.05 -74.48 0.41 Allowed Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.897 -0.668 . . . . 5.7999999999999998 112.476 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -96.23 168.2 10.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.879 0.371 . . . . 7.2199999999999998 110.883 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -145.58 104.87 3.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.104 -0.498 . . . . 3.6000000000000001 110.945 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 56.4 p 50.85 -167.25 0.03 OUTLIER 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.066 -0.516 . . . . 3.02 111.487 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 146.88 128.16 1.86 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.767 -0.73 . . . . 1.3600000000000001 112.554 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 44.3 mm -86.44 124.57 40.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.712 0.291 . . . . 1.28 110.804 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -148.48 144.99 27.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.337 -0.392 . . . . 1.0800000000000001 111.117 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 97.1 t -83.37 126.17 40.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.029 -0.532 . . . . 1.0600000000000001 110.649 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -107.32 -21.95 12.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 2.8900000000000001 110.912 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 76.9 p -152.39 169.64 22.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 1.8700000000000001 111.2 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 67.8 mt -134.59 165.5 25.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.941 -0.572 . . . . 1.1899999999999999 110.771 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.47 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 47.5 mm -107.6 99.21 27.79 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 1.8500000000000001 110.877 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -49.69 141.17 27.93 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.564 2.176 . . . . 1.26 112.652 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 95.66 -22.93 36.41 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.88 -0.676 . . . . 0.52000000000000002 112.562 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.472 ' HG ' ' HA3' ' A' ' 28' ' ' GLY . 83.6 p -76.3 -178.19 4.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.733 0.301 . . . . 1.73 111.059 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.504 ' HB2' HD11 ' A' ' 18' ' ' LEU . . . -66.15 -56.87 9.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.316 -0.402 . . . . 1.1299999999999999 111.229 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.11 -34.46 66.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.458 . . . . 1.0900000000000001 111.314 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.14 -43.05 71.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.28 -0.418 . . . . 1.1100000000000001 111.288 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.4 mt -67.93 -19.62 65.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.257 -0.428 . . . . 1.29 111.118 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -57.33 -46.88 82.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.444 -0.343 . . . . 1.8600000000000001 110.891 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.61 -50.32 1.81 Allowed Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.77 -0.729 . . . . 1.4199999999999999 112.87 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 66.4 mtm180 -64.08 -42.55 96.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.634 0.254 . . . . 3.0499999999999998 111.017 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 61.5 mt -63.86 114.4 2.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.369 -0.378 . . . . 1.6299999999999999 110.962 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -130.5 158.56 74.19 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 1.98 111.179 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -55.0 174.73 0.19 Allowed 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.734 2.29 . . . . 1.4399999999999999 112.211 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 17.4 m120 61.66 35.58 17.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.195 -0.457 . . . . 2.6299999999999999 111.122 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -112.96 152.71 29.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.152 -0.476 . . . . 2.02 110.649 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -116.02 105.81 13.06 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.83 0.347 . . . . 1.6200000000000001 111.138 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 44.1 mm -63.7 131.82 29.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.195 -0.457 . . . . 1.1100000000000001 110.983 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.554 ' HA ' HE21 ' A' ' 78' ' ' GLN . 66.9 mt -102.37 -65.69 0.97 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.134 -0.484 . . . . 1.1299999999999999 110.802 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -146.84 135.31 21.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.988 -0.551 . . . . 3.1499999999999999 111.296 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.55 HG11 ' H ' ' A' ' 73' ' ' ASP . 3.7 t -87.99 175.22 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.622 -0.717 . . . . 1.0900000000000001 109.983 179.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.628 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 21.3 t70 -48.63 109.28 0.23 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.803 0.335 . . . . 0.79000000000000004 111.586 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 56.15 26.37 10.16 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.113 -0.494 . . . . 2.0099999999999998 111.853 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.5 t -145.6 149.26 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.406 -0.361 . . . . 1.1499999999999999 110.777 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -119.06 131.72 55.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.32 -0.4 . . . . 2.8500000000000001 110.459 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.0 m -105.25 26.43 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.879 0.371 . . . . 1.26 111.287 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.554 HE21 ' HA ' ' A' ' 70' ' ' LEU . 84.8 mm-40 -94.93 23.79 5.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.096 -0.502 . . . . 1.74 111.114 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -172.79 17.06 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.641 -0.79 . . . . 0.57999999999999996 112.8 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 38.6 mtm -118.05 135.9 53.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.831 0.348 . . . . 1.1200000000000001 110.849 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.91 160.08 18.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.436 . . . . 1.1200000000000001 111.097 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -48.25 -54.21 14.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.374 -0.376 . . . . 1.52 111.249 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 46.1 t -53.88 -32.84 54.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.327 -0.397 . . . . 2.0299999999999998 111.244 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.408 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 10.4 t70 -73.35 -40.13 64.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.366 -0.379 . . . . 2.1200000000000001 111.0 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 25.8 t -65.12 -30.32 49.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.961 0.41 . . . . 1.0800000000000001 110.661 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 97.5 t -70.94 -49.27 51.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.985 -0.552 . . . . 1.0700000000000001 111.187 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.408 ' HG2' ' O ' ' A' ' 84' ' ' ASP . 11.4 pt-20 -60.44 -30.01 69.37 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.722 0.296 . . . . 1.51 110.752 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 50.2 t -65.27 -56.66 14.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.893 0.378 . . . . 1.0600000000000001 110.825 179.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 93.5 mt -54.93 -35.19 63.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.957 -0.565 . . . . 1.1399999999999999 111.378 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.455 ' HA ' ' NH1' ' A' ' 20' ' ' ARG . 86.9 mtm180 -76.96 -34.32 57.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.424 -0.353 . . . . 2.5600000000000001 111.17 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.29 -18.36 63.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.436 -0.347 . . . . 1.8100000000000001 110.682 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.43 -84.51 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.133 -0.485 . . . . 1.1100000000000001 111.464 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.403 ' H ' ' HD2' ' A' ' 20' ' ' ARG . . . 63.63 22.2 65.75 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.692 -0.766 . . . . 0.77000000000000002 112.186 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -147.17 169.81 8.77 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 110.39 -0.226 . . . . 3.3300000000000001 110.39 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.545 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 33.3 Cg_exo -60.79 93.02 0.1 OUTLIER 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.055 1.837 . . . . 0.92000000000000004 111.248 178.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.5 m -101.79 145.64 11.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.085 0.469 . . . . 1.3200000000000001 111.918 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.628 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 60.4 ttp180 -91.88 136.44 33.16 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.694 -0.685 . . . . 3.02 110.157 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 65.5 mt -111.65 103.74 12.06 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.975 -0.557 . . . . 1.1599999999999999 111.187 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 21.4 tp -97.51 106.77 19.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.889 0.376 . . . . 1.1000000000000001 110.158 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.96 164.93 26.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 1.1100000000000001 111.434 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.405 HD12 ' HB3' ' A' ' 11' ' ' PHE . 12.4 tt -110.34 133.75 54.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.031 -0.532 . . . . 1.1399999999999999 111.033 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 18.2 mmm180 -111.87 130.47 55.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.968 -0.56 . . . . 2.7000000000000002 110.508 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 41.3 ttp180 -89.68 108.28 19.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.311 -0.404 . . . . 4.4000000000000004 110.933 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.804 HD23 ' HH ' ' A' ' 14' ' ' TYR . 79.1 mt -63.91 133.99 95.76 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 2.0 110.786 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -79.98 60.04 7.67 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.64 2.227 . . . . 2.98 112.218 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 78.3 mt -89.58 115.55 27.06 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.533 -0.758 . . . . 3.6699999999999999 110.912 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -76.13 150.95 37.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 5.9699999999999998 110.677 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.303 -0.856 . . . . 6.0 110.909 -179.979 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.07 0 N-CA-C 112.508 -0.237 . . . . 8.1300000000000008 112.508 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 52.0 m -139.65 140.04 36.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.705 0.288 . . . . 7.25 110.933 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 28.3 t60 -168.59 99.56 0.41 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 6.6799999999999997 110.879 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 144.63 -106.99 0.42 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.786 -0.721 . . . . 2.8900000000000001 112.462 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -70.49 145.87 50.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.773 0.32 . . . . 2.46 110.83 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 77.7 p -138.87 96.94 3.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.189 -0.459 . . . . 3.0099999999999998 111.067 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 55.16 35.88 25.78 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.113 -0.494 . . . . 2.6699999999999999 110.988 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -94.29 113.03 24.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.093 -0.503 . . . . 1.74 111.144 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.5 t 56.02 22.95 6.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.182 -0.463 . . . . 2.6299999999999999 110.996 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.66 -29.07 5.53 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.835 -0.698 . . . . 1.8200000000000001 112.688 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.405 ' HB3' HD13 ' A' ' 101' ' ' ILE . 74.5 m-85 -60.64 109.61 1.08 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.878 0.37 . . . . 1.98 111.131 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.9 t -132.16 146.67 52.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.007 -0.542 . . . . 1.26 110.685 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 56.0 mt -81.65 122.56 27.77 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.293 -0.412 . . . . 1.49 111.166 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.512 ' HH ' HD23 ' A' ' 104' ' ' LEU . 65.7 m-85 -121.15 130.58 53.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.066 -0.515 . . . . 3.0899999999999999 110.84 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 47.6 t -125.57 132.9 52.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.31 -0.405 . . . . 1.79 111.214 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 18.3 t -131.13 151.29 35.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.968 -0.56 . . . . 1.26 110.606 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -101.2 118.71 37.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.958 0.408 . . . . 1.74 111.446 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.468 HD13 ' HB2' ' A' ' 60' ' ' ASP . 4.3 mm? -122.23 166.45 14.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.945 -0.57 . . . . 1.4099999999999999 110.191 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.566 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 36.9 p90 -141.86 131.83 24.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.85 0.357 . . . . 2.6600000000000001 111.078 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.405 ' HB2' HD22 ' A' ' 27' ' ' LEU . 3.2 tmm_? -100.83 104.82 16.06 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.21 -0.45 . . . . 3.5899999999999999 110.712 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -146.43 8.88 1.05 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.311 -0.404 . . . . 2.5800000000000001 110.953 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -89.75 162.75 15.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.253 -0.431 . . . . 4.1900000000000004 110.958 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -84.05 34.13 0.5 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.108 -0.497 . . . . 2.8700000000000001 110.958 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 51.6 p -98.1 -8.96 26.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.182 -0.463 . . . . 1.74 110.881 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.7 t 58.35 15.92 3.75 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.829 -0.623 . . . . 2.79 111.098 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 57.3 m -158.04 -176.96 6.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.262 -0.426 . . . . 1.79 110.902 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.405 HD22 ' HB2' ' A' ' 20' ' ' ARG . 37.4 mt -115.28 -5.1 12.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.042 -0.526 . . . . 1.1299999999999999 110.794 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.456 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 94.82 6.27 60.71 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.779 -0.724 . . . . 0.52000000000000002 112.171 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 25.0 mm -79.61 109.24 14.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.817 0.341 . . . . 1.53 110.958 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.481 ' HB2' ' HG ' ' A' ' 50' ' ' SER . 49.7 m -113.33 93.35 4.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.176 -0.465 . . . . 1.4099999999999999 110.796 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 44.6 pt -93.03 163.3 2.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 1.1799999999999999 111.2 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 45.3 t -119.08 130.66 55.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.259 -0.428 . . . . 1.79 110.792 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -67.14 115.84 7.54 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.849 -0.691 . . . . 1.04 112.623 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 26.0 ttt -78.22 114.92 17.55 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.873 0.368 . . . . 2.48 110.854 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.73 155.86 5.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.045 -0.525 . . . . 6.1500000000000004 111.113 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -107.07 -18.21 13.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.045 -0.525 . . . . 4.29 110.984 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 62.74 -175.46 0.15 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.891 -0.595 . . . . 5.79 110.864 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 80.1 p -87.49 22.76 2.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.168 -0.469 . . . . 5.1799999999999997 110.914 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 59.1 p -80.43 138.29 36.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.127 -0.488 . . . . 5.54 111.178 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.8 t -71.57 -4.87 29.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.067 -0.515 . . . . 7.3600000000000003 111.14 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -114.73 114.49 3.25 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.818 -0.706 . . . . 5.7999999999999998 112.468 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -69.87 138.98 52.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.753 0.311 . . . . 7.2199999999999998 110.917 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -150.62 38.53 0.69 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.96 0.409 . . . . 3.6000000000000001 111.206 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 64.7 p -64.27 149.18 48.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.934 -0.575 . . . . 3.02 110.995 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -149.29 135.07 5.2 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.708 -0.758 . . . . 1.3600000000000001 112.617 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 49.7 mm -98.05 114.94 36.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.719 0.295 . . . . 1.28 110.895 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -143.59 137.67 28.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 1.0800000000000001 111.094 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 99.4 t -68.08 127.81 30.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.113 -0.494 . . . . 1.0600000000000001 111.051 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -99.96 -30.58 11.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.912 -0.586 . . . . 2.8900000000000001 110.999 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.481 ' HG ' ' HB2' ' A' ' 30' ' ' SER . 80.1 p -157.17 171.62 20.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.894 0.378 . . . . 1.8700000000000001 111.296 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 63.6 mt -129.26 140.55 51.4 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.921 -0.582 . . . . 1.1899999999999999 110.88 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.456 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 49.5 mm -77.15 118.0 68.95 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 116.21 -0.45 . . . . 1.8500000000000001 110.899 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -68.25 109.43 1.99 Allowed 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.268 1.979 . . . . 1.26 112.255 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 126.93 -5.46 7.39 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.849 -0.691 . . . . 0.52000000000000002 112.448 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.8 m -94.07 -174.83 3.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.709 0.29 . . . . 1.73 111.086 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.441 ' HB1' HD12 ' A' ' 18' ' ' LEU . . . -72.48 -42.8 64.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.379 -0.373 . . . . 1.1299999999999999 111.348 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.98 -42.57 99.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.298 -0.41 . . . . 1.0900000000000001 111.451 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.03 -55.24 11.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 1.1100000000000001 111.317 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.3 mt -59.25 -19.67 47.75 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.3 -0.409 . . . . 1.29 111.23 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.468 ' HB2' HD13 ' A' ' 18' ' ' LEU . 18.8 t70 -59.96 -49.74 76.5 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.837 0.351 . . . . 1.8600000000000001 110.746 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 98.71 -49.73 1.27 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.905 -0.664 . . . . 1.4199999999999999 112.987 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 51.3 mtp180 -60.33 -45.09 94.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.749 0.309 . . . . 3.0499999999999998 111.134 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 71.9 mt -67.59 114.18 4.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.906 0.384 . . . . 1.6299999999999999 111.111 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -117.29 139.75 26.41 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.025 -0.534 . . . . 1.98 110.568 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -47.62 167.18 0.09 OUTLIER 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.557 2.171 . . . . 1.4399999999999999 112.73 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 63.97 60.78 0.99 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.094 -0.503 . . . . 2.6299999999999999 110.554 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -134.28 156.66 48.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.788 -0.642 . . . . 2.02 110.579 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -109.47 113.29 25.96 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.867 0.365 . . . . 1.6200000000000001 111.073 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 34.2 mm -74.05 143.36 13.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.076 -0.511 . . . . 1.1100000000000001 110.857 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 74.7 mt -116.17 -66.51 1.08 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.312 -0.404 . . . . 1.1299999999999999 111.392 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.457 ' HG2' HD21 ' A' ' 76' ' ' ASN . 76.8 mtp180 -140.22 142.45 35.83 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.041 0.448 . . . . 3.1499999999999999 111.558 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.576 HG12 ' H ' ' A' ' 73' ' ' ASP . 3.6 t -100.83 174.48 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.871 -0.604 . . . . 1.0900000000000001 109.788 179.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.688 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 12.7 t70 -49.76 108.66 0.22 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.727 0.299 . . . . 0.79000000000000004 111.191 179.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 55.21 29.7 13.23 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.198 -0.455 . . . . 2.0099999999999998 111.542 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.482 ' HB ' ' HB ' ' A' ' 72' ' ' VAL . 92.4 t -145.36 151.78 14.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.417 -0.356 . . . . 1.1499999999999999 110.947 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.457 HD21 ' HG2' ' A' ' 71' ' ' ARG . 2.7 t-20 -120.66 126.1 49.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.32 -0.4 . . . . 2.8500000000000001 110.565 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.9 m -107.56 19.84 5.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 111.708 0.262 . . . . 1.26 111.708 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.406 ' HG2' HD22 ' A' ' 76' ' ' ASN . 14.0 mm100 -94.26 21.72 6.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.92 0.39 . . . . 1.74 110.465 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -161.68 13.09 0.14 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.004 -0.617 . . . . 0.57999999999999996 112.429 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 52.9 mtm -118.83 144.65 46.22 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.859 0.361 . . . . 1.1200000000000001 110.825 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.87 168.02 18.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.12 -0.491 . . . . 1.1200000000000001 111.086 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.406 ' O ' HG23 ' A' ' 86' ' ' VAL . 63.0 tt0 -49.5 -56.43 9.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.138 -0.483 . . . . 1.52 111.447 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 54.6 m -51.38 -43.31 61.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 2.0299999999999998 111.837 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -60.68 -50.53 73.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.465 -0.334 . . . . 2.1200000000000001 111.507 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 25.7 t -57.86 -36.46 55.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.293 -0.412 . . . . 1.0800000000000001 111.327 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 82' ' ' GLN . 90.6 t -62.54 -48.95 85.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.36 -0.382 . . . . 1.0700000000000001 111.391 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -56.73 -41.46 77.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.339 -0.392 . . . . 1.51 111.143 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 75.1 t -57.33 -58.96 3.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.255 -0.43 . . . . 1.0600000000000001 111.696 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 86.5 mt -54.22 -32.16 55.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 1.1399999999999999 111.58 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 82.6 mtm180 -81.47 -23.47 37.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.503 -0.317 . . . . 2.5600000000000001 111.276 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -84.14 -14.26 50.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.34 -0.391 . . . . 1.8100000000000001 110.955 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.03 -81.61 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.162 -0.472 . . . . 1.1100000000000001 111.49 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 63.84 15.29 57.72 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 120.625 -0.797 . . . . 0.77000000000000002 112.253 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -146.85 167.94 12.57 Favored Pre-proline 0 C--N 1.329 -0.303 0 N-CA-C 110.333 -0.247 . . . . 3.3300000000000001 110.333 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.566 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 34.3 Cg_exo -61.94 98.38 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.051 1.834 . . . . 0.92000000000000004 111.338 178.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.6 m -104.44 153.67 6.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.129 0.49 . . . . 1.3200000000000001 112.108 -178.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.688 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 40.3 ttm180 -93.04 141.26 28.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.459 -0.791 . . . . 3.02 110.063 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.447 HD11 HD21 ' A' ' 18' ' ' LEU . 48.9 mt -117.37 103.58 10.28 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.149 -0.478 . . . . 1.1599999999999999 110.848 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 58.5 tp -99.29 99.63 10.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 1.1000000000000001 110.34 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.2 165.86 20.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 1.1100000000000001 111.093 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.405 HD13 ' HB3' ' A' ' 11' ' ' PHE . 14.9 tt -114.33 130.23 68.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-O 121.096 0.474 . . . . 1.1399999999999999 111.447 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 23.0 mmm180 -108.98 146.33 34.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.443 -0.799 . . . . 2.7000000000000002 110.642 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 31.2 ttp180 -101.54 124.04 46.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.948 0.404 . . . . 4.4000000000000004 110.744 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.512 HD23 ' HH ' ' A' ' 14' ' ' TYR . 18.9 mt -94.74 139.78 22.34 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.004 -0.544 . . . . 2.0 110.814 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -82.12 167.77 15.71 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.53 2.153 . . . . 2.98 112.395 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 88.1 mt -132.25 135.31 46.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.271 -0.422 . . . . 3.6699999999999999 110.903 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 95.3 mt -107.11 138.99 42.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.111 -0.495 . . . . 5.9699999999999998 111.063 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.266 -0.873 . . . . 6.0 110.981 179.979 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.152 0 N-CA-C 112.473 -0.251 . . . . 8.1300000000000008 112.473 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.6 m -151.96 152.65 32.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.731 0.3 . . . . 7.25 110.971 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -133.84 71.43 1.46 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.272 -0.422 . . . . 6.6799999999999997 110.883 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -176.66 112.56 0.39 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.858 -0.687 . . . . 2.8900000000000001 112.411 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -113.9 93.46 4.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.817 0.342 . . . . 2.46 111.136 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.6 p -79.47 82.36 5.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.25 -0.432 . . . . 3.0099999999999998 110.677 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 23.2 t70 57.23 85.15 0.09 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.075 -0.511 . . . . 2.6699999999999999 110.88 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -136.69 115.85 12.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.068 -0.515 . . . . 1.74 111.018 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.3 t 58.37 25.94 13.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.086 -0.506 . . . . 2.6299999999999999 111.017 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.84 -39.99 2.67 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.843 -0.694 . . . . 1.8200000000000001 112.759 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -58.12 102.54 0.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.903 0.383 . . . . 1.98 111.083 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 46.6 t -113.78 148.88 35.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.016 -0.538 . . . . 1.26 110.788 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -84.77 126.09 33.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 1.49 111.211 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -121.16 136.09 55.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.897 -0.592 . . . . 3.0899999999999999 110.586 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 49.4 m -136.75 127.57 27.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.284 -0.416 . . . . 1.79 111.205 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 28.3 t -129.86 145.98 34.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.986 -0.552 . . . . 1.26 110.61 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -107.92 117.51 34.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.949 0.404 . . . . 1.74 111.311 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.493 HD12 ' HB2' ' A' ' 60' ' ' ASP . 4.3 mm? -111.05 166.46 11.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.855 -0.611 . . . . 1.4099999999999999 110.763 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.556 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 28.6 p90 -152.95 132.47 12.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.388 -0.369 . . . . 2.6600000000000001 111.084 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.555 HH21 ' H ' ' A' ' 93' ' ' GLY . 24.2 ttp180 -122.37 156.2 34.46 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.271 -0.422 . . . . 3.5899999999999999 110.637 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -169.39 26.45 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.311 -0.404 . . . . 2.5800000000000001 110.84 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -116.78 164.7 14.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.176 -0.466 . . . . 4.1900000000000004 110.91 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -87.58 25.99 1.36 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.999 -0.546 . . . . 2.8700000000000001 111.007 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.4 p -78.26 -23.94 47.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.927 0.394 . . . . 1.74 110.902 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 59.2 m 56.59 21.75 6.05 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.683 -0.69 . . . . 2.79 111.339 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.7 m -140.03 144.69 37.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.287 -0.415 . . . . 1.79 111.058 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 41.4 mt -113.56 12.48 18.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.125 -0.489 . . . . 1.1299999999999999 110.91 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.463 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 58.29 37.54 87.49 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.833 -0.699 . . . . 0.52000000000000002 112.715 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 65.9 mt -109.51 109.48 28.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.791 0.329 . . . . 1.53 111.144 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 39.5 t -105.64 112.24 25.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.072 -0.513 . . . . 1.4099999999999999 110.633 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 37.1 pt -107.84 167.13 3.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 1.1799999999999999 111.509 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 56.8 m -141.56 134.89 29.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.965 -0.561 . . . . 1.79 110.623 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -91.49 78.19 1.35 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.754 -0.736 . . . . 1.04 112.598 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 10.7 tmm? -103.04 113.26 26.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.804 0.335 . . . . 2.48 110.479 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 28.4 mmm180 -100.72 152.47 20.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 6.1500000000000004 110.966 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -117.16 139.41 50.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.101 -0.499 . . . . 4.29 110.726 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -97.42 158.46 15.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 5.79 110.968 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 52.2 m 56.46 59.89 3.39 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.081 -0.509 . . . . 5.1799999999999997 110.853 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 41.5 p -71.62 152.16 43.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.915 -0.584 . . . . 5.54 111.294 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.8 t -150.99 2.05 0.43 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.052 -0.522 . . . . 7.3600000000000003 111.082 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.81 -46.85 0.15 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.934 -0.65 . . . . 5.7999999999999998 112.448 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -89.44 158.42 17.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.804 0.335 . . . . 7.2199999999999998 110.925 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -155.37 121.05 5.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.211 -0.45 . . . . 3.6000000000000001 111.192 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.2 p -107.79 127.5 53.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.036 -0.529 . . . . 3.02 111.266 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -134.05 -115.43 1.57 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.87 -0.681 . . . . 1.3600000000000001 112.236 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.3 mm -82.93 99.86 6.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.728 0.299 . . . . 1.28 110.648 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -128.48 142.36 51.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.258 -0.428 . . . . 1.0800000000000001 111.22 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 86.3 t -76.9 113.02 15.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.11 -0.496 . . . . 1.0600000000000001 110.47 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -88.35 -29.41 20.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.276 -0.42 . . . . 2.8900000000000001 111.331 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 78.4 p -153.35 176.82 11.56 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.936 0.398 . . . . 1.8700000000000001 111.377 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 69.8 mt -135.58 153.45 51.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.933 -0.576 . . . . 1.1899999999999999 110.882 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.463 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 57.7 mt -90.33 109.71 35.54 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.312 -0.404 . . . . 1.8500000000000001 110.947 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -57.73 124.95 17.23 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.426 2.084 . . . . 1.26 112.331 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.93 -3.86 31.92 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.774 -0.727 . . . . 0.52000000000000002 112.498 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.9 t -100.09 177.86 4.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.743 0.306 . . . . 1.73 110.94 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.48 -58.34 8.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.263 -0.426 . . . . 1.1299999999999999 111.755 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.46 -49.83 66.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.225 -0.443 . . . . 1.0900000000000001 111.844 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.75 -39.45 80.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.385 -0.37 . . . . 1.1100000000000001 111.876 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 81.1 mt -70.75 -23.0 62.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.503 -0.317 . . . . 1.29 111.319 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.493 ' HB2' HD12 ' A' ' 18' ' ' LEU . 15.2 t70 -60.51 -56.23 23.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.829 0.347 . . . . 1.8600000000000001 110.862 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 98.35 -46.34 1.56 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.828 -0.701 . . . . 1.4199999999999999 113.159 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 38.0 mtp180 -60.54 -26.88 67.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.63 0.252 . . . . 3.0499999999999998 111.513 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 70.7 mt -73.06 102.24 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.946 0.403 . . . . 1.6299999999999999 111.04 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -93.98 136.18 23.99 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.001 -0.545 . . . . 1.98 110.574 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.46 171.89 1.68 Allowed 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.41 2.074 . . . . 1.4399999999999999 112.34 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 58.97 29.35 18.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.992 -0.549 . . . . 2.6299999999999999 110.902 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.427 ' OD1' ' HB2' ' A' ' 100' ' ' LEU . 11.9 t0 -102.31 140.07 37.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.046 -0.524 . . . . 2.02 110.405 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -87.32 127.83 35.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.755 0.312 . . . . 1.6200000000000001 111.202 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 39.9 mm -90.56 136.56 23.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.287 -0.415 . . . . 1.1100000000000001 110.672 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 89.5 mt -107.29 -64.38 1.2 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.326 -0.397 . . . . 1.1299999999999999 111.157 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -147.75 135.12 20.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.074 0.464 . . . . 3.1499999999999999 111.704 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.59 HG12 ' H ' ' A' ' 73' ' ' ASP . 3.1 t -89.81 175.4 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.614 -0.721 . . . . 1.0900000000000001 110.084 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.642 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 16.6 t70 -47.24 109.21 0.19 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.721 0.296 . . . . 0.79000000000000004 111.688 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 54.36 28.77 9.85 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.095 -0.502 . . . . 2.0099999999999998 111.73 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.449 HG12 HG13 ' A' ' 88' ' ' VAL . 66.6 t -145.67 147.06 18.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.39 -0.368 . . . . 1.1499999999999999 110.714 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -116.44 128.6 55.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.26 -0.427 . . . . 2.8500000000000001 110.515 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.5 m -109.98 26.44 2.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.818 0.342 . . . . 1.26 111.353 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -97.05 24.48 6.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.451 . . . . 1.74 111.046 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -170.23 15.2 0.06 OUTLIER Glycine 0 C--N 1.329 0.194 0 C-N-CA 120.543 -0.837 . . . . 0.57999999999999996 112.768 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 47.2 mtm -117.56 142.46 47.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.852 0.358 . . . . 1.1200000000000001 110.98 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.29 165.13 14.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.091 -0.504 . . . . 1.1200000000000001 110.99 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -50.01 -56.72 9.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.315 -0.402 . . . . 1.52 111.369 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.3 t -51.89 -39.92 59.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.251 -0.431 . . . . 2.0299999999999998 111.456 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -64.29 -47.07 80.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.487 -0.324 . . . . 2.1200000000000001 111.129 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 54.3 t -58.06 -32.64 44.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.306 -0.406 . . . . 1.0800000000000001 110.886 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.401 HG13 ' NE ' ' A' ' 90' ' ' ARG . 75.0 t -68.72 -42.28 82.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.14 -0.482 . . . . 1.0700000000000001 110.957 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -56.74 -46.55 81.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.839 0.352 . . . . 1.51 110.801 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.449 HG13 HG12 ' A' ' 75' ' ' VAL . 53.0 t -59.09 -56.18 18.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.228 -0.442 . . . . 1.0600000000000001 111.011 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 82.3 mt -58.73 -22.11 56.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.916 -0.584 . . . . 1.1399999999999999 111.355 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.401 ' NE ' HG13 ' A' ' 86' ' ' VAL . 80.4 mtm180 -89.04 -21.96 23.19 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.596 -0.275 . . . . 2.5600000000000001 111.177 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -86.5 -15.69 39.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.496 -0.32 . . . . 1.8100000000000001 111.001 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.97 -87.73 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.256 -0.429 . . . . 1.1100000000000001 111.377 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.555 ' H ' HH21 ' A' ' 20' ' ' ARG . . . 61.68 21.45 60.65 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.809 -0.71 . . . . 0.77000000000000002 112.613 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.438 ' HB3' ' HD2' ' A' ' 95' ' ' PRO . 4.3 m120 -147.24 173.84 3.87 Favored Pre-proline 0 C--N 1.328 -0.345 0 C-N-CA 121.936 0.094 . . . . 3.3300000000000001 110.846 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.556 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 37.1 Cg_exo -59.15 90.82 0.07 OUTLIER 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.141 1.894 . . . . 0.92000000000000004 111.783 178.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 28.8 m -104.73 153.48 6.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 1.3200000000000001 111.937 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.642 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 52.1 ttp180 -99.23 145.12 27.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.689 -0.687 . . . . 3.02 110.282 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.438 HD11 HD23 ' A' ' 18' ' ' LEU . 46.5 mt -120.78 106.21 11.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.261 -0.427 . . . . 1.1599999999999999 111.26 -179.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 22.2 tp -99.3 107.45 19.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.389 -0.369 . . . . 1.1000000000000001 110.116 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.427 ' HB2' ' OD1' ' A' ' 67' ' ' ASP . 0.4 OUTLIER -135.36 163.3 30.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.954 0.406 . . . . 1.1100000000000001 111.539 -179.159 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 15.7 tt -120.9 141.03 43.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.927 -0.579 . . . . 1.1399999999999999 110.965 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 25.7 tpt180 -137.07 135.97 37.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.11 -0.495 . . . . 2.7000000000000002 110.776 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 37.2 ttp180 -87.75 141.71 28.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 4.4000000000000004 110.714 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 49.7 mt -82.7 147.28 54.95 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 2.0 110.78 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -79.39 60.63 7.89 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.793 2.329 . . . . 2.98 112.353 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 80.3 mt -92.05 120.47 32.71 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.508 -0.769 . . . . 3.6699999999999999 111.011 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -84.54 143.25 29.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.103 -0.499 . . . . 5.9699999999999998 110.845 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.181 -0.914 . . . . 6.0 110.856 179.957 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.282 0 N-CA-C 112.467 -0.253 . . . . 8.1300000000000008 112.467 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 60.9 m -141.89 177.04 8.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.693 0.282 . . . . 7.25 110.996 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 53.9 m80 55.3 94.13 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.009 -0.542 . . . . 6.6799999999999997 111.281 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -178.79 40.25 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.695 -0.765 . . . . 2.8900000000000001 112.544 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -99.45 55.88 0.99 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.846 0.355 . . . . 2.46 111.037 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.1 t -68.84 95.11 0.66 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.242 -0.435 . . . . 3.0099999999999998 110.843 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.7 t70 56.65 85.59 0.08 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.197 -0.456 . . . . 2.6699999999999999 110.862 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -132.26 100.5 5.04 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.34 -0.391 . . . . 1.74 111.3 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.2 t 58.25 20.55 7.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.968 -0.56 . . . . 2.6299999999999999 111.422 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.444 ' O ' ' HG ' ' A' ' 104' ' ' LEU . . . 107.07 -29.74 10.29 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.598 -0.811 . . . . 1.8200000000000001 112.717 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -77.85 96.47 4.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.857 0.36 . . . . 1.98 111.081 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.1 t -116.83 145.88 43.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.964 -0.562 . . . . 1.26 110.549 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 70.7 mt -84.66 122.93 29.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.182 -0.463 . . . . 1.49 111.049 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -116.71 149.19 40.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.044 -0.525 . . . . 3.0899999999999999 111.044 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.403 ' HG ' HH21 ' A' ' 97' ' ' ARG . 81.8 p -149.35 130.12 14.17 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.187 -0.461 . . . . 1.79 111.121 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 19.0 t -125.55 153.25 33.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 1.26 110.577 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -101.36 117.93 35.95 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.9 0.381 . . . . 1.74 111.692 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -114.14 166.27 11.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.874 -0.603 . . . . 1.4099999999999999 110.375 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.552 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 42.3 p90 -156.93 137.03 12.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.714 0.292 . . . . 2.6600000000000001 111.305 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.435 HH22 ' HA ' ' A' ' 90' ' ' ARG . 21.3 ttp180 -129.96 153.22 48.58 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.313 -0.403 . . . . 3.5899999999999999 111.1 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -155.69 -34.49 0.09 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.048 -0.523 . . . . 2.5800000000000001 111.054 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -59.92 164.18 4.08 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.09 -0.505 . . . . 4.1900000000000004 110.936 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -93.96 33.98 1.28 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 2.8700000000000001 110.994 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 74.6 p -78.6 -13.34 59.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.277 -0.419 . . . . 1.74 111.136 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 97.2 p 50.22 24.09 1.37 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.615 -0.721 . . . . 2.79 111.605 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 47.7 t -141.84 135.37 29.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.841 0.353 . . . . 1.79 111.03 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 19.0 mt -103.45 -20.64 13.98 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.136 -0.483 . . . . 1.1299999999999999 110.951 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.44 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 97.88 10.89 51.59 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.785 -0.721 . . . . 0.52000000000000002 112.579 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 67.3 mt -94.03 110.69 23.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.721 0.296 . . . . 1.53 111.139 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 46.5 t -112.42 114.21 26.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.244 -0.434 . . . . 1.4099999999999999 110.72 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 43.0 pt -100.55 177.84 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.241 -0.436 . . . . 1.1799999999999999 111.287 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 62.8 m -158.0 132.38 8.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.882 -0.599 . . . . 1.79 110.636 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -85.38 121.0 5.5 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.634 -0.793 . . . . 1.04 112.446 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 58.1 ttp -69.97 137.98 51.9 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.681 0.277 . . . . 2.48 110.549 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.447 ' HD3' ' N ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -89.93 139.07 30.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.843 0.354 . . . . 6.1500000000000004 110.965 -179.854 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -143.74 110.05 5.43 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.048 -0.524 . . . . 4.29 110.909 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -100.71 14.49 31.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 5.79 110.692 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 51.2 m -135.78 126.82 27.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.975 -0.557 . . . . 5.1799999999999997 110.815 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 67.3 p -96.28 136.5 36.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.276 -0.42 . . . . 5.54 111.134 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.0 t -161.94 7.43 0.06 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.22 -0.446 . . . . 7.3600000000000003 111.175 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 138.24 -82.97 0.25 Allowed Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.755 -0.736 . . . . 5.7999999999999998 112.527 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -63.82 163.13 12.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.83 0.348 . . . . 7.2199999999999998 110.96 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -136.75 -158.88 0.9 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.125 -0.489 . . . . 3.6000000000000001 110.724 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 67.3 p -59.61 175.79 0.32 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.075 -0.511 . . . . 3.02 111.365 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -162.22 159.34 31.48 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.84 -0.695 . . . . 1.3600000000000001 112.46 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 43.9 mm -98.85 107.43 20.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.827 0.346 . . . . 1.28 110.982 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -139.02 138.57 37.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.164 -0.471 . . . . 1.0800000000000001 111.072 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 85.5 t -74.01 120.44 23.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.297 -0.411 . . . . 1.0600000000000001 110.822 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -99.77 -22.24 15.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 2.8900000000000001 111.254 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 84.1 p -155.88 170.04 23.01 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.058 0.456 . . . . 1.8700000000000001 111.557 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 90.6 mt -128.71 170.27 13.5 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.607 -0.724 . . . . 1.1899999999999999 110.401 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.44 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 43.1 mm -109.74 98.53 33.8 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.36 -0.382 . . . . 1.8500000000000001 111.084 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.79 111.54 0.76 Allowed 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.596 2.197 . . . . 1.26 112.312 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.15 1.9 7.85 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.794 -0.717 . . . . 0.52000000000000002 112.49 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.462 ' HG ' ' H ' ' A' ' 56' ' ' ALA . 23.0 t -112.01 -176.7 2.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.692 0.282 . . . . 1.73 110.89 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.462 ' H ' ' HG ' ' A' ' 55' ' ' SER . . . -60.15 -53.1 61.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.368 -0.378 . . . . 1.1299999999999999 111.298 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.48 -46.55 70.03 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.169 -0.468 . . . . 1.0900000000000001 111.275 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.95 -37.57 88.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.076 -0.511 . . . . 1.1100000000000001 111.262 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 82.7 mt -73.87 -19.64 60.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.89 0.376 . . . . 1.29 110.894 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.413 ' OD2' ' HB2' ' A' ' 62' ' ' ARG . 26.5 t70 -66.7 -52.04 49.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.109 -0.496 . . . . 1.8600000000000001 110.843 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 89.88 -44.49 3.0 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.846 -0.692 . . . . 1.4199999999999999 113.22 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.413 ' HB2' ' OD2' ' A' ' 60' ' ' ASP . 22.2 mmm180 -59.66 -22.32 61.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.686 0.279 . . . . 3.0499999999999998 111.126 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 52.6 mt -82.53 109.98 17.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.879 0.371 . . . . 1.6299999999999999 111.003 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -101.42 135.67 19.79 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 1.98 110.57 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -57.2 172.18 0.96 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.453 2.102 . . . . 1.4399999999999999 112.44 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 59.33 26.89 15.84 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.918 -0.583 . . . . 2.6299999999999999 111.275 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -94.5 158.87 15.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.341 -0.391 . . . . 2.02 110.645 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -107.76 124.24 49.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.77 0.319 . . . . 1.6200000000000001 110.927 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.521 HD13 ' HB3' ' A' ' 100' ' ' LEU . 45.9 mm -87.33 140.31 15.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.191 -0.459 . . . . 1.1100000000000001 110.983 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 71.6 mt -115.88 -60.58 1.85 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.206 -0.452 . . . . 1.1299999999999999 110.946 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.453 ' O ' ' HB3' ' A' ' 99' ' ' LEU . 81.2 mtt180 -144.72 138.66 27.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 3.1499999999999999 111.254 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.534 HG13 ' H ' ' A' ' 73' ' ' ASP . 4.4 t -94.13 173.82 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.963 -0.562 . . . . 1.0900000000000001 109.941 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.643 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 19.1 t70 -47.67 108.81 0.17 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.703 0.287 . . . . 0.79000000000000004 111.516 179.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 54.83 29.15 11.42 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.194 -0.457 . . . . 2.0099999999999998 111.506 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.447 ' HB ' ' HB ' ' A' ' 72' ' ' VAL . 86.5 t -145.51 151.08 15.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.047 -0.524 . . . . 1.1499999999999999 110.627 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -120.75 129.34 53.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.484 -0.325 . . . . 2.8500000000000001 110.77 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.9 m -107.35 23.84 3.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-O 120.808 0.337 . . . . 1.26 111.366 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -96.71 38.31 1.23 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.293 -0.412 . . . . 1.74 110.692 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 175.94 28.43 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.721 -0.752 . . . . 0.57999999999999996 112.76 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 60.3 mtm -132.39 141.81 49.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.93 0.395 . . . . 1.1200000000000001 110.976 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.434 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -69.05 161.85 28.15 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.994 -0.548 . . . . 1.1200000000000001 110.919 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -45.73 -57.1 4.52 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.195 -0.457 . . . . 1.52 111.638 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.4 m -50.62 -43.44 56.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.178 -0.465 . . . . 2.0299999999999998 111.565 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -63.8 -42.9 97.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.359 -0.382 . . . . 2.1200000000000001 111.471 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 81' ' ' ALA . 38.9 t -59.63 -38.73 77.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 120.857 0.361 . . . . 1.0800000000000001 110.988 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 52.4 t -66.74 -36.58 77.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.11 -0.496 . . . . 1.0700000000000001 110.968 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -60.1 -49.16 78.74 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.217 -0.447 . . . . 1.51 110.714 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.406 HG12 HG12 ' A' ' 75' ' ' VAL . 53.7 t -56.75 -53.52 40.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.082 -0.508 . . . . 1.0600000000000001 111.27 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 79.2 mt -53.89 -32.62 53.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.077 -0.51 . . . . 1.1399999999999999 111.277 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.435 ' HA ' HH22 ' A' ' 20' ' ' ARG . 85.0 mtm180 -81.64 -24.06 36.58 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.256 -0.429 . . . . 2.5600000000000001 111.115 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -78.4 -17.96 55.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.276 -0.42 . . . . 1.8100000000000001 110.835 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.68 -89.62 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.091 -0.504 . . . . 1.1100000000000001 111.474 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.427 ' H ' HH21 ' A' ' 20' ' ' ARG . . . 60.48 21.86 58.12 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.702 -0.761 . . . . 0.77000000000000002 112.429 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.427 HD21 ' HA ' ' A' ' 94' ' ' ASN . 0.1 OUTLIER -147.13 174.79 3.11 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 110.461 -0.199 . . . . 3.3300000000000001 110.461 -179.7 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.552 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 38.2 Cg_exo -59.18 97.53 0.1 OUTLIER 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.021 1.814 . . . . 0.92000000000000004 111.641 178.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 28.8 m -114.53 151.56 16.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.129 0.49 . . . . 1.3200000000000001 111.893 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.643 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 75.2 ttt180 -102.1 145.24 29.62 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.673 -0.694 . . . . 3.02 110.082 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 18.3 mt -115.49 116.18 27.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.187 -0.46 . . . . 1.1599999999999999 111.378 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.453 ' HB3' ' O ' ' A' ' 71' ' ' ARG . 63.6 tp -104.46 99.89 9.58 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.16 -0.473 . . . . 1.1000000000000001 110.261 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.521 ' HB3' HD13 ' A' ' 69' ' ' ILE . 0.5 OUTLIER -129.82 158.25 39.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.197 -0.456 . . . . 1.1100000000000001 111.394 -179.519 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.0 tt -110.37 140.39 29.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 1.1399999999999999 110.949 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -128.08 145.11 51.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.081 -0.509 . . . . 2.7000000000000002 110.942 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -102.49 141.89 34.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.08 -0.509 . . . . 4.4000000000000004 110.785 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 10' ' ' GLY . 52.4 mt -92.58 148.66 36.67 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.107 -0.497 . . . . 2.0 110.895 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -79.83 62.74 8.61 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.83 2.353 . . . . 2.98 112.437 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 89.5 mt -101.36 103.05 13.99 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.672 -0.694 . . . . 3.6699999999999999 110.95 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -82.49 102.55 11.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 5.9699999999999998 110.818 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.306 -0.854 . . . . 6.0 110.888 179.997 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.181 0 N-CA-C 112.337 -0.305 . . . . 8.1300000000000008 112.337 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.7 p -147.13 -178.27 6.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.822 0.344 . . . . 7.25 110.967 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 55.0 m80 56.02 83.57 0.09 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.994 -0.548 . . . . 6.6799999999999997 111.008 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -160.54 68.23 0.25 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.743 -0.742 . . . . 2.8900000000000001 112.65 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -70.39 141.75 52.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.834 0.35 . . . . 2.46 110.907 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.9 t -154.38 108.91 3.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.464 . . . . 3.0099999999999998 110.897 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 55.91 36.26 26.99 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.175 -0.466 . . . . 2.6699999999999999 110.912 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -102.75 119.44 38.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.1 -0.5 . . . . 1.74 111.182 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.9 m 57.08 21.85 6.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.06 -0.518 . . . . 2.6299999999999999 111.169 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.1 33.4 23.62 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.731 -0.747 . . . . 1.8200000000000001 112.544 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.42 ' HB3' HD12 ' A' ' 101' ' ' ILE . 81.9 m-85 -136.81 131.65 33.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.82 0.343 . . . . 1.98 110.65 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.3 t -136.44 135.33 38.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.087 -0.506 . . . . 1.26 110.891 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 79.8 mt -76.11 119.19 19.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.0 -0.545 . . . . 1.49 110.739 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -120.08 132.11 55.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 3.0899999999999999 111.0 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 79.0 p -137.34 126.94 25.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.286 -0.416 . . . . 1.79 110.972 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.17 141.53 46.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.219 -0.446 . . . . 1.26 110.952 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -96.18 116.34 28.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 1.74 111.54 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.442 HD11 ' HB2' ' A' ' 60' ' ' ASP . 4.5 mm? -114.92 166.61 11.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.98 -0.555 . . . . 1.4099999999999999 110.125 179.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.528 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 15.1 p90 -147.11 123.1 10.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.769 0.319 . . . . 2.6600000000000001 111.149 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.556 ' HB2' HD22 ' A' ' 27' ' ' LEU . 14.9 ttp180 -95.61 96.84 9.3 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.325 -0.398 . . . . 3.5899999999999999 110.687 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -107.69 -19.98 13.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.985 -0.552 . . . . 2.5800000000000001 110.672 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -82.37 148.64 28.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.954 -0.566 . . . . 4.1900000000000004 110.794 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -85.96 47.59 1.48 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.188 -0.46 . . . . 2.8700000000000001 110.974 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.428 ' HG1' ' H ' ' A' ' 26' ' ' SER . 65.1 p -87.38 -10.04 53.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.484 . . . . 1.74 111.182 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.2 t 58.05 20.3 6.76 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.988 -0.551 . . . . 2.79 111.248 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.428 ' H ' ' HG1' ' A' ' 24' ' ' THR . 60.5 m -157.47 160.95 38.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.272 -0.422 . . . . 1.79 110.965 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.556 HD22 ' HB2' ' A' ' 20' ' ' ARG . 77.2 mt -113.61 -14.66 12.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.112 -0.494 . . . . 1.1299999999999999 110.78 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.495 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 93.81 29.99 9.38 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.823 -0.703 . . . . 0.52000000000000002 112.406 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.425 HD13 HD23 ' A' ' 89' ' ' LEU . 77.7 mt -109.79 109.25 27.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.737 0.303 . . . . 1.53 111.05 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 40.0 t -111.03 100.44 9.13 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.29 -0.414 . . . . 1.4099999999999999 110.844 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 40.6 pt -92.71 179.66 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.087 -0.506 . . . . 1.1799999999999999 111.175 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 82.0 p -135.42 136.83 41.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.053 -0.521 . . . . 1.79 110.929 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -66.47 99.99 0.5 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.862 -0.685 . . . . 1.04 112.434 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 26.7 ttt -66.78 148.18 52.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.78 0.324 . . . . 2.48 110.811 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.31 162.99 36.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.269 -0.423 . . . . 6.1500000000000004 110.962 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.485 ' HB2' ' HG1' ' A' ' 39' ' ' THR . 4.7 p-10 -136.87 131.27 32.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.017 -0.538 . . . . 4.29 110.82 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -123.36 107.31 11.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 5.79 110.92 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 55.6 m 55.64 41.89 30.05 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.072 -0.513 . . . . 5.1799999999999997 110.918 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.485 ' HG1' ' HB2' ' A' ' 36' ' ' ASP . 82.5 p -92.13 139.73 30.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.063 -0.517 . . . . 5.54 111.317 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.8 t -89.24 16.05 7.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 7.3600000000000003 110.988 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -145.19 89.77 0.16 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.811 -0.709 . . . . 5.7999999999999998 112.472 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -68.47 92.27 0.44 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.761 0.315 . . . . 7.2199999999999998 110.912 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -136.62 60.68 1.66 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.234 -0.439 . . . . 3.6000000000000001 111.082 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 65.9 p -77.89 153.53 32.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.271 -0.422 . . . . 3.02 111.396 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -171.66 -163.32 25.41 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.851 -0.69 . . . . 1.3600000000000001 112.389 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.3 mm -124.61 131.04 73.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.801 0.334 . . . . 1.28 110.787 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.401 ' HB2' ' O ' ' A' ' 67' ' ' ASP . 27.0 p90 -145.4 145.46 31.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.322 -0.399 . . . . 1.0800000000000001 111.091 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 99.7 t -82.16 129.29 37.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.089 -0.505 . . . . 1.0600000000000001 111.061 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.2 ttpp -102.02 -24.48 13.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.996 -0.547 . . . . 2.8900000000000001 110.946 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 79.6 p -155.12 156.24 35.45 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.037 0.446 . . . . 1.8700000000000001 111.36 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 77.1 mt -114.28 162.97 15.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.775 -0.648 . . . . 1.1899999999999999 110.626 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.495 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 62.4 mt -109.7 101.97 48.43 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.367 -0.378 . . . . 1.8500000000000001 111.248 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -52.11 146.44 30.44 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.586 2.191 . . . . 1.26 112.577 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.4 -22.37 30.38 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.827 -0.701 . . . . 0.52000000000000002 112.581 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 67.4 m -80.93 -177.94 6.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.784 0.325 . . . . 1.73 111.071 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.65 -55.09 16.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.218 -0.447 . . . . 1.1299999999999999 111.472 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.63 -39.86 65.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.103 -0.499 . . . . 1.0900000000000001 111.843 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.35 -42.86 71.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.401 -0.363 . . . . 1.1100000000000001 111.438 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.0 mt -70.95 -19.67 62.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.334 -0.394 . . . . 1.29 110.992 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.442 ' HB2' HD11 ' A' ' 18' ' ' LEU . 26.0 t70 -59.52 -56.13 25.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 1.8600000000000001 110.945 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.2 -48.71 1.1 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.768 -0.73 . . . . 1.4199999999999999 112.957 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -57.4 -32.05 66.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.761 0.315 . . . . 3.0499999999999998 111.153 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 68.1 mt -76.83 127.91 37.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.304 -0.407 . . . . 1.6299999999999999 111.095 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -125.49 138.16 31.29 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 116.139 -0.482 . . . . 1.98 110.81 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_exo -52.94 165.9 1.08 Allowed 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.59 2.193 . . . . 1.4399999999999999 112.441 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 18.0 m120 60.18 45.65 11.38 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.046 -0.525 . . . . 2.6299999999999999 110.755 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' A' ' 47' ' ' TYR . 27.1 t70 -118.16 159.77 22.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.935 -0.575 . . . . 2.02 110.505 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.461 ' HB3' HG22 ' A' ' 101' ' ' ILE . 87.6 tttt -105.18 128.29 53.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.843 0.354 . . . . 1.6200000000000001 111.181 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 41.6 mm -94.9 142.18 13.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.055 -0.52 . . . . 1.1100000000000001 110.727 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 56.5 mt -111.31 -73.75 0.67 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 1.1299999999999999 111.129 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.8 ptp180 -147.29 137.85 23.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.174 0.512 . . . . 3.1499999999999999 111.779 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.539 HG11 ' H ' ' A' ' 73' ' ' ASP . 3.8 t -84.68 176.01 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.528 -0.76 . . . . 1.0900000000000001 109.771 179.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.66 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 6.6 t70 -44.25 109.0 0.13 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.17 0.434 . . . . 0.79000000000000004 112.17 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 52.39 27.87 5.29 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.443 0.535 . . . . 2.0099999999999998 112.443 178.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.406 ' O ' ' N ' ' A' ' 72' ' ' VAL . 88.1 t -148.66 140.11 17.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.725 0.298 . . . . 1.1499999999999999 110.88 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.444 ' O ' ' HE2' ' A' ' 80' ' ' MET . 25.4 m-80 -100.23 141.86 32.49 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.922 -0.399 . . . . 2.8500000000000001 109.922 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.8 m -122.59 -16.23 5.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 N-CA-C 112.104 0.409 . . . . 1.26 112.104 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -87.08 25.98 1.25 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.921 0.391 . . . . 1.74 110.886 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -141.3 1.72 1.94 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.869 -0.682 . . . . 0.57999999999999996 112.557 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.444 ' HE2' ' O ' ' A' ' 76' ' ' ASN . 51.4 mtm -123.99 172.14 9.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.748 0.309 . . . . 1.1200000000000001 110.768 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.5 168.71 14.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 1.1200000000000001 111.125 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -58.97 -47.3 85.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.44 -0.345 . . . . 1.52 110.902 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.9 m -55.46 -31.72 62.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 2.0299999999999998 111.304 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -71.98 -39.27 69.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.355 -0.384 . . . . 2.1200000000000001 111.042 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.2 t -67.75 -35.99 74.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.969 0.414 . . . . 1.0800000000000001 111.021 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.475 HG13 ' NE ' ' A' ' 90' ' ' ARG . 56.5 t -70.32 -47.22 67.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.009 -0.541 . . . . 1.0700000000000001 111.598 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -58.86 -40.75 85.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.714 -0.221 . . . . 1.51 111.085 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 52.4 t -60.04 -54.88 28.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 120.924 0.392 . . . . 1.0600000000000001 111.115 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.425 HD23 HD13 ' A' ' 29' ' ' ILE . 66.8 mt -56.83 -27.89 60.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.993 -0.549 . . . . 1.1399999999999999 111.006 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.475 ' NE ' HG13 ' A' ' 86' ' ' VAL . 76.1 mtm180 -89.24 -15.09 34.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.371 -0.377 . . . . 2.5600000000000001 111.514 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -93.47 -10.04 36.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.417 -0.356 . . . . 1.8100000000000001 111.114 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -48.9 -85.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.266 -0.425 . . . . 1.1100000000000001 111.574 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.428 ' N ' ' HE ' ' A' ' 20' ' ' ARG . . . 62.25 14.59 48.23 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.695 -0.764 . . . . 0.77000000000000002 112.556 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -146.97 169.85 8.74 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 110.54 -0.17 . . . . 3.3300000000000001 110.54 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.528 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 24.4 Cg_exo -65.13 92.26 0.21 Allowed 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.223 1.948 . . . . 0.92000000000000004 111.326 178.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 33.8 m -100.15 153.46 4.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.067 -0.515 . . . . 1.3200000000000001 111.577 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.66 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 56.2 ttp180 -102.72 138.07 40.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.969 -0.559 . . . . 3.02 109.816 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 45.4 mt -107.7 109.42 21.01 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.262 -0.426 . . . . 1.1599999999999999 111.137 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 31.7 tp -99.79 100.66 11.64 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.374 -0.375 . . . . 1.1000000000000001 110.172 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -130.37 161.95 30.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.111 -0.495 . . . . 1.1100000000000001 111.373 -179.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.461 HG22 ' HB3' ' A' ' 68' ' ' LYS . 14.2 tt -114.06 135.68 52.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.917 -0.583 . . . . 1.1399999999999999 110.862 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -122.4 133.91 54.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.003 -0.544 . . . . 2.7000000000000002 110.555 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 31.4 ptt180 -89.94 134.84 33.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.143 -0.48 . . . . 4.4000000000000004 111.127 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 51.9 mt -102.55 150.79 37.97 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.015 -0.539 . . . . 2.0 110.596 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -80.87 161.63 21.15 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.467 2.111 . . . . 2.98 112.131 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -104.98 140.19 38.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.026 -0.533 . . . . 3.6699999999999999 111.222 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 89.2 mt -105.01 95.47 5.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.953 -0.567 . . . . 5.9699999999999998 110.879 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.31 -0.853 . . . . 6.0 111.071 -179.901 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.168 0 N-CA-C 112.456 -0.258 . . . . 8.1300000000000008 112.456 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 52.5 m -85.65 -59.42 2.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.798 0.333 . . . . 7.25 110.92 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -85.19 106.39 16.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.208 -0.451 . . . . 6.6799999999999997 110.948 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -91.85 -85.36 1.48 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.738 -0.744 . . . . 2.8900000000000001 112.408 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 55.7 30.24 15.19 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.825 0.345 . . . . 2.46 111.197 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 43.5 t -70.44 98.86 1.5 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 3.0099999999999998 110.716 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 57.94 71.52 0.57 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.116 -0.493 . . . . 2.6699999999999999 110.916 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -119.87 108.78 14.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 1.74 111.242 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 61.9 m 57.04 20.01 5.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.045 -0.525 . . . . 2.6299999999999999 111.329 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.7 30.91 31.18 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.766 -0.731 . . . . 1.8200000000000001 112.788 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -141.19 115.02 9.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.83 0.348 . . . . 1.98 110.825 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 46.6 t -140.18 136.04 33.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 1.26 110.78 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 62.3 mt -75.09 120.9 21.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.168 -0.469 . . . . 1.49 110.749 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -114.53 124.19 51.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.089 -0.505 . . . . 3.0899999999999999 111.328 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 44.9 t -103.27 142.75 33.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 1.79 110.79 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.4 t -136.41 158.16 37.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.238 -0.437 . . . . 1.26 110.666 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -121.93 114.34 20.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.935 0.398 . . . . 1.74 111.353 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.523 HD12 ' HB2' ' A' ' 60' ' ' ASP . 4.4 mm? -119.58 166.82 12.65 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.033 -0.53 . . . . 1.4099999999999999 110.787 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.582 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 30.1 p90 -148.8 129.45 14.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.282 -0.417 . . . . 2.6600000000000001 110.964 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.476 ' HB2' HD23 ' A' ' 27' ' ' LEU . 15.1 ttp180 -106.5 107.66 18.78 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.794 0.33 . . . . 3.5899999999999999 111.006 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -131.29 -5.67 3.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.299 -0.409 . . . . 2.5800000000000001 111.036 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -81.69 170.2 16.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.396 -0.365 . . . . 4.1900000000000004 110.874 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -93.47 30.04 1.83 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.136 -0.484 . . . . 2.8700000000000001 110.959 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 71.6 p -84.25 -14.35 50.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.45 . . . . 1.74 110.863 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 35.2 t 59.17 20.63 8.65 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.849 -0.614 . . . . 2.79 111.18 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 83.0 p -160.56 175.27 12.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.941 0.4 . . . . 1.79 110.992 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.476 HD23 ' HB2' ' A' ' 20' ' ' ARG . 33.5 mt -115.0 -10.35 12.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.827 -0.624 . . . . 1.1299999999999999 110.877 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.416 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 87.86 18.33 56.44 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.782 -0.723 . . . . 0.52000000000000002 112.754 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 70.9 mt -91.36 108.5 19.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.822 0.344 . . . . 1.53 110.847 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 41.9 t -103.14 102.66 12.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.134 -0.485 . . . . 1.4099999999999999 110.958 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.5 pt -100.34 165.68 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.82 -0.627 . . . . 1.1799999999999999 111.291 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.6 m -149.04 145.19 27.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.917 -0.583 . . . . 1.79 110.474 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -97.72 125.49 8.53 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.68 -0.771 . . . . 1.04 112.598 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 52.8 ttp -85.5 112.57 21.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.754 0.312 . . . . 2.48 110.711 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -108.24 139.34 43.08 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.225 -0.443 . . . . 6.1500000000000004 110.74 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -131.89 161.3 33.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.272 -0.422 . . . . 4.29 110.819 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -100.21 69.53 1.49 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.978 0.418 . . . . 5.79 111.109 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 75.2 m -137.2 129.34 29.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 5.1799999999999997 110.986 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 77.3 p -89.75 155.54 19.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 5.54 111.142 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 15.0 t 42.3 33.19 0.39 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.776 -0.647 . . . . 7.3600000000000003 111.372 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -168.8 47.58 0.22 Allowed Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.598 -0.728 . . . . 5.7999999999999998 112.255 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -84.83 159.47 20.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.844 0.354 . . . . 7.2199999999999998 111.012 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -149.72 89.91 1.66 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.187 -0.46 . . . . 3.6000000000000001 111.239 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 73.0 p -92.75 152.86 19.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.243 -0.435 . . . . 3.02 110.907 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -169.65 146.07 9.78 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.656 -0.783 . . . . 1.3600000000000001 112.54 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 37.2 mm -94.11 108.44 20.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.761 0.315 . . . . 1.28 110.703 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -131.38 143.31 50.38 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.218 -0.446 . . . . 1.0800000000000001 111.201 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 84.1 t -84.54 128.6 38.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.051 -0.522 . . . . 1.0600000000000001 110.837 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -107.89 -24.1 11.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.301 -0.408 . . . . 2.8900000000000001 110.952 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.6 t -150.94 170.47 19.24 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.972 0.415 . . . . 1.8700000000000001 111.44 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 91.3 mt -135.25 157.21 47.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.816 -0.629 . . . . 1.1899999999999999 110.583 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.416 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 62.8 mt -101.46 104.05 31.3 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 1.8500000000000001 111.01 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -55.16 132.5 52.67 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.429 2.086 . . . . 1.26 112.224 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 110.55 -24.13 18.34 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.801 -0.714 . . . . 0.52000000000000002 112.544 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 63.2 m -80.91 -178.45 6.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.75 0.31 . . . . 1.73 110.921 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.74 -52.35 51.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.384 -0.371 . . . . 1.1299999999999999 111.494 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.27 -34.61 64.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.25 -0.432 . . . . 1.0900000000000001 111.616 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.79 -50.02 33.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.33 -0.395 . . . . 1.1100000000000001 111.248 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 80.7 mt -64.02 -19.7 65.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.131 -0.486 . . . . 1.29 110.988 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.523 ' HB2' HD12 ' A' ' 18' ' ' LEU . 26.6 t70 -62.05 -56.13 22.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 1.8600000000000001 110.91 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 97.42 -51.24 1.4 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.698 -0.763 . . . . 1.4199999999999999 113.01 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 84.4 mtm180 -55.98 -28.07 55.51 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.743 0.306 . . . . 3.0499999999999998 111.285 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 67.0 mt -81.05 106.25 11.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.292 -0.413 . . . . 1.6299999999999999 110.746 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -108.11 137.53 19.88 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 1.98 110.546 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -53.41 175.52 0.1 Allowed 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.57 2.18 . . . . 1.4399999999999999 112.725 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.7 m120 61.77 37.58 15.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.918 -0.583 . . . . 2.6299999999999999 110.913 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -113.15 161.93 16.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.991 -0.55 . . . . 2.02 110.553 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -110.55 116.71 31.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.822 0.344 . . . . 1.6200000000000001 111.087 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.418 HD12 ' HB3' ' A' ' 100' ' ' LEU . 42.0 mm -77.17 146.22 8.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.489 . . . . 1.1100000000000001 110.834 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 55.3 mt -123.22 -61.59 1.4 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.241 -0.436 . . . . 1.1299999999999999 111.257 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 66.8 mtp180 -144.47 142.73 30.47 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.096 0.474 . . . . 3.1499999999999999 111.808 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.533 HG11 ' H ' ' A' ' 73' ' ' ASP . 9.9 t -99.89 173.92 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.611 -0.722 . . . . 1.0900000000000001 109.582 179.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.626 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 16.8 t70 -46.82 108.44 0.14 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.711 0.291 . . . . 0.79000000000000004 111.418 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 53.32 33.84 16.54 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.18 -0.464 . . . . 2.0099999999999998 111.716 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 87.9 t -147.96 147.81 16.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.409 -0.359 . . . . 1.1499999999999999 110.842 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.526 HD22 ' HB2' ' A' ' 78' ' ' GLN . 7.1 t30 -115.44 124.89 52.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.346 -0.388 . . . . 2.8500000000000001 110.405 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.6 m -106.96 24.46 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 CA-C-O 120.783 0.325 . . . . 1.26 111.52 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.526 ' HB2' HD22 ' A' ' 76' ' ' ASN . 19.2 mm-40 -96.23 34.12 1.64 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.272 -0.422 . . . . 1.74 110.734 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 175.0 22.65 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.757 -0.735 . . . . 0.57999999999999996 112.811 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 54.6 mtm -117.98 144.42 45.54 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.873 0.368 . . . . 1.1200000000000001 110.965 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.417 ' O ' HG22 ' A' ' 85' ' ' VAL . . . -61.19 158.27 14.37 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.977 -0.556 . . . . 1.1200000000000001 111.41 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -51.41 -62.14 1.81 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.141 -0.481 . . . . 1.52 111.33 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 81.6 p -52.78 -33.53 49.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.014 -0.539 . . . . 2.0299999999999998 111.389 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -63.16 -43.46 98.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.512 -0.313 . . . . 2.1200000000000001 110.925 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.417 HG22 ' O ' ' A' ' 81' ' ' ALA . 18.2 t -61.89 -38.94 81.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.297 -0.411 . . . . 1.0800000000000001 110.605 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.1 t -63.22 -36.54 76.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.983 -0.553 . . . . 1.0700000000000001 110.991 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -63.62 -47.74 80.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.15 -0.477 . . . . 1.51 110.977 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 54.4 t -53.86 -54.23 21.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.224 -0.443 . . . . 1.0600000000000001 111.107 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 79.0 mt -57.58 -32.93 67.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 1.1399999999999999 110.94 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 85.2 mtm180 -80.6 -13.5 59.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.312 -0.404 . . . . 2.5600000000000001 111.212 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -95.62 -13.88 23.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 1.8100000000000001 110.692 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.19 -83.53 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.998 -0.547 . . . . 1.1100000000000001 111.588 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.428 ' HA2' ' HE ' ' A' ' 20' ' ' ARG . . . 62.38 15.72 52.76 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.61 -0.805 . . . . 0.77000000000000002 112.152 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -147.08 169.81 8.78 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 110.6 -0.148 . . . . 3.3300000000000001 110.6 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.582 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 32.9 Cg_exo -61.59 98.27 0.16 Allowed 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.258 1.972 . . . . 0.92000000000000004 111.429 177.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 23.6 m -106.42 150.46 9.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.082 0.467 . . . . 1.3200000000000001 111.858 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.626 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 80.9 mtp180 -97.13 140.57 31.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.811 -0.632 . . . . 3.02 110.247 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 30.3 mt -115.03 111.89 21.8 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.041 -0.527 . . . . 1.1599999999999999 110.951 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 43.3 tp -102.5 104.74 15.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 1.1000000000000001 110.75 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.418 ' HB3' HD12 ' A' ' 69' ' ' ILE . 0.4 OUTLIER -134.13 156.43 48.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.212 -0.449 . . . . 1.1100000000000001 111.045 -179.797 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 12.0 tt -104.61 136.17 39.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.23 -0.441 . . . . 1.1399999999999999 111.046 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 25.4 mmm180 -115.74 141.89 47.48 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.866 -0.606 . . . . 2.7000000000000002 110.844 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 53.7 mtm180 -89.99 126.46 35.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.223 -0.444 . . . . 4.4000000000000004 110.978 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 44.5 mt -102.17 103.85 32.92 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.074 -0.512 . . . . 2.0 110.872 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -63.76 176.54 2.27 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.304 2.003 . . . . 2.98 112.326 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 95.8 mt -139.02 146.77 41.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.088 -0.506 . . . . 3.6699999999999999 110.99 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -81.02 103.22 10.69 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.15 -0.477 . . . . 5.9699999999999998 110.797 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.451 -0.785 . . . . 6.0 111.048 179.852 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.117 0 N-CA-C 112.626 -0.19 . . . . 8.1300000000000008 112.626 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.6 m -94.31 -58.15 2.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.836 0.351 . . . . 7.25 110.919 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 51.0 m80 -70.97 -51.05 27.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 6.6799999999999997 110.868 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 137.42 -105.54 0.51 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.835 -0.698 . . . . 2.8900000000000001 112.419 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -88.53 132.75 34.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.917 0.389 . . . . 2.46 110.911 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 78.1 p -153.45 110.6 3.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.13 -0.486 . . . . 3.0099999999999998 110.686 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 57.66 67.1 1.01 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.154 -0.475 . . . . 2.6699999999999999 110.718 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -146.76 110.57 4.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.276 -0.42 . . . . 1.74 111.393 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.0 t 56.02 25.66 9.09 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.081 -0.509 . . . . 2.6299999999999999 111.219 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.98 36.87 34.56 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.66 -0.781 . . . . 1.8200000000000001 112.558 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -137.57 112.48 9.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.758 0.314 . . . . 1.98 110.825 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 46.1 t -135.99 140.84 44.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.134 -0.485 . . . . 1.26 110.795 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 75.4 mt -79.03 121.46 24.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 1.49 110.924 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -117.31 154.53 31.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.111 -0.495 . . . . 3.0899999999999999 110.877 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 84.4 p -151.2 134.82 16.33 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.344 -0.389 . . . . 1.79 111.302 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.1 t -132.23 144.96 35.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.149 -0.478 . . . . 1.26 110.675 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -94.89 115.22 27.19 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.842 0.353 . . . . 1.74 111.59 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.51 HD12 ' HB2' ' A' ' 60' ' ' ASP . 4.3 mm? -123.24 125.47 45.13 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.986 -0.552 . . . . 1.4099999999999999 110.472 179.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.567 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 39.0 p90 -103.44 132.93 49.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.404 -0.362 . . . . 2.6600000000000001 111.21 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.575 ' HE ' ' HA2' ' A' ' 93' ' ' GLY . 19.2 ttp180 -102.31 95.26 6.18 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.881 0.372 . . . . 3.5899999999999999 110.882 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -103.01 -21.37 13.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.056 0.455 . . . . 2.5800000000000001 110.425 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.4 ' HB3' HG23 ' A' ' 24' ' ' THR . 75.0 mmtt -85.16 140.8 30.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.704 -0.68 . . . . 4.1900000000000004 110.659 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -83.37 37.4 0.56 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 2.8700000000000001 111.077 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.4 HG23 ' HB3' ' A' ' 22' ' ' LYS . 57.4 p -73.0 -11.97 60.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 1.74 110.979 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 36.5 t 59.54 15.72 4.77 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.025 -0.534 . . . . 2.79 111.014 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 53.6 m -147.97 138.09 22.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.124 -0.489 . . . . 1.79 110.971 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.434 HD21 ' HB2' ' A' ' 20' ' ' ARG . 88.2 mt -97.55 -22.98 16.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.068 -0.514 . . . . 1.1299999999999999 110.852 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.492 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 110.43 3.85 28.93 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.808 -0.71 . . . . 0.52000000000000002 112.502 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.453 ' N ' HD12 ' A' ' 29' ' ' ILE . 3.0 mp -88.23 114.93 27.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.822 0.344 . . . . 1.53 111.012 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 45.0 t -111.89 93.32 4.4 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.103 -0.499 . . . . 1.4099999999999999 110.522 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.477 ' HA ' ' HA ' ' A' ' 48' ' ' VAL . 44.6 pt -87.87 164.18 2.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.101 -0.499 . . . . 1.1799999999999999 111.432 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 56.3 m -143.47 134.61 25.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.773 -0.649 . . . . 1.79 110.415 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -89.23 125.82 7.96 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.614 -0.803 . . . . 1.04 112.816 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 58.5 ttp -78.5 90.11 4.48 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.816 0.341 . . . . 2.48 110.498 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 19.1 mmm180 -85.4 164.71 17.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 6.1500000000000004 110.867 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -146.99 11.87 1.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.481 . . . . 4.29 110.762 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 57.23 28.75 15.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.1 -0.5 . . . . 5.79 110.847 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 10.0 t -127.88 -158.85 0.9 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.112 -0.495 . . . . 5.1799999999999997 110.457 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 57.7 p -50.54 139.05 16.55 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.782 0.325 . . . . 5.54 111.169 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.5 t -93.53 -2.64 54.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.183 -0.462 . . . . 7.3600000000000003 111.285 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -70.01 -53.57 14.42 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.798 -0.715 . . . . 5.7999999999999998 112.526 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -110.92 -179.32 3.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.808 0.337 . . . . 7.2199999999999998 110.923 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 57.32 41.47 26.53 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.076 -0.511 . . . . 3.6000000000000001 111.108 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 44.7 p -134.11 127.13 31.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.087 -0.506 . . . . 3.02 111.11 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -150.21 172.02 30.08 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.833 -0.698 . . . . 1.3600000000000001 112.606 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 43.8 mm -118.27 116.03 50.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.779 0.323 . . . . 1.28 110.901 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -140.17 137.37 34.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 1.0800000000000001 111.104 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.477 ' HA ' ' HA ' ' A' ' 31' ' ' ILE . 58.3 t -77.63 139.26 18.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.991 -0.55 . . . . 1.0600000000000001 110.852 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -120.58 -28.46 4.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 2.8900000000000001 111.116 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 56.3 m -143.82 173.28 11.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.15 0.5 . . . . 1.8700000000000001 111.594 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 82.1 mt -137.42 161.94 34.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.603 -0.726 . . . . 1.1899999999999999 110.55 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.492 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 71.6 mt -106.74 102.14 40.44 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.485 -0.325 . . . . 1.8500000000000001 111.218 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.6 129.51 35.46 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.59 2.193 . . . . 1.26 112.42 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 110.93 -17.46 27.3 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.794 -0.717 . . . . 0.52000000000000002 112.353 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 57.7 m -85.24 -176.67 6.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.719 0.295 . . . . 1.73 110.85 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.21 -52.55 32.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.916 0.388 . . . . 1.1299999999999999 111.171 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.22 -37.9 75.75 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.045 -0.525 . . . . 1.0900000000000001 111.659 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.99 -54.59 14.45 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.341 -0.391 . . . . 1.1100000000000001 111.572 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.7 mt -60.34 -20.28 58.72 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.343 -0.39 . . . . 1.29 111.09 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.51 ' HB2' HD12 ' A' ' 18' ' ' LEU . 33.3 t70 -59.59 -49.34 78.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.252 -0.431 . . . . 1.8600000000000001 110.927 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.11 -44.9 2.98 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.864 -0.684 . . . . 1.4199999999999999 113.043 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.401 ' HB2' ' OD2' ' A' ' 60' ' ' ASP . 76.6 mtp180 -61.42 -22.13 64.73 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.688 0.28 . . . . 3.0499999999999998 111.077 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.482 ' HA ' HH22 ' A' ' 102' ' ' ARG . 63.2 mt -89.92 116.13 30.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.353 -0.385 . . . . 1.6299999999999999 111.119 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -117.59 140.02 26.98 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.041 -0.527 . . . . 1.98 110.532 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.34 -178.57 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.578 2.185 . . . . 1.4399999999999999 112.295 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.518 ' N ' HD21 ' A' ' 66' ' ' ASN . 0.9 OUTLIER 60.97 44.88 9.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.444 . . . . 2.6299999999999999 110.681 -179.689 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -126.54 177.33 6.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.084 -0.507 . . . . 2.02 110.734 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -130.72 122.48 27.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.427 -0.351 . . . . 1.6200000000000001 111.118 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 39.8 mm -75.04 143.93 12.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 1.1100000000000001 110.618 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.477 ' HA ' ' NE2' ' A' ' 78' ' ' GLN . 71.9 mt -122.54 -66.13 1.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.927 0.394 . . . . 1.1299999999999999 111.428 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.523 ' HG2' HD21 ' A' ' 76' ' ' ASN . 21.5 mtp180 -134.4 138.11 44.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 3.1499999999999999 111.609 -179.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.527 HG12 ' H ' ' A' ' 73' ' ' ASP . 7.6 t -105.32 172.34 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.773 -0.649 . . . . 1.0900000000000001 109.624 178.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.622 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 13.1 t70 -46.81 107.98 0.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.872 0.367 . . . . 0.79000000000000004 111.766 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 49.12 22.43 0.62 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.906 -0.588 . . . . 2.0099999999999998 112.208 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 98.2 t -144.49 104.78 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.775 0.321 . . . . 1.1499999999999999 111.589 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.523 HD21 ' HG2' ' A' ' 71' ' ' ARG . 12.7 m120 -70.67 144.49 51.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.314 -0.403 . . . . 2.8500000000000001 110.371 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 18.3 m -127.89 32.88 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.841 0.353 . . . . 1.26 111.464 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.477 ' NE2' ' HA ' ' A' ' 70' ' ' LEU . 27.2 mm-40 -100.32 31.64 3.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.157 -0.474 . . . . 1.74 111.109 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -178.56 40.6 0.08 OUTLIER Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.478 -0.868 . . . . 0.57999999999999996 112.848 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 68.2 mtm -138.29 145.05 40.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.852 0.358 . . . . 1.1200000000000001 110.879 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.447 ' O ' HG21 ' A' ' 85' ' ' VAL . . . -66.97 160.75 25.76 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.061 -0.518 . . . . 1.1200000000000001 111.155 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -47.81 -53.49 15.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.185 -0.461 . . . . 1.52 111.515 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.7 t -52.51 -38.47 59.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.292 -0.413 . . . . 2.0299999999999998 111.389 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -68.89 -38.5 79.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.312 -0.404 . . . . 2.1200000000000001 111.32 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.447 HG21 ' O ' ' A' ' 81' ' ' ALA . 17.5 t -62.51 -42.38 95.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.468 -0.333 . . . . 1.0800000000000001 110.933 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.0 t -65.63 -36.34 77.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.491 . . . . 1.0700000000000001 111.025 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -58.93 -49.36 78.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.213 -0.449 . . . . 1.51 110.857 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 56.0 t -57.89 -53.16 48.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.295 -0.411 . . . . 1.0600000000000001 111.369 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 83.6 mt -58.88 -31.51 68.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 1.1399999999999999 111.385 -179.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.441 ' HA ' ' NH1' ' A' ' 20' ' ' ARG . 69.7 mtm180 -85.43 -12.16 52.65 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.546 -0.297 . . . . 2.5600000000000001 111.269 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.429 ' N ' HD21 ' A' ' 91' ' ' ASN . 0.9 OUTLIER -97.61 -11.62 23.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.289 -0.414 . . . . 1.8100000000000001 110.942 179.911 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.94 -85.62 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.213 -0.448 . . . . 1.1100000000000001 111.52 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.575 ' HA2' ' HE ' ' A' ' 20' ' ' ARG . . . 63.09 19.82 61.94 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.685 -0.769 . . . . 0.77000000000000002 112.548 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.644 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 1.9 p-10 -147.21 168.59 10.99 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 110.407 -0.22 . . . . 3.3300000000000001 110.407 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.644 ' HD2' ' HB2' ' A' ' 94' ' ' ASN . 19.6 Cg_endo -60.47 89.91 0.08 OUTLIER 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.089 1.86 . . . . 0.92000000000000004 111.325 178.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.3 m -100.13 151.98 4.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.998 -0.546 . . . . 1.3200000000000001 112.087 -178.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.622 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 59.1 mtp180 -98.11 143.85 28.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.787 -0.642 . . . . 3.02 110.055 179.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.497 HD11 HD23 ' A' ' 18' ' ' LEU . 37.3 mt -118.09 104.1 10.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.04 -0.527 . . . . 1.1599999999999999 111.069 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 58.5 tp -100.28 99.87 10.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.34 -0.391 . . . . 1.1000000000000001 110.626 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.11 152.47 49.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 1.1100000000000001 111.234 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.3 tt -94.29 135.93 27.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 1.1399999999999999 110.79 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.482 HH22 ' HA ' ' A' ' 63' ' ' ILE . 18.0 tpp85 -120.74 145.09 47.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.066 -0.515 . . . . 2.7000000000000002 110.993 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -96.69 129.86 44.02 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.067 -0.515 . . . . 4.4000000000000004 110.874 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 86.2 mt -71.05 145.63 91.66 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.088 -0.505 . . . . 2.0 110.766 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -80.99 61.2 8.16 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.807 2.338 . . . . 2.98 112.388 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 99.0 mt -94.25 100.18 12.28 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.51 -0.768 . . . . 3.6699999999999999 110.914 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.403 HD21 ' N ' ' A' ' 107' ' ' LEU . 3.6 mm? -88.05 102.46 14.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.484 . . . . 5.9699999999999998 110.815 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.336 -0.84 . . . . 6.0 110.914 179.972 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.24 0 N-CA-C 112.591 -0.203 . . . . 8.1300000000000008 112.591 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.9 p -90.32 -67.02 0.87 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.778 0.323 . . . . 7.25 111.09 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 60.2 m80 -62.49 128.45 36.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 6.6799999999999997 111.023 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -179.57 43.95 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.707 -0.759 . . . . 2.8900000000000001 112.639 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -101.98 71.69 1.29 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.946 0.403 . . . . 2.46 110.805 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.4 t -70.48 85.49 0.61 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.937 -0.574 . . . . 3.0099999999999998 110.979 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 20.7 t70 55.83 85.8 0.07 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.163 -0.471 . . . . 2.6699999999999999 110.804 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -129.53 115.37 17.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 1.74 111.445 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 27.0 t 55.94 32.62 20.12 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.957 -0.565 . . . . 2.6299999999999999 111.026 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.97 -38.09 3.21 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.659 -0.782 . . . . 1.8200000000000001 112.533 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -61.93 95.28 0.06 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.837 0.351 . . . . 1.98 110.857 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.3 m -111.18 141.67 44.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.155 -0.475 . . . . 1.26 110.929 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 63.5 mt -79.57 122.21 26.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.988 -0.551 . . . . 1.49 110.857 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -113.71 125.53 54.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.466 . . . . 3.0899999999999999 110.983 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 47.6 t -119.81 126.8 51.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.978 -0.556 . . . . 1.79 111.053 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.5 t -124.56 154.06 31.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.01 -0.541 . . . . 1.26 110.576 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -121.83 119.83 32.79 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.95 0.405 . . . . 1.74 111.585 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -114.56 166.62 11.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.87 -0.605 . . . . 1.4099999999999999 110.318 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.528 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 89.3 m-85 -133.29 112.05 11.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.732 0.301 . . . . 2.6600000000000001 111.497 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.463 ' HB2' HD22 ' A' ' 27' ' ' LEU . 50.8 tpt85 -97.34 102.81 14.67 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.272 -0.422 . . . . 3.5899999999999999 110.571 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -160.33 20.72 0.15 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.461 . . . . 2.5800000000000001 110.804 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.459 ' N ' ' HD2' ' A' ' 22' ' ' LYS . 11.5 mptt -106.8 161.52 14.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.113 -0.494 . . . . 4.1900000000000004 110.952 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -83.07 50.17 1.68 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.028 -0.533 . . . . 2.8700000000000001 111.038 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.4 p -117.05 -24.03 7.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.216 -0.447 . . . . 1.74 111.05 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.6 m 58.34 16.65 4.19 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.86 -0.609 . . . . 2.79 111.215 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 81.9 p -144.73 153.81 42.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.288 -0.415 . . . . 1.79 110.997 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.463 HD22 ' HB2' ' A' ' 20' ' ' ARG . 92.6 mt -114.31 -20.13 10.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 1.1299999999999999 110.874 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.11 31.72 7.48 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.831 -0.7 . . . . 0.52000000000000002 112.709 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 46.4 mt -110.02 116.13 51.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.868 0.366 . . . . 1.53 111.025 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 45.8 t -113.3 106.49 14.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 1.4099999999999999 110.704 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 43.9 pt -97.36 148.08 5.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.036 -0.529 . . . . 1.1799999999999999 111.245 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 45.0 t -111.46 139.45 46.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.105 -0.498 . . . . 1.79 110.878 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -89.2 113.25 4.1 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.79 -0.719 . . . . 1.04 112.464 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 56.7 ttp -94.39 116.54 28.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.686 0.279 . . . . 2.48 110.926 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.442 ' HD3' ' N ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -110.61 138.16 47.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.302 -0.408 . . . . 6.1500000000000004 110.881 179.916 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -137.07 122.47 19.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.949 -0.569 . . . . 4.29 110.655 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -123.78 18.88 9.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.278 -0.419 . . . . 5.79 111.167 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.7 p -108.33 173.57 6.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.244 -0.435 . . . . 5.1799999999999997 110.974 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 63.0 p 49.31 -165.25 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.939 -0.573 . . . . 5.54 111.427 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 70.3 p -135.33 36.45 2.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 7.3600000000000003 111.267 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -162.07 35.2 0.36 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.611 -0.804 . . . . 5.7999999999999998 112.779 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -79.47 165.06 23.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.756 0.312 . . . . 7.2199999999999998 110.891 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -146.68 120.39 9.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 3.6000000000000001 111.218 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 70.7 p -86.06 154.73 21.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.154 -0.475 . . . . 3.02 110.984 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -167.73 154.67 24.96 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.626 -0.797 . . . . 1.3600000000000001 112.719 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 43.5 mm -90.31 134.22 29.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.827 0.346 . . . . 1.28 110.857 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -152.83 144.0 23.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 1.0800000000000001 110.897 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 95.7 t -76.71 121.17 28.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.194 -0.457 . . . . 1.0600000000000001 110.861 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -99.72 -23.31 15.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.109 -0.496 . . . . 2.8900000000000001 110.918 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 46.7 t -154.28 165.09 37.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.966 0.412 . . . . 1.8700000000000001 111.213 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 82.9 mt -131.88 154.79 48.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.957 -0.565 . . . . 1.1899999999999999 110.671 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 42.3 mm -97.42 109.15 48.85 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.373 -0.376 . . . . 1.8500000000000001 110.844 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.96 141.13 97.94 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.347 2.031 . . . . 1.26 112.422 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.92 -15.44 63.1 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.758 -0.734 . . . . 0.52000000000000002 112.501 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 59.6 m -80.41 179.15 7.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.663 0.268 . . . . 1.73 110.966 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.49 -47.9 58.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.903 0.382 . . . . 1.1299999999999999 111.096 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.21 -40.33 81.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.097 -0.501 . . . . 1.0900000000000001 111.497 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.1 -54.16 12.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.21 -0.45 . . . . 1.1100000000000001 111.331 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.2 mt -60.83 -19.56 60.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.271 -0.422 . . . . 1.29 111.212 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -52.7 -51.25 61.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.311 -0.404 . . . . 1.8600000000000001 110.758 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 98.05 -32.31 7.02 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.881 -0.676 . . . . 1.4199999999999999 113.145 179.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 23.2 mmm180 -71.57 -46.12 60.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.767 0.318 . . . . 3.0499999999999998 111.284 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 49.5 mt -65.41 132.45 31.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.328 -0.396 . . . . 1.6299999999999999 111.303 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -126.59 138.57 32.73 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.051 -0.522 . . . . 1.98 110.603 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -48.68 157.8 1.38 Allowed 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.443 2.096 . . . . 1.4399999999999999 112.339 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 58.4 t30 58.99 67.27 0.94 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.471 . . . . 2.6299999999999999 110.693 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -133.82 154.91 50.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.974 -0.557 . . . . 2.02 110.629 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -103.79 130.69 51.36 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.562 -0.29 . . . . 1.6200000000000001 111.187 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 36.5 mm -92.54 145.43 7.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.19 -0.459 . . . . 1.1100000000000001 111.022 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 70.2 mt -114.34 -66.9 1.04 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.242 -0.435 . . . . 1.1299999999999999 111.038 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -152.0 141.32 21.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.086 0.47 . . . . 3.1499999999999999 111.41 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.612 HG12 ' H ' ' A' ' 73' ' ' ASP . 2.2 t -90.36 175.26 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.627 -0.715 . . . . 1.0900000000000001 110.033 179.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.612 ' H ' HG12 ' A' ' 72' ' ' VAL . 6.3 p-10 -55.53 114.24 1.76 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.874 0.369 . . . . 0.79000000000000004 111.126 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 60.33 18.53 8.12 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.04 -0.527 . . . . 2.0099999999999998 111.756 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 63.0 t -143.36 149.89 17.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.656 0.265 . . . . 1.1499999999999999 111.139 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -120.01 138.58 53.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.459 -0.337 . . . . 2.8500000000000001 110.587 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.2 m -117.24 28.53 2.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.822 0.344 . . . . 1.26 111.423 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -97.53 33.95 1.93 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 1.74 111.021 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 173.12 28.33 0.02 OUTLIER Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.565 -0.826 . . . . 0.57999999999999996 112.865 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 36.0 mtm -126.25 145.64 50.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.739 0.304 . . . . 1.1200000000000001 110.753 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.01 158.89 24.36 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.28 -0.418 . . . . 1.1200000000000001 111.146 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -49.93 -58.07 6.19 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.215 -0.448 . . . . 1.52 111.531 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 46.5 t -52.65 -39.95 62.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.188 -0.46 . . . . 2.0299999999999998 111.395 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -61.2 -47.9 84.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.832 0.349 . . . . 2.1200000000000001 110.987 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 55.4 t -57.46 -40.79 76.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.108 -0.497 . . . . 1.0800000000000001 111.121 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 90.9 t -63.27 -39.04 83.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 1.0700000000000001 110.928 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.423 ' HG2' HH21 ' A' ' 90' ' ' ARG . 45.8 mt-10 -58.99 -40.83 86.03 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.264 -0.425 . . . . 1.51 110.386 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 52.1 t -60.36 -52.91 55.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.905 -0.589 . . . . 1.0600000000000001 111.203 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 67.0 mt -53.93 -38.02 64.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.095 -0.502 . . . . 1.1399999999999999 111.397 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.423 HH21 ' HG2' ' A' ' 87' ' ' GLU . 76.8 mtm180 -81.28 -21.12 39.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.244 -0.434 . . . . 2.5600000000000001 111.246 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.457 HD21 ' N ' ' A' ' 91' ' ' ASN . 0.9 OUTLIER -90.82 -5.05 56.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.361 -0.381 . . . . 1.8100000000000001 111.16 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.02 -71.66 0.07 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.329 -0.396 . . . . 1.1100000000000001 111.133 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 63.14 10.55 34.58 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.697 -0.763 . . . . 0.77000000000000002 112.522 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -147.51 173.57 4.09 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 110.077 -0.342 . . . . 3.3300000000000001 110.077 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.528 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 86.8 Cg_exo -47.79 100.09 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.005 1.803 . . . . 0.92000000000000004 111.379 178.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.3 t -80.84 113.72 20.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.106 -0.497 . . . . 1.3200000000000001 111.755 -178.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.482 ' H ' ' HB3' ' A' ' 73' ' ' ASP . 80.0 ttt180 -91.38 126.51 36.49 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.532 -0.544 . . . . 3.02 109.532 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 27.7 mt -109.42 103.61 12.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.373 -0.376 . . . . 1.1599999999999999 111.721 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 32.0 tp -96.34 99.75 11.41 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.324 -0.621 . . . . 1.1000000000000001 109.324 178.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -130.14 168.19 17.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.119 -0.491 . . . . 1.1100000000000001 111.862 -178.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 17.3 tt -118.44 143.95 27.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 115.668 -0.696 . . . . 1.1399999999999999 110.782 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.69 123.21 27.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.094 -0.503 . . . . 2.7000000000000002 110.384 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 43.8 ttp180 -79.76 135.99 36.64 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.95 0.405 . . . . 4.4000000000000004 111.3 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 16.2 mt -107.11 152.88 41.23 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.99 -0.55 . . . . 2.0 110.725 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -82.4 162.0 17.24 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.472 2.114 . . . . 2.98 112.279 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 90.7 mt -139.87 73.74 1.44 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.168 -0.469 . . . . 3.6699999999999999 110.794 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 86.6 mt -70.73 167.31 19.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.484 . . . . 5.9699999999999998 111.089 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.238 -0.887 . . . . 6.0 111.022 -179.87 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.141 0 N-CA-C 112.492 -0.243 . . . . 8.1300000000000008 112.492 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 55.3 m -92.92 -32.79 14.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.814 0.34 . . . . 7.25 110.949 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -89.32 -10.15 47.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.19 -0.459 . . . . 6.6799999999999997 110.885 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 95.52 -156.91 21.71 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.849 -0.691 . . . . 2.8900000000000001 112.509 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 55.19 73.14 0.43 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.804 0.335 . . . . 2.46 111.033 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.5 t -99.99 108.58 20.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 3.0099999999999998 110.794 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 40.95 49.55 2.99 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.119 -0.492 . . . . 2.6699999999999999 111.31 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.58 101.74 5.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.996 -0.547 . . . . 1.74 111.267 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.8 m 56.91 27.0 12.4 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.133 -0.485 . . . . 2.6299999999999999 111.094 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.25 35.88 16.42 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.732 -0.747 . . . . 1.8200000000000001 112.378 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -139.0 126.96 22.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.97 0.414 . . . . 1.98 111.0 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.6 t -147.67 141.44 25.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.938 -0.574 . . . . 1.26 110.671 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 58.2 mt -81.07 119.1 23.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 1.49 111.252 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -118.43 151.62 37.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.005 -0.543 . . . . 3.0899999999999999 110.586 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 78.0 p -141.26 145.6 35.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.875 0.369 . . . . 1.79 111.341 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 46.6 t -135.07 139.46 47.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.009 -0.541 . . . . 1.26 110.788 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -100.2 113.09 25.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.321 -0.399 . . . . 1.74 110.848 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 33.8 mt -124.37 141.07 52.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.365 -0.379 . . . . 1.4099999999999999 111.44 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.552 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 44.3 p90 -118.7 141.2 48.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.056 -0.52 . . . . 2.6600000000000001 110.613 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.473 ' HB3' ' HA2' ' A' ' 93' ' ' GLY . 13.0 ttp180 -118.49 80.76 1.58 Allowed 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.702 -0.399 . . . . 3.5899999999999999 111.551 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -99.86 10.07 41.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.436 . . . . 2.5800000000000001 110.779 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.458 ' N ' ' HD2' ' A' ' 22' ' ' LYS . 3.2 mptp? -108.88 156.05 20.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.988 -0.551 . . . . 4.1900000000000004 110.819 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -86.25 73.56 10.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 2.8700000000000001 110.926 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 52.4 p -113.43 -22.61 10.28 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.121 -0.49 . . . . 1.74 111.079 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 51.2 m 59.26 19.89 8.01 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.842 -0.617 . . . . 2.79 111.185 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 77.6 p -158.8 137.9 11.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.307 -0.406 . . . . 1.79 111.162 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.467 HD23 ' HB2' ' A' ' 20' ' ' ARG . 75.4 mt -97.26 -10.75 25.15 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.029 -0.532 . . . . 1.1299999999999999 110.683 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.487 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 92.11 14.85 55.52 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.784 -0.722 . . . . 0.52000000000000002 112.829 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 69.6 mt -98.61 110.57 26.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.778 0.323 . . . . 1.53 111.178 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 34.2 t -111.23 101.1 9.62 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.277 -0.419 . . . . 1.4099999999999999 110.842 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 40.8 pt -92.4 166.67 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.996 -0.547 . . . . 1.1799999999999999 111.43 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 46.0 t -131.94 134.94 46.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.03 -0.532 . . . . 1.79 110.795 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.19 127.99 46.38 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.844 -0.693 . . . . 1.04 112.631 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 27.1 ttt -87.22 102.52 14.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.817 0.341 . . . . 2.48 110.873 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.9 ppt_? -106.07 39.76 1.73 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.482 . . . . 6.1500000000000004 111.016 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -115.2 158.45 22.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.111 -0.495 . . . . 4.29 110.856 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 57.63 88.31 0.06 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.052 -0.522 . . . . 5.79 110.999 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 51.8 m -68.68 85.96 0.31 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 5.1799999999999997 110.919 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 72.0 p -134.78 142.81 46.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.11 -0.495 . . . . 5.54 111.019 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 74.2 p -106.66 29.96 6.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 7.3600000000000003 111.218 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.26 -48.74 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.861 -0.685 . . . . 5.7999999999999998 112.43 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -138.88 95.06 2.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.87 0.367 . . . . 7.2199999999999998 110.842 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -143.73 -160.15 1.08 Allowed 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.125 -0.488 . . . . 3.6000000000000001 110.526 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 80.7 p 49.51 -167.18 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.901 -0.59 . . . . 3.02 111.53 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 159.17 -24.26 0.32 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.611 -0.805 . . . . 1.3600000000000001 112.558 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 49.8 mm 58.97 95.61 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.88 0.372 . . . . 1.28 111.114 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -119.77 138.28 53.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.466 . . . . 1.0800000000000001 111.103 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.8 t -80.51 123.92 37.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.059 -0.519 . . . . 1.0600000000000001 110.807 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -106.43 -29.26 9.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.033 -0.531 . . . . 2.8900000000000001 111.053 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 53.3 m -137.6 167.27 22.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.031 0.443 . . . . 1.8700000000000001 111.606 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 82.4 mt -137.68 163.59 30.9 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.807 -0.633 . . . . 1.1899999999999999 110.752 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.487 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 67.6 mt -102.51 101.02 17.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 1.8500000000000001 110.786 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 52' ' ' ILE . 19.1 Cg_endo -57.56 94.81 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.475 2.116 . . . . 1.26 112.263 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 143.91 -8.09 1.95 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.838 -0.696 . . . . 0.52000000000000002 112.388 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.41 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 53.0 m -96.47 178.66 5.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.757 0.313 . . . . 1.73 110.858 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.46 -53.34 59.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.301 -0.409 . . . . 1.1299999999999999 111.706 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.86 -37.33 66.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.19 -0.459 . . . . 1.0900000000000001 111.853 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -77.98 -32.67 51.41 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.963 0.357 . . . . 1.1100000000000001 111.963 -179.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 55' ' ' SER . 55.1 mt -62.74 -55.47 26.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.727 0.299 . . . . 1.29 111.221 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -57.87 -41.78 83.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 1.8600000000000001 111.1 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 79.6 -11.66 31.6 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.81 -0.709 . . . . 1.4199999999999999 112.681 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 39.7 mtp180 -63.18 -16.83 61.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.807 0.337 . . . . 3.0499999999999998 110.828 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 76.3 mt -104.04 115.56 46.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.081 -0.509 . . . . 1.6299999999999999 110.932 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -86.85 155.46 55.74 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 1.98 111.156 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -78.3 38.19 0.68 Allowed 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.785 2.323 . . . . 1.4399999999999999 112.473 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -164.93 64.14 0.13 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.861 0.362 . . . . 2.6299999999999999 110.746 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -132.19 167.32 19.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.146 -0.479 . . . . 2.02 110.656 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -113.31 106.88 15.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.897 0.38 . . . . 1.6200000000000001 111.171 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 46.5 mm -64.07 143.73 15.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.468 . . . . 1.1100000000000001 110.833 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 57.9 mt -116.42 -58.13 2.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.28 -0.418 . . . . 1.1299999999999999 111.212 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -159.94 136.09 8.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.031 0.443 . . . . 3.1499999999999999 111.465 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.589 HG13 ' H ' ' A' ' 73' ' ' ASP . 2.6 t -88.88 175.87 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.634 -0.712 . . . . 1.0900000000000001 109.909 179.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.664 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 12.2 t70 -44.3 108.74 0.12 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.836 0.35 . . . . 0.79000000000000004 111.802 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 53.13 33.91 16.18 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.115 -0.493 . . . . 2.0099999999999998 112.11 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 92.1 t -147.56 126.39 4.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.535 -0.302 . . . . 1.1499999999999999 111.047 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -96.83 122.98 40.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.401 -0.363 . . . . 2.8500000000000001 110.423 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.7 m -108.42 26.44 2.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 CA-C-O 120.858 0.361 . . . . 1.26 111.586 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -94.4 24.82 4.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.269 -0.423 . . . . 1.74 110.779 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -169.88 16.42 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.663 -0.78 . . . . 0.57999999999999996 112.746 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 60.4 mtm -118.35 143.51 46.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.864 0.364 . . . . 1.1200000000000001 110.856 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.83 164.91 11.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.161 -0.472 . . . . 1.1200000000000001 111.295 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.407 ' O ' HG23 ' A' ' 86' ' ' VAL . 35.3 tt0 -51.74 -55.4 19.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 1.52 111.351 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.2 m -50.44 -42.7 54.44 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.192 -0.458 . . . . 2.0299999999999998 111.577 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -61.05 -49.08 78.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.381 -0.372 . . . . 2.1200000000000001 111.096 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 33.7 t -60.59 -33.44 54.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.486 . . . . 1.0800000000000001 111.276 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 82' ' ' GLN . 89.7 t -67.59 -43.55 86.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.287 -0.415 . . . . 1.0700000000000001 110.98 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -56.95 -45.78 82.57 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.363 -0.381 . . . . 1.51 110.633 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 55.3 t -56.15 -52.43 50.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.083 -0.508 . . . . 1.0600000000000001 110.893 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 82.2 mt -61.38 -25.74 67.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.883 -0.599 . . . . 1.1399999999999999 110.95 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.1 mtm180 -87.93 -11.68 46.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.196 -0.456 . . . . 2.5600000000000001 111.12 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.441 HD21 ' N ' ' A' ' 91' ' ' ASN . 0.9 OUTLIER -99.41 -12.65 20.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.316 -0.402 . . . . 1.8100000000000001 110.605 179.625 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.5 -86.22 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.998 -0.546 . . . . 1.1100000000000001 111.445 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.473 ' HA2' ' HB3' ' A' ' 20' ' ' ARG . . . 61.84 21.97 61.63 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.62 -0.8 . . . . 0.77000000000000002 112.231 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.62 ' HB3' ' HD2' ' A' ' 95' ' ' PRO . 3.7 m120 -147.46 174.54 3.32 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 110.583 -0.155 . . . . 3.3300000000000001 110.583 -179.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.62 ' HD2' ' HB3' ' A' ' 94' ' ' ASN . 36.2 Cg_endo -66.45 81.61 0.3 Allowed 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 122.106 1.871 . . . . 0.92000000000000004 112.004 178.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 22.7 m -91.29 154.21 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.95 -0.568 . . . . 1.3200000000000001 111.48 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.664 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 77.2 ttt180 -94.56 144.07 25.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.782 -0.645 . . . . 3.02 110.112 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 25.9 mt -118.53 103.89 10.16 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.221 -0.445 . . . . 1.1599999999999999 110.986 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 24.8 tp -100.76 104.2 15.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.966 0.412 . . . . 1.1000000000000001 110.781 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.85 168.03 20.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.995 -0.548 . . . . 1.1100000000000001 110.866 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 19.4 tt -114.03 134.8 55.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-O 121.015 0.436 . . . . 1.1399999999999999 111.289 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -115.28 146.43 41.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.584 -0.734 . . . . 2.7000000000000002 110.689 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -97.62 124.1 41.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.36 -0.382 . . . . 4.4000000000000004 111.125 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 66.4 mt -95.02 142.48 24.67 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.122 -0.49 . . . . 2.0 110.74 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -82.34 165.86 16.35 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.526 2.15 . . . . 2.98 112.549 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 89.4 mt -134.53 154.26 51.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 3.6699999999999999 110.833 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -99.55 138.19 36.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.117 -0.492 . . . . 5.9699999999999998 111.001 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.282 -0.866 . . . . 6.0 110.779 -179.951 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.185 0 N-CA-C 112.538 -0.225 . . . . 8.1300000000000008 112.538 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 53.4 m -91.71 -55.73 3.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.84 0.352 . . . . 7.25 111.081 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -96.4 -64.46 1.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 6.6799999999999997 110.973 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -143.45 -98.98 0.29 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.676 -0.774 . . . . 2.8900000000000001 112.409 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.475 ' H ' HD13 ' A' ' 13' ' ' LEU . 41.3 m-85 -94.39 123.83 38.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.896 0.379 . . . . 2.46 111.12 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.3 t -106.13 -169.32 1.56 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.024 -0.535 . . . . 3.0099999999999998 110.543 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -54.17 103.53 0.08 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.857 0.361 . . . . 2.6699999999999999 110.839 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -145.76 112.34 5.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.489 . . . . 1.74 111.051 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 61.4 m 56.86 19.11 4.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.137 -0.483 . . . . 2.6299999999999999 111.095 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.91 -45.8 1.26 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.737 -0.744 . . . . 1.8200000000000001 112.652 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -51.44 110.98 0.51 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.927 0.394 . . . . 1.98 111.357 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.0 t -130.29 141.28 50.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.863 -0.608 . . . . 1.26 110.727 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.475 HD13 ' H ' ' A' ' 5' ' ' TYR . 95.2 mt -79.62 120.6 24.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 1.49 111.276 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -115.0 157.29 23.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.075 -0.511 . . . . 3.0899999999999999 110.656 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 41.1 t -148.91 132.24 16.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.916 0.389 . . . . 1.79 111.161 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 44.4 t -125.16 129.9 73.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.078 -0.51 . . . . 1.26 110.775 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -95.47 109.85 21.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.15 -0.477 . . . . 1.74 111.16 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.401 HD13 HD12 ' A' ' 98' ' ' LEU . 28.5 mt -115.76 166.19 12.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 1.4099999999999999 110.874 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.638 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 39.3 p90 -149.91 133.75 16.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 2.6600000000000001 111.046 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.6 tpp180 -109.49 122.24 46.97 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.001 0.429 . . . . 3.5899999999999999 110.831 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -121.77 -25.69 5.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.893 -0.594 . . . . 2.5800000000000001 110.637 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -71.65 169.71 15.0 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.841 -0.618 . . . . 4.1900000000000004 110.682 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -95.63 51.91 1.32 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.269 -0.423 . . . . 2.8700000000000001 110.788 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 79.7 p -103.36 -24.12 13.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.133 -0.485 . . . . 1.74 111.141 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.7 t 58.41 21.12 8.07 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.951 -0.568 . . . . 2.79 111.228 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 79.0 p -145.03 153.3 41.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.869 0.366 . . . . 1.79 111.122 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 81.7 mt -114.12 -8.5 12.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.008 -0.542 . . . . 1.1299999999999999 110.799 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.406 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 97.78 -12.1 64.38 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.831 -0.699 . . . . 0.52000000000000002 112.8 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 69.8 mt -63.51 108.69 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.727 0.299 . . . . 1.53 111.156 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 36.3 t -112.19 114.22 26.9 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.318 -0.401 . . . . 1.4099999999999999 110.636 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.4 pt -96.22 -178.84 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.381 -0.372 . . . . 1.1799999999999999 111.362 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 77.3 p -163.44 137.4 5.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.138 -0.483 . . . . 1.79 110.75 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -88.73 120.93 5.82 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.796 -0.716 . . . . 1.04 112.561 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 57.1 ttp -71.35 147.19 48.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.762 0.315 . . . . 2.48 110.944 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.441 ' HD3' ' N ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -147.79 140.14 24.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.196 -0.456 . . . . 6.1500000000000004 110.848 -179.907 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -111.65 171.53 7.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 4.29 110.939 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 5.4 pm0 -87.92 28.2 1.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.062 -0.517 . . . . 5.79 110.837 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.4 m -154.77 78.83 1.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 5.1799999999999997 110.723 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 77.6 p -61.0 134.29 56.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.109 -0.496 . . . . 5.54 111.201 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.7 t -168.88 14.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.095 -0.502 . . . . 7.3600000000000003 111.01 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.8 171.21 41.83 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.812 -0.709 . . . . 5.7999999999999998 112.548 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 58.36 -177.56 0.07 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.832 0.348 . . . . 7.2199999999999998 111.202 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 58.27 49.71 10.74 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.099 -0.5 . . . . 3.6000000000000001 111.07 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 50.8 p -141.24 127.05 19.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.1 -0.5 . . . . 3.02 111.079 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -149.74 160.64 28.57 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.734 -0.746 . . . . 1.3600000000000001 112.632 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 39.5 mm -90.92 131.53 37.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.699 0.285 . . . . 1.28 110.861 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 46.5 p90 -153.68 144.84 22.92 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.338 -0.392 . . . . 1.0800000000000001 111.411 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 66.4 t -79.6 132.79 31.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.031 -0.532 . . . . 1.0600000000000001 110.924 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -125.73 -26.19 3.54 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.102 -0.499 . . . . 2.8900000000000001 111.022 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 56.6 m -130.16 161.96 29.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.025 0.441 . . . . 1.8700000000000001 111.275 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 83.6 mt -141.65 129.09 21.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.814 -0.63 . . . . 1.1899999999999999 110.728 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.406 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 63.1 mt -68.26 117.95 54.51 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.28 -0.418 . . . . 1.8500000000000001 110.934 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.21 96.76 0.64 Allowed 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.191 1.927 . . . . 1.26 112.252 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 137.29 0.45 2.7 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.837 -0.697 . . . . 0.52000000000000002 112.511 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 63.6 m -101.32 172.46 6.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.62 0.247 . . . . 1.73 110.902 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.36 -53.13 61.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.431 -0.35 . . . . 1.1299999999999999 111.8 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -47.15 -40.78 16.41 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.243 -0.435 . . . . 1.0900000000000001 112.019 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.37 -38.99 29.35 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.984 0.365 . . . . 1.1100000000000001 111.984 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 60.1 mt -56.3 -56.22 23.77 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.47 -0.332 . . . . 1.29 111.634 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -56.54 -34.26 66.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.402 -0.363 . . . . 1.8600000000000001 111.236 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 78.34 -12.74 18.71 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.784 -0.722 . . . . 1.4199999999999999 112.504 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -59.72 -29.25 68.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.789 0.328 . . . . 3.0499999999999998 110.792 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.446 ' N ' HD11 ' A' ' 63' ' ' ILE . 4.0 mp -93.49 115.1 31.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.479 . . . . 1.6299999999999999 110.651 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.464 ' HB2' ' HD2' ' A' ' 65' ' ' PRO . 12.0 pt-20 -113.03 158.13 38.76 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.458 . . . . 1.98 110.696 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.464 ' HD2' ' HB2' ' A' ' 64' ' ' GLU . 21.2 Cg_endo -60.05 173.18 1.93 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.399 2.066 . . . . 1.4399999999999999 112.095 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 54.09 58.86 4.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.044 0.45 . . . . 2.6299999999999999 110.668 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -136.51 154.28 50.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.976 -0.556 . . . . 2.02 110.537 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -110.15 136.93 48.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.977 0.418 . . . . 1.6200000000000001 111.49 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.454 HD12 ' HB3' ' A' ' 100' ' ' LEU . 45.3 mm -97.79 120.58 47.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.817 -0.629 . . . . 1.1100000000000001 110.346 179.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 77.4 mt -93.25 -63.79 1.17 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.429 -0.35 . . . . 1.1299999999999999 111.33 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 62.6 mtp180 -141.7 142.09 33.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.098 0.475 . . . . 3.1499999999999999 111.664 -179.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.549 HG12 ' H ' ' A' ' 73' ' ' ASP . 4.4 t -100.47 174.04 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.724 -0.671 . . . . 1.0900000000000001 109.944 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.645 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 18.8 t70 -50.43 110.6 0.42 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.657 0.265 . . . . 0.79000000000000004 111.205 179.262 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.4 t70 56.04 26.05 9.58 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.254 -0.43 . . . . 2.0099999999999998 111.248 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.501 ' HB ' ' HB ' ' A' ' 72' ' ' VAL . 86.9 t -144.56 153.93 14.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 1.1499999999999999 110.631 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -129.59 126.56 38.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.743 0.306 . . . . 2.8500000000000001 110.746 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.428 ' HA ' ' HE2' ' A' ' 80' ' ' MET . 33.2 m -104.63 25.14 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.245 -0.434 . . . . 1.26 111.067 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -89.62 26.34 1.77 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.083 -0.508 . . . . 1.74 110.956 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 174.78 34.12 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.535 -0.84 . . . . 0.57999999999999996 112.897 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.428 ' HE2' ' HA ' ' A' ' 77' ' ' VAL . 49.8 mtm -126.62 147.35 49.91 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.834 0.35 . . . . 1.1200000000000001 110.858 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.03 156.23 18.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.1 -0.5 . . . . 1.1200000000000001 111.301 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -51.44 -58.63 5.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.325 -0.398 . . . . 1.52 111.154 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.6 t -55.94 -36.94 68.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.099 -0.5 . . . . 2.0299999999999998 111.179 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -60.15 -46.41 89.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.355 -0.384 . . . . 2.1200000000000001 110.907 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 60.7 t -59.49 -38.3 74.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.454 . . . . 1.0800000000000001 110.886 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 58.8 t -64.35 -41.57 92.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.157 -0.474 . . . . 1.0700000000000001 111.077 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.508 ' HG2' HH21 ' A' ' 90' ' ' ARG . 48.3 mt-10 -57.85 -44.51 86.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.893 0.378 . . . . 1.51 110.547 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 54.0 t -56.18 -55.55 17.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.947 -0.57 . . . . 1.0600000000000001 111.102 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 78.7 mt -57.22 -29.79 64.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.043 -0.526 . . . . 1.1399999999999999 111.259 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.508 HH21 ' HG2' ' A' ' 87' ' ' GLU . 63.5 mtm180 -83.1 -20.76 34.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.462 -0.335 . . . . 2.5600000000000001 111.097 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -86.44 -18.35 31.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 1.8100000000000001 110.825 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.44 -85.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.289 -0.414 . . . . 1.1100000000000001 110.988 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 60.48 23.01 59.88 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.739 -0.743 . . . . 0.77000000000000002 112.583 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.465 ' HB3' ' HD2' ' A' ' 95' ' ' PRO . 2.2 m120 -147.34 175.91 2.48 Favored Pre-proline 0 C--N 1.329 -0.322 0 C-N-CA 121.928 0.091 . . . . 3.3300000000000001 110.863 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.638 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 51.5 Cg_exo -56.76 103.54 0.12 Allowed 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 122.096 1.864 . . . . 0.92000000000000004 111.715 178.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 31.3 m -123.51 149.46 27.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.111 0.482 . . . . 1.3200000000000001 111.945 -179.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.645 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 42.5 ttp180 -94.34 142.96 26.81 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.61 -0.723 . . . . 3.02 109.983 179.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.401 HD12 HD13 ' A' ' 18' ' ' LEU . 52.8 mt -116.58 115.46 25.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.188 -0.46 . . . . 1.1599999999999999 111.273 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 59.3 tp -108.88 103.22 12.23 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.941 0.4 . . . . 1.1000000000000001 110.32 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.454 ' HB3' HD12 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -132.4 166.27 22.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.089 -0.505 . . . . 1.1100000000000001 111.329 -179.249 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 19.0 tt -120.6 140.38 44.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.121 -0.491 . . . . 1.1399999999999999 110.986 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -130.58 126.21 36.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.056 -0.52 . . . . 2.7000000000000002 110.396 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -82.85 138.93 33.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.904 0.383 . . . . 4.4000000000000004 111.216 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.1 mt -101.16 145.23 30.07 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.098 -0.501 . . . . 2.0 110.626 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -81.1 163.22 20.22 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.406 2.071 . . . . 2.98 112.5 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 85.1 mt -137.45 109.97 7.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.95 -0.568 . . . . 3.6699999999999999 110.854 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -74.19 147.38 42.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.133 -0.485 . . . . 5.9699999999999998 110.93 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.249 -0.881 . . . . 6.0 110.877 -179.972 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 112.436 -0.266 . . . . 8.1300000000000008 112.436 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.6 m -111.29 -31.9 6.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.813 0.34 . . . . 7.25 110.843 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 28.3 t60 -88.31 95.06 10.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 6.6799999999999997 110.747 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -149.94 54.43 0.49 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.805 -0.712 . . . . 2.8900000000000001 112.412 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -139.3 157.03 46.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.908 0.385 . . . . 2.46 111.111 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 93.7 p -144.37 -167.99 2.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.991 -0.549 . . . . 3.0099999999999998 110.459 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -55.49 97.63 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.837 0.351 . . . . 2.6699999999999999 110.978 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -134.85 100.05 4.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.062 -0.517 . . . . 1.74 110.788 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.2 t 56.86 22.74 7.38 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.126 -0.488 . . . . 2.6299999999999999 110.887 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.83 -36.36 4.3 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.81 -0.709 . . . . 1.8200000000000001 112.643 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.414 ' HA ' ' HA ' ' A' ' 103' ' ' ARG . 25.1 m-85 -55.99 118.86 5.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.907 0.384 . . . . 1.98 110.961 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.2 t -154.75 159.66 40.8 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.071 -0.513 . . . . 1.26 111.215 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.498 HD23 ' HB ' ' A' ' 101' ' ' ILE . 16.6 mt -96.02 106.99 19.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.614 -0.721 . . . . 1.49 110.242 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.456 ' HH ' ' HB3' ' A' ' 102' ' ' ARG . 32.7 p90 -127.97 150.47 49.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.855 0.36 . . . . 3.0899999999999999 111.06 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 80.3 p -123.84 135.55 53.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.107 -0.497 . . . . 1.79 111.268 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.9 t -110.4 144.62 18.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.94 -0.573 . . . . 1.26 110.477 179.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -88.58 122.26 31.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.872 0.368 . . . . 1.74 111.252 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -127.13 166.25 18.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.964 -0.562 . . . . 1.4099999999999999 110.787 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.53 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 27.9 p90 -152.77 130.52 11.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.25 -0.432 . . . . 2.6600000000000001 111.04 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.452 ' HB2' HD22 ' A' ' 27' ' ' LEU . 2.0 tmm_? -108.17 107.03 17.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.312 -0.403 . . . . 3.5899999999999999 110.659 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -133.06 -28.67 1.51 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.328 -0.396 . . . . 2.5800000000000001 111.33 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -64.0 161.03 16.65 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.137 -0.483 . . . . 4.1900000000000004 111.018 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -83.37 37.54 0.57 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.022 -0.535 . . . . 2.8700000000000001 111.203 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 71.2 p -88.43 -16.18 33.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 1.74 111.028 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 51.6 m 57.54 20.5 6.22 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.903 -0.589 . . . . 2.79 111.082 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 88.5 p -159.32 -176.62 5.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.345 -0.389 . . . . 1.79 110.909 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.452 HD22 ' HB2' ' A' ' 20' ' ' ARG . 68.7 mt -128.83 -0.49 5.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.023 -0.535 . . . . 1.1299999999999999 110.634 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.29 26.76 51.07 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.835 -0.698 . . . . 0.52000000000000002 112.566 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.428 HG21 HG21 ' A' ' 31' ' ' ILE . 85.0 mt -100.94 114.52 40.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.905 0.383 . . . . 1.53 111.1 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.0 m -109.03 92.82 4.21 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.113 -0.494 . . . . 1.4099999999999999 110.722 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.428 HG21 HG21 ' A' ' 29' ' ' ILE . 43.1 pt -90.46 164.99 2.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.0 -0.545 . . . . 1.1799999999999999 111.236 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.2 t -145.4 134.49 22.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 1.79 110.788 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -66.73 131.83 31.64 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.839 -0.696 . . . . 1.04 112.396 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 53.0 ttm -60.52 146.16 45.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.762 0.315 . . . . 2.48 110.97 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -118.9 130.75 55.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 6.1500000000000004 110.935 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -134.97 154.84 51.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.047 -0.524 . . . . 4.29 110.857 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -110.24 134.68 51.99 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.133 -0.485 . . . . 5.79 110.804 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.2 m 53.94 71.46 0.51 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.14 -0.482 . . . . 5.1799999999999997 110.787 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 61.1 p -81.45 147.64 29.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.061 -0.518 . . . . 5.54 111.321 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 72.4 p -99.53 9.07 43.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.051 -0.522 . . . . 7.3600000000000003 110.919 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 155.76 -82.9 0.15 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.915 -0.659 . . . . 5.7999999999999998 112.482 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -125.23 133.83 52.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.872 0.368 . . . . 7.2199999999999998 110.936 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -166.55 56.2 0.09 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.154 -0.475 . . . . 3.6000000000000001 111.163 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 68.2 p -118.44 152.88 35.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 3.02 111.106 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -152.09 142.93 9.83 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.644 -0.789 . . . . 1.3600000000000001 112.598 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 37.6 mm -94.88 126.02 47.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.704 0.288 . . . . 1.28 110.713 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -149.49 145.15 26.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.338 -0.392 . . . . 1.0800000000000001 111.457 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 93.1 t -83.37 115.58 25.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.957 -0.565 . . . . 1.0600000000000001 110.64 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -89.5 -31.34 17.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.073 -0.512 . . . . 2.8900000000000001 111.351 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.0 t -151.29 169.0 23.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.96 0.409 . . . . 1.8700000000000001 111.605 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 86.1 mt -124.94 169.73 11.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.731 -0.668 . . . . 1.1899999999999999 110.514 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 50.4 mm -108.62 99.96 36.24 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.278 -0.419 . . . . 1.8500000000000001 111.047 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -51.73 116.06 2.5 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.56 2.174 . . . . 1.26 112.397 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 111.31 3.49 27.54 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.802 -0.713 . . . . 0.52000000000000002 112.33 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 55.1 m -99.78 174.15 6.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.65 0.262 . . . . 1.73 111.037 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.68 -56.65 19.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.304 -0.407 . . . . 1.1299999999999999 111.353 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.46 -33.06 58.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.256 -0.429 . . . . 1.0900000000000001 111.384 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.08 -26.06 39.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.289 -0.414 . . . . 1.1100000000000001 111.529 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 31.2 mt -70.59 -37.65 73.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.473 -0.331 . . . . 1.29 111.241 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -61.74 -40.59 95.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.41 -0.359 . . . . 1.8600000000000001 110.993 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 79.48 -13.99 19.45 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.797 -0.716 . . . . 1.4199999999999999 112.632 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 69.6 mtp180 -74.99 -23.05 58.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.788 0.327 . . . . 3.0499999999999998 110.935 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.454 ' N ' HD13 ' A' ' 63' ' ' ILE . 3.7 mp -84.19 118.9 32.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.436 . . . . 1.6299999999999999 110.715 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -106.3 136.79 19.31 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.111 -0.495 . . . . 1.98 110.614 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -56.09 163.24 6.31 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.486 2.124 . . . . 1.4399999999999999 112.316 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 62.95 45.78 5.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.065 -0.516 . . . . 2.6299999999999999 111.046 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -109.55 165.45 11.66 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.098 -0.501 . . . . 2.02 110.602 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -113.61 107.05 15.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.819 0.342 . . . . 1.6200000000000001 111.207 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.434 ' HA ' ' HB3' ' A' ' 100' ' ' LEU . 43.7 mm -66.53 136.73 26.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.12 -0.491 . . . . 1.1100000000000001 110.692 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 96.6 mt -113.03 -72.17 0.72 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.45 -0.341 . . . . 1.1299999999999999 111.318 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 -135.89 137.35 41.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.001 0.429 . . . . 3.1499999999999999 111.61 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.456 HG13 ' N ' ' A' ' 73' ' ' ASP . 9.3 t -98.91 168.59 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.872 -0.604 . . . . 1.0900000000000001 109.829 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.67 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 13.4 t70 -47.86 108.3 0.16 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.923 0.392 . . . . 0.79000000000000004 111.95 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.8 t70 58.69 6.68 0.64 Allowed 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.592 0.589 . . . . 2.0099999999999998 112.592 178.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 38.9 t -140.09 101.05 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.718 0.294 . . . . 1.1499999999999999 111.59 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -73.83 153.78 39.78 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.454 -0.339 . . . . 2.8500000000000001 110.427 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.447 ' HA ' ' HE2' ' A' ' 80' ' ' MET . 34.9 m -125.62 28.55 2.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-O 120.853 0.359 . . . . 1.26 111.554 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -94.32 42.25 1.09 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.268 -0.424 . . . . 1.74 111.011 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 165.76 33.23 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.642 -0.79 . . . . 0.57999999999999996 113.04 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.447 ' HE2' ' HA ' ' A' ' 77' ' ' VAL . 50.5 mtm -131.39 152.48 50.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.862 0.363 . . . . 1.1200000000000001 111.01 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.55 152.98 40.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.011 -0.54 . . . . 1.1200000000000001 111.179 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -52.69 -55.86 19.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.355 -0.384 . . . . 1.52 111.286 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 48.0 t -53.7 -40.06 65.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.137 -0.483 . . . . 2.0299999999999998 111.413 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -62.34 -46.24 89.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.322 -0.399 . . . . 2.1200000000000001 111.118 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 75.6 t -57.94 -36.64 56.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.122 -0.49 . . . . 1.0800000000000001 111.128 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 64.9 t -65.99 -43.3 92.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 1.0700000000000001 111.025 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -57.25 -39.41 75.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.183 -0.462 . . . . 1.51 110.612 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 52.9 t -62.3 -53.66 44.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 1.0600000000000001 111.208 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 76.5 mt -53.29 -30.06 36.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.933 -0.576 . . . . 1.1399999999999999 111.174 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -87.53 -26.64 23.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 2.5600000000000001 111.295 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -78.22 -12.17 59.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.421 -0.354 . . . . 1.8100000000000001 111.032 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -49.76 -80.26 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.272 -0.422 . . . . 1.1100000000000001 111.29 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 65.87 10.84 52.54 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.591 -0.814 . . . . 0.77000000000000002 112.379 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.536 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -146.88 168.56 11.15 Favored Pre-proline 0 C--N 1.328 -0.332 0 N-CA-C 110.44 -0.207 . . . . 3.3300000000000001 110.44 -179.827 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.536 ' HD2' ' HB2' ' A' ' 94' ' ' ASN . 19.0 Cg_endo -61.24 102.42 0.22 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.003 1.802 . . . . 0.92000000000000004 111.506 178.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 29.9 m -107.81 146.66 13.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 1.3200000000000001 112.015 -178.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.67 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 20.7 ttm180 -92.18 142.76 27.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.818 -0.628 . . . . 3.02 109.847 179.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 71.8 mt -116.09 103.4 10.52 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.071 -0.513 . . . . 1.1599999999999999 110.892 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 65.1 tp -98.99 114.26 26.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 1.1000000000000001 110.382 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.434 ' HB3' ' HA ' ' A' ' 69' ' ' ILE . 0.5 OUTLIER -147.27 167.95 22.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.475 . . . . 1.1100000000000001 111.487 -179.352 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.498 ' HB ' HD23 ' A' ' 13' ' ' LEU . 11.7 tt -116.23 139.16 44.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.828 -0.624 . . . . 1.1399999999999999 110.807 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.456 ' HB3' ' HH ' ' A' ' 14' ' ' TYR . 32.7 tpt180 -166.22 138.89 3.94 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.206 -0.452 . . . . 2.7000000000000002 110.601 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.414 ' HA ' ' HA ' ' A' ' 11' ' ' PHE . 16.7 ptm180 -62.85 145.5 54.92 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.02 -0.536 . . . . 4.4000000000000004 111.288 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.3 mt -106.19 154.78 39.44 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.657 -0.701 . . . . 2.0 110.791 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.81 171.38 9.88 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.407 2.072 . . . . 2.98 112.275 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 90.5 mt -145.31 127.43 15.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.948 -0.569 . . . . 3.6699999999999999 110.831 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.446 HD21 ' N ' ' A' ' 107' ' ' LEU . 3.3 mm? -93.28 165.65 12.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 5.9699999999999998 110.661 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.276 -0.869 . . . . 6.0 110.778 179.747 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.111 0 N-CA-C 112.528 -0.229 . . . . 8.1300000000000008 112.528 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.2 t -154.59 -72.85 0.12 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.74 0.305 . . . . 7.25 110.839 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 59.6 m80 55.53 82.68 0.1 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.148 -0.478 . . . . 6.6799999999999997 110.88 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 151.0 89.38 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.753 -0.737 . . . . 2.8900000000000001 112.464 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -107.22 93.85 4.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.785 0.326 . . . . 2.46 110.865 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 45.1 t -89.18 99.58 12.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 3.0099999999999998 110.781 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 20.4 t70 56.4 81.64 0.12 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.128 -0.487 . . . . 2.6699999999999999 110.787 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -143.91 111.3 5.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.27 -0.423 . . . . 1.74 111.353 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 63.0 m 56.49 25.62 9.93 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.957 -0.565 . . . . 2.6299999999999999 111.515 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.68 -52.47 1.15 Allowed Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.62 -0.8 . . . . 1.8200000000000001 112.594 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -50.65 103.98 0.07 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.928 0.394 . . . . 1.98 111.068 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 56.2 p -123.16 143.19 50.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.891 -0.595 . . . . 1.26 110.655 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 76.5 mt -77.78 128.72 34.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.121 -0.491 . . . . 1.49 111.319 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -114.74 132.55 56.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.927 -0.579 . . . . 3.0899999999999999 111.058 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 84.9 p -124.56 128.55 49.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.099 -0.501 . . . . 1.79 110.929 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 23.6 t -133.04 149.38 31.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.117 -0.492 . . . . 1.26 110.919 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -111.41 120.77 43.31 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.843 0.354 . . . . 1.74 110.986 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -121.18 166.45 13.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.034 -0.53 . . . . 1.4099999999999999 111.119 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.568 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 33.8 p90 -147.86 129.19 14.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.997 -0.547 . . . . 2.6600000000000001 110.82 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.472 ' HB2' HD23 ' A' ' 27' ' ' LEU . 3.0 tmm_? -108.71 115.31 29.84 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.935 0.398 . . . . 3.5899999999999999 111.007 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -150.93 13.76 0.71 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.101 -0.5 . . . . 2.5800000000000001 110.934 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -103.78 160.52 14.71 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.197 -0.456 . . . . 4.1900000000000004 110.712 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -90.62 57.92 3.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 2.8700000000000001 110.889 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 37.5 p -118.76 -10.49 9.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 1.74 111.103 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 90.7 p 49.71 26.84 1.98 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.76 -0.655 . . . . 2.79 111.413 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 53.4 m -152.69 137.48 17.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.38 -0.373 . . . . 1.79 111.059 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.472 HD23 ' HB2' ' A' ' 20' ' ' ARG . 85.1 mt -91.53 -34.58 14.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.081 -0.509 . . . . 1.1299999999999999 110.778 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.426 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 127.26 -26.82 4.91 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.869 -0.682 . . . . 0.52000000000000002 112.444 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 70.3 mt -63.93 113.67 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.792 0.329 . . . . 1.53 110.928 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.447 ' HB3' ' HG ' ' A' ' 50' ' ' SER . 47.3 t -113.84 99.43 7.68 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.15 -0.477 . . . . 1.4099999999999999 110.997 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.8 pt -96.47 159.2 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.073 -0.512 . . . . 1.1799999999999999 111.071 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 47.4 t -115.2 146.69 41.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.237 -0.438 . . . . 1.79 110.949 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.98 157.54 35.16 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.901 -0.666 . . . . 1.04 112.455 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 16.7 tpt -117.97 145.46 44.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.894 0.378 . . . . 2.48 111.04 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.419 ' N ' ' HD2' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -130.23 72.63 1.49 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.028 -0.533 . . . . 6.1500000000000004 110.69 179.787 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -99.45 152.43 20.0 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.007 -0.542 . . . . 4.29 111.071 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -94.45 147.64 23.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.004 -0.544 . . . . 5.79 110.847 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 53.0 m -59.94 103.23 0.2 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.113 -0.494 . . . . 5.1799999999999997 110.983 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 71.6 p -128.77 163.12 25.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.015 -0.538 . . . . 5.54 110.93 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.4 t -74.06 0.44 13.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.013 -0.539 . . . . 7.3600000000000003 111.246 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -119.83 104.41 1.03 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.742 -0.742 . . . . 5.7999999999999998 112.554 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 58.98 -178.73 0.08 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.822 0.344 . . . . 7.2199999999999998 111.209 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -163.95 117.26 1.45 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.488 . . . . 3.6000000000000001 111.205 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 79.8 p 50.2 -167.41 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.075 -0.512 . . . . 3.02 111.701 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 159.56 140.34 2.88 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.825 -0.703 . . . . 1.3600000000000001 112.337 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 42.7 mm -100.01 138.13 25.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.796 0.331 . . . . 1.28 111.041 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -151.21 143.56 24.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.485 . . . . 1.0800000000000001 111.109 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 79.3 t -76.81 134.89 27.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.215 -0.448 . . . . 1.0600000000000001 110.757 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -113.39 -31.81 6.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.985 -0.552 . . . . 2.8900000000000001 111.169 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.447 ' HG ' ' HB3' ' A' ' 30' ' ' SER . 80.0 p -153.71 177.07 11.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.957 0.408 . . . . 1.8700000000000001 111.395 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 97.6 mt -133.75 149.44 51.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.765 -0.652 . . . . 1.1899999999999999 110.838 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.426 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 57.1 mt -81.16 121.35 80.41 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.289 -0.414 . . . . 1.8500000000000001 111.121 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.16 114.23 3.7 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.441 2.094 . . . . 1.26 112.265 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.82 16.36 15.75 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.63 -0.795 . . . . 0.52000000000000002 112.652 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 78.0 p -107.76 176.45 5.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.717 0.294 . . . . 1.73 110.906 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.57 -57.6 9.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.34 -0.391 . . . . 1.1299999999999999 111.206 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.13 -29.58 13.94 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.118 -0.492 . . . . 1.0900000000000001 111.591 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -77.74 -40.92 39.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.303 -0.408 . . . . 1.1100000000000001 111.455 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.6 mt -61.78 -35.96 79.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.311 -0.404 . . . . 1.29 111.273 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -61.79 -47.32 85.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.287 -0.415 . . . . 1.8600000000000001 111.101 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.06 -20.65 7.92 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.77 -0.728 . . . . 1.4199999999999999 112.477 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 12.8 mmm180 -62.22 -22.39 65.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.827 0.346 . . . . 3.0499999999999998 110.889 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.44 ' N ' HD12 ' A' ' 63' ' ' ILE . 4.1 mp -91.18 111.23 23.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.12 -0.491 . . . . 1.6299999999999999 110.899 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -98.68 134.49 21.62 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.035 -0.529 . . . . 1.98 110.531 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.94 159.9 4.72 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.488 2.125 . . . . 1.4399999999999999 112.279 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 61.13 82.98 0.15 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.992 -0.549 . . . . 2.6299999999999999 110.861 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -156.51 170.77 21.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.072 -0.513 . . . . 2.02 110.707 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -114.42 126.06 54.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.405 -0.361 . . . . 1.6200000000000001 111.096 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 41.4 mm -84.53 137.99 19.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.135 -0.484 . . . . 1.1100000000000001 110.784 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.444 ' HA ' ' NE2' ' A' ' 78' ' ' GLN . 89.1 mt -101.36 -61.51 1.37 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.28 -0.418 . . . . 1.1299999999999999 111.07 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -158.17 138.48 12.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.171 0.51 . . . . 3.1499999999999999 111.676 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.601 HG12 ' H ' ' A' ' 73' ' ' ASP . 2.9 t -86.85 175.48 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.551 -0.749 . . . . 1.0900000000000001 109.997 179.281 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.667 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 14.7 t70 -49.54 110.25 0.36 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.795 0.331 . . . . 0.79000000000000004 111.804 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.1 t70 60.69 9.91 2.39 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.044 -0.526 . . . . 2.0099999999999998 111.978 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.509 HG11 HG21 ' A' ' 88' ' ' VAL . 57.7 t -128.51 141.85 45.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.674 0.273 . . . . 1.1499999999999999 110.999 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -109.26 129.55 55.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.323 -0.399 . . . . 2.8500000000000001 110.709 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.4 m -111.92 26.6 3.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-O 120.89 0.376 . . . . 1.26 111.319 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.444 ' NE2' ' HA ' ' A' ' 70' ' ' LEU . 27.0 mm-40 -86.77 31.62 0.69 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.14 -0.482 . . . . 1.74 111.306 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 162.38 43.3 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.466 -0.873 . . . . 0.57999999999999996 112.974 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 47.7 mtm -129.68 138.34 51.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.874 0.368 . . . . 1.1200000000000001 110.905 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.4 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -60.93 156.66 17.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.107 -0.497 . . . . 1.1200000000000001 111.123 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -48.33 -49.16 35.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.331 -0.395 . . . . 1.52 111.363 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 81.0 p -53.31 -44.96 68.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.121 -0.491 . . . . 2.0299999999999998 111.444 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -61.56 -45.32 94.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.294 -0.412 . . . . 2.1200000000000001 111.426 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 81' ' ' ALA . 15.5 t -59.34 -41.38 84.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.331 -0.395 . . . . 1.0800000000000001 111.003 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 92.2 t -64.14 -37.7 80.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.046 -0.525 . . . . 1.0700000000000001 111.103 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -58.73 -47.5 84.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 1.51 110.655 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.509 HG21 HG11 ' A' ' 75' ' ' VAL . 65.1 t -56.75 -55.09 21.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.022 -0.535 . . . . 1.0600000000000001 111.256 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.429 HD21 HD13 ' A' ' 27' ' ' LEU . 84.5 mt -53.07 -36.69 60.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.82 -0.627 . . . . 1.1399999999999999 111.822 -179.096 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 81.7 mtm180 -84.48 -18.39 36.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.613 -0.267 . . . . 2.5600000000000001 111.67 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -89.98 -8.03 52.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.703 0.287 . . . . 1.8100000000000001 110.87 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -55.49 -83.74 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.251 -0.431 . . . . 1.1100000000000001 111.263 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.454 ' HA2' ' NE ' ' A' ' 20' ' ' ARG . . . 62.11 14.5 46.8 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.717 -0.754 . . . . 0.77000000000000002 112.37 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -146.9 168.51 11.25 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 110.45 -0.204 . . . . 3.3300000000000001 110.45 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.568 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 36.1 Cg_exo -62.33 96.5 0.15 Allowed 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.211 1.941 . . . . 0.92000000000000004 111.161 178.299 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.5 m -105.76 152.76 7.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.124 0.488 . . . . 1.3200000000000001 111.988 -178.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.667 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 52.5 ttp180 -102.49 144.8 30.47 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.737 -0.665 . . . . 3.02 110.048 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.9 mt -117.23 107.5 14.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.106 -0.497 . . . . 1.1599999999999999 110.838 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 53.4 tp -99.01 101.69 13.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.304 -0.407 . . . . 1.1000000000000001 110.499 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.1 162.64 27.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.063 -0.517 . . . . 1.1100000000000001 111.175 -179.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.5 tt -117.27 140.86 38.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.211 -0.45 . . . . 1.1399999999999999 111.207 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 29.4 tpt180 -136.56 130.3 32.19 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.016 -0.538 . . . . 2.7000000000000002 110.766 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -79.19 139.99 37.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.102 -0.499 . . . . 4.4000000000000004 110.941 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 24.9 mt -86.34 137.71 34.53 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.963 -0.562 . . . . 2.0 110.507 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -81.27 58.76 7.08 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.61 2.207 . . . . 2.98 112.111 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 91.2 mt -88.61 145.85 25.45 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.367 -0.833 . . . . 3.6699999999999999 111.013 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -105.45 141.07 37.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.981 -0.554 . . . . 5.9699999999999998 110.781 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.239 -0.886 . . . . 6.0 110.831 179.941 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.197 0 N-CA-C 112.517 -0.233 . . . . 8.1300000000000008 112.517 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.7 t -79.07 -67.33 0.76 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.96 0.41 . . . . 7.25 110.865 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 51.8 m80 -68.11 -23.93 64.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.889 -0.596 . . . . 6.6799999999999997 110.866 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 97.98 -59.86 1.0 Allowed Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.849 -0.691 . . . . 2.8900000000000001 112.372 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -98.29 80.13 2.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.754 0.311 . . . . 2.46 111.008 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.414 ' HA ' ' HG ' ' A' ' 12' ' ' SER . 49.5 m -129.65 21.7 5.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.997 0.427 . . . . 3.0099999999999998 110.815 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -179.53 89.51 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.422 -0.808 . . . . 2.6699999999999999 110.692 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -160.23 102.58 1.42 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.286 -0.415 . . . . 1.74 111.091 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 70.7 m 60.62 21.71 11.56 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.119 -0.491 . . . . 2.6299999999999999 110.867 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.5 10.49 67.75 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.842 -0.694 . . . . 1.8200000000000001 112.75 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.406 ' HB3' HD13 ' A' ' 101' ' ' ILE . 84.1 m-85 -104.85 91.24 3.75 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.944 0.402 . . . . 1.98 111.041 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.414 ' HG ' ' HA ' ' A' ' 6' ' ' SER . 40.1 t -110.72 143.2 41.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.907 -0.588 . . . . 1.26 110.635 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 91.4 mt -84.34 121.65 27.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 1.49 110.945 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -115.6 150.24 36.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.064 -0.516 . . . . 3.0899999999999999 110.921 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 80.9 p -146.43 138.18 24.74 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.385 -0.37 . . . . 1.79 111.274 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.453 HG13 ' HB2' ' A' ' 62' ' ' ARG . 42.0 t -136.99 138.64 45.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.131 -0.486 . . . . 1.26 110.935 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -89.92 112.49 23.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 1.74 111.042 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -115.7 114.05 24.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.011 -0.541 . . . . 1.4099999999999999 110.735 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.605 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 44.2 p90 -95.8 134.42 38.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 2.6600000000000001 111.037 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.529 ' HB2' HD23 ' A' ' 27' ' ' LEU . 14.0 ttp180 -110.94 88.35 2.76 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.416 -0.357 . . . . 3.5899999999999999 111.101 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -157.75 64.19 0.47 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.977 0.418 . . . . 2.5800000000000001 110.998 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -145.64 34.52 1.04 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.303 0.573 . . . . 4.1900000000000004 110.774 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 17.7 t70 59.01 25.34 13.73 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.119 -0.946 . . . . 2.8700000000000001 110.903 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 82.7 p -92.52 -28.24 16.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.338 -0.392 . . . . 1.74 111.213 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 99.0 p 49.62 24.84 1.27 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.811 -0.631 . . . . 2.79 111.505 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 80.9 p -160.0 144.98 15.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.938 0.399 . . . . 1.79 111.075 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.529 HD23 ' HB2' ' A' ' 20' ' ' ARG . 71.7 mt -101.33 -24.41 14.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.056 -0.52 . . . . 1.1299999999999999 110.66 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.09 -9.32 75.23 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.802 -0.713 . . . . 0.52000000000000002 112.648 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.41 HD12 HD12 ' A' ' 89' ' ' LEU . 68.5 mt -58.93 108.56 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.849 0.357 . . . . 1.53 110.877 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 44.4 t -111.79 109.88 19.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.141 -0.481 . . . . 1.4099999999999999 110.79 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 38.3 pt -101.46 172.18 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.028 -0.533 . . . . 1.1799999999999999 111.205 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 57.0 m -146.35 137.92 24.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.476 . . . . 1.79 110.933 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -75.82 161.72 52.53 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.842 -0.694 . . . . 1.04 112.593 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 54.0 ttm -108.88 139.74 43.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.84 0.352 . . . . 2.48 110.925 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.464 ' HD3' ' N ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -164.8 132.5 3.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 6.1500000000000004 110.747 179.76 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -149.67 -68.03 0.21 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.15 -0.477 . . . . 4.29 110.896 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -126.13 145.22 50.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.086 -0.506 . . . . 5.79 111.035 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 52.3 m -65.52 95.62 0.22 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.041 -0.527 . . . . 5.1799999999999997 110.795 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 67.9 p -86.6 146.22 26.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 5.54 111.17 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.8 t -80.97 3.61 22.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.081 -0.509 . . . . 7.3600000000000003 111.144 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -135.05 -121.08 2.09 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.845 -0.693 . . . . 5.7999999999999998 112.311 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -114.98 147.52 39.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.84 0.352 . . . . 7.2199999999999998 110.956 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -168.53 39.03 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.056 -0.52 . . . . 3.6000000000000001 111.228 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 70.6 p -139.67 137.97 35.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 3.02 111.05 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -146.92 158.24 27.67 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.751 -0.738 . . . . 1.3600000000000001 112.598 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 47.4 mm -91.46 128.24 43.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.832 0.349 . . . . 1.28 110.942 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 48.3 p90 -156.97 142.28 17.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.124 -0.489 . . . . 1.0800000000000001 110.969 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 89.0 t -85.78 135.03 25.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 1.0600000000000001 111.006 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -123.65 -20.96 5.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.495 . . . . 2.8900000000000001 111.081 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.7 t -140.31 161.22 38.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.988 0.423 . . . . 1.8700000000000001 111.447 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 96.5 mt -136.6 127.16 26.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.748 -0.66 . . . . 1.1899999999999999 110.569 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 50.8 mm -63.52 112.54 7.35 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.313 -0.403 . . . . 1.8500000000000001 110.899 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.47 102.1 0.39 Allowed 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.398 2.066 . . . . 1.26 112.252 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 129.65 -0.58 5.88 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.794 -0.717 . . . . 0.52000000000000002 112.489 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.9 m -98.2 174.19 6.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.678 0.275 . . . . 1.73 110.903 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -55.75 -58.59 7.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 1.1299999999999999 111.648 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.422 ' HB2' HD11 ' A' ' 63' ' ' ILE . . . -50.72 -32.23 18.91 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.357 -0.383 . . . . 1.0900000000000001 111.479 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.91 -32.79 40.2 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.308 -0.406 . . . . 1.1100000000000001 111.627 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 79.9 mt -63.52 -55.94 19.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.377 -0.374 . . . . 1.29 111.114 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -55.13 -37.06 66.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.246 -0.433 . . . . 1.8600000000000001 111.04 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 62.94 7.17 15.08 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.985 -0.626 . . . . 1.4199999999999999 112.896 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.453 ' HB2' HG13 ' A' ' 16' ' ' VAL . 34.9 mtp180 -82.86 3.28 30.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.738 0.304 . . . . 3.0499999999999998 110.926 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.422 HD11 ' HB2' ' A' ' 57' ' ' ALA . 61.7 mt -110.54 133.51 55.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 1.6299999999999999 110.982 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 20.2 tp10 -108.08 125.39 32.14 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.475 . . . . 1.98 110.787 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -54.66 174.38 0.19 Allowed 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.628 2.219 . . . . 1.4399999999999999 112.168 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.568 ' N ' HD21 ' A' ' 66' ' ' ASN . 0.8 OUTLIER 60.79 25.87 15.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.199 -0.455 . . . . 2.6299999999999999 110.549 -179.66 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -95.7 155.58 16.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.926 -0.579 . . . . 2.02 110.578 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -104.95 109.32 21.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.407 -0.36 . . . . 1.6200000000000001 110.984 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 41.1 mm -68.7 132.52 32.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.113 -0.494 . . . . 1.1100000000000001 110.952 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 76.6 mt -104.12 -63.85 1.16 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.128 -0.487 . . . . 1.1299999999999999 110.814 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -149.59 136.56 19.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.161 0.505 . . . . 3.1499999999999999 111.518 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.457 HG11 ' H ' ' A' ' 73' ' ' ASP . 9.9 t -89.88 171.14 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.593 -0.73 . . . . 1.0900000000000001 109.866 179.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.692 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 14.0 t70 -48.26 108.53 0.17 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.789 0.328 . . . . 0.79000000000000004 111.817 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.5 t70 58.48 6.99 0.64 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.919 -0.582 . . . . 2.0099999999999998 112.328 178.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.1 t -137.85 99.54 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.695 0.283 . . . . 1.1499999999999999 111.435 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -72.57 152.08 42.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.214 -0.448 . . . . 2.8500000000000001 110.769 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.4 m -119.92 26.11 3.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.36 -0.382 . . . . 1.26 111.269 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -91.22 27.58 1.86 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 1.74 111.13 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -175.18 19.91 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.532 -0.842 . . . . 0.57999999999999996 112.905 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 45.7 mtm -120.95 139.46 53.22 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.858 0.361 . . . . 1.1200000000000001 111.0 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.446 ' O ' HG21 ' A' ' 85' ' ' VAL . . . -65.16 156.56 31.32 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.976 -0.556 . . . . 1.1200000000000001 111.108 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -44.75 -44.14 9.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.369 -0.378 . . . . 1.52 111.386 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 48.2 t -58.71 -53.16 61.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.295 -0.411 . . . . 2.0299999999999998 111.404 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -54.52 -39.14 67.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 2.1200000000000001 111.429 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.446 HG21 ' O ' ' A' ' 81' ' ' ALA . 21.1 t -62.29 -41.44 91.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.426 -0.352 . . . . 1.0800000000000001 111.221 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.535 HG11 HH21 ' A' ' 90' ' ' ARG . 85.8 t -63.23 -43.31 98.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.245 -0.434 . . . . 1.0700000000000001 111.148 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -57.74 -46.63 84.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.301 -0.409 . . . . 1.51 111.207 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 71.9 t -56.37 -58.03 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.984 0.421 . . . . 1.0600000000000001 111.345 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.41 HD12 HD12 ' A' ' 29' ' ' ILE . 75.8 mt -60.01 -23.98 64.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.971 -0.558 . . . . 1.1399999999999999 111.297 -179.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.535 HH21 HG11 ' A' ' 86' ' ' VAL . 2.1 tpp180 -89.28 -12.48 40.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.242 -0.436 . . . . 2.5600000000000001 111.432 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -103.92 -9.64 18.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.612 -0.267 . . . . 1.8100000000000001 111.143 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -50.18 -78.72 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.296 -0.411 . . . . 1.1100000000000001 111.458 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.401 ' HA2' ' HE ' ' A' ' 20' ' ' ARG . . . 61.02 19.39 56.68 Favored Glycine 0 C--N 1.331 0.25 0 C-N-CA 120.712 -0.756 . . . . 0.77000000000000002 112.281 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -147.09 169.83 8.75 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 110.433 -0.21 . . . . 3.3300000000000001 110.433 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.605 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 23.0 Cg_exo -65.9 93.23 0.27 Allowed 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.196 1.931 . . . . 0.92000000000000004 111.644 178.386 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 29.8 m -101.96 153.4 5.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.043 0.449 . . . . 1.3200000000000001 111.876 -179.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.692 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 80.0 ttt180 -98.55 144.6 27.69 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.605 -0.725 . . . . 3.02 110.182 179.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 18.2 mt -118.05 103.56 10.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.091 -0.504 . . . . 1.1599999999999999 110.867 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 34.2 tp -97.96 104.59 16.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.879 0.371 . . . . 1.1000000000000001 110.519 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -133.93 158.96 42.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.092 -0.503 . . . . 1.1100000000000001 111.351 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.406 HD13 ' HB3' ' A' ' 11' ' ' PHE . 17.3 tt -105.32 135.33 43.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.102 -0.499 . . . . 1.1399999999999999 110.273 179.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 32.4 tpt180 -128.47 132.96 48.4 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.869 0.366 . . . . 2.7000000000000002 111.379 -179.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 22.6 ttp180 -85.32 142.26 29.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.004 -0.544 . . . . 4.4000000000000004 110.696 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 41.0 mt -85.69 151.92 56.21 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.114 -0.494 . . . . 2.0 110.708 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -78.38 60.89 7.68 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.674 2.249 . . . . 2.98 112.095 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 87.2 mt -59.66 110.7 1.2 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.393 -0.822 . . . . 3.6699999999999999 111.146 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 82.8 mt -102.41 98.09 8.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.471 . . . . 5.9699999999999998 110.786 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.28 -0.867 . . . . 6.0 110.935 -179.86 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.154 0 N-CA-C 112.459 -0.256 . . . . 8.1300000000000008 112.459 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.9 m -104.46 -14.96 15.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.796 0.332 . . . . 7.25 110.903 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -75.14 132.99 41.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 6.6799999999999997 111.044 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 74.01 -124.9 8.68 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.801 -0.714 . . . . 2.8900000000000001 112.674 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -81.37 139.58 35.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.857 0.36 . . . . 2.46 110.966 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.5 t -141.1 90.35 2.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.196 -0.457 . . . . 3.0099999999999998 111.025 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 20.5 t70 55.04 88.07 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.108 -0.497 . . . . 2.6699999999999999 111.028 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -139.49 114.52 9.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.081 -0.509 . . . . 1.74 110.653 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.0 p 53.8 32.11 14.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.048 -0.524 . . . . 2.6299999999999999 110.995 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.428 ' O ' ' HG ' ' A' ' 104' ' ' LEU . . . 92.57 -46.58 2.55 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.797 -0.716 . . . . 1.8200000000000001 112.478 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -62.0 98.16 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.868 0.366 . . . . 1.98 111.074 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 44.6 t -120.51 147.11 45.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.985 -0.552 . . . . 1.26 110.547 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 88.3 mt -85.46 121.75 28.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.281 -0.418 . . . . 1.49 111.126 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -113.79 148.29 36.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.992 -0.549 . . . . 3.0899999999999999 110.893 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.3 m -144.55 136.62 26.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 1.79 111.286 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 33.2 t -135.51 132.55 51.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.027 -0.533 . . . . 1.26 110.599 179.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -93.3 124.65 37.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.292 -0.413 . . . . 1.74 111.398 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -119.63 151.8 38.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.896 -0.593 . . . . 1.4099999999999999 110.725 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.524 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 19.2 m-85 -123.14 106.52 10.84 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.108 -0.496 . . . . 2.6600000000000001 110.462 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.451 ' HE ' ' HA2' ' A' ' 93' ' ' GLY . 5.0 ttp180 -97.56 126.16 42.69 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.56 -0.456 . . . . 3.5899999999999999 110.813 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -141.61 -36.25 0.44 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.117 -0.492 . . . . 2.5800000000000001 110.957 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -68.47 154.25 42.2 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.956 -0.566 . . . . 4.1900000000000004 110.883 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -84.43 56.5 3.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 2.8700000000000001 111.017 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 65.9 p -92.59 -21.16 20.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.306 -0.406 . . . . 1.74 110.994 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.1 t 58.0 18.56 5.2 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.759 -0.655 . . . . 2.79 111.461 179.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.2 t -154.59 141.48 19.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.835 0.35 . . . . 1.79 110.928 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.8 mt -107.95 -15.03 14.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 1.1299999999999999 110.793 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.405 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 108.34 13.69 18.48 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.669 -0.776 . . . . 0.52000000000000002 112.691 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.42 HG21 HG21 ' A' ' 48' ' ' VAL . 76.8 mt -97.56 113.38 31.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.816 0.341 . . . . 1.53 111.058 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.2 t -113.3 103.41 11.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.241 -0.436 . . . . 1.4099999999999999 110.814 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 31.7 pt -101.54 147.48 8.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.247 -0.433 . . . . 1.1799999999999999 111.256 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 71.5 m -114.25 130.73 56.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.479 . . . . 1.79 110.712 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -63.82 132.35 40.44 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.813 -0.708 . . . . 1.04 112.467 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 16.0 tpt -112.06 88.06 2.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.758 0.313 . . . . 2.48 111.081 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.423 ' N ' ' HD2' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -150.48 77.49 1.3 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.077 0.465 . . . . 6.1500000000000004 110.947 179.831 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -59.54 153.54 19.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.09 -0.505 . . . . 4.29 111.064 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -91.71 14.98 13.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.154 -0.476 . . . . 5.79 111.008 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 79.2 p -139.44 27.04 2.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 5.1799999999999997 110.783 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 74.3 p -64.84 138.5 58.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 5.54 111.016 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.8 t -95.9 -5.24 41.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.074 -0.512 . . . . 7.3600000000000003 110.956 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -165.99 -131.52 1.26 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.868 -0.682 . . . . 5.7999999999999998 112.421 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -106.88 127.27 53.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.761 0.315 . . . . 7.2199999999999998 110.839 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -163.71 80.43 0.43 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 3.6000000000000001 111.137 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 50.4 p -139.27 156.07 47.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.36 -0.382 . . . . 3.02 111.406 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.18 153.62 8.04 Favored Glycine 0 C--N 1.329 0.194 0 C-N-CA 120.808 -0.71 . . . . 1.3600000000000001 112.488 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 50.4 mm -90.85 131.23 38.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.719 0.295 . . . . 1.28 110.967 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 25.0 p90 -152.54 135.03 15.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.891 0.377 . . . . 1.0800000000000001 111.214 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.42 HG21 HG21 ' A' ' 29' ' ' ILE . 85.3 t -70.72 112.99 6.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.123 -0.49 . . . . 1.0600000000000001 110.834 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -88.52 -29.39 20.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.866 -0.606 . . . . 2.8900000000000001 111.076 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 78.3 p -156.06 171.27 20.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.006 0.432 . . . . 1.8700000000000001 111.212 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 71.0 mt -128.89 151.7 49.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.911 -0.586 . . . . 1.1899999999999999 110.69 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.405 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 45.5 mm -84.02 113.41 47.71 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 1.8500000000000001 110.921 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -58.5 132.11 46.53 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.576 2.184 . . . . 1.26 112.506 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.56 11.17 78.13 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.9 -0.667 . . . . 0.52000000000000002 112.846 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.2 t -99.71 170.32 8.64 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.656 0.265 . . . . 1.73 111.055 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -56.52 -54.62 43.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.332 -0.395 . . . . 1.1299999999999999 111.489 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -49.18 -44.07 42.65 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.04 -0.527 . . . . 1.0900000000000001 111.533 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.79 -33.58 75.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.48 . . . . 1.1100000000000001 111.477 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 90.9 mt -65.9 -33.42 75.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.378 -0.374 . . . . 1.29 111.187 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -58.8 -46.59 87.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.954 0.407 . . . . 1.8600000000000001 110.764 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.95 -33.46 3.55 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.839 -0.696 . . . . 1.4199999999999999 112.554 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 58.5 mtp180 -67.71 -22.14 65.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.805 0.336 . . . . 3.0499999999999998 110.735 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 70.0 mt -93.84 115.41 32.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.485 . . . . 1.6299999999999999 110.924 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.448 ' HB2' ' HD2' ' A' ' 65' ' ' PRO . 13.5 pt-20 -118.71 158.6 46.99 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.111 -0.495 . . . . 1.98 110.531 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.448 ' HD2' ' HB2' ' A' ' 64' ' ' GLU . 21.2 Cg_endo -59.27 178.05 0.33 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.38 2.053 . . . . 1.4399999999999999 112.216 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 18.2 m120 55.5 34.94 24.09 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.166 -0.47 . . . . 2.6299999999999999 110.809 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.492 ' HB2' ' HD3' ' A' ' 102' ' ' ARG . 5.3 t70 -100.42 153.05 19.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.021 -0.536 . . . . 2.02 110.886 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -110.89 95.67 5.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.861 0.363 . . . . 1.6200000000000001 110.758 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.414 HD13 ' HB3' ' A' ' 100' ' ' LEU . 44.8 mm -60.42 132.58 25.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.059 -0.519 . . . . 1.1100000000000001 110.971 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 73.1 mt -100.99 -65.44 0.97 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.036 -0.529 . . . . 1.1299999999999999 110.866 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -150.54 135.18 17.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.16 0.505 . . . . 3.1499999999999999 111.827 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.472 HG12 ' N ' ' A' ' 73' ' ' ASP . 15.7 t -87.96 170.31 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.46 -0.791 . . . . 1.0900000000000001 109.822 179.025 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.649 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 11.8 t70 -46.51 117.95 1.8 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.723 0.297 . . . . 0.79000000000000004 111.593 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.5 p30 47.32 19.4 0.12 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.755 -0.657 . . . . 2.0099999999999998 112.696 179.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.5 t -147.87 100.1 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.655 0.264 . . . . 1.1499999999999999 110.969 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -76.35 144.04 40.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.36 -0.382 . . . . 2.8500000000000001 110.814 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.6 m -117.04 30.41 2.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.36 -0.382 . . . . 1.26 111.242 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -89.94 41.74 1.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 1.74 111.174 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 157.5 25.77 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.503 -0.856 . . . . 0.57999999999999996 112.982 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 37.1 mtm -117.73 138.73 51.83 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.856 0.36 . . . . 1.1200000000000001 110.742 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.401 ' O ' HG22 ' A' ' 85' ' ' VAL . . . -59.66 160.95 6.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.019 -0.537 . . . . 1.1200000000000001 111.234 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.403 ' O ' HG22 ' A' ' 86' ' ' VAL . 36.2 tt0 -54.12 -57.61 10.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.35 -0.386 . . . . 1.52 111.087 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 79.7 p -49.93 -32.9 15.9 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.209 -0.451 . . . . 2.0299999999999998 111.271 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.404 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 12.4 t70 -69.04 -46.75 67.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.379 -0.373 . . . . 2.1200000000000001 110.969 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.401 HG22 ' O ' ' A' ' 81' ' ' ALA . 15.2 t -64.6 -29.16 46.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.99 0.424 . . . . 1.0800000000000001 110.953 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.403 HG22 ' O ' ' A' ' 82' ' ' GLN . 95.9 t -66.18 -58.58 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.964 -0.562 . . . . 1.0700000000000001 111.287 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 84' ' ' ASP . 13.6 pt-20 -54.16 -36.59 63.51 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.495 -0.32 . . . . 1.51 110.975 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 51.7 t -57.11 -56.1 16.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.889 0.376 . . . . 1.0600000000000001 111.041 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 65.4 mt -57.72 -27.25 62.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.001 -0.545 . . . . 1.1399999999999999 111.192 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -86.83 -17.63 32.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.335 -0.393 . . . . 2.5600000000000001 111.302 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -91.47 -13.24 32.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.459 -0.337 . . . . 1.8100000000000001 110.923 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -50.48 -84.18 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.099 -0.5 . . . . 1.1100000000000001 111.529 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.451 ' HA2' ' HE ' ' A' ' 20' ' ' ARG . . . 62.79 17.77 58.47 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.8 -0.714 . . . . 0.77000000000000002 112.532 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.407 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -146.94 172.82 4.76 Favored Pre-proline 0 C--N 1.328 -0.354 0 C-N-CA 121.974 0.11 . . . . 3.3300000000000001 110.922 -179.734 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.524 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 32.0 Cg_exo -61.43 92.22 0.11 Allowed 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 122.233 1.955 . . . . 0.92000000000000004 111.497 178.086 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.0 m -97.0 144.97 9.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.93 0.395 . . . . 1.3200000000000001 111.855 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.649 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 75.2 ttt180 -101.64 143.2 31.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.766 -0.652 . . . . 3.02 109.711 179.121 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 36.6 mt -113.35 107.16 15.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.189 -0.46 . . . . 1.1599999999999999 111.334 -179.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 33.6 tp -100.07 99.84 10.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.411 -0.358 . . . . 1.1000000000000001 110.294 179.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.414 ' HB3' HD13 ' A' ' 69' ' ' ILE . 0.4 OUTLIER -127.99 164.42 22.38 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.224 -0.444 . . . . 1.1100000000000001 111.379 -179.507 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.3 tt -118.02 139.25 45.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 116.087 -0.506 . . . . 1.1399999999999999 111.133 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.492 ' HD3' ' HB2' ' A' ' 67' ' ' ASP . 15.5 mmm180 -130.91 135.05 47.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.738 -0.664 . . . . 2.7000000000000002 110.867 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 34.8 ptt180 -97.12 136.29 37.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.123 -0.49 . . . . 4.4000000000000004 110.806 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' A' ' 10' ' ' GLY . 28.3 mt -87.14 148.47 45.1 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.049 -0.523 . . . . 2.0 110.697 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -80.37 59.41 7.43 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.639 2.226 . . . . 2.98 112.171 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 92.0 mt -90.17 97.49 11.22 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.436 -0.802 . . . . 3.6699999999999999 111.007 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -100.67 175.78 5.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.142 -0.481 . . . . 5.9699999999999998 110.819 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.297 -0.859 . . . . 6.0 110.93 -179.948 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.557 -0.217 . . . . 8.1300000000000008 112.557 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 61.3 p -78.01 -177.93 5.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.702 0.287 . . . . 7.25 110.962 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 54.6 m-70 57.5 45.57 19.36 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.144 -0.48 . . . . 6.6799999999999997 110.979 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -142.25 64.57 0.5 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.764 -0.731 . . . . 2.8900000000000001 112.497 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -119.79 62.53 0.82 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.914 0.388 . . . . 2.46 110.782 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 51.4 m -88.11 100.42 12.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.975 -0.557 . . . . 3.0099999999999998 111.02 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 54.29 74.19 0.35 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.078 -0.51 . . . . 2.6699999999999999 110.809 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -106.1 -34.35 7.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.139 -0.482 . . . . 1.74 111.316 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 93.0 p -178.11 32.01 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.111 -0.495 . . . . 2.6299999999999999 110.563 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.68 19.19 5.79 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 121.004 -0.617 . . . . 1.8200000000000001 112.479 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -134.33 131.9 38.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.683 0.278 . . . . 1.98 110.709 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.6 t -151.9 138.63 18.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.439 . . . . 1.26 111.103 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.3 mt -77.33 119.44 20.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.816 -0.629 . . . . 1.49 110.883 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -119.09 163.68 16.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.127 -0.488 . . . . 3.0899999999999999 110.859 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 84.4 p -151.63 146.88 26.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.878 0.371 . . . . 1.79 111.04 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 13.5 t -131.61 136.01 58.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.091 -0.504 . . . . 1.26 110.799 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -89.63 113.19 24.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.289 -0.414 . . . . 1.74 111.364 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -118.0 166.04 13.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.904 -0.589 . . . . 1.4099999999999999 110.64 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.516 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 30.9 p90 -158.92 128.59 5.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.276 -0.42 . . . . 2.6600000000000001 111.104 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.673 HH21 ' HG ' ' A' ' 27' ' ' LEU . 21.0 ttm180 -101.47 82.72 2.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.905 0.383 . . . . 3.5899999999999999 110.835 179.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -97.99 -18.05 18.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.05 -0.523 . . . . 2.5800000000000001 110.747 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -95.11 144.95 25.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.034 -0.53 . . . . 4.1900000000000004 110.644 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -81.06 70.93 8.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.306 -0.406 . . . . 2.8700000000000001 110.749 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 72.2 p -108.21 -9.85 15.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 1.74 111.138 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 83.3 p 51.99 22.51 1.85 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.788 -0.642 . . . . 2.79 111.211 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 56.3 m -157.09 131.78 8.73 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.306 -0.406 . . . . 1.79 110.962 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.673 ' HG ' HH21 ' A' ' 20' ' ' ARG . 49.7 mt -92.69 -25.24 18.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 1.1299999999999999 110.619 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.528 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 99.6 31.76 5.96 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.819 -0.705 . . . . 0.52000000000000002 112.759 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.413 HG23 HG21 ' A' ' 31' ' ' ILE . 45.4 mt -109.32 108.69 25.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.661 0.267 . . . . 1.53 110.926 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 46.5 m -104.14 90.22 3.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.345 -0.388 . . . . 1.4099999999999999 110.884 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.415 HG13 ' NE2' ' A' ' 82' ' ' GLN . 28.7 pt -88.3 165.98 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.0 -0.545 . . . . 1.1799999999999999 111.295 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 53.2 m -142.85 136.42 28.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.121 -0.49 . . . . 1.79 110.909 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.96 160.29 42.38 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.87 -0.681 . . . . 1.04 112.769 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 28.1 ttt -114.56 113.74 24.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.766 0.317 . . . . 2.48 110.896 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.418 ' N ' ' HD2' ' A' ' 35' ' ' ARG . 4.2 mpt_? -111.65 98.81 7.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 6.1500000000000004 110.695 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -147.46 152.23 37.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.336 -0.393 . . . . 4.29 111.023 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -99.61 127.2 45.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 5.79 111.051 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 61.7 m -144.3 128.72 17.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 5.1799999999999997 110.592 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 69.6 p -94.16 171.81 8.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 5.54 111.523 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 15.3 t 42.25 33.08 0.37 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.627 -0.715 . . . . 7.3600000000000003 111.58 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 159.7 168.05 21.16 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.849 -0.691 . . . . 5.7999999999999998 112.437 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -94.92 177.11 6.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.665 0.269 . . . . 7.2199999999999998 110.7 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -161.82 40.51 0.13 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.274 -0.421 . . . . 3.6000000000000001 111.123 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.9 p -103.67 142.88 33.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 3.02 111.021 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -170.23 150.26 14.27 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.828 -0.701 . . . . 1.3600000000000001 112.479 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 45.4 mm -101.76 131.82 48.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.765 0.317 . . . . 1.28 110.965 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 51.6 p90 -144.18 152.95 41.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.247 -0.433 . . . . 1.0800000000000001 111.165 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 81.3 t -86.77 123.58 39.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.077 -0.51 . . . . 1.0600000000000001 110.898 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -99.49 -26.91 13.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.072 -0.513 . . . . 2.8900000000000001 110.941 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 64.0 m -151.85 170.64 19.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.308 -0.405 . . . . 1.8700000000000001 111.122 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.5 mt -133.91 146.85 50.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.04 -0.527 . . . . 1.1899999999999999 110.77 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.528 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 44.0 mm -90.06 108.64 27.43 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.239 -0.437 . . . . 1.8500000000000001 110.892 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -60.94 138.09 76.54 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.351 2.034 . . . . 1.26 112.287 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 98.39 -11.12 63.4 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.75 -0.738 . . . . 0.52000000000000002 112.499 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.1 m -89.44 -176.25 4.98 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.699 0.285 . . . . 1.73 110.963 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.73 -58.98 3.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 1.1299999999999999 111.45 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.13 -32.13 45.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.13 -0.486 . . . . 1.0900000000000001 111.649 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.81 -49.59 17.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.44 -0.345 . . . . 1.1100000000000001 111.447 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.8 mt -63.24 -19.97 65.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.417 -0.356 . . . . 1.29 111.084 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -58.86 -55.27 37.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.357 -0.383 . . . . 1.8600000000000001 110.852 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.3 -44.46 1.61 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.74 -0.743 . . . . 1.4199999999999999 112.832 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 20.3 mtp180 -61.42 -29.28 69.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.635 0.255 . . . . 3.0499999999999998 111.2 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 55.6 mt -85.49 109.18 18.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.914 0.388 . . . . 1.6299999999999999 111.128 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.566 ' HB3' HH12 ' A' ' 102' ' ' ARG . 36.7 tt0 -111.23 139.28 21.74 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.947 -0.57 . . . . 1.98 110.296 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -47.27 165.64 0.1 Allowed 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.504 2.136 . . . . 1.4399999999999999 112.643 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 64.04 54.17 1.73 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.002 -0.545 . . . . 2.6299999999999999 110.831 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -128.42 160.99 30.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.846 -0.616 . . . . 2.02 110.269 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.464 ' HB3' HG23 ' A' ' 101' ' ' ILE . 88.0 tttt -110.35 122.56 47.99 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.828 0.347 . . . . 1.6200000000000001 111.244 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.405 HD13 ' HB3' ' A' ' 100' ' ' LEU . 36.3 mm -90.17 145.85 6.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.173 -0.467 . . . . 1.1100000000000001 110.699 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 87.2 mt -115.74 -65.8 1.15 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.257 -0.429 . . . . 1.1299999999999999 111.274 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.447 ' HG2' HD21 ' A' ' 99' ' ' LEU . 15.8 ptm180 -149.88 137.15 19.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.252 0.549 . . . . 3.1499999999999999 112.037 -179.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.542 HG11 ' H ' ' A' ' 73' ' ' ASP . 11.5 t -84.82 175.22 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.505 -0.771 . . . . 1.0900000000000001 109.409 178.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.644 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 8.8 t70 -47.69 108.07 0.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.954 0.407 . . . . 0.79000000000000004 111.684 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 52.3 19.03 1.01 Allowed 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.599 0.592 . . . . 2.0099999999999998 112.599 179.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.9 t -146.38 102.14 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.63 0.252 . . . . 1.1499999999999999 111.335 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -62.85 152.76 35.24 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.538 -0.301 . . . . 2.8500000000000001 110.663 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.1 m -143.07 49.98 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 120.791 0.329 . . . . 1.26 111.862 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -143.3 21.33 1.89 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.069 0.461 . . . . 1.74 110.561 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -142.97 -4.21 0.85 Allowed Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.731 -0.668 . . . . 0.57999999999999996 112.259 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 71.1 mtm -108.16 173.89 6.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.822 0.344 . . . . 1.1200000000000001 110.719 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.17 166.28 18.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.212 -0.449 . . . . 1.1200000000000001 111.104 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.415 ' NE2' HG13 ' A' ' 31' ' ' ILE . 7.8 tp60 -58.94 -58.39 8.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 1.52 110.948 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 45.0 t -51.75 -39.82 59.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.026 -0.534 . . . . 2.0299999999999998 111.295 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -57.28 -44.92 84.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.345 -0.389 . . . . 2.1200000000000001 110.835 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 55.6 t -61.24 -38.4 79.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.223 -0.444 . . . . 1.0800000000000001 110.926 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 17.9 t -63.93 -39.62 86.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 1.0700000000000001 110.995 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -58.62 -51.83 68.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.285 -0.416 . . . . 1.51 110.75 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 63.6 t -52.83 -53.58 20.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 1.0600000000000001 111.431 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 80.0 mt -58.44 -30.92 67.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.049 -0.523 . . . . 1.1399999999999999 111.366 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 73.2 mtm180 -85.81 -13.6 47.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.42 -0.354 . . . . 2.5600000000000001 111.175 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -93.86 -13.76 26.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.405 -0.361 . . . . 1.8100000000000001 110.917 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.15 -83.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.213 -0.449 . . . . 1.1100000000000001 111.432 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.498 ' H ' ' HD2' ' A' ' 20' ' ' ARG . . . 63.76 13.2 50.89 Favored Glycine 0 CA--C 1.517 0.216 0 C-N-CA 120.664 -0.779 . . . . 0.77000000000000002 112.419 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.414 HD21 ' C ' ' A' ' 94' ' ' ASN . 0.2 OUTLIER -146.78 170.4 7.87 Favored Pre-proline 0 C--N 1.329 -0.318 0 O-C-N 122.999 -0.118 . . . . 3.3300000000000001 110.82 -179.725 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.516 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 31.8 Cg_exo -60.55 106.27 0.35 Allowed 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.241 1.961 . . . . 0.92000000000000004 111.669 178.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 34.7 m -114.33 154.37 15.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.95 0.405 . . . . 1.3200000000000001 111.699 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.644 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 73.7 ttt180 -101.9 142.2 33.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.833 -0.621 . . . . 3.02 109.932 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 21.8 mt -116.81 109.1 16.67 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.431 -0.35 . . . . 1.1599999999999999 111.271 -179.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.447 HD21 ' HG2' ' A' ' 71' ' ' ARG . 52.4 tp -96.19 103.32 15.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.3 -0.409 . . . . 1.1000000000000001 110.396 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.405 ' HB3' HD13 ' A' ' 69' ' ' ILE . 0.4 OUTLIER -129.8 154.11 47.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.454 . . . . 1.1100000000000001 111.403 -179.557 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.464 HG23 ' HB3' ' A' ' 68' ' ' LYS . 13.9 tt -105.89 136.71 39.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-N 116.157 -0.474 . . . . 1.1399999999999999 110.773 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.566 HH12 ' HB3' ' A' ' 64' ' ' GLU . 29.1 mmm-85 -116.92 146.05 43.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.741 -0.663 . . . . 2.7000000000000002 110.429 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -93.33 112.83 24.86 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.915 0.388 . . . . 4.4000000000000004 111.088 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 82.6 mt -83.89 141.63 41.16 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.938 -0.574 . . . . 2.0 110.767 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -83.44 160.35 14.84 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.502 2.135 . . . . 2.98 112.027 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 96.4 mt -137.91 115.86 11.58 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.19 -0.459 . . . . 3.6699999999999999 110.712 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -63.7 120.63 12.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.485 . . . . 5.9699999999999998 110.974 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.276 -0.869 . . . . 6.0 110.883 179.939 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.161 0 N-CA-C 112.456 -0.258 . . . . 8.1300000000000008 112.456 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.2 m 60.08 -178.99 0.09 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.832 0.348 . . . . 7.25 111.132 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -134.72 79.16 1.78 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 6.6799999999999997 110.926 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 99.41 174.04 31.18 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.83 -0.7 . . . . 2.8900000000000001 112.443 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -68.02 91.35 0.34 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.86 0.362 . . . . 2.46 111.015 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 79.6 p -95.31 109.64 21.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.026 -0.534 . . . . 3.0099999999999998 110.965 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 57.79 49.12 12.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.055 -0.52 . . . . 2.6699999999999999 110.999 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -108.64 111.29 23.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.027 -0.533 . . . . 1.74 111.098 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.0 m 57.42 27.9 14.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.051 -0.522 . . . . 2.6299999999999999 110.957 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.67 -37.68 3.47 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.85 -0.69 . . . . 1.8200000000000001 112.498 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.421 ' HB3' HD11 ' A' ' 101' ' ' ILE . 90.7 m-85 -62.6 107.37 0.93 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.87 0.367 . . . . 1.98 111.031 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.0 t -120.0 134.04 55.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.935 -0.575 . . . . 1.26 110.628 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 91.4 mt -76.71 121.51 23.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.244 -0.434 . . . . 1.49 110.824 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -113.38 155.18 25.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.978 -0.555 . . . . 3.0899999999999999 110.862 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 48.3 t -151.35 132.69 14.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.271 -0.422 . . . . 1.79 111.154 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.4 t -131.56 128.77 61.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.11 -0.495 . . . . 1.26 110.676 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -92.7 119.15 31.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 1.74 111.525 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.416 HD11 HD11 ' A' ' 98' ' ' LEU . 19.6 mt -119.16 113.09 20.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.093 -0.503 . . . . 1.4099999999999999 110.542 179.311 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.621 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 33.1 m-85 -79.58 114.21 18.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.092 -0.504 . . . . 2.6600000000000001 111.022 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.518 ' HG2' ' HA2' ' A' ' 93' ' ' GLY . 20.3 ttt180 -100.16 104.9 16.46 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.836 0.35 . . . . 3.5899999999999999 110.565 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -147.63 11.25 0.98 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.277 -0.42 . . . . 2.5800000000000001 111.019 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -94.7 156.44 16.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 4.1900000000000004 110.67 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -83.06 53.33 2.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.348 -0.387 . . . . 2.8700000000000001 110.69 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.2 p -120.31 -29.27 4.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 1.74 110.95 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.432 ' HA ' ' NH2' ' A' ' 20' ' ' ARG . 41.2 t 59.61 14.88 4.24 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.691 -0.686 . . . . 2.79 111.153 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 47.6 t -125.05 132.81 53.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 1.79 110.699 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.2 mt -102.27 -11.8 18.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 1.1299999999999999 110.697 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.478 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 87.02 6.67 78.83 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.812 -0.709 . . . . 0.52000000000000002 112.584 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.401 HG23 HG21 ' A' ' 48' ' ' VAL . 67.7 mt -85.1 109.0 17.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.713 0.292 . . . . 1.53 111.026 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.5 m -113.84 99.81 7.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.37 -0.377 . . . . 1.4099999999999999 110.822 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 36.7 pt -92.49 152.46 3.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.196 -0.456 . . . . 1.1799999999999999 111.343 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.9 p -108.07 133.25 52.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.033 -0.531 . . . . 1.79 110.994 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.85 108.87 2.2 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.904 -0.665 . . . . 1.04 112.529 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 27.9 ttt -81.87 102.55 10.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.762 0.315 . . . . 2.48 110.977 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.27 160.55 15.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 6.1500000000000004 110.913 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -100.64 142.64 31.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.064 -0.516 . . . . 4.29 110.695 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -95.54 48.29 1.14 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.278 -0.419 . . . . 5.79 111.13 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 52.4 m 54.21 77.73 0.18 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.471 . . . . 5.1799999999999997 110.993 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 50.9 p -134.09 137.52 44.65 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.249 -0.432 . . . . 5.54 111.084 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.9 t -88.26 11.4 16.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 7.3600000000000003 110.847 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -118.21 4.31 15.91 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.829 -0.7 . . . . 5.7999999999999998 112.388 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 57.3 88.53 0.05 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.863 0.363 . . . . 7.2199999999999998 111.031 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -101.68 38.57 1.59 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.121 -0.49 . . . . 3.6000000000000001 110.834 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 67.0 p -85.3 153.95 22.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.003 -0.544 . . . . 3.02 111.105 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.17 148.6 18.14 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.706 -0.759 . . . . 1.3600000000000001 112.599 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 50.5 mm -108.71 131.1 60.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.758 0.313 . . . . 1.28 110.913 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -153.67 137.23 15.96 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.362 -0.381 . . . . 1.0800000000000001 111.203 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.401 HG21 HG23 ' A' ' 29' ' ' ILE . 91.1 t -63.41 119.11 6.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.15 -0.477 . . . . 1.0600000000000001 110.888 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -98.1 -26.04 14.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.81 -0.632 . . . . 2.8900000000000001 110.952 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 79.8 p -153.56 162.32 41.37 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.926 0.393 . . . . 1.8700000000000001 111.31 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.2 mt -123.84 156.03 36.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.96 -0.564 . . . . 1.1899999999999999 110.774 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.478 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 49.4 mm -99.28 114.02 65.23 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.312 -0.403 . . . . 1.8500000000000001 110.871 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -62.15 119.73 6.97 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.446 2.097 . . . . 1.26 112.196 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.34 7.76 29.93 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.893 -0.67 . . . . 0.52000000000000002 112.514 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.4 m -105.75 -174.48 2.54 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.626 0.251 . . . . 1.73 110.941 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.65 -47.38 66.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.888 0.375 . . . . 1.1299999999999999 111.14 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.523 ' HB1' HG22 ' A' ' 63' ' ' ILE . . . -57.31 -41.15 79.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.939 -0.573 . . . . 1.0900000000000001 111.533 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.49 -53.53 15.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 1.1100000000000001 111.593 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 98.5 mt -60.55 -19.78 58.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.366 -0.379 . . . . 1.29 111.295 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -62.34 -55.41 28.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.811 0.338 . . . . 1.8600000000000001 110.795 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 105.59 -49.75 0.87 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.826 -0.702 . . . . 1.4199999999999999 112.752 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -68.26 -23.41 64.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.739 0.304 . . . . 3.0499999999999998 111.126 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.523 HG22 ' HB1' ' A' ' 57' ' ' ALA . 39.5 mm -76.12 123.62 32.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.826 0.346 . . . . 1.6299999999999999 110.937 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -111.9 155.05 43.85 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.138 -0.483 . . . . 1.98 111.028 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -78.81 36.95 0.63 Allowed 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.943 2.429 . . . . 1.4399999999999999 112.259 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -169.29 75.93 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.296 -0.411 . . . . 2.6299999999999999 110.872 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -143.28 150.01 38.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 2.02 110.877 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.439 ' HB3' HG21 ' A' ' 101' ' ' ILE . 87.7 tttt -90.62 114.68 27.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.828 0.346 . . . . 1.6200000000000001 111.129 -179.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.497 HD13 ' HB3' ' A' ' 100' ' ' LEU . 41.0 mm -84.16 137.54 20.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.215 -0.448 . . . . 1.1100000000000001 110.729 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 65.8 mt -117.08 -65.04 1.23 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.434 . . . . 1.1299999999999999 111.17 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -131.07 163.7 27.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.097 -0.501 . . . . 3.1499999999999999 111.703 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.5 HG12 ' N ' ' A' ' 73' ' ' ASP . 44.8 t -127.97 167.64 22.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.566 -0.743 . . . . 1.0900000000000001 109.562 179.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.636 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 7.7 t70 -41.6 108.11 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.5 0.555 . . . . 0.79000000000000004 112.5 -179.384 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 56.66 2.76 0.1 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.468 0.914 . . . . 2.0099999999999998 113.468 178.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.444 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 84.7 t -143.57 112.79 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.679 0.276 . . . . 1.1499999999999999 111.534 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -68.75 163.26 24.43 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.005 -0.368 . . . . 2.8500000000000001 110.005 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.7 m -134.38 0.08 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.718 0.294 . . . . 1.26 111.651 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -91.5 109.32 20.61 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 120.883 0.373 . . . . 1.74 110.385 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 125.57 -12.94 7.38 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.843 -0.694 . . . . 0.57999999999999996 112.516 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 74.4 mtm -105.44 158.66 16.5 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.839 0.352 . . . . 1.1200000000000001 110.996 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.39 162.19 15.53 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.198 -0.455 . . . . 1.1200000000000001 111.328 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -56.77 -46.38 81.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.329 -0.396 . . . . 1.52 111.136 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 85.4 p -53.42 -41.24 65.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.234 -0.439 . . . . 2.0299999999999998 111.162 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -66.02 -44.04 85.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.296 -0.411 . . . . 2.1200000000000001 111.13 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 57.7 t -58.34 -39.8 75.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.154 -0.476 . . . . 1.0800000000000001 111.372 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 64.7 t -68.04 -43.52 85.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.496 -0.32 . . . . 1.0700000000000001 111.145 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -57.35 -43.67 83.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.355 -0.384 . . . . 1.51 110.944 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 57.3 t -61.16 -55.47 24.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.46 . . . . 1.0600000000000001 111.181 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 90.8 mt -52.62 -27.56 17.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.974 -0.557 . . . . 1.1399999999999999 111.301 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 74.4 mtm180 -89.17 -28.25 20.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.286 -0.415 . . . . 2.5600000000000001 111.271 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -74.07 -14.99 61.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.399 -0.364 . . . . 1.8100000000000001 110.693 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.475 ' HB3' ' HD3' ' A' ' 20' ' ' ARG . . . -54.33 -81.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.994 -0.548 . . . . 1.1100000000000001 111.364 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.518 ' HA2' ' HG2' ' A' ' 20' ' ' ARG . . . 61.1 17.42 51.93 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.655 -0.783 . . . . 0.77000000000000002 112.139 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.431 HD21 ' C ' ' A' ' 94' ' ' ASN . 0.2 OUTLIER -147.13 170.88 7.05 Favored Pre-proline 0 CA--C 1.534 0.329 0 C-N-CA 122.06 0.144 . . . . 3.3300000000000001 110.877 -179.824 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.621 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 47.4 Cg_exo -58.25 104.2 0.17 Allowed 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.081 1.854 . . . . 0.92000000000000004 111.555 178.299 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 23.6 m -112.68 155.1 14.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.041 0.448 . . . . 1.3200000000000001 112.011 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.636 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 35.3 ttp180 -111.46 145.25 39.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.695 -0.684 . . . . 3.02 109.949 179.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.416 HD11 HD11 ' A' ' 18' ' ' LEU . 25.9 mt -110.02 124.1 50.86 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.356 -0.383 . . . . 1.1599999999999999 111.255 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 32.7 tp -109.88 101.08 9.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.332 -0.395 . . . . 1.1000000000000001 110.245 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.497 ' HB3' HD13 ' A' ' 69' ' ' ILE . 0.4 OUTLIER -130.55 160.67 33.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 1.1100000000000001 111.396 -179.467 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.439 HG21 ' HB3' ' A' ' 68' ' ' LYS . 12.6 tt -116.08 141.92 31.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.873 -0.603 . . . . 1.1399999999999999 110.896 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 32.3 tpt180 -141.49 132.29 25.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.043 -0.526 . . . . 2.7000000000000002 110.979 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 22.5 ttm180 -74.09 143.85 45.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.116 -0.493 . . . . 4.4000000000000004 110.623 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 59.9 mt -87.2 140.91 32.52 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.299 -0.41 . . . . 2.0 110.897 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -81.96 62.09 8.03 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.805 2.337 . . . . 2.98 112.363 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 91.5 mt -61.19 112.35 2.09 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.602 -0.726 . . . . 3.6699999999999999 110.887 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 80.4 mt -69.8 130.01 41.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 5.9699999999999998 111.085 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 . . . . . 0 C--O 1.251 1.155 0 CA-C-O 118.344 -0.836 . . . . 6.0 111.054 179.919 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.128 0 N-CA-C 112.5 -0.24 . . . . 8.1300000000000008 112.5 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.1 p -119.72 155.05 33.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.871 0.367 . . . . 7.25 111.266 179.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -145.75 -4.42 0.66 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.951 -0.568 . . . . 6.6799999999999997 110.871 179.548 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 132.78 -62.26 0.64 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.822 -0.704 . . . . 2.8900000000000001 112.352 -179.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -106.16 125.85 51.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.771 0.32 . . . . 2.46 110.729 179.762 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 45.0 t -128.33 95.16 4.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 3.0099999999999998 111.076 -179.688 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.7 t70 56.54 79.88 0.17 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.053 -0.521 . . . . 2.6699999999999999 111.144 179.872 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -133.88 113.45 12.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.043 -0.526 . . . . 1.74 110.751 179.825 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.6 t 57.52 20.09 5.84 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.16 -0.473 . . . . 2.6299999999999999 110.864 -179.948 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.7 37.58 11.66 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.847 -0.692 . . . . 1.8200000000000001 112.634 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -135.83 137.33 41.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.878 0.37 . . . . 1.98 110.917 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 44.2 t -156.86 139.65 15.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.072 -0.513 . . . . 1.26 110.869 -179.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 62.6 mt -77.55 126.37 30.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.06 -0.518 . . . . 1.49 110.824 179.826 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.473 ' HH ' HD21 ' A' ' 104' ' ' LEU . 58.5 m-85 -123.65 130.42 52.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.12 -0.491 . . . . 3.0899999999999999 111.023 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 80.8 p -120.42 139.26 53.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.285 -0.416 . . . . 1.79 111.091 -179.815 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.3 t -131.58 146.4 33.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.116 -0.493 . . . . 1.26 110.743 179.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -103.0 114.04 28.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.381 -0.372 . . . . 1.74 111.386 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.41 HD12 ' HB3' ' A' ' 56' ' ' ALA . 4.6 mm? -115.5 166.1 12.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.079 -0.509 . . . . 1.4099999999999999 110.702 179.537 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.526 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 37.9 p90 -159.51 131.69 6.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.277 -0.42 . . . . 2.6600000000000001 111.053 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.671 HH21 ' HG ' ' A' ' 27' ' ' LEU . 27.8 ttm180 -109.85 130.86 55.47 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.68 -0.408 . . . . 3.5899999999999999 110.879 179.635 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -134.67 6.68 3.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.01 -0.541 . . . . 2.5800000000000001 110.73 179.777 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -112.47 162.7 15.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.007 -0.542 . . . . 4.1900000000000004 110.788 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -86.7 42.98 1.05 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.262 -0.426 . . . . 2.8700000000000001 110.958 -179.911 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 69.3 p -86.98 -13.01 45.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 1.74 111.339 -179.924 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 94.8 p 50.56 24.56 1.67 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.778 -0.646 . . . . 2.79 111.504 179.89 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 80.5 p -158.7 153.32 24.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.297 -0.41 . . . . 1.79 110.904 -179.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.671 ' HG ' HH21 ' A' ' 20' ' ' ARG . 84.0 mt -107.76 -13.17 15.07 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.012 -0.54 . . . . 1.1299999999999999 110.998 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.514 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 100.69 18.94 19.25 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.828 -0.701 . . . . 0.52000000000000002 112.741 179.748 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 78.2 mt -97.52 112.46 29.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.702 0.287 . . . . 1.53 110.694 179.751 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.9 t -110.12 101.93 10.68 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.337 -0.392 . . . . 1.4099999999999999 111.019 -179.713 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.411 ' HA ' ' HA ' ' A' ' 48' ' ' VAL . 33.2 pt -92.33 163.41 2.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.967 -0.56 . . . . 1.1799999999999999 110.914 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 47.9 t -147.33 156.69 43.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.179 -0.464 . . . . 1.79 110.782 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -114.79 103.62 1.28 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.722 -0.752 . . . . 1.04 112.558 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 48.6 ttm -64.55 138.7 58.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.841 0.353 . . . . 2.48 110.788 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 24.8 mmm180 -127.58 43.92 3.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.208 -0.451 . . . . 6.1500000000000004 110.953 -179.872 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -114.1 140.62 48.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.103 -0.499 . . . . 4.29 110.974 -180.0 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -97.75 110.61 23.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 5.79 110.946 179.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.3 t -113.29 132.77 55.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.469 . . . . 5.1799999999999997 110.901 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 67.7 p -68.73 133.98 49.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.084 -0.507 . . . . 5.54 111.055 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 14.6 t 41.96 33.52 0.37 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.791 -0.641 . . . . 7.3600000000000003 111.424 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -125.0 170.22 16.95 Favored Glycine 0 N--CA 1.451 -0.301 0 CA-C-N 115.632 -0.713 . . . . 5.7999999999999998 112.518 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -90.24 153.14 20.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.805 0.336 . . . . 7.2199999999999998 110.94 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -163.93 -168.92 1.72 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 116.154 -0.475 . . . . 3.6000000000000001 110.357 179.872 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 58.9 p 48.31 -163.0 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.768 -0.651 . . . . 3.02 111.491 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.09 155.66 9.34 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.785 -0.722 . . . . 1.3600000000000001 112.551 179.836 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 42.8 mm -83.92 114.09 23.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.784 0.326 . . . . 1.28 110.806 179.87 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -132.52 141.17 48.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 1.0800000000000001 111.074 -179.888 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 31' ' ' ILE . 97.8 t -80.19 111.86 17.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.147 -0.479 . . . . 1.0600000000000001 110.51 179.444 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -84.39 -34.67 23.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.092 -0.503 . . . . 2.8900000000000001 111.284 -179.607 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 83.0 p -151.06 179.07 8.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.064 0.459 . . . . 1.8700000000000001 111.527 -179.718 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 66.6 mt -134.06 160.84 36.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.725 -0.67 . . . . 1.1899999999999999 110.558 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.514 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 53.2 mt -96.54 108.55 43.1 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.257 -0.429 . . . . 1.8500000000000001 111.12 179.954 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -59.34 127.54 24.29 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.348 2.032 . . . . 1.26 112.324 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 104.69 -2.68 42.1 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.763 -0.732 . . . . 0.52000000000000002 112.549 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.45 ' HG ' ' HB ' ' A' ' 52' ' ' ILE . 49.6 m -95.68 -179.03 4.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.659 0.266 . . . . 1.73 110.99 -179.998 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.41 ' HB3' HD12 ' A' ' 18' ' ' LEU . . . -65.69 -55.44 17.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.36 -0.382 . . . . 1.1299999999999999 111.189 179.937 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.72 -33.05 63.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.061 -0.518 . . . . 1.0900000000000001 111.413 -179.852 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.38 -50.47 31.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.259 -0.428 . . . . 1.1100000000000001 111.442 -179.739 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.2 mt -61.4 -21.27 63.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.312 -0.404 . . . . 1.29 111.123 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -60.66 -54.72 41.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.405 -0.361 . . . . 1.8600000000000001 110.977 -179.782 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.34 -46.85 1.79 Allowed Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.742 -0.742 . . . . 1.4199999999999999 112.927 179.458 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 66.9 mtp180 -56.45 -39.27 72.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.772 0.32 . . . . 3.0499999999999998 110.991 -179.772 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 64.6 mt -68.57 108.55 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 1.6299999999999999 110.883 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -107.29 137.41 19.6 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.038 -0.528 . . . . 1.98 110.715 -179.702 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -54.91 175.64 0.15 Allowed 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.571 2.181 . . . . 1.4399999999999999 112.278 179.855 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 59.32 44.48 15.28 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.031 0.443 . . . . 2.6299999999999999 110.285 -179.632 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -119.51 167.22 12.18 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.895 -0.593 . . . . 2.02 110.807 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -116.71 123.07 46.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.316 -0.402 . . . . 1.6200000000000001 110.962 179.911 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.448 HD12 ' HB3' ' A' ' 100' ' ' LEU . 47.5 mm -81.16 139.11 18.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.159 -0.473 . . . . 1.1100000000000001 111.202 -179.729 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 79.2 mt -105.53 -68.75 0.85 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.906 -0.588 . . . . 1.1299999999999999 110.723 179.844 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -150.24 137.42 19.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 3.1499999999999999 111.21 -179.868 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.581 HG11 ' H ' ' A' ' 73' ' ' ASP . 2.6 t -87.19 175.29 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.712 -0.676 . . . . 1.0900000000000001 110.285 179.579 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.629 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 17.7 t70 -50.49 112.7 0.73 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.773 0.321 . . . . 0.79000000000000004 111.465 179.432 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 56.69 23.23 7.61 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.079 -0.51 . . . . 2.0099999999999998 111.806 179.548 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.447 HG11 HG12 ' A' ' 88' ' ' VAL . 68.2 t -143.74 144.44 23.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.82 0.343 . . . . 1.1499999999999999 110.923 179.855 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -115.69 133.05 56.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.311 -0.404 . . . . 2.8500000000000001 110.504 179.668 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.485 HG12 HG12 ' A' ' 85' ' ' VAL . 31.2 m -121.15 35.49 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.849 0.357 . . . . 1.26 111.722 -179.39 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -97.51 41.46 1.12 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.302 -0.408 . . . . 1.74 111.051 179.948 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.19 36.18 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.449 -0.881 . . . . 0.57999999999999996 113.235 179.77 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.414 ' HE3' ' HA ' ' A' ' 77' ' ' VAL . 52.4 mtm -127.91 158.55 37.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.844 0.354 . . . . 1.1200000000000001 110.849 179.562 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.08 151.5 42.95 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.104 -0.498 . . . . 1.1200000000000001 111.149 -179.935 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -53.57 -55.0 29.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.334 -0.393 . . . . 1.52 111.308 -179.556 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 59.4 m -53.57 -37.37 62.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 2.0299999999999998 111.445 -179.512 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -64.02 -42.35 97.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.478 -0.328 . . . . 2.1200000000000001 110.926 -179.826 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.485 HG12 HG12 ' A' ' 77' ' ' VAL . 48.0 t -61.08 -41.71 90.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.218 -0.447 . . . . 1.0800000000000001 111.05 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 47.8 t -63.3 -39.89 86.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.262 -0.426 . . . . 1.0700000000000001 111.013 179.929 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.417 ' HG2' HH21 ' A' ' 90' ' ' ARG . 47.8 mt-10 -57.72 -48.05 80.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 1.51 111.072 -179.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.447 HG12 HG11 ' A' ' 75' ' ' VAL . 65.7 t -57.26 -55.86 18.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 1.0600000000000001 111.368 -179.889 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 91.4 mt -52.11 -32.64 36.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.028 -0.533 . . . . 1.1399999999999999 111.222 -179.445 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.57 ' HA ' HH22 ' A' ' 20' ' ' ARG . 80.0 mtm180 -81.04 -30.27 34.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.34 -0.391 . . . . 2.5600000000000001 111.291 -179.912 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -68.96 -22.26 64.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.443 -0.344 . . . . 1.8100000000000001 110.707 179.891 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.38 -84.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.093 -0.503 . . . . 1.1100000000000001 111.275 179.778 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.651 ' HA2' ' HD2' ' A' ' 20' ' ' ARG . . . 64.11 19.41 63.73 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.81 -0.709 . . . . 0.77000000000000002 112.555 -179.794 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -146.96 178.63 1.37 Allowed Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 110.263 -0.273 . . . . 3.3300000000000001 110.263 -179.752 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.526 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 33.2 Cg_exo -60.46 102.79 0.2 Allowed 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.07 1.847 . . . . 0.92000000000000004 111.954 178.196 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 30.1 m -121.15 156.79 24.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.062 0.458 . . . . 1.3200000000000001 111.508 -179.552 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.629 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 76.3 ttt180 -101.58 142.51 32.83 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.826 -0.625 . . . . 3.02 110.351 179.791 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 13.1 mt -118.21 111.63 19.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.191 -0.459 . . . . 1.1599999999999999 111.024 -179.6 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 45.1 tp -101.65 103.82 14.64 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.834 0.349 . . . . 1.1000000000000001 110.561 179.489 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.448 ' HB3' HD12 ' A' ' 69' ' ' ILE . 0.5 OUTLIER -132.38 155.14 48.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.125 -0.489 . . . . 1.1100000000000001 111.102 -179.548 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 15.2 tt -103.13 136.92 33.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.194 -0.457 . . . . 1.1399999999999999 111.103 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -117.62 129.0 55.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.702 -0.681 . . . . 2.7000000000000002 110.518 179.809 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -87.75 118.76 27.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.239 -0.437 . . . . 4.4000000000000004 110.956 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.473 HD21 ' HH ' ' A' ' 14' ' ' TYR . 54.6 mt -84.55 148.13 51.24 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.074 -0.512 . . . . 2.0 110.611 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -82.75 162.08 16.37 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.577 2.185 . . . . 2.98 112.184 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -108.49 111.49 23.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.165 -0.47 . . . . 3.6699999999999999 111.139 -179.815 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -100.9 98.33 8.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.144 -0.48 . . . . 5.9699999999999998 110.793 179.872 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.206 -0.902 . . . . 6.0 110.898 179.99 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.166 0 N-CA-C 112.484 -0.247 . . . . 8.1300000000000008 112.484 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 63.6 m -109.31 172.8 6.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.912 0.387 . . . . 7.25 110.914 -179.961 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 65.1 m-70 -131.64 125.16 31.47 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.974 -0.557 . . . . 6.6799999999999997 110.744 179.892 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -158.24 42.43 0.5 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.851 -0.69 . . . . 2.8900000000000001 112.262 179.879 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -101.55 84.36 2.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.94 0.4 . . . . 2.46 110.971 -179.876 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.4 t -88.76 82.7 6.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.087 -0.506 . . . . 3.0099999999999998 110.718 179.779 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.1 t70 58.93 97.8 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.997 -0.547 . . . . 2.6699999999999999 111.013 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -128.32 88.7 2.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.106 -0.497 . . . . 1.74 111.128 179.946 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 69.9 m 56.41 23.62 7.58 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.01 -0.541 . . . . 2.6299999999999999 111.056 179.957 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.401 ' HA3' ' HG3' ' A' ' 103' ' ' ARG . . . 101.98 -41.53 2.11 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.776 -0.726 . . . . 1.8200000000000001 112.624 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -58.88 123.52 16.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.795 0.331 . . . . 1.98 110.918 179.956 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.436 ' HB3' HD12 ' A' ' 104' ' ' LEU . 46.0 t -161.38 156.92 24.46 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.098 -0.501 . . . . 1.26 111.276 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.475 HD22 ' HB ' ' A' ' 101' ' ' ILE . 17.8 mt -97.21 103.31 15.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.497 -0.774 . . . . 1.49 110.1 179.599 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 36.5 p90 -124.5 151.91 44.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.858 0.361 . . . . 3.0899999999999999 111.119 -179.344 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 48.4 t -120.68 155.81 33.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.024 0.44 . . . . 1.79 111.383 -179.436 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.8 t -131.66 137.69 54.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.758 -0.656 . . . . 1.26 110.416 179.801 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -88.51 114.43 25.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.947 0.403 . . . . 1.74 111.406 -179.491 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -124.95 117.67 24.57 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.892 -0.595 . . . . 1.4099999999999999 110.614 179.614 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.543 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 28.2 p90 -107.66 132.97 52.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.378 -0.374 . . . . 2.6600000000000001 111.053 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.602 ' HE ' ' HA2' ' A' ' 93' ' ' GLY . 20.7 ttp180 -107.78 102.89 12.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.853 0.359 . . . . 3.5899999999999999 110.861 179.56 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -128.08 -3.03 5.75 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.149 -0.478 . . . . 2.5800000000000001 111.113 -179.797 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.417 ' N ' ' HD2' ' A' ' 22' ' ' LYS . 0.9 OUTLIER -83.78 159.77 21.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.306 -0.407 . . . . 4.1900000000000004 110.792 179.825 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -83.32 34.65 0.47 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.468 . . . . 2.8700000000000001 110.978 -179.885 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 50.3 p -92.14 -23.22 19.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.283 -0.417 . . . . 1.74 111.127 -179.872 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.7 m 56.91 24.67 9.62 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.879 -0.601 . . . . 2.79 111.361 179.785 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 52.5 m -147.19 157.9 43.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.359 -0.382 . . . . 1.79 111.053 -179.885 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.555 HD21 ' HB2' ' A' ' 20' ' ' ARG . 86.1 mt -114.98 1.1 13.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.175 -0.466 . . . . 1.1299999999999999 110.981 179.876 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 67.87 23.44 74.22 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.795 -0.717 . . . . 0.52000000000000002 112.735 179.898 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 62.5 mt -97.61 110.01 24.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.648 0.261 . . . . 1.53 110.919 179.896 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 35.9 t -107.54 98.48 8.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.386 -0.37 . . . . 1.4099999999999999 111.01 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 40.6 pt -83.58 159.39 3.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.294 -0.412 . . . . 1.1799999999999999 111.142 -179.878 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 47.9 t -138.7 152.02 47.66 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.049 -0.523 . . . . 1.79 110.989 -179.78 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -97.85 140.19 14.89 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.772 -0.727 . . . . 1.04 112.471 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 59.8 ttp -89.16 120.26 30.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.789 0.328 . . . . 2.48 110.722 -179.919 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.414 ' HD3' ' N ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -97.14 89.22 4.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 6.1500000000000004 110.965 -179.923 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -104.98 127.59 52.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.043 -0.526 . . . . 4.29 110.72 179.84 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -99.09 17.66 19.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 5.79 111.029 -179.826 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 61.2 m -156.25 130.58 8.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 5.1799999999999997 110.811 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 77.8 p -97.57 142.2 29.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.073 -0.512 . . . . 5.54 111.107 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.6 t -164.76 9.52 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.241 -0.436 . . . . 7.3600000000000003 111.242 -179.991 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 156.8 -56.9 0.38 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.689 -0.767 . . . . 5.7999999999999998 112.551 179.905 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -103.0 125.86 49.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.768 0.318 . . . . 7.2199999999999998 110.954 -179.877 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -123.8 105.98 10.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.207 -0.451 . . . . 3.6000000000000001 111.128 -179.897 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 40.0 p 52.84 -171.92 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.037 -0.529 . . . . 3.02 111.543 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 146.72 168.69 13.84 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.762 -0.732 . . . . 1.3600000000000001 112.64 -179.946 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 45.9 mm -106.39 127.25 61.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.752 0.31 . . . . 1.28 111.032 -179.922 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -152.72 140.9 20.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.283 -0.417 . . . . 1.0800000000000001 110.825 179.796 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 97.0 t -74.48 116.29 16.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.078 -0.51 . . . . 1.0600000000000001 110.869 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -103.9 -25.08 13.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.22 -0.445 . . . . 2.8900000000000001 110.917 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 42.3 t -141.13 165.86 26.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 1.8700000000000001 111.216 -179.926 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.463 HD12 HG21 ' A' ' 63' ' ' ILE . 95.6 mt -136.67 163.64 30.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.913 -0.585 . . . . 1.1899999999999999 110.792 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 50.1 mm -108.02 103.52 50.31 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.321 -0.399 . . . . 1.8500000000000001 111.076 -179.853 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.93 132.1 47.99 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.426 2.084 . . . . 1.26 112.297 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 99.68 -4.9 58.14 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.789 -0.72 . . . . 0.52000000000000002 112.408 -179.779 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.8 t -93.66 167.98 11.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.614 0.245 . . . . 1.73 110.944 -179.876 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -53.91 -57.84 9.5 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.283 -0.417 . . . . 1.1299999999999999 111.704 -179.75 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.35 -43.78 61.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 1.0900000000000001 111.468 -179.638 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.7 -34.57 77.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 1.1100000000000001 111.719 -179.52 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 70.2 mt -62.94 -37.04 85.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.456 -0.338 . . . . 1.29 111.444 -179.622 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.03 -44.88 95.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.469 -0.332 . . . . 1.8600000000000001 111.017 -179.878 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.76 -27.29 4.36 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.79 -0.719 . . . . 1.4199999999999999 112.652 179.892 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 78.4 mtp180 -62.51 -19.23 63.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.837 0.351 . . . . 3.0499999999999998 111.102 -179.955 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.463 HG21 HD12 ' A' ' 51' ' ' LEU . 3.2 mp -82.5 104.55 11.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.115 -0.493 . . . . 1.6299999999999999 110.695 179.808 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -93.71 137.23 23.3 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.088 -0.506 . . . . 1.98 110.7 -179.764 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -51.47 160.8 2.24 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.38 2.053 . . . . 1.4399999999999999 112.316 179.693 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.1 m120 58.7 44.89 16.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.186 -0.461 . . . . 2.6299999999999999 110.787 -179.855 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -95.11 143.19 26.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.906 -0.588 . . . . 2.02 111.049 -179.88 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.576 ' HB3' HG21 ' A' ' 101' ' ' ILE . 25.9 tptp -91.85 101.49 14.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.108 -0.497 . . . . 1.6200000000000001 111.152 -179.948 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.427 HG22 HG23 ' A' ' 77' ' ' VAL . 40.0 mm -74.33 134.39 29.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.494 -0.321 . . . . 1.1100000000000001 110.62 179.627 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.617 ' HA ' HE21 ' A' ' 78' ' ' GLN . 88.3 mt -108.91 -57.26 2.17 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.395 -0.366 . . . . 1.1299999999999999 111.139 -179.766 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -157.87 138.95 13.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.088 0.47 . . . . 3.1499999999999999 111.623 -179.738 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.532 HG12 ' H ' ' A' ' 73' ' ' ASP . 5.3 t -88.45 174.23 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.543 -0.753 . . . . 1.0900000000000001 109.855 179.242 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.684 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 14.9 t70 -46.6 111.0 0.33 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.866 0.365 . . . . 0.79000000000000004 111.957 179.845 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 54.1 29.02 9.64 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.021 -0.536 . . . . 2.0099999999999998 112.084 179.113 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 96.2 t -147.28 137.27 16.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.419 -0.355 . . . . 1.1499999999999999 110.771 179.729 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -103.51 132.19 49.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.42 -0.355 . . . . 2.8500000000000001 110.594 179.716 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.513 ' HA ' ' HE2' ' A' ' 80' ' ' MET . 34.6 m -112.24 26.07 3.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-O 120.817 0.342 . . . . 1.26 111.423 -179.588 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.617 HE21 ' HA ' ' A' ' 70' ' ' LEU . 72.5 mm-40 -95.26 31.03 2.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 1.74 111.158 179.823 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 173.53 37.23 0.04 OUTLIER Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.575 -0.821 . . . . 0.57999999999999996 112.751 179.818 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.513 ' HE2' ' HA ' ' A' ' 77' ' ' VAL . 51.6 mtm -128.99 142.71 50.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.787 0.327 . . . . 1.1200000000000001 110.83 179.824 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.32 161.5 9.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 1.1200000000000001 111.254 -179.884 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -53.96 -60.97 2.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.256 -0.429 . . . . 1.52 110.949 -179.847 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 54.5 m -55.29 -26.74 42.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.244 -0.434 . . . . 2.0299999999999998 111.386 -179.737 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -69.64 -54.21 14.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.771 0.319 . . . . 2.1200000000000001 110.894 -179.786 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.7 t -56.1 -39.08 56.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.298 -0.41 . . . . 1.0800000000000001 110.922 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.477 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 59.7 t -58.53 -55.86 20.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.232 -0.44 . . . . 1.0700000000000001 110.628 179.586 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -47.6 -41.6 22.12 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.073 -0.512 . . . . 1.51 111.001 179.893 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 54.0 t -56.29 -51.84 58.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.164 -0.471 . . . . 1.0600000000000001 110.711 179.309 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 76.1 mt -56.28 -28.61 59.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.755 -0.657 . . . . 1.1399999999999999 110.792 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.477 ' HG2' ' O ' ' A' ' 86' ' ' VAL . 20.9 mmt180 -79.6 -30.3 41.44 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.082 -0.508 . . . . 2.5600000000000001 110.654 179.982 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -75.16 -18.41 60.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.052 -0.522 . . . . 1.8100000000000001 110.845 -179.824 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.53 -88.63 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.049 -0.523 . . . . 1.1100000000000001 111.636 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.602 ' HA2' ' HE ' ' A' ' 20' ' ' ARG . . . 60.97 16.97 49.98 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.746 -0.74 . . . . 0.77000000000000002 112.509 -179.741 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -146.99 172.9 4.66 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 110.657 -0.127 . . . . 3.3300000000000001 110.657 -179.677 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.543 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 37.5 Cg_exo -62.39 97.45 0.17 Allowed 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 122.068 1.845 . . . . 0.92000000000000004 111.625 178.338 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 29.0 m -105.64 156.41 6.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 1.3200000000000001 111.717 -179.307 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.684 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 78.5 ttt180 -103.55 142.14 34.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.713 -0.676 . . . . 3.02 110.029 179.366 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 21.3 mt -115.14 104.37 11.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 1.1599999999999999 111.35 -179.214 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 34.3 tp -95.8 111.59 23.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.82 0.343 . . . . 1.1000000000000001 110.172 179.173 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.09 166.84 23.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.086 0.469 . . . . 1.1100000000000001 111.628 -179.105 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.576 HG21 ' HB3' ' A' ' 68' ' ' LYS . 4.1 tt -121.92 138.32 52.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.684 -0.689 . . . . 1.1399999999999999 110.478 179.71 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 33.0 tpt180 -166.29 145.78 5.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.322 -0.399 . . . . 2.7000000000000002 110.784 -179.831 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.401 ' HG3' ' HA3' ' A' ' 10' ' ' GLY . 19.4 ttm180 -62.53 144.95 55.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.932 -0.576 . . . . 4.4000000000000004 111.147 -179.672 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.436 HD12 ' HB3' ' A' ' 12' ' ' SER . 1.9 mt -111.34 150.52 42.19 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.778 -0.646 . . . . 2.0 110.774 -179.684 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -81.75 160.95 18.97 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.477 2.118 . . . . 2.98 112.07 179.67 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 98.5 mt -139.39 116.21 10.85 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.078 -0.51 . . . . 3.6699999999999999 110.764 -179.877 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 91.7 mt -70.33 108.19 4.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 5.9699999999999998 111.001 -179.874 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.132 -0.937 . . . . 6.0 110.963 179.871 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.186 0 N-CA-C 112.441 -0.264 . . . . 8.1300000000000008 112.441 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 53.4 m -151.39 -54.42 0.14 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.784 0.326 . . . . 7.25 110.938 179.998 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 69.9 m80 -91.05 92.17 8.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.45 . . . . 6.6799999999999997 110.952 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -148.73 85.2 0.16 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.768 -0.73 . . . . 2.8900000000000001 112.562 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -111.56 163.87 13.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.746 0.308 . . . . 2.46 110.709 179.867 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.5 m -147.84 87.15 1.61 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.253 -0.43 . . . . 3.0099999999999998 110.823 179.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 55.34 85.84 0.06 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.128 -0.487 . . . . 2.6699999999999999 111.015 -179.899 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -127.9 100.98 6.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.182 -0.463 . . . . 1.74 111.147 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.2 t 58.0 28.41 16.21 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.985 -0.552 . . . . 2.6299999999999999 111.041 179.763 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.77 -49.53 1.59 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.742 -0.742 . . . . 1.8200000000000001 112.323 -179.855 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -56.27 106.46 0.28 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.789 0.328 . . . . 1.98 110.719 179.764 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 48.3 t -142.09 158.46 43.73 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 116.122 -0.49 . . . . 1.26 111.383 -179.649 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.502 HD23 ' HB ' ' A' ' 101' ' ' ILE . 15.6 mt -93.88 101.86 13.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.468 -0.787 . . . . 1.49 110.076 179.58 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -121.88 148.08 45.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.927 0.394 . . . . 3.0899999999999999 111.117 -179.464 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 80.3 p -112.57 146.99 37.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.052 -0.522 . . . . 1.79 111.143 -179.68 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 17.2 t -120.31 135.3 61.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.096 -0.502 . . . . 1.26 110.644 179.751 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -92.09 111.53 23.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.323 -0.399 . . . . 1.74 111.614 -179.509 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.51 HD11 ' HB3' ' A' ' 56' ' ' ALA . 3.5 mm? -116.14 166.16 12.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.94 -0.573 . . . . 1.4099999999999999 110.184 179.112 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.565 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 42.2 p90 -153.61 136.93 15.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.796 0.332 . . . . 2.6600000000000001 111.433 -179.745 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.445 ' HB2' HD21 ' A' ' 27' ' ' LEU . 21.5 ttp180 -121.31 140.32 52.25 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.175 -0.466 . . . . 3.5899999999999999 110.607 179.317 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -160.63 26.15 0.15 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.388 -0.369 . . . . 2.5800000000000001 111.317 -179.947 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -123.17 165.46 16.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.33 -0.395 . . . . 4.1900000000000004 110.712 179.602 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -88.96 72.58 8.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.243 -0.435 . . . . 2.8700000000000001 110.799 -179.951 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 48.3 p -124.07 -24.89 4.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.06 -0.518 . . . . 1.74 110.987 179.935 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.0 t 58.35 23.82 10.93 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.775 -0.648 . . . . 2.79 111.189 179.687 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 56.5 m -151.18 136.08 17.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.893 0.378 . . . . 1.79 111.086 -179.918 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.445 HD21 ' HB2' ' A' ' 20' ' ' ARG . 46.7 mt -97.11 -12.29 23.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.017 -0.538 . . . . 1.1299999999999999 110.608 179.707 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.477 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 92.78 20.59 33.56 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.851 -0.69 . . . . 0.52000000000000002 112.509 179.91 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 75.9 mt -98.59 112.14 29.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.717 0.294 . . . . 1.53 111.064 179.956 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 70.4 m -113.68 98.89 7.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 1.4099999999999999 110.834 179.921 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 36.9 pt -91.34 166.7 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.186 -0.461 . . . . 1.1799999999999999 111.376 -179.854 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 44.8 t -147.4 153.59 39.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.029 -0.532 . . . . 1.79 110.654 -179.981 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.95 146.36 16.32 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.738 -0.744 . . . . 1.04 112.529 -179.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 71.6 mtm -82.49 141.26 32.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.754 0.311 . . . . 2.48 110.737 179.919 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.415 ' HD3' ' N ' ' A' ' 35' ' ' ARG . 0.1 OUTLIER -96.92 84.45 3.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 6.1500000000000004 110.966 -179.971 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -95.49 135.95 36.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 4.29 110.953 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -115.89 27.03 9.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.141 -0.482 . . . . 5.79 110.903 -179.928 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 46.8 t -156.08 112.9 3.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 5.1799999999999997 110.916 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 39.4 p -87.04 138.34 31.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.072 -0.513 . . . . 5.54 111.14 179.909 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.2 t -146.05 -3.08 0.68 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 7.3600000000000003 111.059 179.864 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 162.7 -61.11 0.27 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.801 -0.714 . . . . 5.7999999999999998 112.352 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -95.76 166.15 11.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.76 0.314 . . . . 7.2199999999999998 110.886 -179.907 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -139.39 115.75 10.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.26 -0.427 . . . . 3.6000000000000001 111.203 -179.872 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 46.5 p 52.13 -171.92 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.917 -0.583 . . . . 3.02 111.812 179.866 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -175.48 138.02 4.04 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.904 -0.665 . . . . 1.3600000000000001 112.395 -179.965 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 40.5 mm -84.74 124.11 39.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.723 0.297 . . . . 1.28 111.164 -179.899 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -155.94 139.19 15.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.238 -0.437 . . . . 1.0800000000000001 110.715 179.862 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 57.5 t -76.74 127.11 37.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.222 -0.445 . . . . 1.0600000000000001 111.111 -179.84 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -116.71 -22.55 8.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.036 -0.529 . . . . 2.8900000000000001 111.165 -179.763 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 46.9 t -139.58 163.39 32.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.952 0.406 . . . . 1.8700000000000001 111.304 -179.871 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 76.0 mt -134.78 163.17 30.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.888 -0.596 . . . . 1.1899999999999999 110.807 179.984 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.477 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 48.5 mm -110.32 98.92 38.15 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.29 -0.414 . . . . 1.8500000000000001 110.96 179.67 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.07 126.88 22.92 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.404 2.069 . . . . 1.26 112.28 -179.928 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.76 -4.54 32.41 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.905 -0.664 . . . . 0.52000000000000002 112.625 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.441 ' HG ' ' HA3' ' A' ' 28' ' ' GLY . 93.1 p -99.47 -172.54 2.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.903 0.383 . . . . 1.73 111.058 -179.814 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.51 ' HB3' HD11 ' A' ' 18' ' ' LEU . . . -67.8 -58.06 5.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.052 -0.522 . . . . 1.1299999999999999 111.333 -179.951 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.81 -22.91 62.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.079 -0.51 . . . . 1.0900000000000001 111.438 -179.782 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.15 -31.62 34.06 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.511 -0.313 . . . . 1.1100000000000001 111.776 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.5 mt -83.45 -59.27 2.5 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.313 0.486 . . . . 1.29 112.313 -179.038 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -103.98 -24.53 13.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.665 0.269 . . . . 1.8600000000000001 111.331 -178.781 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.502 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -64.53 87.15 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.516 -0.85 . . . . 1.4199999999999999 112.246 179.959 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 -61.31 0.75 0.24 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.603 0.24 . . . . 3.0499999999999998 111.234 179.751 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.502 ' H ' ' C ' ' A' ' 61' ' ' GLY . 59.2 mt -48.95 125.65 2.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.276 -0.42 . . . . 1.6299999999999999 111.194 179.582 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.459 ' C ' ' H ' ' A' ' 66' ' ' ASN . 11.5 mt-10 -78.93 159.85 72.66 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 1.98 110.93 179.86 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -73.61 28.06 0.31 Allowed 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.656 2.237 . . . . 1.4399999999999999 112.443 179.654 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.459 ' H ' ' C ' ' A' ' 64' ' ' GLU . 3.1 t-20 -163.03 49.44 0.15 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.094 0.473 . . . . 2.6299999999999999 110.281 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -108.55 152.62 24.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.867 -0.606 . . . . 2.02 110.904 -179.716 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -107.09 111.21 23.56 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.41 -0.359 . . . . 1.6200000000000001 110.981 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 34.7 mm -70.43 141.55 16.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.256 -0.429 . . . . 1.1100000000000001 110.768 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 82.8 mt -117.86 -66.11 1.11 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 1.1299999999999999 111.35 -179.724 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -137.69 135.62 36.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.972 0.415 . . . . 3.1499999999999999 111.431 -179.62 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.516 HG13 ' H ' ' A' ' 73' ' ' ASP . 3.1 t -94.41 174.49 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.899 -0.591 . . . . 1.0900000000000001 110.083 179.329 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.661 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 14.2 t70 -53.49 108.79 0.37 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.839 0.352 . . . . 0.79000000000000004 111.392 179.807 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.4 t70 61.48 15.91 7.1 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.008 -0.542 . . . . 2.0099999999999998 111.699 179.434 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.407 ' HB ' ' HB ' ' A' ' 72' ' ' VAL . 26.0 t -138.42 157.18 30.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.559 -0.291 . . . . 1.1499999999999999 110.802 179.795 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 65.6 m-20 -127.71 129.59 47.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.442 -0.345 . . . . 2.8500000000000001 110.907 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.7 m -106.41 21.02 4.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.337 -0.392 . . . . 1.26 111.004 179.954 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -86.27 23.66 1.52 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.013 -0.54 . . . . 1.74 110.918 -179.958 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -177.02 18.85 0.04 OUTLIER Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.706 -0.759 . . . . 0.57999999999999996 112.828 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.426 ' HE2' HG23 ' A' ' 88' ' ' VAL . 51.6 mtm -115.12 139.16 50.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.843 0.354 . . . . 1.1200000000000001 110.876 179.809 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.432 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -65.97 156.86 32.35 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.159 -0.473 . . . . 1.1200000000000001 111.025 -179.932 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -44.04 -55.03 4.97 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.199 -0.455 . . . . 1.52 111.546 -179.568 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 79.3 p -51.29 -46.78 62.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.312 -0.404 . . . . 2.0299999999999998 111.256 -179.68 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -60.62 -40.74 93.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 2.1200000000000001 111.104 -179.915 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 81' ' ' ALA . 35.0 t -60.07 -39.69 81.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.295 -0.412 . . . . 1.0800000000000001 110.766 179.85 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.431 HG11 ' NE ' ' A' ' 90' ' ' ARG . 39.9 t -64.43 -37.06 79.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.168 -0.469 . . . . 1.0700000000000001 110.658 179.711 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -58.92 -48.62 80.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.162 -0.472 . . . . 1.51 110.808 179.798 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.426 HG23 ' HE2' ' A' ' 80' ' ' MET . 61.4 t -57.1 -55.15 22.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.205 -0.452 . . . . 1.0600000000000001 111.37 179.972 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 85.3 mt -56.33 -32.59 64.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.998 -0.546 . . . . 1.1399999999999999 111.385 -179.36 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.431 ' NE ' HG11 ' A' ' 86' ' ' VAL . 79.0 mtm180 -81.23 -20.07 41.81 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.458 -0.337 . . . . 2.5600000000000001 111.272 -179.687 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.432 ' N ' HD21 ' A' ' 91' ' ' ASN . 0.9 OUTLIER -86.05 -16.85 36.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.33 -0.395 . . . . 1.8100000000000001 111.077 -179.953 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.2 -86.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.267 -0.424 . . . . 1.1100000000000001 111.424 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.443 ' HA2' ' HE ' ' A' ' 20' ' ' ARG . . . 60.81 17.18 49.45 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.756 -0.735 . . . . 0.77000000000000002 112.578 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.38 175.56 2.66 Favored Pre-proline 0 CA--C 1.534 0.33 0 N-CA-C 110.377 -0.231 . . . . 3.3300000000000001 110.377 -179.804 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.565 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 32.9 Cg_exo -61.47 99.38 0.17 Allowed 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 122.088 1.859 . . . . 0.92000000000000004 111.604 178.247 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.6 m -116.43 155.77 17.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.265 -0.425 . . . . 1.3200000000000001 111.837 -179.191 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.661 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 44.4 ttp180 -101.71 145.38 29.2 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.881 -0.6 . . . . 3.02 110.484 179.788 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.6 mt -121.54 104.77 9.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.173 -0.467 . . . . 1.1599999999999999 111.358 -179.228 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 61.6 tp -91.81 108.1 19.68 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.777 0.322 . . . . 1.1000000000000001 110.381 179.421 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.467 HD23 HG12 ' A' ' 63' ' ' ILE . 0.5 OUTLIER -138.21 168.43 19.76 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.24 -0.436 . . . . 1.1100000000000001 111.579 -179.212 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.502 ' HB ' HD23 ' A' ' 13' ' ' LEU . 9.8 tt -119.95 141.1 41.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.862 -0.608 . . . . 1.1399999999999999 111.048 179.873 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 27.2 tpt180 -166.44 138.41 3.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.101 -0.5 . . . . 2.7000000000000002 110.711 179.65 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -64.9 143.22 58.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.039 -0.528 . . . . 4.4000000000000004 110.93 -179.799 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.8 mt -94.97 148.42 34.67 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.872 -0.604 . . . . 2.0 111.091 -179.576 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -81.35 60.71 7.85 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.911 2.407 . . . . 2.98 112.355 179.821 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 71.1 mt -74.11 127.96 34.29 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.581 -0.736 . . . . 3.6699999999999999 110.92 -179.899 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.416 HD21 ' N ' ' A' ' 107' ' ' LEU . 3.7 mm? -74.08 114.12 12.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.03 -0.532 . . . . 5.9699999999999998 111.102 -179.878 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.236 -0.887 . . . . 6.0 111.086 179.876 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.219 0 N-CA-C 112.515 -0.234 . . . . 8.1300000000000008 112.515 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.7 m -123.82 143.7 50.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.806 0.336 . . . . 7.25 111.105 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -165.12 88.48 0.45 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.16 -0.473 . . . . 6.6799999999999997 110.866 179.866 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 91.54 -30.13 6.72 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.673 -0.775 . . . . 2.8900000000000001 112.735 179.881 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -119.19 122.09 41.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.847 0.356 . . . . 2.46 111.163 -179.848 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 46.2 t -157.51 98.98 1.72 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.078 -0.51 . . . . 3.0099999999999998 110.92 179.961 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 58.36 75.82 0.37 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.092 -0.504 . . . . 2.6699999999999999 110.961 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -133.25 113.56 12.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.479 . . . . 1.74 111.194 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.2 m 53.56 34.53 18.72 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.111 -0.495 . . . . 2.6299999999999999 111.107 179.987 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.53 -55.61 3.48 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.736 -0.745 . . . . 1.8200000000000001 112.451 -179.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.506 ' HA ' ' HA ' ' A' ' 103' ' ' ARG . 47.2 m-85 -57.34 123.99 17.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.839 0.352 . . . . 1.98 110.88 179.96 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.5 t -151.42 155.01 37.73 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.191 -0.458 . . . . 1.26 111.263 -179.878 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.497 HD22 ' HB ' ' A' ' 101' ' ' ILE . 23.8 mt -94.39 102.31 14.28 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.555 -0.748 . . . . 1.49 110.209 179.53 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.413 ' CE1' ' HB3' ' A' ' 102' ' ' ARG . 39.5 p90 -123.46 151.17 42.99 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.887 0.375 . . . . 3.0899999999999999 110.992 -179.602 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 80.2 p -122.39 161.28 23.74 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.279 -0.419 . . . . 1.79 111.465 -179.472 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 12.4 t -131.22 149.88 33.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.86 -0.609 . . . . 1.26 110.682 179.857 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -103.46 110.05 21.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.441 -0.345 . . . . 1.74 111.526 -179.47 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -126.49 123.84 38.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.179 -0.464 . . . . 1.4099999999999999 110.759 179.577 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.529 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 35.6 p90 -112.02 142.77 44.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.301 -0.409 . . . . 2.6600000000000001 110.747 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.554 ' HE ' ' HA2' ' A' ' 93' ' ' GLY . 47.5 ttp180 -125.97 160.85 28.91 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.859 -0.336 . . . . 3.5899999999999999 110.916 179.717 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -168.07 -33.06 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.139 -0.482 . . . . 2.5800000000000001 111.077 -179.891 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -59.07 160.93 5.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.949 -0.568 . . . . 4.1900000000000004 110.788 179.924 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -84.77 49.29 1.69 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.261 -0.427 . . . . 2.8700000000000001 111.069 -179.874 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 82.1 p -99.1 -24.59 14.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 1.74 111.163 -179.977 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 36.4 t 56.41 18.04 3.25 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.797 -0.638 . . . . 2.79 111.259 179.803 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 53.8 m -140.74 148.1 40.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.874 0.368 . . . . 1.79 111.206 -179.882 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 61.5 mt -113.37 -23.58 9.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.991 -0.549 . . . . 1.1299999999999999 110.833 179.905 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.484 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 110.5 -23.64 19.69 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.804 -0.713 . . . . 0.52000000000000002 112.383 -179.791 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 76.5 mt -62.41 109.0 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.805 0.336 . . . . 1.53 110.798 179.841 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 48.3 t -111.3 100.02 8.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.147 -0.479 . . . . 1.4099999999999999 110.853 -179.704 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.579 ' HA ' ' HA ' ' A' ' 48' ' ' VAL . 31.5 pt -85.19 172.75 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.825 -0.625 . . . . 1.1799999999999999 111.269 -179.928 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 43.9 t -139.67 132.12 28.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.485 . . . . 1.79 110.838 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -65.62 155.2 50.17 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.806 -0.711 . . . . 1.04 112.537 -179.905 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.441 ' HG2' ' HA ' ' A' ' 44' ' ' THR . 53.2 tpp -99.48 132.5 44.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.806 0.336 . . . . 2.48 110.891 -179.881 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.435 ' HD3' ' N ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -160.43 65.22 0.32 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.034 0.445 . . . . 6.1500000000000004 111.06 179.936 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -66.99 -177.34 0.62 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.212 -0.449 . . . . 4.29 111.022 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -64.81 173.75 2.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.199 -0.455 . . . . 5.79 110.988 -179.967 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 59.9 p 51.18 -164.97 0.05 OUTLIER 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.094 -0.503 . . . . 5.1799999999999997 111.081 -179.95 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 68.6 p -56.22 139.43 47.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.935 0.398 . . . . 5.54 111.091 179.792 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 67.2 p -82.19 15.45 2.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.111 -0.495 . . . . 7.3600000000000003 111.277 -179.876 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -78.92 -26.07 58.96 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.795 -0.716 . . . . 5.7999999999999998 112.445 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -106.68 149.48 27.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.784 0.326 . . . . 7.2199999999999998 110.915 -179.98 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 57.06 88.7 0.05 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.139 -0.482 . . . . 3.6000000000000001 111.178 -179.942 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.441 ' HA ' ' HG2' ' A' ' 34' ' ' MET . 59.8 p -135.34 151.8 50.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.106 -0.497 . . . . 3.02 110.997 179.905 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 156.89 144.55 3.96 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.826 -0.702 . . . . 1.3600000000000001 112.399 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.1 tp -85.71 159.36 3.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.572 0.225 . . . . 1.28 110.962 -179.891 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -163.31 139.49 6.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.749 0.309 . . . . 1.0800000000000001 111.336 -179.884 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.579 ' HA ' ' HA ' ' A' ' 31' ' ' ILE . 90.5 t -71.24 105.85 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.258 -0.428 . . . . 1.0600000000000001 110.761 179.483 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -66.89 -38.08 85.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.041 -0.527 . . . . 2.8900000000000001 111.013 -179.923 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 35.9 t -168.1 175.61 6.52 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.96 0.41 . . . . 1.8700000000000001 111.252 -179.907 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 76.5 mt -115.13 155.7 26.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.842 -0.617 . . . . 1.1899999999999999 110.713 179.918 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.484 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 70.4 mt -98.93 108.51 49.53 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 1.8500000000000001 111.388 -179.62 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.05 136.12 72.96 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.432 2.088 . . . . 1.26 112.304 -179.919 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 103.99 -17.01 49.66 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.732 -0.747 . . . . 0.52000000000000002 112.645 179.92 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 95.6 p -88.54 -176.07 5.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.809 0.338 . . . . 1.73 111.118 -179.878 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.86 -54.84 13.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 1.1299999999999999 111.258 -179.853 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.64 -36.48 62.11 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.133 -0.485 . . . . 1.0900000000000001 111.522 -179.827 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.02 -46.38 62.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 1.1100000000000001 111.316 -179.887 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 97.4 mt -66.16 -19.75 65.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.364 -0.38 . . . . 1.29 110.834 179.73 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -61.24 -56.14 23.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 1.8600000000000001 110.826 179.981 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 97.3 -49.04 1.52 Allowed Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.805 -0.712 . . . . 1.4199999999999999 112.977 179.47 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -56.0 -36.25 67.71 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.727 0.299 . . . . 3.0499999999999998 111.164 -179.583 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 62.5 mt -70.27 116.18 11.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.875 0.369 . . . . 1.6299999999999999 110.713 179.776 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -102.97 131.87 21.74 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.056 -0.52 . . . . 1.98 110.786 -179.684 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -60.91 171.88 3.39 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.443 2.096 . . . . 1.4399999999999999 112.03 179.897 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 57.5 52.85 8.0 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.303 -0.408 . . . . 2.6299999999999999 110.548 -179.469 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -123.52 174.19 7.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.124 -0.489 . . . . 2.02 111.017 -179.594 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -115.01 127.0 55.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.199 -0.455 . . . . 1.6200000000000001 110.969 -179.964 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 47.9 mm -89.43 139.99 16.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.258 -0.428 . . . . 1.1100000000000001 111.014 -179.924 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 84.8 mt -110.83 -62.73 1.49 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.176 -0.465 . . . . 1.1299999999999999 111.109 -179.786 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -150.94 136.65 18.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.031 0.443 . . . . 3.1499999999999999 111.609 -179.402 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.604 HG11 ' H ' ' A' ' 73' ' ' ASP . 2.3 t -89.06 175.46 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.777 -0.647 . . . . 1.0900000000000001 110.186 179.437 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.656 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 14.5 t70 -49.15 108.66 0.2 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.725 0.298 . . . . 0.79000000000000004 111.493 179.558 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.7 t70 57.03 28.4 14.78 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.164 -0.471 . . . . 2.0099999999999998 111.544 179.306 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.7 t -145.88 144.27 20.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.334 -0.394 . . . . 1.1499999999999999 110.874 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -114.35 129.87 56.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.437 -0.347 . . . . 2.8500000000000001 110.585 179.62 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.404 ' HA ' ' HE3' ' A' ' 80' ' ' MET . 35.2 m -112.29 26.12 3.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-N 116.548 -0.296 . . . . 1.26 111.479 -179.441 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -94.25 31.64 1.67 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.92 0.39 . . . . 1.74 110.724 179.739 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 177.37 34.87 0.05 OUTLIER Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.715 -0.755 . . . . 0.57999999999999996 112.704 -179.974 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.404 ' HE3' ' HA ' ' A' ' 77' ' ' VAL . 54.9 mtm -134.62 145.28 48.47 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.905 0.383 . . . . 1.1200000000000001 110.758 179.8 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.61 150.55 40.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.063 -0.517 . . . . 1.1200000000000001 111.028 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -46.05 -51.58 13.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.298 -0.41 . . . . 1.52 111.399 -179.638 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.1 m -50.49 -47.82 57.08 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.215 -0.448 . . . . 2.0299999999999998 111.33 -179.676 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -59.4 -41.88 90.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.341 -0.39 . . . . 2.1200000000000001 111.065 -179.866 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.6 t -58.96 -38.5 73.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.275 -0.421 . . . . 1.0800000000000001 110.947 179.909 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.4 t -66.95 -38.02 80.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.173 -0.467 . . . . 1.0700000000000001 111.033 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -57.77 -46.1 85.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.305 -0.407 . . . . 1.51 110.674 179.734 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 54.8 t -59.27 -53.98 40.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.058 -0.519 . . . . 1.0600000000000001 111.073 179.747 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 78.5 mt -55.97 -26.77 49.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.996 -0.547 . . . . 1.1399999999999999 111.107 -179.612 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -89.41 -19.79 24.74 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.388 -0.369 . . . . 2.5600000000000001 111.308 179.978 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -89.68 -9.19 50.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.739 0.305 . . . . 1.8100000000000001 111.177 179.981 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.03 -87.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.439 . . . . 1.1100000000000001 111.404 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.554 ' HA2' ' HE ' ' A' ' 20' ' ' ARG . . . 60.74 20.07 56.14 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.66 -0.781 . . . . 0.77000000000000002 112.342 -179.838 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.607 ' HB3' ' HD2' ' A' ' 95' ' ' PRO . 5.9 m120 -147.17 172.63 4.97 Favored Pre-proline 0 C--N 1.33 -0.263 0 C-N-CA 122.106 0.162 . . . . 3.3300000000000001 110.775 -179.53 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.607 ' HD2' ' HB3' ' A' ' 94' ' ' ASN . 23.1 Cg_endo -62.86 89.53 0.12 Allowed 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 122.035 1.823 . . . . 0.92000000000000004 111.624 178.191 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.7 m -103.38 151.76 6.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.177 0.513 . . . . 1.3200000000000001 111.923 -179.216 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.656 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 79.4 ttt180 -101.2 143.95 30.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.566 -0.743 . . . . 3.02 110.159 179.378 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.02 105.11 10.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.432 -0.349 . . . . 1.1599999999999999 111.368 -179.525 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 51.4 tp -94.75 105.6 17.54 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.889 0.376 . . . . 1.1000000000000001 110.309 179.215 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.32 168.18 19.06 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.051 -0.522 . . . . 1.1100000000000001 111.41 -179.597 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.497 ' HB ' HD22 ' A' ' 13' ' ' LEU . 10.7 tt -122.63 142.1 40.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.916 -0.584 . . . . 1.1399999999999999 111.019 -179.962 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.413 ' HB3' ' CE1' ' A' ' 14' ' ' TYR . 31.5 tpt180 -166.06 136.28 3.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.986 -0.552 . . . . 2.7000000000000002 110.5 179.618 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.506 ' HA ' ' HA ' ' A' ' 11' ' ' PHE . 59.7 ttp180 -62.02 143.21 56.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.026 -0.534 . . . . 4.4000000000000004 111.251 -179.454 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.5 mt -103.44 153.05 38.81 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.659 -0.7 . . . . 2.0 110.652 -179.76 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -81.15 159.84 20.48 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.36 2.04 . . . . 2.98 112.045 179.921 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 91.5 mt -143.16 125.82 15.94 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.048 -0.524 . . . . 3.6699999999999999 110.791 -179.734 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -67.05 101.39 0.86 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.479 . . . . 5.9699999999999998 110.828 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.356 -0.83 . . . . 6.0 111.143 -179.837 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.203 0 N-CA-C 112.495 -0.242 . . . . 8.1300000000000008 112.495 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 52.5 m -120.43 149.24 42.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.757 0.313 . . . . 7.25 110.825 179.97 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -164.69 100.64 0.8 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 6.6799999999999997 110.813 179.928 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -140.35 -44.22 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.791 -0.719 . . . . 2.8900000000000001 112.711 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -80.61 84.05 6.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.815 0.34 . . . . 2.46 110.824 -179.846 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 53.6 m -92.87 88.3 6.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 3.0099999999999998 110.92 -179.987 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 57.47 38.87 28.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.001 -0.545 . . . . 2.6699999999999999 111.071 179.94 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -90.1 120.99 31.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.087 -0.506 . . . . 1.74 111.001 179.788 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.4 m 55.98 25.98 9.38 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.274 -0.421 . . . . 2.6299999999999999 110.753 -179.695 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.56 ' HA3' ' HG3' ' A' ' 103' ' ' ARG . . . 98.01 -39.21 2.83 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.835 -0.698 . . . . 1.8200000000000001 112.491 -179.945 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -60.26 128.6 37.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.718 0.294 . . . . 1.98 110.73 179.855 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 46.9 t -149.48 147.02 27.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 1.26 111.238 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.487 HD21 ' HB ' ' A' ' 101' ' ' ILE . 45.7 mt -90.42 102.32 15.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.777 -0.647 . . . . 1.49 110.329 179.627 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.631 ' HH ' ' HB2' ' A' ' 102' ' ' ARG . 43.5 p90 -124.48 149.2 47.11 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.949 0.404 . . . . 3.0899999999999999 111.229 -179.646 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.0 m -115.3 154.57 28.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.098 -0.501 . . . . 1.79 110.883 -179.792 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.4 t -124.12 157.42 31.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 1.26 110.529 179.827 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -116.18 107.69 15.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.864 0.364 . . . . 1.74 111.398 -179.672 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.441 HD12 ' HB2' ' A' ' 60' ' ' ASP . 4.3 mm? -116.98 144.76 44.21 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.079 -0.51 . . . . 1.4099999999999999 110.546 179.696 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.679 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 21.8 p90 -118.66 117.87 30.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.936 0.398 . . . . 2.6600000000000001 110.868 179.85 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.595 ' HG2' ' HA2' ' A' ' 93' ' ' GLY . 15.0 ttt180 -110.16 153.85 24.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.002 -0.545 . . . . 3.5899999999999999 110.585 179.924 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -113.51 -70.26 0.81 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.097 0.475 . . . . 2.5800000000000001 111.131 -179.862 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -136.22 -169.85 2.53 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.712 -0.676 . . . . 4.1900000000000004 110.969 -179.812 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -55.51 -27.26 47.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.338 -0.392 . . . . 2.8700000000000001 110.869 179.775 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.3 m -66.95 -36.99 83.47 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.16 -0.473 . . . . 1.74 110.744 179.875 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.9 m -81.85 61.41 5.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.122 -0.49 . . . . 2.79 110.931 179.869 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 51.0 m -57.88 138.34 55.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.479 . . . . 1.79 110.833 179.773 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.498 HD23 ' HB2' ' A' ' 20' ' ' ARG . 75.0 mt -78.8 -35.3 44.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.033 -0.531 . . . . 1.1299999999999999 110.67 -179.845 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.75 -6.74 73.91 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.787 -0.72 . . . . 0.52000000000000002 113.219 179.212 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 74.5 mt -60.07 108.67 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.747 0.308 . . . . 1.53 111.17 -179.851 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 39.6 t -112.31 97.91 6.95 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.21 -0.45 . . . . 1.4099999999999999 110.662 179.729 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.462 ' HA ' ' HA ' ' A' ' 48' ' ' VAL . 38.6 pt -89.72 166.66 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.051 -0.522 . . . . 1.1799999999999999 111.272 -179.838 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 54.7 m -143.71 138.94 29.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.095 -0.502 . . . . 1.79 110.953 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -88.42 121.77 6.09 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.825 -0.702 . . . . 1.04 112.48 179.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 53.2 ttm -64.05 152.99 38.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.708 0.29 . . . . 2.48 110.847 -179.946 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.453 ' N ' ' HD2' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -144.04 42.12 1.42 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.249 -0.432 . . . . 6.1500000000000004 110.888 179.982 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -57.61 141.85 46.73 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.223 -0.444 . . . . 4.29 110.85 179.934 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -119.36 -177.08 3.28 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.254 -0.43 . . . . 5.79 110.974 -179.772 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 52.6 m 60.33 -178.87 0.1 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.957 -0.565 . . . . 5.1799999999999997 111.067 -179.969 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 23.7 p 53.56 -172.74 0.04 OUTLIER 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.002 -0.545 . . . . 5.54 111.614 179.77 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.1 t -133.83 29.72 3.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.985 -0.552 . . . . 7.3600000000000003 110.832 179.863 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -147.93 77.44 0.24 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.815 -0.707 . . . . 5.7999999999999998 112.57 -179.978 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -91.78 153.83 19.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.757 0.313 . . . . 7.2199999999999998 110.724 179.872 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -132.24 75.69 1.65 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.269 -0.423 . . . . 3.6000000000000001 111.302 -179.805 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 82.6 p -78.66 127.06 31.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 3.02 110.901 179.728 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -146.39 176.86 25.08 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.619 -0.8 . . . . 1.3600000000000001 112.726 -179.803 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 37.5 mm -95.97 106.46 18.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.707 0.289 . . . . 1.28 110.822 179.979 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -131.73 142.77 49.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.287 -0.415 . . . . 1.0800000000000001 111.189 -179.726 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.462 ' HA ' ' HA ' ' A' ' 31' ' ' ILE . 46.8 t -81.54 116.64 26.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.116 -0.493 . . . . 1.0600000000000001 111.004 179.847 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -84.79 -35.71 22.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.452 . . . . 2.8900000000000001 111.22 -179.705 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 54.6 m -149.66 172.68 14.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.125 0.488 . . . . 1.8700000000000001 111.63 -179.527 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.431 HD11 HG21 ' A' ' 63' ' ' ILE . 63.0 mt -131.73 141.45 49.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.723 -0.671 . . . . 1.1899999999999999 110.538 179.835 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 43.2 mm -75.4 115.56 46.57 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.337 -0.392 . . . . 1.8500000000000001 111.074 -179.89 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -58.07 126.26 21.07 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.387 2.058 . . . . 1.26 112.391 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 98.53 -13.66 62.57 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.799 -0.715 . . . . 0.52000000000000002 112.785 179.659 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 92.8 p -72.02 -177.33 2.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.779 0.324 . . . . 1.73 110.914 -179.861 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.39 -55.29 12.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 1.1299999999999999 111.178 179.976 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.82 -33.88 67.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.108 -0.497 . . . . 1.0900000000000001 111.397 -179.804 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.78 -55.55 8.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 1.1100000000000001 111.509 -179.649 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.0 mt -59.1 -20.23 51.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 1.29 111.187 -179.835 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.441 ' HB2' HD12 ' A' ' 18' ' ' LEU . 17.4 t70 -59.05 -52.54 65.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.36 -0.382 . . . . 1.8600000000000001 110.642 -179.909 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.91 -31.7 7.36 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.707 -0.759 . . . . 1.4199999999999999 113.126 179.387 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 82.2 mtm180 -83.85 0.84 45.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.686 0.279 . . . . 3.0499999999999998 111.238 -179.571 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.431 HG21 HD11 ' A' ' 51' ' ' LEU . 53.6 mt -116.47 122.78 70.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.848 0.356 . . . . 1.6299999999999999 110.979 179.592 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -129.41 158.1 74.25 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.125 -0.489 . . . . 1.98 110.809 179.971 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -57.08 176.97 0.2 Allowed 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.587 2.191 . . . . 1.4399999999999999 112.308 179.674 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 56.38 50.08 13.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.013 -0.54 . . . . 2.6299999999999999 110.637 -179.805 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.401 ' HA ' ' HG2' ' A' ' 102' ' ' ARG . 8.3 t70 -120.81 151.85 39.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.815 -0.629 . . . . 2.02 110.83 -179.934 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -109.62 109.06 19.7 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.857 0.36 . . . . 1.6200000000000001 110.912 179.979 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 49.2 mm -71.03 142.41 15.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.143 -0.48 . . . . 1.1100000000000001 110.982 179.896 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 73.3 mt -114.97 -71.77 0.73 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.097 -0.501 . . . . 1.1299999999999999 110.98 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.41 ' O ' ' HB3' ' A' ' 99' ' ' LEU . 75.9 mtp180 -135.95 135.33 39.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 3.1499999999999999 111.406 -179.611 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.477 HG11 ' H ' ' A' ' 73' ' ' ASP . 6.6 t -93.55 170.69 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.922 -0.581 . . . . 1.0900000000000001 109.842 179.166 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.619 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 16.8 t70 -46.7 108.7 0.15 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.917 0.389 . . . . 0.79000000000000004 111.841 179.928 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 53.41 14.52 0.57 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.817 -0.629 . . . . 2.0099999999999998 112.479 179.013 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 65.2 t -144.72 99.67 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.76 0.314 . . . . 1.1499999999999999 111.388 -179.887 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -68.07 155.58 39.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.386 -0.37 . . . . 2.8500000000000001 110.355 179.462 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.424 HG13 HG11 ' A' ' 85' ' ' VAL . 17.4 m -133.44 39.84 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.846 0.355 . . . . 1.26 111.391 -179.814 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -109.8 35.84 3.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 1.74 111.048 179.795 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -179.6 26.64 0.05 OUTLIER Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.481 -0.866 . . . . 0.57999999999999996 112.927 179.962 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 65.6 mtm -130.61 153.16 49.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.853 0.358 . . . . 1.1200000000000001 110.918 179.75 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.408 ' O ' HG21 ' A' ' 85' ' ' VAL . . . -62.18 151.98 34.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.011 -0.54 . . . . 1.1200000000000001 111.333 -179.86 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -50.36 -55.75 14.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.238 -0.437 . . . . 1.52 111.249 -179.744 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.1 m -52.95 -41.03 64.12 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.07 -0.514 . . . . 2.0299999999999998 111.171 -179.813 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -59.08 -43.56 91.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.288 -0.414 . . . . 2.1200000000000001 110.89 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.424 HG11 HG13 ' A' ' 77' ' ' VAL . 22.8 t -60.16 -36.46 68.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.143 -0.48 . . . . 1.0800000000000001 110.818 179.883 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.2 t -63.76 -40.89 90.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.036 -0.529 . . . . 1.0700000000000001 111.015 179.92 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -59.1 -49.73 76.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.265 -0.425 . . . . 1.51 110.732 179.812 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 54.6 t -52.25 -53.83 17.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.95 -0.568 . . . . 1.0600000000000001 111.333 179.876 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 71.3 mt -56.71 -33.83 66.86 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.103 -0.499 . . . . 1.1399999999999999 111.329 -179.516 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 -82.2 -14.95 54.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.484 -0.325 . . . . 2.5600000000000001 111.226 -179.793 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -92.14 -15.4 27.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.365 -0.38 . . . . 1.8100000000000001 111.086 179.976 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.77 -83.51 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.287 -0.415 . . . . 1.1100000000000001 111.454 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.595 ' HA2' ' HG2' ' A' ' 20' ' ' ARG . . . 62.49 21.76 62.85 Favored Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.638 -0.791 . . . . 0.77000000000000002 112.431 -179.724 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.59 169.65 8.98 Favored Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 110.527 -0.175 . . . . 3.3300000000000001 110.527 -179.823 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.679 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 48.8 Cg_exo -57.39 92.47 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.048 1.832 . . . . 0.92000000000000004 111.427 178.349 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.9 m -103.72 148.83 8.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.133 0.492 . . . . 1.3200000000000001 111.84 -179.051 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.619 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 71.6 ttt180 -99.7 144.11 29.15 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.618 -0.719 . . . . 3.02 110.002 179.726 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 13.6 mt -118.38 103.79 10.12 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.386 -0.37 . . . . 1.1599999999999999 111.525 -179.146 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.41 ' HB3' ' O ' ' A' ' 71' ' ' ARG . 65.3 tp -90.98 109.35 20.58 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.857 -0.423 . . . . 1.1000000000000001 109.857 179.062 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -143.25 168.34 20.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.247 0.546 . . . . 1.1100000000000001 111.963 -179.115 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.487 ' HB ' HD21 ' A' ' 13' ' ' LEU . 13.0 tt -119.49 143.1 31.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.572 -0.74 . . . . 1.1399999999999999 110.556 179.838 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.631 ' HB2' ' HH ' ' A' ' 14' ' ' TYR . 0.4 OUTLIER -166.1 133.63 2.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.34 -0.391 . . . . 2.7000000000000002 110.751 -179.955 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.56 ' HG3' ' HA3' ' A' ' 10' ' ' GLY . 70.4 ttt180 -61.41 146.91 46.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.072 -0.513 . . . . 4.4000000000000004 110.961 179.99 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.3 mt -90.47 144.23 30.44 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.734 -0.667 . . . . 2.0 110.917 -179.683 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -81.08 60.79 7.98 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.706 2.271 . . . . 2.98 112.232 179.865 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 96.4 mt -54.12 111.07 0.69 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.482 -0.781 . . . . 3.6699999999999999 111.13 179.959 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 81.4 mt -80.61 155.86 26.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.047 -0.524 . . . . 5.9699999999999998 111.014 -179.934 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.182 -0.913 . . . . 6.0 111.008 179.976 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.0 t . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.924 0.392 . . . . 0.90000000000000002 110.908 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 85.0 mt -80.26 127.77 32.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.873 -0.603 . . . . 0.89000000000000001 110.757 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -124.56 137.82 54.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.169 -0.468 . . . . 2.73 110.882 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 80.8 p -132.58 132.19 42.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.305 -0.407 . . . . 1.1899999999999999 111.096 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.9 t -118.26 157.55 19.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 0.56000000000000005 110.704 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -109.72 110.01 20.89 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.816 0.341 . . . . 1.74 111.282 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.478 HD11 ' HB2' ' A' ' 60' ' ' ASP . 4.6 mm? -118.6 166.48 12.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.154 -0.475 . . . . 0.81000000000000005 110.318 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.608 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 35.0 p90 -144.14 132.33 21.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.906 0.384 . . . . 2.0800000000000001 111.638 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.536 ' HE ' ' HG ' ' A' ' 27' ' ' LEU . 15.7 tpp85 -97.22 94.75 7.28 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.04 -0.527 . . . . 3.0600000000000001 110.21 179.271 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -130.25 9.93 5.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.383 -0.371 . . . . 2.5800000000000001 111.168 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -110.29 151.22 27.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.435 . . . . 3.7200000000000002 110.836 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -80.68 17.16 1.19 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.068 -0.515 . . . . 2.8700000000000001 110.998 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 63.0 p -69.0 -10.99 60.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 1.3799999999999999 111.157 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.2 m 59.13 20.17 8.13 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.999 -0.546 . . . . 2.4500000000000002 111.194 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 90.0 p -164.26 158.55 19.01 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.956 0.408 . . . . 1.3999999999999999 111.077 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.536 ' HG ' ' HE ' ' A' ' 20' ' ' ARG . 87.4 mt -102.6 -12.09 17.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.064 -0.517 . . . . 0.45000000000000001 110.614 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.531 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 100.15 24.86 9.31 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.831 -0.7 . . . . 0.52000000000000002 112.373 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 75.6 mt -102.56 115.73 45.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.822 0.344 . . . . 0.83999999999999997 110.927 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.7 t -110.67 102.44 11.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.94999999999999996 110.666 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 25.3 pt -99.43 160.53 3.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.40999999999999998 111.447 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 48.1 t -150.85 145.68 25.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.918 -0.583 . . . . 1.3200000000000001 110.726 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 C-N-CA 120.72 -0.752 . . . . 0.94999999999999996 112.609 -179.818 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 41.8 mm . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.667 0.27 . . . . 0.65000000000000002 111.094 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 52.9 p90 -147.34 147.0 29.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.978 0.418 . . . . 0.69999999999999996 111.086 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.1 t -84.27 136.64 22.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.969 -0.559 . . . . 0.39000000000000001 111.223 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -125.96 -25.96 3.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.029 -0.532 . . . . 2.3999999999999999 110.87 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 43.1 t -135.85 170.41 16.02 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.234 -0.439 . . . . 1.28 110.89 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 69.5 mt -141.66 160.28 40.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.211 -0.45 . . . . 0.41999999999999998 110.963 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.531 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 51.0 mt -107.08 102.01 40.96 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.242 -0.435 . . . . 1.26 110.918 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.67 136.25 64.38 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.409 2.073 . . . . 0.81999999999999995 112.31 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 99.91 -12.32 60.79 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.791 -0.718 . . . . 0.48999999999999999 112.691 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 56.3 m -88.19 179.11 6.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.706 0.289 . . . . 1.23 111.023 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.406 ' HB1' HD12 ' A' ' 18' ' ' LEU . . . -63.48 -54.41 36.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.319 -0.401 . . . . 0.41999999999999998 111.455 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.411 ' HB1' HG21 ' A' ' 63' ' ' ILE . . . -54.16 -48.02 71.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 0.34999999999999998 111.744 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.53 -56.76 13.47 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.428 -0.351 . . . . 0.44 111.656 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 81.5 mt -59.86 -20.43 57.05 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.26 -0.427 . . . . 0.66000000000000003 111.527 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.478 ' HB2' HD11 ' A' ' 18' ' ' LEU . 18.2 t70 -58.96 -48.37 81.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.875 0.369 . . . . 1.8600000000000001 110.957 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.46 -48.49 1.11 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.782 -0.723 . . . . 1.0600000000000001 112.689 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -65.24 -23.7 67.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.71 0.29 . . . . 2.5899999999999999 110.921 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.411 HG21 ' HB1' ' A' ' 57' ' ' ALA . 39.8 mm -76.68 98.72 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.267 -0.424 . . . . 0.92000000000000004 110.792 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -107.92 156.3 38.44 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 1.98 110.632 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.96 172.79 5.57 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.448 2.099 . . . . 1.4399999999999999 112.271 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 57.88 74.54 0.42 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.187 -0.461 . . . . 2.1499999999999999 111.243 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -149.6 151.33 33.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 2.02 110.433 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -109.88 114.67 28.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.816 0.341 . . . . 1.02 111.244 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 43.7 mm -70.31 140.03 19.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.069 -0.514 . . . . 0.28999999999999998 110.597 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 90.5 mt -116.89 -65.1 1.22 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.298 -0.41 . . . . 0.40000000000000002 111.274 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -141.2 134.91 30.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.955 0.407 . . . . 2.6099999999999999 111.625 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.662 HG12 ' H ' ' A' ' 73' ' ' ASP . 6.6 t -90.4 175.09 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.861 -0.608 . . . . 0.28000000000000003 109.596 178.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.668 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 18.6 t70 -47.55 108.97 0.18 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.693 0.283 . . . . 0.79000000000000004 111.696 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 54.24 26.26 6.61 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.244 -0.434 . . . . 2.0099999999999998 111.768 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 73' ' ' ASP . 58.2 t -143.02 152.04 17.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.296 -0.411 . . . . 0.79000000000000004 110.696 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.507 ' ND2' ' H ' ' A' ' 78' ' ' GLN . 5.7 t30 -121.06 130.98 54.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.368 -0.378 . . . . 2.2400000000000002 110.718 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.7 m -110.2 17.39 7.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.379 -0.373 . . . . 0.67000000000000004 111.444 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.507 ' H ' ' ND2' ' A' ' 76' ' ' ASN . 14.5 mm100 -85.84 28.92 0.75 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.264 -0.426 . . . . 1.3899999999999999 111.07 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -178.4 19.04 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.56 -0.829 . . . . 0.55000000000000004 112.95 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 43.8 mtm -118.4 146.07 44.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.799 0.333 . . . . 0.52000000000000002 110.711 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.437 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -62.11 155.79 23.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.1 -0.5 . . . . 0.39000000000000001 111.068 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -51.73 -57.76 8.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.425 -0.352 . . . . 1.52 111.178 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.9 t -54.56 -37.88 65.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 1.48 111.306 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -60.94 -45.51 94.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.322 -0.399 . . . . 2.1200000000000001 110.781 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 81' ' ' ALA . 45.6 t -60.09 -34.14 55.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.159 -0.473 . . . . 0.32000000000000001 110.769 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.566 HG12 ' HE ' ' A' ' 90' ' ' ARG . 56.7 t -64.25 -43.93 97.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.111 -0.495 . . . . 0.37 110.533 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -58.1 -41.77 84.22 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.163 -0.471 . . . . 1.51 110.647 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 49.5 t -56.86 -52.52 54.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.954 -0.566 . . . . 0.27000000000000002 111.049 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 71.2 mt -54.41 -36.07 63.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.026 -0.534 . . . . 0.40999999999999998 110.923 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.566 ' HE ' HG12 ' A' ' 86' ' ' VAL . 74.7 mtt180 -75.14 -30.12 60.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 2.1000000000000001 110.872 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -74.68 -18.01 60.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.123 -0.489 . . . . 1.1399999999999999 111.019 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.21 -83.0 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.072 -0.513 . . . . 0.55000000000000004 111.415 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.41 ' H ' ' HG2' ' A' ' 20' ' ' ARG . . . 65.64 11.76 54.53 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.477 -0.868 . . . . 0.76000000000000001 112.315 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -146.7 166.33 16.87 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 110.557 -0.164 . . . . 2.52 110.557 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.608 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 46.2 Cg_exo -57.07 105.1 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.278 1.985 . . . . 0.64000000000000001 111.366 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.7 m -107.29 154.46 8.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.224 0.535 . . . . 0.64000000000000001 111.994 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.668 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 79.6 ttt180 -103.53 143.07 33.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.549 -0.75 . . . . 2.3700000000000001 109.932 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 20.5 mt -114.83 131.01 56.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.249 -0.432 . . . . 0.37 110.972 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 62.2 tp -120.62 99.8 6.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 0.37 110.234 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.46 153.31 48.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.053 -0.522 . . . . 0.31 111.322 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.9 tt -100.91 138.68 24.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.069 -0.514 . . . . 0.45000000000000001 110.708 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 24.8 tpt180 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.437 . . . . 2.2599999999999998 110.885 -179.907 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 46.9 t . . . . . 0 C--O 1.233 0.192 0 CA-C-O 120.756 0.312 . . . . 0.90000000000000002 110.818 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 89.6 mt -79.52 121.58 25.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.013 -0.54 . . . . 0.89000000000000001 110.851 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -113.86 151.44 32.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.123 -0.49 . . . . 2.73 110.961 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 48.5 t -150.47 135.85 17.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.245 -0.434 . . . . 1.1899999999999999 111.073 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.416 HG11 ' HB2' ' A' ' 62' ' ' ARG . 21.7 t -130.29 147.17 33.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.041 -0.527 . . . . 0.56000000000000005 110.806 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -99.13 118.38 35.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.917 0.389 . . . . 1.74 111.076 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.53 HD11 ' HB2' ' A' ' 60' ' ' ASP . 4.2 mm? -116.97 166.91 11.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.937 -0.574 . . . . 0.81000000000000005 110.788 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.595 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 30.4 p90 -160.49 130.5 5.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.247 -0.433 . . . . 2.0800000000000001 111.151 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.652 ' HE ' ' HA2' ' A' ' 93' ' ' GLY . 57.2 ttp180 -112.68 97.43 6.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.399 -0.364 . . . . 3.0600000000000001 110.919 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -95.65 -20.52 18.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.121 -0.491 . . . . 2.5800000000000001 110.702 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -83.75 160.51 21.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.071 -0.513 . . . . 3.7200000000000002 110.953 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -95.23 40.4 1.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.035 -0.53 . . . . 2.8700000000000001 110.902 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 82.1 p -71.93 -13.96 61.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 1.3799999999999999 111.127 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.2 m 57.76 19.1 5.32 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.921 -0.582 . . . . 2.4500000000000002 111.256 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.8 m -154.9 154.93 33.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.435 -0.348 . . . . 1.3999999999999999 111.005 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.468 HD21 ' HB2' ' A' ' 20' ' ' ARG . 52.0 mt -114.02 -24.43 9.04 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.097 -0.501 . . . . 0.45000000000000001 111.141 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.18 -19.98 49.25 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.692 -0.766 . . . . 0.52000000000000002 112.857 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 66.2 mt -61.64 110.27 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.676 0.274 . . . . 0.83999999999999997 110.979 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.6 t -112.25 106.64 15.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.445 . . . . 0.94999999999999996 110.964 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.557 ' HA ' ' HA ' ' A' ' 48' ' ' VAL . 46.3 pt -86.81 -177.88 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.015 -0.539 . . . . 0.40999999999999998 111.144 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.2 t -156.14 146.24 21.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.358 -0.383 . . . . 1.3200000000000001 111.137 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.378 0 C-N-CA 120.836 -0.697 . . . . 0.94999999999999996 112.191 179.653 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.1 mm . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.68 0.276 . . . . 0.65000000000000002 110.929 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -157.53 142.38 16.7 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.278 -0.419 . . . . 0.69999999999999996 111.022 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.557 ' HA ' ' HA ' ' A' ' 31' ' ' ILE . 99.3 t -77.96 127.21 38.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.151 -0.477 . . . . 0.39000000000000001 110.804 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -114.63 -23.22 9.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.031 -0.531 . . . . 2.3999999999999999 111.139 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 78.1 p -146.09 161.76 39.45 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.134 0.492 . . . . 1.28 111.645 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 91.6 mt -133.55 154.35 50.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.662 -0.699 . . . . 0.41999999999999998 110.572 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 49.0 mm -97.24 113.89 63.9 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.346 -0.388 . . . . 1.26 110.846 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -61.58 136.2 61.5 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.414 2.076 . . . . 0.81999999999999995 112.122 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 97.9 -23.29 36.68 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.864 -0.684 . . . . 0.48999999999999999 112.307 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.404 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 67.1 m -73.14 170.86 14.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.619 0.247 . . . . 1.23 111.079 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.64 -55.64 30.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.427 -0.351 . . . . 0.41999999999999998 111.463 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.61 -39.33 57.8 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.203 -0.453 . . . . 0.34999999999999998 111.333 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.69 -46.99 67.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 0.44 111.425 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 55' ' ' SER . 94.8 mt -63.15 -19.68 64.7 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.222 -0.444 . . . . 0.66000000000000003 111.184 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.53 ' HB2' HD11 ' A' ' 18' ' ' LEU . 18.4 t70 -62.5 -50.81 69.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.294 -0.412 . . . . 1.8600000000000001 110.808 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.49 -48.4 1.69 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.761 -0.733 . . . . 1.0600000000000001 113.151 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.416 ' HB2' HG11 ' A' ' 16' ' ' VAL . 21.7 mmm180 -59.93 -29.25 68.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.638 0.256 . . . . 2.5899999999999999 111.204 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 66.1 mt -77.19 111.73 14.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.896 0.379 . . . . 0.92000000000000004 111.254 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -95.69 140.13 22.2 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.994 -0.548 . . . . 1.98 110.293 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -74.1 44.84 1.06 Allowed 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.495 2.13 . . . . 1.4399999999999999 112.963 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -167.75 69.5 0.09 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.285 -0.416 . . . . 2.1499999999999999 110.409 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -146.17 170.85 15.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.486 . . . . 2.02 110.835 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -115.0 104.47 11.94 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.288 -0.414 . . . . 1.02 110.986 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.5 HD13 ' HB3' ' A' ' 100' ' ' LEU . 49.5 mm -58.48 145.49 9.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.159 -0.473 . . . . 0.28999999999999998 111.054 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.439 HD11 ' HB ' ' A' ' 101' ' ' ILE . 92.7 mt -124.35 -67.11 0.94 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.236 -0.438 . . . . 0.40000000000000002 111.453 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 27.2 mtm180 -132.34 134.92 45.78 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.027 0.442 . . . . 2.6099999999999999 111.695 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.607 HG12 ' H ' ' A' ' 73' ' ' ASP . 3.8 t -97.97 172.88 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.761 -0.654 . . . . 0.28000000000000003 110.02 179.18 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.607 ' H ' HG12 ' A' ' 72' ' ' VAL . 28.1 t70 -51.07 108.81 0.27 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.784 0.326 . . . . 0.79000000000000004 111.44 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 59.39 14.21 3.63 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.045 -0.525 . . . . 2.0099999999999998 111.844 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.488 ' HB ' ' HB ' ' A' ' 72' ' ' VAL . 40.9 t -135.56 157.36 39.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.532 -0.304 . . . . 0.79000000000000004 110.849 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.451 ' N ' HG12 ' A' ' 75' ' ' VAL . 3.2 p-10 -129.07 128.61 43.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.396 -0.366 . . . . 2.2400000000000002 110.575 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.0 m -105.29 24.65 2.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.805 0.336 . . . . 0.67000000000000004 111.399 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -90.72 33.6 0.92 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.277 -0.419 . . . . 1.3899999999999999 110.763 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 170.15 23.55 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.77 -0.728 . . . . 0.55000000000000004 112.815 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.433 ' HB2' ' HE2' ' A' ' 80' ' ' MET . 43.3 mtm -119.12 140.74 49.61 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.788 0.327 . . . . 0.52000000000000002 110.668 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.419 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -58.77 156.62 10.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.165 -0.471 . . . . 0.39000000000000001 111.484 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -50.49 -57.81 7.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 1.52 111.272 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 79.3 p -53.67 -38.85 64.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.022 -0.535 . . . . 1.48 111.369 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -61.18 -44.54 97.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.272 -0.422 . . . . 2.1200000000000001 111.024 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 81' ' ' ALA . 47.4 t -59.42 -40.99 83.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.32000000000000001 111.038 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.4 t -62.14 -39.14 82.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.199 -0.455 . . . . 0.37 110.926 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -59.91 -44.79 94.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 1.51 110.778 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 53.3 t -56.92 -54.16 33.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.173 -0.467 . . . . 0.27000000000000002 111.124 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 92.9 mt -55.69 -34.29 64.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.887 -0.597 . . . . 0.40999999999999998 111.364 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 79.3 mtm180 -80.46 -17.1 52.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.299 -0.41 . . . . 2.1000000000000001 111.341 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -89.84 -15.47 32.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.42 -0.354 . . . . 1.1399999999999999 111.142 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.62 -86.64 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.299 -0.41 . . . . 0.55000000000000004 111.512 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.652 ' HA2' ' HE ' ' A' ' 20' ' ' ARG . . . 64.19 15.49 58.77 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.688 -0.768 . . . . 0.76000000000000001 112.279 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.489 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 6.2 p30 -146.92 174.07 3.69 Favored Pre-proline 0 C--N 1.327 -0.37 0 N-CA-C 110.408 -0.219 . . . . 2.52 110.408 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.595 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 46.2 Cg_exo -58.24 107.23 0.31 Allowed 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 121.897 1.731 . . . . 0.64000000000000001 111.477 178.075 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.3 m -116.6 141.54 34.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.164 0.506 . . . . 0.64000000000000001 112.173 -178.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.584 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 75.4 ttt180 -94.61 145.07 25.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.692 -0.685 . . . . 2.3700000000000001 109.707 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 13.5 mt -121.75 136.12 54.94 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.845 0.355 . . . . 0.37 111.366 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 38.5 tp -123.88 104.1 8.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.004 -0.544 . . . . 0.37 110.495 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.5 ' HB3' HD13 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -128.87 147.03 50.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.276 -0.42 . . . . 0.31 111.118 -179.59 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.439 ' HB ' HD11 ' A' ' 70' ' ' LEU . 16.1 tt -98.52 143.84 12.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 0.45000000000000001 111.029 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 13.7 mmm180 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 115.995 -0.548 . . . . 2.2599999999999998 111.013 179.97 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.5 t . . . . . 0 C--O 1.232 0.183 0 CA-C-O 120.883 0.373 . . . . 0.90000000000000002 111.021 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 62.5 mt -81.93 122.18 27.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.919 -0.582 . . . . 0.89000000000000001 110.494 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -113.35 150.73 32.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 2.73 110.964 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 80.3 p -151.05 138.42 19.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 1.1899999999999999 111.264 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.9 t -129.67 145.64 35.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.072 -0.513 . . . . 0.56000000000000005 110.823 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -95.14 114.18 25.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.997 0.427 . . . . 1.74 111.376 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -117.26 166.66 12.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.861 -0.609 . . . . 0.81000000000000005 110.591 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.508 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 30.4 p90 -157.94 134.39 9.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.81 0.338 . . . . 2.0800000000000001 111.073 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.766 ' HE ' ' H ' ' A' ' 93' ' ' GLY . 12.2 ttp180 -121.75 160.27 24.92 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.344 -0.389 . . . . 3.0600000000000001 110.847 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -165.87 -32.83 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.113 -0.494 . . . . 2.5800000000000001 110.845 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -67.76 162.43 23.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.906 -0.588 . . . . 3.7200000000000002 110.939 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -86.26 22.9 1.67 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.12 -0.491 . . . . 2.8700000000000001 110.715 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 74.6 p -63.47 -23.11 67.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.119 -0.491 . . . . 1.3799999999999999 111.095 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.474 ' HA ' ' NH1' ' A' ' 20' ' ' ARG . 52.5 m 56.73 26.19 11.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.822 -0.626 . . . . 2.4500000000000002 111.299 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.7 m -152.24 153.68 34.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.916 0.388 . . . . 1.3999999999999999 111.12 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.541 HD21 ' HB2' ' A' ' 20' ' ' ARG . 81.0 mt -119.77 -5.66 10.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.016 -0.538 . . . . 0.45000000000000001 110.879 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.464 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 89.02 16.78 57.35 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.724 -0.751 . . . . 0.52000000000000002 112.363 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.428 HG22 HG23 ' A' ' 31' ' ' ILE . 69.9 mt -97.19 115.65 37.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.7 0.286 . . . . 0.83999999999999997 110.994 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.1 t -110.66 90.32 3.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.358 -0.383 . . . . 0.94999999999999996 110.734 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.428 HG23 HG22 ' A' ' 29' ' ' ILE . 41.9 pt -87.18 167.52 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.034 -0.53 . . . . 0.40999999999999998 111.197 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 47.5 t -150.6 134.42 16.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.088 -0.505 . . . . 1.3200000000000001 110.792 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.267 0 C-N-CA 120.843 -0.694 . . . . 0.94999999999999996 112.556 -179.863 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.8 mp . . . . . 0 CA--C 1.528 0.117 0 CA-C-O 120.735 0.302 . . . . 0.65000000000000002 110.823 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -145.33 153.07 40.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.162 -0.472 . . . . 0.69999999999999996 110.94 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 95.2 t -83.89 125.79 40.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.247 -0.433 . . . . 0.39000000000000001 111.195 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -108.54 -27.34 9.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.95 -0.568 . . . . 2.3999999999999999 111.001 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 59.2 m -147.71 172.1 14.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.045 0.45 . . . . 1.28 111.633 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 97.1 mt -132.14 165.72 23.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.669 -0.696 . . . . 0.41999999999999998 110.741 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.464 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 43.0 mm -106.36 104.48 50.5 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.186 -0.461 . . . . 1.26 110.958 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.61 129.77 36.68 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.424 2.082 . . . . 0.81999999999999995 112.407 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 98.01 0.44 58.7 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.768 -0.729 . . . . 0.48999999999999999 112.76 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.424 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 27.9 t -100.41 170.88 8.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.637 0.256 . . . . 1.23 110.999 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -51.81 -58.54 6.12 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.226 -0.443 . . . . 0.41999999999999998 111.659 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.3 -32.36 64.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.248 -0.433 . . . . 0.34999999999999998 111.514 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.91 -24.47 55.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.349 -0.387 . . . . 0.44 111.344 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 55' ' ' SER . 90.8 mt -74.7 -37.65 62.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.277 -0.42 . . . . 0.66000000000000003 111.033 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -57.18 -46.83 82.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.401 -0.363 . . . . 1.8600000000000001 110.913 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.46 -34.93 2.65 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.905 -0.664 . . . . 1.0600000000000001 112.709 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 78.0 mtm180 -65.11 -18.46 65.32 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.712 0.292 . . . . 2.5899999999999999 111.096 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 67.8 mt -87.23 108.94 18.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.888 0.375 . . . . 0.92000000000000004 110.919 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -82.67 138.25 44.05 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.011 -0.54 . . . . 1.98 110.5 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.54 53.41 3.98 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.45 2.1 . . . . 1.4399999999999999 112.524 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -174.59 72.09 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.125 -0.489 . . . . 2.1499999999999999 110.531 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -145.23 170.38 16.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.147 -0.479 . . . . 2.02 110.847 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -110.68 107.49 17.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.316 -0.402 . . . . 1.02 111.028 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 43.7 mm -63.0 142.69 16.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.146 -0.479 . . . . 0.28999999999999998 110.732 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 94.4 mt -121.56 -59.22 1.71 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.286 -0.416 . . . . 0.40000000000000002 111.281 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.467 ' HG2' HD22 ' A' ' 76' ' ' ASN . 77.3 mtp180 -142.02 140.92 32.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.025 0.44 . . . . 2.6099999999999999 111.583 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.624 HG12 ' H ' ' A' ' 73' ' ' ASP . 3.9 t -103.41 173.99 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.86 -0.609 . . . . 0.28000000000000003 109.646 178.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.644 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 15.3 t70 -47.28 108.62 0.16 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.736 0.303 . . . . 0.79000000000000004 111.455 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 54.98 31.0 15.14 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.224 -0.444 . . . . 2.0099999999999998 111.576 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.435 ' HB ' ' HB ' ' A' ' 72' ' ' VAL . 92.7 t -145.51 148.14 17.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.354 -0.385 . . . . 0.79000000000000004 110.904 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.467 HD22 ' HG2' ' A' ' 71' ' ' ARG . 22.1 t-20 -120.2 118.33 30.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.148 -0.478 . . . . 2.2400000000000002 110.552 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.8 m -102.21 25.24 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.871 0.367 . . . . 0.67000000000000004 111.455 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -92.28 42.4 1.1 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.166 -0.47 . . . . 1.3899999999999999 110.841 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 158.15 36.79 0.02 OUTLIER Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.661 -0.781 . . . . 0.55000000000000004 112.901 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 57.6 mtm -131.36 146.88 52.47 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.826 0.345 . . . . 0.52000000000000002 110.768 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.27 142.49 31.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.067 -0.515 . . . . 0.39000000000000001 111.029 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -48.07 -54.3 13.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.804 0.335 . . . . 1.52 111.03 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 56.8 m -54.15 -42.93 70.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.987 -0.551 . . . . 1.48 110.98 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -58.1 -43.54 87.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 2.1200000000000001 110.983 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 52.5 t -58.19 -41.63 81.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 0.32000000000000001 110.702 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.3 t -61.61 -37.57 78.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.108 -0.496 . . . . 0.37 110.758 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.483 ' HG2' HH21 ' A' ' 90' ' ' ARG . 42.4 mt-10 -58.92 -48.46 81.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.193 -0.458 . . . . 1.51 110.595 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 55.5 t -54.17 -54.1 23.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.133 -0.485 . . . . 0.27000000000000002 111.193 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.408 HD13 HD12 ' A' ' 29' ' ' ILE . 93.0 mt -59.26 -29.88 67.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.886 -0.597 . . . . 0.40999999999999998 111.456 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.483 HH21 ' HG2' ' A' ' 87' ' ' GLU . 87.3 mtm180 -85.9 -11.46 53.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.414 -0.357 . . . . 2.1000000000000001 111.154 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -100.02 -11.3 20.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.39 -0.368 . . . . 1.1399999999999999 111.178 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.33 -85.03 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.343 -0.39 . . . . 0.55000000000000004 111.571 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.766 ' H ' ' HE ' ' A' ' 20' ' ' ARG . . . 66.61 17.39 66.78 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.637 -0.792 . . . . 0.76000000000000001 112.318 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.407 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 12.6 p30 -146.9 169.62 9.13 Favored Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 110.295 -0.261 . . . . 2.52 110.295 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.508 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 34.6 Cg_exo -58.91 104.1 0.18 Allowed 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.025 1.817 . . . . 0.64000000000000001 111.423 178.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 18.2 m -112.07 152.43 13.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.128 0.49 . . . . 0.64000000000000001 112.209 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.644 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 79.5 ttt180 -104.01 145.01 30.78 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.606 -0.724 . . . . 2.3700000000000001 109.825 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 17.9 mt -115.1 114.33 25.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.197 -0.456 . . . . 0.37 111.137 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 45.0 tp -105.63 102.21 11.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.407 -0.36 . . . . 0.37 110.448 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.4 162.0 31.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.31 111.388 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.2 tt -110.34 139.25 34.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.95 -0.568 . . . . 0.45000000000000001 110.934 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 18.8 tpt180 . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.085 -0.507 . . . . 2.2599999999999998 110.924 179.99 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 48.0 t . . . . . 0 C--O 1.233 0.203 0 CA-C-O 120.905 0.383 . . . . 0.90000000000000002 110.787 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 70.9 mt -81.36 122.03 26.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.98 -0.555 . . . . 0.89000000000000001 110.313 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -113.56 143.33 44.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.298 -0.41 . . . . 2.73 111.055 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 77.7 p -142.31 127.0 18.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.447 . . . . 1.1899999999999999 111.09 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 19.5 t -118.36 143.86 28.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.078 -0.51 . . . . 0.56000000000000005 110.699 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -96.74 114.55 26.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.946 0.403 . . . . 1.74 111.369 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.571 HD11 ' HB2' ' A' ' 60' ' ' ASP . 4.5 mm? -115.47 166.56 11.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.812 -0.631 . . . . 0.81000000000000005 110.558 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.612 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 43.4 p90 -157.8 132.89 8.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.292 -0.413 . . . . 2.0800000000000001 110.979 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.476 ' HB2' HD21 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -112.83 127.43 56.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.452 . . . . 3.0600000000000001 110.599 179.718 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -125.29 -8.63 6.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 2.5800000000000001 110.892 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -91.99 156.71 17.24 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.105 -0.498 . . . . 3.7200000000000002 110.74 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -87.37 34.09 0.69 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 2.8700000000000001 110.748 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 72.0 p -86.07 -21.41 27.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.964 -0.562 . . . . 1.3799999999999999 111.091 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 55.7 m 58.32 17.62 4.86 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.893 -0.594 . . . . 2.4500000000000002 111.398 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 54.5 m -127.84 142.42 51.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.853 0.359 . . . . 1.3999999999999999 111.036 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.476 HD21 ' HB2' ' A' ' 20' ' ' ARG . 95.4 mt -113.4 -13.05 12.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.086 -0.507 . . . . 0.45000000000000001 110.902 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.449 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 91.53 30.78 10.19 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.802 -0.714 . . . . 0.52000000000000002 113.188 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.449 ' HB ' HD13 ' A' ' 89' ' ' LEU . 42.2 mm -101.6 113.31 37.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.676 0.274 . . . . 0.83999999999999997 111.219 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 36.7 t -109.82 97.75 7.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.262 -0.426 . . . . 0.94999999999999996 110.765 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 23.6 pt -86.23 154.0 3.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 0.40999999999999998 111.18 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 48.3 t -131.27 139.17 49.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.091 -0.504 . . . . 1.3200000000000001 110.873 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 C-N-CA 120.768 -0.73 . . . . 0.94999999999999996 112.538 179.924 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.501 HG21 HG11 ' A' ' 85' ' ' VAL . 42.1 mm . . . . . 0 C--O 1.233 0.187 0 CA-C-O 120.893 0.378 . . . . 0.65000000000000002 110.903 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -117.98 137.06 53.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.11 -0.496 . . . . 0.69999999999999996 110.868 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.9 t -66.92 110.47 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.083 -0.508 . . . . 0.39000000000000001 110.793 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -86.57 -28.87 23.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.0 -0.545 . . . . 2.3999999999999999 110.876 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 75.9 p -153.62 168.19 27.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.003 0.43 . . . . 1.28 111.292 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.449 HD11 HG22 ' A' ' 63' ' ' ILE . 87.8 mt -123.76 165.03 17.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.849 -0.614 . . . . 0.41999999999999998 110.865 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.449 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 43.8 mm -112.01 107.95 55.69 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.079 -0.51 . . . . 1.26 110.971 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -60.59 132.32 42.51 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.417 2.078 . . . . 0.81999999999999995 112.276 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.73 -9.44 40.68 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.813 -0.708 . . . . 0.48999999999999999 112.57 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.421 ' OG ' ' HA3' ' A' ' 28' ' ' GLY . 97.0 p -91.91 -173.2 3.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.778 0.323 . . . . 1.23 111.03 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.42 ' HB2' HH21 ' A' ' 20' ' ' ARG . . . -70.95 -52.41 20.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.282 -0.417 . . . . 0.41999999999999998 111.251 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.423 ' HA ' HD11 ' A' ' 18' ' ' LEU . . . -57.53 -42.74 83.48 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.161 -0.472 . . . . 0.34999999999999998 111.555 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.71 -52.93 47.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.278 -0.419 . . . . 0.44 111.729 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.3 mt -64.03 -19.69 65.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.398 -0.365 . . . . 0.66000000000000003 111.424 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.571 ' HB2' HD11 ' A' ' 18' ' ' LEU . 14.3 t70 -57.27 -48.77 78.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.406 -0.361 . . . . 1.8600000000000001 110.863 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.63 -42.15 2.26 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.8 -0.714 . . . . 1.0600000000000001 112.86 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 67.9 mtp180 -70.38 -20.98 62.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.657 0.265 . . . . 2.5899999999999999 111.18 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.449 HG22 HD11 ' A' ' 51' ' ' LEU . 41.3 mm -72.99 134.08 30.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.816 0.341 . . . . 0.92000000000000004 110.833 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -129.77 136.71 29.5 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.105 -0.498 . . . . 1.98 110.707 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.18 168.27 16.26 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.394 2.063 . . . . 1.4399999999999999 112.22 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 63.0 t30 61.89 56.45 2.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.023 -0.535 . . . . 2.1499999999999999 110.614 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -131.92 149.93 52.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.971 -0.559 . . . . 2.02 110.683 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -96.58 117.38 30.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.342 -0.39 . . . . 1.02 111.218 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.606 HD13 ' HB3' ' A' ' 100' ' ' LEU . 46.5 mm -78.0 136.35 24.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 0.28999999999999998 110.714 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.535 HD11 ' HB ' ' A' ' 101' ' ' ILE . 82.6 mt -107.34 -60.19 1.72 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.122 -0.49 . . . . 0.40000000000000002 110.788 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -154.32 137.18 15.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.169 0.509 . . . . 2.6099999999999999 111.377 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.672 HG12 ' H ' ' A' ' 73' ' ' ASP . 2.4 t -87.4 175.85 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.606 -0.724 . . . . 0.28000000000000003 110.138 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.672 ' H ' HG12 ' A' ' 72' ' ' VAL . 24.2 t70 -49.91 110.09 0.35 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.874 0.369 . . . . 0.79000000000000004 111.642 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 56.84 23.85 8.55 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.034 -0.53 . . . . 2.0099999999999998 111.801 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.6 t -142.37 144.4 24.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.437 -0.347 . . . . 0.79000000000000004 110.788 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -112.65 138.18 49.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.484 -0.325 . . . . 2.2400000000000002 110.809 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.0 m -119.91 24.62 4.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.89 0.376 . . . . 0.67000000000000004 111.212 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -95.41 44.85 1.09 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.093 -0.503 . . . . 1.3899999999999999 110.908 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 164.66 24.95 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.612 -0.804 . . . . 0.55000000000000004 112.672 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 38.9 mtm -124.01 142.23 51.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.714 0.292 . . . . 0.52000000000000002 110.721 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.408 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -65.11 163.12 15.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.268 -0.423 . . . . 0.39000000000000001 111.041 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.404 ' O ' HG23 ' A' ' 86' ' ' VAL . 34.8 tt0 -48.83 -52.54 23.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.205 -0.452 . . . . 1.52 111.343 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 80.1 p -54.13 -42.23 69.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.116 -0.493 . . . . 1.48 111.534 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -62.24 -43.91 97.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.47 -0.332 . . . . 2.1200000000000001 111.471 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.501 HG11 HG21 ' A' ' 46' ' ' ILE . 21.7 t -61.48 -43.82 97.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.855 0.359 . . . . 0.32000000000000001 111.175 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 82' ' ' GLN . 59.4 t -59.88 -41.02 84.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.069 -0.514 . . . . 0.37 111.154 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.51 ' HG2' HH21 ' A' ' 90' ' ' ARG . 44.0 mt-10 -59.46 -44.45 92.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 1.51 110.967 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 71.8 t -57.82 -57.39 10.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 0.27000000000000002 111.574 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.449 HD13 ' HB ' ' A' ' 29' ' ' ILE . 86.8 mt -52.24 -34.93 48.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.049 -0.523 . . . . 0.40999999999999998 111.376 -179.204 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.51 HH21 ' HG2' ' A' ' 87' ' ' GLU . 65.1 mtm180 -78.09 -29.12 48.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.39 -0.368 . . . . 2.1000000000000001 111.011 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -71.03 -22.58 62.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 1.1399999999999999 110.852 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.06 -86.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.115 -0.493 . . . . 0.55000000000000004 111.279 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.462 ' HA2' ' HG2' ' A' ' 20' ' ' ARG . . . 60.76 17.04 48.61 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.676 -0.773 . . . . 0.76000000000000001 112.472 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.487 ' HB3' ' HD2' ' A' ' 95' ' ' PRO . 50.5 m-20 -147.52 175.13 2.88 Favored Pre-proline 0 CA--C 1.533 0.297 0 C-N-CA 122.001 0.121 . . . . 2.52 110.909 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.612 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 50.8 Cg_exo -56.28 104.93 0.15 Allowed 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 122.121 1.88 . . . . 0.64000000000000001 111.762 178.226 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 30.5 m -125.45 150.31 30.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.027 0.441 . . . . 0.64000000000000001 111.896 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.628 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 77.2 ttt180 -98.05 145.33 26.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.714 -0.675 . . . . 2.3700000000000001 109.856 179.258 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 16.0 mt -119.89 125.33 48.21 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.329 -0.396 . . . . 0.37 111.247 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 50.8 tp -112.78 100.03 8.36 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.404 -0.362 . . . . 0.37 110.723 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.606 ' HB3' HD13 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -124.39 141.65 51.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.961 -0.563 . . . . 0.31 111.184 -179.897 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.535 ' HB ' HD11 ' A' ' 70' ' ' LEU . 15.0 tt -97.31 141.93 15.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.469 . . . . 0.45000000000000001 111.126 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.031 -0.531 . . . . 2.2599999999999998 110.839 179.933 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 46.8 t . . . . . 0 C--O 1.233 0.217 0 CA-C-O 120.749 0.309 . . . . 0.90000000000000002 110.824 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 62.2 mt -78.87 121.25 24.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.113 -0.494 . . . . 0.89000000000000001 110.772 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.401 ' CD1' ' HB2' ' A' ' 102' ' ' ARG . 57.7 m-85 -114.88 129.15 56.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.038 0.447 . . . . 2.73 111.194 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 48.4 t -101.36 137.17 40.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.843 -0.617 . . . . 1.1899999999999999 111.084 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.1 t -131.28 158.38 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.047 -0.524 . . . . 0.56000000000000005 110.526 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -136.35 112.93 10.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.827 0.346 . . . . 1.74 111.257 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.557 HD12 ' HB1' ' A' ' 56' ' ' ALA . 4.0 mm? -122.88 166.64 14.7 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.084 -0.507 . . . . 0.81000000000000005 110.737 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.572 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 34.1 p90 -141.18 131.26 24.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.289 -0.414 . . . . 2.0800000000000001 111.019 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.529 HH21 ' HG ' ' A' ' 27' ' ' LEU . 14.5 ttm180 -102.48 93.53 5.2 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.38 -0.373 . . . . 3.0600000000000001 110.91 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -130.08 -0.08 4.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.35 -0.387 . . . . 2.5800000000000001 110.824 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -88.25 161.09 17.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.067 -0.515 . . . . 3.7200000000000002 110.881 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -84.46 39.72 0.74 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.14 -0.482 . . . . 2.8700000000000001 110.865 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 71.5 p -98.06 -19.48 17.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.281 -0.418 . . . . 1.3799999999999999 111.175 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 29.3 t 56.83 17.39 3.21 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.0 -0.545 . . . . 2.4500000000000002 111.194 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.8 m -151.95 153.74 34.69 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.294 -0.412 . . . . 1.3999999999999999 110.947 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.529 ' HG ' HH21 ' A' ' 20' ' ' ARG . 58.2 mt -102.88 -20.65 14.2 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.134 -0.485 . . . . 0.45000000000000001 110.837 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.504 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 101.8 3.69 52.19 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.767 -0.73 . . . . 0.52000000000000002 112.742 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 44.9 mm -76.27 109.01 9.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.729 0.299 . . . . 0.83999999999999997 111.044 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 44.4 t -110.75 92.8 4.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.341 -0.391 . . . . 0.94999999999999996 110.82 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 26.7 pt -91.01 167.8 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.968 -0.56 . . . . 0.40999999999999998 111.22 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 77.8 p -137.95 142.26 40.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.02 -0.536 . . . . 1.3200000000000001 110.853 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.247 0 C-N-CA 120.873 -0.679 . . . . 0.94999999999999996 112.516 -179.998 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 44.3 mm . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.712 0.291 . . . . 0.65000000000000002 110.804 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -148.48 144.99 27.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.337 -0.392 . . . . 0.69999999999999996 111.117 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 97.1 t -83.37 126.17 40.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.029 -0.532 . . . . 0.39000000000000001 110.649 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -107.32 -21.95 12.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 2.3999999999999999 110.912 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 76.9 p -152.39 169.64 22.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 1.28 111.2 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 67.8 mt -134.59 165.5 25.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.941 -0.572 . . . . 0.41999999999999998 110.771 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.504 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 47.5 mm -107.6 99.21 27.79 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 1.26 110.877 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -49.69 141.17 27.93 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.564 2.176 . . . . 0.81999999999999995 112.652 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 95.66 -22.93 36.41 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.88 -0.676 . . . . 0.48999999999999999 112.562 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 83.6 p -76.3 -178.19 4.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.733 0.301 . . . . 1.23 111.059 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.557 ' HB1' HD12 ' A' ' 18' ' ' LEU . . . -66.15 -56.87 9.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.316 -0.402 . . . . 0.41999999999999998 111.229 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.11 -34.46 66.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.458 . . . . 0.34999999999999998 111.314 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.14 -43.05 71.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.28 -0.418 . . . . 0.44 111.288 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.4 mt -67.93 -19.62 65.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.257 -0.428 . . . . 0.66000000000000003 111.118 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -57.33 -46.88 82.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.444 -0.343 . . . . 1.8600000000000001 110.891 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.61 -50.32 1.81 Allowed Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.77 -0.729 . . . . 1.0600000000000001 112.87 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 66.4 mtm180 -64.08 -42.55 96.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.634 0.254 . . . . 2.5899999999999999 111.017 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 61.5 mt -63.86 114.4 2.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.369 -0.378 . . . . 0.92000000000000004 110.962 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -130.5 158.56 74.19 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 1.98 111.179 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -55.0 174.73 0.19 Allowed 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.734 2.29 . . . . 1.4399999999999999 112.211 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 17.4 m120 61.66 35.58 17.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.195 -0.457 . . . . 2.1499999999999999 111.122 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -112.96 152.71 29.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.152 -0.476 . . . . 2.02 110.649 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -116.02 105.81 13.06 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.83 0.347 . . . . 1.02 111.138 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 44.1 mm -63.7 131.82 29.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.195 -0.457 . . . . 0.28999999999999998 110.983 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 66.9 mt -102.37 -65.69 0.97 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.134 -0.484 . . . . 0.40000000000000002 110.802 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -146.84 135.31 21.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.988 -0.551 . . . . 2.6099999999999999 111.296 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.657 HG12 ' H ' ' A' ' 73' ' ' ASP . 3.7 t -87.99 175.22 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.622 -0.717 . . . . 0.28000000000000003 109.983 179.324 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.657 ' H ' HG12 ' A' ' 72' ' ' VAL . 21.3 t70 -48.63 109.28 0.23 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.803 0.335 . . . . 0.79000000000000004 111.586 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 56.15 26.37 10.16 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.113 -0.494 . . . . 2.0099999999999998 111.853 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.5 t -145.6 149.26 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.406 -0.361 . . . . 0.79000000000000004 110.777 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -119.06 131.72 55.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.32 -0.4 . . . . 2.2400000000000002 110.459 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.463 ' HA ' ' HE2' ' A' ' 80' ' ' MET . 30.0 m -105.25 26.43 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.879 0.371 . . . . 0.67000000000000004 111.287 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -94.93 23.79 5.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.096 -0.502 . . . . 1.3899999999999999 111.114 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -172.79 17.06 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.641 -0.79 . . . . 0.55000000000000004 112.8 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.463 ' HE2' ' HA ' ' A' ' 77' ' ' VAL . 38.6 mtm -118.05 135.9 53.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.831 0.348 . . . . 0.52000000000000002 110.849 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.91 160.08 18.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.436 . . . . 0.39000000000000001 111.097 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -48.25 -54.21 14.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.374 -0.376 . . . . 1.52 111.249 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 46.1 t -53.88 -32.84 54.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.327 -0.397 . . . . 1.48 111.244 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.499 ' O ' HG23 ' A' ' 88' ' ' VAL . 10.4 t70 -73.35 -40.13 64.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.366 -0.379 . . . . 2.1200000000000001 111.0 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 25.8 t -65.12 -30.32 49.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.961 0.41 . . . . 0.32000000000000001 110.661 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 97.5 t -70.94 -49.27 51.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.985 -0.552 . . . . 0.37 111.187 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.433 ' HG2' ' O ' ' A' ' 84' ' ' ASP . 11.4 pt-20 -60.44 -30.01 69.37 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.722 0.296 . . . . 1.51 110.752 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 84' ' ' ASP . 50.2 t -65.27 -56.66 14.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.893 0.378 . . . . 0.27000000000000002 110.825 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 93.5 mt -54.93 -35.19 63.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.957 -0.565 . . . . 0.40999999999999998 111.378 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.466 ' HA ' ' NH1' ' A' ' 20' ' ' ARG . 86.9 mtm180 -76.96 -34.32 57.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.424 -0.353 . . . . 2.1000000000000001 111.17 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -70.29 -18.36 63.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.436 -0.347 . . . . 1.1399999999999999 110.682 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.43 -84.51 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.133 -0.485 . . . . 0.55000000000000004 111.464 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.487 ' H ' ' HD2' ' A' ' 20' ' ' ARG . . . 63.63 22.2 65.75 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.692 -0.766 . . . . 0.76000000000000001 112.186 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -147.17 169.81 8.77 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 110.39 -0.226 . . . . 2.52 110.39 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.572 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 33.3 Cg_exo -60.79 93.02 0.1 OUTLIER 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.055 1.837 . . . . 0.64000000000000001 111.248 178.163 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.5 m -101.79 145.64 11.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.085 0.469 . . . . 0.64000000000000001 111.918 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.629 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 60.4 ttp180 -91.88 136.44 33.16 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.694 -0.685 . . . . 2.3700000000000001 110.157 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 65.5 mt -111.65 103.74 12.06 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.975 -0.557 . . . . 0.37 111.187 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 21.4 tp -97.51 106.77 19.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.889 0.376 . . . . 0.37 110.158 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.96 164.93 26.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.31 111.434 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 12.4 tt -110.34 133.75 54.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.031 -0.532 . . . . 0.45000000000000001 111.033 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.401 ' HB2' ' CD1' ' A' ' 14' ' ' TYR . 18.2 mmm180 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 115.968 -0.56 . . . . 2.2599999999999998 110.508 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.9 t . . . . . 0 CA--C 1.527 0.088 0 CA-C-O 120.669 0.271 . . . . 0.90000000000000002 110.685 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 56.0 mt -81.65 122.56 27.77 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.293 -0.412 . . . . 0.89000000000000001 111.166 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -121.15 130.58 53.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.066 -0.515 . . . . 2.73 110.84 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 47.6 t -125.57 132.9 52.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.31 -0.405 . . . . 1.1899999999999999 111.214 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 18.3 t -131.13 151.29 35.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.968 -0.56 . . . . 0.56000000000000005 110.606 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -101.2 118.71 37.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.958 0.408 . . . . 1.74 111.446 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.566 HD23 HD12 ' A' ' 98' ' ' LEU . 4.3 mm? -122.23 166.45 14.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.945 -0.57 . . . . 0.81000000000000005 110.191 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.587 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 36.9 p90 -141.86 131.83 24.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.85 0.357 . . . . 2.0800000000000001 111.078 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.432 ' HB2' HD21 ' A' ' 27' ' ' LEU . 3.2 tmm_? -100.83 104.82 16.06 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.21 -0.45 . . . . 3.0600000000000001 110.712 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -146.43 8.88 1.05 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.311 -0.404 . . . . 2.5800000000000001 110.953 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -89.75 162.75 15.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.253 -0.431 . . . . 3.7200000000000002 110.958 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -84.05 34.13 0.5 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.108 -0.497 . . . . 2.8700000000000001 110.958 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 51.6 p -98.1 -8.96 26.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.182 -0.463 . . . . 1.3799999999999999 110.881 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.7 t 58.35 15.92 3.75 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.829 -0.623 . . . . 2.4500000000000002 111.098 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 57.3 m -158.04 -176.96 6.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.262 -0.426 . . . . 1.3999999999999999 110.902 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.432 HD21 ' HB2' ' A' ' 20' ' ' ARG . 37.4 mt -115.28 -5.1 12.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.042 -0.526 . . . . 0.45000000000000001 110.794 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.491 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 94.82 6.27 60.71 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.779 -0.724 . . . . 0.52000000000000002 112.171 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 25.0 mm -79.61 109.24 14.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.817 0.341 . . . . 0.83999999999999997 110.958 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.7 m -113.33 93.35 4.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.176 -0.465 . . . . 0.94999999999999996 110.796 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 44.6 pt -93.03 163.3 2.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.40999999999999998 111.2 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 45.3 t -119.08 130.66 55.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.259 -0.428 . . . . 1.3200000000000001 110.792 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.237 0 C-N-CA 120.849 -0.691 . . . . 0.94999999999999996 112.623 -179.973 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 49.7 mm . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.719 0.295 . . . . 0.65000000000000002 110.895 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -143.59 137.67 28.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.69999999999999996 111.094 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 99.4 t -68.08 127.81 30.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.113 -0.494 . . . . 0.39000000000000001 111.051 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -99.96 -30.58 11.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.912 -0.586 . . . . 2.3999999999999999 110.999 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 80.1 p -157.17 171.62 20.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.894 0.378 . . . . 1.28 111.296 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.433 HD11 HG22 ' A' ' 63' ' ' ILE . 63.6 mt -129.26 140.55 51.4 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.921 -0.582 . . . . 0.41999999999999998 110.88 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.491 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 49.5 mm -77.15 118.0 68.95 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 116.21 -0.45 . . . . 1.26 110.899 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -68.25 109.43 1.99 Allowed 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.268 1.979 . . . . 0.81999999999999995 112.255 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 126.93 -5.46 7.39 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.849 -0.691 . . . . 0.48999999999999999 112.448 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.8 m -94.07 -174.83 3.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.709 0.29 . . . . 1.23 111.086 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.51 ' HB1' HD12 ' A' ' 18' ' ' LEU . . . -72.48 -42.8 64.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.379 -0.373 . . . . 0.41999999999999998 111.348 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.98 -42.57 99.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.298 -0.41 . . . . 0.34999999999999998 111.451 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.03 -55.24 11.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.44 111.317 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.3 mt -59.25 -19.67 47.75 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.3 -0.409 . . . . 0.66000000000000003 111.23 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.48 ' HB2' HD11 ' A' ' 18' ' ' LEU . 18.8 t70 -59.96 -49.74 76.5 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.837 0.351 . . . . 1.8600000000000001 110.746 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 98.71 -49.73 1.27 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.905 -0.664 . . . . 1.0600000000000001 112.987 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 51.3 mtp180 -60.33 -45.09 94.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.749 0.309 . . . . 2.5899999999999999 111.134 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.433 HG22 HD11 ' A' ' 51' ' ' LEU . 71.9 mt -67.59 114.18 4.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.906 0.384 . . . . 0.92000000000000004 111.111 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -117.29 139.75 26.41 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.025 -0.534 . . . . 1.98 110.568 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -47.62 167.18 0.09 OUTLIER 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.557 2.171 . . . . 1.4399999999999999 112.73 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 63.97 60.78 0.99 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.094 -0.503 . . . . 2.1499999999999999 110.554 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -134.28 156.66 48.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.788 -0.642 . . . . 2.02 110.579 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -109.47 113.29 25.96 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.867 0.365 . . . . 1.02 111.073 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 34.2 mm -74.05 143.36 13.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.076 -0.511 . . . . 0.28999999999999998 110.857 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 74.7 mt -116.17 -66.51 1.08 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.312 -0.404 . . . . 0.40000000000000002 111.392 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 76.8 mtp180 -140.22 142.45 35.83 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.041 0.448 . . . . 2.6099999999999999 111.558 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.652 HG12 ' H ' ' A' ' 73' ' ' ASP . 3.6 t -100.83 174.48 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.871 -0.604 . . . . 0.28000000000000003 109.788 179.108 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.689 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 12.7 t70 -49.76 108.66 0.22 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.727 0.299 . . . . 0.79000000000000004 111.191 179.326 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 55.21 29.7 13.23 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.198 -0.455 . . . . 2.0099999999999998 111.542 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.502 ' HB ' ' HB ' ' A' ' 72' ' ' VAL . 92.4 t -145.36 151.78 14.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.417 -0.356 . . . . 0.79000000000000004 110.947 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -120.66 126.1 49.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.32 -0.4 . . . . 2.2400000000000002 110.565 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.9 m -107.56 19.84 5.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 111.708 0.262 . . . . 0.67000000000000004 111.708 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -94.26 21.72 6.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.92 0.39 . . . . 1.3899999999999999 110.465 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -161.68 13.09 0.14 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.004 -0.617 . . . . 0.55000000000000004 112.429 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 52.9 mtm -118.83 144.65 46.22 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.859 0.361 . . . . 0.52000000000000002 110.825 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.4 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -71.87 168.02 18.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.12 -0.491 . . . . 0.39000000000000001 111.086 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.448 ' O ' HG23 ' A' ' 86' ' ' VAL . 63.0 tt0 -49.5 -56.43 9.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.138 -0.483 . . . . 1.52 111.447 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 54.6 m -51.38 -43.31 61.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 1.48 111.837 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -60.68 -50.53 73.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.465 -0.334 . . . . 2.1200000000000001 111.507 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 81' ' ' ALA . 25.7 t -57.86 -36.46 55.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.293 -0.412 . . . . 0.32000000000000001 111.327 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 82' ' ' GLN . 90.6 t -62.54 -48.95 85.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.36 -0.382 . . . . 0.37 111.391 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -56.73 -41.46 77.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.339 -0.392 . . . . 1.51 111.143 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 75.1 t -57.33 -58.96 3.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.255 -0.43 . . . . 0.27000000000000002 111.696 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 86.5 mt -54.22 -32.16 55.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 0.40999999999999998 111.58 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 82.6 mtm180 -81.47 -23.47 37.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.503 -0.317 . . . . 2.1000000000000001 111.276 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -84.14 -14.26 50.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.34 -0.391 . . . . 1.1399999999999999 110.955 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.03 -81.61 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.162 -0.472 . . . . 0.55000000000000004 111.49 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.409 ' H ' ' HE ' ' A' ' 20' ' ' ARG . . . 63.84 15.29 57.72 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 120.625 -0.797 . . . . 0.76000000000000001 112.253 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -146.85 167.94 12.57 Favored Pre-proline 0 C--N 1.329 -0.303 0 N-CA-C 110.333 -0.247 . . . . 2.52 110.333 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.587 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 34.3 Cg_exo -61.94 98.38 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.051 1.834 . . . . 0.64000000000000001 111.338 178.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.6 m -104.44 153.67 6.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.129 0.49 . . . . 0.64000000000000001 112.108 -178.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.689 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 40.3 ttm180 -93.04 141.26 28.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.459 -0.791 . . . . 2.3700000000000001 110.063 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.566 HD12 HD23 ' A' ' 18' ' ' LEU . 48.9 mt -117.37 103.58 10.28 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.149 -0.478 . . . . 0.37 110.848 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 58.5 tp -99.29 99.63 10.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.37 110.34 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.2 165.86 20.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.31 111.093 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.9 tt -114.33 130.23 68.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-O 121.096 0.474 . . . . 0.45000000000000001 111.447 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 23.0 mmm180 . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 115.443 -0.799 . . . . 2.2599999999999998 110.642 179.818 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 46.6 t . . . . . 0 C--O 1.233 0.205 0 CA-C-O 120.796 0.331 . . . . 0.90000000000000002 110.788 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -84.77 126.09 33.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.89000000000000001 111.211 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -121.16 136.09 55.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.897 -0.592 . . . . 2.73 110.586 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 49.4 m -136.75 127.57 27.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.284 -0.416 . . . . 1.1899999999999999 111.205 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 28.3 t -129.86 145.98 34.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.986 -0.552 . . . . 0.56000000000000005 110.61 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -107.92 117.51 34.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.949 0.404 . . . . 1.74 111.311 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.518 HD11 ' HB2' ' A' ' 60' ' ' ASP . 4.3 mm? -111.05 166.46 11.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.855 -0.611 . . . . 0.81000000000000005 110.763 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.569 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 28.6 p90 -152.95 132.47 12.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.388 -0.369 . . . . 2.0800000000000001 111.084 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.564 HH21 ' H ' ' A' ' 93' ' ' GLY . 24.2 ttp180 -122.37 156.2 34.46 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.271 -0.422 . . . . 3.0600000000000001 110.637 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -169.39 26.45 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.311 -0.404 . . . . 2.5800000000000001 110.84 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -116.78 164.7 14.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.176 -0.466 . . . . 3.7200000000000002 110.91 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -87.58 25.99 1.36 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.999 -0.546 . . . . 2.8700000000000001 111.007 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.4 p -78.26 -23.94 47.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.927 0.394 . . . . 1.3799999999999999 110.902 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 59.2 m 56.59 21.75 6.05 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.683 -0.69 . . . . 2.4500000000000002 111.339 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.7 m -140.03 144.69 37.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.287 -0.415 . . . . 1.3999999999999999 111.058 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 41.4 mt -113.56 12.48 18.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.125 -0.489 . . . . 0.45000000000000001 110.91 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.501 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 58.29 37.54 87.49 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.833 -0.699 . . . . 0.52000000000000002 112.715 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 65.9 mt -109.51 109.48 28.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.791 0.329 . . . . 0.83999999999999997 111.144 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 39.5 t -105.64 112.24 25.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.072 -0.513 . . . . 0.94999999999999996 110.633 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.407 HD12 HG23 ' A' ' 46' ' ' ILE . 37.1 pt -107.84 167.13 3.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 0.40999999999999998 111.509 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 56.8 m -141.56 134.89 29.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.965 -0.561 . . . . 1.3200000000000001 110.623 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 C-N-CA 120.754 -0.736 . . . . 0.94999999999999996 112.598 -179.897 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.407 HG23 HD12 ' A' ' 31' ' ' ILE . 48.3 mm . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.728 0.299 . . . . 0.65000000000000002 110.648 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -128.48 142.36 51.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.258 -0.428 . . . . 0.69999999999999996 111.22 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 86.3 t -76.9 113.02 15.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.11 -0.496 . . . . 0.39000000000000001 110.47 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -88.35 -29.41 20.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.276 -0.42 . . . . 2.3999999999999999 111.331 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 78.4 p -153.35 176.82 11.56 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.936 0.398 . . . . 1.28 111.377 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 69.8 mt -135.58 153.45 51.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.933 -0.576 . . . . 0.41999999999999998 110.882 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.501 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 57.7 mt -90.33 109.71 35.54 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.312 -0.404 . . . . 1.26 110.947 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -57.73 124.95 17.23 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.426 2.084 . . . . 0.81999999999999995 112.331 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.93 -3.86 31.92 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.774 -0.727 . . . . 0.48999999999999999 112.498 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.9 t -100.09 177.86 4.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.743 0.306 . . . . 1.23 110.94 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.48 -58.34 8.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.263 -0.426 . . . . 0.41999999999999998 111.755 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.46 -49.83 66.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.225 -0.443 . . . . 0.34999999999999998 111.844 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.75 -39.45 80.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.385 -0.37 . . . . 0.44 111.876 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 81.1 mt -70.75 -23.0 62.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.503 -0.317 . . . . 0.66000000000000003 111.319 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.518 ' HB2' HD11 ' A' ' 18' ' ' LEU . 15.2 t70 -60.51 -56.23 23.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.829 0.347 . . . . 1.8600000000000001 110.862 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 98.35 -46.34 1.56 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.828 -0.701 . . . . 1.0600000000000001 113.159 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 38.0 mtp180 -60.54 -26.88 67.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.63 0.252 . . . . 2.5899999999999999 111.513 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 70.7 mt -73.06 102.24 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.946 0.403 . . . . 0.92000000000000004 111.04 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -93.98 136.18 23.99 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.001 -0.545 . . . . 1.98 110.574 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.46 171.89 1.68 Allowed 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.41 2.074 . . . . 1.4399999999999999 112.34 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 58.97 29.35 18.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.992 -0.549 . . . . 2.1499999999999999 110.902 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.438 ' OD1' ' HB2' ' A' ' 100' ' ' LEU . 11.9 t0 -102.31 140.07 37.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.046 -0.524 . . . . 2.02 110.405 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -87.32 127.83 35.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.755 0.312 . . . . 1.02 111.202 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 39.9 mm -90.56 136.56 23.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.287 -0.415 . . . . 0.28999999999999998 110.672 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 89.5 mt -107.29 -64.38 1.2 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.326 -0.397 . . . . 0.40000000000000002 111.157 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -147.75 135.12 20.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.074 0.464 . . . . 2.6099999999999999 111.704 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.675 HG12 ' H ' ' A' ' 73' ' ' ASP . 3.1 t -89.81 175.4 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.614 -0.721 . . . . 0.28000000000000003 110.084 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.675 ' H ' HG12 ' A' ' 72' ' ' VAL . 16.6 t70 -47.24 109.21 0.19 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.721 0.296 . . . . 0.79000000000000004 111.688 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 54.36 28.77 9.85 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.095 -0.502 . . . . 2.0099999999999998 111.73 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.474 HG11 HG11 ' A' ' 88' ' ' VAL . 66.6 t -145.67 147.06 18.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.39 -0.368 . . . . 0.79000000000000004 110.714 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -116.44 128.6 55.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.26 -0.427 . . . . 2.2400000000000002 110.515 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.5 m -109.98 26.44 2.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.818 0.342 . . . . 0.67000000000000004 111.353 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -97.05 24.48 6.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.451 . . . . 1.3899999999999999 111.046 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -170.23 15.2 0.06 OUTLIER Glycine 0 C--N 1.329 0.194 0 C-N-CA 120.543 -0.837 . . . . 0.55000000000000004 112.768 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 47.2 mtm -117.56 142.46 47.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.852 0.358 . . . . 0.52000000000000002 110.98 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.41 ' HB3' ' OD2' ' A' ' 84' ' ' ASP . . . -66.29 165.13 14.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.091 -0.504 . . . . 0.39000000000000001 110.99 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.401 ' O ' HG23 ' A' ' 86' ' ' VAL . 36.0 tt0 -50.01 -56.72 9.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.315 -0.402 . . . . 1.52 111.369 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.3 t -51.89 -39.92 59.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.251 -0.431 . . . . 1.48 111.456 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.41 ' OD2' ' HB3' ' A' ' 81' ' ' ALA . 11.6 m-20 -64.29 -47.07 80.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.487 -0.324 . . . . 2.1200000000000001 111.129 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 54.3 t -58.06 -32.64 44.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.306 -0.406 . . . . 0.32000000000000001 110.886 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.41 HG12 ' NE ' ' A' ' 90' ' ' ARG . 75.0 t -68.72 -42.28 82.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.14 -0.482 . . . . 0.37 110.957 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.436 ' HG2' HH21 ' A' ' 90' ' ' ARG . 44.7 mt-10 -56.74 -46.55 81.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.839 0.352 . . . . 1.51 110.801 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.474 HG11 HG11 ' A' ' 75' ' ' VAL . 53.0 t -59.09 -56.18 18.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.228 -0.442 . . . . 0.27000000000000002 111.011 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 82.3 mt -58.73 -22.11 56.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.916 -0.584 . . . . 0.40999999999999998 111.355 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.436 HH21 ' HG2' ' A' ' 87' ' ' GLU . 80.4 mtm180 -89.04 -21.96 23.19 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.596 -0.275 . . . . 2.1000000000000001 111.177 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -86.5 -15.69 39.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.496 -0.32 . . . . 1.1399999999999999 111.001 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.97 -87.73 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.256 -0.429 . . . . 0.55000000000000004 111.377 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.564 ' H ' HH21 ' A' ' 20' ' ' ARG . . . 61.68 21.45 60.65 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.809 -0.71 . . . . 0.76000000000000001 112.613 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.455 ' HB3' ' HD2' ' A' ' 95' ' ' PRO . 69.2 m-20 -147.24 173.84 3.87 Favored Pre-proline 0 C--N 1.328 -0.345 0 C-N-CA 121.936 0.094 . . . . 2.52 110.846 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.569 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 37.1 Cg_exo -59.15 90.82 0.07 OUTLIER 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.141 1.894 . . . . 0.64000000000000001 111.783 178.347 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 28.8 m -104.73 153.48 6.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.64000000000000001 111.937 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.654 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 52.1 ttp180 -99.23 145.12 27.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.689 -0.687 . . . . 2.3700000000000001 110.282 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.501 HD12 HD23 ' A' ' 18' ' ' LEU . 46.5 mt -120.78 106.21 11.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.261 -0.427 . . . . 0.37 111.26 -179.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 22.2 tp -99.3 107.45 19.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.389 -0.369 . . . . 0.37 110.116 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.438 ' HB2' ' OD1' ' A' ' 67' ' ' ASP . 0.4 OUTLIER -135.36 163.3 30.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.954 0.406 . . . . 0.31 111.539 -179.159 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 15.7 tt -120.9 141.03 43.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.927 -0.579 . . . . 0.45000000000000001 110.965 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.402 ' HB2' ' OD2' ' A' ' 67' ' ' ASP . 25.7 tpt180 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.11 -0.495 . . . . 2.2599999999999998 110.776 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.1 t . . . . . 0 C--O 1.233 0.186 0 CA-C-O 120.765 0.317 . . . . 0.90000000000000002 110.549 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 70.7 mt -84.66 122.93 29.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.182 -0.463 . . . . 0.89000000000000001 111.049 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -116.71 149.19 40.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.044 -0.525 . . . . 2.73 111.044 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 81.8 p -149.35 130.12 14.17 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.187 -0.461 . . . . 1.1899999999999999 111.121 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 19.0 t -125.55 153.25 33.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 0.56000000000000005 110.577 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -101.36 117.93 35.95 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.9 0.381 . . . . 1.74 111.692 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.412 HD11 ' HB2' ' A' ' 60' ' ' ASP . 4.5 mm? -114.14 166.27 11.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.874 -0.603 . . . . 0.81000000000000005 110.375 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.58 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 42.3 p90 -156.93 137.03 12.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.714 0.292 . . . . 2.0800000000000001 111.305 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.466 HH21 ' H ' ' A' ' 93' ' ' GLY . 21.3 ttp180 -129.96 153.22 48.58 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.313 -0.403 . . . . 3.0600000000000001 111.1 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -155.69 -34.49 0.09 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.048 -0.523 . . . . 2.5800000000000001 111.054 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -59.92 164.18 4.08 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.09 -0.505 . . . . 3.7200000000000002 110.936 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -93.96 33.98 1.28 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 2.8700000000000001 110.994 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 74.6 p -78.6 -13.34 59.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.277 -0.419 . . . . 1.3799999999999999 111.136 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 97.2 p 50.22 24.09 1.37 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.615 -0.721 . . . . 2.4500000000000002 111.605 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 47.7 t -141.84 135.37 29.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.841 0.353 . . . . 1.3999999999999999 111.03 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 19.0 mt -103.45 -20.64 13.98 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.136 -0.483 . . . . 0.45000000000000001 110.951 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.476 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 97.88 10.89 51.59 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.785 -0.721 . . . . 0.52000000000000002 112.579 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 67.3 mt -94.03 110.69 23.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.721 0.296 . . . . 0.83999999999999997 111.139 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 46.5 t -112.42 114.21 26.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.244 -0.434 . . . . 0.94999999999999996 110.72 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 43.0 pt -100.55 177.84 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.241 -0.436 . . . . 0.40999999999999998 111.287 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 62.8 m -158.0 132.38 8.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.882 -0.599 . . . . 1.3200000000000001 110.636 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 C-N-CA 120.634 -0.793 . . . . 0.94999999999999996 112.446 -179.889 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 43.9 mm . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.827 0.346 . . . . 0.65000000000000002 110.982 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -139.02 138.57 37.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.164 -0.471 . . . . 0.69999999999999996 111.072 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 85.5 t -74.01 120.44 23.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.297 -0.411 . . . . 0.39000000000000001 110.822 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -99.77 -22.24 15.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 2.3999999999999999 111.254 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 84.1 p -155.88 170.04 23.01 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.058 0.456 . . . . 1.28 111.557 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 90.6 mt -128.71 170.27 13.5 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.607 -0.724 . . . . 0.41999999999999998 110.401 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.476 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 43.1 mm -109.74 98.53 33.8 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.36 -0.382 . . . . 1.26 111.084 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.79 111.54 0.76 Allowed 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.596 2.197 . . . . 0.81999999999999995 112.312 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.15 1.9 7.85 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.794 -0.717 . . . . 0.48999999999999999 112.49 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.0 t -112.01 -176.7 2.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.692 0.282 . . . . 1.23 110.89 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.15 -53.1 61.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.368 -0.378 . . . . 0.41999999999999998 111.298 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.48 -46.55 70.03 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.169 -0.468 . . . . 0.34999999999999998 111.275 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.95 -37.57 88.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.076 -0.511 . . . . 0.44 111.262 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 82.7 mt -73.87 -19.64 60.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.89 0.376 . . . . 0.66000000000000003 110.894 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.412 ' HB2' HD11 ' A' ' 18' ' ' LEU . 26.5 t70 -66.7 -52.04 49.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.109 -0.496 . . . . 1.8600000000000001 110.843 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 89.88 -44.49 3.0 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.846 -0.692 . . . . 1.0600000000000001 113.22 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.406 ' HB2' ' OD2' ' A' ' 60' ' ' ASP . 22.2 mmm180 -59.66 -22.32 61.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.686 0.279 . . . . 2.5899999999999999 111.126 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 52.6 mt -82.53 109.98 17.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.879 0.371 . . . . 0.92000000000000004 111.003 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.401 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 39.9 tt0 -101.42 135.67 19.79 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 1.98 110.57 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 64' ' ' GLU . 40.7 Cg_exo -57.2 172.18 0.96 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.453 2.102 . . . . 1.4399999999999999 112.44 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 59.33 26.89 15.84 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.918 -0.583 . . . . 2.1499999999999999 111.275 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -94.5 158.87 15.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.341 -0.391 . . . . 2.02 110.645 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -107.76 124.24 49.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.77 0.319 . . . . 1.02 110.927 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.548 HD13 ' HB3' ' A' ' 100' ' ' LEU . 45.9 mm -87.33 140.31 15.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.191 -0.459 . . . . 0.28999999999999998 110.983 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 71.6 mt -115.88 -60.58 1.85 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.206 -0.452 . . . . 0.40000000000000002 110.946 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.466 ' O ' ' HB3' ' A' ' 99' ' ' LEU . 81.2 mtt180 -144.72 138.66 27.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 2.6099999999999999 111.254 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.634 HG12 ' H ' ' A' ' 73' ' ' ASP . 4.4 t -94.13 173.82 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.963 -0.562 . . . . 0.28000000000000003 109.941 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.645 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 19.1 t70 -47.67 108.81 0.17 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.703 0.287 . . . . 0.79000000000000004 111.516 179.424 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 54.83 29.15 11.42 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.194 -0.457 . . . . 2.0099999999999998 111.506 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.463 ' HB ' ' HB ' ' A' ' 72' ' ' VAL . 86.5 t -145.51 151.08 15.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.047 -0.524 . . . . 0.79000000000000004 110.627 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -120.75 129.34 53.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.484 -0.325 . . . . 2.2400000000000002 110.77 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.9 m -107.35 23.84 3.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-O 120.808 0.337 . . . . 0.67000000000000004 111.366 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -96.71 38.31 1.23 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.293 -0.412 . . . . 1.3899999999999999 110.692 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 175.94 28.43 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.721 -0.752 . . . . 0.55000000000000004 112.76 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 60.3 mtm -132.39 141.81 49.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.93 0.395 . . . . 0.52000000000000002 110.976 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.443 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -69.05 161.85 28.15 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.994 -0.548 . . . . 0.39000000000000001 110.919 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -45.73 -57.1 4.52 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.195 -0.457 . . . . 1.52 111.638 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.4 m -50.62 -43.44 56.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.178 -0.465 . . . . 1.48 111.565 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -63.8 -42.9 97.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.359 -0.382 . . . . 2.1200000000000001 111.471 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 81' ' ' ALA . 38.9 t -59.63 -38.73 77.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 120.857 0.361 . . . . 0.32000000000000001 110.988 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 52.4 t -66.74 -36.58 77.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.11 -0.496 . . . . 0.37 110.968 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -60.1 -49.16 78.74 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.217 -0.447 . . . . 1.51 110.714 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.405 HG11 HG11 ' A' ' 75' ' ' VAL . 53.7 t -56.75 -53.52 40.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.082 -0.508 . . . . 0.27000000000000002 111.27 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 79.2 mt -53.89 -32.62 53.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.077 -0.51 . . . . 0.40999999999999998 111.277 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.465 ' HA ' HH22 ' A' ' 20' ' ' ARG . 85.0 mtm180 -81.64 -24.06 36.58 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.256 -0.429 . . . . 2.1000000000000001 111.115 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -78.4 -17.96 55.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.276 -0.42 . . . . 1.1399999999999999 110.835 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.68 -89.62 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.091 -0.504 . . . . 0.55000000000000004 111.474 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.466 ' H ' HH21 ' A' ' 20' ' ' ARG . . . 60.48 21.86 58.12 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.702 -0.761 . . . . 0.76000000000000001 112.429 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -147.13 174.79 3.11 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 110.461 -0.199 . . . . 2.52 110.461 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.58 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 38.2 Cg_exo -59.18 97.53 0.1 OUTLIER 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.021 1.814 . . . . 0.64000000000000001 111.641 178.271 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 28.8 m -114.53 151.56 16.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.129 0.49 . . . . 0.64000000000000001 111.893 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.645 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 75.2 ttt180 -102.1 145.24 29.62 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.673 -0.694 . . . . 2.3700000000000001 110.082 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 18.3 mt -115.49 116.18 27.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.187 -0.46 . . . . 0.37 111.378 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.466 ' HB3' ' O ' ' A' ' 71' ' ' ARG . 63.6 tp -104.46 99.89 9.58 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.16 -0.473 . . . . 0.37 110.261 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.548 ' HB3' HD13 ' A' ' 69' ' ' ILE . 0.5 OUTLIER -129.82 158.25 39.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.197 -0.456 . . . . 0.31 111.394 -179.519 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.0 tt -110.37 140.39 29.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.45000000000000001 110.949 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.081 -0.509 . . . . 2.2599999999999998 110.942 -179.927 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.3 t . . . . . 0 C--O 1.233 0.23 0 CA-C-O 120.854 0.359 . . . . 0.90000000000000002 110.891 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 79.8 mt -76.11 119.19 19.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.0 -0.545 . . . . 0.89000000000000001 110.739 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -120.08 132.11 55.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 2.73 111.0 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 79.0 p -137.34 126.94 25.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.286 -0.416 . . . . 1.1899999999999999 110.972 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.17 141.53 46.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.219 -0.446 . . . . 0.56000000000000005 110.952 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -96.18 116.34 28.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 1.74 111.54 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.438 HD11 ' HB2' ' A' ' 60' ' ' ASP . 4.5 mm? -114.92 166.61 11.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.98 -0.555 . . . . 0.81000000000000005 110.125 179.33 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.539 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 15.1 p90 -147.11 123.1 10.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.769 0.319 . . . . 2.0800000000000001 111.149 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.578 ' HB2' HD21 ' A' ' 27' ' ' LEU . 14.9 ttp180 -95.61 96.84 9.3 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.325 -0.398 . . . . 3.0600000000000001 110.687 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -107.69 -19.98 13.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.985 -0.552 . . . . 2.5800000000000001 110.672 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -82.37 148.64 28.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.954 -0.566 . . . . 3.7200000000000002 110.794 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -85.96 47.59 1.48 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.188 -0.46 . . . . 2.8700000000000001 110.974 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 65.1 p -87.38 -10.04 53.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.484 . . . . 1.3799999999999999 111.182 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.2 t 58.05 20.3 6.76 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.988 -0.551 . . . . 2.4500000000000002 111.248 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 60.5 m -157.47 160.95 38.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.272 -0.422 . . . . 1.3999999999999999 110.965 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.578 HD21 ' HB2' ' A' ' 20' ' ' ARG . 77.2 mt -113.61 -14.66 12.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.112 -0.494 . . . . 0.45000000000000001 110.78 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.528 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 93.81 29.99 9.38 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.823 -0.703 . . . . 0.52000000000000002 112.406 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.437 HD12 HD22 ' A' ' 89' ' ' LEU . 77.7 mt -109.79 109.25 27.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.737 0.303 . . . . 0.83999999999999997 111.05 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 40.0 t -111.03 100.44 9.13 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.29 -0.414 . . . . 0.94999999999999996 110.844 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 40.6 pt -92.71 179.66 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.087 -0.506 . . . . 0.40999999999999998 111.175 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 82.0 p -135.42 136.83 41.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.053 -0.521 . . . . 1.3200000000000001 110.929 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.254 0 C-N-CA 120.862 -0.685 . . . . 0.94999999999999996 112.434 -179.943 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.3 mm . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.801 0.334 . . . . 0.65000000000000002 110.787 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.414 ' HB2' ' O ' ' A' ' 67' ' ' ASP . 27.0 p90 -145.4 145.46 31.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.322 -0.399 . . . . 0.69999999999999996 111.091 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 99.7 t -82.16 129.29 37.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.089 -0.505 . . . . 0.39000000000000001 111.061 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.2 ttpp -102.02 -24.48 13.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.996 -0.547 . . . . 2.3999999999999999 110.946 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 79.6 p -155.12 156.24 35.45 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.037 0.446 . . . . 1.28 111.36 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 77.1 mt -114.28 162.97 15.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.775 -0.648 . . . . 0.41999999999999998 110.626 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.528 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 62.4 mt -109.7 101.97 48.43 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.367 -0.378 . . . . 1.26 111.248 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -52.11 146.44 30.44 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.586 2.191 . . . . 0.81999999999999995 112.577 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.4 -22.37 30.38 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.827 -0.701 . . . . 0.48999999999999999 112.581 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 67.4 m -80.93 -177.94 6.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.784 0.325 . . . . 1.23 111.071 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.65 -55.09 16.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.218 -0.447 . . . . 0.41999999999999998 111.472 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.63 -39.86 65.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.103 -0.499 . . . . 0.34999999999999998 111.843 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.35 -42.86 71.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.401 -0.363 . . . . 0.44 111.438 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.0 mt -70.95 -19.67 62.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.334 -0.394 . . . . 0.66000000000000003 110.992 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.438 ' HB2' HD11 ' A' ' 18' ' ' LEU . 26.0 t70 -59.52 -56.13 25.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 1.8600000000000001 110.945 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.2 -48.71 1.1 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.768 -0.73 . . . . 1.0600000000000001 112.957 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -57.4 -32.05 66.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.761 0.315 . . . . 2.5899999999999999 111.153 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 68.1 mt -76.83 127.91 37.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.304 -0.407 . . . . 0.92000000000000004 111.095 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -125.49 138.16 31.29 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 116.139 -0.482 . . . . 1.98 110.81 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_exo -52.94 165.9 1.08 Allowed 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.59 2.193 . . . . 1.4399999999999999 112.441 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 18.0 m120 60.18 45.65 11.38 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.046 -0.525 . . . . 2.1499999999999999 110.755 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.414 ' O ' ' HB2' ' A' ' 47' ' ' TYR . 27.1 t70 -118.16 159.77 22.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.935 -0.575 . . . . 2.02 110.505 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.494 ' HB3' HG23 ' A' ' 101' ' ' ILE . 87.6 tttt -105.18 128.29 53.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.843 0.354 . . . . 1.02 111.181 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 41.6 mm -94.9 142.18 13.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.055 -0.52 . . . . 0.28999999999999998 110.727 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 56.5 mt -111.31 -73.75 0.67 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 0.40000000000000002 111.129 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.8 ptp180 -147.29 137.85 23.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.174 0.512 . . . . 2.6099999999999999 111.779 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.678 HG12 ' H ' ' A' ' 73' ' ' ASP . 3.8 t -84.68 176.01 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.528 -0.76 . . . . 0.28000000000000003 109.771 179.004 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.678 ' H ' HG12 ' A' ' 72' ' ' VAL . 6.6 t70 -44.25 109.0 0.13 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.17 0.434 . . . . 0.79000000000000004 112.17 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 52.39 27.87 5.29 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.443 0.535 . . . . 2.0099999999999998 112.443 178.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.406 ' O ' ' N ' ' A' ' 72' ' ' VAL . 88.1 t -148.66 140.11 17.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.725 0.298 . . . . 0.79000000000000004 110.88 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 25.4 m-80 -100.23 141.86 32.49 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.922 -0.399 . . . . 2.2400000000000002 109.922 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.8 m -122.59 -16.23 5.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 N-CA-C 112.104 0.409 . . . . 0.67000000000000004 112.104 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -87.08 25.98 1.25 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.921 0.391 . . . . 1.3899999999999999 110.886 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -141.3 1.72 1.94 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.869 -0.682 . . . . 0.55000000000000004 112.557 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 51.4 mtm -123.99 172.14 9.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.748 0.309 . . . . 0.52000000000000002 110.768 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.5 168.71 14.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.39000000000000001 111.125 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.406 ' O ' HG23 ' A' ' 86' ' ' VAL . 63.4 tt0 -58.97 -47.3 85.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.44 -0.345 . . . . 1.52 110.902 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.9 m -55.46 -31.72 62.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 1.48 111.304 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -71.98 -39.27 69.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.355 -0.384 . . . . 2.1200000000000001 111.042 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.2 t -67.75 -35.99 74.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.969 0.414 . . . . 0.32000000000000001 111.021 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.485 HG12 ' NE ' ' A' ' 90' ' ' ARG . 56.5 t -70.32 -47.22 67.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.009 -0.541 . . . . 0.37 111.598 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -58.86 -40.75 85.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.714 -0.221 . . . . 1.51 111.085 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 52.4 t -60.04 -54.88 28.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 120.924 0.392 . . . . 0.27000000000000002 111.115 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.437 HD22 HD12 ' A' ' 29' ' ' ILE . 66.8 mt -56.83 -27.89 60.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.993 -0.549 . . . . 0.40999999999999998 111.006 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.485 ' NE ' HG12 ' A' ' 86' ' ' VAL . 76.1 mtm180 -89.24 -15.09 34.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.371 -0.377 . . . . 2.1000000000000001 111.514 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -93.47 -10.04 36.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.417 -0.356 . . . . 1.1399999999999999 111.114 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -48.9 -85.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.266 -0.425 . . . . 0.55000000000000004 111.574 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.481 ' H ' ' HE ' ' A' ' 20' ' ' ARG . . . 62.25 14.59 48.23 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.695 -0.764 . . . . 0.76000000000000001 112.556 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -146.97 169.85 8.74 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 110.54 -0.17 . . . . 2.52 110.54 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.539 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 24.4 Cg_exo -65.13 92.26 0.21 Allowed 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.223 1.948 . . . . 0.64000000000000001 111.326 178.215 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 33.8 m -100.15 153.46 4.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.067 -0.515 . . . . 0.64000000000000001 111.577 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.676 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 56.2 ttp180 -102.72 138.07 40.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.969 -0.559 . . . . 2.3700000000000001 109.816 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 45.4 mt -107.7 109.42 21.01 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.262 -0.426 . . . . 0.37 111.137 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 31.7 tp -99.79 100.66 11.64 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.374 -0.375 . . . . 0.37 110.172 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -130.37 161.95 30.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.111 -0.495 . . . . 0.31 111.373 -179.303 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.494 HG23 ' HB3' ' A' ' 68' ' ' LYS . 14.2 tt -114.06 135.68 52.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.917 -0.583 . . . . 0.45000000000000001 110.862 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.003 -0.544 . . . . 2.2599999999999998 110.555 179.966 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 46.6 t . . . . . 0 C--O 1.233 0.228 0 CA-C-O 120.77 0.319 . . . . 0.90000000000000002 110.78 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 62.3 mt -75.09 120.9 21.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.168 -0.469 . . . . 0.89000000000000001 110.749 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -114.53 124.19 51.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.089 -0.505 . . . . 2.73 111.328 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 44.9 t -103.27 142.75 33.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 1.1899999999999999 110.79 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.4 t -136.41 158.16 37.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.238 -0.437 . . . . 0.56000000000000005 110.666 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -121.93 114.34 20.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.935 0.398 . . . . 1.74 111.353 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.558 HD11 ' HB2' ' A' ' 60' ' ' ASP . 4.4 mm? -119.58 166.82 12.65 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.033 -0.53 . . . . 0.81000000000000005 110.787 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.605 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 30.1 p90 -148.8 129.45 14.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.282 -0.417 . . . . 2.0800000000000001 110.964 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.508 ' HB2' HD21 ' A' ' 27' ' ' LEU . 15.1 ttp180 -106.5 107.66 18.78 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.794 0.33 . . . . 3.0600000000000001 111.006 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -131.29 -5.67 3.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.299 -0.409 . . . . 2.5800000000000001 111.036 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -81.69 170.2 16.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.396 -0.365 . . . . 3.7200000000000002 110.874 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -93.47 30.04 1.83 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.136 -0.484 . . . . 2.8700000000000001 110.959 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 71.6 p -84.25 -14.35 50.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.45 . . . . 1.3799999999999999 110.863 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 35.2 t 59.17 20.63 8.65 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.849 -0.614 . . . . 2.4500000000000002 111.18 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 83.0 p -160.56 175.27 12.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.941 0.4 . . . . 1.3999999999999999 110.992 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.508 HD21 ' HB2' ' A' ' 20' ' ' ARG . 33.5 mt -115.0 -10.35 12.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.827 -0.624 . . . . 0.45000000000000001 110.877 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.452 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 87.86 18.33 56.44 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.782 -0.723 . . . . 0.52000000000000002 112.754 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 70.9 mt -91.36 108.5 19.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.822 0.344 . . . . 0.83999999999999997 110.847 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 41.9 t -103.14 102.66 12.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.134 -0.485 . . . . 0.94999999999999996 110.958 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.5 pt -100.34 165.68 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.82 -0.627 . . . . 0.40999999999999998 111.291 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.6 m -149.04 145.19 27.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.917 -0.583 . . . . 1.3200000000000001 110.474 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 C-N-CA 120.68 -0.771 . . . . 0.94999999999999996 112.598 -179.846 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 37.2 mm . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.761 0.315 . . . . 0.65000000000000002 110.703 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -131.38 143.31 50.38 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.218 -0.446 . . . . 0.69999999999999996 111.201 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 84.1 t -84.54 128.6 38.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.051 -0.522 . . . . 0.39000000000000001 110.837 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -107.89 -24.1 11.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.301 -0.408 . . . . 2.3999999999999999 110.952 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.6 t -150.94 170.47 19.24 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.972 0.415 . . . . 1.28 111.44 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 91.3 mt -135.25 157.21 47.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.816 -0.629 . . . . 0.41999999999999998 110.583 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.452 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 62.8 mt -101.46 104.05 31.3 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 1.26 111.01 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -55.16 132.5 52.67 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.429 2.086 . . . . 0.81999999999999995 112.224 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 110.55 -24.13 18.34 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.801 -0.714 . . . . 0.48999999999999999 112.544 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 63.2 m -80.91 -178.45 6.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.75 0.31 . . . . 1.23 110.921 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.74 -52.35 51.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.384 -0.371 . . . . 0.41999999999999998 111.494 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.27 -34.61 64.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.25 -0.432 . . . . 0.34999999999999998 111.616 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.79 -50.02 33.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.33 -0.395 . . . . 0.44 111.248 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 80.7 mt -64.02 -19.7 65.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.131 -0.486 . . . . 0.66000000000000003 110.988 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.558 ' HB2' HD11 ' A' ' 18' ' ' LEU . 26.6 t70 -62.05 -56.13 22.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 1.8600000000000001 110.91 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 97.42 -51.24 1.4 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.698 -0.763 . . . . 1.0600000000000001 113.01 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 84.4 mtm180 -55.98 -28.07 55.51 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.743 0.306 . . . . 2.5899999999999999 111.285 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 67.0 mt -81.05 106.25 11.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.292 -0.413 . . . . 0.92000000000000004 110.746 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -108.11 137.53 19.88 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 1.98 110.546 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -53.41 175.52 0.1 Allowed 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.57 2.18 . . . . 1.4399999999999999 112.725 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 61.77 37.58 15.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.918 -0.583 . . . . 2.1499999999999999 110.913 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -113.15 161.93 16.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.991 -0.55 . . . . 2.02 110.553 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.411 ' HB3' HG23 ' A' ' 101' ' ' ILE . 87.6 tttt -110.55 116.71 31.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.822 0.344 . . . . 1.02 111.087 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.443 HD13 ' HB3' ' A' ' 100' ' ' LEU . 42.0 mm -77.17 146.22 8.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.489 . . . . 0.28999999999999998 110.834 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 55.3 mt -123.22 -61.59 1.4 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.241 -0.436 . . . . 0.40000000000000002 111.257 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 66.8 mtp180 -144.47 142.73 30.47 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.096 0.474 . . . . 2.6099999999999999 111.808 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.626 HG12 ' H ' ' A' ' 73' ' ' ASP . 9.9 t -99.89 173.92 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.611 -0.722 . . . . 0.28000000000000003 109.582 179.016 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.626 ' H ' HG12 ' A' ' 72' ' ' VAL . 16.8 t70 -46.82 108.44 0.14 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.711 0.291 . . . . 0.79000000000000004 111.418 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 53.32 33.84 16.54 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.18 -0.464 . . . . 2.0099999999999998 111.716 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.411 ' HB ' ' HB ' ' A' ' 72' ' ' VAL . 87.9 t -147.96 147.81 16.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.409 -0.359 . . . . 0.79000000000000004 110.842 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -115.44 124.89 52.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.346 -0.388 . . . . 2.2400000000000002 110.405 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.6 m -106.96 24.46 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 CA-C-O 120.783 0.325 . . . . 0.67000000000000004 111.52 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 19.2 mm-40 -96.23 34.12 1.64 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.272 -0.422 . . . . 1.3899999999999999 110.734 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 175.0 22.65 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.757 -0.735 . . . . 0.55000000000000004 112.811 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 54.6 mtm -117.98 144.42 45.54 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.873 0.368 . . . . 0.52000000000000002 110.965 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.449 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -61.19 158.27 14.37 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.977 -0.556 . . . . 0.39000000000000001 111.41 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -51.41 -62.14 1.81 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.141 -0.481 . . . . 1.52 111.33 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 81.6 p -52.78 -33.53 49.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.014 -0.539 . . . . 1.48 111.389 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -63.16 -43.46 98.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.512 -0.313 . . . . 2.1200000000000001 110.925 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 81' ' ' ALA . 18.2 t -61.89 -38.94 81.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.297 -0.411 . . . . 0.32000000000000001 110.605 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.1 t -63.22 -36.54 76.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.983 -0.553 . . . . 0.37 110.991 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -63.62 -47.74 80.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.15 -0.477 . . . . 1.51 110.977 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 54.4 t -53.86 -54.23 21.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.224 -0.443 . . . . 0.27000000000000002 111.107 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 79.0 mt -57.58 -32.93 67.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.40999999999999998 110.94 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 85.2 mtm180 -80.6 -13.5 59.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.312 -0.404 . . . . 2.1000000000000001 111.212 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -95.62 -13.88 23.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 1.1399999999999999 110.692 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.19 -83.53 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.998 -0.547 . . . . 0.55000000000000004 111.588 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.478 ' H ' ' HE ' ' A' ' 20' ' ' ARG . . . 62.38 15.72 52.76 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.61 -0.805 . . . . 0.76000000000000001 112.152 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 12.9 p30 -147.08 169.81 8.78 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 110.6 -0.148 . . . . 2.52 110.6 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.605 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 32.9 Cg_exo -61.59 98.27 0.16 Allowed 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.258 1.972 . . . . 0.64000000000000001 111.429 177.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 23.6 m -106.42 150.46 9.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.082 0.467 . . . . 0.64000000000000001 111.858 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.622 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 80.9 mtp180 -97.13 140.57 31.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.811 -0.632 . . . . 2.3700000000000001 110.247 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 30.3 mt -115.03 111.89 21.8 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.041 -0.527 . . . . 0.37 110.951 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 43.3 tp -102.5 104.74 15.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 0.37 110.75 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.443 ' HB3' HD13 ' A' ' 69' ' ' ILE . 0.4 OUTLIER -134.13 156.43 48.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.212 -0.449 . . . . 0.31 111.045 -179.797 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.411 HG23 ' HB3' ' A' ' 68' ' ' LYS . 12.0 tt -104.61 136.17 39.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.23 -0.441 . . . . 0.45000000000000001 111.046 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 25.4 mmm180 . . . . . 0 C--N 1.332 -0.185 0 CA-C-N 115.866 -0.606 . . . . 2.2599999999999998 110.844 -179.986 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 46.1 t . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.887 0.375 . . . . 0.90000000000000002 110.795 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 75.4 mt -79.03 121.46 24.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.89000000000000001 110.924 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -117.31 154.53 31.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.111 -0.495 . . . . 2.73 110.877 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 84.4 p -151.2 134.82 16.33 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.344 -0.389 . . . . 1.1899999999999999 111.302 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.1 t -132.23 144.96 35.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.149 -0.478 . . . . 0.56000000000000005 110.675 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.439 ' C ' HD22 ' A' ' 18' ' ' LEU . 1.8 mp0 -94.89 115.22 27.19 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.842 0.353 . . . . 1.74 111.59 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.587 HD23 HD12 ' A' ' 98' ' ' LEU . 4.3 mm? -123.24 125.47 45.13 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.986 -0.552 . . . . 0.81000000000000005 110.472 179.422 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.587 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 39.0 p90 -103.44 132.93 49.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.404 -0.362 . . . . 2.0800000000000001 111.21 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.622 ' HE ' ' HA2' ' A' ' 93' ' ' GLY . 19.2 ttp180 -102.31 95.26 6.18 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.881 0.372 . . . . 3.0600000000000001 110.882 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -103.01 -21.37 13.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.056 0.455 . . . . 2.5800000000000001 110.425 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.432 ' HB3' HG23 ' A' ' 24' ' ' THR . 75.0 mmtt -85.16 140.8 30.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.704 -0.68 . . . . 3.7200000000000002 110.659 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -83.37 37.4 0.56 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 2.8700000000000001 111.077 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.432 HG23 ' HB3' ' A' ' 22' ' ' LYS . 57.4 p -73.0 -11.97 60.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 1.3799999999999999 110.979 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 36.5 t 59.54 15.72 4.77 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.025 -0.534 . . . . 2.4500000000000002 111.014 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 53.6 m -147.97 138.09 22.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.124 -0.489 . . . . 1.3999999999999999 110.971 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.442 HD21 ' HB2' ' A' ' 20' ' ' ARG . 88.2 mt -97.55 -22.98 16.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.068 -0.514 . . . . 0.45000000000000001 110.852 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.523 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 110.43 3.85 28.93 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.808 -0.71 . . . . 0.52000000000000002 112.502 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.468 ' N ' HD12 ' A' ' 29' ' ' ILE . 3.0 mp -88.23 114.93 27.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.822 0.344 . . . . 0.83999999999999997 111.012 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 45.0 t -111.89 93.32 4.4 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.103 -0.499 . . . . 0.94999999999999996 110.522 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.499 ' HA ' ' HA ' ' A' ' 48' ' ' VAL . 44.6 pt -87.87 164.18 2.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.101 -0.499 . . . . 0.40999999999999998 111.432 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 56.3 m -143.47 134.61 25.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.773 -0.649 . . . . 1.3200000000000001 110.415 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.225 0 C-N-CA 120.614 -0.803 . . . . 0.94999999999999996 112.816 -179.567 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 43.8 mm . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.779 0.323 . . . . 0.65000000000000002 110.901 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -140.17 137.37 34.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.69999999999999996 111.104 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.499 ' HA ' ' HA ' ' A' ' 31' ' ' ILE . 58.3 t -77.63 139.26 18.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.991 -0.55 . . . . 0.39000000000000001 110.852 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -120.58 -28.46 4.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 2.3999999999999999 111.116 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 56.3 m -143.82 173.28 11.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.15 0.5 . . . . 1.28 111.594 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 82.1 mt -137.42 161.94 34.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.603 -0.726 . . . . 0.41999999999999998 110.55 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.523 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 71.6 mt -106.74 102.14 40.44 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.485 -0.325 . . . . 1.26 111.218 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.6 129.51 35.46 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.59 2.193 . . . . 0.81999999999999995 112.42 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 110.93 -17.46 27.3 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.794 -0.717 . . . . 0.48999999999999999 112.353 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 57.7 m -85.24 -176.67 6.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.719 0.295 . . . . 1.23 110.85 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.21 -52.55 32.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.916 0.388 . . . . 0.41999999999999998 111.171 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.22 -37.9 75.75 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.045 -0.525 . . . . 0.34999999999999998 111.659 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.99 -54.59 14.45 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.341 -0.391 . . . . 0.44 111.572 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.7 mt -60.34 -20.28 58.72 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.343 -0.39 . . . . 0.66000000000000003 111.09 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.508 ' HB2' HD11 ' A' ' 18' ' ' LEU . 33.3 t70 -59.59 -49.34 78.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.252 -0.431 . . . . 1.8600000000000001 110.927 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.11 -44.9 2.98 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.864 -0.684 . . . . 1.0600000000000001 113.043 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 76.6 mtp180 -61.42 -22.13 64.73 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.688 0.28 . . . . 2.5899999999999999 111.077 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.506 ' HA ' HH22 ' A' ' 102' ' ' ARG . 63.2 mt -89.92 116.13 30.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.353 -0.385 . . . . 0.92000000000000004 111.119 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.421 ' H ' ' NH2' ' A' ' 102' ' ' ARG . 36.2 tt0 -117.59 140.02 26.98 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.041 -0.527 . . . . 1.98 110.532 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.34 -178.57 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.578 2.185 . . . . 1.4399999999999999 112.295 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 60.97 44.88 9.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.444 . . . . 2.1499999999999999 110.681 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -126.54 177.33 6.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.084 -0.507 . . . . 2.02 110.734 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -130.72 122.48 27.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.427 -0.351 . . . . 1.02 111.118 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 39.8 mm -75.04 143.93 12.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.28999999999999998 110.618 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 71.9 mt -122.54 -66.13 1.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.927 0.394 . . . . 0.40000000000000002 111.428 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.4 ' HB2' HD23 ' A' ' 99' ' ' LEU . 21.5 mtp180 -134.4 138.11 44.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 2.6099999999999999 111.609 -179.312 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.593 HG12 ' H ' ' A' ' 73' ' ' ASP . 7.6 t -105.32 172.34 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.773 -0.649 . . . . 0.28000000000000003 109.624 178.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.607 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 13.1 t70 -46.81 107.98 0.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.872 0.367 . . . . 0.79000000000000004 111.766 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 49.12 22.43 0.62 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.906 -0.588 . . . . 2.0099999999999998 112.208 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 98.2 t -144.49 104.78 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.775 0.321 . . . . 0.79000000000000004 111.589 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -70.67 144.49 51.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.314 -0.403 . . . . 2.2400000000000002 110.371 179.387 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 18.3 m -127.89 32.88 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.841 0.353 . . . . 0.67000000000000004 111.464 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -100.32 31.64 3.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.157 -0.474 . . . . 1.3899999999999999 111.109 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -178.56 40.6 0.08 OUTLIER Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.478 -0.868 . . . . 0.55000000000000004 112.848 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 68.2 mtm -138.29 145.05 40.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.852 0.358 . . . . 0.52000000000000002 110.879 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.464 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -66.97 160.75 25.76 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.061 -0.518 . . . . 0.39000000000000001 111.155 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -47.81 -53.49 15.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.185 -0.461 . . . . 1.52 111.515 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.7 t -52.51 -38.47 59.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.292 -0.413 . . . . 1.48 111.389 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -68.89 -38.5 79.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.312 -0.404 . . . . 2.1200000000000001 111.32 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 81' ' ' ALA . 17.5 t -62.51 -42.38 95.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.468 -0.333 . . . . 0.32000000000000001 110.933 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.0 t -65.63 -36.34 77.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.491 . . . . 0.37 111.025 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -58.93 -49.36 78.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.213 -0.449 . . . . 1.51 110.857 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 56.0 t -57.89 -53.16 48.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.295 -0.411 . . . . 0.27000000000000002 111.369 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 83.6 mt -58.88 -31.51 68.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.40999999999999998 111.385 -179.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.454 ' HA ' ' NH1' ' A' ' 20' ' ' ARG . 69.7 mtm180 -85.43 -12.16 52.65 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.546 -0.297 . . . . 2.1000000000000001 111.269 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -97.61 -11.62 23.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.289 -0.414 . . . . 1.1399999999999999 110.942 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.94 -85.62 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.213 -0.448 . . . . 0.55000000000000004 111.52 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.622 ' HA2' ' HE ' ' A' ' 20' ' ' ARG . . . 63.09 19.82 61.94 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.685 -0.769 . . . . 0.76000000000000001 112.548 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.651 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 12.6 p30 -147.21 168.59 10.99 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 110.407 -0.22 . . . . 2.52 110.407 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.651 ' HD2' ' HB2' ' A' ' 94' ' ' ASN . 19.6 Cg_endo -60.47 89.91 0.08 OUTLIER 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.089 1.86 . . . . 0.64000000000000001 111.325 178.285 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.422 ' HB ' ' HB2' ' A' ' 73' ' ' ASP . 17.3 m -100.13 151.98 4.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.998 -0.546 . . . . 0.64000000000000001 112.087 -178.689 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.607 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 59.1 mtp180 -98.11 143.85 28.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.787 -0.642 . . . . 2.3700000000000001 110.055 179.334 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.587 HD12 HD23 ' A' ' 18' ' ' LEU . 37.3 mt -118.09 104.1 10.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.04 -0.527 . . . . 0.37 111.069 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.4 HD23 ' HB2' ' A' ' 71' ' ' ARG . 58.5 tp -100.28 99.87 10.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.34 -0.391 . . . . 0.37 110.626 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.432 ' O ' HD12 ' A' ' 100' ' ' LEU . 0.5 OUTLIER -130.11 152.47 49.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 0.31 111.234 -179.782 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.3 tt -94.29 135.93 27.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 0.45000000000000001 110.79 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.506 HH22 ' HA ' ' A' ' 63' ' ' ILE . 18.0 tpp85 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.066 -0.515 . . . . 2.2599999999999998 110.993 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.3 m . . . . . 0 C--O 1.233 0.197 0 CA-C-O 120.772 0.32 . . . . 0.90000000000000002 110.929 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 63.5 mt -79.57 122.21 26.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.988 -0.551 . . . . 0.89000000000000001 110.857 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -113.71 125.53 54.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.466 . . . . 2.73 110.983 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 47.6 t -119.81 126.8 51.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.978 -0.556 . . . . 1.1899999999999999 111.053 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.5 t -124.56 154.06 31.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.01 -0.541 . . . . 0.56000000000000005 110.576 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -121.83 119.83 32.79 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.95 0.405 . . . . 1.74 111.585 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -114.56 166.62 11.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.87 -0.605 . . . . 0.81000000000000005 110.318 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.541 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 89.3 m-85 -133.29 112.05 11.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.732 0.301 . . . . 2.0800000000000001 111.497 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.472 ' HB2' HD21 ' A' ' 27' ' ' LEU . 50.8 tpt85 -97.34 102.81 14.67 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.272 -0.422 . . . . 3.0600000000000001 110.571 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -160.33 20.72 0.15 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.461 . . . . 2.5800000000000001 110.804 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.471 ' N ' ' HD2' ' A' ' 22' ' ' LYS . 11.5 mptt -106.8 161.52 14.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.113 -0.494 . . . . 3.7200000000000002 110.952 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -83.07 50.17 1.68 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.028 -0.533 . . . . 2.8700000000000001 111.038 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.4 p -117.05 -24.03 7.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.216 -0.447 . . . . 1.3799999999999999 111.05 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.6 m 58.34 16.65 4.19 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.86 -0.609 . . . . 2.4500000000000002 111.215 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 81.9 p -144.73 153.81 42.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.288 -0.415 . . . . 1.3999999999999999 110.997 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.472 HD21 ' HB2' ' A' ' 20' ' ' ARG . 92.6 mt -114.31 -20.13 10.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 0.45000000000000001 110.874 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.11 31.72 7.48 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.831 -0.7 . . . . 0.52000000000000002 112.709 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 46.4 mt -110.02 116.13 51.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.868 0.366 . . . . 0.83999999999999997 111.025 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 45.8 t -113.3 106.49 14.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.94999999999999996 110.704 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 43.9 pt -97.36 148.08 5.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.036 -0.529 . . . . 0.40999999999999998 111.245 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 45.0 t -111.46 139.45 46.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.105 -0.498 . . . . 1.3200000000000001 110.878 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 C-N-CA 120.79 -0.719 . . . . 0.94999999999999996 112.464 179.954 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 43.5 mm . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.827 0.346 . . . . 0.65000000000000002 110.857 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -152.83 144.0 23.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.69999999999999996 110.897 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 95.7 t -76.71 121.17 28.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.194 -0.457 . . . . 0.39000000000000001 110.861 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -99.72 -23.31 15.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.109 -0.496 . . . . 2.3999999999999999 110.918 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 46.7 t -154.28 165.09 37.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.966 0.412 . . . . 1.28 111.213 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 82.9 mt -131.88 154.79 48.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.957 -0.565 . . . . 0.41999999999999998 110.671 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 42.3 mm -97.42 109.15 48.85 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.373 -0.376 . . . . 1.26 110.844 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.96 141.13 97.94 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.347 2.031 . . . . 0.81999999999999995 112.422 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.92 -15.44 63.1 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.758 -0.734 . . . . 0.48999999999999999 112.501 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 59.6 m -80.41 179.15 7.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.663 0.268 . . . . 1.23 110.966 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.49 -47.9 58.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.903 0.382 . . . . 0.41999999999999998 111.096 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.21 -40.33 81.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.097 -0.501 . . . . 0.34999999999999998 111.497 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.1 -54.16 12.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.21 -0.45 . . . . 0.44 111.331 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.2 mt -60.83 -19.56 60.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.271 -0.422 . . . . 0.66000000000000003 111.212 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -52.7 -51.25 61.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.311 -0.404 . . . . 1.8600000000000001 110.758 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 98.05 -32.31 7.02 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.881 -0.676 . . . . 1.0600000000000001 113.145 179.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 23.2 mmm180 -71.57 -46.12 60.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.767 0.318 . . . . 2.5899999999999999 111.284 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 49.5 mt -65.41 132.45 31.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.328 -0.396 . . . . 0.92000000000000004 111.303 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -126.59 138.57 32.73 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.051 -0.522 . . . . 1.98 110.603 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -48.68 157.8 1.38 Allowed 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.443 2.096 . . . . 1.4399999999999999 112.339 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 58.4 t30 58.99 67.27 0.94 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.471 . . . . 2.1499999999999999 110.693 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -133.82 154.91 50.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.974 -0.557 . . . . 2.02 110.629 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -103.79 130.69 51.36 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.562 -0.29 . . . . 1.02 111.187 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 36.5 mm -92.54 145.43 7.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.19 -0.459 . . . . 0.28999999999999998 111.022 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 70.2 mt -114.34 -66.9 1.04 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.242 -0.435 . . . . 0.40000000000000002 111.038 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -152.0 141.32 21.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.086 0.47 . . . . 2.6099999999999999 111.41 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.615 HG12 ' H ' ' A' ' 73' ' ' ASP . 2.2 t -90.36 175.26 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.627 -0.715 . . . . 0.28000000000000003 110.033 179.373 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.615 ' H ' HG12 ' A' ' 72' ' ' VAL . 6.3 p-10 -55.53 114.24 1.76 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.874 0.369 . . . . 0.79000000000000004 111.126 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 60.33 18.53 8.12 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.04 -0.527 . . . . 2.0099999999999998 111.756 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 63.0 t -143.36 149.89 17.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.656 0.265 . . . . 0.79000000000000004 111.139 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -120.01 138.58 53.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.459 -0.337 . . . . 2.2400000000000002 110.587 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.2 m -117.24 28.53 2.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.822 0.344 . . . . 0.67000000000000004 111.423 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -97.53 33.95 1.93 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 1.3899999999999999 111.021 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 173.12 28.33 0.02 OUTLIER Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.565 -0.826 . . . . 0.55000000000000004 112.865 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 36.0 mtm -126.25 145.64 50.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.739 0.304 . . . . 0.52000000000000002 110.753 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.01 158.89 24.36 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.28 -0.418 . . . . 0.39000000000000001 111.146 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -49.93 -58.07 6.19 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.215 -0.448 . . . . 1.52 111.531 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 46.5 t -52.65 -39.95 62.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.188 -0.46 . . . . 1.48 111.395 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -61.2 -47.9 84.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.832 0.349 . . . . 2.1200000000000001 110.987 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 55.4 t -57.46 -40.79 76.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.108 -0.497 . . . . 0.32000000000000001 111.121 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 90.9 t -63.27 -39.04 83.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 0.37 110.928 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.454 ' HG2' HH21 ' A' ' 90' ' ' ARG . 45.8 mt-10 -58.99 -40.83 86.03 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.264 -0.425 . . . . 1.51 110.386 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 52.1 t -60.36 -52.91 55.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.905 -0.589 . . . . 0.27000000000000002 111.203 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 67.0 mt -53.93 -38.02 64.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.095 -0.502 . . . . 0.40999999999999998 111.397 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.454 HH21 ' HG2' ' A' ' 87' ' ' GLU . 76.8 mtm180 -81.28 -21.12 39.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.244 -0.434 . . . . 2.1000000000000001 111.246 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -90.82 -5.05 56.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.361 -0.381 . . . . 1.1399999999999999 111.16 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.475 ' HB1' HG22 ' A' ' 96' ' ' VAL . . . -54.02 -71.66 0.07 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.329 -0.396 . . . . 0.55000000000000004 111.133 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 63.14 10.55 34.58 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.697 -0.763 . . . . 0.76000000000000001 112.522 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -147.51 173.57 4.09 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 110.077 -0.342 . . . . 2.52 110.077 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.541 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 86.8 Cg_exo -47.79 100.09 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.005 1.803 . . . . 0.64000000000000001 111.379 178.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.475 HG22 ' HB1' ' A' ' 92' ' ' ALA . 2.3 t -80.84 113.72 20.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.106 -0.497 . . . . 0.64000000000000001 111.755 -178.721 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.563 ' H ' ' HB3' ' A' ' 73' ' ' ASP . 80.0 ttt180 -91.38 126.51 36.49 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.532 -0.544 . . . . 2.3700000000000001 109.532 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 27.7 mt -109.42 103.61 12.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.373 -0.376 . . . . 0.37 111.721 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 32.0 tp -96.34 99.75 11.41 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.324 -0.621 . . . . 0.37 109.324 178.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -130.14 168.19 17.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.119 -0.491 . . . . 0.31 111.862 -178.474 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 17.3 tt -118.44 143.95 27.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 115.668 -0.696 . . . . 0.45000000000000001 110.782 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.39 0 CA-C-N 116.094 -0.503 . . . . 2.2599999999999998 110.384 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.6 t . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.859 0.361 . . . . 0.90000000000000002 110.671 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 58.2 mt -81.07 119.1 23.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.89000000000000001 111.252 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -118.43 151.62 37.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.005 -0.543 . . . . 2.73 110.586 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 78.0 p -141.26 145.6 35.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.875 0.369 . . . . 1.1899999999999999 111.341 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 46.6 t -135.07 139.46 47.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.009 -0.541 . . . . 0.56000000000000005 110.788 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -100.2 113.09 25.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.321 -0.399 . . . . 1.74 110.848 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 33.8 mt -124.37 141.07 52.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.365 -0.379 . . . . 0.81000000000000005 111.44 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.558 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 44.3 p90 -118.7 141.2 48.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.056 -0.52 . . . . 2.0800000000000001 110.613 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.485 HH21 ' N ' ' A' ' 93' ' ' GLY . 13.0 ttp180 -118.49 80.76 1.58 Allowed 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.702 -0.399 . . . . 3.0600000000000001 111.551 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -99.86 10.07 41.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.436 . . . . 2.5800000000000001 110.779 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.468 ' N ' ' HD2' ' A' ' 22' ' ' LYS . 3.2 mptp? -108.88 156.05 20.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.988 -0.551 . . . . 3.7200000000000002 110.819 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -86.25 73.56 10.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 2.8700000000000001 110.926 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 52.4 p -113.43 -22.61 10.28 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.121 -0.49 . . . . 1.3799999999999999 111.079 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 51.2 m 59.26 19.89 8.01 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.842 -0.617 . . . . 2.4500000000000002 111.185 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 77.6 p -158.8 137.9 11.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.307 -0.406 . . . . 1.3999999999999999 111.162 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.479 HD21 ' HB2' ' A' ' 20' ' ' ARG . 75.4 mt -97.26 -10.75 25.15 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.029 -0.532 . . . . 0.45000000000000001 110.683 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.521 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 92.11 14.85 55.52 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.784 -0.722 . . . . 0.52000000000000002 112.829 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 69.6 mt -98.61 110.57 26.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.778 0.323 . . . . 0.83999999999999997 111.178 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 34.2 t -111.23 101.1 9.62 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.277 -0.419 . . . . 0.94999999999999996 110.842 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 40.8 pt -92.4 166.67 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.996 -0.547 . . . . 0.40999999999999998 111.43 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 46.0 t -131.94 134.94 46.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.03 -0.532 . . . . 1.3200000000000001 110.795 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 0.294 0 C-N-CA 120.844 -0.693 . . . . 0.94999999999999996 112.631 -179.977 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 49.8 mm . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.88 0.372 . . . . 0.65000000000000002 111.114 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -119.77 138.28 53.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.466 . . . . 0.69999999999999996 111.103 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.8 t -80.51 123.92 37.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.059 -0.519 . . . . 0.39000000000000001 110.807 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -106.43 -29.26 9.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.033 -0.531 . . . . 2.3999999999999999 111.053 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 53.3 m -137.6 167.27 22.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.031 0.443 . . . . 1.28 111.606 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 82.4 mt -137.68 163.59 30.9 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.807 -0.633 . . . . 0.41999999999999998 110.752 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.521 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 67.6 mt -102.51 101.02 17.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 1.26 110.786 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.452 ' HD2' ' HA ' ' A' ' 52' ' ' ILE . 19.1 Cg_endo -57.56 94.81 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.475 2.116 . . . . 0.81999999999999995 112.263 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 143.91 -8.09 1.95 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.838 -0.696 . . . . 0.48999999999999999 112.388 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.423 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 53.0 m -96.47 178.66 5.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.757 0.313 . . . . 1.23 110.858 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.46 -53.34 59.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.301 -0.409 . . . . 0.41999999999999998 111.706 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.86 -37.33 66.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.19 -0.459 . . . . 0.34999999999999998 111.853 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -77.98 -32.67 51.41 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.963 0.357 . . . . 0.44 111.963 -179.266 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 55' ' ' SER . 55.1 mt -62.74 -55.47 26.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.727 0.299 . . . . 0.66000000000000003 111.221 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -57.87 -41.78 83.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 1.8600000000000001 111.1 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 79.6 -11.66 31.6 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.81 -0.709 . . . . 1.0600000000000001 112.681 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 39.7 mtp180 -63.18 -16.83 61.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.807 0.337 . . . . 2.5899999999999999 110.828 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 76.3 mt -104.04 115.56 46.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.081 -0.509 . . . . 0.92000000000000004 110.932 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -86.85 155.46 55.74 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 1.98 111.156 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -78.3 38.19 0.68 Allowed 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.785 2.323 . . . . 1.4399999999999999 112.473 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -164.93 64.14 0.13 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.861 0.362 . . . . 2.1499999999999999 110.746 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -132.19 167.32 19.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.146 -0.479 . . . . 2.02 110.656 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -113.31 106.88 15.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.897 0.38 . . . . 1.02 111.171 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 46.5 mm -64.07 143.73 15.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.468 . . . . 0.28999999999999998 110.833 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 57.9 mt -116.42 -58.13 2.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.28 -0.418 . . . . 0.40000000000000002 111.212 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -159.94 136.09 8.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.031 0.443 . . . . 2.6099999999999999 111.465 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.682 HG12 ' H ' ' A' ' 73' ' ' ASP . 2.6 t -88.88 175.87 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.634 -0.712 . . . . 0.28000000000000003 109.909 179.267 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.682 ' H ' HG12 ' A' ' 72' ' ' VAL . 12.2 t70 -44.3 108.74 0.12 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.836 0.35 . . . . 0.79000000000000004 111.802 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 53.13 33.91 16.18 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.115 -0.493 . . . . 2.0099999999999998 112.11 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 92.1 t -147.56 126.39 4.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.535 -0.302 . . . . 0.79000000000000004 111.047 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -96.83 122.98 40.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.401 -0.363 . . . . 2.2400000000000002 110.423 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.49 HG11 HG13 ' A' ' 85' ' ' VAL . 29.7 m -108.42 26.44 2.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 CA-C-O 120.858 0.361 . . . . 0.67000000000000004 111.586 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -94.4 24.82 4.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.269 -0.423 . . . . 1.3899999999999999 110.779 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -169.88 16.42 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.663 -0.78 . . . . 0.55000000000000004 112.746 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 60.4 mtm -118.35 143.51 46.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.864 0.364 . . . . 0.52000000000000002 110.856 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.414 ' HB3' ' OD2' ' A' ' 84' ' ' ASP . . . -64.83 164.91 11.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.161 -0.472 . . . . 0.39000000000000001 111.295 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.445 ' O ' HG23 ' A' ' 86' ' ' VAL . 35.3 tt0 -51.74 -55.4 19.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 1.52 111.351 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.2 m -50.44 -42.7 54.44 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.192 -0.458 . . . . 1.48 111.577 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.414 ' OD2' ' HB3' ' A' ' 81' ' ' ALA . 20.4 m-20 -61.05 -49.08 78.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.381 -0.372 . . . . 2.1200000000000001 111.096 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.49 HG13 HG11 ' A' ' 77' ' ' VAL . 33.7 t -60.59 -33.44 54.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.486 . . . . 0.32000000000000001 111.276 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 82' ' ' GLN . 89.7 t -67.59 -43.55 86.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.287 -0.415 . . . . 0.37 110.98 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.425 ' HG2' HH21 ' A' ' 90' ' ' ARG . 44.1 mt-10 -56.95 -45.78 82.57 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.363 -0.381 . . . . 1.51 110.633 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 55.3 t -56.15 -52.43 50.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.083 -0.508 . . . . 0.27000000000000002 110.893 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 82.2 mt -61.38 -25.74 67.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.883 -0.599 . . . . 0.40999999999999998 110.95 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.425 HH21 ' HG2' ' A' ' 87' ' ' GLU . 78.1 mtm180 -87.93 -11.68 46.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.196 -0.456 . . . . 2.1000000000000001 111.12 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -99.41 -12.65 20.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.316 -0.402 . . . . 1.1399999999999999 110.605 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.5 -86.22 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.998 -0.546 . . . . 0.55000000000000004 111.445 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.485 ' N ' HH21 ' A' ' 20' ' ' ARG . . . 61.84 21.97 61.63 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.62 -0.8 . . . . 0.76000000000000001 112.231 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.622 ' HB3' ' HD2' ' A' ' 95' ' ' PRO . 67.9 m-20 -147.46 174.54 3.32 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 110.583 -0.155 . . . . 2.52 110.583 -179.515 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.622 ' HD2' ' HB3' ' A' ' 94' ' ' ASN . 36.2 Cg_endo -66.45 81.61 0.3 Allowed 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 122.106 1.871 . . . . 0.64000000000000001 112.004 178.199 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 22.7 m -91.29 154.21 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.95 -0.568 . . . . 0.64000000000000001 111.48 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.65 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 77.2 ttt180 -94.56 144.07 25.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.782 -0.645 . . . . 2.3700000000000001 110.112 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 25.9 mt -118.53 103.89 10.16 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.221 -0.445 . . . . 0.37 110.986 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 24.8 tp -100.76 104.2 15.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.966 0.412 . . . . 0.37 110.781 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.85 168.03 20.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.995 -0.548 . . . . 0.31 110.866 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 19.4 tt -114.03 134.8 55.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-O 121.015 0.436 . . . . 0.45000000000000001 111.289 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 115.584 -0.734 . . . . 2.2599999999999998 110.689 179.997 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.0 t . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.79 0.329 . . . . 0.90000000000000002 110.727 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.2 mt -79.62 120.6 24.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 0.89000000000000001 111.276 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -115.0 157.29 23.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.075 -0.511 . . . . 2.73 110.656 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 41.1 t -148.91 132.24 16.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.916 0.389 . . . . 1.1899999999999999 111.161 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 44.4 t -125.16 129.9 73.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.078 -0.51 . . . . 0.56000000000000005 110.775 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -95.47 109.85 21.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.15 -0.477 . . . . 1.74 111.16 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.435 HD12 HD11 ' A' ' 98' ' ' LEU . 28.5 mt -115.76 166.19 12.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 0.81000000000000005 110.874 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.66 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 39.3 p90 -149.91 133.75 16.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 2.0800000000000001 111.046 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.6 tpp180 -109.49 122.24 46.97 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.001 0.429 . . . . 3.0600000000000001 110.831 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -121.77 -25.69 5.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.893 -0.594 . . . . 2.5800000000000001 110.637 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -71.65 169.71 15.0 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.841 -0.618 . . . . 3.7200000000000002 110.682 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -95.63 51.91 1.32 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.269 -0.423 . . . . 2.8700000000000001 110.788 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 79.7 p -103.36 -24.12 13.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.133 -0.485 . . . . 1.3799999999999999 111.141 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.7 t 58.41 21.12 8.07 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.951 -0.568 . . . . 2.4500000000000002 111.228 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 79.0 p -145.03 153.3 41.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.869 0.366 . . . . 1.3999999999999999 111.122 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 81.7 mt -114.12 -8.5 12.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.008 -0.542 . . . . 0.45000000000000001 110.799 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.438 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 97.78 -12.1 64.38 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.831 -0.699 . . . . 0.52000000000000002 112.8 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 69.8 mt -63.51 108.69 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.727 0.299 . . . . 0.83999999999999997 111.156 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 36.3 t -112.19 114.22 26.9 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.318 -0.401 . . . . 0.94999999999999996 110.636 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.4 pt -96.22 -178.84 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.381 -0.372 . . . . 0.40999999999999998 111.362 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 77.3 p -163.44 137.4 5.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.138 -0.483 . . . . 1.3200000000000001 110.75 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.246 0 C-N-CA 120.796 -0.716 . . . . 0.94999999999999996 112.561 -179.962 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 39.5 mm . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 120.699 0.285 . . . . 0.65000000000000002 110.861 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 46.5 p90 -153.68 144.84 22.92 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.338 -0.392 . . . . 0.69999999999999996 111.411 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 66.4 t -79.6 132.79 31.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.031 -0.532 . . . . 0.39000000000000001 110.924 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -125.73 -26.19 3.54 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.102 -0.499 . . . . 2.3999999999999999 111.022 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 56.6 m -130.16 161.96 29.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.025 0.441 . . . . 1.28 111.275 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 83.6 mt -141.65 129.09 21.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.814 -0.63 . . . . 0.41999999999999998 110.728 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.438 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 63.1 mt -68.26 117.95 54.51 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.28 -0.418 . . . . 1.26 110.934 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.21 96.76 0.64 Allowed 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.191 1.927 . . . . 0.81999999999999995 112.252 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 137.29 0.45 2.7 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.837 -0.697 . . . . 0.48999999999999999 112.511 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 63.6 m -101.32 172.46 6.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.62 0.247 . . . . 1.23 110.902 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.36 -53.13 61.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.431 -0.35 . . . . 0.41999999999999998 111.8 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -47.15 -40.78 16.41 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.243 -0.435 . . . . 0.34999999999999998 112.019 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.37 -38.99 29.35 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.984 0.365 . . . . 0.44 111.984 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 60.1 mt -56.3 -56.22 23.77 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.47 -0.332 . . . . 0.66000000000000003 111.634 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -56.54 -34.26 66.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.402 -0.363 . . . . 1.8600000000000001 111.236 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 78.34 -12.74 18.71 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.784 -0.722 . . . . 1.0600000000000001 112.504 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -59.72 -29.25 68.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.789 0.328 . . . . 2.5899999999999999 110.792 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.507 ' N ' HD12 ' A' ' 63' ' ' ILE . 4.0 mp -93.49 115.1 31.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.479 . . . . 0.92000000000000004 110.651 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.466 ' HB2' ' HD2' ' A' ' 65' ' ' PRO . 12.0 pt-20 -113.03 158.13 38.76 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.458 . . . . 1.98 110.696 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.466 ' HD2' ' HB2' ' A' ' 64' ' ' GLU . 21.2 Cg_endo -60.05 173.18 1.93 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.399 2.066 . . . . 1.4399999999999999 112.095 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 54.2 t30 54.09 58.86 4.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.044 0.45 . . . . 2.1499999999999999 110.668 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -136.51 154.28 50.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.976 -0.556 . . . . 2.02 110.537 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -110.15 136.93 48.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.977 0.418 . . . . 1.02 111.49 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.471 HD13 ' HB3' ' A' ' 100' ' ' LEU . 45.3 mm -97.79 120.58 47.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.817 -0.629 . . . . 0.28999999999999998 110.346 179.388 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 77.4 mt -93.25 -63.79 1.17 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.429 -0.35 . . . . 0.40000000000000002 111.33 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.404 ' O ' ' HB3' ' A' ' 99' ' ' LEU . 62.6 mtp180 -141.7 142.09 33.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.098 0.475 . . . . 2.6099999999999999 111.664 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.637 HG12 ' H ' ' A' ' 73' ' ' ASP . 4.4 t -100.47 174.04 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.724 -0.671 . . . . 0.28000000000000003 109.944 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.653 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 18.8 t70 -50.43 110.6 0.42 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.657 0.265 . . . . 0.79000000000000004 111.205 179.262 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.4 t70 56.04 26.05 9.58 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.254 -0.43 . . . . 2.0099999999999998 111.248 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.52 ' HB ' ' HB ' ' A' ' 72' ' ' VAL . 86.9 t -144.56 153.93 14.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.79000000000000004 110.631 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -129.59 126.56 38.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.743 0.306 . . . . 2.2400000000000002 110.746 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.2 m -104.63 25.14 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.245 -0.434 . . . . 0.67000000000000004 111.067 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -89.62 26.34 1.77 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.083 -0.508 . . . . 1.3899999999999999 110.956 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 174.78 34.12 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.535 -0.84 . . . . 0.55000000000000004 112.897 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 49.8 mtm -126.62 147.35 49.91 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.834 0.35 . . . . 0.52000000000000002 110.858 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.03 156.23 18.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.1 -0.5 . . . . 0.39000000000000001 111.301 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -51.44 -58.63 5.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.325 -0.398 . . . . 1.52 111.154 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.6 t -55.94 -36.94 68.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.099 -0.5 . . . . 1.48 111.179 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -60.15 -46.41 89.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.355 -0.384 . . . . 2.1200000000000001 110.907 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 60.7 t -59.49 -38.3 74.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.454 . . . . 0.32000000000000001 110.886 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 58.8 t -64.35 -41.57 92.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.157 -0.474 . . . . 0.37 111.077 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.546 ' HG2' HH21 ' A' ' 90' ' ' ARG . 48.3 mt-10 -57.85 -44.51 86.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.893 0.378 . . . . 1.51 110.547 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 54.0 t -56.18 -55.55 17.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.947 -0.57 . . . . 0.27000000000000002 111.102 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 78.7 mt -57.22 -29.79 64.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.043 -0.526 . . . . 0.40999999999999998 111.259 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.546 HH21 ' HG2' ' A' ' 87' ' ' GLU . 63.5 mtm180 -83.1 -20.76 34.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.462 -0.335 . . . . 2.1000000000000001 111.097 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -86.44 -18.35 31.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 1.1399999999999999 110.825 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.44 -85.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.289 -0.414 . . . . 0.55000000000000004 110.988 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 60.48 23.01 59.88 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.739 -0.743 . . . . 0.76000000000000001 112.583 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.483 ' HB3' ' HD2' ' A' ' 95' ' ' PRO . 47.3 m-20 -147.34 175.91 2.48 Favored Pre-proline 0 C--N 1.329 -0.322 0 C-N-CA 121.928 0.091 . . . . 2.52 110.863 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.66 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 51.5 Cg_exo -56.76 103.54 0.12 Allowed 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 122.096 1.864 . . . . 0.64000000000000001 111.715 178.208 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 31.3 m -123.51 149.46 27.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.111 0.482 . . . . 0.64000000000000001 111.945 -179.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.653 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 42.5 ttp180 -94.34 142.96 26.81 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.61 -0.723 . . . . 2.3700000000000001 109.983 179.419 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.435 HD11 HD12 ' A' ' 18' ' ' LEU . 52.8 mt -116.58 115.46 25.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.188 -0.46 . . . . 0.37 111.273 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.404 ' HB3' ' O ' ' A' ' 71' ' ' ARG . 59.3 tp -108.88 103.22 12.23 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.941 0.4 . . . . 0.37 110.32 179.24 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.471 ' HB3' HD13 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -132.4 166.27 22.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.089 -0.505 . . . . 0.31 111.329 -179.249 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 19.0 tt -120.6 140.38 44.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.121 -0.491 . . . . 0.45000000000000001 110.986 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.056 -0.52 . . . . 2.2599999999999998 110.396 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.2 t . . . . . 0 C--O 1.235 0.332 0 CA-C-O 121.031 0.443 . . . . 0.90000000000000002 111.215 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.539 HD23 ' HB ' ' A' ' 101' ' ' ILE . 16.6 mt -96.02 106.99 19.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.614 -0.721 . . . . 0.89000000000000001 110.242 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.432 ' HE1' ' HB3' ' A' ' 102' ' ' ARG . 32.7 p90 -127.97 150.47 49.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.855 0.36 . . . . 2.73 111.06 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 80.3 p -123.84 135.55 53.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.107 -0.497 . . . . 1.1899999999999999 111.268 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.9 t -110.4 144.62 18.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.94 -0.573 . . . . 0.56000000000000005 110.477 179.456 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -88.58 122.26 31.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.872 0.368 . . . . 1.74 111.252 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -127.13 166.25 18.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.964 -0.562 . . . . 0.81000000000000005 110.787 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.558 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 27.9 p90 -152.77 130.52 11.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.25 -0.432 . . . . 2.0800000000000001 111.04 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.465 ' HB2' HD21 ' A' ' 27' ' ' LEU . 2.0 tmm_? -108.17 107.03 17.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.312 -0.403 . . . . 3.0600000000000001 110.659 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -133.06 -28.67 1.51 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.328 -0.396 . . . . 2.5800000000000001 111.33 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -64.0 161.03 16.65 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.137 -0.483 . . . . 3.7200000000000002 111.018 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -83.37 37.54 0.57 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.022 -0.535 . . . . 2.8700000000000001 111.203 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 71.2 p -88.43 -16.18 33.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 1.3799999999999999 111.028 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 51.6 m 57.54 20.5 6.22 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.903 -0.589 . . . . 2.4500000000000002 111.082 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 88.5 p -159.32 -176.62 5.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.345 -0.389 . . . . 1.3999999999999999 110.909 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.465 HD21 ' HB2' ' A' ' 20' ' ' ARG . 68.7 mt -128.83 -0.49 5.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.023 -0.535 . . . . 0.45000000000000001 110.634 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.29 26.76 51.07 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.835 -0.698 . . . . 0.52000000000000002 112.566 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.443 HG22 HG23 ' A' ' 31' ' ' ILE . 85.0 mt -100.94 114.52 40.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.905 0.383 . . . . 0.83999999999999997 111.1 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.0 m -109.03 92.82 4.21 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.113 -0.494 . . . . 0.94999999999999996 110.722 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.443 HG23 HG22 ' A' ' 29' ' ' ILE . 43.1 pt -90.46 164.99 2.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.0 -0.545 . . . . 0.40999999999999998 111.236 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.2 t -145.4 134.49 22.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 1.3200000000000001 110.788 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.266 0 C-N-CA 120.839 -0.696 . . . . 0.94999999999999996 112.396 179.999 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 37.6 mm . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.704 0.288 . . . . 0.65000000000000002 110.713 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -149.49 145.15 26.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.338 -0.392 . . . . 0.69999999999999996 111.457 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 93.1 t -83.37 115.58 25.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.957 -0.565 . . . . 0.39000000000000001 110.64 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -89.5 -31.34 17.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.073 -0.512 . . . . 2.3999999999999999 111.351 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.0 t -151.29 169.0 23.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.96 0.409 . . . . 1.28 111.605 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 86.1 mt -124.94 169.73 11.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.731 -0.668 . . . . 0.41999999999999998 110.514 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 50.4 mm -108.62 99.96 36.24 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.278 -0.419 . . . . 1.26 111.047 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -51.73 116.06 2.5 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.56 2.174 . . . . 0.81999999999999995 112.397 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 111.31 3.49 27.54 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.802 -0.713 . . . . 0.48999999999999999 112.33 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 55.1 m -99.78 174.15 6.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.65 0.262 . . . . 1.23 111.037 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.68 -56.65 19.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.304 -0.407 . . . . 0.41999999999999998 111.353 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.46 -33.06 58.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.256 -0.429 . . . . 0.34999999999999998 111.384 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.08 -26.06 39.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.289 -0.414 . . . . 0.44 111.529 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 31.2 mt -70.59 -37.65 73.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.473 -0.331 . . . . 0.66000000000000003 111.241 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -61.74 -40.59 95.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.41 -0.359 . . . . 1.8600000000000001 110.993 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 79.48 -13.99 19.45 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.797 -0.716 . . . . 1.0600000000000001 112.632 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 69.6 mtp180 -74.99 -23.05 58.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.788 0.327 . . . . 2.5899999999999999 110.935 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.488 ' N ' HD12 ' A' ' 63' ' ' ILE . 3.7 mp -84.19 118.9 32.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.436 . . . . 0.92000000000000004 110.715 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -106.3 136.79 19.31 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.111 -0.495 . . . . 1.98 110.614 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -56.09 163.24 6.31 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.486 2.124 . . . . 1.4399999999999999 112.316 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 62.95 45.78 5.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.065 -0.516 . . . . 2.1499999999999999 111.046 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -109.55 165.45 11.66 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.098 -0.501 . . . . 2.02 110.602 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -113.61 107.05 15.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.819 0.342 . . . . 1.02 111.207 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.462 ' HA ' ' HB3' ' A' ' 100' ' ' LEU . 43.7 mm -66.53 136.73 26.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.12 -0.491 . . . . 0.28999999999999998 110.692 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 96.6 mt -113.03 -72.17 0.72 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.45 -0.341 . . . . 0.40000000000000002 111.318 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 -135.89 137.35 41.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.001 0.429 . . . . 2.6099999999999999 111.61 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.515 HG12 ' H ' ' A' ' 73' ' ' ASP . 9.3 t -98.91 168.59 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.872 -0.604 . . . . 0.28000000000000003 109.829 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.652 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 13.4 t70 -47.86 108.3 0.16 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.923 0.392 . . . . 0.79000000000000004 111.95 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.8 t70 58.69 6.68 0.64 Allowed 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.592 0.589 . . . . 2.0099999999999998 112.592 178.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 38.9 t -140.09 101.05 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.718 0.294 . . . . 0.79000000000000004 111.59 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -73.83 153.78 39.78 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.454 -0.339 . . . . 2.2400000000000002 110.427 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.402 HG11 HG13 ' A' ' 85' ' ' VAL . 34.9 m -125.62 28.55 2.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-O 120.853 0.359 . . . . 0.67000000000000004 111.554 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -94.32 42.25 1.09 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.268 -0.424 . . . . 1.3899999999999999 111.011 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 165.76 33.23 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.642 -0.79 . . . . 0.55000000000000004 113.04 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 50.5 mtm -131.39 152.48 50.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.862 0.363 . . . . 0.52000000000000002 111.01 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.402 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -64.55 152.98 40.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.011 -0.54 . . . . 0.39000000000000001 111.179 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -52.69 -55.86 19.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.355 -0.384 . . . . 1.52 111.286 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 48.0 t -53.7 -40.06 65.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.137 -0.483 . . . . 1.48 111.413 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -62.34 -46.24 89.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.322 -0.399 . . . . 2.1200000000000001 111.118 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.402 HG13 HG11 ' A' ' 77' ' ' VAL . 75.6 t -57.94 -36.64 56.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.122 -0.49 . . . . 0.32000000000000001 111.128 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 64.9 t -65.99 -43.3 92.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 0.37 111.025 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -57.25 -39.41 75.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.183 -0.462 . . . . 1.51 110.612 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 52.9 t -62.3 -53.66 44.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.27000000000000002 111.208 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 76.5 mt -53.29 -30.06 36.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.933 -0.576 . . . . 0.40999999999999998 111.174 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -87.53 -26.64 23.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 2.1000000000000001 111.295 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -78.22 -12.17 59.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.421 -0.354 . . . . 1.1399999999999999 111.032 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -49.76 -80.26 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.272 -0.422 . . . . 0.55000000000000004 111.29 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 65.87 10.84 52.54 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.591 -0.814 . . . . 0.76000000000000001 112.379 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.548 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 5.3 p30 -146.88 168.56 11.15 Favored Pre-proline 0 C--N 1.328 -0.332 0 N-CA-C 110.44 -0.207 . . . . 2.52 110.44 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.558 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 19.0 Cg_endo -61.24 102.42 0.22 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.003 1.802 . . . . 0.64000000000000001 111.506 178.595 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 29.9 m -107.81 146.66 13.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.64000000000000001 112.015 -178.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.652 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 20.7 ttm180 -92.18 142.76 27.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.818 -0.628 . . . . 2.3700000000000001 109.847 179.169 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 71.8 mt -116.09 103.4 10.52 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.071 -0.513 . . . . 0.37 110.892 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 65.1 tp -98.99 114.26 26.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 0.37 110.382 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.462 ' HB3' ' HA ' ' A' ' 69' ' ' ILE . 0.5 OUTLIER -147.27 167.95 22.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.475 . . . . 0.31 111.487 -179.352 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.539 ' HB ' HD23 ' A' ' 13' ' ' LEU . 11.7 tt -116.23 139.16 44.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.828 -0.624 . . . . 0.45000000000000001 110.807 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.432 ' HB3' ' HE1' ' A' ' 14' ' ' TYR . 32.7 tpt180 . . . . . 0 C--N 1.327 -0.413 0 CA-C-N 116.206 -0.452 . . . . 2.2599999999999998 110.601 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 56.2 p . . . . . 0 C--O 1.233 0.197 0 CA-C-O 120.767 0.318 . . . . 0.90000000000000002 110.655 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 76.5 mt -77.78 128.72 34.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.121 -0.491 . . . . 0.89000000000000001 111.319 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -114.74 132.55 56.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.927 -0.579 . . . . 2.73 111.058 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 84.9 p -124.56 128.55 49.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.099 -0.501 . . . . 1.1899999999999999 110.929 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 23.6 t -133.04 149.38 31.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.117 -0.492 . . . . 0.56000000000000005 110.919 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -111.41 120.77 43.31 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.843 0.354 . . . . 1.74 110.986 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -121.18 166.45 13.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.034 -0.53 . . . . 0.81000000000000005 111.119 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.6 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 33.8 p90 -147.86 129.19 14.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.997 -0.547 . . . . 2.0800000000000001 110.82 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.472 ' HB2' HD21 ' A' ' 27' ' ' LEU . 3.0 tmm_? -108.71 115.31 29.84 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.935 0.398 . . . . 3.0600000000000001 111.007 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -150.93 13.76 0.71 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.101 -0.5 . . . . 2.5800000000000001 110.934 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -103.78 160.52 14.71 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.197 -0.456 . . . . 3.7200000000000002 110.712 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -90.62 57.92 3.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 2.8700000000000001 110.889 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 37.5 p -118.76 -10.49 9.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 1.3799999999999999 111.103 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 90.7 p 49.71 26.84 1.98 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.76 -0.655 . . . . 2.4500000000000002 111.413 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 53.4 m -152.69 137.48 17.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.38 -0.373 . . . . 1.3999999999999999 111.059 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.472 HD21 ' HB2' ' A' ' 20' ' ' ARG . 85.1 mt -91.53 -34.58 14.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.081 -0.509 . . . . 0.45000000000000001 110.778 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.459 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 127.26 -26.82 4.91 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.869 -0.682 . . . . 0.52000000000000002 112.444 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 70.3 mt -63.93 113.67 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.792 0.329 . . . . 0.83999999999999997 110.928 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.3 t -113.84 99.43 7.68 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.15 -0.477 . . . . 0.94999999999999996 110.997 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.8 pt -96.47 159.2 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.073 -0.512 . . . . 0.40999999999999998 111.071 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 47.4 t -115.2 146.69 41.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.237 -0.438 . . . . 1.3200000000000001 110.949 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.246 0 C-N-CA 120.901 -0.666 . . . . 0.94999999999999996 112.455 179.901 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 42.7 mm . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.796 0.331 . . . . 0.65000000000000002 111.041 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -151.21 143.56 24.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.485 . . . . 0.69999999999999996 111.109 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 79.3 t -76.81 134.89 27.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.215 -0.448 . . . . 0.39000000000000001 110.757 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -113.39 -31.81 6.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.985 -0.552 . . . . 2.3999999999999999 111.169 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 80.0 p -153.71 177.07 11.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.957 0.408 . . . . 1.28 111.395 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 97.6 mt -133.75 149.44 51.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.765 -0.652 . . . . 0.41999999999999998 110.838 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.459 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 57.1 mt -81.16 121.35 80.41 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.289 -0.414 . . . . 1.26 111.121 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.16 114.23 3.7 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.441 2.094 . . . . 0.81999999999999995 112.265 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.82 16.36 15.75 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.63 -0.795 . . . . 0.48999999999999999 112.652 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 78.0 p -107.76 176.45 5.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.717 0.294 . . . . 1.23 110.906 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.57 -57.6 9.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.34 -0.391 . . . . 0.41999999999999998 111.206 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.13 -29.58 13.94 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.118 -0.492 . . . . 0.34999999999999998 111.591 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -77.74 -40.92 39.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.303 -0.408 . . . . 0.44 111.455 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.6 mt -61.78 -35.96 79.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.311 -0.404 . . . . 0.66000000000000003 111.273 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -61.79 -47.32 85.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.287 -0.415 . . . . 1.8600000000000001 111.101 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.06 -20.65 7.92 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.77 -0.728 . . . . 1.0600000000000001 112.477 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 12.8 mmm180 -62.22 -22.39 65.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.827 0.346 . . . . 2.5899999999999999 110.889 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.472 ' N ' HD12 ' A' ' 63' ' ' ILE . 4.1 mp -91.18 111.23 23.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.12 -0.491 . . . . 0.92000000000000004 110.899 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -98.68 134.49 21.62 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.035 -0.529 . . . . 1.98 110.531 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.94 159.9 4.72 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.488 2.125 . . . . 1.4399999999999999 112.279 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 61.13 82.98 0.15 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.992 -0.549 . . . . 2.1499999999999999 110.861 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -156.51 170.77 21.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.072 -0.513 . . . . 2.02 110.707 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -114.42 126.06 54.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.405 -0.361 . . . . 1.02 111.096 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 41.4 mm -84.53 137.99 19.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.135 -0.484 . . . . 0.28999999999999998 110.784 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 89.1 mt -101.36 -61.51 1.37 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.28 -0.418 . . . . 0.40000000000000002 111.07 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -158.17 138.48 12.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.171 0.51 . . . . 2.6099999999999999 111.676 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.671 HG12 ' H ' ' A' ' 73' ' ' ASP . 2.9 t -86.85 175.48 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.551 -0.749 . . . . 0.28000000000000003 109.997 179.281 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.671 ' H ' HG12 ' A' ' 72' ' ' VAL . 14.7 t70 -49.54 110.25 0.36 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.795 0.331 . . . . 0.79000000000000004 111.804 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.1 t70 60.69 9.91 2.39 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.044 -0.526 . . . . 2.0099999999999998 111.978 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.558 HG11 HG21 ' A' ' 88' ' ' VAL . 57.7 t -128.51 141.85 45.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.674 0.273 . . . . 0.79000000000000004 110.999 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -109.26 129.55 55.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.323 -0.399 . . . . 2.2400000000000002 110.709 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.4 m -111.92 26.6 3.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-O 120.89 0.376 . . . . 0.67000000000000004 111.319 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -86.77 31.62 0.69 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.14 -0.482 . . . . 1.3899999999999999 111.306 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 162.38 43.3 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.466 -0.873 . . . . 0.55000000000000004 112.974 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 47.7 mtm -129.68 138.34 51.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.874 0.368 . . . . 0.52000000000000002 110.905 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.41 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -60.93 156.66 17.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.107 -0.497 . . . . 0.39000000000000001 111.123 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -48.33 -49.16 35.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.331 -0.395 . . . . 1.52 111.363 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 81.0 p -53.31 -44.96 68.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.121 -0.491 . . . . 1.48 111.444 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -61.56 -45.32 94.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.294 -0.412 . . . . 2.1200000000000001 111.426 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 81' ' ' ALA . 15.5 t -59.34 -41.38 84.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.331 -0.395 . . . . 0.32000000000000001 111.003 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 92.2 t -64.14 -37.7 80.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.046 -0.525 . . . . 0.37 111.103 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -58.73 -47.5 84.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 1.51 110.655 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.558 HG21 HG11 ' A' ' 75' ' ' VAL . 65.1 t -56.75 -55.09 21.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.022 -0.535 . . . . 0.27000000000000002 111.256 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.404 HD22 HD12 ' A' ' 27' ' ' LEU . 84.5 mt -53.07 -36.69 60.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.82 -0.627 . . . . 0.40999999999999998 111.822 -179.096 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 81.7 mtm180 -84.48 -18.39 36.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.613 -0.267 . . . . 2.1000000000000001 111.67 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -89.98 -8.03 52.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.703 0.287 . . . . 1.1399999999999999 110.87 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -55.49 -83.74 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.251 -0.431 . . . . 0.55000000000000004 111.263 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.463 ' HA2' ' NE ' ' A' ' 20' ' ' ARG . . . 62.11 14.5 46.8 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.717 -0.754 . . . . 0.76000000000000001 112.37 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -146.9 168.51 11.25 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 110.45 -0.204 . . . . 2.52 110.45 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.6 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 36.1 Cg_exo -62.33 96.5 0.15 Allowed 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.211 1.941 . . . . 0.64000000000000001 111.161 178.299 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.5 m -105.76 152.76 7.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.124 0.488 . . . . 0.64000000000000001 111.988 -178.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.649 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 52.5 ttp180 -102.49 144.8 30.47 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.737 -0.665 . . . . 2.3700000000000001 110.048 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.9 mt -117.23 107.5 14.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.106 -0.497 . . . . 0.37 110.838 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 53.4 tp -99.01 101.69 13.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.304 -0.407 . . . . 0.37 110.499 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.1 162.64 27.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.063 -0.517 . . . . 0.31 111.175 -179.608 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.5 tt -117.27 140.86 38.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.211 -0.45 . . . . 0.45000000000000001 111.207 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 29.4 tpt180 . . . . . 0 C--N 1.331 -0.214 0 CA-C-N 116.016 -0.538 . . . . 2.2599999999999998 110.766 179.82 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.1 t . . . . . 0 C--O 1.235 0.292 0 CA-C-O 120.825 0.345 . . . . 0.90000000000000002 110.635 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 91.4 mt -84.34 121.65 27.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.89000000000000001 110.945 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -115.6 150.24 36.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.064 -0.516 . . . . 2.73 110.921 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 80.9 p -146.43 138.18 24.74 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.385 -0.37 . . . . 1.1899999999999999 111.274 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.479 HG11 ' HB2' ' A' ' 62' ' ' ARG . 42.0 t -136.99 138.64 45.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.131 -0.486 . . . . 0.56000000000000005 110.935 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -89.92 112.49 23.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 1.74 111.042 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -115.7 114.05 24.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.011 -0.541 . . . . 0.81000000000000005 110.735 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.618 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 44.2 p90 -95.8 134.42 38.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 2.0800000000000001 111.037 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.59 ' HB2' HD21 ' A' ' 27' ' ' LEU . 14.0 ttp180 -110.94 88.35 2.76 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.416 -0.357 . . . . 3.0600000000000001 111.101 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -157.75 64.19 0.47 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.977 0.418 . . . . 2.5800000000000001 110.998 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -145.64 34.52 1.04 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.303 0.573 . . . . 3.7200000000000002 110.774 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 17.7 t70 59.01 25.34 13.73 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.119 -0.946 . . . . 2.8700000000000001 110.903 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 82.7 p -92.52 -28.24 16.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.338 -0.392 . . . . 1.3799999999999999 111.213 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 99.0 p 49.62 24.84 1.27 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.811 -0.631 . . . . 2.4500000000000002 111.505 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 80.9 p -160.0 144.98 15.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.938 0.399 . . . . 1.3999999999999999 111.075 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.59 HD21 ' HB2' ' A' ' 20' ' ' ARG . 71.7 mt -101.33 -24.41 14.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.056 -0.52 . . . . 0.45000000000000001 110.66 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.09 -9.32 75.23 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.802 -0.713 . . . . 0.52000000000000002 112.648 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.5 mt -58.93 108.56 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.849 0.357 . . . . 0.83999999999999997 110.877 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 44.4 t -111.79 109.88 19.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.141 -0.481 . . . . 0.94999999999999996 110.79 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 38.3 pt -101.46 172.18 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.028 -0.533 . . . . 0.40999999999999998 111.205 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 57.0 m -146.35 137.92 24.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.476 . . . . 1.3200000000000001 110.933 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.268 0 C-N-CA 120.842 -0.694 . . . . 0.94999999999999996 112.593 -179.931 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 47.4 mm . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.832 0.349 . . . . 0.65000000000000002 110.942 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 48.3 p90 -156.97 142.28 17.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.124 -0.489 . . . . 0.69999999999999996 110.969 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 89.0 t -85.78 135.03 25.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.39000000000000001 111.006 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -123.65 -20.96 5.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.495 . . . . 2.3999999999999999 111.081 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.7 t -140.31 161.22 38.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.988 0.423 . . . . 1.28 111.447 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 96.5 mt -136.6 127.16 26.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.748 -0.66 . . . . 0.41999999999999998 110.569 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 50.8 mm -63.52 112.54 7.35 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.313 -0.403 . . . . 1.26 110.899 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.47 102.1 0.39 Allowed 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.398 2.066 . . . . 0.81999999999999995 112.252 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 129.65 -0.58 5.88 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.794 -0.717 . . . . 0.48999999999999999 112.489 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.9 m -98.2 174.19 6.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.678 0.275 . . . . 1.23 110.903 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -55.75 -58.59 7.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 0.41999999999999998 111.648 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.407 ' HB1' HD12 ' A' ' 63' ' ' ILE . . . -50.72 -32.23 18.91 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.357 -0.383 . . . . 0.34999999999999998 111.479 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.91 -32.79 40.2 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.308 -0.406 . . . . 0.44 111.627 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 79.9 mt -63.52 -55.94 19.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.377 -0.374 . . . . 0.66000000000000003 111.114 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -55.13 -37.06 66.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.246 -0.433 . . . . 1.8600000000000001 111.04 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 62.94 7.17 15.08 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.985 -0.626 . . . . 1.0600000000000001 112.896 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.479 ' HB2' HG11 ' A' ' 16' ' ' VAL . 34.9 mtp180 -82.86 3.28 30.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.738 0.304 . . . . 2.5899999999999999 110.926 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.407 HD12 ' HB1' ' A' ' 57' ' ' ALA . 61.7 mt -110.54 133.51 55.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.92000000000000004 110.982 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.407 ' HA ' ' HD2' ' A' ' 65' ' ' PRO . 20.2 tp10 -108.08 125.39 32.14 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.475 . . . . 1.98 110.787 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 64' ' ' GLU . 11.2 Cg_endo -54.66 174.38 0.19 Allowed 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.628 2.219 . . . . 1.4399999999999999 112.168 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 60.79 25.87 15.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.199 -0.455 . . . . 2.1499999999999999 110.549 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -95.7 155.58 16.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.926 -0.579 . . . . 2.02 110.578 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -104.95 109.32 21.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.407 -0.36 . . . . 1.02 110.984 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 41.1 mm -68.7 132.52 32.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.113 -0.494 . . . . 0.28999999999999998 110.952 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 76.6 mt -104.12 -63.85 1.16 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.128 -0.487 . . . . 0.40000000000000002 110.814 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -149.59 136.56 19.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.161 0.505 . . . . 2.6099999999999999 111.518 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.573 HG12 ' H ' ' A' ' 73' ' ' ASP . 9.9 t -89.88 171.14 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.593 -0.73 . . . . 0.28000000000000003 109.866 179.125 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.683 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 14.0 t70 -48.26 108.53 0.17 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.789 0.328 . . . . 0.79000000000000004 111.817 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.5 t70 58.48 6.99 0.64 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.919 -0.582 . . . . 2.0099999999999998 112.328 178.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.1 t -137.85 99.54 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.695 0.283 . . . . 0.79000000000000004 111.435 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -72.57 152.08 42.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.214 -0.448 . . . . 2.2400000000000002 110.769 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.452 HG13 HG23 ' A' ' 72' ' ' VAL . 34.4 m -119.92 26.11 3.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.36 -0.382 . . . . 0.67000000000000004 111.269 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -91.22 27.58 1.86 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 1.3899999999999999 111.13 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -175.18 19.91 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.532 -0.842 . . . . 0.55000000000000004 112.905 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.411 ' HE2' ' HA ' ' A' ' 77' ' ' VAL . 45.7 mtm -120.95 139.46 53.22 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.858 0.361 . . . . 0.52000000000000002 111.0 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.46 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -65.16 156.56 31.32 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.976 -0.556 . . . . 0.39000000000000001 111.108 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -44.75 -44.14 9.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.369 -0.378 . . . . 1.52 111.386 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 48.2 t -58.71 -53.16 61.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.295 -0.411 . . . . 1.48 111.404 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -54.52 -39.14 67.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 2.1200000000000001 111.429 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 81' ' ' ALA . 21.1 t -62.29 -41.44 91.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.426 -0.352 . . . . 0.32000000000000001 111.221 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.568 HG13 HH21 ' A' ' 90' ' ' ARG . 85.8 t -63.23 -43.31 98.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.245 -0.434 . . . . 0.37 111.148 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -57.74 -46.63 84.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.301 -0.409 . . . . 1.51 111.207 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 71.9 t -56.37 -58.03 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.984 0.421 . . . . 0.27000000000000002 111.345 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 75.8 mt -60.01 -23.98 64.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.971 -0.558 . . . . 0.40999999999999998 111.297 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.568 HH21 HG13 ' A' ' 86' ' ' VAL . 2.1 tpp180 -89.28 -12.48 40.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.242 -0.436 . . . . 2.1000000000000001 111.432 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -103.92 -9.64 18.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.612 -0.267 . . . . 1.1399999999999999 111.143 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -50.18 -78.72 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.296 -0.411 . . . . 0.55000000000000004 111.458 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.47 ' H ' ' HE ' ' A' ' 20' ' ' ARG . . . 61.02 19.39 56.68 Favored Glycine 0 C--N 1.331 0.25 0 C-N-CA 120.712 -0.756 . . . . 0.76000000000000001 112.281 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -147.09 169.83 8.75 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 110.433 -0.21 . . . . 2.52 110.433 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.618 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 23.0 Cg_exo -65.9 93.23 0.27 Allowed 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.196 1.931 . . . . 0.64000000000000001 111.644 178.386 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 29.8 m -101.96 153.4 5.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.043 0.449 . . . . 0.64000000000000001 111.876 -179.265 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.683 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 80.0 ttt180 -98.55 144.6 27.69 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.605 -0.725 . . . . 2.3700000000000001 110.182 179.328 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 18.2 mt -118.05 103.56 10.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.091 -0.504 . . . . 0.37 110.867 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 34.2 tp -97.96 104.59 16.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.879 0.371 . . . . 0.37 110.519 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -133.93 158.96 42.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.092 -0.503 . . . . 0.31 111.351 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 17.3 tt -105.32 135.33 43.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.102 -0.499 . . . . 0.45000000000000001 110.273 179.282 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 32.4 tpt180 . . . . . 0 C--N 1.331 -0.231 0 CA-C-O 120.869 0.366 . . . . 2.2599999999999998 111.379 -179.28 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 44.6 t . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.749 0.309 . . . . 0.90000000000000002 110.547 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 88.3 mt -85.46 121.75 28.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.281 -0.418 . . . . 0.89000000000000001 111.126 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -113.79 148.29 36.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.992 -0.549 . . . . 2.73 110.893 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.3 m -144.55 136.62 26.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 1.1899999999999999 111.286 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 33.2 t -135.51 132.55 51.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.027 -0.533 . . . . 0.56000000000000005 110.599 179.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -93.3 124.65 37.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.292 -0.413 . . . . 1.74 111.398 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -119.63 151.8 38.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.896 -0.593 . . . . 0.81000000000000005 110.725 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.519 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 19.2 m-85 -123.14 106.52 10.84 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.108 -0.496 . . . . 2.0800000000000001 110.462 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.487 ' HE ' ' HA2' ' A' ' 93' ' ' GLY . 5.0 ttp180 -97.56 126.16 42.69 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.56 -0.456 . . . . 3.0600000000000001 110.813 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -141.61 -36.25 0.44 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.117 -0.492 . . . . 2.5800000000000001 110.957 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -68.47 154.25 42.2 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.956 -0.566 . . . . 3.7200000000000002 110.883 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -84.43 56.5 3.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 2.8700000000000001 111.017 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 65.9 p -92.59 -21.16 20.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.306 -0.406 . . . . 1.3799999999999999 110.994 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.1 t 58.0 18.56 5.2 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.759 -0.655 . . . . 2.4500000000000002 111.461 179.588 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.2 t -154.59 141.48 19.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.835 0.35 . . . . 1.3999999999999999 110.928 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.8 mt -107.95 -15.03 14.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.45000000000000001 110.793 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.437 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 108.34 13.69 18.48 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.669 -0.776 . . . . 0.52000000000000002 112.691 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.428 HG23 HG22 ' A' ' 48' ' ' VAL . 76.8 mt -97.56 113.38 31.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.816 0.341 . . . . 0.83999999999999997 111.058 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.2 t -113.3 103.41 11.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.241 -0.436 . . . . 0.94999999999999996 110.814 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 31.7 pt -101.54 147.48 8.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.247 -0.433 . . . . 0.40999999999999998 111.256 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 71.5 m -114.25 130.73 56.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.479 . . . . 1.3200000000000001 110.712 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 C-N-CA 120.813 -0.708 . . . . 0.94999999999999996 112.467 -179.942 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 50.4 mm . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.719 0.295 . . . . 0.65000000000000002 110.967 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 25.0 p90 -152.54 135.03 15.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.891 0.377 . . . . 0.69999999999999996 111.214 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.428 HG22 HG23 ' A' ' 29' ' ' ILE . 85.3 t -70.72 112.99 6.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.123 -0.49 . . . . 0.39000000000000001 110.834 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -88.52 -29.39 20.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.866 -0.606 . . . . 2.3999999999999999 111.076 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 78.3 p -156.06 171.27 20.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.006 0.432 . . . . 1.28 111.212 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 71.0 mt -128.89 151.7 49.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.911 -0.586 . . . . 0.41999999999999998 110.69 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.437 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 45.5 mm -84.02 113.41 47.71 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 1.26 110.921 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -58.5 132.11 46.53 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.576 2.184 . . . . 0.81999999999999995 112.506 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.56 11.17 78.13 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.9 -0.667 . . . . 0.48999999999999999 112.846 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.413 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 22.2 t -99.71 170.32 8.64 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.656 0.265 . . . . 1.23 111.055 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -56.52 -54.62 43.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.332 -0.395 . . . . 0.41999999999999998 111.489 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -49.18 -44.07 42.65 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.04 -0.527 . . . . 0.34999999999999998 111.533 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.79 -33.58 75.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.48 . . . . 0.44 111.477 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 55' ' ' SER . 90.9 mt -65.9 -33.42 75.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.378 -0.374 . . . . 0.66000000000000003 111.187 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -58.8 -46.59 87.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.954 0.407 . . . . 1.8600000000000001 110.764 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.95 -33.46 3.55 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.839 -0.696 . . . . 1.0600000000000001 112.554 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 58.5 mtp180 -67.71 -22.14 65.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.805 0.336 . . . . 2.5899999999999999 110.735 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 70.0 mt -93.84 115.41 32.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.485 . . . . 0.92000000000000004 110.924 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.453 ' HB2' ' HD2' ' A' ' 65' ' ' PRO . 13.5 pt-20 -118.71 158.6 46.99 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.111 -0.495 . . . . 1.98 110.531 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.453 ' HD2' ' HB2' ' A' ' 64' ' ' GLU . 21.2 Cg_endo -59.27 178.05 0.33 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.38 2.053 . . . . 1.4399999999999999 112.216 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 18.2 m120 55.5 34.94 24.09 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.166 -0.47 . . . . 2.1499999999999999 110.809 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.507 ' HB2' ' HD3' ' A' ' 102' ' ' ARG . 5.3 t70 -100.42 153.05 19.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.021 -0.536 . . . . 2.02 110.886 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -110.89 95.67 5.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.861 0.363 . . . . 1.02 110.758 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.452 HD13 ' HB3' ' A' ' 100' ' ' LEU . 44.8 mm -60.42 132.58 25.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.059 -0.519 . . . . 0.28999999999999998 110.971 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 73.1 mt -100.99 -65.44 0.97 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.036 -0.529 . . . . 0.40000000000000002 110.866 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.425 ' CG ' HD23 ' A' ' 99' ' ' LEU . 7.7 ptp180 -150.54 135.18 17.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.16 0.505 . . . . 2.6099999999999999 111.827 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.533 HG12 ' N ' ' A' ' 73' ' ' ASP . 15.7 t -87.96 170.31 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.46 -0.791 . . . . 0.28000000000000003 109.822 179.025 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.654 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 11.8 t70 -46.51 117.95 1.8 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.723 0.297 . . . . 0.79000000000000004 111.593 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.5 p30 47.32 19.4 0.12 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.755 -0.657 . . . . 2.0099999999999998 112.696 179.378 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.5 t -147.87 100.1 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.655 0.264 . . . . 0.79000000000000004 110.969 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -76.35 144.04 40.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.36 -0.382 . . . . 2.2400000000000002 110.814 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.6 m -117.04 30.41 2.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.36 -0.382 . . . . 0.67000000000000004 111.242 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -89.94 41.74 1.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 1.3899999999999999 111.174 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 157.5 25.77 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.503 -0.856 . . . . 0.55000000000000004 112.982 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 37.1 mtm -117.73 138.73 51.83 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.856 0.36 . . . . 0.52000000000000002 110.742 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.412 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -59.66 160.95 6.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.019 -0.537 . . . . 0.39000000000000001 111.234 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.446 ' O ' HG23 ' A' ' 86' ' ' VAL . 36.2 tt0 -54.12 -57.61 10.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.35 -0.386 . . . . 1.52 111.087 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 79.7 p -49.93 -32.9 15.9 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.209 -0.451 . . . . 1.48 111.271 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.477 ' O ' HG23 ' A' ' 88' ' ' VAL . 12.4 t70 -69.04 -46.75 67.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.379 -0.373 . . . . 2.1200000000000001 110.969 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 81' ' ' ALA . 15.2 t -64.6 -29.16 46.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.99 0.424 . . . . 0.32000000000000001 110.953 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 82' ' ' GLN . 95.9 t -66.18 -58.58 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.964 -0.562 . . . . 0.37 111.287 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 84' ' ' ASP . 13.6 pt-20 -54.16 -36.59 63.51 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.495 -0.32 . . . . 1.51 110.975 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 84' ' ' ASP . 51.7 t -57.11 -56.1 16.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.889 0.376 . . . . 0.27000000000000002 111.041 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 65.4 mt -57.72 -27.25 62.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.001 -0.545 . . . . 0.40999999999999998 111.192 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -86.83 -17.63 32.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.335 -0.393 . . . . 2.1000000000000001 111.302 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -91.47 -13.24 32.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.459 -0.337 . . . . 1.1399999999999999 110.923 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -50.48 -84.18 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.099 -0.5 . . . . 0.55000000000000004 111.529 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.487 ' HA2' ' HE ' ' A' ' 20' ' ' ARG . . . 62.79 17.77 58.47 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.8 -0.714 . . . . 0.76000000000000001 112.532 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.441 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 5.8 p30 -146.94 172.82 4.76 Favored Pre-proline 0 C--N 1.328 -0.354 0 C-N-CA 121.974 0.11 . . . . 2.52 110.922 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.519 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 32.0 Cg_exo -61.43 92.22 0.11 Allowed 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 122.233 1.955 . . . . 0.64000000000000001 111.497 178.086 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.0 m -97.0 144.97 9.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.93 0.395 . . . . 0.64000000000000001 111.855 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.654 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 75.2 ttt180 -101.64 143.2 31.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.766 -0.652 . . . . 2.3700000000000001 109.711 179.121 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 36.6 mt -113.35 107.16 15.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.189 -0.46 . . . . 0.37 111.334 -179.213 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.425 HD23 ' CG ' ' A' ' 71' ' ' ARG . 33.6 tp -100.07 99.84 10.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.411 -0.358 . . . . 0.37 110.294 179.369 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.452 ' HB3' HD13 ' A' ' 69' ' ' ILE . 0.4 OUTLIER -127.99 164.42 22.38 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.224 -0.444 . . . . 0.31 111.379 -179.507 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.3 tt -118.02 139.25 45.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 116.087 -0.506 . . . . 0.45000000000000001 111.133 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.507 ' HD3' ' HB2' ' A' ' 67' ' ' ASP . 15.5 mmm180 . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 115.738 -0.664 . . . . 2.2599999999999998 110.867 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.6 t . . . . . 0 C--O 1.233 0.228 0 CA-C-O 120.996 0.427 . . . . 0.90000000000000002 111.103 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.3 mt -77.33 119.44 20.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.816 -0.629 . . . . 0.89000000000000001 110.883 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -119.09 163.68 16.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.127 -0.488 . . . . 2.73 110.859 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 84.4 p -151.63 146.88 26.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.878 0.371 . . . . 1.1899999999999999 111.04 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 13.5 t -131.61 136.01 58.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.091 -0.504 . . . . 0.56000000000000005 110.799 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -89.63 113.19 24.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.289 -0.414 . . . . 1.74 111.364 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -118.0 166.04 13.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.904 -0.589 . . . . 0.81000000000000005 110.64 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.544 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 30.9 p90 -158.92 128.59 5.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.276 -0.42 . . . . 2.0800000000000001 111.104 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.704 HH21 ' HG ' ' A' ' 27' ' ' LEU . 21.0 ttm180 -101.47 82.72 2.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.905 0.383 . . . . 3.0600000000000001 110.835 179.609 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -97.99 -18.05 18.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.05 -0.523 . . . . 2.5800000000000001 110.747 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -95.11 144.95 25.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.034 -0.53 . . . . 3.7200000000000002 110.644 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -81.06 70.93 8.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.306 -0.406 . . . . 2.8700000000000001 110.749 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 72.2 p -108.21 -9.85 15.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 1.3799999999999999 111.138 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 83.3 p 51.99 22.51 1.85 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.788 -0.642 . . . . 2.4500000000000002 111.211 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 56.3 m -157.09 131.78 8.73 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.306 -0.406 . . . . 1.3999999999999999 110.962 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.704 ' HG ' HH21 ' A' ' 20' ' ' ARG . 49.7 mt -92.69 -25.24 18.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.45000000000000001 110.619 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.568 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 99.6 31.76 5.96 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.819 -0.705 . . . . 0.52000000000000002 112.759 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.438 HG22 HG23 ' A' ' 31' ' ' ILE . 45.4 mt -109.32 108.69 25.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.661 0.267 . . . . 0.83999999999999997 110.926 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 46.5 m -104.14 90.22 3.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.345 -0.388 . . . . 0.94999999999999996 110.884 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.438 HG23 HG22 ' A' ' 29' ' ' ILE . 28.7 pt -88.3 165.98 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.0 -0.545 . . . . 0.40999999999999998 111.295 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 53.2 m -142.85 136.42 28.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.121 -0.49 . . . . 1.3200000000000001 110.909 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 0.23 0 C-N-CA 120.87 -0.681 . . . . 0.94999999999999996 112.769 -179.802 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 45.4 mm . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.765 0.317 . . . . 0.65000000000000002 110.965 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 51.6 p90 -144.18 152.95 41.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.247 -0.433 . . . . 0.69999999999999996 111.165 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.407 HG23 ' CG1' ' A' ' 69' ' ' ILE . 81.3 t -86.77 123.58 39.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.077 -0.51 . . . . 0.39000000000000001 110.898 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -99.49 -26.91 13.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.072 -0.513 . . . . 2.3999999999999999 110.941 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 64.0 m -151.85 170.64 19.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.308 -0.405 . . . . 1.28 111.122 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.5 mt -133.91 146.85 50.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.04 -0.527 . . . . 0.41999999999999998 110.77 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.568 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 44.0 mm -90.06 108.64 27.43 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.239 -0.437 . . . . 1.26 110.892 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -60.94 138.09 76.54 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.351 2.034 . . . . 0.81999999999999995 112.287 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 98.39 -11.12 63.4 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.75 -0.738 . . . . 0.48999999999999999 112.499 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.1 m -89.44 -176.25 4.98 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.699 0.285 . . . . 1.23 110.963 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.73 -58.98 3.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.41999999999999998 111.45 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.13 -32.13 45.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.13 -0.486 . . . . 0.34999999999999998 111.649 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.81 -49.59 17.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.44 -0.345 . . . . 0.44 111.447 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.8 mt -63.24 -19.97 65.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.417 -0.356 . . . . 0.66000000000000003 111.084 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -58.86 -55.27 37.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.357 -0.383 . . . . 1.8600000000000001 110.852 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.3 -44.46 1.61 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.74 -0.743 . . . . 1.0600000000000001 112.832 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 20.3 mtp180 -61.42 -29.28 69.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.635 0.255 . . . . 2.5899999999999999 111.2 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 55.6 mt -85.49 109.18 18.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.914 0.388 . . . . 0.92000000000000004 111.128 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.597 ' HB3' HH12 ' A' ' 102' ' ' ARG . 36.7 tt0 -111.23 139.28 21.74 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.947 -0.57 . . . . 1.98 110.296 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -47.27 165.64 0.1 Allowed 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.504 2.136 . . . . 1.4399999999999999 112.643 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 64.04 54.17 1.73 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.002 -0.545 . . . . 2.1499999999999999 110.831 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -128.42 160.99 30.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.846 -0.616 . . . . 2.02 110.269 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.486 ' HB3' HG23 ' A' ' 101' ' ' ILE . 88.0 tttt -110.35 122.56 47.99 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.828 0.347 . . . . 1.02 111.244 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.464 HD13 ' HB3' ' A' ' 100' ' ' LEU . 36.3 mm -90.17 145.85 6.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.173 -0.467 . . . . 0.28999999999999998 110.699 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 87.2 mt -115.74 -65.8 1.15 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.257 -0.429 . . . . 0.40000000000000002 111.274 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.535 ' HG2' HD23 ' A' ' 99' ' ' LEU . 15.8 ptm180 -149.88 137.15 19.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.252 0.549 . . . . 2.6099999999999999 112.037 -179.35 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.648 HG12 ' H ' ' A' ' 73' ' ' ASP . 11.5 t -84.82 175.22 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.505 -0.771 . . . . 0.28000000000000003 109.409 178.646 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.661 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 8.8 t70 -47.69 108.07 0.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.954 0.407 . . . . 0.79000000000000004 111.684 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 52.3 19.03 1.01 Allowed 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.599 0.592 . . . . 2.0099999999999998 112.599 179.024 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.9 t -146.38 102.14 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.63 0.252 . . . . 0.79000000000000004 111.335 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -62.85 152.76 35.24 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.538 -0.301 . . . . 2.2400000000000002 110.663 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.1 m -143.07 49.98 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 120.791 0.329 . . . . 0.67000000000000004 111.862 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -143.3 21.33 1.89 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.069 0.461 . . . . 1.3899999999999999 110.561 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -142.97 -4.21 0.85 Allowed Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.731 -0.668 . . . . 0.55000000000000004 112.259 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 71.1 mtm -108.16 173.89 6.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.822 0.344 . . . . 0.52000000000000002 110.719 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.413 ' HB3' ' OD1' ' A' ' 84' ' ' ASP . . . -69.17 166.28 18.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.212 -0.449 . . . . 0.39000000000000001 111.104 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.418 ' NE2' HG13 ' A' ' 31' ' ' ILE . 7.8 tp60 -58.94 -58.39 8.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 1.52 110.948 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 45.0 t -51.75 -39.82 59.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.026 -0.534 . . . . 1.48 111.295 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.413 ' OD1' ' HB3' ' A' ' 81' ' ' ALA . 1.2 m-20 -57.28 -44.92 84.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.345 -0.389 . . . . 2.1200000000000001 110.835 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 81' ' ' ALA . 55.6 t -61.24 -38.4 79.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.223 -0.444 . . . . 0.32000000000000001 110.926 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 17.9 t -63.93 -39.62 86.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 0.37 110.995 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -58.62 -51.83 68.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.285 -0.416 . . . . 1.51 110.75 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 63.6 t -52.83 -53.58 20.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.27000000000000002 111.431 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 80.0 mt -58.44 -30.92 67.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.049 -0.523 . . . . 0.40999999999999998 111.366 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 73.2 mtm180 -85.81 -13.6 47.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.42 -0.354 . . . . 2.1000000000000001 111.175 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -93.86 -13.76 26.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.405 -0.361 . . . . 1.1399999999999999 110.917 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.15 -83.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.213 -0.449 . . . . 0.55000000000000004 111.432 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.591 ' H ' ' HD2' ' A' ' 20' ' ' ARG . . . 63.76 13.2 50.89 Favored Glycine 0 CA--C 1.517 0.216 0 C-N-CA 120.664 -0.779 . . . . 0.76000000000000001 112.419 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.409 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 8.0 p30 -146.78 170.4 7.87 Favored Pre-proline 0 C--N 1.329 -0.318 0 O-C-N 122.999 -0.118 . . . . 2.52 110.82 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.544 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 31.8 Cg_exo -60.55 106.27 0.35 Allowed 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.241 1.961 . . . . 0.64000000000000001 111.669 178.419 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 34.7 m -114.33 154.37 15.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.95 0.405 . . . . 0.64000000000000001 111.699 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.661 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 73.7 ttt180 -101.9 142.2 33.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.833 -0.621 . . . . 2.3700000000000001 109.932 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 21.8 mt -116.81 109.1 16.67 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.431 -0.35 . . . . 0.37 111.271 -179.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.535 HD23 ' HG2' ' A' ' 71' ' ' ARG . 52.4 tp -96.19 103.32 15.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.3 -0.409 . . . . 0.37 110.396 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.464 ' HB3' HD13 ' A' ' 69' ' ' ILE . 0.4 OUTLIER -129.8 154.11 47.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.454 . . . . 0.31 111.403 -179.557 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.486 HG23 ' HB3' ' A' ' 68' ' ' LYS . 13.9 tt -105.89 136.71 39.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-N 116.157 -0.474 . . . . 0.45000000000000001 110.773 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.597 HH12 ' HB3' ' A' ' 64' ' ' GLU . 29.1 mmm-85 . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 115.741 -0.663 . . . . 2.2599999999999998 110.429 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.0 t . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 120.732 0.301 . . . . 0.90000000000000002 110.628 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 91.4 mt -76.71 121.51 23.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.244 -0.434 . . . . 0.89000000000000001 110.824 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -113.38 155.18 25.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.978 -0.555 . . . . 2.73 110.862 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 48.3 t -151.35 132.69 14.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.271 -0.422 . . . . 1.1899999999999999 111.154 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.4 t -131.56 128.77 61.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.11 -0.495 . . . . 0.56000000000000005 110.676 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -92.7 119.15 31.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 1.74 111.525 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.439 HD12 HD11 ' A' ' 98' ' ' LEU . 19.6 mt -119.16 113.09 20.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.093 -0.503 . . . . 0.81000000000000005 110.542 179.311 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.63 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 33.1 m-85 -79.58 114.21 18.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.092 -0.504 . . . . 2.0800000000000001 111.022 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.515 ' HG2' ' HA2' ' A' ' 93' ' ' GLY . 20.3 ttt180 -100.16 104.9 16.46 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.836 0.35 . . . . 3.0600000000000001 110.565 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -147.63 11.25 0.98 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.277 -0.42 . . . . 2.5800000000000001 111.019 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -94.7 156.44 16.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 3.7200000000000002 110.67 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -83.06 53.33 2.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.348 -0.387 . . . . 2.8700000000000001 110.69 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.2 p -120.31 -29.27 4.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 1.3799999999999999 110.95 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.441 ' HA ' ' NH2' ' A' ' 20' ' ' ARG . 41.2 t 59.61 14.88 4.24 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.691 -0.686 . . . . 2.4500000000000002 111.153 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 47.6 t -125.05 132.81 53.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 1.3999999999999999 110.699 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.428 HD21 ' HD2' ' A' ' 20' ' ' ARG . 95.2 mt -102.27 -11.8 18.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.45000000000000001 110.697 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.513 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 87.02 6.67 78.83 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.812 -0.709 . . . . 0.52000000000000002 112.584 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.42 HG23 HG22 ' A' ' 48' ' ' VAL . 67.7 mt -85.1 109.0 17.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.713 0.292 . . . . 0.83999999999999997 111.026 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.5 m -113.84 99.81 7.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.37 -0.377 . . . . 0.94999999999999996 110.822 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 36.7 pt -92.49 152.46 3.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.196 -0.456 . . . . 0.40999999999999998 111.343 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.9 p -108.07 133.25 52.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.033 -0.531 . . . . 1.3200000000000001 110.994 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 0.303 0 C-N-CA 120.904 -0.665 . . . . 0.94999999999999996 112.529 179.964 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 50.5 mm . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.758 0.313 . . . . 0.65000000000000002 110.913 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -153.67 137.23 15.96 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.362 -0.381 . . . . 0.69999999999999996 111.203 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.42 HG22 HG23 ' A' ' 29' ' ' ILE . 91.1 t -63.41 119.11 6.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.15 -0.477 . . . . 0.39000000000000001 110.888 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -98.1 -26.04 14.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.81 -0.632 . . . . 2.3999999999999999 110.952 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 79.8 p -153.56 162.32 41.37 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.926 0.393 . . . . 1.28 111.31 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.2 mt -123.84 156.03 36.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.96 -0.564 . . . . 0.41999999999999998 110.774 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.513 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 49.4 mm -99.28 114.02 65.23 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.312 -0.403 . . . . 1.26 110.871 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -62.15 119.73 6.97 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.446 2.097 . . . . 0.81999999999999995 112.196 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.34 7.76 29.93 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.893 -0.67 . . . . 0.48999999999999999 112.514 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.4 m -105.75 -174.48 2.54 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.626 0.251 . . . . 1.23 110.941 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.65 -47.38 66.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.888 0.375 . . . . 0.41999999999999998 111.14 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.546 ' HB1' HG21 ' A' ' 63' ' ' ILE . . . -57.31 -41.15 79.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.939 -0.573 . . . . 0.34999999999999998 111.533 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.49 -53.53 15.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.44 111.593 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 98.5 mt -60.55 -19.78 58.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.366 -0.379 . . . . 0.66000000000000003 111.295 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -62.34 -55.41 28.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.811 0.338 . . . . 1.8600000000000001 110.795 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 105.59 -49.75 0.87 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.826 -0.702 . . . . 1.0600000000000001 112.752 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -68.26 -23.41 64.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.739 0.304 . . . . 2.5899999999999999 111.126 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.546 HG21 ' HB1' ' A' ' 57' ' ' ALA . 39.5 mm -76.12 123.62 32.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.826 0.346 . . . . 0.92000000000000004 110.937 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -111.9 155.05 43.85 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.138 -0.483 . . . . 1.98 111.028 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -78.81 36.95 0.63 Allowed 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.943 2.429 . . . . 1.4399999999999999 112.259 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -169.29 75.93 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.296 -0.411 . . . . 2.1499999999999999 110.872 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -143.28 150.01 38.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 2.02 110.877 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.462 ' HB3' HG23 ' A' ' 101' ' ' ILE . 87.7 tttt -90.62 114.68 27.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.828 0.346 . . . . 1.02 111.129 -179.551 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.516 HD13 ' HB3' ' A' ' 100' ' ' LEU . 41.0 mm -84.16 137.54 20.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.215 -0.448 . . . . 0.28999999999999998 110.729 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 65.8 mt -117.08 -65.04 1.23 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.434 . . . . 0.40000000000000002 111.17 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -131.07 163.7 27.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.097 -0.501 . . . . 2.6099999999999999 111.703 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.551 HG12 ' N ' ' A' ' 73' ' ' ASP . 44.8 t -127.97 167.64 22.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.566 -0.743 . . . . 0.28000000000000003 109.562 179.017 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.617 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 7.7 t70 -41.6 108.11 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.5 0.555 . . . . 0.79000000000000004 112.5 -179.384 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 56.66 2.76 0.1 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.468 0.914 . . . . 2.0099999999999998 113.468 178.437 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.454 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 84.7 t -143.57 112.79 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.679 0.276 . . . . 0.79000000000000004 111.534 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -68.75 163.26 24.43 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.005 -0.368 . . . . 2.2400000000000002 110.005 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.7 m -134.38 0.08 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.718 0.294 . . . . 0.67000000000000004 111.651 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -91.5 109.32 20.61 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 120.883 0.373 . . . . 1.3899999999999999 110.385 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 125.57 -12.94 7.38 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.843 -0.694 . . . . 0.55000000000000004 112.516 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 74.4 mtm -105.44 158.66 16.5 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.839 0.352 . . . . 0.52000000000000002 110.996 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.39 162.19 15.53 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.198 -0.455 . . . . 0.39000000000000001 111.328 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -56.77 -46.38 81.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.329 -0.396 . . . . 1.52 111.136 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 85.4 p -53.42 -41.24 65.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.234 -0.439 . . . . 1.48 111.162 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -66.02 -44.04 85.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.296 -0.411 . . . . 2.1200000000000001 111.13 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 57.7 t -58.34 -39.8 75.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.154 -0.476 . . . . 0.32000000000000001 111.372 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 64.7 t -68.04 -43.52 85.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.496 -0.32 . . . . 0.37 111.145 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -57.35 -43.67 83.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.355 -0.384 . . . . 1.51 110.944 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 57.3 t -61.16 -55.47 24.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.46 . . . . 0.27000000000000002 111.181 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 90.8 mt -52.62 -27.56 17.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.974 -0.557 . . . . 0.40999999999999998 111.301 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 74.4 mtm180 -89.17 -28.25 20.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.286 -0.415 . . . . 2.1000000000000001 111.271 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -74.07 -14.99 61.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.399 -0.364 . . . . 1.1399999999999999 110.693 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.47 ' HB3' ' HD3' ' A' ' 20' ' ' ARG . . . -54.33 -81.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.994 -0.548 . . . . 0.55000000000000004 111.364 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.515 ' HA2' ' HG2' ' A' ' 20' ' ' ARG . . . 61.1 17.42 51.93 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.655 -0.783 . . . . 0.76000000000000001 112.139 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.443 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 8.2 p30 -147.13 170.88 7.05 Favored Pre-proline 0 CA--C 1.534 0.329 0 C-N-CA 122.06 0.144 . . . . 2.52 110.877 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.63 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 47.4 Cg_exo -58.25 104.2 0.17 Allowed 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.081 1.854 . . . . 0.64000000000000001 111.555 178.299 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 23.6 m -112.68 155.1 14.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.041 0.448 . . . . 0.64000000000000001 112.011 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.617 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 35.3 ttp180 -111.46 145.25 39.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.695 -0.684 . . . . 2.3700000000000001 109.949 179.295 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.439 HD11 HD12 ' A' ' 18' ' ' LEU . 25.9 mt -110.02 124.1 50.86 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.356 -0.383 . . . . 0.37 111.255 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 32.7 tp -109.88 101.08 9.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.332 -0.395 . . . . 0.37 110.245 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.516 ' HB3' HD13 ' A' ' 69' ' ' ILE . 0.4 OUTLIER -130.55 160.67 33.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.31 111.396 -179.467 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.462 HG23 ' HB3' ' A' ' 68' ' ' LYS . 12.6 tt -116.08 141.92 31.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.873 -0.603 . . . . 0.45000000000000001 110.896 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 32.3 tpt180 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.043 -0.526 . . . . 2.2599999999999998 110.979 -179.761 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 44.2 t . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.827 0.346 . . . . 0.90000000000000002 110.869 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 62.6 mt -77.55 126.37 30.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.06 -0.518 . . . . 0.89000000000000001 110.824 179.826 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.404 ' CD2' ' HB2' ' A' ' 102' ' ' ARG . 58.5 m-85 -123.65 130.42 52.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.12 -0.491 . . . . 2.73 111.023 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 80.8 p -120.42 139.26 53.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.285 -0.416 . . . . 1.1899999999999999 111.091 -179.815 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.3 t -131.58 146.4 33.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.116 -0.493 . . . . 0.56000000000000005 110.743 179.991 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -103.0 114.04 28.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.381 -0.372 . . . . 1.74 111.386 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.475 HD12 ' HB1' ' A' ' 56' ' ' ALA . 4.6 mm? -115.5 166.1 12.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.079 -0.509 . . . . 0.81000000000000005 110.702 179.537 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.545 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 37.9 p90 -159.51 131.69 6.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.277 -0.42 . . . . 2.0800000000000001 111.053 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.7 HH21 ' HG ' ' A' ' 27' ' ' LEU . 27.8 ttm180 -109.85 130.86 55.47 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.68 -0.408 . . . . 3.0600000000000001 110.879 179.635 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -134.67 6.68 3.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.01 -0.541 . . . . 2.5800000000000001 110.73 179.777 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -112.47 162.7 15.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.007 -0.542 . . . . 3.7200000000000002 110.788 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -86.7 42.98 1.05 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.262 -0.426 . . . . 2.8700000000000001 110.958 -179.911 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 69.3 p -86.98 -13.01 45.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 1.3799999999999999 111.339 -179.924 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 94.8 p 50.56 24.56 1.67 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.778 -0.646 . . . . 2.4500000000000002 111.504 179.89 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 80.5 p -158.7 153.32 24.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.297 -0.41 . . . . 1.3999999999999999 110.904 -179.938 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.7 ' HG ' HH21 ' A' ' 20' ' ' ARG . 84.0 mt -107.76 -13.17 15.07 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.012 -0.54 . . . . 0.45000000000000001 110.998 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.546 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 100.69 18.94 19.25 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.828 -0.701 . . . . 0.52000000000000002 112.741 179.748 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 78.2 mt -97.52 112.46 29.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.702 0.287 . . . . 0.83999999999999997 110.694 179.751 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.9 t -110.12 101.93 10.68 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.337 -0.392 . . . . 0.94999999999999996 111.019 -179.713 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.436 ' HA ' ' HA ' ' A' ' 48' ' ' VAL . 33.2 pt -92.33 163.41 2.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.967 -0.56 . . . . 0.40999999999999998 110.914 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 47.9 t -147.33 156.69 43.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.179 -0.464 . . . . 1.3200000000000001 110.782 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.247 0 C-N-CA 120.722 -0.752 . . . . 0.94999999999999996 112.558 -179.953 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 42.8 mm . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.784 0.326 . . . . 0.65000000000000002 110.806 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -132.52 141.17 48.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 0.69999999999999996 111.074 -179.888 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.436 ' HA ' ' HA ' ' A' ' 31' ' ' ILE . 97.8 t -80.19 111.86 17.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.147 -0.479 . . . . 0.39000000000000001 110.51 179.444 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -84.39 -34.67 23.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.092 -0.503 . . . . 2.3999999999999999 111.284 -179.607 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 83.0 p -151.06 179.07 8.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.064 0.459 . . . . 1.28 111.527 -179.718 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 66.6 mt -134.06 160.84 36.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.725 -0.67 . . . . 0.41999999999999998 110.558 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.546 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 53.2 mt -96.54 108.55 43.1 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.257 -0.429 . . . . 1.26 111.12 179.954 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -59.34 127.54 24.29 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.348 2.032 . . . . 0.81999999999999995 112.324 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 104.69 -2.68 42.1 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.763 -0.732 . . . . 0.48999999999999999 112.549 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.6 m -95.68 -179.03 4.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.659 0.266 . . . . 1.23 110.99 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.475 ' HB1' HD12 ' A' ' 18' ' ' LEU . . . -65.69 -55.44 17.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.36 -0.382 . . . . 0.41999999999999998 111.189 179.937 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.72 -33.05 63.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.061 -0.518 . . . . 0.34999999999999998 111.413 -179.852 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.38 -50.47 31.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.259 -0.428 . . . . 0.44 111.442 -179.739 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.2 mt -61.4 -21.27 63.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.312 -0.404 . . . . 0.66000000000000003 111.123 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -60.66 -54.72 41.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.405 -0.361 . . . . 1.8600000000000001 110.977 -179.782 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.34 -46.85 1.79 Allowed Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.742 -0.742 . . . . 1.0600000000000001 112.927 179.458 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 66.9 mtp180 -56.45 -39.27 72.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.772 0.32 . . . . 2.5899999999999999 110.991 -179.772 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 64.6 mt -68.57 108.55 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.92000000000000004 110.883 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -107.29 137.41 19.6 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.038 -0.528 . . . . 1.98 110.715 -179.702 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -54.91 175.64 0.15 Allowed 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.571 2.181 . . . . 1.4399999999999999 112.278 179.855 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 59.32 44.48 15.28 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.031 0.443 . . . . 2.1499999999999999 110.285 -179.632 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -119.51 167.22 12.18 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.895 -0.593 . . . . 2.02 110.807 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -116.71 123.07 46.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.316 -0.402 . . . . 1.02 110.962 179.911 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.495 HD13 ' HB3' ' A' ' 100' ' ' LEU . 47.5 mm -81.16 139.11 18.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.159 -0.473 . . . . 0.28999999999999998 111.202 -179.729 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 79.2 mt -105.53 -68.75 0.85 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.906 -0.588 . . . . 0.40000000000000002 110.723 179.844 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.437 ' HG2' HD23 ' A' ' 99' ' ' LEU . 10.3 ptp180 -150.24 137.42 19.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 2.6099999999999999 111.21 -179.868 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.676 HG12 ' H ' ' A' ' 73' ' ' ASP . 2.6 t -87.19 175.29 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.712 -0.676 . . . . 0.28000000000000003 110.285 179.579 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.676 ' H ' HG12 ' A' ' 72' ' ' VAL . 17.7 t70 -50.49 112.7 0.73 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.773 0.321 . . . . 0.79000000000000004 111.465 179.432 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 56.69 23.23 7.61 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.079 -0.51 . . . . 2.0099999999999998 111.806 179.548 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.465 HG11 HG11 ' A' ' 88' ' ' VAL . 68.2 t -143.74 144.44 23.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.82 0.343 . . . . 0.79000000000000004 110.923 179.855 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -115.69 133.05 56.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.311 -0.404 . . . . 2.2400000000000002 110.504 179.668 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.543 HG11 HG13 ' A' ' 85' ' ' VAL . 31.2 m -121.15 35.49 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.849 0.357 . . . . 0.67000000000000004 111.722 -179.39 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -97.51 41.46 1.12 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.302 -0.408 . . . . 1.3899999999999999 111.051 179.948 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.19 36.18 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.449 -0.881 . . . . 0.55000000000000004 113.235 179.77 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 52.4 mtm -127.91 158.55 37.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.844 0.354 . . . . 0.52000000000000002 110.849 179.562 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.08 151.5 42.95 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.104 -0.498 . . . . 0.39000000000000001 111.149 -179.935 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -53.57 -55.0 29.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.334 -0.393 . . . . 1.52 111.308 -179.556 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 59.4 m -53.57 -37.37 62.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 1.48 111.445 -179.512 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -64.02 -42.35 97.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.478 -0.328 . . . . 2.1200000000000001 110.926 -179.826 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.543 HG13 HG11 ' A' ' 77' ' ' VAL . 48.0 t -61.08 -41.71 90.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.218 -0.447 . . . . 0.32000000000000001 111.05 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 47.8 t -63.3 -39.89 86.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.262 -0.426 . . . . 0.37 111.013 179.929 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.451 ' HG2' HH21 ' A' ' 90' ' ' ARG . 47.8 mt-10 -57.72 -48.05 80.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 1.51 111.072 -179.953 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.465 HG11 HG11 ' A' ' 75' ' ' VAL . 65.7 t -57.26 -55.86 18.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.27000000000000002 111.368 -179.889 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 91.4 mt -52.11 -32.64 36.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.028 -0.533 . . . . 0.40999999999999998 111.222 -179.445 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.6 ' HA ' HH22 ' A' ' 20' ' ' ARG . 80.0 mtm180 -81.04 -30.27 34.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.34 -0.391 . . . . 2.1000000000000001 111.291 -179.912 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -68.96 -22.26 64.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.443 -0.344 . . . . 1.1399999999999999 110.707 179.891 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.38 -84.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.093 -0.503 . . . . 0.55000000000000004 111.275 179.778 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.66 ' HA2' ' HD2' ' A' ' 20' ' ' ARG . . . 64.11 19.41 63.73 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.81 -0.709 . . . . 0.76000000000000001 112.555 -179.794 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -146.96 178.63 1.37 Allowed Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 110.263 -0.273 . . . . 2.52 110.263 -179.752 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.545 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 33.2 Cg_exo -60.46 102.79 0.2 Allowed 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.07 1.847 . . . . 0.64000000000000001 111.954 178.196 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 30.1 m -121.15 156.79 24.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.062 0.458 . . . . 0.64000000000000001 111.508 -179.552 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.625 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 76.3 ttt180 -101.58 142.51 32.83 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.826 -0.625 . . . . 2.3700000000000001 110.351 179.791 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 13.1 mt -118.21 111.63 19.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.191 -0.459 . . . . 0.37 111.024 -179.6 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.437 HD23 ' HG2' ' A' ' 71' ' ' ARG . 45.1 tp -101.65 103.82 14.64 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.834 0.349 . . . . 0.37 110.561 179.489 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.495 ' HB3' HD13 ' A' ' 69' ' ' ILE . 0.5 OUTLIER -132.38 155.14 48.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.125 -0.489 . . . . 0.31 111.102 -179.548 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 15.2 tt -103.13 136.92 33.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.45000000000000001 111.103 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.404 ' HB2' ' CD2' ' A' ' 14' ' ' TYR . 21.6 mmm180 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 115.702 -0.681 . . . . 2.2599999999999998 110.518 179.809 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 46.0 t . . . . . 0 C--O 1.236 0.371 0 CA-C-O 121.015 0.436 . . . . 0.90000000000000002 111.276 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.544 HD23 ' HB ' ' A' ' 101' ' ' ILE . 17.8 mt -97.21 103.31 15.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.497 -0.774 . . . . 0.89000000000000001 110.1 179.599 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 36.5 p90 -124.5 151.91 44.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.858 0.361 . . . . 2.73 111.119 -179.344 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 48.4 t -120.68 155.81 33.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.024 0.44 . . . . 1.1899999999999999 111.383 -179.436 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.8 t -131.66 137.69 54.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.758 -0.656 . . . . 0.56000000000000005 110.416 179.801 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -88.51 114.43 25.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.947 0.403 . . . . 1.74 111.406 -179.491 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -124.95 117.67 24.57 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.892 -0.595 . . . . 0.81000000000000005 110.614 179.614 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.582 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 28.2 p90 -107.66 132.97 52.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.378 -0.374 . . . . 2.0800000000000001 111.053 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.65 ' HE ' ' HA2' ' A' ' 93' ' ' GLY . 20.7 ttp180 -107.78 102.89 12.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.853 0.359 . . . . 3.0600000000000001 110.861 179.56 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -128.08 -3.03 5.75 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.149 -0.478 . . . . 2.5800000000000001 111.113 -179.797 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.431 ' N ' ' HD2' ' A' ' 22' ' ' LYS . 0.9 OUTLIER -83.78 159.77 21.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.306 -0.407 . . . . 3.7200000000000002 110.792 179.825 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -83.32 34.65 0.47 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.468 . . . . 2.8700000000000001 110.978 -179.885 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 50.3 p -92.14 -23.22 19.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.283 -0.417 . . . . 1.3799999999999999 111.127 -179.872 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.7 m 56.91 24.67 9.62 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.879 -0.601 . . . . 2.4500000000000002 111.361 179.785 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 52.5 m -147.19 157.9 43.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.359 -0.382 . . . . 1.3999999999999999 111.053 -179.885 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.585 HD21 ' HB2' ' A' ' 20' ' ' ARG . 86.1 mt -114.98 1.1 13.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.175 -0.466 . . . . 0.45000000000000001 110.981 179.876 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 67.87 23.44 74.22 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.795 -0.717 . . . . 0.52000000000000002 112.735 179.898 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 62.5 mt -97.61 110.01 24.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.648 0.261 . . . . 0.83999999999999997 110.919 179.896 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 35.9 t -107.54 98.48 8.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.386 -0.37 . . . . 0.94999999999999996 111.01 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 40.6 pt -83.58 159.39 3.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.294 -0.412 . . . . 0.40999999999999998 111.142 -179.878 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 47.9 t -138.7 152.02 47.66 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.049 -0.523 . . . . 1.3200000000000001 110.989 -179.78 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 C-N-CA 120.772 -0.727 . . . . 0.94999999999999996 112.471 179.94 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 45.9 mm . . . . . 0 C--O 1.233 0.189 0 CA-C-O 120.752 0.31 . . . . 0.65000000000000002 111.032 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -152.72 140.9 20.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.283 -0.417 . . . . 0.69999999999999996 110.825 179.796 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 97.0 t -74.48 116.29 16.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.078 -0.51 . . . . 0.39000000000000001 110.869 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -103.9 -25.08 13.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.22 -0.445 . . . . 2.3999999999999999 110.917 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 42.3 t -141.13 165.86 26.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 1.28 111.216 -179.926 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.463 HD11 HG22 ' A' ' 63' ' ' ILE . 95.6 mt -136.67 163.64 30.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.913 -0.585 . . . . 0.41999999999999998 110.792 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 50.1 mm -108.02 103.52 50.31 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.321 -0.399 . . . . 1.26 111.076 -179.853 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.93 132.1 47.99 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.426 2.084 . . . . 0.81999999999999995 112.297 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 99.68 -4.9 58.14 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.789 -0.72 . . . . 0.48999999999999999 112.408 -179.779 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.8 t -93.66 167.98 11.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.614 0.245 . . . . 1.23 110.944 -179.876 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -53.91 -57.84 9.5 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.283 -0.417 . . . . 0.41999999999999998 111.704 -179.75 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.35 -43.78 61.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.34999999999999998 111.468 -179.638 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.7 -34.57 77.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.44 111.719 -179.52 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 70.2 mt -62.94 -37.04 85.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.456 -0.338 . . . . 0.66000000000000003 111.444 -179.622 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.03 -44.88 95.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.469 -0.332 . . . . 1.8600000000000001 111.017 -179.878 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.76 -27.29 4.36 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.79 -0.719 . . . . 1.0600000000000001 112.652 179.892 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 78.4 mtp180 -62.51 -19.23 63.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.837 0.351 . . . . 2.5899999999999999 111.102 -179.955 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.509 ' N ' HD12 ' A' ' 63' ' ' ILE . 3.2 mp -82.5 104.55 11.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.115 -0.493 . . . . 0.92000000000000004 110.695 179.808 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -93.71 137.23 23.3 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.088 -0.506 . . . . 1.98 110.7 -179.764 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -51.47 160.8 2.24 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.38 2.053 . . . . 1.4399999999999999 112.316 179.693 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.1 m120 58.7 44.89 16.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.186 -0.461 . . . . 2.1499999999999999 110.787 -179.855 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -95.11 143.19 26.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.906 -0.588 . . . . 2.02 111.049 -179.88 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.675 ' HB3' HG23 ' A' ' 101' ' ' ILE . 25.9 tptp -91.85 101.49 14.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.108 -0.497 . . . . 1.02 111.152 -179.948 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.455 HG22 HG21 ' A' ' 77' ' ' VAL . 40.0 mm -74.33 134.39 29.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.494 -0.321 . . . . 0.28999999999999998 110.62 179.627 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 88.3 mt -108.91 -57.26 2.17 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.395 -0.366 . . . . 0.40000000000000002 111.139 -179.766 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -157.87 138.95 13.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.088 0.47 . . . . 2.6099999999999999 111.623 -179.738 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.631 HG12 ' H ' ' A' ' 73' ' ' ASP . 5.3 t -88.45 174.23 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.543 -0.753 . . . . 0.28000000000000003 109.855 179.242 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.67 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 14.9 t70 -46.6 111.0 0.33 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.866 0.365 . . . . 0.79000000000000004 111.957 179.845 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 54.1 29.02 9.64 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.021 -0.536 . . . . 2.0099999999999998 112.084 179.113 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 96.2 t -147.28 137.27 16.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.419 -0.355 . . . . 0.79000000000000004 110.771 179.729 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -103.51 132.19 49.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.42 -0.355 . . . . 2.2400000000000002 110.594 179.716 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.455 HG21 HG22 ' A' ' 69' ' ' ILE . 34.6 m -112.24 26.07 3.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-O 120.817 0.342 . . . . 0.67000000000000004 111.423 -179.588 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -95.26 31.03 2.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 1.3899999999999999 111.158 179.823 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 173.53 37.23 0.04 OUTLIER Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.575 -0.821 . . . . 0.55000000000000004 112.751 179.818 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 51.6 mtm -128.99 142.71 50.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.787 0.327 . . . . 0.52000000000000002 110.83 179.824 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.32 161.5 9.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.39000000000000001 111.254 -179.884 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.436 ' O ' HG23 ' A' ' 86' ' ' VAL . 35.6 tt0 -53.96 -60.97 2.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.256 -0.429 . . . . 1.52 110.949 -179.847 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 54.5 m -55.29 -26.74 42.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.244 -0.434 . . . . 1.48 111.386 -179.737 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -69.64 -54.21 14.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.771 0.319 . . . . 2.1200000000000001 110.894 -179.786 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.7 t -56.1 -39.08 56.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.298 -0.41 . . . . 0.32000000000000001 110.922 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.491 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 59.7 t -58.53 -55.86 20.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.232 -0.44 . . . . 0.37 110.628 179.586 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -47.6 -41.6 22.12 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.073 -0.512 . . . . 1.51 111.001 179.893 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 54.0 t -56.29 -51.84 58.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.164 -0.471 . . . . 0.27000000000000002 110.711 179.309 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 76.1 mt -56.28 -28.61 59.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.755 -0.657 . . . . 0.40999999999999998 110.792 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.491 ' HG2' ' O ' ' A' ' 86' ' ' VAL . 20.9 mmt180 -79.6 -30.3 41.44 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.082 -0.508 . . . . 2.1000000000000001 110.654 179.982 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -75.16 -18.41 60.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.052 -0.522 . . . . 1.1399999999999999 110.845 -179.824 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.53 -88.63 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.049 -0.523 . . . . 0.55000000000000004 111.636 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.65 ' HA2' ' HE ' ' A' ' 20' ' ' ARG . . . 60.97 16.97 49.98 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.746 -0.74 . . . . 0.76000000000000001 112.509 -179.741 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.435 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 5.7 p30 -146.99 172.9 4.66 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 110.657 -0.127 . . . . 2.52 110.657 -179.677 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.582 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 37.5 Cg_exo -62.39 97.45 0.17 Allowed 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 122.068 1.845 . . . . 0.64000000000000001 111.625 178.338 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 29.0 m -105.64 156.41 6.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.64000000000000001 111.717 -179.307 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.67 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 78.5 ttt180 -103.55 142.14 34.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.713 -0.676 . . . . 2.3700000000000001 110.029 179.366 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 21.3 mt -115.14 104.37 11.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 0.37 111.35 -179.214 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 34.3 tp -95.8 111.59 23.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.82 0.343 . . . . 0.37 110.172 179.173 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.09 166.84 23.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.086 0.469 . . . . 0.31 111.628 -179.105 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.675 HG23 ' HB3' ' A' ' 68' ' ' LYS . 4.1 tt -121.92 138.32 52.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.684 -0.689 . . . . 0.45000000000000001 110.478 179.71 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 33.0 tpt180 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.322 -0.399 . . . . 2.2599999999999998 110.784 -179.831 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 48.3 t . . . . . 0 C--O 1.237 0.411 0 CA-C-O 121.033 0.444 . . . . 0.90000000000000002 111.383 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.529 HD23 ' HB ' ' A' ' 101' ' ' ILE . 15.6 mt -93.88 101.86 13.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.468 -0.787 . . . . 0.89000000000000001 110.076 179.58 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.416 ' HE1' ' HB3' ' A' ' 102' ' ' ARG . 40.5 p90 -121.88 148.08 45.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.927 0.394 . . . . 2.73 111.117 -179.464 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 80.3 p -112.57 146.99 37.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.052 -0.522 . . . . 1.1899999999999999 111.143 -179.68 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 17.2 t -120.31 135.3 61.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.096 -0.502 . . . . 0.56000000000000005 110.644 179.751 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -92.09 111.53 23.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.323 -0.399 . . . . 1.74 111.614 -179.509 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.56 HD12 ' HB1' ' A' ' 56' ' ' ALA . 3.5 mm? -116.14 166.16 12.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.94 -0.573 . . . . 0.81000000000000005 110.184 179.112 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.576 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 42.2 p90 -153.61 136.93 15.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.796 0.332 . . . . 2.0800000000000001 111.433 -179.745 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.461 HH21 ' N ' ' A' ' 93' ' ' GLY . 21.5 ttp180 -121.31 140.32 52.25 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.175 -0.466 . . . . 3.0600000000000001 110.607 179.317 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -160.63 26.15 0.15 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.388 -0.369 . . . . 2.5800000000000001 111.317 -179.947 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -123.17 165.46 16.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.33 -0.395 . . . . 3.7200000000000002 110.712 179.602 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -88.96 72.58 8.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.243 -0.435 . . . . 2.8700000000000001 110.799 -179.951 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 48.3 p -124.07 -24.89 4.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.06 -0.518 . . . . 1.3799999999999999 110.987 179.935 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.0 t 58.35 23.82 10.93 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.775 -0.648 . . . . 2.4500000000000002 111.189 179.687 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 56.5 m -151.18 136.08 17.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.893 0.378 . . . . 1.3999999999999999 111.086 -179.918 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.456 HD21 ' HB2' ' A' ' 20' ' ' ARG . 46.7 mt -97.11 -12.29 23.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.017 -0.538 . . . . 0.45000000000000001 110.608 179.707 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.516 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 92.78 20.59 33.56 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.851 -0.69 . . . . 0.52000000000000002 112.509 179.91 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 75.9 mt -98.59 112.14 29.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.717 0.294 . . . . 0.83999999999999997 111.064 179.956 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 70.4 m -113.68 98.89 7.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.94999999999999996 110.834 179.921 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 36.9 pt -91.34 166.7 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.186 -0.461 . . . . 0.40999999999999998 111.376 -179.854 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 44.8 t -147.4 153.59 39.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.029 -0.532 . . . . 1.3200000000000001 110.654 -179.981 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 C-N-CA 120.738 -0.744 . . . . 0.94999999999999996 112.529 -179.991 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 40.5 mm . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.723 0.297 . . . . 0.65000000000000002 111.164 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -155.94 139.19 15.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.238 -0.437 . . . . 0.69999999999999996 110.715 179.862 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 57.5 t -76.74 127.11 37.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.222 -0.445 . . . . 0.39000000000000001 111.111 -179.84 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -116.71 -22.55 8.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.036 -0.529 . . . . 2.3999999999999999 111.165 -179.763 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 46.9 t -139.58 163.39 32.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.952 0.406 . . . . 1.28 111.304 -179.871 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 76.0 mt -134.78 163.17 30.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.888 -0.596 . . . . 0.41999999999999998 110.807 179.984 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.516 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 48.5 mm -110.32 98.92 38.15 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.29 -0.414 . . . . 1.26 110.96 179.67 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.07 126.88 22.92 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.404 2.069 . . . . 0.81999999999999995 112.28 -179.928 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.76 -4.54 32.41 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.905 -0.664 . . . . 0.48999999999999999 112.625 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.442 ' OG ' ' HA3' ' A' ' 28' ' ' GLY . 93.1 p -99.47 -172.54 2.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.903 0.383 . . . . 1.23 111.058 -179.814 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.56 ' HB1' HD12 ' A' ' 18' ' ' LEU . . . -67.8 -58.06 5.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.052 -0.522 . . . . 0.41999999999999998 111.333 -179.951 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.4 ' HA ' ' HA3' ' A' ' 61' ' ' GLY . . . -59.81 -22.91 62.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.079 -0.51 . . . . 0.34999999999999998 111.438 -179.782 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.15 -31.62 34.06 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.511 -0.313 . . . . 0.44 111.776 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.5 mt -83.45 -59.27 2.5 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.313 0.486 . . . . 0.66000000000000003 112.313 -179.038 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -103.98 -24.53 13.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.665 0.269 . . . . 1.8600000000000001 111.331 -178.781 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.469 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -64.53 87.15 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.516 -0.85 . . . . 1.0600000000000001 112.246 179.959 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 -61.31 0.75 0.24 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.603 0.24 . . . . 2.5899999999999999 111.234 179.751 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.469 ' H ' ' C ' ' A' ' 61' ' ' GLY . 59.2 mt -48.95 125.65 2.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.276 -0.42 . . . . 0.92000000000000004 111.194 179.582 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.425 ' C ' ' H ' ' A' ' 66' ' ' ASN . 11.5 mt-10 -78.93 159.85 72.66 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 1.98 110.93 179.86 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -73.61 28.06 0.31 Allowed 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.656 2.237 . . . . 1.4399999999999999 112.443 179.654 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.425 ' H ' ' C ' ' A' ' 64' ' ' GLU . 61.7 t30 -163.03 49.44 0.15 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.094 0.473 . . . . 2.1499999999999999 110.281 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -108.55 152.62 24.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.867 -0.606 . . . . 2.02 110.904 -179.716 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -107.09 111.21 23.56 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.41 -0.359 . . . . 1.02 110.981 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 34.7 mm -70.43 141.55 16.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.256 -0.429 . . . . 0.28999999999999998 110.768 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 82.8 mt -117.86 -66.11 1.11 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 0.40000000000000002 111.35 -179.724 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -137.69 135.62 36.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.972 0.415 . . . . 2.6099999999999999 111.431 -179.62 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.657 HG12 ' H ' ' A' ' 73' ' ' ASP . 3.1 t -94.41 174.49 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.899 -0.591 . . . . 0.28000000000000003 110.083 179.329 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.69 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 14.2 t70 -53.49 108.79 0.37 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.839 0.352 . . . . 0.79000000000000004 111.392 179.807 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.4 t70 61.48 15.91 7.1 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.008 -0.542 . . . . 2.0099999999999998 111.699 179.434 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.433 HG12 ' N ' ' A' ' 76' ' ' ASN . 26.0 t -138.42 157.18 30.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.559 -0.291 . . . . 0.79000000000000004 110.802 179.795 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.433 ' N ' HG12 ' A' ' 75' ' ' VAL . 65.6 m-20 -127.71 129.59 47.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.442 -0.345 . . . . 2.2400000000000002 110.907 -179.96 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.405 ' HA ' ' HE2' ' A' ' 80' ' ' MET . 34.7 m -106.41 21.02 4.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.337 -0.392 . . . . 0.67000000000000004 111.004 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -86.27 23.66 1.52 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.013 -0.54 . . . . 1.3899999999999999 110.918 -179.958 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -177.02 18.85 0.04 OUTLIER Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.706 -0.759 . . . . 0.55000000000000004 112.828 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.405 ' HE2' ' HA ' ' A' ' 77' ' ' VAL . 51.6 mtm -115.12 139.16 50.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.843 0.354 . . . . 0.52000000000000002 110.876 179.809 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.461 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -65.97 156.86 32.35 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.159 -0.473 . . . . 0.39000000000000001 111.025 -179.932 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -44.04 -55.03 4.97 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.199 -0.455 . . . . 1.52 111.546 -179.568 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 79.3 p -51.29 -46.78 62.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.312 -0.404 . . . . 1.48 111.256 -179.68 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -60.62 -40.74 93.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 2.1200000000000001 111.104 -179.915 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 81' ' ' ALA . 35.0 t -60.07 -39.69 81.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.295 -0.412 . . . . 0.32000000000000001 110.766 179.85 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.457 HG12 ' NE ' ' A' ' 90' ' ' ARG . 39.9 t -64.43 -37.06 79.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.168 -0.469 . . . . 0.37 110.658 179.711 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -58.92 -48.62 80.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.162 -0.472 . . . . 1.51 110.808 179.798 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 61.4 t -57.1 -55.15 22.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.205 -0.452 . . . . 0.27000000000000002 111.37 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 85.3 mt -56.33 -32.59 64.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.998 -0.546 . . . . 0.40999999999999998 111.385 -179.36 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.457 ' NE ' HG12 ' A' ' 86' ' ' VAL . 79.0 mtm180 -81.23 -20.07 41.81 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.458 -0.337 . . . . 2.1000000000000001 111.272 -179.687 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -86.05 -16.85 36.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.33 -0.395 . . . . 1.1399999999999999 111.077 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.2 -86.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.267 -0.424 . . . . 0.55000000000000004 111.424 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.461 ' N ' HH21 ' A' ' 20' ' ' ARG . . . 60.81 17.18 49.45 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.756 -0.735 . . . . 0.76000000000000001 112.578 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -147.38 175.56 2.66 Favored Pre-proline 0 CA--C 1.534 0.33 0 N-CA-C 110.377 -0.231 . . . . 2.52 110.377 -179.804 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.576 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 32.9 Cg_exo -61.47 99.38 0.17 Allowed 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 122.088 1.859 . . . . 0.64000000000000001 111.604 178.247 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.6 m -116.43 155.77 17.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.265 -0.425 . . . . 0.64000000000000001 111.837 -179.191 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.69 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 44.4 ttp180 -101.71 145.38 29.2 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.881 -0.6 . . . . 2.3700000000000001 110.484 179.788 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.6 mt -121.54 104.77 9.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.173 -0.467 . . . . 0.37 111.358 -179.228 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 61.6 tp -91.81 108.1 19.68 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.777 0.322 . . . . 0.37 110.381 179.421 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.467 HD21 HG12 ' A' ' 63' ' ' ILE . 0.5 OUTLIER -138.21 168.43 19.76 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.24 -0.436 . . . . 0.31 111.579 -179.212 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.529 ' HB ' HD23 ' A' ' 13' ' ' LEU . 9.8 tt -119.95 141.1 41.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.862 -0.608 . . . . 0.45000000000000001 111.048 179.873 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.416 ' HB3' ' HE1' ' A' ' 14' ' ' TYR . 27.2 tpt180 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.101 -0.5 . . . . 2.2599999999999998 110.711 179.65 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.5 t . . . . . 0 C--O 1.236 0.348 0 CA-C-O 121.049 0.452 . . . . 0.90000000000000002 111.263 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.539 HD23 ' HB ' ' A' ' 101' ' ' ILE . 23.8 mt -94.39 102.31 14.28 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.555 -0.748 . . . . 0.89000000000000001 110.209 179.53 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.43 ' CE1' ' HB3' ' A' ' 102' ' ' ARG . 39.5 p90 -123.46 151.17 42.99 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.887 0.375 . . . . 2.73 110.992 -179.602 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 80.2 p -122.39 161.28 23.74 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.279 -0.419 . . . . 1.1899999999999999 111.465 -179.472 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 12.4 t -131.22 149.88 33.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.86 -0.609 . . . . 0.56000000000000005 110.682 179.857 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.419 ' H ' ' NH2' ' A' ' 62' ' ' ARG . 14.8 mm-40 -103.46 110.05 21.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.441 -0.345 . . . . 1.74 111.526 -179.47 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.404 HD22 ' O ' ' A' ' 17' ' ' GLU . 3.4 mm? -126.49 123.84 38.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.179 -0.464 . . . . 0.81000000000000005 110.759 179.577 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.563 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 35.6 p90 -112.02 142.77 44.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.301 -0.409 . . . . 2.0800000000000001 110.747 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.583 ' HE ' ' HA2' ' A' ' 93' ' ' GLY . 47.5 ttp180 -125.97 160.85 28.91 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.859 -0.336 . . . . 3.0600000000000001 110.916 179.717 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -168.07 -33.06 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.139 -0.482 . . . . 2.5800000000000001 111.077 -179.891 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -59.07 160.93 5.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.949 -0.568 . . . . 3.7200000000000002 110.788 179.924 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -84.77 49.29 1.69 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.261 -0.427 . . . . 2.8700000000000001 111.069 -179.874 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 82.1 p -99.1 -24.59 14.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 1.3799999999999999 111.163 -179.977 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 36.4 t 56.41 18.04 3.25 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.797 -0.638 . . . . 2.4500000000000002 111.259 179.803 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 53.8 m -140.74 148.1 40.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.874 0.368 . . . . 1.3999999999999999 111.206 -179.882 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 61.5 mt -113.37 -23.58 9.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.991 -0.549 . . . . 0.45000000000000001 110.833 179.905 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.519 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 110.5 -23.64 19.69 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.804 -0.713 . . . . 0.52000000000000002 112.383 -179.791 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 76.5 mt -62.41 109.0 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.805 0.336 . . . . 0.83999999999999997 110.798 179.841 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 48.3 t -111.3 100.02 8.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.147 -0.479 . . . . 0.94999999999999996 110.853 -179.704 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.609 ' HA ' ' HA ' ' A' ' 48' ' ' VAL . 31.5 pt -85.19 172.75 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.825 -0.625 . . . . 0.40999999999999998 111.269 -179.928 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 43.9 t -139.67 132.12 28.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.485 . . . . 1.3200000000000001 110.838 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 C-N-CA 120.806 -0.711 . . . . 0.94999999999999996 112.537 -179.905 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.407 HG12 HD12 ' A' ' 31' ' ' ILE . 5.1 tp . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.572 0.225 . . . . 0.65000000000000002 110.962 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -163.31 139.49 6.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.749 0.309 . . . . 0.69999999999999996 111.336 -179.884 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.609 ' HA ' ' HA ' ' A' ' 31' ' ' ILE . 90.5 t -71.24 105.85 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.258 -0.428 . . . . 0.39000000000000001 110.761 179.483 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -66.89 -38.08 85.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.041 -0.527 . . . . 2.3999999999999999 111.013 -179.923 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 35.9 t -168.1 175.61 6.52 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.96 0.41 . . . . 1.28 111.252 -179.907 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 76.5 mt -115.13 155.7 26.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.842 -0.617 . . . . 0.41999999999999998 110.713 179.918 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.519 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 70.4 mt -98.93 108.51 49.53 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 1.26 111.388 -179.62 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.05 136.12 72.96 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.432 2.088 . . . . 0.81999999999999995 112.304 -179.919 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 103.99 -17.01 49.66 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.732 -0.747 . . . . 0.48999999999999999 112.645 179.92 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 95.6 p -88.54 -176.07 5.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.809 0.338 . . . . 1.23 111.118 -179.878 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.86 -54.84 13.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.41999999999999998 111.258 -179.853 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.64 -36.48 62.11 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.133 -0.485 . . . . 0.34999999999999998 111.522 -179.827 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.02 -46.38 62.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.44 111.316 -179.887 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 97.4 mt -66.16 -19.75 65.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.364 -0.38 . . . . 0.66000000000000003 110.834 179.73 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -61.24 -56.14 23.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 1.8600000000000001 110.826 179.981 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 97.3 -49.04 1.52 Allowed Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.805 -0.712 . . . . 1.0600000000000001 112.977 179.47 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.419 ' NH2' ' H ' ' A' ' 17' ' ' GLU . 83.1 mtm180 -56.0 -36.25 67.71 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.727 0.299 . . . . 2.5899999999999999 111.164 -179.583 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 62.5 mt -70.27 116.18 11.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.875 0.369 . . . . 0.92000000000000004 110.713 179.776 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -102.97 131.87 21.74 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.056 -0.52 . . . . 1.98 110.786 -179.684 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -60.91 171.88 3.39 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.443 2.096 . . . . 1.4399999999999999 112.03 179.897 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 57.5 52.85 8.0 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.303 -0.408 . . . . 2.1499999999999999 110.548 -179.469 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -123.52 174.19 7.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.124 -0.489 . . . . 2.02 111.017 -179.594 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -115.01 127.0 55.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.199 -0.455 . . . . 1.02 110.969 -179.964 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 47.9 mm -89.43 139.99 16.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.258 -0.428 . . . . 0.28999999999999998 111.014 -179.924 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 84.8 mt -110.83 -62.73 1.49 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.176 -0.465 . . . . 0.40000000000000002 111.109 -179.786 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -150.94 136.65 18.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.031 0.443 . . . . 2.6099999999999999 111.609 -179.402 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.651 HG12 ' H ' ' A' ' 73' ' ' ASP . 2.3 t -89.06 175.46 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.777 -0.647 . . . . 0.28000000000000003 110.186 179.437 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.655 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 14.5 t70 -49.15 108.66 0.2 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.725 0.298 . . . . 0.79000000000000004 111.493 179.558 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.7 t70 57.03 28.4 14.78 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.164 -0.471 . . . . 2.0099999999999998 111.544 179.306 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.7 t -145.88 144.27 20.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.334 -0.394 . . . . 0.79000000000000004 110.874 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -114.35 129.87 56.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.437 -0.347 . . . . 2.2400000000000002 110.585 179.62 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.2 m -112.29 26.12 3.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-N 116.548 -0.296 . . . . 0.67000000000000004 111.479 -179.441 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -94.25 31.64 1.67 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.92 0.39 . . . . 1.3899999999999999 110.724 179.739 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 177.37 34.87 0.05 OUTLIER Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.715 -0.755 . . . . 0.55000000000000004 112.704 -179.974 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 54.9 mtm -134.62 145.28 48.47 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.905 0.383 . . . . 0.52000000000000002 110.758 179.8 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.406 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -62.61 150.55 40.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.063 -0.517 . . . . 0.39000000000000001 111.028 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -46.05 -51.58 13.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.298 -0.41 . . . . 1.52 111.399 -179.638 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.1 m -50.49 -47.82 57.08 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.215 -0.448 . . . . 1.48 111.33 -179.676 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -59.4 -41.88 90.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.341 -0.39 . . . . 2.1200000000000001 111.065 -179.866 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 81' ' ' ALA . 18.6 t -58.96 -38.5 73.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.275 -0.421 . . . . 0.32000000000000001 110.947 179.909 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.4 t -66.95 -38.02 80.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.173 -0.467 . . . . 0.37 111.033 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -57.77 -46.1 85.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.305 -0.407 . . . . 1.51 110.674 179.734 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 54.8 t -59.27 -53.98 40.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.058 -0.519 . . . . 0.27000000000000002 111.073 179.747 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 78.5 mt -55.97 -26.77 49.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.996 -0.547 . . . . 0.40999999999999998 111.107 -179.612 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -89.41 -19.79 24.74 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.388 -0.369 . . . . 2.1000000000000001 111.308 179.978 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -89.68 -9.19 50.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.739 0.305 . . . . 1.1399999999999999 111.177 179.981 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.03 -87.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.439 . . . . 0.55000000000000004 111.404 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.583 ' HA2' ' HE ' ' A' ' 20' ' ' ARG . . . 60.74 20.07 56.14 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.66 -0.781 . . . . 0.76000000000000001 112.342 -179.838 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.607 ' HB3' ' HD2' ' A' ' 95' ' ' PRO . 73.8 m-20 -147.17 172.63 4.97 Favored Pre-proline 0 C--N 1.33 -0.263 0 C-N-CA 122.106 0.162 . . . . 2.52 110.775 -179.53 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.607 ' HD2' ' HB3' ' A' ' 94' ' ' ASN . 23.1 Cg_endo -62.86 89.53 0.12 Allowed 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 122.035 1.823 . . . . 0.64000000000000001 111.624 178.191 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.7 m -103.38 151.76 6.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.177 0.513 . . . . 0.64000000000000001 111.923 -179.216 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.655 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 79.4 ttt180 -101.2 143.95 30.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.566 -0.743 . . . . 2.3700000000000001 110.159 179.378 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.02 105.11 10.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.432 -0.349 . . . . 0.37 111.368 -179.525 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 51.4 tp -94.75 105.6 17.54 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.889 0.376 . . . . 0.37 110.309 179.215 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.32 168.18 19.06 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.051 -0.522 . . . . 0.31 111.41 -179.597 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.539 ' HB ' HD23 ' A' ' 13' ' ' LEU . 10.7 tt -122.63 142.1 40.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.916 -0.584 . . . . 0.45000000000000001 111.019 -179.962 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.43 ' HB3' ' CE1' ' A' ' 14' ' ' TYR . 31.5 tpt180 . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 115.986 -0.552 . . . . 2.2599999999999998 110.5 179.618 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 46.9 t . . . . . 0 C--O 1.235 0.297 0 CA-C-O 120.88 0.372 . . . . 0.90000000000000002 111.238 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.53 HD23 ' HB ' ' A' ' 101' ' ' ILE . 45.7 mt -90.42 102.32 15.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.777 -0.647 . . . . 0.89000000000000001 110.329 179.627 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -124.48 149.2 47.11 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.949 0.404 . . . . 2.73 111.229 -179.646 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.0 m -115.3 154.57 28.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.098 -0.501 . . . . 1.1899999999999999 110.883 -179.792 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.4 t -124.12 157.42 31.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 0.56000000000000005 110.529 179.827 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -116.18 107.69 15.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.864 0.364 . . . . 1.74 111.398 -179.672 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.455 HD11 ' HB2' ' A' ' 60' ' ' ASP . 4.3 mm? -116.98 144.76 44.21 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.079 -0.51 . . . . 0.81000000000000005 110.546 179.696 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.696 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 21.8 p90 -118.66 117.87 30.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.936 0.398 . . . . 2.0800000000000001 110.868 179.85 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.596 ' HG2' ' HA2' ' A' ' 93' ' ' GLY . 15.0 ttt180 -110.16 153.85 24.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.002 -0.545 . . . . 3.0600000000000001 110.585 179.924 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -113.51 -70.26 0.81 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.097 0.475 . . . . 2.5800000000000001 111.131 -179.862 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -136.22 -169.85 2.53 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.712 -0.676 . . . . 3.7200000000000002 110.969 -179.812 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -55.51 -27.26 47.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.338 -0.392 . . . . 2.8700000000000001 110.869 179.775 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.3 m -66.95 -36.99 83.47 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.16 -0.473 . . . . 1.3799999999999999 110.744 179.875 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.9 m -81.85 61.41 5.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.122 -0.49 . . . . 2.4500000000000002 110.931 179.869 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 51.0 m -57.88 138.34 55.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.479 . . . . 1.3999999999999999 110.833 179.773 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.518 HD21 ' HB2' ' A' ' 20' ' ' ARG . 75.0 mt -78.8 -35.3 44.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.033 -0.531 . . . . 0.45000000000000001 110.67 -179.845 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.428 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 93.75 -6.74 73.91 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.787 -0.72 . . . . 0.52000000000000002 113.219 179.212 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 74.5 mt -60.07 108.67 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.747 0.308 . . . . 0.83999999999999997 111.17 -179.851 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 39.6 t -112.31 97.91 6.95 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.21 -0.45 . . . . 0.94999999999999996 110.662 179.729 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.491 ' HA ' ' HA ' ' A' ' 48' ' ' VAL . 38.6 pt -89.72 166.66 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.051 -0.522 . . . . 0.40999999999999998 111.272 -179.838 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 54.7 m -143.71 138.94 29.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.095 -0.502 . . . . 1.3200000000000001 110.953 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 C-N-CA 120.825 -0.702 . . . . 0.94999999999999996 112.48 179.966 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 37.5 mm . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.707 0.289 . . . . 0.65000000000000002 110.822 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -131.73 142.77 49.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.287 -0.415 . . . . 0.69999999999999996 111.189 -179.726 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.491 ' HA ' ' HA ' ' A' ' 31' ' ' ILE . 46.8 t -81.54 116.64 26.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.116 -0.493 . . . . 0.39000000000000001 111.004 179.847 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -84.79 -35.71 22.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.452 . . . . 2.3999999999999999 111.22 -179.705 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 54.6 m -149.66 172.68 14.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.125 0.488 . . . . 1.28 111.63 -179.527 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.467 HD11 HG22 ' A' ' 63' ' ' ILE . 63.0 mt -131.73 141.45 49.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.723 -0.671 . . . . 0.41999999999999998 110.538 179.835 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.428 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 43.2 mm -75.4 115.56 46.57 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.337 -0.392 . . . . 1.26 111.074 -179.89 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -58.07 126.26 21.07 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.387 2.058 . . . . 0.81999999999999995 112.391 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 98.53 -13.66 62.57 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.799 -0.715 . . . . 0.48999999999999999 112.785 179.659 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 92.8 p -72.02 -177.33 2.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.779 0.324 . . . . 1.23 110.914 -179.861 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.39 -55.29 12.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.41999999999999998 111.178 179.976 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.82 -33.88 67.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.108 -0.497 . . . . 0.34999999999999998 111.397 -179.804 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.78 -55.55 8.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.44 111.509 -179.649 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.0 mt -59.1 -20.23 51.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.66000000000000003 111.187 -179.835 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.455 ' HB2' HD11 ' A' ' 18' ' ' LEU . 17.4 t70 -59.05 -52.54 65.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.36 -0.382 . . . . 1.8600000000000001 110.642 -179.909 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.91 -31.7 7.36 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.707 -0.759 . . . . 1.0600000000000001 113.126 179.387 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 82.2 mtm180 -83.85 0.84 45.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.686 0.279 . . . . 2.5899999999999999 111.238 -179.571 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.467 HG22 HD11 ' A' ' 51' ' ' LEU . 53.6 mt -116.47 122.78 70.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.848 0.356 . . . . 0.92000000000000004 110.979 179.592 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -129.41 158.1 74.25 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.125 -0.489 . . . . 1.98 110.809 179.971 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -57.08 176.97 0.2 Allowed 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.587 2.191 . . . . 1.4399999999999999 112.308 179.674 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 56.38 50.08 13.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.013 -0.54 . . . . 2.1499999999999999 110.637 -179.805 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.429 ' HA ' ' HG2' ' A' ' 102' ' ' ARG . 8.3 t70 -120.81 151.85 39.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.815 -0.629 . . . . 2.02 110.83 -179.934 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -109.62 109.06 19.7 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.857 0.36 . . . . 1.02 110.912 179.979 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 49.2 mm -71.03 142.41 15.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.143 -0.48 . . . . 0.28999999999999998 110.982 179.896 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 73.3 mt -114.97 -71.77 0.73 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.097 -0.501 . . . . 0.40000000000000002 110.98 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.423 ' O ' ' HB3' ' A' ' 99' ' ' LEU . 75.9 mtp180 -135.95 135.33 39.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 2.6099999999999999 111.406 -179.611 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.564 HG12 ' H ' ' A' ' 73' ' ' ASP . 6.6 t -93.55 170.69 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.922 -0.581 . . . . 0.28000000000000003 109.842 179.166 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.606 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 16.8 t70 -46.7 108.7 0.15 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.917 0.389 . . . . 0.79000000000000004 111.841 179.928 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 53.41 14.52 0.57 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.817 -0.629 . . . . 2.0099999999999998 112.479 179.013 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 65.2 t -144.72 99.67 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.76 0.314 . . . . 0.79000000000000004 111.388 -179.887 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -68.07 155.58 39.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.386 -0.37 . . . . 2.2400000000000002 110.355 179.462 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.46 HG11 HG13 ' A' ' 85' ' ' VAL . 17.4 m -133.44 39.84 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.846 0.355 . . . . 0.67000000000000004 111.391 -179.814 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -109.8 35.84 3.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 1.3899999999999999 111.048 179.795 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -179.6 26.64 0.05 OUTLIER Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.481 -0.866 . . . . 0.55000000000000004 112.927 179.962 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 65.6 mtm -130.61 153.16 49.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.853 0.358 . . . . 0.52000000000000002 110.918 179.75 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.432 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -62.18 151.98 34.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.011 -0.54 . . . . 0.39000000000000001 111.333 -179.86 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -50.36 -55.75 14.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.238 -0.437 . . . . 1.52 111.249 -179.744 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.1 m -52.95 -41.03 64.12 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.07 -0.514 . . . . 1.48 111.171 -179.813 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -59.08 -43.56 91.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.288 -0.414 . . . . 2.1200000000000001 110.89 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.46 HG13 HG11 ' A' ' 77' ' ' VAL . 22.8 t -60.16 -36.46 68.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.143 -0.48 . . . . 0.32000000000000001 110.818 179.883 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.2 t -63.76 -40.89 90.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.036 -0.529 . . . . 0.37 111.015 179.92 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -59.1 -49.73 76.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.265 -0.425 . . . . 1.51 110.732 179.812 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 54.6 t -52.25 -53.83 17.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.95 -0.568 . . . . 0.27000000000000002 111.333 179.876 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 71.3 mt -56.71 -33.83 66.86 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.103 -0.499 . . . . 0.40999999999999998 111.329 -179.516 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 -82.2 -14.95 54.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.484 -0.325 . . . . 2.1000000000000001 111.226 -179.793 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -92.14 -15.4 27.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.365 -0.38 . . . . 1.1399999999999999 111.086 179.976 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.77 -83.51 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.287 -0.415 . . . . 0.55000000000000004 111.454 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.596 ' HA2' ' HG2' ' A' ' 20' ' ' ARG . . . 62.49 21.76 62.85 Favored Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.638 -0.791 . . . . 0.76000000000000001 112.431 -179.724 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -147.59 169.65 8.98 Favored Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 110.527 -0.175 . . . . 2.52 110.527 -179.823 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.696 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 48.8 Cg_exo -57.39 92.47 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.048 1.832 . . . . 0.64000000000000001 111.427 178.349 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.9 m -103.72 148.83 8.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.133 0.492 . . . . 0.64000000000000001 111.84 -179.051 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.606 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 71.6 ttt180 -99.7 144.11 29.15 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.618 -0.719 . . . . 2.3700000000000001 110.002 179.726 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 13.6 mt -118.38 103.79 10.12 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.386 -0.37 . . . . 0.37 111.525 -179.146 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.423 ' HB3' ' O ' ' A' ' 71' ' ' ARG . 65.3 tp -90.98 109.35 20.58 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.857 -0.423 . . . . 0.37 109.857 179.062 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -143.25 168.34 20.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.247 0.546 . . . . 0.31 111.963 -179.115 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.53 ' HB ' HD23 ' A' ' 13' ' ' LEU . 13.0 tt -119.49 143.1 31.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.572 -0.74 . . . . 0.45000000000000001 110.556 179.838 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.429 ' HG2' ' HA ' ' A' ' 67' ' ' ASP . 0.4 OUTLIER . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.34 -0.391 . . . . 2.2599999999999998 110.751 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.188 0 N-CA-C 112.498 -0.241 . . . . 7.9199999999999999 112.498 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.0 m -106.39 -12.5 15.64 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.732 0.301 . . . . 7.1799999999999997 111.062 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 45.5 m80 -61.88 121.41 12.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 5.9100000000000001 111.015 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -134.88 -60.14 0.07 OUTLIER Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.714 -0.755 . . . . 2.4500000000000002 112.619 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 56.07 46.53 21.5 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.835 0.35 . . . . 2.3300000000000001 111.021 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 58.0 m -73.61 102.01 3.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 2.5899999999999999 110.845 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 58.14 86.42 0.08 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.246 -0.434 . . . . 2.6699999999999999 110.992 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -145.25 102.42 3.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.143 -0.48 . . . . 1.5800000000000001 111.103 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 69.0 m 58.29 20.83 7.59 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.049 -0.523 . . . . 2.5499999999999998 111.119 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.58 40.24 8.44 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.785 -0.721 . . . . 1.8200000000000001 112.751 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -143.6 119.38 10.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.844 0.355 . . . . 1.7 110.742 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.0 t -143.38 144.36 32.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.90000000000000002 110.908 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 85.0 mt -80.26 127.77 32.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.873 -0.603 . . . . 0.89000000000000001 110.757 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -124.56 137.82 54.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.169 -0.468 . . . . 2.73 110.882 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 80.8 p -132.58 132.19 42.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.305 -0.407 . . . . 1.1899999999999999 111.096 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.9 t -118.26 157.55 19.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 0.56000000000000005 110.704 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -109.72 110.01 20.89 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.816 0.341 . . . . 1.74 111.282 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.478 HD11 ' HB2' ' A' ' 60' ' ' ASP . 4.6 mm? -118.6 166.48 12.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.154 -0.475 . . . . 0.81000000000000005 110.318 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.608 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 35.0 p90 -144.14 132.33 21.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.906 0.384 . . . . 2.0800000000000001 111.638 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.536 ' HE ' ' HG ' ' A' ' 27' ' ' LEU . 15.7 tpp85 -97.22 94.75 7.28 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.04 -0.527 . . . . 3.0600000000000001 110.21 179.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -130.25 9.93 5.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.383 -0.371 . . . . 2.5800000000000001 111.168 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -110.29 151.22 27.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.435 . . . . 3.7200000000000002 110.836 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -80.68 17.16 1.19 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.068 -0.515 . . . . 2.8700000000000001 110.998 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 63.0 p -69.0 -10.99 60.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 1.3799999999999999 111.157 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.2 m 59.13 20.17 8.13 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.999 -0.546 . . . . 2.4500000000000002 111.194 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 90.0 p -164.26 158.55 19.01 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.956 0.408 . . . . 1.3999999999999999 111.077 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.536 ' HG ' ' HE ' ' A' ' 20' ' ' ARG . 87.4 mt -102.6 -12.09 17.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.064 -0.517 . . . . 0.45000000000000001 110.614 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.531 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 100.15 24.86 9.31 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.831 -0.7 . . . . 0.52000000000000002 112.373 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 75.6 mt -102.56 115.73 45.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.822 0.344 . . . . 0.83999999999999997 110.927 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.7 t -110.67 102.44 11.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.94999999999999996 110.666 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 25.3 pt -99.43 160.53 3.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.40999999999999998 111.447 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 48.1 t -150.85 145.68 25.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.918 -0.583 . . . . 1.3200000000000001 110.726 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -86.1 149.13 22.79 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.72 -0.752 . . . . 0.94999999999999996 112.609 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 56.7 ttm -92.89 151.41 19.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.791 0.329 . . . . 2.04 110.864 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.435 ' N ' ' HD2' ' A' ' 35' ' ' ARG . 7.7 mpt_? -106.19 94.82 5.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 5.46 110.932 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -100.45 132.04 46.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 4.29 110.682 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -121.12 11.28 10.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.237 -0.438 . . . . 5.25 111.138 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 75.3 m -155.44 143.13 19.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.233 -0.44 . . . . 4.8799999999999999 111.012 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 50.5 p -85.91 134.31 33.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 5.2699999999999996 111.13 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.3 t -154.84 23.42 0.45 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.129 -0.487 . . . . 6.9100000000000001 110.972 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 110.71 -48.33 0.95 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.956 -0.64 . . . . 5.3600000000000003 112.471 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -108.55 151.59 25.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.779 0.323 . . . . 7.2199999999999998 110.881 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -163.78 133.78 4.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.253 -0.43 . . . . 3.0499999999999998 111.006 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 63.6 p 51.39 -169.66 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.88 -0.6 . . . . 2.5299999999999998 111.479 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 128.24 144.69 5.9 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.823 -0.703 . . . . 1.1399999999999999 112.456 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 41.8 mm -87.33 123.9 40.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.667 0.27 . . . . 0.65000000000000002 111.094 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 52.9 p90 -147.34 147.0 29.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.978 0.418 . . . . 0.69999999999999996 111.086 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.1 t -84.27 136.64 22.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.969 -0.559 . . . . 0.39000000000000001 111.223 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -125.96 -25.96 3.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.029 -0.532 . . . . 2.3999999999999999 110.87 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 43.1 t -135.85 170.41 16.02 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.234 -0.439 . . . . 1.28 110.89 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 69.5 mt -141.66 160.28 40.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.211 -0.45 . . . . 0.41999999999999998 110.963 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.531 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 51.0 mt -107.08 102.01 40.96 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.242 -0.435 . . . . 1.26 110.918 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.67 136.25 64.38 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.409 2.073 . . . . 0.81999999999999995 112.31 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 99.91 -12.32 60.79 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.791 -0.718 . . . . 0.48999999999999999 112.691 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 56.3 m -88.19 179.11 6.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.706 0.289 . . . . 1.23 111.023 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.406 ' HB1' HD12 ' A' ' 18' ' ' LEU . . . -63.48 -54.41 36.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.319 -0.401 . . . . 0.41999999999999998 111.455 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.411 ' HB1' HG21 ' A' ' 63' ' ' ILE . . . -54.16 -48.02 71.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 0.34999999999999998 111.744 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.53 -56.76 13.47 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.428 -0.351 . . . . 0.44 111.656 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 81.5 mt -59.86 -20.43 57.05 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.26 -0.427 . . . . 0.66000000000000003 111.527 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.478 ' HB2' HD11 ' A' ' 18' ' ' LEU . 18.2 t70 -58.96 -48.37 81.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.875 0.369 . . . . 1.8600000000000001 110.957 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.46 -48.49 1.11 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.782 -0.723 . . . . 1.0600000000000001 112.689 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -65.24 -23.7 67.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.71 0.29 . . . . 2.5899999999999999 110.921 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.411 HG21 ' HB1' ' A' ' 57' ' ' ALA . 39.8 mm -76.68 98.72 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.267 -0.424 . . . . 0.92000000000000004 110.792 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -107.92 156.3 38.44 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 1.98 110.632 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.96 172.79 5.57 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.448 2.099 . . . . 1.4399999999999999 112.271 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 57.88 74.54 0.42 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.187 -0.461 . . . . 2.1499999999999999 111.243 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -149.6 151.33 33.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 2.02 110.433 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -109.88 114.67 28.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.816 0.341 . . . . 1.02 111.244 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 43.7 mm -70.31 140.03 19.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.069 -0.514 . . . . 0.28999999999999998 110.597 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 90.5 mt -116.89 -65.1 1.22 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.298 -0.41 . . . . 0.40000000000000002 111.274 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -141.2 134.91 30.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.955 0.407 . . . . 2.6099999999999999 111.625 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.662 HG12 ' H ' ' A' ' 73' ' ' ASP . 6.6 t -90.4 175.09 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.861 -0.608 . . . . 0.28000000000000003 109.596 178.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.668 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 18.6 t70 -47.55 108.97 0.18 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.693 0.283 . . . . 0.79000000000000004 111.696 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 54.24 26.26 6.61 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.244 -0.434 . . . . 2.0099999999999998 111.768 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 73' ' ' ASP . 58.2 t -143.02 152.04 17.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.296 -0.411 . . . . 0.79000000000000004 110.696 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.507 ' ND2' ' H ' ' A' ' 78' ' ' GLN . 5.7 t30 -121.06 130.98 54.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.368 -0.378 . . . . 2.2400000000000002 110.718 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.7 m -110.2 17.39 7.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.379 -0.373 . . . . 0.67000000000000004 111.444 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.507 ' H ' ' ND2' ' A' ' 76' ' ' ASN . 14.5 mm100 -85.84 28.92 0.75 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.264 -0.426 . . . . 1.3899999999999999 111.07 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -178.4 19.04 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.56 -0.829 . . . . 0.55000000000000004 112.95 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 43.8 mtm -118.4 146.07 44.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.799 0.333 . . . . 0.52000000000000002 110.711 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.437 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -62.11 155.79 23.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.1 -0.5 . . . . 0.39000000000000001 111.068 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -51.73 -57.76 8.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.425 -0.352 . . . . 1.52 111.178 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.9 t -54.56 -37.88 65.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 1.48 111.306 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -60.94 -45.51 94.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.322 -0.399 . . . . 2.1200000000000001 110.781 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 81' ' ' ALA . 45.6 t -60.09 -34.14 55.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.159 -0.473 . . . . 0.32000000000000001 110.769 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.566 HG12 ' HE ' ' A' ' 90' ' ' ARG . 56.7 t -64.25 -43.93 97.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.111 -0.495 . . . . 0.37 110.533 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -58.1 -41.77 84.22 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.163 -0.471 . . . . 1.51 110.647 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 49.5 t -56.86 -52.52 54.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.954 -0.566 . . . . 0.27000000000000002 111.049 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 71.2 mt -54.41 -36.07 63.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.026 -0.534 . . . . 0.40999999999999998 110.923 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.566 ' HE ' HG12 ' A' ' 86' ' ' VAL . 74.7 mtt180 -75.14 -30.12 60.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 2.1000000000000001 110.872 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -74.68 -18.01 60.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.123 -0.489 . . . . 1.1399999999999999 111.019 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.21 -83.0 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.072 -0.513 . . . . 0.55000000000000004 111.415 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.41 ' H ' ' HG2' ' A' ' 20' ' ' ARG . . . 65.64 11.76 54.53 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.477 -0.868 . . . . 0.76000000000000001 112.315 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -146.7 166.33 16.87 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 110.557 -0.164 . . . . 2.52 110.557 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.608 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 46.2 Cg_exo -57.07 105.1 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.278 1.985 . . . . 0.64000000000000001 111.366 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.7 m -107.29 154.46 8.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.224 0.535 . . . . 0.64000000000000001 111.994 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.668 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 79.6 ttt180 -103.53 143.07 33.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.549 -0.75 . . . . 2.3700000000000001 109.932 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 20.5 mt -114.83 131.01 56.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.249 -0.432 . . . . 0.37 110.972 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 62.2 tp -120.62 99.8 6.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 0.37 110.234 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.46 153.31 48.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.053 -0.522 . . . . 0.31 111.322 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.9 tt -100.91 138.68 24.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.069 -0.514 . . . . 0.45000000000000001 110.708 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 24.8 tpt180 -130.26 133.42 46.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.437 . . . . 2.2599999999999998 110.885 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 75.6 mtp180 -83.42 132.34 34.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.019 -0.537 . . . . 3.9300000000000002 110.969 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 59.7 mt -99.68 148.48 34.81 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.022 -0.536 . . . . 2.0 110.624 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -80.71 163.01 21.33 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.576 2.184 . . . . 2.98 112.456 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 78.2 mt -130.57 93.55 3.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.863 -0.608 . . . . 3.6699999999999999 110.669 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 72.2 mt -93.01 124.54 37.05 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.108 -0.496 . . . . 5.5899999999999999 111.261 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.139 -0.934 . . . . 6.0 111.061 -179.987 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.204 0 N-CA-C 112.514 -0.234 . . . . 7.9199999999999999 112.514 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.6 p -103.86 -65.81 0.99 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.824 0.345 . . . . 7.1799999999999997 110.936 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -60.14 130.86 48.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 5.9100000000000001 110.955 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 134.17 133.72 3.35 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.874 -0.679 . . . . 2.4500000000000002 112.374 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -104.69 164.51 11.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.942 0.401 . . . . 2.3300000000000001 111.144 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.1 m -134.98 83.22 2.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.911 -0.586 . . . . 2.5899999999999999 110.483 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.9 t70 57.72 76.49 0.32 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.976 -0.556 . . . . 2.6699999999999999 110.73 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -113.06 104.38 12.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.073 -0.512 . . . . 1.5800000000000001 111.297 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.8 t 57.96 22.18 8.51 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.057 -0.52 . . . . 2.5499999999999998 111.186 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.48 32.31 10.49 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.706 -0.759 . . . . 1.8200000000000001 112.685 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -138.85 136.67 35.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.848 0.356 . . . . 1.7 110.762 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 46.9 t -153.77 140.38 18.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.088 -0.506 . . . . 0.90000000000000002 110.818 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 89.6 mt -79.52 121.58 25.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.013 -0.54 . . . . 0.89000000000000001 110.851 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.444 ' OH ' HD21 ' A' ' 104' ' ' LEU . 43.1 m-85 -113.86 151.44 32.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.123 -0.49 . . . . 2.73 110.961 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 48.5 t -150.47 135.85 17.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.245 -0.434 . . . . 1.1899999999999999 111.073 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.416 HG11 ' HB2' ' A' ' 62' ' ' ARG . 21.7 t -130.29 147.17 33.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.041 -0.527 . . . . 0.56000000000000005 110.806 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -99.13 118.38 35.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.917 0.389 . . . . 1.74 111.076 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.53 HD11 ' HB2' ' A' ' 60' ' ' ASP . 4.2 mm? -116.97 166.91 11.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.937 -0.574 . . . . 0.81000000000000005 110.788 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.595 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 30.4 p90 -160.49 130.5 5.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.247 -0.433 . . . . 2.0800000000000001 111.151 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.652 ' HE ' ' HA2' ' A' ' 93' ' ' GLY . 57.2 ttp180 -112.68 97.43 6.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.399 -0.364 . . . . 3.0600000000000001 110.919 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -95.65 -20.52 18.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.121 -0.491 . . . . 2.5800000000000001 110.702 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -83.75 160.51 21.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.071 -0.513 . . . . 3.7200000000000002 110.953 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -95.23 40.4 1.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.035 -0.53 . . . . 2.8700000000000001 110.902 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 82.1 p -71.93 -13.96 61.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 1.3799999999999999 111.127 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.2 m 57.76 19.1 5.32 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.921 -0.582 . . . . 2.4500000000000002 111.256 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.8 m -154.9 154.93 33.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.435 -0.348 . . . . 1.3999999999999999 111.005 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.468 HD21 ' HB2' ' A' ' 20' ' ' ARG . 52.0 mt -114.02 -24.43 9.04 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.097 -0.501 . . . . 0.45000000000000001 111.141 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.18 -19.98 49.25 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.692 -0.766 . . . . 0.52000000000000002 112.857 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 66.2 mt -61.64 110.27 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.676 0.274 . . . . 0.83999999999999997 110.979 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.6 t -112.25 106.64 15.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.445 . . . . 0.94999999999999996 110.964 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.557 ' HA ' ' HA ' ' A' ' 48' ' ' VAL . 46.3 pt -86.81 -177.88 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.015 -0.539 . . . . 0.40999999999999998 111.144 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.2 t -156.14 146.24 21.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.358 -0.383 . . . . 1.3200000000000001 111.137 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -81.53 132.13 10.94 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.836 -0.697 . . . . 0.94999999999999996 112.191 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 27.2 ttt -58.12 150.72 20.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.774 0.321 . . . . 2.04 111.084 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -151.79 157.27 41.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.231 -0.441 . . . . 5.46 111.167 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -158.07 161.87 38.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.013 -0.539 . . . . 4.29 110.59 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -93.72 24.89 3.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.392 -0.367 . . . . 5.25 111.442 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 93.1 p -165.72 102.44 0.69 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.916 0.389 . . . . 4.8799999999999999 111.051 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 69.6 p -106.41 135.64 47.55 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.001 -0.545 . . . . 5.2699999999999996 111.095 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.7 t -159.24 19.41 0.18 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.146 -0.479 . . . . 6.9100000000000001 110.991 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.417 ' H ' ' H ' ' A' ' 42' ' ' GLU . . . -170.69 -6.47 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.849 -0.691 . . . . 5.3600000000000003 112.448 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.417 ' H ' ' H ' ' A' ' 41' ' ' GLY . 44.8 mt-10 57.17 90.38 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.878 0.37 . . . . 7.2199999999999998 111.156 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -130.29 91.77 3.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.121 -0.491 . . . . 3.0499999999999998 111.015 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 81.0 p -119.73 155.29 32.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 2.5299999999999998 111.015 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -146.8 173.08 27.13 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.635 -0.793 . . . . 1.1399999999999999 112.792 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.1 mm -100.2 129.55 50.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.68 0.276 . . . . 0.65000000000000002 110.929 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -157.53 142.38 16.7 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.278 -0.419 . . . . 0.69999999999999996 111.022 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.557 ' HA ' ' HA ' ' A' ' 31' ' ' ILE . 99.3 t -77.96 127.21 38.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.151 -0.477 . . . . 0.39000000000000001 110.804 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -114.63 -23.22 9.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.031 -0.531 . . . . 2.3999999999999999 111.139 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 78.1 p -146.09 161.76 39.45 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.134 0.492 . . . . 1.28 111.645 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 91.6 mt -133.55 154.35 50.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.662 -0.699 . . . . 0.41999999999999998 110.572 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 49.0 mm -97.24 113.89 63.9 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.346 -0.388 . . . . 1.26 110.846 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -61.58 136.2 61.5 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.414 2.076 . . . . 0.81999999999999995 112.122 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 97.9 -23.29 36.68 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.864 -0.684 . . . . 0.48999999999999999 112.307 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.404 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 67.1 m -73.14 170.86 14.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.619 0.247 . . . . 1.23 111.079 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.64 -55.64 30.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.427 -0.351 . . . . 0.41999999999999998 111.463 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.61 -39.33 57.8 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.203 -0.453 . . . . 0.34999999999999998 111.333 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.69 -46.99 67.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 0.44 111.425 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 55' ' ' SER . 94.8 mt -63.15 -19.68 64.7 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.222 -0.444 . . . . 0.66000000000000003 111.184 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.53 ' HB2' HD11 ' A' ' 18' ' ' LEU . 18.4 t70 -62.5 -50.81 69.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.294 -0.412 . . . . 1.8600000000000001 110.808 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.49 -48.4 1.69 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.761 -0.733 . . . . 1.0600000000000001 113.151 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.416 ' HB2' HG11 ' A' ' 16' ' ' VAL . 21.7 mmm180 -59.93 -29.25 68.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.638 0.256 . . . . 2.5899999999999999 111.204 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 66.1 mt -77.19 111.73 14.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.896 0.379 . . . . 0.92000000000000004 111.254 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -95.69 140.13 22.2 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.994 -0.548 . . . . 1.98 110.293 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -74.1 44.84 1.06 Allowed 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.495 2.13 . . . . 1.4399999999999999 112.963 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -167.75 69.5 0.09 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.285 -0.416 . . . . 2.1499999999999999 110.409 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -146.17 170.85 15.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.486 . . . . 2.02 110.835 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -115.0 104.47 11.94 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.288 -0.414 . . . . 1.02 110.986 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.5 HD13 ' HB3' ' A' ' 100' ' ' LEU . 49.5 mm -58.48 145.49 9.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.159 -0.473 . . . . 0.28999999999999998 111.054 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.439 HD11 ' HB ' ' A' ' 101' ' ' ILE . 92.7 mt -124.35 -67.11 0.94 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.236 -0.438 . . . . 0.40000000000000002 111.453 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 27.2 mtm180 -132.34 134.92 45.78 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.027 0.442 . . . . 2.6099999999999999 111.695 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.607 HG12 ' H ' ' A' ' 73' ' ' ASP . 3.8 t -97.97 172.88 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.761 -0.654 . . . . 0.28000000000000003 110.02 179.18 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.607 ' H ' HG12 ' A' ' 72' ' ' VAL . 28.1 t70 -51.07 108.81 0.27 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.784 0.326 . . . . 0.79000000000000004 111.44 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 59.39 14.21 3.63 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.045 -0.525 . . . . 2.0099999999999998 111.844 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.488 ' HB ' ' HB ' ' A' ' 72' ' ' VAL . 40.9 t -135.56 157.36 39.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.532 -0.304 . . . . 0.79000000000000004 110.849 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.451 ' N ' HG12 ' A' ' 75' ' ' VAL . 3.2 p-10 -129.07 128.61 43.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.396 -0.366 . . . . 2.2400000000000002 110.575 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.0 m -105.29 24.65 2.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.805 0.336 . . . . 0.67000000000000004 111.399 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -90.72 33.6 0.92 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.277 -0.419 . . . . 1.3899999999999999 110.763 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 170.15 23.55 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.77 -0.728 . . . . 0.55000000000000004 112.815 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.433 ' HB2' ' HE2' ' A' ' 80' ' ' MET . 43.3 mtm -119.12 140.74 49.61 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.788 0.327 . . . . 0.52000000000000002 110.668 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.419 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -58.77 156.62 10.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.165 -0.471 . . . . 0.39000000000000001 111.484 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -50.49 -57.81 7.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 1.52 111.272 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 79.3 p -53.67 -38.85 64.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.022 -0.535 . . . . 1.48 111.369 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -61.18 -44.54 97.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.272 -0.422 . . . . 2.1200000000000001 111.024 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 81' ' ' ALA . 47.4 t -59.42 -40.99 83.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.32000000000000001 111.038 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.4 t -62.14 -39.14 82.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.199 -0.455 . . . . 0.37 110.926 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -59.91 -44.79 94.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 1.51 110.778 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 53.3 t -56.92 -54.16 33.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.173 -0.467 . . . . 0.27000000000000002 111.124 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 92.9 mt -55.69 -34.29 64.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.887 -0.597 . . . . 0.40999999999999998 111.364 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 79.3 mtm180 -80.46 -17.1 52.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.299 -0.41 . . . . 2.1000000000000001 111.341 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -89.84 -15.47 32.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.42 -0.354 . . . . 1.1399999999999999 111.142 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.62 -86.64 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.299 -0.41 . . . . 0.55000000000000004 111.512 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.652 ' HA2' ' HE ' ' A' ' 20' ' ' ARG . . . 64.19 15.49 58.77 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.688 -0.768 . . . . 0.76000000000000001 112.279 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.489 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 6.2 p30 -146.92 174.07 3.69 Favored Pre-proline 0 C--N 1.327 -0.37 0 N-CA-C 110.408 -0.219 . . . . 2.52 110.408 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.595 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 46.2 Cg_exo -58.24 107.23 0.31 Allowed 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 121.897 1.731 . . . . 0.64000000000000001 111.477 178.075 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.3 m -116.6 141.54 34.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.164 0.506 . . . . 0.64000000000000001 112.173 -178.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.584 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 75.4 ttt180 -94.61 145.07 25.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.692 -0.685 . . . . 2.3700000000000001 109.707 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 13.5 mt -121.75 136.12 54.94 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.845 0.355 . . . . 0.37 111.366 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 38.5 tp -123.88 104.1 8.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.004 -0.544 . . . . 0.37 110.495 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.5 ' HB3' HD13 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -128.87 147.03 50.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.276 -0.42 . . . . 0.31 111.118 -179.59 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.439 ' HB ' HD11 ' A' ' 70' ' ' LEU . 16.1 tt -98.52 143.84 12.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 0.45000000000000001 111.029 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 13.7 mmm180 -132.56 139.02 47.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.995 -0.548 . . . . 2.2599999999999998 111.013 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -90.18 131.41 36.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.134 -0.484 . . . . 3.9300000000000002 110.931 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.444 HD21 ' OH ' ' A' ' 14' ' ' TYR . 62.2 mt -98.49 134.37 21.87 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.25 -0.432 . . . . 2.0 110.938 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -81.89 162.4 18.47 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.473 2.115 . . . . 2.98 112.285 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 96.7 mt -128.19 98.78 5.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.484 . . . . 3.6699999999999999 110.921 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 90.2 mt -73.48 114.22 11.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.122 -0.49 . . . . 5.5899999999999999 111.043 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.257 -0.878 . . . . 6.0 110.892 -179.968 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.167 0 N-CA-C 112.576 -0.209 . . . . 7.9199999999999999 112.576 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.7 m -147.54 -53.35 0.21 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.732 0.301 . . . . 7.1799999999999997 110.89 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 69.1 t60 -83.5 130.83 35.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 5.9100000000000001 110.88 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 173.07 -150.03 11.89 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.81 -0.709 . . . . 2.4500000000000002 112.359 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 56.55 48.66 16.2 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.707 0.289 . . . . 2.3300000000000001 111.112 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.2 m -82.65 113.13 20.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.431 -0.35 . . . . 2.5899999999999999 110.818 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 57.0 82.87 0.11 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.174 -0.466 . . . . 2.6699999999999999 110.656 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -129.14 90.95 3.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.247 -0.433 . . . . 1.5800000000000001 111.61 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 52.2 m 55.76 27.78 11.29 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.035 -0.53 . . . . 2.5499999999999998 111.512 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.06 35.4 6.73 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.684 -0.769 . . . . 1.8200000000000001 112.682 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -139.24 119.72 13.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.848 0.356 . . . . 1.7 110.703 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.5 t -139.38 145.69 39.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.096 -0.502 . . . . 0.90000000000000002 111.021 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 62.5 mt -81.93 122.18 27.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.919 -0.582 . . . . 0.89000000000000001 110.494 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -113.35 150.73 32.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 2.73 110.964 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 80.3 p -151.05 138.42 19.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 1.1899999999999999 111.264 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.9 t -129.67 145.64 35.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.072 -0.513 . . . . 0.56000000000000005 110.823 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -95.14 114.18 25.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.997 0.427 . . . . 1.74 111.376 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -117.26 166.66 12.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.861 -0.609 . . . . 0.81000000000000005 110.591 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.508 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 30.4 p90 -157.94 134.39 9.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.81 0.338 . . . . 2.0800000000000001 111.073 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.766 ' HE ' ' H ' ' A' ' 93' ' ' GLY . 12.2 ttp180 -121.75 160.27 24.92 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.344 -0.389 . . . . 3.0600000000000001 110.847 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -165.87 -32.83 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.113 -0.494 . . . . 2.5800000000000001 110.845 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -67.76 162.43 23.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.906 -0.588 . . . . 3.7200000000000002 110.939 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -86.26 22.9 1.67 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.12 -0.491 . . . . 2.8700000000000001 110.715 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 74.6 p -63.47 -23.11 67.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.119 -0.491 . . . . 1.3799999999999999 111.095 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.474 ' HA ' ' NH1' ' A' ' 20' ' ' ARG . 52.5 m 56.73 26.19 11.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.822 -0.626 . . . . 2.4500000000000002 111.299 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.7 m -152.24 153.68 34.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.916 0.388 . . . . 1.3999999999999999 111.12 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.541 HD21 ' HB2' ' A' ' 20' ' ' ARG . 81.0 mt -119.77 -5.66 10.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.016 -0.538 . . . . 0.45000000000000001 110.879 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.464 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 89.02 16.78 57.35 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.724 -0.751 . . . . 0.52000000000000002 112.363 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.428 HG22 HG23 ' A' ' 31' ' ' ILE . 69.9 mt -97.19 115.65 37.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.7 0.286 . . . . 0.83999999999999997 110.994 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.1 t -110.66 90.32 3.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.358 -0.383 . . . . 0.94999999999999996 110.734 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.428 HG23 HG22 ' A' ' 29' ' ' ILE . 41.9 pt -87.18 167.52 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.034 -0.53 . . . . 0.40999999999999998 111.197 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 47.5 t -150.6 134.42 16.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.088 -0.505 . . . . 1.3200000000000001 110.792 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.92 132.02 43.18 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.843 -0.694 . . . . 0.94999999999999996 112.556 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 15.9 tpt -65.1 129.42 39.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.872 0.367 . . . . 2.04 110.751 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -62.36 162.88 9.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.003 -0.544 . . . . 5.46 111.06 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -87.8 124.49 33.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.055 -0.52 . . . . 4.29 111.125 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -109.58 169.58 8.61 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.161 -0.472 . . . . 5.25 110.826 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.8 m -91.31 27.45 1.93 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.122 -0.49 . . . . 4.8799999999999999 111.063 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 60.8 p -114.25 135.37 54.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 5.2699999999999996 111.079 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 80.4 p -85.97 -0.57 55.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.169 -0.468 . . . . 6.9100000000000001 111.241 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.42 -52.97 5.31 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.803 -0.713 . . . . 5.3600000000000003 112.445 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -117.45 144.93 44.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.699 0.285 . . . . 7.2199999999999998 110.574 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -146.88 122.16 10.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.441 -0.345 . . . . 3.0499999999999998 111.483 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 44.1 p 51.55 -172.08 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.798 -0.637 . . . . 2.5299999999999998 111.739 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 141.76 146.62 4.72 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.705 -0.76 . . . . 1.1399999999999999 112.681 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.8 mp -100.64 122.31 52.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.735 0.302 . . . . 0.65000000000000002 110.823 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -145.33 153.07 40.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.162 -0.472 . . . . 0.69999999999999996 110.94 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 95.2 t -83.89 125.79 40.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.247 -0.433 . . . . 0.39000000000000001 111.195 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -108.54 -27.34 9.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.95 -0.568 . . . . 2.3999999999999999 111.001 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 59.2 m -147.71 172.1 14.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.045 0.45 . . . . 1.28 111.633 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 97.1 mt -132.14 165.72 23.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.669 -0.696 . . . . 0.41999999999999998 110.741 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.464 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 43.0 mm -106.36 104.48 50.5 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.186 -0.461 . . . . 1.26 110.958 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.61 129.77 36.68 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.424 2.082 . . . . 0.81999999999999995 112.407 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 98.01 0.44 58.7 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.768 -0.729 . . . . 0.48999999999999999 112.76 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.424 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 27.9 t -100.41 170.88 8.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.637 0.256 . . . . 1.23 110.999 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -51.81 -58.54 6.12 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.226 -0.443 . . . . 0.41999999999999998 111.659 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.3 -32.36 64.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.248 -0.433 . . . . 0.34999999999999998 111.514 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.91 -24.47 55.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.349 -0.387 . . . . 0.44 111.344 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 55' ' ' SER . 90.8 mt -74.7 -37.65 62.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.277 -0.42 . . . . 0.66000000000000003 111.033 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -57.18 -46.83 82.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.401 -0.363 . . . . 1.8600000000000001 110.913 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.46 -34.93 2.65 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.905 -0.664 . . . . 1.0600000000000001 112.709 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 78.0 mtm180 -65.11 -18.46 65.32 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.712 0.292 . . . . 2.5899999999999999 111.096 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 67.8 mt -87.23 108.94 18.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.888 0.375 . . . . 0.92000000000000004 110.919 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -82.67 138.25 44.05 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.011 -0.54 . . . . 1.98 110.5 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.54 53.41 3.98 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.45 2.1 . . . . 1.4399999999999999 112.524 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -174.59 72.09 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.125 -0.489 . . . . 2.1499999999999999 110.531 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -145.23 170.38 16.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.147 -0.479 . . . . 2.02 110.847 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -110.68 107.49 17.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.316 -0.402 . . . . 1.02 111.028 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 43.7 mm -63.0 142.69 16.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.146 -0.479 . . . . 0.28999999999999998 110.732 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 94.4 mt -121.56 -59.22 1.71 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.286 -0.416 . . . . 0.40000000000000002 111.281 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.467 ' HG2' HD22 ' A' ' 76' ' ' ASN . 77.3 mtp180 -142.02 140.92 32.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.025 0.44 . . . . 2.6099999999999999 111.583 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.624 HG12 ' H ' ' A' ' 73' ' ' ASP . 3.9 t -103.41 173.99 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.86 -0.609 . . . . 0.28000000000000003 109.646 178.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.644 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 15.3 t70 -47.28 108.62 0.16 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.736 0.303 . . . . 0.79000000000000004 111.455 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 54.98 31.0 15.14 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.224 -0.444 . . . . 2.0099999999999998 111.576 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.435 ' HB ' ' HB ' ' A' ' 72' ' ' VAL . 92.7 t -145.51 148.14 17.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.354 -0.385 . . . . 0.79000000000000004 110.904 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.467 HD22 ' HG2' ' A' ' 71' ' ' ARG . 22.1 t-20 -120.2 118.33 30.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.148 -0.478 . . . . 2.2400000000000002 110.552 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.8 m -102.21 25.24 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.871 0.367 . . . . 0.67000000000000004 111.455 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -92.28 42.4 1.1 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.166 -0.47 . . . . 1.3899999999999999 110.841 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 158.15 36.79 0.02 OUTLIER Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.661 -0.781 . . . . 0.55000000000000004 112.901 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 57.6 mtm -131.36 146.88 52.47 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.826 0.345 . . . . 0.52000000000000002 110.768 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.27 142.49 31.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.067 -0.515 . . . . 0.39000000000000001 111.029 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -48.07 -54.3 13.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.804 0.335 . . . . 1.52 111.03 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 56.8 m -54.15 -42.93 70.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.987 -0.551 . . . . 1.48 110.98 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -58.1 -43.54 87.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 2.1200000000000001 110.983 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 52.5 t -58.19 -41.63 81.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 0.32000000000000001 110.702 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.3 t -61.61 -37.57 78.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.108 -0.496 . . . . 0.37 110.758 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.483 ' HG2' HH21 ' A' ' 90' ' ' ARG . 42.4 mt-10 -58.92 -48.46 81.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.193 -0.458 . . . . 1.51 110.595 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 55.5 t -54.17 -54.1 23.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.133 -0.485 . . . . 0.27000000000000002 111.193 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.408 HD13 HD12 ' A' ' 29' ' ' ILE . 93.0 mt -59.26 -29.88 67.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.886 -0.597 . . . . 0.40999999999999998 111.456 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.483 HH21 ' HG2' ' A' ' 87' ' ' GLU . 87.3 mtm180 -85.9 -11.46 53.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.414 -0.357 . . . . 2.1000000000000001 111.154 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -100.02 -11.3 20.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.39 -0.368 . . . . 1.1399999999999999 111.178 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.33 -85.03 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.343 -0.39 . . . . 0.55000000000000004 111.571 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.766 ' H ' ' HE ' ' A' ' 20' ' ' ARG . . . 66.61 17.39 66.78 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.637 -0.792 . . . . 0.76000000000000001 112.318 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.407 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 12.6 p30 -146.9 169.62 9.13 Favored Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 110.295 -0.261 . . . . 2.52 110.295 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.508 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 34.6 Cg_exo -58.91 104.1 0.18 Allowed 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.025 1.817 . . . . 0.64000000000000001 111.423 178.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 18.2 m -112.07 152.43 13.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.128 0.49 . . . . 0.64000000000000001 112.209 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.644 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 79.5 ttt180 -104.01 145.01 30.78 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.606 -0.724 . . . . 2.3700000000000001 109.825 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 17.9 mt -115.1 114.33 25.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.197 -0.456 . . . . 0.37 111.137 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 45.0 tp -105.63 102.21 11.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.407 -0.36 . . . . 0.37 110.448 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.4 162.0 31.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.31 111.388 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.2 tt -110.34 139.25 34.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.95 -0.568 . . . . 0.45000000000000001 110.934 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 18.8 tpt180 -133.99 139.1 45.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.085 -0.507 . . . . 2.2599999999999998 110.924 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -85.26 125.2 32.7 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.136 -0.483 . . . . 3.9300000000000002 110.964 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 68.9 mt -64.37 150.4 93.14 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.068 -0.515 . . . . 2.0 110.991 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -81.55 61.84 8.13 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.799 2.333 . . . . 2.98 112.61 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 93.0 mt -85.14 119.04 25.08 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.769 -0.65 . . . . 3.6699999999999999 110.842 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -87.48 165.54 15.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.202 -0.454 . . . . 5.5899999999999999 110.871 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.199 -0.905 . . . . 6.0 110.866 179.926 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 112.594 -0.203 . . . . 7.9199999999999999 112.594 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.8 m -88.28 145.93 25.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.844 0.354 . . . . 7.1799999999999997 111.142 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -148.89 -24.91 0.31 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.034 -0.53 . . . . 5.9100000000000001 110.564 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -164.02 -104.95 0.19 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.837 -0.697 . . . . 2.4500000000000002 112.475 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -92.9 127.32 38.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.801 0.334 . . . . 2.3300000000000001 111.071 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 72.6 p -112.38 95.07 5.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.458 . . . . 2.5899999999999999 110.785 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 20.3 t70 54.29 78.74 0.15 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.025 -0.534 . . . . 2.6699999999999999 110.894 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -123.18 107.55 11.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 1.5800000000000001 111.246 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 64.3 m 55.57 25.87 8.47 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.094 -0.503 . . . . 2.5499999999999998 111.199 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.65 42.76 9.7 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.753 -0.737 . . . . 1.8200000000000001 112.654 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -143.52 112.88 6.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.944 0.402 . . . . 1.7 110.685 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 48.0 t -126.19 140.62 52.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.964 -0.562 . . . . 0.90000000000000002 110.787 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 70.9 mt -81.36 122.03 26.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.98 -0.555 . . . . 0.89000000000000001 110.313 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -113.56 143.33 44.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.298 -0.41 . . . . 2.73 111.055 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 77.7 p -142.31 127.0 18.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.447 . . . . 1.1899999999999999 111.09 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 19.5 t -118.36 143.86 28.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.078 -0.51 . . . . 0.56000000000000005 110.699 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -96.74 114.55 26.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.946 0.403 . . . . 1.74 111.369 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.571 HD11 ' HB2' ' A' ' 60' ' ' ASP . 4.5 mm? -115.47 166.56 11.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.812 -0.631 . . . . 0.81000000000000005 110.558 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.612 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 43.4 p90 -157.8 132.89 8.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.292 -0.413 . . . . 2.0800000000000001 110.979 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.476 ' HB2' HD21 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -112.83 127.43 56.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.452 . . . . 3.0600000000000001 110.599 179.718 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -125.29 -8.63 6.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 2.5800000000000001 110.892 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -91.99 156.71 17.24 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.105 -0.498 . . . . 3.7200000000000002 110.74 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -87.37 34.09 0.69 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 2.8700000000000001 110.748 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 72.0 p -86.07 -21.41 27.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.964 -0.562 . . . . 1.3799999999999999 111.091 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 55.7 m 58.32 17.62 4.86 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.893 -0.594 . . . . 2.4500000000000002 111.398 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 54.5 m -127.84 142.42 51.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.853 0.359 . . . . 1.3999999999999999 111.036 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.476 HD21 ' HB2' ' A' ' 20' ' ' ARG . 95.4 mt -113.4 -13.05 12.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.086 -0.507 . . . . 0.45000000000000001 110.902 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.449 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 91.53 30.78 10.19 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.802 -0.714 . . . . 0.52000000000000002 113.188 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.449 ' HB ' HD13 ' A' ' 89' ' ' LEU . 42.2 mm -101.6 113.31 37.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.676 0.274 . . . . 0.83999999999999997 111.219 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 36.7 t -109.82 97.75 7.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.262 -0.426 . . . . 0.94999999999999996 110.765 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 23.6 pt -86.23 154.0 3.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 0.40999999999999998 111.18 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 48.3 t -131.27 139.17 49.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.091 -0.504 . . . . 1.3200000000000001 110.873 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -73.27 143.11 32.53 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.768 -0.73 . . . . 0.94999999999999996 112.538 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 27.2 ttt -98.74 107.31 19.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.818 0.342 . . . . 2.04 110.817 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.45 ' N ' ' HD2' ' A' ' 35' ' ' ARG . 6.8 mpt_? -97.23 124.52 41.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.168 -0.469 . . . . 5.46 110.899 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -92.63 155.51 17.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 4.29 110.817 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -77.93 16.07 0.78 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.936 -0.575 . . . . 5.25 111.249 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 44.3 t -165.11 163.74 20.43 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.41 -0.359 . . . . 4.8799999999999999 110.893 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 68.0 p -122.7 139.12 54.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.163 -0.471 . . . . 5.2699999999999996 111.049 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.9 t -161.16 8.97 0.08 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.082 -0.508 . . . . 6.9100000000000001 111.067 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 143.89 -109.64 0.55 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.752 -0.737 . . . . 5.3600000000000003 112.413 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -105.25 135.17 47.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.82 0.343 . . . . 7.2199999999999998 110.816 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -161.8 61.57 0.25 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.025 -0.534 . . . . 3.0499999999999998 111.102 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 82.4 p -131.4 138.9 49.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.149 -0.478 . . . . 2.5299999999999998 111.007 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -132.7 126.28 4.42 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.674 -0.774 . . . . 1.1399999999999999 112.686 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.501 HG21 HG11 ' A' ' 85' ' ' VAL . 42.1 mm -88.32 83.98 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.893 0.378 . . . . 0.65000000000000002 110.903 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -117.98 137.06 53.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.11 -0.496 . . . . 0.69999999999999996 110.868 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.9 t -66.92 110.47 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.083 -0.508 . . . . 0.39000000000000001 110.793 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -86.57 -28.87 23.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.0 -0.545 . . . . 2.3999999999999999 110.876 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 75.9 p -153.62 168.19 27.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.003 0.43 . . . . 1.28 111.292 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.449 HD11 HG22 ' A' ' 63' ' ' ILE . 87.8 mt -123.76 165.03 17.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.849 -0.614 . . . . 0.41999999999999998 110.865 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.449 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 43.8 mm -112.01 107.95 55.69 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.079 -0.51 . . . . 1.26 110.971 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -60.59 132.32 42.51 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.417 2.078 . . . . 0.81999999999999995 112.276 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.73 -9.44 40.68 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.813 -0.708 . . . . 0.48999999999999999 112.57 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.421 ' OG ' ' HA3' ' A' ' 28' ' ' GLY . 97.0 p -91.91 -173.2 3.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.778 0.323 . . . . 1.23 111.03 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.42 ' HB2' HH21 ' A' ' 20' ' ' ARG . . . -70.95 -52.41 20.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.282 -0.417 . . . . 0.41999999999999998 111.251 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.423 ' HA ' HD11 ' A' ' 18' ' ' LEU . . . -57.53 -42.74 83.48 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.161 -0.472 . . . . 0.34999999999999998 111.555 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.71 -52.93 47.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.278 -0.419 . . . . 0.44 111.729 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.3 mt -64.03 -19.69 65.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.398 -0.365 . . . . 0.66000000000000003 111.424 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.571 ' HB2' HD11 ' A' ' 18' ' ' LEU . 14.3 t70 -57.27 -48.77 78.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.406 -0.361 . . . . 1.8600000000000001 110.863 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.63 -42.15 2.26 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.8 -0.714 . . . . 1.0600000000000001 112.86 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 67.9 mtp180 -70.38 -20.98 62.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.657 0.265 . . . . 2.5899999999999999 111.18 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.449 HG22 HD11 ' A' ' 51' ' ' LEU . 41.3 mm -72.99 134.08 30.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.816 0.341 . . . . 0.92000000000000004 110.833 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -129.77 136.71 29.5 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.105 -0.498 . . . . 1.98 110.707 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.18 168.27 16.26 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.394 2.063 . . . . 1.4399999999999999 112.22 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 63.0 t30 61.89 56.45 2.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.023 -0.535 . . . . 2.1499999999999999 110.614 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -131.92 149.93 52.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.971 -0.559 . . . . 2.02 110.683 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -96.58 117.38 30.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.342 -0.39 . . . . 1.02 111.218 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.606 HD13 ' HB3' ' A' ' 100' ' ' LEU . 46.5 mm -78.0 136.35 24.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 0.28999999999999998 110.714 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.535 HD11 ' HB ' ' A' ' 101' ' ' ILE . 82.6 mt -107.34 -60.19 1.72 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.122 -0.49 . . . . 0.40000000000000002 110.788 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -154.32 137.18 15.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.169 0.509 . . . . 2.6099999999999999 111.377 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.672 HG12 ' H ' ' A' ' 73' ' ' ASP . 2.4 t -87.4 175.85 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.606 -0.724 . . . . 0.28000000000000003 110.138 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.672 ' H ' HG12 ' A' ' 72' ' ' VAL . 24.2 t70 -49.91 110.09 0.35 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.874 0.369 . . . . 0.79000000000000004 111.642 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 56.84 23.85 8.55 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.034 -0.53 . . . . 2.0099999999999998 111.801 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.6 t -142.37 144.4 24.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.437 -0.347 . . . . 0.79000000000000004 110.788 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -112.65 138.18 49.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.484 -0.325 . . . . 2.2400000000000002 110.809 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.0 m -119.91 24.62 4.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.89 0.376 . . . . 0.67000000000000004 111.212 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -95.41 44.85 1.09 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.093 -0.503 . . . . 1.3899999999999999 110.908 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 164.66 24.95 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.612 -0.804 . . . . 0.55000000000000004 112.672 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 38.9 mtm -124.01 142.23 51.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.714 0.292 . . . . 0.52000000000000002 110.721 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.408 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -65.11 163.12 15.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.268 -0.423 . . . . 0.39000000000000001 111.041 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.404 ' O ' HG23 ' A' ' 86' ' ' VAL . 34.8 tt0 -48.83 -52.54 23.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.205 -0.452 . . . . 1.52 111.343 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 80.1 p -54.13 -42.23 69.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.116 -0.493 . . . . 1.48 111.534 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -62.24 -43.91 97.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.47 -0.332 . . . . 2.1200000000000001 111.471 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.501 HG11 HG21 ' A' ' 46' ' ' ILE . 21.7 t -61.48 -43.82 97.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.855 0.359 . . . . 0.32000000000000001 111.175 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 82' ' ' GLN . 59.4 t -59.88 -41.02 84.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.069 -0.514 . . . . 0.37 111.154 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.51 ' HG2' HH21 ' A' ' 90' ' ' ARG . 44.0 mt-10 -59.46 -44.45 92.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 1.51 110.967 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 71.8 t -57.82 -57.39 10.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 0.27000000000000002 111.574 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.449 HD13 ' HB ' ' A' ' 29' ' ' ILE . 86.8 mt -52.24 -34.93 48.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.049 -0.523 . . . . 0.40999999999999998 111.376 -179.204 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.51 HH21 ' HG2' ' A' ' 87' ' ' GLU . 65.1 mtm180 -78.09 -29.12 48.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.39 -0.368 . . . . 2.1000000000000001 111.011 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -71.03 -22.58 62.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 1.1399999999999999 110.852 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.06 -86.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.115 -0.493 . . . . 0.55000000000000004 111.279 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.462 ' HA2' ' HG2' ' A' ' 20' ' ' ARG . . . 60.76 17.04 48.61 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.676 -0.773 . . . . 0.76000000000000001 112.472 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.487 ' HB3' ' HD2' ' A' ' 95' ' ' PRO . 50.5 m-20 -147.52 175.13 2.88 Favored Pre-proline 0 CA--C 1.533 0.297 0 C-N-CA 122.001 0.121 . . . . 2.52 110.909 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.612 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 50.8 Cg_exo -56.28 104.93 0.15 Allowed 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 122.121 1.88 . . . . 0.64000000000000001 111.762 178.226 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 30.5 m -125.45 150.31 30.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.027 0.441 . . . . 0.64000000000000001 111.896 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.628 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 77.2 ttt180 -98.05 145.33 26.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.714 -0.675 . . . . 2.3700000000000001 109.856 179.258 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 16.0 mt -119.89 125.33 48.21 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.329 -0.396 . . . . 0.37 111.247 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 50.8 tp -112.78 100.03 8.36 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.404 -0.362 . . . . 0.37 110.723 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.606 ' HB3' HD13 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -124.39 141.65 51.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.961 -0.563 . . . . 0.31 111.184 -179.897 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.535 ' HB ' HD11 ' A' ' 70' ' ' LEU . 15.0 tt -97.31 141.93 15.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.469 . . . . 0.45000000000000001 111.126 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -138.06 131.58 30.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.031 -0.531 . . . . 2.2599999999999998 110.839 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -85.96 141.95 29.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 3.9300000000000002 111.053 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 75.6 mt -84.44 147.55 50.07 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.984 -0.553 . . . . 2.0 110.914 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -81.37 60.55 7.77 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.82 2.346 . . . . 2.98 112.043 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 50.9 mt -84.97 111.72 19.95 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.449 -0.796 . . . . 3.6699999999999999 110.985 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -90.56 96.51 10.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 5.5899999999999999 110.794 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.266 -0.873 . . . . 6.0 110.899 -179.787 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.213 0 N-CA-C 112.561 -0.215 . . . . 7.9199999999999999 112.561 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 56.8 m -91.72 163.07 14.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.82 0.343 . . . . 7.1799999999999997 110.966 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 54.8 m80 -137.33 26.72 2.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.168 -0.469 . . . . 5.9100000000000001 110.887 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.24 -103.92 0.18 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.725 -0.75 . . . . 2.4500000000000002 112.564 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -108.18 157.76 18.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.803 0.335 . . . . 2.3300000000000001 111.017 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.8 m -119.0 94.9 4.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.495 . . . . 2.5899999999999999 110.83 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 55.71 46.82 21.79 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.136 -0.484 . . . . 2.6699999999999999 111.102 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -95.21 113.74 25.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.195 -0.457 . . . . 1.5800000000000001 111.158 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 54.5 m 56.51 25.73 10.11 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.129 -0.487 . . . . 2.5499999999999998 111.173 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.71 -35.23 4.04 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.758 -0.734 . . . . 1.8200000000000001 112.657 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.419 ' HB3' HD11 ' A' ' 101' ' ' ILE . 94.0 m-85 -65.56 112.86 3.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.9 0.381 . . . . 1.7 110.961 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 46.8 t -136.01 140.83 44.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.032 -0.531 . . . . 0.90000000000000002 110.824 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 62.2 mt -78.87 121.25 24.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.113 -0.494 . . . . 0.89000000000000001 110.772 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.401 ' CD1' ' HB2' ' A' ' 102' ' ' ARG . 57.7 m-85 -114.88 129.15 56.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.038 0.447 . . . . 2.73 111.194 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 48.4 t -101.36 137.17 40.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.843 -0.617 . . . . 1.1899999999999999 111.084 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.1 t -131.28 158.38 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.047 -0.524 . . . . 0.56000000000000005 110.526 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -136.35 112.93 10.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.827 0.346 . . . . 1.74 111.257 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.557 HD12 ' HB1' ' A' ' 56' ' ' ALA . 4.0 mm? -122.88 166.64 14.7 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.084 -0.507 . . . . 0.81000000000000005 110.737 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.572 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 34.1 p90 -141.18 131.26 24.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.289 -0.414 . . . . 2.0800000000000001 111.019 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.529 HH21 ' HG ' ' A' ' 27' ' ' LEU . 14.5 ttm180 -102.48 93.53 5.2 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.38 -0.373 . . . . 3.0600000000000001 110.91 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -130.08 -0.08 4.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.35 -0.387 . . . . 2.5800000000000001 110.824 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -88.25 161.09 17.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.067 -0.515 . . . . 3.7200000000000002 110.881 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -84.46 39.72 0.74 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.14 -0.482 . . . . 2.8700000000000001 110.865 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 71.5 p -98.06 -19.48 17.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.281 -0.418 . . . . 1.3799999999999999 111.175 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 29.3 t 56.83 17.39 3.21 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.0 -0.545 . . . . 2.4500000000000002 111.194 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.8 m -151.95 153.74 34.69 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.294 -0.412 . . . . 1.3999999999999999 110.947 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.529 ' HG ' HH21 ' A' ' 20' ' ' ARG . 58.2 mt -102.88 -20.65 14.2 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.134 -0.485 . . . . 0.45000000000000001 110.837 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.504 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 101.8 3.69 52.19 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.767 -0.73 . . . . 0.52000000000000002 112.742 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 44.9 mm -76.27 109.01 9.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.729 0.299 . . . . 0.83999999999999997 111.044 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 44.4 t -110.75 92.8 4.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.341 -0.391 . . . . 0.94999999999999996 110.82 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 26.7 pt -91.01 167.8 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.968 -0.56 . . . . 0.40999999999999998 111.22 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 77.8 p -137.95 142.26 40.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.02 -0.536 . . . . 1.3200000000000001 110.853 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.04 128.78 37.44 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.873 -0.679 . . . . 0.94999999999999996 112.516 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 17.3 tpt -65.23 142.2 58.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.806 0.336 . . . . 2.04 110.943 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 -109.6 119.11 38.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.197 -0.456 . . . . 5.46 110.629 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -103.53 -65.91 0.98 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.063 -0.517 . . . . 4.29 111.3 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 60.44 77.87 0.3 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.242 -0.435 . . . . 5.25 110.762 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 52.4 m 58.18 86.49 0.08 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.088 -0.505 . . . . 4.8799999999999999 111.098 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 75.3 p -135.5 136.71 41.46 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.132 -0.485 . . . . 5.2699999999999996 111.207 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.7 t -109.66 19.2 19.46 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.177 -0.465 . . . . 6.9100000000000001 110.76 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -120.05 -74.48 0.41 Allowed Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.897 -0.668 . . . . 5.3600000000000003 112.476 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -96.23 168.2 10.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.879 0.371 . . . . 7.2199999999999998 110.883 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -145.58 104.87 3.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.104 -0.498 . . . . 3.0499999999999998 110.945 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 56.4 p 50.85 -167.25 0.03 OUTLIER 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.066 -0.516 . . . . 2.5299999999999998 111.487 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 146.88 128.16 1.86 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.767 -0.73 . . . . 1.1399999999999999 112.554 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 44.3 mm -86.44 124.57 40.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.712 0.291 . . . . 0.65000000000000002 110.804 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -148.48 144.99 27.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.337 -0.392 . . . . 0.69999999999999996 111.117 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 97.1 t -83.37 126.17 40.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.029 -0.532 . . . . 0.39000000000000001 110.649 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -107.32 -21.95 12.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 2.3999999999999999 110.912 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 76.9 p -152.39 169.64 22.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 1.28 111.2 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 67.8 mt -134.59 165.5 25.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.941 -0.572 . . . . 0.41999999999999998 110.771 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.504 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 47.5 mm -107.6 99.21 27.79 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 1.26 110.877 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -49.69 141.17 27.93 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.564 2.176 . . . . 0.81999999999999995 112.652 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 95.66 -22.93 36.41 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.88 -0.676 . . . . 0.48999999999999999 112.562 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 83.6 p -76.3 -178.19 4.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.733 0.301 . . . . 1.23 111.059 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.557 ' HB1' HD12 ' A' ' 18' ' ' LEU . . . -66.15 -56.87 9.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.316 -0.402 . . . . 0.41999999999999998 111.229 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.11 -34.46 66.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.458 . . . . 0.34999999999999998 111.314 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.14 -43.05 71.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.28 -0.418 . . . . 0.44 111.288 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.4 mt -67.93 -19.62 65.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.257 -0.428 . . . . 0.66000000000000003 111.118 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -57.33 -46.88 82.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.444 -0.343 . . . . 1.8600000000000001 110.891 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.61 -50.32 1.81 Allowed Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.77 -0.729 . . . . 1.0600000000000001 112.87 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 66.4 mtm180 -64.08 -42.55 96.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.634 0.254 . . . . 2.5899999999999999 111.017 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 61.5 mt -63.86 114.4 2.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.369 -0.378 . . . . 0.92000000000000004 110.962 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -130.5 158.56 74.19 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 1.98 111.179 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -55.0 174.73 0.19 Allowed 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.734 2.29 . . . . 1.4399999999999999 112.211 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 17.4 m120 61.66 35.58 17.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.195 -0.457 . . . . 2.1499999999999999 111.122 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -112.96 152.71 29.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.152 -0.476 . . . . 2.02 110.649 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -116.02 105.81 13.06 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.83 0.347 . . . . 1.02 111.138 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 44.1 mm -63.7 131.82 29.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.195 -0.457 . . . . 0.28999999999999998 110.983 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 66.9 mt -102.37 -65.69 0.97 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.134 -0.484 . . . . 0.40000000000000002 110.802 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -146.84 135.31 21.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.988 -0.551 . . . . 2.6099999999999999 111.296 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.657 HG12 ' H ' ' A' ' 73' ' ' ASP . 3.7 t -87.99 175.22 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.622 -0.717 . . . . 0.28000000000000003 109.983 179.324 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.657 ' H ' HG12 ' A' ' 72' ' ' VAL . 21.3 t70 -48.63 109.28 0.23 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.803 0.335 . . . . 0.79000000000000004 111.586 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 56.15 26.37 10.16 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.113 -0.494 . . . . 2.0099999999999998 111.853 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.5 t -145.6 149.26 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.406 -0.361 . . . . 0.79000000000000004 110.777 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -119.06 131.72 55.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.32 -0.4 . . . . 2.2400000000000002 110.459 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.463 ' HA ' ' HE2' ' A' ' 80' ' ' MET . 30.0 m -105.25 26.43 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.879 0.371 . . . . 0.67000000000000004 111.287 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -94.93 23.79 5.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.096 -0.502 . . . . 1.3899999999999999 111.114 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -172.79 17.06 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.641 -0.79 . . . . 0.55000000000000004 112.8 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.463 ' HE2' ' HA ' ' A' ' 77' ' ' VAL . 38.6 mtm -118.05 135.9 53.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.831 0.348 . . . . 0.52000000000000002 110.849 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.91 160.08 18.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.436 . . . . 0.39000000000000001 111.097 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -48.25 -54.21 14.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.374 -0.376 . . . . 1.52 111.249 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 46.1 t -53.88 -32.84 54.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.327 -0.397 . . . . 1.48 111.244 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.499 ' O ' HG23 ' A' ' 88' ' ' VAL . 10.4 t70 -73.35 -40.13 64.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.366 -0.379 . . . . 2.1200000000000001 111.0 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 25.8 t -65.12 -30.32 49.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.961 0.41 . . . . 0.32000000000000001 110.661 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 97.5 t -70.94 -49.27 51.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.985 -0.552 . . . . 0.37 111.187 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.433 ' HG2' ' O ' ' A' ' 84' ' ' ASP . 11.4 pt-20 -60.44 -30.01 69.37 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.722 0.296 . . . . 1.51 110.752 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 84' ' ' ASP . 50.2 t -65.27 -56.66 14.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.893 0.378 . . . . 0.27000000000000002 110.825 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 93.5 mt -54.93 -35.19 63.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.957 -0.565 . . . . 0.40999999999999998 111.378 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.466 ' HA ' ' NH1' ' A' ' 20' ' ' ARG . 86.9 mtm180 -76.96 -34.32 57.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.424 -0.353 . . . . 2.1000000000000001 111.17 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -70.29 -18.36 63.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.436 -0.347 . . . . 1.1399999999999999 110.682 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.43 -84.51 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.133 -0.485 . . . . 0.55000000000000004 111.464 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.487 ' H ' ' HD2' ' A' ' 20' ' ' ARG . . . 63.63 22.2 65.75 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.692 -0.766 . . . . 0.76000000000000001 112.186 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -147.17 169.81 8.77 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 110.39 -0.226 . . . . 2.52 110.39 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.572 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 33.3 Cg_exo -60.79 93.02 0.1 OUTLIER 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.055 1.837 . . . . 0.64000000000000001 111.248 178.163 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.5 m -101.79 145.64 11.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.085 0.469 . . . . 0.64000000000000001 111.918 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.629 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 60.4 ttp180 -91.88 136.44 33.16 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.694 -0.685 . . . . 2.3700000000000001 110.157 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 65.5 mt -111.65 103.74 12.06 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.975 -0.557 . . . . 0.37 111.187 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 21.4 tp -97.51 106.77 19.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.889 0.376 . . . . 0.37 110.158 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.96 164.93 26.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.31 111.434 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.419 HD11 ' HB3' ' A' ' 11' ' ' PHE . 12.4 tt -110.34 133.75 54.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.031 -0.532 . . . . 0.45000000000000001 111.033 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.401 ' HB2' ' CD1' ' A' ' 14' ' ' TYR . 18.2 mmm180 -111.87 130.47 55.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.968 -0.56 . . . . 2.2599999999999998 110.508 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 41.3 ttp180 -89.68 108.28 19.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.311 -0.404 . . . . 3.9300000000000002 110.933 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 79.1 mt -63.91 133.99 95.76 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 2.0 110.786 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -79.98 60.04 7.67 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.64 2.227 . . . . 2.98 112.218 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 78.3 mt -89.58 115.55 27.06 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.533 -0.758 . . . . 3.6699999999999999 110.912 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -76.13 150.95 37.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 5.5899999999999999 110.677 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.303 -0.856 . . . . 6.0 110.909 -179.979 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.07 0 N-CA-C 112.508 -0.237 . . . . 7.9199999999999999 112.508 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 52.0 m -139.65 140.04 36.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.705 0.288 . . . . 7.1799999999999997 110.933 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 28.3 t60 -168.59 99.56 0.41 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 5.9100000000000001 110.879 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 144.63 -106.99 0.42 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.786 -0.721 . . . . 2.4500000000000002 112.462 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -70.49 145.87 50.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.773 0.32 . . . . 2.3300000000000001 110.83 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 77.7 p -138.87 96.94 3.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.189 -0.459 . . . . 2.5899999999999999 111.067 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 55.16 35.88 25.78 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.113 -0.494 . . . . 2.6699999999999999 110.988 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -94.29 113.03 24.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.093 -0.503 . . . . 1.5800000000000001 111.144 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.5 t 56.02 22.95 6.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.182 -0.463 . . . . 2.5499999999999998 110.996 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.66 -29.07 5.53 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.835 -0.698 . . . . 1.8200000000000001 112.688 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.413 ' HB3' HD11 ' A' ' 101' ' ' ILE . 74.5 m-85 -60.64 109.61 1.08 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.878 0.37 . . . . 1.7 111.131 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.9 t -132.16 146.67 52.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.007 -0.542 . . . . 0.90000000000000002 110.685 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 56.0 mt -81.65 122.56 27.77 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.293 -0.412 . . . . 0.89000000000000001 111.166 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -121.15 130.58 53.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.066 -0.515 . . . . 2.73 110.84 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 47.6 t -125.57 132.9 52.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.31 -0.405 . . . . 1.1899999999999999 111.214 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 18.3 t -131.13 151.29 35.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.968 -0.56 . . . . 0.56000000000000005 110.606 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -101.2 118.71 37.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.958 0.408 . . . . 1.74 111.446 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.566 HD23 HD12 ' A' ' 98' ' ' LEU . 4.3 mm? -122.23 166.45 14.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.945 -0.57 . . . . 0.81000000000000005 110.191 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.587 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 36.9 p90 -141.86 131.83 24.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.85 0.357 . . . . 2.0800000000000001 111.078 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.432 ' HB2' HD21 ' A' ' 27' ' ' LEU . 3.2 tmm_? -100.83 104.82 16.06 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.21 -0.45 . . . . 3.0600000000000001 110.712 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -146.43 8.88 1.05 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.311 -0.404 . . . . 2.5800000000000001 110.953 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -89.75 162.75 15.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.253 -0.431 . . . . 3.7200000000000002 110.958 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -84.05 34.13 0.5 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.108 -0.497 . . . . 2.8700000000000001 110.958 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 51.6 p -98.1 -8.96 26.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.182 -0.463 . . . . 1.3799999999999999 110.881 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.7 t 58.35 15.92 3.75 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.829 -0.623 . . . . 2.4500000000000002 111.098 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 57.3 m -158.04 -176.96 6.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.262 -0.426 . . . . 1.3999999999999999 110.902 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.432 HD21 ' HB2' ' A' ' 20' ' ' ARG . 37.4 mt -115.28 -5.1 12.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.042 -0.526 . . . . 0.45000000000000001 110.794 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.491 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 94.82 6.27 60.71 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.779 -0.724 . . . . 0.52000000000000002 112.171 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 25.0 mm -79.61 109.24 14.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.817 0.341 . . . . 0.83999999999999997 110.958 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.7 m -113.33 93.35 4.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.176 -0.465 . . . . 0.94999999999999996 110.796 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 44.6 pt -93.03 163.3 2.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.40999999999999998 111.2 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 45.3 t -119.08 130.66 55.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.259 -0.428 . . . . 1.3200000000000001 110.792 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -67.14 115.84 7.54 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.849 -0.691 . . . . 0.94999999999999996 112.623 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 26.0 ttt -78.22 114.92 17.55 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.873 0.368 . . . . 2.04 110.854 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.73 155.86 5.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.045 -0.525 . . . . 5.46 111.113 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -107.07 -18.21 13.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.045 -0.525 . . . . 4.29 110.984 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 62.74 -175.46 0.15 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.891 -0.595 . . . . 5.25 110.864 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 80.1 p -87.49 22.76 2.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.168 -0.469 . . . . 4.8799999999999999 110.914 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 59.1 p -80.43 138.29 36.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.127 -0.488 . . . . 5.2699999999999996 111.178 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.8 t -71.57 -4.87 29.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.067 -0.515 . . . . 6.9100000000000001 111.14 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -114.73 114.49 3.25 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.818 -0.706 . . . . 5.3600000000000003 112.468 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -69.87 138.98 52.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.753 0.311 . . . . 7.2199999999999998 110.917 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -150.62 38.53 0.69 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.96 0.409 . . . . 3.0499999999999998 111.206 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 64.7 p -64.27 149.18 48.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.934 -0.575 . . . . 2.5299999999999998 110.995 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -149.29 135.07 5.2 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.708 -0.758 . . . . 1.1399999999999999 112.617 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 49.7 mm -98.05 114.94 36.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.719 0.295 . . . . 0.65000000000000002 110.895 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -143.59 137.67 28.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.69999999999999996 111.094 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 99.4 t -68.08 127.81 30.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.113 -0.494 . . . . 0.39000000000000001 111.051 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -99.96 -30.58 11.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.912 -0.586 . . . . 2.3999999999999999 110.999 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 80.1 p -157.17 171.62 20.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.894 0.378 . . . . 1.28 111.296 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.433 HD11 HG22 ' A' ' 63' ' ' ILE . 63.6 mt -129.26 140.55 51.4 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.921 -0.582 . . . . 0.41999999999999998 110.88 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.491 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 49.5 mm -77.15 118.0 68.95 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 116.21 -0.45 . . . . 1.26 110.899 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -68.25 109.43 1.99 Allowed 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.268 1.979 . . . . 0.81999999999999995 112.255 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 126.93 -5.46 7.39 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.849 -0.691 . . . . 0.48999999999999999 112.448 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.8 m -94.07 -174.83 3.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.709 0.29 . . . . 1.23 111.086 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.51 ' HB1' HD12 ' A' ' 18' ' ' LEU . . . -72.48 -42.8 64.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.379 -0.373 . . . . 0.41999999999999998 111.348 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.98 -42.57 99.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.298 -0.41 . . . . 0.34999999999999998 111.451 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.03 -55.24 11.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.44 111.317 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.3 mt -59.25 -19.67 47.75 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.3 -0.409 . . . . 0.66000000000000003 111.23 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.48 ' HB2' HD11 ' A' ' 18' ' ' LEU . 18.8 t70 -59.96 -49.74 76.5 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.837 0.351 . . . . 1.8600000000000001 110.746 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 98.71 -49.73 1.27 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.905 -0.664 . . . . 1.0600000000000001 112.987 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 51.3 mtp180 -60.33 -45.09 94.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.749 0.309 . . . . 2.5899999999999999 111.134 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.433 HG22 HD11 ' A' ' 51' ' ' LEU . 71.9 mt -67.59 114.18 4.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.906 0.384 . . . . 0.92000000000000004 111.111 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -117.29 139.75 26.41 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.025 -0.534 . . . . 1.98 110.568 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -47.62 167.18 0.09 OUTLIER 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.557 2.171 . . . . 1.4399999999999999 112.73 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 63.97 60.78 0.99 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.094 -0.503 . . . . 2.1499999999999999 110.554 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -134.28 156.66 48.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.788 -0.642 . . . . 2.02 110.579 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -109.47 113.29 25.96 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.867 0.365 . . . . 1.02 111.073 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 34.2 mm -74.05 143.36 13.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.076 -0.511 . . . . 0.28999999999999998 110.857 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 74.7 mt -116.17 -66.51 1.08 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.312 -0.404 . . . . 0.40000000000000002 111.392 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 76.8 mtp180 -140.22 142.45 35.83 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.041 0.448 . . . . 2.6099999999999999 111.558 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.652 HG12 ' H ' ' A' ' 73' ' ' ASP . 3.6 t -100.83 174.48 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.871 -0.604 . . . . 0.28000000000000003 109.788 179.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.689 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 12.7 t70 -49.76 108.66 0.22 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.727 0.299 . . . . 0.79000000000000004 111.191 179.326 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 55.21 29.7 13.23 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.198 -0.455 . . . . 2.0099999999999998 111.542 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.502 ' HB ' ' HB ' ' A' ' 72' ' ' VAL . 92.4 t -145.36 151.78 14.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.417 -0.356 . . . . 0.79000000000000004 110.947 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -120.66 126.1 49.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.32 -0.4 . . . . 2.2400000000000002 110.565 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.9 m -107.56 19.84 5.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 111.708 0.262 . . . . 0.67000000000000004 111.708 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -94.26 21.72 6.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.92 0.39 . . . . 1.3899999999999999 110.465 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -161.68 13.09 0.14 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.004 -0.617 . . . . 0.55000000000000004 112.429 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 52.9 mtm -118.83 144.65 46.22 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.859 0.361 . . . . 0.52000000000000002 110.825 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.4 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -71.87 168.02 18.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.12 -0.491 . . . . 0.39000000000000001 111.086 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.448 ' O ' HG23 ' A' ' 86' ' ' VAL . 63.0 tt0 -49.5 -56.43 9.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.138 -0.483 . . . . 1.52 111.447 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 54.6 m -51.38 -43.31 61.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 1.48 111.837 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -60.68 -50.53 73.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.465 -0.334 . . . . 2.1200000000000001 111.507 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 81' ' ' ALA . 25.7 t -57.86 -36.46 55.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.293 -0.412 . . . . 0.32000000000000001 111.327 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 82' ' ' GLN . 90.6 t -62.54 -48.95 85.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.36 -0.382 . . . . 0.37 111.391 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -56.73 -41.46 77.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.339 -0.392 . . . . 1.51 111.143 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 75.1 t -57.33 -58.96 3.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.255 -0.43 . . . . 0.27000000000000002 111.696 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 86.5 mt -54.22 -32.16 55.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 0.40999999999999998 111.58 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 82.6 mtm180 -81.47 -23.47 37.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.503 -0.317 . . . . 2.1000000000000001 111.276 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -84.14 -14.26 50.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.34 -0.391 . . . . 1.1399999999999999 110.955 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.03 -81.61 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.162 -0.472 . . . . 0.55000000000000004 111.49 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.409 ' H ' ' HE ' ' A' ' 20' ' ' ARG . . . 63.84 15.29 57.72 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 120.625 -0.797 . . . . 0.76000000000000001 112.253 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -146.85 167.94 12.57 Favored Pre-proline 0 C--N 1.329 -0.303 0 N-CA-C 110.333 -0.247 . . . . 2.52 110.333 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.587 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 34.3 Cg_exo -61.94 98.38 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.051 1.834 . . . . 0.64000000000000001 111.338 178.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.6 m -104.44 153.67 6.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.129 0.49 . . . . 0.64000000000000001 112.108 -178.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.689 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 40.3 ttm180 -93.04 141.26 28.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.459 -0.791 . . . . 2.3700000000000001 110.063 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.566 HD12 HD23 ' A' ' 18' ' ' LEU . 48.9 mt -117.37 103.58 10.28 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.149 -0.478 . . . . 0.37 110.848 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 58.5 tp -99.29 99.63 10.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.37 110.34 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.2 165.86 20.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.31 111.093 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.413 HD11 ' HB3' ' A' ' 11' ' ' PHE . 14.9 tt -114.33 130.23 68.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-O 121.096 0.474 . . . . 0.45000000000000001 111.447 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 23.0 mmm180 -108.98 146.33 34.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.443 -0.799 . . . . 2.2599999999999998 110.642 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 31.2 ttp180 -101.54 124.04 46.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.948 0.404 . . . . 3.9300000000000002 110.744 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.9 mt -94.74 139.78 22.34 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.004 -0.544 . . . . 2.0 110.814 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -82.12 167.77 15.71 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.53 2.153 . . . . 2.98 112.395 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 88.1 mt -132.25 135.31 46.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.271 -0.422 . . . . 3.6699999999999999 110.903 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 95.3 mt -107.11 138.99 42.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.111 -0.495 . . . . 5.5899999999999999 111.063 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.266 -0.873 . . . . 6.0 110.981 179.979 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.152 0 N-CA-C 112.473 -0.251 . . . . 7.9199999999999999 112.473 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.6 m -151.96 152.65 32.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.731 0.3 . . . . 7.1799999999999997 110.971 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -133.84 71.43 1.46 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.272 -0.422 . . . . 5.9100000000000001 110.883 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -176.66 112.56 0.39 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.858 -0.687 . . . . 2.4500000000000002 112.411 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -113.9 93.46 4.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.817 0.342 . . . . 2.3300000000000001 111.136 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.6 p -79.47 82.36 5.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.25 -0.432 . . . . 2.5899999999999999 110.677 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 23.2 t70 57.23 85.15 0.09 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.075 -0.511 . . . . 2.6699999999999999 110.88 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -136.69 115.85 12.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.068 -0.515 . . . . 1.5800000000000001 111.018 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.3 t 58.37 25.94 13.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.086 -0.506 . . . . 2.5499999999999998 111.017 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.84 -39.99 2.67 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.843 -0.694 . . . . 1.8200000000000001 112.759 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -58.12 102.54 0.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.903 0.383 . . . . 1.7 111.083 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 46.6 t -113.78 148.88 35.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.016 -0.538 . . . . 0.90000000000000002 110.788 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -84.77 126.09 33.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.89000000000000001 111.211 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -121.16 136.09 55.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.897 -0.592 . . . . 2.73 110.586 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 49.4 m -136.75 127.57 27.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.284 -0.416 . . . . 1.1899999999999999 111.205 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 28.3 t -129.86 145.98 34.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.986 -0.552 . . . . 0.56000000000000005 110.61 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -107.92 117.51 34.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.949 0.404 . . . . 1.74 111.311 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.518 HD11 ' HB2' ' A' ' 60' ' ' ASP . 4.3 mm? -111.05 166.46 11.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.855 -0.611 . . . . 0.81000000000000005 110.763 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.569 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 28.6 p90 -152.95 132.47 12.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.388 -0.369 . . . . 2.0800000000000001 111.084 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.564 HH21 ' H ' ' A' ' 93' ' ' GLY . 24.2 ttp180 -122.37 156.2 34.46 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.271 -0.422 . . . . 3.0600000000000001 110.637 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -169.39 26.45 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.311 -0.404 . . . . 2.5800000000000001 110.84 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -116.78 164.7 14.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.176 -0.466 . . . . 3.7200000000000002 110.91 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -87.58 25.99 1.36 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.999 -0.546 . . . . 2.8700000000000001 111.007 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.4 p -78.26 -23.94 47.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.927 0.394 . . . . 1.3799999999999999 110.902 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 59.2 m 56.59 21.75 6.05 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.683 -0.69 . . . . 2.4500000000000002 111.339 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.7 m -140.03 144.69 37.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.287 -0.415 . . . . 1.3999999999999999 111.058 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 41.4 mt -113.56 12.48 18.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.125 -0.489 . . . . 0.45000000000000001 110.91 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.501 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 58.29 37.54 87.49 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.833 -0.699 . . . . 0.52000000000000002 112.715 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 65.9 mt -109.51 109.48 28.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.791 0.329 . . . . 0.83999999999999997 111.144 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 39.5 t -105.64 112.24 25.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.072 -0.513 . . . . 0.94999999999999996 110.633 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.407 HD12 HG23 ' A' ' 46' ' ' ILE . 37.1 pt -107.84 167.13 3.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 0.40999999999999998 111.509 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 56.8 m -141.56 134.89 29.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.965 -0.561 . . . . 1.3200000000000001 110.623 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -91.49 78.19 1.35 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.754 -0.736 . . . . 0.94999999999999996 112.598 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 10.7 tmm? -103.04 113.26 26.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.804 0.335 . . . . 2.04 110.479 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 28.4 mmm180 -100.72 152.47 20.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 5.46 110.966 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -117.16 139.41 50.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.101 -0.499 . . . . 4.29 110.726 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -97.42 158.46 15.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 5.25 110.968 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 52.2 m 56.46 59.89 3.39 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.081 -0.509 . . . . 4.8799999999999999 110.853 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 41.5 p -71.62 152.16 43.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.915 -0.584 . . . . 5.2699999999999996 111.294 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.8 t -150.99 2.05 0.43 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.052 -0.522 . . . . 6.9100000000000001 111.082 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.81 -46.85 0.15 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.934 -0.65 . . . . 5.3600000000000003 112.448 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -89.44 158.42 17.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.804 0.335 . . . . 7.2199999999999998 110.925 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -155.37 121.05 5.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.211 -0.45 . . . . 3.0499999999999998 111.192 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.2 p -107.79 127.5 53.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.036 -0.529 . . . . 2.5299999999999998 111.266 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -134.05 -115.43 1.57 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.87 -0.681 . . . . 1.1399999999999999 112.236 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.407 HG23 HD12 ' A' ' 31' ' ' ILE . 48.3 mm -82.93 99.86 6.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.728 0.299 . . . . 0.65000000000000002 110.648 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -128.48 142.36 51.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.258 -0.428 . . . . 0.69999999999999996 111.22 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 86.3 t -76.9 113.02 15.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.11 -0.496 . . . . 0.39000000000000001 110.47 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -88.35 -29.41 20.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.276 -0.42 . . . . 2.3999999999999999 111.331 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 78.4 p -153.35 176.82 11.56 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.936 0.398 . . . . 1.28 111.377 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 69.8 mt -135.58 153.45 51.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.933 -0.576 . . . . 0.41999999999999998 110.882 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.501 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 57.7 mt -90.33 109.71 35.54 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.312 -0.404 . . . . 1.26 110.947 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -57.73 124.95 17.23 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.426 2.084 . . . . 0.81999999999999995 112.331 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.93 -3.86 31.92 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.774 -0.727 . . . . 0.48999999999999999 112.498 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.9 t -100.09 177.86 4.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.743 0.306 . . . . 1.23 110.94 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.48 -58.34 8.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.263 -0.426 . . . . 0.41999999999999998 111.755 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.46 -49.83 66.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.225 -0.443 . . . . 0.34999999999999998 111.844 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.75 -39.45 80.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.385 -0.37 . . . . 0.44 111.876 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 81.1 mt -70.75 -23.0 62.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.503 -0.317 . . . . 0.66000000000000003 111.319 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.518 ' HB2' HD11 ' A' ' 18' ' ' LEU . 15.2 t70 -60.51 -56.23 23.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.829 0.347 . . . . 1.8600000000000001 110.862 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 98.35 -46.34 1.56 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.828 -0.701 . . . . 1.0600000000000001 113.159 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 38.0 mtp180 -60.54 -26.88 67.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.63 0.252 . . . . 2.5899999999999999 111.513 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 70.7 mt -73.06 102.24 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.946 0.403 . . . . 0.92000000000000004 111.04 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -93.98 136.18 23.99 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.001 -0.545 . . . . 1.98 110.574 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.46 171.89 1.68 Allowed 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.41 2.074 . . . . 1.4399999999999999 112.34 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 58.97 29.35 18.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.992 -0.549 . . . . 2.1499999999999999 110.902 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.438 ' OD1' ' HB2' ' A' ' 100' ' ' LEU . 11.9 t0 -102.31 140.07 37.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.046 -0.524 . . . . 2.02 110.405 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -87.32 127.83 35.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.755 0.312 . . . . 1.02 111.202 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 39.9 mm -90.56 136.56 23.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.287 -0.415 . . . . 0.28999999999999998 110.672 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 89.5 mt -107.29 -64.38 1.2 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.326 -0.397 . . . . 0.40000000000000002 111.157 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -147.75 135.12 20.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.074 0.464 . . . . 2.6099999999999999 111.704 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.675 HG12 ' H ' ' A' ' 73' ' ' ASP . 3.1 t -89.81 175.4 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.614 -0.721 . . . . 0.28000000000000003 110.084 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.675 ' H ' HG12 ' A' ' 72' ' ' VAL . 16.6 t70 -47.24 109.21 0.19 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.721 0.296 . . . . 0.79000000000000004 111.688 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 54.36 28.77 9.85 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.095 -0.502 . . . . 2.0099999999999998 111.73 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.474 HG11 HG11 ' A' ' 88' ' ' VAL . 66.6 t -145.67 147.06 18.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.39 -0.368 . . . . 0.79000000000000004 110.714 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -116.44 128.6 55.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.26 -0.427 . . . . 2.2400000000000002 110.515 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.5 m -109.98 26.44 2.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.818 0.342 . . . . 0.67000000000000004 111.353 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -97.05 24.48 6.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.451 . . . . 1.3899999999999999 111.046 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -170.23 15.2 0.06 OUTLIER Glycine 0 C--N 1.329 0.194 0 C-N-CA 120.543 -0.837 . . . . 0.55000000000000004 112.768 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 47.2 mtm -117.56 142.46 47.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.852 0.358 . . . . 0.52000000000000002 110.98 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.41 ' HB3' ' OD2' ' A' ' 84' ' ' ASP . . . -66.29 165.13 14.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.091 -0.504 . . . . 0.39000000000000001 110.99 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.401 ' O ' HG23 ' A' ' 86' ' ' VAL . 36.0 tt0 -50.01 -56.72 9.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.315 -0.402 . . . . 1.52 111.369 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.3 t -51.89 -39.92 59.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.251 -0.431 . . . . 1.48 111.456 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.41 ' OD2' ' HB3' ' A' ' 81' ' ' ALA . 11.6 m-20 -64.29 -47.07 80.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.487 -0.324 . . . . 2.1200000000000001 111.129 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 54.3 t -58.06 -32.64 44.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.306 -0.406 . . . . 0.32000000000000001 110.886 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.41 HG12 ' NE ' ' A' ' 90' ' ' ARG . 75.0 t -68.72 -42.28 82.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.14 -0.482 . . . . 0.37 110.957 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.436 ' HG2' HH21 ' A' ' 90' ' ' ARG . 44.7 mt-10 -56.74 -46.55 81.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.839 0.352 . . . . 1.51 110.801 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.474 HG11 HG11 ' A' ' 75' ' ' VAL . 53.0 t -59.09 -56.18 18.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.228 -0.442 . . . . 0.27000000000000002 111.011 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 82.3 mt -58.73 -22.11 56.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.916 -0.584 . . . . 0.40999999999999998 111.355 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.436 HH21 ' HG2' ' A' ' 87' ' ' GLU . 80.4 mtm180 -89.04 -21.96 23.19 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.596 -0.275 . . . . 2.1000000000000001 111.177 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -86.5 -15.69 39.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.496 -0.32 . . . . 1.1399999999999999 111.001 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.97 -87.73 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.256 -0.429 . . . . 0.55000000000000004 111.377 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.564 ' H ' HH21 ' A' ' 20' ' ' ARG . . . 61.68 21.45 60.65 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.809 -0.71 . . . . 0.76000000000000001 112.613 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.455 ' HB3' ' HD2' ' A' ' 95' ' ' PRO . 69.2 m-20 -147.24 173.84 3.87 Favored Pre-proline 0 C--N 1.328 -0.345 0 C-N-CA 121.936 0.094 . . . . 2.52 110.846 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.569 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 37.1 Cg_exo -59.15 90.82 0.07 OUTLIER 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.141 1.894 . . . . 0.64000000000000001 111.783 178.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 28.8 m -104.73 153.48 6.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.64000000000000001 111.937 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.654 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 52.1 ttp180 -99.23 145.12 27.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.689 -0.687 . . . . 2.3700000000000001 110.282 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.501 HD12 HD23 ' A' ' 18' ' ' LEU . 46.5 mt -120.78 106.21 11.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.261 -0.427 . . . . 0.37 111.26 -179.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 22.2 tp -99.3 107.45 19.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.389 -0.369 . . . . 0.37 110.116 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.438 ' HB2' ' OD1' ' A' ' 67' ' ' ASP . 0.4 OUTLIER -135.36 163.3 30.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.954 0.406 . . . . 0.31 111.539 -179.159 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 15.7 tt -120.9 141.03 43.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.927 -0.579 . . . . 0.45000000000000001 110.965 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.402 ' HB2' ' OD2' ' A' ' 67' ' ' ASP . 25.7 tpt180 -137.07 135.97 37.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.11 -0.495 . . . . 2.2599999999999998 110.776 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 37.2 ttp180 -87.75 141.71 28.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 3.9300000000000002 110.714 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 49.7 mt -82.7 147.28 54.95 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 2.0 110.78 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -79.39 60.63 7.89 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.793 2.329 . . . . 2.98 112.353 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 80.3 mt -92.05 120.47 32.71 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.508 -0.769 . . . . 3.6699999999999999 111.011 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.412 ' N ' HD22 ' A' ' 107' ' ' LEU . 3.8 mm? -84.54 143.25 29.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.103 -0.499 . . . . 5.5899999999999999 110.845 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.181 -0.914 . . . . 6.0 110.856 179.957 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.282 0 N-CA-C 112.467 -0.253 . . . . 7.9199999999999999 112.467 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 60.9 m -141.89 177.04 8.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.693 0.282 . . . . 7.1799999999999997 110.996 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 53.9 m80 55.3 94.13 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.009 -0.542 . . . . 5.9100000000000001 111.281 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -178.79 40.25 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.695 -0.765 . . . . 2.4500000000000002 112.544 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -99.45 55.88 0.99 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.846 0.355 . . . . 2.3300000000000001 111.037 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.1 t -68.84 95.11 0.66 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.242 -0.435 . . . . 2.5899999999999999 110.843 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.7 t70 56.65 85.59 0.08 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.197 -0.456 . . . . 2.6699999999999999 110.862 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -132.26 100.5 5.04 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.34 -0.391 . . . . 1.5800000000000001 111.3 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.2 t 58.25 20.55 7.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.968 -0.56 . . . . 2.5499999999999998 111.422 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.455 ' O ' ' HG ' ' A' ' 104' ' ' LEU . . . 107.07 -29.74 10.29 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.598 -0.811 . . . . 1.8200000000000001 112.717 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -77.85 96.47 4.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.857 0.36 . . . . 1.7 111.081 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.1 t -116.83 145.88 43.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.964 -0.562 . . . . 0.90000000000000002 110.549 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 70.7 mt -84.66 122.93 29.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.182 -0.463 . . . . 0.89000000000000001 111.049 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -116.71 149.19 40.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.044 -0.525 . . . . 2.73 111.044 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 81.8 p -149.35 130.12 14.17 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.187 -0.461 . . . . 1.1899999999999999 111.121 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 19.0 t -125.55 153.25 33.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 0.56000000000000005 110.577 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -101.36 117.93 35.95 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.9 0.381 . . . . 1.74 111.692 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.412 HD11 ' HB2' ' A' ' 60' ' ' ASP . 4.5 mm? -114.14 166.27 11.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.874 -0.603 . . . . 0.81000000000000005 110.375 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.58 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 42.3 p90 -156.93 137.03 12.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.714 0.292 . . . . 2.0800000000000001 111.305 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.466 HH21 ' H ' ' A' ' 93' ' ' GLY . 21.3 ttp180 -129.96 153.22 48.58 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.313 -0.403 . . . . 3.0600000000000001 111.1 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -155.69 -34.49 0.09 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.048 -0.523 . . . . 2.5800000000000001 111.054 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -59.92 164.18 4.08 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.09 -0.505 . . . . 3.7200000000000002 110.936 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -93.96 33.98 1.28 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 2.8700000000000001 110.994 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 74.6 p -78.6 -13.34 59.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.277 -0.419 . . . . 1.3799999999999999 111.136 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 97.2 p 50.22 24.09 1.37 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.615 -0.721 . . . . 2.4500000000000002 111.605 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 47.7 t -141.84 135.37 29.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.841 0.353 . . . . 1.3999999999999999 111.03 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 19.0 mt -103.45 -20.64 13.98 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.136 -0.483 . . . . 0.45000000000000001 110.951 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.476 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 97.88 10.89 51.59 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.785 -0.721 . . . . 0.52000000000000002 112.579 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 67.3 mt -94.03 110.69 23.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.721 0.296 . . . . 0.83999999999999997 111.139 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 46.5 t -112.42 114.21 26.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.244 -0.434 . . . . 0.94999999999999996 110.72 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 43.0 pt -100.55 177.84 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.241 -0.436 . . . . 0.40999999999999998 111.287 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 62.8 m -158.0 132.38 8.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.882 -0.599 . . . . 1.3200000000000001 110.636 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -85.38 121.0 5.5 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.634 -0.793 . . . . 0.94999999999999996 112.446 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 58.1 ttp -69.97 137.98 51.9 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.681 0.277 . . . . 2.04 110.549 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.434 ' HD3' ' N ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -89.93 139.07 30.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.843 0.354 . . . . 5.46 110.965 -179.854 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -143.74 110.05 5.43 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.048 -0.524 . . . . 4.29 110.909 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -100.71 14.49 31.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 5.25 110.692 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 51.2 m -135.78 126.82 27.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.975 -0.557 . . . . 4.8799999999999999 110.815 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 67.3 p -96.28 136.5 36.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.276 -0.42 . . . . 5.2699999999999996 111.134 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.0 t -161.94 7.43 0.06 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.22 -0.446 . . . . 6.9100000000000001 111.175 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 138.24 -82.97 0.25 Allowed Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.755 -0.736 . . . . 5.3600000000000003 112.527 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -63.82 163.13 12.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.83 0.348 . . . . 7.2199999999999998 110.96 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -136.75 -158.88 0.9 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.125 -0.489 . . . . 3.0499999999999998 110.724 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 67.3 p -59.61 175.79 0.32 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.075 -0.511 . . . . 2.5299999999999998 111.365 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -162.22 159.34 31.48 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.84 -0.695 . . . . 1.1399999999999999 112.46 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 43.9 mm -98.85 107.43 20.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.827 0.346 . . . . 0.65000000000000002 110.982 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -139.02 138.57 37.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.164 -0.471 . . . . 0.69999999999999996 111.072 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 85.5 t -74.01 120.44 23.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.297 -0.411 . . . . 0.39000000000000001 110.822 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -99.77 -22.24 15.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 2.3999999999999999 111.254 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 84.1 p -155.88 170.04 23.01 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.058 0.456 . . . . 1.28 111.557 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 90.6 mt -128.71 170.27 13.5 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.607 -0.724 . . . . 0.41999999999999998 110.401 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.476 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 43.1 mm -109.74 98.53 33.8 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.36 -0.382 . . . . 1.26 111.084 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.79 111.54 0.76 Allowed 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.596 2.197 . . . . 0.81999999999999995 112.312 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.15 1.9 7.85 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.794 -0.717 . . . . 0.48999999999999999 112.49 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.0 t -112.01 -176.7 2.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.692 0.282 . . . . 1.23 110.89 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.15 -53.1 61.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.368 -0.378 . . . . 0.41999999999999998 111.298 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.48 -46.55 70.03 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.169 -0.468 . . . . 0.34999999999999998 111.275 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.95 -37.57 88.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.076 -0.511 . . . . 0.44 111.262 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 82.7 mt -73.87 -19.64 60.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.89 0.376 . . . . 0.66000000000000003 110.894 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.412 ' HB2' HD11 ' A' ' 18' ' ' LEU . 26.5 t70 -66.7 -52.04 49.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.109 -0.496 . . . . 1.8600000000000001 110.843 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 89.88 -44.49 3.0 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.846 -0.692 . . . . 1.0600000000000001 113.22 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.406 ' HB2' ' OD2' ' A' ' 60' ' ' ASP . 22.2 mmm180 -59.66 -22.32 61.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.686 0.279 . . . . 2.5899999999999999 111.126 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 52.6 mt -82.53 109.98 17.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.879 0.371 . . . . 0.92000000000000004 111.003 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.401 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 39.9 tt0 -101.42 135.67 19.79 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 1.98 110.57 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 64' ' ' GLU . 40.7 Cg_exo -57.2 172.18 0.96 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.453 2.102 . . . . 1.4399999999999999 112.44 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 59.33 26.89 15.84 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.918 -0.583 . . . . 2.1499999999999999 111.275 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -94.5 158.87 15.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.341 -0.391 . . . . 2.02 110.645 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -107.76 124.24 49.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.77 0.319 . . . . 1.02 110.927 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.548 HD13 ' HB3' ' A' ' 100' ' ' LEU . 45.9 mm -87.33 140.31 15.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.191 -0.459 . . . . 0.28999999999999998 110.983 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 71.6 mt -115.88 -60.58 1.85 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.206 -0.452 . . . . 0.40000000000000002 110.946 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.466 ' O ' ' HB3' ' A' ' 99' ' ' LEU . 81.2 mtt180 -144.72 138.66 27.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 2.6099999999999999 111.254 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.634 HG12 ' H ' ' A' ' 73' ' ' ASP . 4.4 t -94.13 173.82 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.963 -0.562 . . . . 0.28000000000000003 109.941 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.645 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 19.1 t70 -47.67 108.81 0.17 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.703 0.287 . . . . 0.79000000000000004 111.516 179.424 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 54.83 29.15 11.42 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.194 -0.457 . . . . 2.0099999999999998 111.506 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.463 ' HB ' ' HB ' ' A' ' 72' ' ' VAL . 86.5 t -145.51 151.08 15.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.047 -0.524 . . . . 0.79000000000000004 110.627 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -120.75 129.34 53.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.484 -0.325 . . . . 2.2400000000000002 110.77 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.9 m -107.35 23.84 3.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-O 120.808 0.337 . . . . 0.67000000000000004 111.366 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -96.71 38.31 1.23 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.293 -0.412 . . . . 1.3899999999999999 110.692 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 175.94 28.43 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.721 -0.752 . . . . 0.55000000000000004 112.76 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 60.3 mtm -132.39 141.81 49.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.93 0.395 . . . . 0.52000000000000002 110.976 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.443 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -69.05 161.85 28.15 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.994 -0.548 . . . . 0.39000000000000001 110.919 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -45.73 -57.1 4.52 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.195 -0.457 . . . . 1.52 111.638 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.4 m -50.62 -43.44 56.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.178 -0.465 . . . . 1.48 111.565 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -63.8 -42.9 97.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.359 -0.382 . . . . 2.1200000000000001 111.471 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 81' ' ' ALA . 38.9 t -59.63 -38.73 77.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 120.857 0.361 . . . . 0.32000000000000001 110.988 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 52.4 t -66.74 -36.58 77.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.11 -0.496 . . . . 0.37 110.968 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -60.1 -49.16 78.74 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.217 -0.447 . . . . 1.51 110.714 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.405 HG11 HG11 ' A' ' 75' ' ' VAL . 53.7 t -56.75 -53.52 40.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.082 -0.508 . . . . 0.27000000000000002 111.27 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 79.2 mt -53.89 -32.62 53.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.077 -0.51 . . . . 0.40999999999999998 111.277 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.465 ' HA ' HH22 ' A' ' 20' ' ' ARG . 85.0 mtm180 -81.64 -24.06 36.58 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.256 -0.429 . . . . 2.1000000000000001 111.115 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -78.4 -17.96 55.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.276 -0.42 . . . . 1.1399999999999999 110.835 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.68 -89.62 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.091 -0.504 . . . . 0.55000000000000004 111.474 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.466 ' H ' HH21 ' A' ' 20' ' ' ARG . . . 60.48 21.86 58.12 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.702 -0.761 . . . . 0.76000000000000001 112.429 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -147.13 174.79 3.11 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 110.461 -0.199 . . . . 2.52 110.461 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.58 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 38.2 Cg_exo -59.18 97.53 0.1 OUTLIER 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.021 1.814 . . . . 0.64000000000000001 111.641 178.271 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 28.8 m -114.53 151.56 16.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.129 0.49 . . . . 0.64000000000000001 111.893 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.645 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 75.2 ttt180 -102.1 145.24 29.62 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.673 -0.694 . . . . 2.3700000000000001 110.082 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 18.3 mt -115.49 116.18 27.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.187 -0.46 . . . . 0.37 111.378 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.466 ' HB3' ' O ' ' A' ' 71' ' ' ARG . 63.6 tp -104.46 99.89 9.58 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.16 -0.473 . . . . 0.37 110.261 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.548 ' HB3' HD13 ' A' ' 69' ' ' ILE . 0.5 OUTLIER -129.82 158.25 39.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.197 -0.456 . . . . 0.31 111.394 -179.519 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.0 tt -110.37 140.39 29.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.45000000000000001 110.949 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -128.08 145.11 51.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.081 -0.509 . . . . 2.2599999999999998 110.942 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -102.49 141.89 34.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.08 -0.509 . . . . 3.9300000000000002 110.785 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 10' ' ' GLY . 52.4 mt -92.58 148.66 36.67 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.107 -0.497 . . . . 2.0 110.895 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -79.83 62.74 8.61 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.83 2.353 . . . . 2.98 112.437 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 89.5 mt -101.36 103.05 13.99 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.672 -0.694 . . . . 3.6699999999999999 110.95 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -82.49 102.55 11.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 5.5899999999999999 110.818 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.306 -0.854 . . . . 6.0 110.888 179.997 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.181 0 N-CA-C 112.337 -0.305 . . . . 7.9199999999999999 112.337 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.7 p -147.13 -178.27 6.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.822 0.344 . . . . 7.1799999999999997 110.967 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 55.0 m80 56.02 83.57 0.09 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.994 -0.548 . . . . 5.9100000000000001 111.008 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -160.54 68.23 0.25 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.743 -0.742 . . . . 2.4500000000000002 112.65 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -70.39 141.75 52.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.834 0.35 . . . . 2.3300000000000001 110.907 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.9 t -154.38 108.91 3.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.464 . . . . 2.5899999999999999 110.897 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 55.91 36.26 26.99 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.175 -0.466 . . . . 2.6699999999999999 110.912 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -102.75 119.44 38.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.1 -0.5 . . . . 1.5800000000000001 111.182 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.9 m 57.08 21.85 6.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.06 -0.518 . . . . 2.5499999999999998 111.169 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.1 33.4 23.62 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.731 -0.747 . . . . 1.8200000000000001 112.544 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.427 ' HB3' HD11 ' A' ' 101' ' ' ILE . 81.9 m-85 -136.81 131.65 33.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.82 0.343 . . . . 1.7 110.65 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.3 t -136.44 135.33 38.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.087 -0.506 . . . . 0.90000000000000002 110.891 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 79.8 mt -76.11 119.19 19.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.0 -0.545 . . . . 0.89000000000000001 110.739 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -120.08 132.11 55.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 2.73 111.0 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 79.0 p -137.34 126.94 25.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.286 -0.416 . . . . 1.1899999999999999 110.972 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.17 141.53 46.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.219 -0.446 . . . . 0.56000000000000005 110.952 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -96.18 116.34 28.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 1.74 111.54 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.438 HD11 ' HB2' ' A' ' 60' ' ' ASP . 4.5 mm? -114.92 166.61 11.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.98 -0.555 . . . . 0.81000000000000005 110.125 179.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.539 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 15.1 p90 -147.11 123.1 10.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.769 0.319 . . . . 2.0800000000000001 111.149 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.578 ' HB2' HD21 ' A' ' 27' ' ' LEU . 14.9 ttp180 -95.61 96.84 9.3 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.325 -0.398 . . . . 3.0600000000000001 110.687 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -107.69 -19.98 13.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.985 -0.552 . . . . 2.5800000000000001 110.672 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -82.37 148.64 28.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.954 -0.566 . . . . 3.7200000000000002 110.794 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -85.96 47.59 1.48 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.188 -0.46 . . . . 2.8700000000000001 110.974 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 65.1 p -87.38 -10.04 53.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.484 . . . . 1.3799999999999999 111.182 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.2 t 58.05 20.3 6.76 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.988 -0.551 . . . . 2.4500000000000002 111.248 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 60.5 m -157.47 160.95 38.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.272 -0.422 . . . . 1.3999999999999999 110.965 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.578 HD21 ' HB2' ' A' ' 20' ' ' ARG . 77.2 mt -113.61 -14.66 12.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.112 -0.494 . . . . 0.45000000000000001 110.78 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.528 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 93.81 29.99 9.38 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.823 -0.703 . . . . 0.52000000000000002 112.406 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.437 HD12 HD22 ' A' ' 89' ' ' LEU . 77.7 mt -109.79 109.25 27.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.737 0.303 . . . . 0.83999999999999997 111.05 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 40.0 t -111.03 100.44 9.13 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.29 -0.414 . . . . 0.94999999999999996 110.844 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 40.6 pt -92.71 179.66 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.087 -0.506 . . . . 0.40999999999999998 111.175 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 82.0 p -135.42 136.83 41.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.053 -0.521 . . . . 1.3200000000000001 110.929 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -66.47 99.99 0.5 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.862 -0.685 . . . . 0.94999999999999996 112.434 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 26.7 ttt -66.78 148.18 52.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.78 0.324 . . . . 2.04 110.811 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.31 162.99 36.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.269 -0.423 . . . . 5.46 110.962 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -136.87 131.27 32.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.017 -0.538 . . . . 4.29 110.82 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -123.36 107.31 11.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 5.25 110.92 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 55.6 m 55.64 41.89 30.05 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.072 -0.513 . . . . 4.8799999999999999 110.918 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 82.5 p -92.13 139.73 30.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.063 -0.517 . . . . 5.2699999999999996 111.317 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.8 t -89.24 16.05 7.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 6.9100000000000001 110.988 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -145.19 89.77 0.16 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.811 -0.709 . . . . 5.3600000000000003 112.472 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -68.47 92.27 0.44 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.761 0.315 . . . . 7.2199999999999998 110.912 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -136.62 60.68 1.66 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.234 -0.439 . . . . 3.0499999999999998 111.082 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 65.9 p -77.89 153.53 32.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.271 -0.422 . . . . 2.5299999999999998 111.396 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -171.66 -163.32 25.41 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.851 -0.69 . . . . 1.1399999999999999 112.389 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.3 mm -124.61 131.04 73.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.801 0.334 . . . . 0.65000000000000002 110.787 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.414 ' HB2' ' O ' ' A' ' 67' ' ' ASP . 27.0 p90 -145.4 145.46 31.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.322 -0.399 . . . . 0.69999999999999996 111.091 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 99.7 t -82.16 129.29 37.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.089 -0.505 . . . . 0.39000000000000001 111.061 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.2 ttpp -102.02 -24.48 13.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.996 -0.547 . . . . 2.3999999999999999 110.946 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 79.6 p -155.12 156.24 35.45 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.037 0.446 . . . . 1.28 111.36 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 77.1 mt -114.28 162.97 15.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.775 -0.648 . . . . 0.41999999999999998 110.626 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.528 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 62.4 mt -109.7 101.97 48.43 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.367 -0.378 . . . . 1.26 111.248 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -52.11 146.44 30.44 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.586 2.191 . . . . 0.81999999999999995 112.577 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.4 -22.37 30.38 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.827 -0.701 . . . . 0.48999999999999999 112.581 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 67.4 m -80.93 -177.94 6.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.784 0.325 . . . . 1.23 111.071 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.65 -55.09 16.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.218 -0.447 . . . . 0.41999999999999998 111.472 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.63 -39.86 65.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.103 -0.499 . . . . 0.34999999999999998 111.843 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.35 -42.86 71.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.401 -0.363 . . . . 0.44 111.438 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.0 mt -70.95 -19.67 62.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.334 -0.394 . . . . 0.66000000000000003 110.992 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.438 ' HB2' HD11 ' A' ' 18' ' ' LEU . 26.0 t70 -59.52 -56.13 25.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 1.8600000000000001 110.945 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.2 -48.71 1.1 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.768 -0.73 . . . . 1.0600000000000001 112.957 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -57.4 -32.05 66.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.761 0.315 . . . . 2.5899999999999999 111.153 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 68.1 mt -76.83 127.91 37.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.304 -0.407 . . . . 0.92000000000000004 111.095 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -125.49 138.16 31.29 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 116.139 -0.482 . . . . 1.98 110.81 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_exo -52.94 165.9 1.08 Allowed 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.59 2.193 . . . . 1.4399999999999999 112.441 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 18.0 m120 60.18 45.65 11.38 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.046 -0.525 . . . . 2.1499999999999999 110.755 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.414 ' O ' ' HB2' ' A' ' 47' ' ' TYR . 27.1 t70 -118.16 159.77 22.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.935 -0.575 . . . . 2.02 110.505 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.494 ' HB3' HG23 ' A' ' 101' ' ' ILE . 87.6 tttt -105.18 128.29 53.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.843 0.354 . . . . 1.02 111.181 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 41.6 mm -94.9 142.18 13.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.055 -0.52 . . . . 0.28999999999999998 110.727 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 56.5 mt -111.31 -73.75 0.67 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 0.40000000000000002 111.129 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.8 ptp180 -147.29 137.85 23.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.174 0.512 . . . . 2.6099999999999999 111.779 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.678 HG12 ' H ' ' A' ' 73' ' ' ASP . 3.8 t -84.68 176.01 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.528 -0.76 . . . . 0.28000000000000003 109.771 179.004 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.678 ' H ' HG12 ' A' ' 72' ' ' VAL . 6.6 t70 -44.25 109.0 0.13 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.17 0.434 . . . . 0.79000000000000004 112.17 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 52.39 27.87 5.29 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.443 0.535 . . . . 2.0099999999999998 112.443 178.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.406 ' O ' ' N ' ' A' ' 72' ' ' VAL . 88.1 t -148.66 140.11 17.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.725 0.298 . . . . 0.79000000000000004 110.88 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 25.4 m-80 -100.23 141.86 32.49 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.922 -0.399 . . . . 2.2400000000000002 109.922 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.8 m -122.59 -16.23 5.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 N-CA-C 112.104 0.409 . . . . 0.67000000000000004 112.104 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -87.08 25.98 1.25 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.921 0.391 . . . . 1.3899999999999999 110.886 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -141.3 1.72 1.94 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.869 -0.682 . . . . 0.55000000000000004 112.557 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 51.4 mtm -123.99 172.14 9.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.748 0.309 . . . . 0.52000000000000002 110.768 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.5 168.71 14.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.39000000000000001 111.125 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.406 ' O ' HG23 ' A' ' 86' ' ' VAL . 63.4 tt0 -58.97 -47.3 85.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.44 -0.345 . . . . 1.52 110.902 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.9 m -55.46 -31.72 62.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 1.48 111.304 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -71.98 -39.27 69.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.355 -0.384 . . . . 2.1200000000000001 111.042 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.2 t -67.75 -35.99 74.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.969 0.414 . . . . 0.32000000000000001 111.021 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.485 HG12 ' NE ' ' A' ' 90' ' ' ARG . 56.5 t -70.32 -47.22 67.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.009 -0.541 . . . . 0.37 111.598 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -58.86 -40.75 85.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.714 -0.221 . . . . 1.51 111.085 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 52.4 t -60.04 -54.88 28.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 120.924 0.392 . . . . 0.27000000000000002 111.115 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.437 HD22 HD12 ' A' ' 29' ' ' ILE . 66.8 mt -56.83 -27.89 60.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.993 -0.549 . . . . 0.40999999999999998 111.006 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.485 ' NE ' HG12 ' A' ' 86' ' ' VAL . 76.1 mtm180 -89.24 -15.09 34.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.371 -0.377 . . . . 2.1000000000000001 111.514 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -93.47 -10.04 36.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.417 -0.356 . . . . 1.1399999999999999 111.114 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -48.9 -85.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.266 -0.425 . . . . 0.55000000000000004 111.574 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.481 ' H ' ' HE ' ' A' ' 20' ' ' ARG . . . 62.25 14.59 48.23 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.695 -0.764 . . . . 0.76000000000000001 112.556 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -146.97 169.85 8.74 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 110.54 -0.17 . . . . 2.52 110.54 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.539 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 24.4 Cg_exo -65.13 92.26 0.21 Allowed 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.223 1.948 . . . . 0.64000000000000001 111.326 178.215 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 33.8 m -100.15 153.46 4.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.067 -0.515 . . . . 0.64000000000000001 111.577 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.676 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 56.2 ttp180 -102.72 138.07 40.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.969 -0.559 . . . . 2.3700000000000001 109.816 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 45.4 mt -107.7 109.42 21.01 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.262 -0.426 . . . . 0.37 111.137 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 31.7 tp -99.79 100.66 11.64 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.374 -0.375 . . . . 0.37 110.172 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -130.37 161.95 30.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.111 -0.495 . . . . 0.31 111.373 -179.303 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.494 HG23 ' HB3' ' A' ' 68' ' ' LYS . 14.2 tt -114.06 135.68 52.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.917 -0.583 . . . . 0.45000000000000001 110.862 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -122.4 133.91 54.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.003 -0.544 . . . . 2.2599999999999998 110.555 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 31.4 ptt180 -89.94 134.84 33.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.143 -0.48 . . . . 3.9300000000000002 111.127 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 51.9 mt -102.55 150.79 37.97 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.015 -0.539 . . . . 2.0 110.596 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -80.87 161.63 21.15 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.467 2.111 . . . . 2.98 112.131 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -104.98 140.19 38.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.026 -0.533 . . . . 3.6699999999999999 111.222 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 89.2 mt -105.01 95.47 5.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.953 -0.567 . . . . 5.5899999999999999 110.879 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.31 -0.853 . . . . 6.0 111.071 -179.901 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.168 0 N-CA-C 112.456 -0.258 . . . . 7.9199999999999999 112.456 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 52.5 m -85.65 -59.42 2.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.798 0.333 . . . . 7.1799999999999997 110.92 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -85.19 106.39 16.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.208 -0.451 . . . . 5.9100000000000001 110.948 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -91.85 -85.36 1.48 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.738 -0.744 . . . . 2.4500000000000002 112.408 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 55.7 30.24 15.19 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.825 0.345 . . . . 2.3300000000000001 111.197 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 43.5 t -70.44 98.86 1.5 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 2.5899999999999999 110.716 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 57.94 71.52 0.57 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.116 -0.493 . . . . 2.6699999999999999 110.916 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -119.87 108.78 14.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 1.5800000000000001 111.242 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 61.9 m 57.04 20.01 5.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.045 -0.525 . . . . 2.5499999999999998 111.329 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.7 30.91 31.18 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.766 -0.731 . . . . 1.8200000000000001 112.788 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.4 ' HB3' HD11 ' A' ' 101' ' ' ILE . 92.0 m-85 -141.19 115.02 9.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.83 0.348 . . . . 1.7 110.825 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 46.6 t -140.18 136.04 33.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.90000000000000002 110.78 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 62.3 mt -75.09 120.9 21.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.168 -0.469 . . . . 0.89000000000000001 110.749 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -114.53 124.19 51.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.089 -0.505 . . . . 2.73 111.328 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 44.9 t -103.27 142.75 33.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 1.1899999999999999 110.79 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.4 t -136.41 158.16 37.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.238 -0.437 . . . . 0.56000000000000005 110.666 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -121.93 114.34 20.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.935 0.398 . . . . 1.74 111.353 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.558 HD11 ' HB2' ' A' ' 60' ' ' ASP . 4.4 mm? -119.58 166.82 12.65 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.033 -0.53 . . . . 0.81000000000000005 110.787 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.605 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 30.1 p90 -148.8 129.45 14.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.282 -0.417 . . . . 2.0800000000000001 110.964 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.508 ' HB2' HD21 ' A' ' 27' ' ' LEU . 15.1 ttp180 -106.5 107.66 18.78 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.794 0.33 . . . . 3.0600000000000001 111.006 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -131.29 -5.67 3.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.299 -0.409 . . . . 2.5800000000000001 111.036 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -81.69 170.2 16.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.396 -0.365 . . . . 3.7200000000000002 110.874 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -93.47 30.04 1.83 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.136 -0.484 . . . . 2.8700000000000001 110.959 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 71.6 p -84.25 -14.35 50.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.45 . . . . 1.3799999999999999 110.863 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 35.2 t 59.17 20.63 8.65 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.849 -0.614 . . . . 2.4500000000000002 111.18 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 83.0 p -160.56 175.27 12.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.941 0.4 . . . . 1.3999999999999999 110.992 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.508 HD21 ' HB2' ' A' ' 20' ' ' ARG . 33.5 mt -115.0 -10.35 12.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.827 -0.624 . . . . 0.45000000000000001 110.877 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.452 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 87.86 18.33 56.44 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.782 -0.723 . . . . 0.52000000000000002 112.754 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 70.9 mt -91.36 108.5 19.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.822 0.344 . . . . 0.83999999999999997 110.847 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 41.9 t -103.14 102.66 12.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.134 -0.485 . . . . 0.94999999999999996 110.958 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.5 pt -100.34 165.68 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.82 -0.627 . . . . 0.40999999999999998 111.291 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.6 m -149.04 145.19 27.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.917 -0.583 . . . . 1.3200000000000001 110.474 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -97.72 125.49 8.53 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.68 -0.771 . . . . 0.94999999999999996 112.598 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 52.8 ttp -85.5 112.57 21.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.754 0.312 . . . . 2.04 110.711 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -108.24 139.34 43.08 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.225 -0.443 . . . . 5.46 110.74 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -131.89 161.3 33.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.272 -0.422 . . . . 4.29 110.819 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -100.21 69.53 1.49 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.978 0.418 . . . . 5.25 111.109 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 75.2 m -137.2 129.34 29.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 4.8799999999999999 110.986 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 77.3 p -89.75 155.54 19.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 5.2699999999999996 111.142 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 15.0 t 42.3 33.19 0.39 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.776 -0.647 . . . . 6.9100000000000001 111.372 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -168.8 47.58 0.22 Allowed Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.598 -0.728 . . . . 5.3600000000000003 112.255 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -84.83 159.47 20.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.844 0.354 . . . . 7.2199999999999998 111.012 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -149.72 89.91 1.66 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.187 -0.46 . . . . 3.0499999999999998 111.239 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 73.0 p -92.75 152.86 19.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.243 -0.435 . . . . 2.5299999999999998 110.907 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -169.65 146.07 9.78 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.656 -0.783 . . . . 1.1399999999999999 112.54 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 37.2 mm -94.11 108.44 20.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.761 0.315 . . . . 0.65000000000000002 110.703 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -131.38 143.31 50.38 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.218 -0.446 . . . . 0.69999999999999996 111.201 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 84.1 t -84.54 128.6 38.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.051 -0.522 . . . . 0.39000000000000001 110.837 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -107.89 -24.1 11.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.301 -0.408 . . . . 2.3999999999999999 110.952 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.6 t -150.94 170.47 19.24 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.972 0.415 . . . . 1.28 111.44 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 91.3 mt -135.25 157.21 47.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.816 -0.629 . . . . 0.41999999999999998 110.583 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.452 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 62.8 mt -101.46 104.05 31.3 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 1.26 111.01 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -55.16 132.5 52.67 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.429 2.086 . . . . 0.81999999999999995 112.224 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 110.55 -24.13 18.34 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.801 -0.714 . . . . 0.48999999999999999 112.544 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 63.2 m -80.91 -178.45 6.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.75 0.31 . . . . 1.23 110.921 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.74 -52.35 51.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.384 -0.371 . . . . 0.41999999999999998 111.494 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.27 -34.61 64.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.25 -0.432 . . . . 0.34999999999999998 111.616 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.79 -50.02 33.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.33 -0.395 . . . . 0.44 111.248 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 80.7 mt -64.02 -19.7 65.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.131 -0.486 . . . . 0.66000000000000003 110.988 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.558 ' HB2' HD11 ' A' ' 18' ' ' LEU . 26.6 t70 -62.05 -56.13 22.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 1.8600000000000001 110.91 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 97.42 -51.24 1.4 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.698 -0.763 . . . . 1.0600000000000001 113.01 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 84.4 mtm180 -55.98 -28.07 55.51 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.743 0.306 . . . . 2.5899999999999999 111.285 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 67.0 mt -81.05 106.25 11.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.292 -0.413 . . . . 0.92000000000000004 110.746 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -108.11 137.53 19.88 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 1.98 110.546 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -53.41 175.52 0.1 Allowed 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.57 2.18 . . . . 1.4399999999999999 112.725 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 61.77 37.58 15.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.918 -0.583 . . . . 2.1499999999999999 110.913 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -113.15 161.93 16.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.991 -0.55 . . . . 2.02 110.553 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.411 ' HB3' HG23 ' A' ' 101' ' ' ILE . 87.6 tttt -110.55 116.71 31.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.822 0.344 . . . . 1.02 111.087 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.443 HD13 ' HB3' ' A' ' 100' ' ' LEU . 42.0 mm -77.17 146.22 8.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.489 . . . . 0.28999999999999998 110.834 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 55.3 mt -123.22 -61.59 1.4 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.241 -0.436 . . . . 0.40000000000000002 111.257 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 66.8 mtp180 -144.47 142.73 30.47 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.096 0.474 . . . . 2.6099999999999999 111.808 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.626 HG12 ' H ' ' A' ' 73' ' ' ASP . 9.9 t -99.89 173.92 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.611 -0.722 . . . . 0.28000000000000003 109.582 179.016 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.626 ' H ' HG12 ' A' ' 72' ' ' VAL . 16.8 t70 -46.82 108.44 0.14 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.711 0.291 . . . . 0.79000000000000004 111.418 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 53.32 33.84 16.54 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.18 -0.464 . . . . 2.0099999999999998 111.716 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.411 ' HB ' ' HB ' ' A' ' 72' ' ' VAL . 87.9 t -147.96 147.81 16.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.409 -0.359 . . . . 0.79000000000000004 110.842 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -115.44 124.89 52.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.346 -0.388 . . . . 2.2400000000000002 110.405 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.6 m -106.96 24.46 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 CA-C-O 120.783 0.325 . . . . 0.67000000000000004 111.52 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 19.2 mm-40 -96.23 34.12 1.64 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.272 -0.422 . . . . 1.3899999999999999 110.734 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 175.0 22.65 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.757 -0.735 . . . . 0.55000000000000004 112.811 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 54.6 mtm -117.98 144.42 45.54 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.873 0.368 . . . . 0.52000000000000002 110.965 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.449 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -61.19 158.27 14.37 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.977 -0.556 . . . . 0.39000000000000001 111.41 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -51.41 -62.14 1.81 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.141 -0.481 . . . . 1.52 111.33 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 81.6 p -52.78 -33.53 49.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.014 -0.539 . . . . 1.48 111.389 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -63.16 -43.46 98.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.512 -0.313 . . . . 2.1200000000000001 110.925 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 81' ' ' ALA . 18.2 t -61.89 -38.94 81.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.297 -0.411 . . . . 0.32000000000000001 110.605 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.1 t -63.22 -36.54 76.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.983 -0.553 . . . . 0.37 110.991 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -63.62 -47.74 80.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.15 -0.477 . . . . 1.51 110.977 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 54.4 t -53.86 -54.23 21.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.224 -0.443 . . . . 0.27000000000000002 111.107 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 79.0 mt -57.58 -32.93 67.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.40999999999999998 110.94 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 85.2 mtm180 -80.6 -13.5 59.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.312 -0.404 . . . . 2.1000000000000001 111.212 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -95.62 -13.88 23.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 1.1399999999999999 110.692 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.19 -83.53 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.998 -0.547 . . . . 0.55000000000000004 111.588 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.478 ' H ' ' HE ' ' A' ' 20' ' ' ARG . . . 62.38 15.72 52.76 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.61 -0.805 . . . . 0.76000000000000001 112.152 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 12.9 p30 -147.08 169.81 8.78 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 110.6 -0.148 . . . . 2.52 110.6 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.605 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 32.9 Cg_exo -61.59 98.27 0.16 Allowed 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.258 1.972 . . . . 0.64000000000000001 111.429 177.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 23.6 m -106.42 150.46 9.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.082 0.467 . . . . 0.64000000000000001 111.858 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.622 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 80.9 mtp180 -97.13 140.57 31.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.811 -0.632 . . . . 2.3700000000000001 110.247 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 30.3 mt -115.03 111.89 21.8 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.041 -0.527 . . . . 0.37 110.951 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 43.3 tp -102.5 104.74 15.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 0.37 110.75 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.443 ' HB3' HD13 ' A' ' 69' ' ' ILE . 0.4 OUTLIER -134.13 156.43 48.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.212 -0.449 . . . . 0.31 111.045 -179.797 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.411 HG23 ' HB3' ' A' ' 68' ' ' LYS . 12.0 tt -104.61 136.17 39.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.23 -0.441 . . . . 0.45000000000000001 111.046 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 25.4 mmm180 -115.74 141.89 47.48 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.866 -0.606 . . . . 2.2599999999999998 110.844 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 53.7 mtm180 -89.99 126.46 35.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.223 -0.444 . . . . 3.9300000000000002 110.978 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 44.5 mt -102.17 103.85 32.92 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.074 -0.512 . . . . 2.0 110.872 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -63.76 176.54 2.27 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.304 2.003 . . . . 2.98 112.326 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 95.8 mt -139.02 146.77 41.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.088 -0.506 . . . . 3.6699999999999999 110.99 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.404 ' N ' HD22 ' A' ' 107' ' ' LEU . 3.8 mm? -81.02 103.22 10.69 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.15 -0.477 . . . . 5.5899999999999999 110.797 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.451 -0.785 . . . . 6.0 111.048 179.852 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.117 0 N-CA-C 112.626 -0.19 . . . . 7.9199999999999999 112.626 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.6 m -94.31 -58.15 2.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.836 0.351 . . . . 7.1799999999999997 110.919 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 51.0 m80 -70.97 -51.05 27.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 5.9100000000000001 110.868 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 137.42 -105.54 0.51 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.835 -0.698 . . . . 2.4500000000000002 112.419 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -88.53 132.75 34.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.917 0.389 . . . . 2.3300000000000001 110.911 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 78.1 p -153.45 110.6 3.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.13 -0.486 . . . . 2.5899999999999999 110.686 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 57.66 67.1 1.01 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.154 -0.475 . . . . 2.6699999999999999 110.718 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -146.76 110.57 4.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.276 -0.42 . . . . 1.5800000000000001 111.393 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.0 t 56.02 25.66 9.09 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.081 -0.509 . . . . 2.5499999999999998 111.219 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.98 36.87 34.56 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.66 -0.781 . . . . 1.8200000000000001 112.558 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -137.57 112.48 9.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.758 0.314 . . . . 1.7 110.825 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 46.1 t -135.99 140.84 44.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.134 -0.485 . . . . 0.90000000000000002 110.795 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 75.4 mt -79.03 121.46 24.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.89000000000000001 110.924 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -117.31 154.53 31.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.111 -0.495 . . . . 2.73 110.877 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 84.4 p -151.2 134.82 16.33 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.344 -0.389 . . . . 1.1899999999999999 111.302 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.1 t -132.23 144.96 35.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.149 -0.478 . . . . 0.56000000000000005 110.675 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.439 ' C ' HD22 ' A' ' 18' ' ' LEU . 1.8 mp0 -94.89 115.22 27.19 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.842 0.353 . . . . 1.74 111.59 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.587 HD23 HD12 ' A' ' 98' ' ' LEU . 4.3 mm? -123.24 125.47 45.13 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.986 -0.552 . . . . 0.81000000000000005 110.472 179.422 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.587 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 39.0 p90 -103.44 132.93 49.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.404 -0.362 . . . . 2.0800000000000001 111.21 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.622 ' HE ' ' HA2' ' A' ' 93' ' ' GLY . 19.2 ttp180 -102.31 95.26 6.18 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.881 0.372 . . . . 3.0600000000000001 110.882 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -103.01 -21.37 13.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.056 0.455 . . . . 2.5800000000000001 110.425 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.432 ' HB3' HG23 ' A' ' 24' ' ' THR . 75.0 mmtt -85.16 140.8 30.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.704 -0.68 . . . . 3.7200000000000002 110.659 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -83.37 37.4 0.56 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 2.8700000000000001 111.077 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.432 HG23 ' HB3' ' A' ' 22' ' ' LYS . 57.4 p -73.0 -11.97 60.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 1.3799999999999999 110.979 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 36.5 t 59.54 15.72 4.77 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.025 -0.534 . . . . 2.4500000000000002 111.014 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 53.6 m -147.97 138.09 22.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.124 -0.489 . . . . 1.3999999999999999 110.971 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.442 HD21 ' HB2' ' A' ' 20' ' ' ARG . 88.2 mt -97.55 -22.98 16.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.068 -0.514 . . . . 0.45000000000000001 110.852 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.523 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 110.43 3.85 28.93 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.808 -0.71 . . . . 0.52000000000000002 112.502 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.468 ' N ' HD12 ' A' ' 29' ' ' ILE . 3.0 mp -88.23 114.93 27.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.822 0.344 . . . . 0.83999999999999997 111.012 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 45.0 t -111.89 93.32 4.4 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.103 -0.499 . . . . 0.94999999999999996 110.522 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.499 ' HA ' ' HA ' ' A' ' 48' ' ' VAL . 44.6 pt -87.87 164.18 2.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.101 -0.499 . . . . 0.40999999999999998 111.432 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 56.3 m -143.47 134.61 25.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.773 -0.649 . . . . 1.3200000000000001 110.415 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -89.23 125.82 7.96 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.614 -0.803 . . . . 0.94999999999999996 112.816 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 58.5 ttp -78.5 90.11 4.48 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.816 0.341 . . . . 2.04 110.498 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 19.1 mmm180 -85.4 164.71 17.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 5.46 110.867 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -146.99 11.87 1.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.481 . . . . 4.29 110.762 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 57.23 28.75 15.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.1 -0.5 . . . . 5.25 110.847 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 10.0 t -127.88 -158.85 0.9 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.112 -0.495 . . . . 4.8799999999999999 110.457 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 57.7 p -50.54 139.05 16.55 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.782 0.325 . . . . 5.2699999999999996 111.169 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.5 t -93.53 -2.64 54.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.183 -0.462 . . . . 6.9100000000000001 111.285 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -70.01 -53.57 14.42 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.798 -0.715 . . . . 5.3600000000000003 112.526 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -110.92 -179.32 3.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.808 0.337 . . . . 7.2199999999999998 110.923 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 57.32 41.47 26.53 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.076 -0.511 . . . . 3.0499999999999998 111.108 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 44.7 p -134.11 127.13 31.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.087 -0.506 . . . . 2.5299999999999998 111.11 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -150.21 172.02 30.08 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.833 -0.698 . . . . 1.1399999999999999 112.606 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 43.8 mm -118.27 116.03 50.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.779 0.323 . . . . 0.65000000000000002 110.901 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -140.17 137.37 34.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.69999999999999996 111.104 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.499 ' HA ' ' HA ' ' A' ' 31' ' ' ILE . 58.3 t -77.63 139.26 18.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.991 -0.55 . . . . 0.39000000000000001 110.852 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -120.58 -28.46 4.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 2.3999999999999999 111.116 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 56.3 m -143.82 173.28 11.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.15 0.5 . . . . 1.28 111.594 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 82.1 mt -137.42 161.94 34.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.603 -0.726 . . . . 0.41999999999999998 110.55 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.523 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 71.6 mt -106.74 102.14 40.44 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.485 -0.325 . . . . 1.26 111.218 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.6 129.51 35.46 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.59 2.193 . . . . 0.81999999999999995 112.42 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 110.93 -17.46 27.3 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.794 -0.717 . . . . 0.48999999999999999 112.353 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 57.7 m -85.24 -176.67 6.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.719 0.295 . . . . 1.23 110.85 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.21 -52.55 32.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.916 0.388 . . . . 0.41999999999999998 111.171 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.22 -37.9 75.75 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.045 -0.525 . . . . 0.34999999999999998 111.659 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.99 -54.59 14.45 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.341 -0.391 . . . . 0.44 111.572 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.7 mt -60.34 -20.28 58.72 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.343 -0.39 . . . . 0.66000000000000003 111.09 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.508 ' HB2' HD11 ' A' ' 18' ' ' LEU . 33.3 t70 -59.59 -49.34 78.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.252 -0.431 . . . . 1.8600000000000001 110.927 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.11 -44.9 2.98 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.864 -0.684 . . . . 1.0600000000000001 113.043 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 76.6 mtp180 -61.42 -22.13 64.73 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.688 0.28 . . . . 2.5899999999999999 111.077 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.506 ' HA ' HH22 ' A' ' 102' ' ' ARG . 63.2 mt -89.92 116.13 30.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.353 -0.385 . . . . 0.92000000000000004 111.119 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.421 ' H ' ' NH2' ' A' ' 102' ' ' ARG . 36.2 tt0 -117.59 140.02 26.98 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.041 -0.527 . . . . 1.98 110.532 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.34 -178.57 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.578 2.185 . . . . 1.4399999999999999 112.295 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 60.97 44.88 9.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.444 . . . . 2.1499999999999999 110.681 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -126.54 177.33 6.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.084 -0.507 . . . . 2.02 110.734 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -130.72 122.48 27.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.427 -0.351 . . . . 1.02 111.118 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 39.8 mm -75.04 143.93 12.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.28999999999999998 110.618 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 71.9 mt -122.54 -66.13 1.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.927 0.394 . . . . 0.40000000000000002 111.428 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.4 ' HB2' HD23 ' A' ' 99' ' ' LEU . 21.5 mtp180 -134.4 138.11 44.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 2.6099999999999999 111.609 -179.312 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.593 HG12 ' H ' ' A' ' 73' ' ' ASP . 7.6 t -105.32 172.34 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.773 -0.649 . . . . 0.28000000000000003 109.624 178.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.607 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 13.1 t70 -46.81 107.98 0.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.872 0.367 . . . . 0.79000000000000004 111.766 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 49.12 22.43 0.62 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.906 -0.588 . . . . 2.0099999999999998 112.208 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 98.2 t -144.49 104.78 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.775 0.321 . . . . 0.79000000000000004 111.589 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -70.67 144.49 51.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.314 -0.403 . . . . 2.2400000000000002 110.371 179.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 18.3 m -127.89 32.88 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.841 0.353 . . . . 0.67000000000000004 111.464 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -100.32 31.64 3.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.157 -0.474 . . . . 1.3899999999999999 111.109 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -178.56 40.6 0.08 OUTLIER Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.478 -0.868 . . . . 0.55000000000000004 112.848 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 68.2 mtm -138.29 145.05 40.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.852 0.358 . . . . 0.52000000000000002 110.879 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.464 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -66.97 160.75 25.76 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.061 -0.518 . . . . 0.39000000000000001 111.155 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -47.81 -53.49 15.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.185 -0.461 . . . . 1.52 111.515 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.7 t -52.51 -38.47 59.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.292 -0.413 . . . . 1.48 111.389 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -68.89 -38.5 79.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.312 -0.404 . . . . 2.1200000000000001 111.32 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 81' ' ' ALA . 17.5 t -62.51 -42.38 95.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.468 -0.333 . . . . 0.32000000000000001 110.933 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.0 t -65.63 -36.34 77.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.491 . . . . 0.37 111.025 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -58.93 -49.36 78.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.213 -0.449 . . . . 1.51 110.857 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 56.0 t -57.89 -53.16 48.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.295 -0.411 . . . . 0.27000000000000002 111.369 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 83.6 mt -58.88 -31.51 68.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.40999999999999998 111.385 -179.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.454 ' HA ' ' NH1' ' A' ' 20' ' ' ARG . 69.7 mtm180 -85.43 -12.16 52.65 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.546 -0.297 . . . . 2.1000000000000001 111.269 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -97.61 -11.62 23.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.289 -0.414 . . . . 1.1399999999999999 110.942 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.94 -85.62 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.213 -0.448 . . . . 0.55000000000000004 111.52 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.622 ' HA2' ' HE ' ' A' ' 20' ' ' ARG . . . 63.09 19.82 61.94 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.685 -0.769 . . . . 0.76000000000000001 112.548 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.651 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 12.6 p30 -147.21 168.59 10.99 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 110.407 -0.22 . . . . 2.52 110.407 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.651 ' HD2' ' HB2' ' A' ' 94' ' ' ASN . 19.6 Cg_endo -60.47 89.91 0.08 OUTLIER 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.089 1.86 . . . . 0.64000000000000001 111.325 178.285 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.422 ' HB ' ' HB2' ' A' ' 73' ' ' ASP . 17.3 m -100.13 151.98 4.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.998 -0.546 . . . . 0.64000000000000001 112.087 -178.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.607 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 59.1 mtp180 -98.11 143.85 28.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.787 -0.642 . . . . 2.3700000000000001 110.055 179.334 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.587 HD12 HD23 ' A' ' 18' ' ' LEU . 37.3 mt -118.09 104.1 10.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.04 -0.527 . . . . 0.37 111.069 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.4 HD23 ' HB2' ' A' ' 71' ' ' ARG . 58.5 tp -100.28 99.87 10.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.34 -0.391 . . . . 0.37 110.626 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.432 ' O ' HD12 ' A' ' 100' ' ' LEU . 0.5 OUTLIER -130.11 152.47 49.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 0.31 111.234 -179.782 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.3 tt -94.29 135.93 27.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 0.45000000000000001 110.79 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.506 HH22 ' HA ' ' A' ' 63' ' ' ILE . 18.0 tpp85 -120.74 145.09 47.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.066 -0.515 . . . . 2.2599999999999998 110.993 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -96.69 129.86 44.02 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.067 -0.515 . . . . 3.9300000000000002 110.874 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 86.2 mt -71.05 145.63 91.66 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.088 -0.505 . . . . 2.0 110.766 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -80.99 61.2 8.16 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.807 2.338 . . . . 2.98 112.388 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 99.0 mt -94.25 100.18 12.28 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.51 -0.768 . . . . 3.6699999999999999 110.914 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.44 ' N ' HD22 ' A' ' 107' ' ' LEU . 3.6 mm? -88.05 102.46 14.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.484 . . . . 5.5899999999999999 110.815 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.336 -0.84 . . . . 6.0 110.914 179.972 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.24 0 N-CA-C 112.591 -0.203 . . . . 7.9199999999999999 112.591 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.9 p -90.32 -67.02 0.87 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.778 0.323 . . . . 7.1799999999999997 111.09 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 60.2 m80 -62.49 128.45 36.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 5.9100000000000001 111.023 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -179.57 43.95 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.707 -0.759 . . . . 2.4500000000000002 112.639 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -101.98 71.69 1.29 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.946 0.403 . . . . 2.3300000000000001 110.805 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.4 t -70.48 85.49 0.61 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.937 -0.574 . . . . 2.5899999999999999 110.979 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 20.7 t70 55.83 85.8 0.07 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.163 -0.471 . . . . 2.6699999999999999 110.804 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -129.53 115.37 17.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 1.5800000000000001 111.445 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 27.0 t 55.94 32.62 20.12 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.957 -0.565 . . . . 2.5499999999999998 111.026 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.97 -38.09 3.21 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.659 -0.782 . . . . 1.8200000000000001 112.533 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.408 ' HB3' HD11 ' A' ' 101' ' ' ILE . 98.7 m-85 -61.93 95.28 0.06 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.837 0.351 . . . . 1.7 110.857 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.3 m -111.18 141.67 44.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.155 -0.475 . . . . 0.90000000000000002 110.929 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 63.5 mt -79.57 122.21 26.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.988 -0.551 . . . . 0.89000000000000001 110.857 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -113.71 125.53 54.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.466 . . . . 2.73 110.983 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 47.6 t -119.81 126.8 51.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.978 -0.556 . . . . 1.1899999999999999 111.053 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.5 t -124.56 154.06 31.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.01 -0.541 . . . . 0.56000000000000005 110.576 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -121.83 119.83 32.79 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.95 0.405 . . . . 1.74 111.585 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -114.56 166.62 11.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.87 -0.605 . . . . 0.81000000000000005 110.318 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.541 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 89.3 m-85 -133.29 112.05 11.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.732 0.301 . . . . 2.0800000000000001 111.497 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.472 ' HB2' HD21 ' A' ' 27' ' ' LEU . 50.8 tpt85 -97.34 102.81 14.67 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.272 -0.422 . . . . 3.0600000000000001 110.571 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -160.33 20.72 0.15 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.461 . . . . 2.5800000000000001 110.804 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.471 ' N ' ' HD2' ' A' ' 22' ' ' LYS . 11.5 mptt -106.8 161.52 14.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.113 -0.494 . . . . 3.7200000000000002 110.952 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -83.07 50.17 1.68 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.028 -0.533 . . . . 2.8700000000000001 111.038 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.4 p -117.05 -24.03 7.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.216 -0.447 . . . . 1.3799999999999999 111.05 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.6 m 58.34 16.65 4.19 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.86 -0.609 . . . . 2.4500000000000002 111.215 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 81.9 p -144.73 153.81 42.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.288 -0.415 . . . . 1.3999999999999999 110.997 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.472 HD21 ' HB2' ' A' ' 20' ' ' ARG . 92.6 mt -114.31 -20.13 10.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 0.45000000000000001 110.874 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.11 31.72 7.48 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.831 -0.7 . . . . 0.52000000000000002 112.709 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 46.4 mt -110.02 116.13 51.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.868 0.366 . . . . 0.83999999999999997 111.025 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 45.8 t -113.3 106.49 14.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.94999999999999996 110.704 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 43.9 pt -97.36 148.08 5.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.036 -0.529 . . . . 0.40999999999999998 111.245 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 45.0 t -111.46 139.45 46.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.105 -0.498 . . . . 1.3200000000000001 110.878 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -89.2 113.25 4.1 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.79 -0.719 . . . . 0.94999999999999996 112.464 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.405 ' HB2' ' HE1' ' A' ' 47' ' ' TYR . 56.7 ttp -94.39 116.54 28.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.686 0.279 . . . . 2.04 110.926 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.428 ' HD3' ' N ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -110.61 138.16 47.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.302 -0.408 . . . . 5.46 110.881 179.916 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -137.07 122.47 19.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.949 -0.569 . . . . 4.29 110.655 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 26.2 pt20 -123.78 18.88 9.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.278 -0.419 . . . . 5.25 111.167 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.7 p -108.33 173.57 6.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.244 -0.435 . . . . 4.8799999999999999 110.974 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 63.0 p 49.31 -165.25 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.939 -0.573 . . . . 5.2699999999999996 111.427 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 70.3 p -135.33 36.45 2.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 6.9100000000000001 111.267 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -162.07 35.2 0.36 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.611 -0.804 . . . . 5.3600000000000003 112.779 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -79.47 165.06 23.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.756 0.312 . . . . 7.2199999999999998 110.891 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -146.68 120.39 9.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 3.0499999999999998 111.218 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 70.7 p -86.06 154.73 21.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.154 -0.475 . . . . 2.5299999999999998 110.984 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -167.73 154.67 24.96 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.626 -0.797 . . . . 1.1399999999999999 112.719 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 43.5 mm -90.31 134.22 29.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.827 0.346 . . . . 0.65000000000000002 110.857 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.405 ' HE1' ' HB2' ' A' ' 34' ' ' MET . 31.6 p90 -152.83 144.0 23.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.69999999999999996 110.897 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 95.7 t -76.71 121.17 28.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.194 -0.457 . . . . 0.39000000000000001 110.861 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -99.72 -23.31 15.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.109 -0.496 . . . . 2.3999999999999999 110.918 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 46.7 t -154.28 165.09 37.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.966 0.412 . . . . 1.28 111.213 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 82.9 mt -131.88 154.79 48.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.957 -0.565 . . . . 0.41999999999999998 110.671 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 42.3 mm -97.42 109.15 48.85 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.373 -0.376 . . . . 1.26 110.844 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.96 141.13 97.94 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.347 2.031 . . . . 0.81999999999999995 112.422 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.92 -15.44 63.1 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.758 -0.734 . . . . 0.48999999999999999 112.501 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 59.6 m -80.41 179.15 7.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.663 0.268 . . . . 1.23 110.966 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.49 -47.9 58.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.903 0.382 . . . . 0.41999999999999998 111.096 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.21 -40.33 81.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.097 -0.501 . . . . 0.34999999999999998 111.497 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.1 -54.16 12.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.21 -0.45 . . . . 0.44 111.331 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.2 mt -60.83 -19.56 60.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.271 -0.422 . . . . 0.66000000000000003 111.212 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -52.7 -51.25 61.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.311 -0.404 . . . . 1.8600000000000001 110.758 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 98.05 -32.31 7.02 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.881 -0.676 . . . . 1.0600000000000001 113.145 179.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 23.2 mmm180 -71.57 -46.12 60.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.767 0.318 . . . . 2.5899999999999999 111.284 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 49.5 mt -65.41 132.45 31.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.328 -0.396 . . . . 0.92000000000000004 111.303 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -126.59 138.57 32.73 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.051 -0.522 . . . . 1.98 110.603 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -48.68 157.8 1.38 Allowed 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.443 2.096 . . . . 1.4399999999999999 112.339 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 58.4 t30 58.99 67.27 0.94 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.471 . . . . 2.1499999999999999 110.693 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -133.82 154.91 50.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.974 -0.557 . . . . 2.02 110.629 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -103.79 130.69 51.36 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.562 -0.29 . . . . 1.02 111.187 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 36.5 mm -92.54 145.43 7.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.19 -0.459 . . . . 0.28999999999999998 111.022 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 70.2 mt -114.34 -66.9 1.04 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.242 -0.435 . . . . 0.40000000000000002 111.038 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -152.0 141.32 21.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.086 0.47 . . . . 2.6099999999999999 111.41 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.615 HG12 ' H ' ' A' ' 73' ' ' ASP . 2.2 t -90.36 175.26 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.627 -0.715 . . . . 0.28000000000000003 110.033 179.373 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.615 ' H ' HG12 ' A' ' 72' ' ' VAL . 6.3 p-10 -55.53 114.24 1.76 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.874 0.369 . . . . 0.79000000000000004 111.126 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 60.33 18.53 8.12 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.04 -0.527 . . . . 2.0099999999999998 111.756 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 63.0 t -143.36 149.89 17.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.656 0.265 . . . . 0.79000000000000004 111.139 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -120.01 138.58 53.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.459 -0.337 . . . . 2.2400000000000002 110.587 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.2 m -117.24 28.53 2.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.822 0.344 . . . . 0.67000000000000004 111.423 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -97.53 33.95 1.93 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 1.3899999999999999 111.021 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 173.12 28.33 0.02 OUTLIER Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.565 -0.826 . . . . 0.55000000000000004 112.865 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 36.0 mtm -126.25 145.64 50.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.739 0.304 . . . . 0.52000000000000002 110.753 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.01 158.89 24.36 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.28 -0.418 . . . . 0.39000000000000001 111.146 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -49.93 -58.07 6.19 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.215 -0.448 . . . . 1.52 111.531 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 46.5 t -52.65 -39.95 62.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.188 -0.46 . . . . 1.48 111.395 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -61.2 -47.9 84.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.832 0.349 . . . . 2.1200000000000001 110.987 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 55.4 t -57.46 -40.79 76.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.108 -0.497 . . . . 0.32000000000000001 111.121 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 90.9 t -63.27 -39.04 83.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 0.37 110.928 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.454 ' HG2' HH21 ' A' ' 90' ' ' ARG . 45.8 mt-10 -58.99 -40.83 86.03 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.264 -0.425 . . . . 1.51 110.386 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 52.1 t -60.36 -52.91 55.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.905 -0.589 . . . . 0.27000000000000002 111.203 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 67.0 mt -53.93 -38.02 64.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.095 -0.502 . . . . 0.40999999999999998 111.397 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.454 HH21 ' HG2' ' A' ' 87' ' ' GLU . 76.8 mtm180 -81.28 -21.12 39.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.244 -0.434 . . . . 2.1000000000000001 111.246 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -90.82 -5.05 56.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.361 -0.381 . . . . 1.1399999999999999 111.16 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.475 ' HB1' HG22 ' A' ' 96' ' ' VAL . . . -54.02 -71.66 0.07 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.329 -0.396 . . . . 0.55000000000000004 111.133 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 63.14 10.55 34.58 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.697 -0.763 . . . . 0.76000000000000001 112.522 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -147.51 173.57 4.09 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 110.077 -0.342 . . . . 2.52 110.077 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.541 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 86.8 Cg_exo -47.79 100.09 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.005 1.803 . . . . 0.64000000000000001 111.379 178.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.475 HG22 ' HB1' ' A' ' 92' ' ' ALA . 2.3 t -80.84 113.72 20.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.106 -0.497 . . . . 0.64000000000000001 111.755 -178.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.563 ' H ' ' HB3' ' A' ' 73' ' ' ASP . 80.0 ttt180 -91.38 126.51 36.49 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.532 -0.544 . . . . 2.3700000000000001 109.532 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 27.7 mt -109.42 103.61 12.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.373 -0.376 . . . . 0.37 111.721 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 32.0 tp -96.34 99.75 11.41 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.324 -0.621 . . . . 0.37 109.324 178.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -130.14 168.19 17.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.119 -0.491 . . . . 0.31 111.862 -178.474 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.408 HD11 ' HB3' ' A' ' 11' ' ' PHE . 17.3 tt -118.44 143.95 27.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 115.668 -0.696 . . . . 0.45000000000000001 110.782 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.69 123.21 27.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.094 -0.503 . . . . 2.2599999999999998 110.384 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 43.8 ttp180 -79.76 135.99 36.64 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.95 0.405 . . . . 3.9300000000000002 111.3 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 16.2 mt -107.11 152.88 41.23 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.99 -0.55 . . . . 2.0 110.725 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -82.4 162.0 17.24 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.472 2.114 . . . . 2.98 112.279 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 90.7 mt -139.87 73.74 1.44 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.168 -0.469 . . . . 3.6699999999999999 110.794 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 86.6 mt -70.73 167.31 19.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.484 . . . . 5.5899999999999999 111.089 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.238 -0.887 . . . . 6.0 111.022 -179.87 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.141 0 N-CA-C 112.492 -0.243 . . . . 7.9199999999999999 112.492 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 55.3 m -92.92 -32.79 14.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.814 0.34 . . . . 7.1799999999999997 110.949 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -89.32 -10.15 47.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.19 -0.459 . . . . 5.9100000000000001 110.885 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 95.52 -156.91 21.71 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.849 -0.691 . . . . 2.4500000000000002 112.509 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 55.19 73.14 0.43 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.804 0.335 . . . . 2.3300000000000001 111.033 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.5 t -99.99 108.58 20.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 2.5899999999999999 110.794 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 40.95 49.55 2.99 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.119 -0.492 . . . . 2.6699999999999999 111.31 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.58 101.74 5.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.996 -0.547 . . . . 1.5800000000000001 111.267 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.8 m 56.91 27.0 12.4 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.133 -0.485 . . . . 2.5499999999999998 111.094 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.25 35.88 16.42 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.732 -0.747 . . . . 1.8200000000000001 112.378 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -139.0 126.96 22.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.97 0.414 . . . . 1.7 111.0 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.6 t -147.67 141.44 25.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.938 -0.574 . . . . 0.90000000000000002 110.671 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 58.2 mt -81.07 119.1 23.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.89000000000000001 111.252 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -118.43 151.62 37.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.005 -0.543 . . . . 2.73 110.586 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 78.0 p -141.26 145.6 35.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.875 0.369 . . . . 1.1899999999999999 111.341 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 46.6 t -135.07 139.46 47.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.009 -0.541 . . . . 0.56000000000000005 110.788 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -100.2 113.09 25.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.321 -0.399 . . . . 1.74 110.848 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 33.8 mt -124.37 141.07 52.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.365 -0.379 . . . . 0.81000000000000005 111.44 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.558 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 44.3 p90 -118.7 141.2 48.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.056 -0.52 . . . . 2.0800000000000001 110.613 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.485 HH21 ' N ' ' A' ' 93' ' ' GLY . 13.0 ttp180 -118.49 80.76 1.58 Allowed 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.702 -0.399 . . . . 3.0600000000000001 111.551 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -99.86 10.07 41.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.436 . . . . 2.5800000000000001 110.779 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.468 ' N ' ' HD2' ' A' ' 22' ' ' LYS . 3.2 mptp? -108.88 156.05 20.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.988 -0.551 . . . . 3.7200000000000002 110.819 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -86.25 73.56 10.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 2.8700000000000001 110.926 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 52.4 p -113.43 -22.61 10.28 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.121 -0.49 . . . . 1.3799999999999999 111.079 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 51.2 m 59.26 19.89 8.01 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.842 -0.617 . . . . 2.4500000000000002 111.185 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 77.6 p -158.8 137.9 11.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.307 -0.406 . . . . 1.3999999999999999 111.162 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.479 HD21 ' HB2' ' A' ' 20' ' ' ARG . 75.4 mt -97.26 -10.75 25.15 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.029 -0.532 . . . . 0.45000000000000001 110.683 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.521 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 92.11 14.85 55.52 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.784 -0.722 . . . . 0.52000000000000002 112.829 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 69.6 mt -98.61 110.57 26.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.778 0.323 . . . . 0.83999999999999997 111.178 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 34.2 t -111.23 101.1 9.62 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.277 -0.419 . . . . 0.94999999999999996 110.842 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 40.8 pt -92.4 166.67 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.996 -0.547 . . . . 0.40999999999999998 111.43 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 46.0 t -131.94 134.94 46.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.03 -0.532 . . . . 1.3200000000000001 110.795 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.19 127.99 46.38 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.844 -0.693 . . . . 0.94999999999999996 112.631 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 27.1 ttt -87.22 102.52 14.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.817 0.341 . . . . 2.04 110.873 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.9 ppt_? -106.07 39.76 1.73 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.482 . . . . 5.46 111.016 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -115.2 158.45 22.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.111 -0.495 . . . . 4.29 110.856 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 57.63 88.31 0.06 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.052 -0.522 . . . . 5.25 110.999 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 51.8 m -68.68 85.96 0.31 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 4.8799999999999999 110.919 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 72.0 p -134.78 142.81 46.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.11 -0.495 . . . . 5.2699999999999996 111.019 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 74.2 p -106.66 29.96 6.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 6.9100000000000001 111.218 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.26 -48.74 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.861 -0.685 . . . . 5.3600000000000003 112.43 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -138.88 95.06 2.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.87 0.367 . . . . 7.2199999999999998 110.842 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -143.73 -160.15 1.08 Allowed 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.125 -0.488 . . . . 3.0499999999999998 110.526 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 80.7 p 49.51 -167.18 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.901 -0.59 . . . . 2.5299999999999998 111.53 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 159.17 -24.26 0.32 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.611 -0.805 . . . . 1.1399999999999999 112.558 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 49.8 mm 58.97 95.61 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.88 0.372 . . . . 0.65000000000000002 111.114 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -119.77 138.28 53.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.466 . . . . 0.69999999999999996 111.103 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.8 t -80.51 123.92 37.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.059 -0.519 . . . . 0.39000000000000001 110.807 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -106.43 -29.26 9.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.033 -0.531 . . . . 2.3999999999999999 111.053 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 53.3 m -137.6 167.27 22.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.031 0.443 . . . . 1.28 111.606 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 82.4 mt -137.68 163.59 30.9 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.807 -0.633 . . . . 0.41999999999999998 110.752 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.521 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 67.6 mt -102.51 101.02 17.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 1.26 110.786 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.452 ' HD2' ' HA ' ' A' ' 52' ' ' ILE . 19.1 Cg_endo -57.56 94.81 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.475 2.116 . . . . 0.81999999999999995 112.263 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 143.91 -8.09 1.95 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.838 -0.696 . . . . 0.48999999999999999 112.388 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.423 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 53.0 m -96.47 178.66 5.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.757 0.313 . . . . 1.23 110.858 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.46 -53.34 59.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.301 -0.409 . . . . 0.41999999999999998 111.706 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.86 -37.33 66.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.19 -0.459 . . . . 0.34999999999999998 111.853 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -77.98 -32.67 51.41 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.963 0.357 . . . . 0.44 111.963 -179.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 55' ' ' SER . 55.1 mt -62.74 -55.47 26.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.727 0.299 . . . . 0.66000000000000003 111.221 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -57.87 -41.78 83.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 1.8600000000000001 111.1 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 79.6 -11.66 31.6 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.81 -0.709 . . . . 1.0600000000000001 112.681 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 39.7 mtp180 -63.18 -16.83 61.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.807 0.337 . . . . 2.5899999999999999 110.828 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 76.3 mt -104.04 115.56 46.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.081 -0.509 . . . . 0.92000000000000004 110.932 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -86.85 155.46 55.74 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 1.98 111.156 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -78.3 38.19 0.68 Allowed 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.785 2.323 . . . . 1.4399999999999999 112.473 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -164.93 64.14 0.13 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.861 0.362 . . . . 2.1499999999999999 110.746 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -132.19 167.32 19.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.146 -0.479 . . . . 2.02 110.656 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -113.31 106.88 15.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.897 0.38 . . . . 1.02 111.171 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 46.5 mm -64.07 143.73 15.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.468 . . . . 0.28999999999999998 110.833 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 57.9 mt -116.42 -58.13 2.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.28 -0.418 . . . . 0.40000000000000002 111.212 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -159.94 136.09 8.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.031 0.443 . . . . 2.6099999999999999 111.465 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.682 HG12 ' H ' ' A' ' 73' ' ' ASP . 2.6 t -88.88 175.87 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.634 -0.712 . . . . 0.28000000000000003 109.909 179.267 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.682 ' H ' HG12 ' A' ' 72' ' ' VAL . 12.2 t70 -44.3 108.74 0.12 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.836 0.35 . . . . 0.79000000000000004 111.802 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 53.13 33.91 16.18 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.115 -0.493 . . . . 2.0099999999999998 112.11 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 92.1 t -147.56 126.39 4.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.535 -0.302 . . . . 0.79000000000000004 111.047 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -96.83 122.98 40.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.401 -0.363 . . . . 2.2400000000000002 110.423 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.49 HG11 HG13 ' A' ' 85' ' ' VAL . 29.7 m -108.42 26.44 2.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 CA-C-O 120.858 0.361 . . . . 0.67000000000000004 111.586 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -94.4 24.82 4.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.269 -0.423 . . . . 1.3899999999999999 110.779 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -169.88 16.42 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.663 -0.78 . . . . 0.55000000000000004 112.746 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 60.4 mtm -118.35 143.51 46.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.864 0.364 . . . . 0.52000000000000002 110.856 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.414 ' HB3' ' OD2' ' A' ' 84' ' ' ASP . . . -64.83 164.91 11.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.161 -0.472 . . . . 0.39000000000000001 111.295 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.445 ' O ' HG23 ' A' ' 86' ' ' VAL . 35.3 tt0 -51.74 -55.4 19.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 1.52 111.351 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.2 m -50.44 -42.7 54.44 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.192 -0.458 . . . . 1.48 111.577 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.414 ' OD2' ' HB3' ' A' ' 81' ' ' ALA . 20.4 m-20 -61.05 -49.08 78.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.381 -0.372 . . . . 2.1200000000000001 111.096 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.49 HG13 HG11 ' A' ' 77' ' ' VAL . 33.7 t -60.59 -33.44 54.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.486 . . . . 0.32000000000000001 111.276 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 82' ' ' GLN . 89.7 t -67.59 -43.55 86.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.287 -0.415 . . . . 0.37 110.98 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.425 ' HG2' HH21 ' A' ' 90' ' ' ARG . 44.1 mt-10 -56.95 -45.78 82.57 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.363 -0.381 . . . . 1.51 110.633 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 55.3 t -56.15 -52.43 50.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.083 -0.508 . . . . 0.27000000000000002 110.893 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 82.2 mt -61.38 -25.74 67.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.883 -0.599 . . . . 0.40999999999999998 110.95 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.425 HH21 ' HG2' ' A' ' 87' ' ' GLU . 78.1 mtm180 -87.93 -11.68 46.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.196 -0.456 . . . . 2.1000000000000001 111.12 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -99.41 -12.65 20.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.316 -0.402 . . . . 1.1399999999999999 110.605 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.5 -86.22 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.998 -0.546 . . . . 0.55000000000000004 111.445 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.485 ' N ' HH21 ' A' ' 20' ' ' ARG . . . 61.84 21.97 61.63 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.62 -0.8 . . . . 0.76000000000000001 112.231 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.622 ' HB3' ' HD2' ' A' ' 95' ' ' PRO . 67.9 m-20 -147.46 174.54 3.32 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 110.583 -0.155 . . . . 2.52 110.583 -179.515 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.622 ' HD2' ' HB3' ' A' ' 94' ' ' ASN . 36.2 Cg_endo -66.45 81.61 0.3 Allowed 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 122.106 1.871 . . . . 0.64000000000000001 112.004 178.199 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 22.7 m -91.29 154.21 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.95 -0.568 . . . . 0.64000000000000001 111.48 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.65 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 77.2 ttt180 -94.56 144.07 25.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.782 -0.645 . . . . 2.3700000000000001 110.112 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 25.9 mt -118.53 103.89 10.16 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.221 -0.445 . . . . 0.37 110.986 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 24.8 tp -100.76 104.2 15.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.966 0.412 . . . . 0.37 110.781 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.85 168.03 20.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.995 -0.548 . . . . 0.31 110.866 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 19.4 tt -114.03 134.8 55.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-O 121.015 0.436 . . . . 0.45000000000000001 111.289 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -115.28 146.43 41.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.584 -0.734 . . . . 2.2599999999999998 110.689 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -97.62 124.1 41.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.36 -0.382 . . . . 3.9300000000000002 111.125 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 66.4 mt -95.02 142.48 24.67 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.122 -0.49 . . . . 2.0 110.74 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -82.34 165.86 16.35 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.526 2.15 . . . . 2.98 112.549 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 89.4 mt -134.53 154.26 51.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 3.6699999999999999 110.833 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -99.55 138.19 36.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.117 -0.492 . . . . 5.5899999999999999 111.001 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.282 -0.866 . . . . 6.0 110.779 -179.951 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.185 0 N-CA-C 112.538 -0.225 . . . . 7.9199999999999999 112.538 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 53.4 m -91.71 -55.73 3.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.84 0.352 . . . . 7.1799999999999997 111.081 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -96.4 -64.46 1.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 5.9100000000000001 110.973 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -143.45 -98.98 0.29 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.676 -0.774 . . . . 2.4500000000000002 112.409 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.551 ' H ' HD11 ' A' ' 13' ' ' LEU . 41.3 m-85 -94.39 123.83 38.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.896 0.379 . . . . 2.3300000000000001 111.12 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.3 t -106.13 -169.32 1.56 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.024 -0.535 . . . . 2.5899999999999999 110.543 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -54.17 103.53 0.08 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.857 0.361 . . . . 2.6699999999999999 110.839 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -145.76 112.34 5.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.489 . . . . 1.5800000000000001 111.051 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 61.4 m 56.86 19.11 4.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.137 -0.483 . . . . 2.5499999999999998 111.095 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.91 -45.8 1.26 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.737 -0.744 . . . . 1.8200000000000001 112.652 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -51.44 110.98 0.51 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.927 0.394 . . . . 1.7 111.357 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.0 t -130.29 141.28 50.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.863 -0.608 . . . . 0.90000000000000002 110.727 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.551 HD11 ' H ' ' A' ' 5' ' ' TYR . 95.2 mt -79.62 120.6 24.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 0.89000000000000001 111.276 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -115.0 157.29 23.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.075 -0.511 . . . . 2.73 110.656 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 41.1 t -148.91 132.24 16.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.916 0.389 . . . . 1.1899999999999999 111.161 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 44.4 t -125.16 129.9 73.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.078 -0.51 . . . . 0.56000000000000005 110.775 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -95.47 109.85 21.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.15 -0.477 . . . . 1.74 111.16 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.435 HD12 HD11 ' A' ' 98' ' ' LEU . 28.5 mt -115.76 166.19 12.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 0.81000000000000005 110.874 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.66 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 39.3 p90 -149.91 133.75 16.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 2.0800000000000001 111.046 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.6 tpp180 -109.49 122.24 46.97 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.001 0.429 . . . . 3.0600000000000001 110.831 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -121.77 -25.69 5.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.893 -0.594 . . . . 2.5800000000000001 110.637 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -71.65 169.71 15.0 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.841 -0.618 . . . . 3.7200000000000002 110.682 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -95.63 51.91 1.32 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.269 -0.423 . . . . 2.8700000000000001 110.788 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 79.7 p -103.36 -24.12 13.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.133 -0.485 . . . . 1.3799999999999999 111.141 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.7 t 58.41 21.12 8.07 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.951 -0.568 . . . . 2.4500000000000002 111.228 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 79.0 p -145.03 153.3 41.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.869 0.366 . . . . 1.3999999999999999 111.122 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 81.7 mt -114.12 -8.5 12.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.008 -0.542 . . . . 0.45000000000000001 110.799 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.438 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 97.78 -12.1 64.38 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.831 -0.699 . . . . 0.52000000000000002 112.8 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 69.8 mt -63.51 108.69 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.727 0.299 . . . . 0.83999999999999997 111.156 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 36.3 t -112.19 114.22 26.9 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.318 -0.401 . . . . 0.94999999999999996 110.636 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.4 pt -96.22 -178.84 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.381 -0.372 . . . . 0.40999999999999998 111.362 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 77.3 p -163.44 137.4 5.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.138 -0.483 . . . . 1.3200000000000001 110.75 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -88.73 120.93 5.82 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.796 -0.716 . . . . 0.94999999999999996 112.561 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 57.1 ttp -71.35 147.19 48.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.762 0.315 . . . . 2.04 110.944 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.446 ' HD3' ' N ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -147.79 140.14 24.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.196 -0.456 . . . . 5.46 110.848 -179.907 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -111.65 171.53 7.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 4.29 110.939 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.467 ' CD ' ' H ' ' A' ' 37' ' ' GLN . 5.4 pm0 -87.92 28.2 1.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.062 -0.517 . . . . 5.25 110.837 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.4 m -154.77 78.83 1.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 4.8799999999999999 110.723 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 77.6 p -61.0 134.29 56.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.109 -0.496 . . . . 5.2699999999999996 111.201 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.7 t -168.88 14.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.095 -0.502 . . . . 6.9100000000000001 111.01 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.8 171.21 41.83 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.812 -0.709 . . . . 5.3600000000000003 112.548 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 58.36 -177.56 0.07 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.832 0.348 . . . . 7.2199999999999998 111.202 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 58.27 49.71 10.74 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.099 -0.5 . . . . 3.0499999999999998 111.07 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 50.8 p -141.24 127.05 19.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.1 -0.5 . . . . 2.5299999999999998 111.079 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -149.74 160.64 28.57 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.734 -0.746 . . . . 1.1399999999999999 112.632 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 39.5 mm -90.92 131.53 37.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.699 0.285 . . . . 0.65000000000000002 110.861 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 46.5 p90 -153.68 144.84 22.92 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.338 -0.392 . . . . 0.69999999999999996 111.411 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 66.4 t -79.6 132.79 31.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.031 -0.532 . . . . 0.39000000000000001 110.924 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -125.73 -26.19 3.54 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.102 -0.499 . . . . 2.3999999999999999 111.022 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 56.6 m -130.16 161.96 29.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.025 0.441 . . . . 1.28 111.275 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 83.6 mt -141.65 129.09 21.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.814 -0.63 . . . . 0.41999999999999998 110.728 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.438 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 63.1 mt -68.26 117.95 54.51 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.28 -0.418 . . . . 1.26 110.934 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.21 96.76 0.64 Allowed 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.191 1.927 . . . . 0.81999999999999995 112.252 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 137.29 0.45 2.7 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.837 -0.697 . . . . 0.48999999999999999 112.511 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 63.6 m -101.32 172.46 6.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.62 0.247 . . . . 1.23 110.902 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.36 -53.13 61.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.431 -0.35 . . . . 0.41999999999999998 111.8 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -47.15 -40.78 16.41 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.243 -0.435 . . . . 0.34999999999999998 112.019 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.37 -38.99 29.35 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.984 0.365 . . . . 0.44 111.984 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 60.1 mt -56.3 -56.22 23.77 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.47 -0.332 . . . . 0.66000000000000003 111.634 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -56.54 -34.26 66.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.402 -0.363 . . . . 1.8600000000000001 111.236 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 78.34 -12.74 18.71 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.784 -0.722 . . . . 1.0600000000000001 112.504 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -59.72 -29.25 68.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.789 0.328 . . . . 2.5899999999999999 110.792 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.507 ' N ' HD12 ' A' ' 63' ' ' ILE . 4.0 mp -93.49 115.1 31.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.479 . . . . 0.92000000000000004 110.651 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.466 ' HB2' ' HD2' ' A' ' 65' ' ' PRO . 12.0 pt-20 -113.03 158.13 38.76 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.458 . . . . 1.98 110.696 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.466 ' HD2' ' HB2' ' A' ' 64' ' ' GLU . 21.2 Cg_endo -60.05 173.18 1.93 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.399 2.066 . . . . 1.4399999999999999 112.095 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 54.2 t30 54.09 58.86 4.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.044 0.45 . . . . 2.1499999999999999 110.668 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -136.51 154.28 50.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.976 -0.556 . . . . 2.02 110.537 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -110.15 136.93 48.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.977 0.418 . . . . 1.02 111.49 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.471 HD13 ' HB3' ' A' ' 100' ' ' LEU . 45.3 mm -97.79 120.58 47.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.817 -0.629 . . . . 0.28999999999999998 110.346 179.388 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 77.4 mt -93.25 -63.79 1.17 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.429 -0.35 . . . . 0.40000000000000002 111.33 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.404 ' O ' ' HB3' ' A' ' 99' ' ' LEU . 62.6 mtp180 -141.7 142.09 33.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.098 0.475 . . . . 2.6099999999999999 111.664 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.637 HG12 ' H ' ' A' ' 73' ' ' ASP . 4.4 t -100.47 174.04 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.724 -0.671 . . . . 0.28000000000000003 109.944 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.653 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 18.8 t70 -50.43 110.6 0.42 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.657 0.265 . . . . 0.79000000000000004 111.205 179.262 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.4 t70 56.04 26.05 9.58 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.254 -0.43 . . . . 2.0099999999999998 111.248 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.52 ' HB ' ' HB ' ' A' ' 72' ' ' VAL . 86.9 t -144.56 153.93 14.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.79000000000000004 110.631 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -129.59 126.56 38.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.743 0.306 . . . . 2.2400000000000002 110.746 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.2 m -104.63 25.14 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.245 -0.434 . . . . 0.67000000000000004 111.067 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -89.62 26.34 1.77 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.083 -0.508 . . . . 1.3899999999999999 110.956 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 174.78 34.12 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.535 -0.84 . . . . 0.55000000000000004 112.897 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 49.8 mtm -126.62 147.35 49.91 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.834 0.35 . . . . 0.52000000000000002 110.858 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.03 156.23 18.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.1 -0.5 . . . . 0.39000000000000001 111.301 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -51.44 -58.63 5.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.325 -0.398 . . . . 1.52 111.154 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.6 t -55.94 -36.94 68.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.099 -0.5 . . . . 1.48 111.179 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -60.15 -46.41 89.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.355 -0.384 . . . . 2.1200000000000001 110.907 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 60.7 t -59.49 -38.3 74.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.454 . . . . 0.32000000000000001 110.886 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 58.8 t -64.35 -41.57 92.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.157 -0.474 . . . . 0.37 111.077 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.546 ' HG2' HH21 ' A' ' 90' ' ' ARG . 48.3 mt-10 -57.85 -44.51 86.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.893 0.378 . . . . 1.51 110.547 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 54.0 t -56.18 -55.55 17.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.947 -0.57 . . . . 0.27000000000000002 111.102 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 78.7 mt -57.22 -29.79 64.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.043 -0.526 . . . . 0.40999999999999998 111.259 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.546 HH21 ' HG2' ' A' ' 87' ' ' GLU . 63.5 mtm180 -83.1 -20.76 34.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.462 -0.335 . . . . 2.1000000000000001 111.097 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -86.44 -18.35 31.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 1.1399999999999999 110.825 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.44 -85.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.289 -0.414 . . . . 0.55000000000000004 110.988 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 60.48 23.01 59.88 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.739 -0.743 . . . . 0.76000000000000001 112.583 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.483 ' HB3' ' HD2' ' A' ' 95' ' ' PRO . 47.3 m-20 -147.34 175.91 2.48 Favored Pre-proline 0 C--N 1.329 -0.322 0 C-N-CA 121.928 0.091 . . . . 2.52 110.863 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.66 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 51.5 Cg_exo -56.76 103.54 0.12 Allowed 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 122.096 1.864 . . . . 0.64000000000000001 111.715 178.208 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 31.3 m -123.51 149.46 27.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.111 0.482 . . . . 0.64000000000000001 111.945 -179.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.653 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 42.5 ttp180 -94.34 142.96 26.81 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.61 -0.723 . . . . 2.3700000000000001 109.983 179.419 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.435 HD11 HD12 ' A' ' 18' ' ' LEU . 52.8 mt -116.58 115.46 25.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.188 -0.46 . . . . 0.37 111.273 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.404 ' HB3' ' O ' ' A' ' 71' ' ' ARG . 59.3 tp -108.88 103.22 12.23 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.941 0.4 . . . . 0.37 110.32 179.24 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.471 ' HB3' HD13 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -132.4 166.27 22.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.089 -0.505 . . . . 0.31 111.329 -179.249 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 19.0 tt -120.6 140.38 44.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.121 -0.491 . . . . 0.45000000000000001 110.986 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -130.58 126.21 36.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.056 -0.52 . . . . 2.2599999999999998 110.396 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -82.85 138.93 33.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.904 0.383 . . . . 3.9300000000000002 111.216 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.1 mt -101.16 145.23 30.07 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.098 -0.501 . . . . 2.0 110.626 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -81.1 163.22 20.22 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.406 2.071 . . . . 2.98 112.5 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 85.1 mt -137.45 109.97 7.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.95 -0.568 . . . . 3.6699999999999999 110.854 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -74.19 147.38 42.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.133 -0.485 . . . . 5.5899999999999999 110.93 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.249 -0.881 . . . . 6.0 110.877 -179.972 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 112.436 -0.266 . . . . 7.9199999999999999 112.436 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.6 m -111.29 -31.9 6.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.813 0.34 . . . . 7.1799999999999997 110.843 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 28.3 t60 -88.31 95.06 10.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 5.9100000000000001 110.747 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -149.94 54.43 0.49 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.805 -0.712 . . . . 2.4500000000000002 112.412 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -139.3 157.03 46.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.908 0.385 . . . . 2.3300000000000001 111.111 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 93.7 p -144.37 -167.99 2.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.991 -0.549 . . . . 2.5899999999999999 110.459 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -55.49 97.63 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.837 0.351 . . . . 2.6699999999999999 110.978 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -134.85 100.05 4.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.062 -0.517 . . . . 1.5800000000000001 110.788 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.2 t 56.86 22.74 7.38 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.126 -0.488 . . . . 2.5499999999999998 110.887 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.83 -36.36 4.3 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.81 -0.709 . . . . 1.8200000000000001 112.643 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.42 ' HA ' ' HA ' ' A' ' 103' ' ' ARG . 25.1 m-85 -55.99 118.86 5.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.907 0.384 . . . . 1.7 110.961 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.2 t -154.75 159.66 40.8 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.071 -0.513 . . . . 0.90000000000000002 111.215 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.539 HD23 ' HB ' ' A' ' 101' ' ' ILE . 16.6 mt -96.02 106.99 19.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.614 -0.721 . . . . 0.89000000000000001 110.242 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.432 ' HE1' ' HB3' ' A' ' 102' ' ' ARG . 32.7 p90 -127.97 150.47 49.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.855 0.36 . . . . 2.73 111.06 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 80.3 p -123.84 135.55 53.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.107 -0.497 . . . . 1.1899999999999999 111.268 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.9 t -110.4 144.62 18.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.94 -0.573 . . . . 0.56000000000000005 110.477 179.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -88.58 122.26 31.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.872 0.368 . . . . 1.74 111.252 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -127.13 166.25 18.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.964 -0.562 . . . . 0.81000000000000005 110.787 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.558 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 27.9 p90 -152.77 130.52 11.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.25 -0.432 . . . . 2.0800000000000001 111.04 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.465 ' HB2' HD21 ' A' ' 27' ' ' LEU . 2.0 tmm_? -108.17 107.03 17.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.312 -0.403 . . . . 3.0600000000000001 110.659 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -133.06 -28.67 1.51 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.328 -0.396 . . . . 2.5800000000000001 111.33 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -64.0 161.03 16.65 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.137 -0.483 . . . . 3.7200000000000002 111.018 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -83.37 37.54 0.57 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.022 -0.535 . . . . 2.8700000000000001 111.203 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 71.2 p -88.43 -16.18 33.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 1.3799999999999999 111.028 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 51.6 m 57.54 20.5 6.22 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.903 -0.589 . . . . 2.4500000000000002 111.082 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 88.5 p -159.32 -176.62 5.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.345 -0.389 . . . . 1.3999999999999999 110.909 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.465 HD21 ' HB2' ' A' ' 20' ' ' ARG . 68.7 mt -128.83 -0.49 5.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.023 -0.535 . . . . 0.45000000000000001 110.634 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.29 26.76 51.07 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.835 -0.698 . . . . 0.52000000000000002 112.566 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.443 HG22 HG23 ' A' ' 31' ' ' ILE . 85.0 mt -100.94 114.52 40.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.905 0.383 . . . . 0.83999999999999997 111.1 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.0 m -109.03 92.82 4.21 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.113 -0.494 . . . . 0.94999999999999996 110.722 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.443 HG23 HG22 ' A' ' 29' ' ' ILE . 43.1 pt -90.46 164.99 2.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.0 -0.545 . . . . 0.40999999999999998 111.236 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.2 t -145.4 134.49 22.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 1.3200000000000001 110.788 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -66.73 131.83 31.64 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.839 -0.696 . . . . 0.94999999999999996 112.396 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 53.0 ttm -60.52 146.16 45.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.762 0.315 . . . . 2.04 110.97 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -118.9 130.75 55.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 5.46 110.935 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -134.97 154.84 51.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.047 -0.524 . . . . 4.29 110.857 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.425 ' CD ' ' H ' ' A' ' 37' ' ' GLN . 5.1 pm0 -110.24 134.68 51.99 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.133 -0.485 . . . . 5.25 110.804 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.2 m 53.94 71.46 0.51 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.14 -0.482 . . . . 4.8799999999999999 110.787 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 61.1 p -81.45 147.64 29.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.061 -0.518 . . . . 5.2699999999999996 111.321 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 72.4 p -99.53 9.07 43.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.051 -0.522 . . . . 6.9100000000000001 110.919 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 155.76 -82.9 0.15 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.915 -0.659 . . . . 5.3600000000000003 112.482 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -125.23 133.83 52.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.872 0.368 . . . . 7.2199999999999998 110.936 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -166.55 56.2 0.09 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.154 -0.475 . . . . 3.0499999999999998 111.163 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 68.2 p -118.44 152.88 35.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 2.5299999999999998 111.106 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -152.09 142.93 9.83 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.644 -0.789 . . . . 1.1399999999999999 112.598 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 37.6 mm -94.88 126.02 47.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.704 0.288 . . . . 0.65000000000000002 110.713 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -149.49 145.15 26.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.338 -0.392 . . . . 0.69999999999999996 111.457 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 93.1 t -83.37 115.58 25.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.957 -0.565 . . . . 0.39000000000000001 110.64 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -89.5 -31.34 17.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.073 -0.512 . . . . 2.3999999999999999 111.351 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.0 t -151.29 169.0 23.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.96 0.409 . . . . 1.28 111.605 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 86.1 mt -124.94 169.73 11.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.731 -0.668 . . . . 0.41999999999999998 110.514 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 50.4 mm -108.62 99.96 36.24 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.278 -0.419 . . . . 1.26 111.047 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -51.73 116.06 2.5 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.56 2.174 . . . . 0.81999999999999995 112.397 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 111.31 3.49 27.54 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.802 -0.713 . . . . 0.48999999999999999 112.33 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 55.1 m -99.78 174.15 6.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.65 0.262 . . . . 1.23 111.037 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.68 -56.65 19.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.304 -0.407 . . . . 0.41999999999999998 111.353 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.46 -33.06 58.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.256 -0.429 . . . . 0.34999999999999998 111.384 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.08 -26.06 39.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.289 -0.414 . . . . 0.44 111.529 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 31.2 mt -70.59 -37.65 73.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.473 -0.331 . . . . 0.66000000000000003 111.241 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -61.74 -40.59 95.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.41 -0.359 . . . . 1.8600000000000001 110.993 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 79.48 -13.99 19.45 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.797 -0.716 . . . . 1.0600000000000001 112.632 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 69.6 mtp180 -74.99 -23.05 58.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.788 0.327 . . . . 2.5899999999999999 110.935 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.488 ' N ' HD12 ' A' ' 63' ' ' ILE . 3.7 mp -84.19 118.9 32.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.436 . . . . 0.92000000000000004 110.715 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -106.3 136.79 19.31 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.111 -0.495 . . . . 1.98 110.614 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -56.09 163.24 6.31 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.486 2.124 . . . . 1.4399999999999999 112.316 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 62.95 45.78 5.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.065 -0.516 . . . . 2.1499999999999999 111.046 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -109.55 165.45 11.66 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.098 -0.501 . . . . 2.02 110.602 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -113.61 107.05 15.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.819 0.342 . . . . 1.02 111.207 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.462 ' HA ' ' HB3' ' A' ' 100' ' ' LEU . 43.7 mm -66.53 136.73 26.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.12 -0.491 . . . . 0.28999999999999998 110.692 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 96.6 mt -113.03 -72.17 0.72 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.45 -0.341 . . . . 0.40000000000000002 111.318 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 -135.89 137.35 41.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.001 0.429 . . . . 2.6099999999999999 111.61 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.515 HG12 ' H ' ' A' ' 73' ' ' ASP . 9.3 t -98.91 168.59 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.872 -0.604 . . . . 0.28000000000000003 109.829 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.652 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 13.4 t70 -47.86 108.3 0.16 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.923 0.392 . . . . 0.79000000000000004 111.95 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.8 t70 58.69 6.68 0.64 Allowed 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.592 0.589 . . . . 2.0099999999999998 112.592 178.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 38.9 t -140.09 101.05 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.718 0.294 . . . . 0.79000000000000004 111.59 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -73.83 153.78 39.78 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.454 -0.339 . . . . 2.2400000000000002 110.427 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.402 HG11 HG13 ' A' ' 85' ' ' VAL . 34.9 m -125.62 28.55 2.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-O 120.853 0.359 . . . . 0.67000000000000004 111.554 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -94.32 42.25 1.09 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.268 -0.424 . . . . 1.3899999999999999 111.011 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 165.76 33.23 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.642 -0.79 . . . . 0.55000000000000004 113.04 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 50.5 mtm -131.39 152.48 50.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.862 0.363 . . . . 0.52000000000000002 111.01 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.402 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -64.55 152.98 40.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.011 -0.54 . . . . 0.39000000000000001 111.179 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -52.69 -55.86 19.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.355 -0.384 . . . . 1.52 111.286 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 48.0 t -53.7 -40.06 65.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.137 -0.483 . . . . 1.48 111.413 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -62.34 -46.24 89.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.322 -0.399 . . . . 2.1200000000000001 111.118 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.402 HG13 HG11 ' A' ' 77' ' ' VAL . 75.6 t -57.94 -36.64 56.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.122 -0.49 . . . . 0.32000000000000001 111.128 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 64.9 t -65.99 -43.3 92.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 0.37 111.025 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -57.25 -39.41 75.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.183 -0.462 . . . . 1.51 110.612 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 52.9 t -62.3 -53.66 44.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.27000000000000002 111.208 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 76.5 mt -53.29 -30.06 36.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.933 -0.576 . . . . 0.40999999999999998 111.174 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -87.53 -26.64 23.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 2.1000000000000001 111.295 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -78.22 -12.17 59.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.421 -0.354 . . . . 1.1399999999999999 111.032 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -49.76 -80.26 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.272 -0.422 . . . . 0.55000000000000004 111.29 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 65.87 10.84 52.54 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.591 -0.814 . . . . 0.76000000000000001 112.379 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.548 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 5.3 p30 -146.88 168.56 11.15 Favored Pre-proline 0 C--N 1.328 -0.332 0 N-CA-C 110.44 -0.207 . . . . 2.52 110.44 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.558 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 19.0 Cg_endo -61.24 102.42 0.22 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.003 1.802 . . . . 0.64000000000000001 111.506 178.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 29.9 m -107.81 146.66 13.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.64000000000000001 112.015 -178.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.652 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 20.7 ttm180 -92.18 142.76 27.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.818 -0.628 . . . . 2.3700000000000001 109.847 179.169 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 71.8 mt -116.09 103.4 10.52 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.071 -0.513 . . . . 0.37 110.892 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 65.1 tp -98.99 114.26 26.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 0.37 110.382 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.462 ' HB3' ' HA ' ' A' ' 69' ' ' ILE . 0.5 OUTLIER -147.27 167.95 22.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.475 . . . . 0.31 111.487 -179.352 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.539 ' HB ' HD23 ' A' ' 13' ' ' LEU . 11.7 tt -116.23 139.16 44.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.828 -0.624 . . . . 0.45000000000000001 110.807 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.432 ' HB3' ' HE1' ' A' ' 14' ' ' TYR . 32.7 tpt180 -166.22 138.89 3.94 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.206 -0.452 . . . . 2.2599999999999998 110.601 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.42 ' HA ' ' HA ' ' A' ' 11' ' ' PHE . 16.7 ptm180 -62.85 145.5 54.92 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.02 -0.536 . . . . 3.9300000000000002 111.288 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.3 mt -106.19 154.78 39.44 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.657 -0.701 . . . . 2.0 110.791 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.81 171.38 9.88 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.407 2.072 . . . . 2.98 112.275 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 90.5 mt -145.31 127.43 15.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.948 -0.569 . . . . 3.6699999999999999 110.831 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.476 HD22 ' N ' ' A' ' 107' ' ' LEU . 3.3 mm? -93.28 165.65 12.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 5.5899999999999999 110.661 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.276 -0.869 . . . . 6.0 110.778 179.747 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.111 0 N-CA-C 112.528 -0.229 . . . . 7.9199999999999999 112.528 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.2 t -154.59 -72.85 0.12 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.74 0.305 . . . . 7.1799999999999997 110.839 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 59.6 m80 55.53 82.68 0.1 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.148 -0.478 . . . . 5.9100000000000001 110.88 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 151.0 89.38 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.753 -0.737 . . . . 2.4500000000000002 112.464 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -107.22 93.85 4.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.785 0.326 . . . . 2.3300000000000001 110.865 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 45.1 t -89.18 99.58 12.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 2.5899999999999999 110.781 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 20.4 t70 56.4 81.64 0.12 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.128 -0.487 . . . . 2.6699999999999999 110.787 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -143.91 111.3 5.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.27 -0.423 . . . . 1.5800000000000001 111.353 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 63.0 m 56.49 25.62 9.93 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.957 -0.565 . . . . 2.5499999999999998 111.515 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.68 -52.47 1.15 Allowed Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.62 -0.8 . . . . 1.8200000000000001 112.594 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -50.65 103.98 0.07 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.928 0.394 . . . . 1.7 111.068 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 56.2 p -123.16 143.19 50.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.891 -0.595 . . . . 0.90000000000000002 110.655 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 76.5 mt -77.78 128.72 34.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.121 -0.491 . . . . 0.89000000000000001 111.319 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -114.74 132.55 56.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.927 -0.579 . . . . 2.73 111.058 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 84.9 p -124.56 128.55 49.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.099 -0.501 . . . . 1.1899999999999999 110.929 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 23.6 t -133.04 149.38 31.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.117 -0.492 . . . . 0.56000000000000005 110.919 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -111.41 120.77 43.31 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.843 0.354 . . . . 1.74 110.986 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -121.18 166.45 13.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.034 -0.53 . . . . 0.81000000000000005 111.119 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.6 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 33.8 p90 -147.86 129.19 14.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.997 -0.547 . . . . 2.0800000000000001 110.82 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.472 ' HB2' HD21 ' A' ' 27' ' ' LEU . 3.0 tmm_? -108.71 115.31 29.84 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.935 0.398 . . . . 3.0600000000000001 111.007 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -150.93 13.76 0.71 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.101 -0.5 . . . . 2.5800000000000001 110.934 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -103.78 160.52 14.71 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.197 -0.456 . . . . 3.7200000000000002 110.712 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -90.62 57.92 3.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 2.8700000000000001 110.889 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 37.5 p -118.76 -10.49 9.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 1.3799999999999999 111.103 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 90.7 p 49.71 26.84 1.98 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.76 -0.655 . . . . 2.4500000000000002 111.413 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 53.4 m -152.69 137.48 17.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.38 -0.373 . . . . 1.3999999999999999 111.059 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.472 HD21 ' HB2' ' A' ' 20' ' ' ARG . 85.1 mt -91.53 -34.58 14.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.081 -0.509 . . . . 0.45000000000000001 110.778 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.459 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 127.26 -26.82 4.91 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.869 -0.682 . . . . 0.52000000000000002 112.444 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 70.3 mt -63.93 113.67 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.792 0.329 . . . . 0.83999999999999997 110.928 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.3 t -113.84 99.43 7.68 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.15 -0.477 . . . . 0.94999999999999996 110.997 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.8 pt -96.47 159.2 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.073 -0.512 . . . . 0.40999999999999998 111.071 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 47.4 t -115.2 146.69 41.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.237 -0.438 . . . . 1.3200000000000001 110.949 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.98 157.54 35.16 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.901 -0.666 . . . . 0.94999999999999996 112.455 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 16.7 tpt -117.97 145.46 44.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.894 0.378 . . . . 2.04 111.04 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.41 ' N ' ' HD2' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -130.23 72.63 1.49 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.028 -0.533 . . . . 5.46 110.69 179.787 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -99.45 152.43 20.0 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.007 -0.542 . . . . 4.29 111.071 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -94.45 147.64 23.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.004 -0.544 . . . . 5.25 110.847 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 53.0 m -59.94 103.23 0.2 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.113 -0.494 . . . . 4.8799999999999999 110.983 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 71.6 p -128.77 163.12 25.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.015 -0.538 . . . . 5.2699999999999996 110.93 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.4 t -74.06 0.44 13.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.013 -0.539 . . . . 6.9100000000000001 111.246 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -119.83 104.41 1.03 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.742 -0.742 . . . . 5.3600000000000003 112.554 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 58.98 -178.73 0.08 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.822 0.344 . . . . 7.2199999999999998 111.209 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -163.95 117.26 1.45 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.488 . . . . 3.0499999999999998 111.205 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 79.8 p 50.2 -167.41 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.075 -0.512 . . . . 2.5299999999999998 111.701 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 159.56 140.34 2.88 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.825 -0.703 . . . . 1.1399999999999999 112.337 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 42.7 mm -100.01 138.13 25.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.796 0.331 . . . . 0.65000000000000002 111.041 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -151.21 143.56 24.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.485 . . . . 0.69999999999999996 111.109 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 79.3 t -76.81 134.89 27.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.215 -0.448 . . . . 0.39000000000000001 110.757 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -113.39 -31.81 6.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.985 -0.552 . . . . 2.3999999999999999 111.169 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 80.0 p -153.71 177.07 11.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.957 0.408 . . . . 1.28 111.395 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 97.6 mt -133.75 149.44 51.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.765 -0.652 . . . . 0.41999999999999998 110.838 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.459 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 57.1 mt -81.16 121.35 80.41 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.289 -0.414 . . . . 1.26 111.121 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.16 114.23 3.7 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.441 2.094 . . . . 0.81999999999999995 112.265 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.82 16.36 15.75 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.63 -0.795 . . . . 0.48999999999999999 112.652 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 78.0 p -107.76 176.45 5.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.717 0.294 . . . . 1.23 110.906 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.57 -57.6 9.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.34 -0.391 . . . . 0.41999999999999998 111.206 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.13 -29.58 13.94 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.118 -0.492 . . . . 0.34999999999999998 111.591 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -77.74 -40.92 39.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.303 -0.408 . . . . 0.44 111.455 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.6 mt -61.78 -35.96 79.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.311 -0.404 . . . . 0.66000000000000003 111.273 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -61.79 -47.32 85.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.287 -0.415 . . . . 1.8600000000000001 111.101 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.06 -20.65 7.92 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.77 -0.728 . . . . 1.0600000000000001 112.477 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 12.8 mmm180 -62.22 -22.39 65.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.827 0.346 . . . . 2.5899999999999999 110.889 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.472 ' N ' HD12 ' A' ' 63' ' ' ILE . 4.1 mp -91.18 111.23 23.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.12 -0.491 . . . . 0.92000000000000004 110.899 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -98.68 134.49 21.62 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.035 -0.529 . . . . 1.98 110.531 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.94 159.9 4.72 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.488 2.125 . . . . 1.4399999999999999 112.279 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 61.13 82.98 0.15 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.992 -0.549 . . . . 2.1499999999999999 110.861 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -156.51 170.77 21.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.072 -0.513 . . . . 2.02 110.707 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -114.42 126.06 54.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.405 -0.361 . . . . 1.02 111.096 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 41.4 mm -84.53 137.99 19.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.135 -0.484 . . . . 0.28999999999999998 110.784 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 89.1 mt -101.36 -61.51 1.37 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.28 -0.418 . . . . 0.40000000000000002 111.07 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -158.17 138.48 12.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.171 0.51 . . . . 2.6099999999999999 111.676 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.671 HG12 ' H ' ' A' ' 73' ' ' ASP . 2.9 t -86.85 175.48 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.551 -0.749 . . . . 0.28000000000000003 109.997 179.281 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.671 ' H ' HG12 ' A' ' 72' ' ' VAL . 14.7 t70 -49.54 110.25 0.36 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.795 0.331 . . . . 0.79000000000000004 111.804 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.1 t70 60.69 9.91 2.39 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.044 -0.526 . . . . 2.0099999999999998 111.978 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.558 HG11 HG21 ' A' ' 88' ' ' VAL . 57.7 t -128.51 141.85 45.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.674 0.273 . . . . 0.79000000000000004 110.999 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -109.26 129.55 55.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.323 -0.399 . . . . 2.2400000000000002 110.709 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.4 m -111.92 26.6 3.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-O 120.89 0.376 . . . . 0.67000000000000004 111.319 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -86.77 31.62 0.69 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.14 -0.482 . . . . 1.3899999999999999 111.306 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 162.38 43.3 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.466 -0.873 . . . . 0.55000000000000004 112.974 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 47.7 mtm -129.68 138.34 51.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.874 0.368 . . . . 0.52000000000000002 110.905 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.41 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -60.93 156.66 17.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.107 -0.497 . . . . 0.39000000000000001 111.123 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -48.33 -49.16 35.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.331 -0.395 . . . . 1.52 111.363 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 81.0 p -53.31 -44.96 68.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.121 -0.491 . . . . 1.48 111.444 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -61.56 -45.32 94.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.294 -0.412 . . . . 2.1200000000000001 111.426 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 81' ' ' ALA . 15.5 t -59.34 -41.38 84.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.331 -0.395 . . . . 0.32000000000000001 111.003 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 92.2 t -64.14 -37.7 80.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.046 -0.525 . . . . 0.37 111.103 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -58.73 -47.5 84.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 1.51 110.655 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.558 HG21 HG11 ' A' ' 75' ' ' VAL . 65.1 t -56.75 -55.09 21.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.022 -0.535 . . . . 0.27000000000000002 111.256 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.404 HD22 HD12 ' A' ' 27' ' ' LEU . 84.5 mt -53.07 -36.69 60.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.82 -0.627 . . . . 0.40999999999999998 111.822 -179.096 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 81.7 mtm180 -84.48 -18.39 36.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.613 -0.267 . . . . 2.1000000000000001 111.67 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -89.98 -8.03 52.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.703 0.287 . . . . 1.1399999999999999 110.87 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -55.49 -83.74 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.251 -0.431 . . . . 0.55000000000000004 111.263 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.463 ' HA2' ' NE ' ' A' ' 20' ' ' ARG . . . 62.11 14.5 46.8 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.717 -0.754 . . . . 0.76000000000000001 112.37 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -146.9 168.51 11.25 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 110.45 -0.204 . . . . 2.52 110.45 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.6 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 36.1 Cg_exo -62.33 96.5 0.15 Allowed 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.211 1.941 . . . . 0.64000000000000001 111.161 178.299 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.5 m -105.76 152.76 7.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.124 0.488 . . . . 0.64000000000000001 111.988 -178.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.649 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 52.5 ttp180 -102.49 144.8 30.47 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.737 -0.665 . . . . 2.3700000000000001 110.048 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.9 mt -117.23 107.5 14.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.106 -0.497 . . . . 0.37 110.838 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 53.4 tp -99.01 101.69 13.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.304 -0.407 . . . . 0.37 110.499 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.1 162.64 27.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.063 -0.517 . . . . 0.31 111.175 -179.608 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.5 tt -117.27 140.86 38.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.211 -0.45 . . . . 0.45000000000000001 111.207 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 29.4 tpt180 -136.56 130.3 32.19 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.016 -0.538 . . . . 2.2599999999999998 110.766 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -79.19 139.99 37.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.102 -0.499 . . . . 3.9300000000000002 110.941 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 24.9 mt -86.34 137.71 34.53 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.963 -0.562 . . . . 2.0 110.507 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -81.27 58.76 7.08 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.61 2.207 . . . . 2.98 112.111 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 91.2 mt -88.61 145.85 25.45 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.367 -0.833 . . . . 3.6699999999999999 111.013 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -105.45 141.07 37.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.981 -0.554 . . . . 5.5899999999999999 110.781 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.239 -0.886 . . . . 6.0 110.831 179.941 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.197 0 N-CA-C 112.517 -0.233 . . . . 7.9199999999999999 112.517 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.7 t -79.07 -67.33 0.76 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.96 0.41 . . . . 7.1799999999999997 110.865 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 51.8 m80 -68.11 -23.93 64.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.889 -0.596 . . . . 5.9100000000000001 110.866 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 97.98 -59.86 1.0 Allowed Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.849 -0.691 . . . . 2.4500000000000002 112.372 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -98.29 80.13 2.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.754 0.311 . . . . 2.3300000000000001 111.008 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.5 m -129.65 21.7 5.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.997 0.427 . . . . 2.5899999999999999 110.815 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -179.53 89.51 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.422 -0.808 . . . . 2.6699999999999999 110.692 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -160.23 102.58 1.42 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.286 -0.415 . . . . 1.5800000000000001 111.091 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 70.7 m 60.62 21.71 11.56 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.119 -0.491 . . . . 2.5499999999999998 110.867 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.407 ' HA2' HD12 ' A' ' 104' ' ' LEU . . . 88.5 10.49 67.75 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.842 -0.694 . . . . 1.8200000000000001 112.75 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.419 ' HB3' HD11 ' A' ' 101' ' ' ILE . 84.1 m-85 -104.85 91.24 3.75 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.944 0.402 . . . . 1.7 111.041 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.1 t -110.72 143.2 41.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.907 -0.588 . . . . 0.90000000000000002 110.635 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 91.4 mt -84.34 121.65 27.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.89000000000000001 110.945 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -115.6 150.24 36.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.064 -0.516 . . . . 2.73 110.921 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 80.9 p -146.43 138.18 24.74 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.385 -0.37 . . . . 1.1899999999999999 111.274 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.479 HG11 ' HB2' ' A' ' 62' ' ' ARG . 42.0 t -136.99 138.64 45.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.131 -0.486 . . . . 0.56000000000000005 110.935 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -89.92 112.49 23.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 1.74 111.042 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -115.7 114.05 24.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.011 -0.541 . . . . 0.81000000000000005 110.735 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.618 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 44.2 p90 -95.8 134.42 38.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 2.0800000000000001 111.037 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.59 ' HB2' HD21 ' A' ' 27' ' ' LEU . 14.0 ttp180 -110.94 88.35 2.76 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.416 -0.357 . . . . 3.0600000000000001 111.101 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -157.75 64.19 0.47 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.977 0.418 . . . . 2.5800000000000001 110.998 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -145.64 34.52 1.04 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.303 0.573 . . . . 3.7200000000000002 110.774 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 17.7 t70 59.01 25.34 13.73 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.119 -0.946 . . . . 2.8700000000000001 110.903 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 82.7 p -92.52 -28.24 16.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.338 -0.392 . . . . 1.3799999999999999 111.213 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 99.0 p 49.62 24.84 1.27 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.811 -0.631 . . . . 2.4500000000000002 111.505 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 80.9 p -160.0 144.98 15.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.938 0.399 . . . . 1.3999999999999999 111.075 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.59 HD21 ' HB2' ' A' ' 20' ' ' ARG . 71.7 mt -101.33 -24.41 14.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.056 -0.52 . . . . 0.45000000000000001 110.66 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.09 -9.32 75.23 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.802 -0.713 . . . . 0.52000000000000002 112.648 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.5 mt -58.93 108.56 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.849 0.357 . . . . 0.83999999999999997 110.877 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 44.4 t -111.79 109.88 19.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.141 -0.481 . . . . 0.94999999999999996 110.79 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 38.3 pt -101.46 172.18 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.028 -0.533 . . . . 0.40999999999999998 111.205 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 57.0 m -146.35 137.92 24.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.476 . . . . 1.3200000000000001 110.933 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -75.82 161.72 52.53 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.842 -0.694 . . . . 0.94999999999999996 112.593 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 54.0 ttm -108.88 139.74 43.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.84 0.352 . . . . 2.04 110.925 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.471 ' HD3' ' N ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -164.8 132.5 3.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 5.46 110.747 179.76 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -149.67 -68.03 0.21 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.15 -0.477 . . . . 4.29 110.896 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -126.13 145.22 50.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.086 -0.506 . . . . 5.25 111.035 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 52.3 m -65.52 95.62 0.22 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.041 -0.527 . . . . 4.8799999999999999 110.795 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 67.9 p -86.6 146.22 26.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 5.2699999999999996 111.17 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.8 t -80.97 3.61 22.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.081 -0.509 . . . . 6.9100000000000001 111.144 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -135.05 -121.08 2.09 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.845 -0.693 . . . . 5.3600000000000003 112.311 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -114.98 147.52 39.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.84 0.352 . . . . 7.2199999999999998 110.956 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -168.53 39.03 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.056 -0.52 . . . . 3.0499999999999998 111.228 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 70.6 p -139.67 137.97 35.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 2.5299999999999998 111.05 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -146.92 158.24 27.67 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.751 -0.738 . . . . 1.1399999999999999 112.598 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 47.4 mm -91.46 128.24 43.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.832 0.349 . . . . 0.65000000000000002 110.942 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 48.3 p90 -156.97 142.28 17.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.124 -0.489 . . . . 0.69999999999999996 110.969 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 89.0 t -85.78 135.03 25.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.39000000000000001 111.006 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -123.65 -20.96 5.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.495 . . . . 2.3999999999999999 111.081 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.7 t -140.31 161.22 38.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.988 0.423 . . . . 1.28 111.447 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 96.5 mt -136.6 127.16 26.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.748 -0.66 . . . . 0.41999999999999998 110.569 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 50.8 mm -63.52 112.54 7.35 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.313 -0.403 . . . . 1.26 110.899 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.47 102.1 0.39 Allowed 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.398 2.066 . . . . 0.81999999999999995 112.252 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 129.65 -0.58 5.88 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.794 -0.717 . . . . 0.48999999999999999 112.489 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.9 m -98.2 174.19 6.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.678 0.275 . . . . 1.23 110.903 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -55.75 -58.59 7.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 0.41999999999999998 111.648 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.407 ' HB1' HD12 ' A' ' 63' ' ' ILE . . . -50.72 -32.23 18.91 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.357 -0.383 . . . . 0.34999999999999998 111.479 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.91 -32.79 40.2 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.308 -0.406 . . . . 0.44 111.627 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 79.9 mt -63.52 -55.94 19.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.377 -0.374 . . . . 0.66000000000000003 111.114 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -55.13 -37.06 66.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.246 -0.433 . . . . 1.8600000000000001 111.04 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 62.94 7.17 15.08 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.985 -0.626 . . . . 1.0600000000000001 112.896 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.479 ' HB2' HG11 ' A' ' 16' ' ' VAL . 34.9 mtp180 -82.86 3.28 30.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.738 0.304 . . . . 2.5899999999999999 110.926 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.407 HD12 ' HB1' ' A' ' 57' ' ' ALA . 61.7 mt -110.54 133.51 55.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.92000000000000004 110.982 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.407 ' HA ' ' HD2' ' A' ' 65' ' ' PRO . 20.2 tp10 -108.08 125.39 32.14 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.475 . . . . 1.98 110.787 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 64' ' ' GLU . 11.2 Cg_endo -54.66 174.38 0.19 Allowed 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.628 2.219 . . . . 1.4399999999999999 112.168 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 60.79 25.87 15.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.199 -0.455 . . . . 2.1499999999999999 110.549 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -95.7 155.58 16.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.926 -0.579 . . . . 2.02 110.578 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -104.95 109.32 21.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.407 -0.36 . . . . 1.02 110.984 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 41.1 mm -68.7 132.52 32.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.113 -0.494 . . . . 0.28999999999999998 110.952 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 76.6 mt -104.12 -63.85 1.16 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.128 -0.487 . . . . 0.40000000000000002 110.814 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -149.59 136.56 19.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.161 0.505 . . . . 2.6099999999999999 111.518 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.573 HG12 ' H ' ' A' ' 73' ' ' ASP . 9.9 t -89.88 171.14 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.593 -0.73 . . . . 0.28000000000000003 109.866 179.125 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.683 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 14.0 t70 -48.26 108.53 0.17 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.789 0.328 . . . . 0.79000000000000004 111.817 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.5 t70 58.48 6.99 0.64 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.919 -0.582 . . . . 2.0099999999999998 112.328 178.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.1 t -137.85 99.54 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.695 0.283 . . . . 0.79000000000000004 111.435 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -72.57 152.08 42.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.214 -0.448 . . . . 2.2400000000000002 110.769 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.452 HG13 HG23 ' A' ' 72' ' ' VAL . 34.4 m -119.92 26.11 3.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.36 -0.382 . . . . 0.67000000000000004 111.269 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -91.22 27.58 1.86 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 1.3899999999999999 111.13 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -175.18 19.91 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.532 -0.842 . . . . 0.55000000000000004 112.905 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.411 ' HE2' ' HA ' ' A' ' 77' ' ' VAL . 45.7 mtm -120.95 139.46 53.22 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.858 0.361 . . . . 0.52000000000000002 111.0 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.46 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -65.16 156.56 31.32 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.976 -0.556 . . . . 0.39000000000000001 111.108 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -44.75 -44.14 9.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.369 -0.378 . . . . 1.52 111.386 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 48.2 t -58.71 -53.16 61.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.295 -0.411 . . . . 1.48 111.404 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -54.52 -39.14 67.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 2.1200000000000001 111.429 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 81' ' ' ALA . 21.1 t -62.29 -41.44 91.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.426 -0.352 . . . . 0.32000000000000001 111.221 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.568 HG13 HH21 ' A' ' 90' ' ' ARG . 85.8 t -63.23 -43.31 98.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.245 -0.434 . . . . 0.37 111.148 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -57.74 -46.63 84.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.301 -0.409 . . . . 1.51 111.207 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 71.9 t -56.37 -58.03 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.984 0.421 . . . . 0.27000000000000002 111.345 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 75.8 mt -60.01 -23.98 64.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.971 -0.558 . . . . 0.40999999999999998 111.297 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.568 HH21 HG13 ' A' ' 86' ' ' VAL . 2.1 tpp180 -89.28 -12.48 40.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.242 -0.436 . . . . 2.1000000000000001 111.432 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -103.92 -9.64 18.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.612 -0.267 . . . . 1.1399999999999999 111.143 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -50.18 -78.72 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.296 -0.411 . . . . 0.55000000000000004 111.458 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.47 ' H ' ' HE ' ' A' ' 20' ' ' ARG . . . 61.02 19.39 56.68 Favored Glycine 0 C--N 1.331 0.25 0 C-N-CA 120.712 -0.756 . . . . 0.76000000000000001 112.281 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -147.09 169.83 8.75 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 110.433 -0.21 . . . . 2.52 110.433 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.618 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 23.0 Cg_exo -65.9 93.23 0.27 Allowed 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.196 1.931 . . . . 0.64000000000000001 111.644 178.386 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 29.8 m -101.96 153.4 5.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.043 0.449 . . . . 0.64000000000000001 111.876 -179.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.683 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 80.0 ttt180 -98.55 144.6 27.69 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.605 -0.725 . . . . 2.3700000000000001 110.182 179.328 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 18.2 mt -118.05 103.56 10.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.091 -0.504 . . . . 0.37 110.867 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 34.2 tp -97.96 104.59 16.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.879 0.371 . . . . 0.37 110.519 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -133.93 158.96 42.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.092 -0.503 . . . . 0.31 111.351 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.419 HD11 ' HB3' ' A' ' 11' ' ' PHE . 17.3 tt -105.32 135.33 43.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.102 -0.499 . . . . 0.45000000000000001 110.273 179.282 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 32.4 tpt180 -128.47 132.96 48.4 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.869 0.366 . . . . 2.2599999999999998 111.379 -179.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 22.6 ttp180 -85.32 142.26 29.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.004 -0.544 . . . . 3.9300000000000002 110.696 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.407 HD12 ' HA2' ' A' ' 10' ' ' GLY . 41.0 mt -85.69 151.92 56.21 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.114 -0.494 . . . . 2.0 110.708 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -78.38 60.89 7.68 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.674 2.249 . . . . 2.98 112.095 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 87.2 mt -59.66 110.7 1.2 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.393 -0.822 . . . . 3.6699999999999999 111.146 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 82.8 mt -102.41 98.09 8.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.471 . . . . 5.5899999999999999 110.786 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.28 -0.867 . . . . 6.0 110.935 -179.86 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.154 0 N-CA-C 112.459 -0.256 . . . . 7.9199999999999999 112.459 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.9 m -104.46 -14.96 15.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.796 0.332 . . . . 7.1799999999999997 110.903 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -75.14 132.99 41.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 5.9100000000000001 111.044 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 74.01 -124.9 8.68 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.801 -0.714 . . . . 2.4500000000000002 112.674 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -81.37 139.58 35.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.857 0.36 . . . . 2.3300000000000001 110.966 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.5 t -141.1 90.35 2.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.196 -0.457 . . . . 2.5899999999999999 111.025 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 20.5 t70 55.04 88.07 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.108 -0.497 . . . . 2.6699999999999999 111.028 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -139.49 114.52 9.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.081 -0.509 . . . . 1.5800000000000001 110.653 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.0 p 53.8 32.11 14.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.048 -0.524 . . . . 2.5499999999999998 110.995 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.437 ' O ' ' HG ' ' A' ' 104' ' ' LEU . . . 92.57 -46.58 2.55 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.797 -0.716 . . . . 1.8200000000000001 112.478 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -62.0 98.16 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.868 0.366 . . . . 1.7 111.074 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 44.6 t -120.51 147.11 45.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.985 -0.552 . . . . 0.90000000000000002 110.547 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 88.3 mt -85.46 121.75 28.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.281 -0.418 . . . . 0.89000000000000001 111.126 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -113.79 148.29 36.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.992 -0.549 . . . . 2.73 110.893 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.3 m -144.55 136.62 26.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 1.1899999999999999 111.286 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 33.2 t -135.51 132.55 51.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.027 -0.533 . . . . 0.56000000000000005 110.599 179.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -93.3 124.65 37.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.292 -0.413 . . . . 1.74 111.398 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -119.63 151.8 38.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.896 -0.593 . . . . 0.81000000000000005 110.725 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.519 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 19.2 m-85 -123.14 106.52 10.84 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.108 -0.496 . . . . 2.0800000000000001 110.462 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.487 ' HE ' ' HA2' ' A' ' 93' ' ' GLY . 5.0 ttp180 -97.56 126.16 42.69 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.56 -0.456 . . . . 3.0600000000000001 110.813 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -141.61 -36.25 0.44 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.117 -0.492 . . . . 2.5800000000000001 110.957 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -68.47 154.25 42.2 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.956 -0.566 . . . . 3.7200000000000002 110.883 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -84.43 56.5 3.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 2.8700000000000001 111.017 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 65.9 p -92.59 -21.16 20.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.306 -0.406 . . . . 1.3799999999999999 110.994 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.1 t 58.0 18.56 5.2 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.759 -0.655 . . . . 2.4500000000000002 111.461 179.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.2 t -154.59 141.48 19.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.835 0.35 . . . . 1.3999999999999999 110.928 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.8 mt -107.95 -15.03 14.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.45000000000000001 110.793 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.437 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 108.34 13.69 18.48 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.669 -0.776 . . . . 0.52000000000000002 112.691 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.428 HG23 HG22 ' A' ' 48' ' ' VAL . 76.8 mt -97.56 113.38 31.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.816 0.341 . . . . 0.83999999999999997 111.058 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.2 t -113.3 103.41 11.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.241 -0.436 . . . . 0.94999999999999996 110.814 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 31.7 pt -101.54 147.48 8.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.247 -0.433 . . . . 0.40999999999999998 111.256 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 71.5 m -114.25 130.73 56.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.479 . . . . 1.3200000000000001 110.712 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -63.82 132.35 40.44 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.813 -0.708 . . . . 0.94999999999999996 112.467 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.416 ' HB2' ' HE1' ' A' ' 47' ' ' TYR . 16.0 tpt -112.06 88.06 2.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.758 0.313 . . . . 2.04 111.081 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -150.48 77.49 1.3 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.077 0.465 . . . . 5.46 110.947 179.831 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -59.54 153.54 19.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.09 -0.505 . . . . 4.29 111.064 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.467 ' H ' ' CD ' ' A' ' 37' ' ' GLN . 0.1 OUTLIER -91.71 14.98 13.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.154 -0.476 . . . . 5.25 111.008 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 79.2 p -139.44 27.04 2.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 4.8799999999999999 110.783 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 74.3 p -64.84 138.5 58.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 5.2699999999999996 111.016 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.8 t -95.9 -5.24 41.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.074 -0.512 . . . . 6.9100000000000001 110.956 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -165.99 -131.52 1.26 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.868 -0.682 . . . . 5.3600000000000003 112.421 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -106.88 127.27 53.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.761 0.315 . . . . 7.2199999999999998 110.839 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -163.71 80.43 0.43 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 3.0499999999999998 111.137 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 50.4 p -139.27 156.07 47.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.36 -0.382 . . . . 2.5299999999999998 111.406 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.18 153.62 8.04 Favored Glycine 0 C--N 1.329 0.194 0 C-N-CA 120.808 -0.71 . . . . 1.1399999999999999 112.488 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 50.4 mm -90.85 131.23 38.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.719 0.295 . . . . 0.65000000000000002 110.967 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.416 ' HE1' ' HB2' ' A' ' 34' ' ' MET . 25.0 p90 -152.54 135.03 15.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.891 0.377 . . . . 0.69999999999999996 111.214 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.428 HG22 HG23 ' A' ' 29' ' ' ILE . 85.3 t -70.72 112.99 6.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.123 -0.49 . . . . 0.39000000000000001 110.834 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -88.52 -29.39 20.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.866 -0.606 . . . . 2.3999999999999999 111.076 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 78.3 p -156.06 171.27 20.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.006 0.432 . . . . 1.28 111.212 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 71.0 mt -128.89 151.7 49.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.911 -0.586 . . . . 0.41999999999999998 110.69 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.437 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 45.5 mm -84.02 113.41 47.71 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 1.26 110.921 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -58.5 132.11 46.53 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.576 2.184 . . . . 0.81999999999999995 112.506 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.56 11.17 78.13 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.9 -0.667 . . . . 0.48999999999999999 112.846 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.413 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 22.2 t -99.71 170.32 8.64 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.656 0.265 . . . . 1.23 111.055 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -56.52 -54.62 43.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.332 -0.395 . . . . 0.41999999999999998 111.489 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -49.18 -44.07 42.65 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.04 -0.527 . . . . 0.34999999999999998 111.533 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.79 -33.58 75.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.48 . . . . 0.44 111.477 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 55' ' ' SER . 90.9 mt -65.9 -33.42 75.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.378 -0.374 . . . . 0.66000000000000003 111.187 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -58.8 -46.59 87.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.954 0.407 . . . . 1.8600000000000001 110.764 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.95 -33.46 3.55 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.839 -0.696 . . . . 1.0600000000000001 112.554 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 58.5 mtp180 -67.71 -22.14 65.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.805 0.336 . . . . 2.5899999999999999 110.735 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 70.0 mt -93.84 115.41 32.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.485 . . . . 0.92000000000000004 110.924 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.453 ' HB2' ' HD2' ' A' ' 65' ' ' PRO . 13.5 pt-20 -118.71 158.6 46.99 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.111 -0.495 . . . . 1.98 110.531 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.453 ' HD2' ' HB2' ' A' ' 64' ' ' GLU . 21.2 Cg_endo -59.27 178.05 0.33 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.38 2.053 . . . . 1.4399999999999999 112.216 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 18.2 m120 55.5 34.94 24.09 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.166 -0.47 . . . . 2.1499999999999999 110.809 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.507 ' HB2' ' HD3' ' A' ' 102' ' ' ARG . 5.3 t70 -100.42 153.05 19.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.021 -0.536 . . . . 2.02 110.886 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -110.89 95.67 5.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.861 0.363 . . . . 1.02 110.758 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.452 HD13 ' HB3' ' A' ' 100' ' ' LEU . 44.8 mm -60.42 132.58 25.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.059 -0.519 . . . . 0.28999999999999998 110.971 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 73.1 mt -100.99 -65.44 0.97 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.036 -0.529 . . . . 0.40000000000000002 110.866 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.425 ' CG ' HD23 ' A' ' 99' ' ' LEU . 7.7 ptp180 -150.54 135.18 17.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.16 0.505 . . . . 2.6099999999999999 111.827 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.533 HG12 ' N ' ' A' ' 73' ' ' ASP . 15.7 t -87.96 170.31 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.46 -0.791 . . . . 0.28000000000000003 109.822 179.025 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.654 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 11.8 t70 -46.51 117.95 1.8 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.723 0.297 . . . . 0.79000000000000004 111.593 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.5 p30 47.32 19.4 0.12 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.755 -0.657 . . . . 2.0099999999999998 112.696 179.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.5 t -147.87 100.1 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.655 0.264 . . . . 0.79000000000000004 110.969 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -76.35 144.04 40.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.36 -0.382 . . . . 2.2400000000000002 110.814 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.6 m -117.04 30.41 2.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.36 -0.382 . . . . 0.67000000000000004 111.242 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -89.94 41.74 1.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 1.3899999999999999 111.174 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 157.5 25.77 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.503 -0.856 . . . . 0.55000000000000004 112.982 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 37.1 mtm -117.73 138.73 51.83 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.856 0.36 . . . . 0.52000000000000002 110.742 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.412 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -59.66 160.95 6.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.019 -0.537 . . . . 0.39000000000000001 111.234 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.446 ' O ' HG23 ' A' ' 86' ' ' VAL . 36.2 tt0 -54.12 -57.61 10.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.35 -0.386 . . . . 1.52 111.087 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 79.7 p -49.93 -32.9 15.9 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.209 -0.451 . . . . 1.48 111.271 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.477 ' O ' HG23 ' A' ' 88' ' ' VAL . 12.4 t70 -69.04 -46.75 67.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.379 -0.373 . . . . 2.1200000000000001 110.969 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 81' ' ' ALA . 15.2 t -64.6 -29.16 46.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.99 0.424 . . . . 0.32000000000000001 110.953 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 82' ' ' GLN . 95.9 t -66.18 -58.58 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.964 -0.562 . . . . 0.37 111.287 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 84' ' ' ASP . 13.6 pt-20 -54.16 -36.59 63.51 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.495 -0.32 . . . . 1.51 110.975 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 84' ' ' ASP . 51.7 t -57.11 -56.1 16.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.889 0.376 . . . . 0.27000000000000002 111.041 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 65.4 mt -57.72 -27.25 62.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.001 -0.545 . . . . 0.40999999999999998 111.192 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -86.83 -17.63 32.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.335 -0.393 . . . . 2.1000000000000001 111.302 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -91.47 -13.24 32.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.459 -0.337 . . . . 1.1399999999999999 110.923 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -50.48 -84.18 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.099 -0.5 . . . . 0.55000000000000004 111.529 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.487 ' HA2' ' HE ' ' A' ' 20' ' ' ARG . . . 62.79 17.77 58.47 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.8 -0.714 . . . . 0.76000000000000001 112.532 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.441 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 5.8 p30 -146.94 172.82 4.76 Favored Pre-proline 0 C--N 1.328 -0.354 0 C-N-CA 121.974 0.11 . . . . 2.52 110.922 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.519 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 32.0 Cg_exo -61.43 92.22 0.11 Allowed 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 122.233 1.955 . . . . 0.64000000000000001 111.497 178.086 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.0 m -97.0 144.97 9.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.93 0.395 . . . . 0.64000000000000001 111.855 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.654 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 75.2 ttt180 -101.64 143.2 31.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.766 -0.652 . . . . 2.3700000000000001 109.711 179.121 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 36.6 mt -113.35 107.16 15.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.189 -0.46 . . . . 0.37 111.334 -179.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.425 HD23 ' CG ' ' A' ' 71' ' ' ARG . 33.6 tp -100.07 99.84 10.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.411 -0.358 . . . . 0.37 110.294 179.369 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.452 ' HB3' HD13 ' A' ' 69' ' ' ILE . 0.4 OUTLIER -127.99 164.42 22.38 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.224 -0.444 . . . . 0.31 111.379 -179.507 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.3 tt -118.02 139.25 45.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 116.087 -0.506 . . . . 0.45000000000000001 111.133 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.507 ' HD3' ' HB2' ' A' ' 67' ' ' ASP . 15.5 mmm180 -130.91 135.05 47.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.738 -0.664 . . . . 2.2599999999999998 110.867 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 34.8 ptt180 -97.12 136.29 37.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.123 -0.49 . . . . 3.9300000000000002 110.806 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 10' ' ' GLY . 28.3 mt -87.14 148.47 45.1 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.049 -0.523 . . . . 2.0 110.697 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -80.37 59.41 7.43 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.639 2.226 . . . . 2.98 112.171 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 92.0 mt -90.17 97.49 11.22 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.436 -0.802 . . . . 3.6699999999999999 111.007 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -100.67 175.78 5.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.142 -0.481 . . . . 5.5899999999999999 110.819 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.297 -0.859 . . . . 6.0 110.93 -179.948 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.557 -0.217 . . . . 7.9199999999999999 112.557 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 61.3 p -78.01 -177.93 5.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.702 0.287 . . . . 7.1799999999999997 110.962 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 70.3 m80 57.5 45.57 19.36 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.144 -0.48 . . . . 5.9100000000000001 110.979 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -142.25 64.57 0.5 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.764 -0.731 . . . . 2.4500000000000002 112.497 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -119.79 62.53 0.82 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.914 0.388 . . . . 2.3300000000000001 110.782 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 51.4 m -88.11 100.42 12.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.975 -0.557 . . . . 2.5899999999999999 111.02 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 54.29 74.19 0.35 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.078 -0.51 . . . . 2.6699999999999999 110.809 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -106.1 -34.35 7.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.139 -0.482 . . . . 1.5800000000000001 111.316 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 93.0 p -178.11 32.01 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.111 -0.495 . . . . 2.5499999999999998 110.563 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.68 19.19 5.79 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 121.004 -0.617 . . . . 1.8200000000000001 112.479 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -134.33 131.9 38.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.683 0.278 . . . . 1.7 110.709 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.6 t -151.9 138.63 18.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.439 . . . . 0.90000000000000002 111.103 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.3 mt -77.33 119.44 20.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.816 -0.629 . . . . 0.89000000000000001 110.883 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -119.09 163.68 16.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.127 -0.488 . . . . 2.73 110.859 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 84.4 p -151.63 146.88 26.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.878 0.371 . . . . 1.1899999999999999 111.04 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 13.5 t -131.61 136.01 58.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.091 -0.504 . . . . 0.56000000000000005 110.799 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -89.63 113.19 24.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.289 -0.414 . . . . 1.74 111.364 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -118.0 166.04 13.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.904 -0.589 . . . . 0.81000000000000005 110.64 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.544 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 30.9 p90 -158.92 128.59 5.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.276 -0.42 . . . . 2.0800000000000001 111.104 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.704 HH21 ' HG ' ' A' ' 27' ' ' LEU . 21.0 ttm180 -101.47 82.72 2.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.905 0.383 . . . . 3.0600000000000001 110.835 179.609 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -97.99 -18.05 18.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.05 -0.523 . . . . 2.5800000000000001 110.747 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -95.11 144.95 25.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.034 -0.53 . . . . 3.7200000000000002 110.644 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -81.06 70.93 8.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.306 -0.406 . . . . 2.8700000000000001 110.749 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 72.2 p -108.21 -9.85 15.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 1.3799999999999999 111.138 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 83.3 p 51.99 22.51 1.85 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.788 -0.642 . . . . 2.4500000000000002 111.211 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 56.3 m -157.09 131.78 8.73 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.306 -0.406 . . . . 1.3999999999999999 110.962 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.704 ' HG ' HH21 ' A' ' 20' ' ' ARG . 49.7 mt -92.69 -25.24 18.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.45000000000000001 110.619 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.568 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 99.6 31.76 5.96 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.819 -0.705 . . . . 0.52000000000000002 112.759 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.438 HG22 HG23 ' A' ' 31' ' ' ILE . 45.4 mt -109.32 108.69 25.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.661 0.267 . . . . 0.83999999999999997 110.926 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 46.5 m -104.14 90.22 3.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.345 -0.388 . . . . 0.94999999999999996 110.884 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.438 HG23 HG22 ' A' ' 29' ' ' ILE . 28.7 pt -88.3 165.98 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.0 -0.545 . . . . 0.40999999999999998 111.295 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 53.2 m -142.85 136.42 28.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.121 -0.49 . . . . 1.3200000000000001 110.909 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.96 160.29 42.38 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.87 -0.681 . . . . 0.94999999999999996 112.769 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 28.1 ttt -114.56 113.74 24.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.766 0.317 . . . . 2.04 110.896 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.425 ' N ' ' HD2' ' A' ' 35' ' ' ARG . 4.2 mpt_? -111.65 98.81 7.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 5.46 110.695 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -147.46 152.23 37.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.336 -0.393 . . . . 4.29 111.023 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -99.61 127.2 45.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 5.25 111.051 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 61.7 m -144.3 128.72 17.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 4.8799999999999999 110.592 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 69.6 p -94.16 171.81 8.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 5.2699999999999996 111.523 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 15.3 t 42.25 33.08 0.37 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.627 -0.715 . . . . 6.9100000000000001 111.58 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 159.7 168.05 21.16 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.849 -0.691 . . . . 5.3600000000000003 112.437 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -94.92 177.11 6.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.665 0.269 . . . . 7.2199999999999998 110.7 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -161.82 40.51 0.13 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.274 -0.421 . . . . 3.0499999999999998 111.123 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.9 p -103.67 142.88 33.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 2.5299999999999998 111.021 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -170.23 150.26 14.27 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.828 -0.701 . . . . 1.1399999999999999 112.479 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 45.4 mm -101.76 131.82 48.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.765 0.317 . . . . 0.65000000000000002 110.965 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 51.6 p90 -144.18 152.95 41.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.247 -0.433 . . . . 0.69999999999999996 111.165 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.407 HG23 ' CG1' ' A' ' 69' ' ' ILE . 81.3 t -86.77 123.58 39.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.077 -0.51 . . . . 0.39000000000000001 110.898 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -99.49 -26.91 13.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.072 -0.513 . . . . 2.3999999999999999 110.941 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 64.0 m -151.85 170.64 19.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.308 -0.405 . . . . 1.28 111.122 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.5 mt -133.91 146.85 50.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.04 -0.527 . . . . 0.41999999999999998 110.77 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.568 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 44.0 mm -90.06 108.64 27.43 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.239 -0.437 . . . . 1.26 110.892 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -60.94 138.09 76.54 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.351 2.034 . . . . 0.81999999999999995 112.287 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 98.39 -11.12 63.4 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.75 -0.738 . . . . 0.48999999999999999 112.499 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.1 m -89.44 -176.25 4.98 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.699 0.285 . . . . 1.23 110.963 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.73 -58.98 3.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.41999999999999998 111.45 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.13 -32.13 45.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.13 -0.486 . . . . 0.34999999999999998 111.649 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.81 -49.59 17.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.44 -0.345 . . . . 0.44 111.447 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.8 mt -63.24 -19.97 65.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.417 -0.356 . . . . 0.66000000000000003 111.084 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -58.86 -55.27 37.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.357 -0.383 . . . . 1.8600000000000001 110.852 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.3 -44.46 1.61 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.74 -0.743 . . . . 1.0600000000000001 112.832 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 20.3 mtp180 -61.42 -29.28 69.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.635 0.255 . . . . 2.5899999999999999 111.2 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 55.6 mt -85.49 109.18 18.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.914 0.388 . . . . 0.92000000000000004 111.128 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.597 ' HB3' HH12 ' A' ' 102' ' ' ARG . 36.7 tt0 -111.23 139.28 21.74 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.947 -0.57 . . . . 1.98 110.296 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -47.27 165.64 0.1 Allowed 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.504 2.136 . . . . 1.4399999999999999 112.643 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 64.04 54.17 1.73 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.002 -0.545 . . . . 2.1499999999999999 110.831 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -128.42 160.99 30.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.846 -0.616 . . . . 2.02 110.269 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.486 ' HB3' HG23 ' A' ' 101' ' ' ILE . 88.0 tttt -110.35 122.56 47.99 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.828 0.347 . . . . 1.02 111.244 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.464 HD13 ' HB3' ' A' ' 100' ' ' LEU . 36.3 mm -90.17 145.85 6.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.173 -0.467 . . . . 0.28999999999999998 110.699 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 87.2 mt -115.74 -65.8 1.15 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.257 -0.429 . . . . 0.40000000000000002 111.274 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.535 ' HG2' HD23 ' A' ' 99' ' ' LEU . 15.8 ptm180 -149.88 137.15 19.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.252 0.549 . . . . 2.6099999999999999 112.037 -179.35 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.648 HG12 ' H ' ' A' ' 73' ' ' ASP . 11.5 t -84.82 175.22 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.505 -0.771 . . . . 0.28000000000000003 109.409 178.646 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.661 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 8.8 t70 -47.69 108.07 0.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.954 0.407 . . . . 0.79000000000000004 111.684 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 52.3 19.03 1.01 Allowed 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.599 0.592 . . . . 2.0099999999999998 112.599 179.024 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.9 t -146.38 102.14 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.63 0.252 . . . . 0.79000000000000004 111.335 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -62.85 152.76 35.24 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.538 -0.301 . . . . 2.2400000000000002 110.663 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.1 m -143.07 49.98 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 120.791 0.329 . . . . 0.67000000000000004 111.862 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -143.3 21.33 1.89 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.069 0.461 . . . . 1.3899999999999999 110.561 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -142.97 -4.21 0.85 Allowed Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.731 -0.668 . . . . 0.55000000000000004 112.259 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 71.1 mtm -108.16 173.89 6.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.822 0.344 . . . . 0.52000000000000002 110.719 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.413 ' HB3' ' OD1' ' A' ' 84' ' ' ASP . . . -69.17 166.28 18.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.212 -0.449 . . . . 0.39000000000000001 111.104 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.418 ' NE2' HG13 ' A' ' 31' ' ' ILE . 7.8 tp60 -58.94 -58.39 8.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 1.52 110.948 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 45.0 t -51.75 -39.82 59.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.026 -0.534 . . . . 1.48 111.295 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.413 ' OD1' ' HB3' ' A' ' 81' ' ' ALA . 1.2 m-20 -57.28 -44.92 84.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.345 -0.389 . . . . 2.1200000000000001 110.835 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 81' ' ' ALA . 55.6 t -61.24 -38.4 79.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.223 -0.444 . . . . 0.32000000000000001 110.926 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 17.9 t -63.93 -39.62 86.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 0.37 110.995 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -58.62 -51.83 68.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.285 -0.416 . . . . 1.51 110.75 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 63.6 t -52.83 -53.58 20.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.27000000000000002 111.431 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 80.0 mt -58.44 -30.92 67.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.049 -0.523 . . . . 0.40999999999999998 111.366 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 73.2 mtm180 -85.81 -13.6 47.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.42 -0.354 . . . . 2.1000000000000001 111.175 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -93.86 -13.76 26.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.405 -0.361 . . . . 1.1399999999999999 110.917 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.15 -83.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.213 -0.449 . . . . 0.55000000000000004 111.432 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.591 ' H ' ' HD2' ' A' ' 20' ' ' ARG . . . 63.76 13.2 50.89 Favored Glycine 0 CA--C 1.517 0.216 0 C-N-CA 120.664 -0.779 . . . . 0.76000000000000001 112.419 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.409 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 8.0 p30 -146.78 170.4 7.87 Favored Pre-proline 0 C--N 1.329 -0.318 0 O-C-N 122.999 -0.118 . . . . 2.52 110.82 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.544 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 31.8 Cg_exo -60.55 106.27 0.35 Allowed 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.241 1.961 . . . . 0.64000000000000001 111.669 178.419 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 34.7 m -114.33 154.37 15.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.95 0.405 . . . . 0.64000000000000001 111.699 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.661 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 73.7 ttt180 -101.9 142.2 33.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.833 -0.621 . . . . 2.3700000000000001 109.932 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 21.8 mt -116.81 109.1 16.67 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.431 -0.35 . . . . 0.37 111.271 -179.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.535 HD23 ' HG2' ' A' ' 71' ' ' ARG . 52.4 tp -96.19 103.32 15.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.3 -0.409 . . . . 0.37 110.396 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.464 ' HB3' HD13 ' A' ' 69' ' ' ILE . 0.4 OUTLIER -129.8 154.11 47.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.454 . . . . 0.31 111.403 -179.557 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.486 HG23 ' HB3' ' A' ' 68' ' ' LYS . 13.9 tt -105.89 136.71 39.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-N 116.157 -0.474 . . . . 0.45000000000000001 110.773 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.597 HH12 ' HB3' ' A' ' 64' ' ' GLU . 29.1 mmm-85 -116.92 146.05 43.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.741 -0.663 . . . . 2.2599999999999998 110.429 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -93.33 112.83 24.86 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.915 0.388 . . . . 3.9300000000000002 111.088 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 82.6 mt -83.89 141.63 41.16 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.938 -0.574 . . . . 2.0 110.767 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -83.44 160.35 14.84 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.502 2.135 . . . . 2.98 112.027 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 96.4 mt -137.91 115.86 11.58 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.19 -0.459 . . . . 3.6699999999999999 110.712 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -63.7 120.63 12.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.485 . . . . 5.5899999999999999 110.974 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.276 -0.869 . . . . 6.0 110.883 179.939 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.161 0 N-CA-C 112.456 -0.258 . . . . 7.9199999999999999 112.456 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.2 m 60.08 -178.99 0.09 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.832 0.348 . . . . 7.1799999999999997 111.132 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -134.72 79.16 1.78 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 5.9100000000000001 110.926 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 99.41 174.04 31.18 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.83 -0.7 . . . . 2.4500000000000002 112.443 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -68.02 91.35 0.34 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.86 0.362 . . . . 2.3300000000000001 111.015 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 79.6 p -95.31 109.64 21.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.026 -0.534 . . . . 2.5899999999999999 110.965 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 57.79 49.12 12.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.055 -0.52 . . . . 2.6699999999999999 110.999 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -108.64 111.29 23.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.027 -0.533 . . . . 1.5800000000000001 111.098 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.0 m 57.42 27.9 14.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.051 -0.522 . . . . 2.5499999999999998 110.957 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.67 -37.68 3.47 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.85 -0.69 . . . . 1.8200000000000001 112.498 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.442 ' HB3' HD11 ' A' ' 101' ' ' ILE . 90.7 m-85 -62.6 107.37 0.93 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.87 0.367 . . . . 1.7 111.031 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.0 t -120.0 134.04 55.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.935 -0.575 . . . . 0.90000000000000002 110.628 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 91.4 mt -76.71 121.51 23.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.244 -0.434 . . . . 0.89000000000000001 110.824 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -113.38 155.18 25.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.978 -0.555 . . . . 2.73 110.862 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 48.3 t -151.35 132.69 14.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.271 -0.422 . . . . 1.1899999999999999 111.154 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.4 t -131.56 128.77 61.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.11 -0.495 . . . . 0.56000000000000005 110.676 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -92.7 119.15 31.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 1.74 111.525 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.439 HD12 HD11 ' A' ' 98' ' ' LEU . 19.6 mt -119.16 113.09 20.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.093 -0.503 . . . . 0.81000000000000005 110.542 179.311 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.63 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 33.1 m-85 -79.58 114.21 18.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.092 -0.504 . . . . 2.0800000000000001 111.022 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.515 ' HG2' ' HA2' ' A' ' 93' ' ' GLY . 20.3 ttt180 -100.16 104.9 16.46 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.836 0.35 . . . . 3.0600000000000001 110.565 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -147.63 11.25 0.98 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.277 -0.42 . . . . 2.5800000000000001 111.019 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -94.7 156.44 16.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 3.7200000000000002 110.67 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -83.06 53.33 2.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.348 -0.387 . . . . 2.8700000000000001 110.69 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.2 p -120.31 -29.27 4.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 1.3799999999999999 110.95 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.441 ' HA ' ' NH2' ' A' ' 20' ' ' ARG . 41.2 t 59.61 14.88 4.24 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.691 -0.686 . . . . 2.4500000000000002 111.153 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 47.6 t -125.05 132.81 53.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 1.3999999999999999 110.699 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.428 HD21 ' HD2' ' A' ' 20' ' ' ARG . 95.2 mt -102.27 -11.8 18.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.45000000000000001 110.697 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.513 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 87.02 6.67 78.83 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.812 -0.709 . . . . 0.52000000000000002 112.584 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.42 HG23 HG22 ' A' ' 48' ' ' VAL . 67.7 mt -85.1 109.0 17.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.713 0.292 . . . . 0.83999999999999997 111.026 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.5 m -113.84 99.81 7.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.37 -0.377 . . . . 0.94999999999999996 110.822 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 36.7 pt -92.49 152.46 3.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.196 -0.456 . . . . 0.40999999999999998 111.343 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.9 p -108.07 133.25 52.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.033 -0.531 . . . . 1.3200000000000001 110.994 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.85 108.87 2.2 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.904 -0.665 . . . . 0.94999999999999996 112.529 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 27.9 ttt -81.87 102.55 10.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.762 0.315 . . . . 2.04 110.977 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.27 160.55 15.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 5.46 110.913 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -100.64 142.64 31.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.064 -0.516 . . . . 4.29 110.695 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -95.54 48.29 1.14 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.278 -0.419 . . . . 5.25 111.13 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 52.4 m 54.21 77.73 0.18 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.471 . . . . 4.8799999999999999 110.993 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 50.9 p -134.09 137.52 44.65 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.249 -0.432 . . . . 5.2699999999999996 111.084 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.9 t -88.26 11.4 16.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 6.9100000000000001 110.847 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -118.21 4.31 15.91 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.829 -0.7 . . . . 5.3600000000000003 112.388 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 57.3 88.53 0.05 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.863 0.363 . . . . 7.2199999999999998 111.031 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -101.68 38.57 1.59 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.121 -0.49 . . . . 3.0499999999999998 110.834 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 67.0 p -85.3 153.95 22.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.003 -0.544 . . . . 2.5299999999999998 111.105 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.17 148.6 18.14 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.706 -0.759 . . . . 1.1399999999999999 112.599 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 50.5 mm -108.71 131.1 60.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.758 0.313 . . . . 0.65000000000000002 110.913 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -153.67 137.23 15.96 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.362 -0.381 . . . . 0.69999999999999996 111.203 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.42 HG22 HG23 ' A' ' 29' ' ' ILE . 91.1 t -63.41 119.11 6.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.15 -0.477 . . . . 0.39000000000000001 110.888 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -98.1 -26.04 14.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.81 -0.632 . . . . 2.3999999999999999 110.952 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 79.8 p -153.56 162.32 41.37 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.926 0.393 . . . . 1.28 111.31 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.2 mt -123.84 156.03 36.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.96 -0.564 . . . . 0.41999999999999998 110.774 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.513 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 49.4 mm -99.28 114.02 65.23 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.312 -0.403 . . . . 1.26 110.871 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -62.15 119.73 6.97 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.446 2.097 . . . . 0.81999999999999995 112.196 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.34 7.76 29.93 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.893 -0.67 . . . . 0.48999999999999999 112.514 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.4 m -105.75 -174.48 2.54 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.626 0.251 . . . . 1.23 110.941 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.65 -47.38 66.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.888 0.375 . . . . 0.41999999999999998 111.14 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.546 ' HB1' HG21 ' A' ' 63' ' ' ILE . . . -57.31 -41.15 79.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.939 -0.573 . . . . 0.34999999999999998 111.533 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.49 -53.53 15.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.44 111.593 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 98.5 mt -60.55 -19.78 58.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.366 -0.379 . . . . 0.66000000000000003 111.295 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -62.34 -55.41 28.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.811 0.338 . . . . 1.8600000000000001 110.795 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 105.59 -49.75 0.87 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.826 -0.702 . . . . 1.0600000000000001 112.752 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -68.26 -23.41 64.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.739 0.304 . . . . 2.5899999999999999 111.126 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.546 HG21 ' HB1' ' A' ' 57' ' ' ALA . 39.5 mm -76.12 123.62 32.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.826 0.346 . . . . 0.92000000000000004 110.937 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -111.9 155.05 43.85 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.138 -0.483 . . . . 1.98 111.028 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -78.81 36.95 0.63 Allowed 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.943 2.429 . . . . 1.4399999999999999 112.259 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -169.29 75.93 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.296 -0.411 . . . . 2.1499999999999999 110.872 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -143.28 150.01 38.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 2.02 110.877 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.462 ' HB3' HG23 ' A' ' 101' ' ' ILE . 87.7 tttt -90.62 114.68 27.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.828 0.346 . . . . 1.02 111.129 -179.551 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.516 HD13 ' HB3' ' A' ' 100' ' ' LEU . 41.0 mm -84.16 137.54 20.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.215 -0.448 . . . . 0.28999999999999998 110.729 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 65.8 mt -117.08 -65.04 1.23 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.434 . . . . 0.40000000000000002 111.17 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -131.07 163.7 27.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.097 -0.501 . . . . 2.6099999999999999 111.703 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.551 HG12 ' N ' ' A' ' 73' ' ' ASP . 44.8 t -127.97 167.64 22.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.566 -0.743 . . . . 0.28000000000000003 109.562 179.017 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.617 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 7.7 t70 -41.6 108.11 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.5 0.555 . . . . 0.79000000000000004 112.5 -179.384 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 56.66 2.76 0.1 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.468 0.914 . . . . 2.0099999999999998 113.468 178.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.454 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 84.7 t -143.57 112.79 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.679 0.276 . . . . 0.79000000000000004 111.534 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -68.75 163.26 24.43 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.005 -0.368 . . . . 2.2400000000000002 110.005 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.7 m -134.38 0.08 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.718 0.294 . . . . 0.67000000000000004 111.651 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -91.5 109.32 20.61 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 120.883 0.373 . . . . 1.3899999999999999 110.385 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 125.57 -12.94 7.38 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.843 -0.694 . . . . 0.55000000000000004 112.516 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 74.4 mtm -105.44 158.66 16.5 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.839 0.352 . . . . 0.52000000000000002 110.996 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.39 162.19 15.53 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.198 -0.455 . . . . 0.39000000000000001 111.328 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -56.77 -46.38 81.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.329 -0.396 . . . . 1.52 111.136 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 85.4 p -53.42 -41.24 65.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.234 -0.439 . . . . 1.48 111.162 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -66.02 -44.04 85.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.296 -0.411 . . . . 2.1200000000000001 111.13 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 57.7 t -58.34 -39.8 75.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.154 -0.476 . . . . 0.32000000000000001 111.372 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 64.7 t -68.04 -43.52 85.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.496 -0.32 . . . . 0.37 111.145 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -57.35 -43.67 83.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.355 -0.384 . . . . 1.51 110.944 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 57.3 t -61.16 -55.47 24.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.46 . . . . 0.27000000000000002 111.181 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 90.8 mt -52.62 -27.56 17.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.974 -0.557 . . . . 0.40999999999999998 111.301 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 74.4 mtm180 -89.17 -28.25 20.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.286 -0.415 . . . . 2.1000000000000001 111.271 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -74.07 -14.99 61.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.399 -0.364 . . . . 1.1399999999999999 110.693 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.47 ' HB3' ' HD3' ' A' ' 20' ' ' ARG . . . -54.33 -81.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.994 -0.548 . . . . 0.55000000000000004 111.364 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.515 ' HA2' ' HG2' ' A' ' 20' ' ' ARG . . . 61.1 17.42 51.93 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.655 -0.783 . . . . 0.76000000000000001 112.139 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.443 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 8.2 p30 -147.13 170.88 7.05 Favored Pre-proline 0 CA--C 1.534 0.329 0 C-N-CA 122.06 0.144 . . . . 2.52 110.877 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.63 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 47.4 Cg_exo -58.25 104.2 0.17 Allowed 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.081 1.854 . . . . 0.64000000000000001 111.555 178.299 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 23.6 m -112.68 155.1 14.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.041 0.448 . . . . 0.64000000000000001 112.011 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.617 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 35.3 ttp180 -111.46 145.25 39.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.695 -0.684 . . . . 2.3700000000000001 109.949 179.295 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.439 HD11 HD12 ' A' ' 18' ' ' LEU . 25.9 mt -110.02 124.1 50.86 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.356 -0.383 . . . . 0.37 111.255 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 32.7 tp -109.88 101.08 9.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.332 -0.395 . . . . 0.37 110.245 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.516 ' HB3' HD13 ' A' ' 69' ' ' ILE . 0.4 OUTLIER -130.55 160.67 33.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.31 111.396 -179.467 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.462 HG23 ' HB3' ' A' ' 68' ' ' LYS . 12.6 tt -116.08 141.92 31.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.873 -0.603 . . . . 0.45000000000000001 110.896 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 32.3 tpt180 -141.49 132.29 25.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.043 -0.526 . . . . 2.2599999999999998 110.979 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 22.5 ttm180 -74.09 143.85 45.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.116 -0.493 . . . . 3.9300000000000002 110.623 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 59.9 mt -87.2 140.91 32.52 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.299 -0.41 . . . . 2.0 110.897 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -81.96 62.09 8.03 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.805 2.337 . . . . 2.98 112.363 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 91.5 mt -61.19 112.35 2.09 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.602 -0.726 . . . . 3.6699999999999999 110.887 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 80.4 mt -69.8 130.01 41.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 5.5899999999999999 111.085 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 . . . . . 0 C--O 1.251 1.155 0 CA-C-O 118.344 -0.836 . . . . 6.0 111.054 179.919 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.128 0 N-CA-C 112.5 -0.24 . . . . 7.9199999999999999 112.5 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.1 p -119.72 155.05 33.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.871 0.367 . . . . 7.1799999999999997 111.266 179.972 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -145.75 -4.42 0.66 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.951 -0.568 . . . . 5.9100000000000001 110.871 179.548 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 132.78 -62.26 0.64 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.822 -0.704 . . . . 2.4500000000000002 112.352 -179.881 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -106.16 125.85 51.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.771 0.32 . . . . 2.3300000000000001 110.729 179.762 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 45.0 t -128.33 95.16 4.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 2.5899999999999999 111.076 -179.688 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.7 t70 56.54 79.88 0.17 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.053 -0.521 . . . . 2.6699999999999999 111.144 179.872 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -133.88 113.45 12.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.043 -0.526 . . . . 1.5800000000000001 110.751 179.825 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.6 t 57.52 20.09 5.84 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.16 -0.473 . . . . 2.5499999999999998 110.864 -179.948 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.7 37.58 11.66 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.847 -0.692 . . . . 1.8200000000000001 112.634 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -135.83 137.33 41.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.878 0.37 . . . . 1.7 110.917 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 44.2 t -156.86 139.65 15.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.072 -0.513 . . . . 0.90000000000000002 110.869 -179.945 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 62.6 mt -77.55 126.37 30.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.06 -0.518 . . . . 0.89000000000000001 110.824 179.826 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.404 ' CD2' ' HB2' ' A' ' 102' ' ' ARG . 58.5 m-85 -123.65 130.42 52.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.12 -0.491 . . . . 2.73 111.023 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 80.8 p -120.42 139.26 53.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.285 -0.416 . . . . 1.1899999999999999 111.091 -179.815 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.3 t -131.58 146.4 33.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.116 -0.493 . . . . 0.56000000000000005 110.743 179.991 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -103.0 114.04 28.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.381 -0.372 . . . . 1.74 111.386 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.475 HD12 ' HB1' ' A' ' 56' ' ' ALA . 4.6 mm? -115.5 166.1 12.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.079 -0.509 . . . . 0.81000000000000005 110.702 179.537 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.545 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 37.9 p90 -159.51 131.69 6.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.277 -0.42 . . . . 2.0800000000000001 111.053 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.7 HH21 ' HG ' ' A' ' 27' ' ' LEU . 27.8 ttm180 -109.85 130.86 55.47 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.68 -0.408 . . . . 3.0600000000000001 110.879 179.635 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -134.67 6.68 3.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.01 -0.541 . . . . 2.5800000000000001 110.73 179.777 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -112.47 162.7 15.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.007 -0.542 . . . . 3.7200000000000002 110.788 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -86.7 42.98 1.05 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.262 -0.426 . . . . 2.8700000000000001 110.958 -179.911 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 69.3 p -86.98 -13.01 45.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 1.3799999999999999 111.339 -179.924 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 94.8 p 50.56 24.56 1.67 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.778 -0.646 . . . . 2.4500000000000002 111.504 179.89 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 80.5 p -158.7 153.32 24.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.297 -0.41 . . . . 1.3999999999999999 110.904 -179.938 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.7 ' HG ' HH21 ' A' ' 20' ' ' ARG . 84.0 mt -107.76 -13.17 15.07 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.012 -0.54 . . . . 0.45000000000000001 110.998 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.546 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 100.69 18.94 19.25 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.828 -0.701 . . . . 0.52000000000000002 112.741 179.748 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 78.2 mt -97.52 112.46 29.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.702 0.287 . . . . 0.83999999999999997 110.694 179.751 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.9 t -110.12 101.93 10.68 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.337 -0.392 . . . . 0.94999999999999996 111.019 -179.713 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.436 ' HA ' ' HA ' ' A' ' 48' ' ' VAL . 33.2 pt -92.33 163.41 2.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.967 -0.56 . . . . 0.40999999999999998 110.914 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 47.9 t -147.33 156.69 43.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.179 -0.464 . . . . 1.3200000000000001 110.782 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -114.79 103.62 1.28 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.722 -0.752 . . . . 0.94999999999999996 112.558 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.431 ' H ' ' HE1' ' A' ' 47' ' ' TYR . 48.6 ttm -64.55 138.7 58.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.841 0.353 . . . . 2.04 110.788 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 24.8 mmm180 -127.58 43.92 3.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.208 -0.451 . . . . 5.46 110.953 -179.872 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -114.1 140.62 48.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.103 -0.499 . . . . 4.29 110.974 -180.0 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -97.75 110.61 23.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 5.25 110.946 179.843 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.3 t -113.29 132.77 55.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.469 . . . . 4.8799999999999999 110.901 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 67.7 p -68.73 133.98 49.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.084 -0.507 . . . . 5.2699999999999996 111.055 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 14.6 t 41.96 33.52 0.37 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.791 -0.641 . . . . 6.9100000000000001 111.424 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -125.0 170.22 16.95 Favored Glycine 0 N--CA 1.451 -0.301 0 CA-C-N 115.632 -0.713 . . . . 5.3600000000000003 112.518 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -90.24 153.14 20.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.805 0.336 . . . . 7.2199999999999998 110.94 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -163.93 -168.92 1.72 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 116.154 -0.475 . . . . 3.0499999999999998 110.357 179.872 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 58.9 p 48.31 -163.0 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.768 -0.651 . . . . 2.5299999999999998 111.491 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.09 155.66 9.34 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.785 -0.722 . . . . 1.1399999999999999 112.551 179.836 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 42.8 mm -83.92 114.09 23.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.784 0.326 . . . . 0.65000000000000002 110.806 179.87 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.431 ' HE1' ' H ' ' A' ' 34' ' ' MET . 54.2 p90 -132.52 141.17 48.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 0.69999999999999996 111.074 -179.888 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.436 ' HA ' ' HA ' ' A' ' 31' ' ' ILE . 97.8 t -80.19 111.86 17.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.147 -0.479 . . . . 0.39000000000000001 110.51 179.444 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -84.39 -34.67 23.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.092 -0.503 . . . . 2.3999999999999999 111.284 -179.607 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 83.0 p -151.06 179.07 8.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.064 0.459 . . . . 1.28 111.527 -179.718 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 66.6 mt -134.06 160.84 36.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.725 -0.67 . . . . 0.41999999999999998 110.558 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.546 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 53.2 mt -96.54 108.55 43.1 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.257 -0.429 . . . . 1.26 111.12 179.954 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -59.34 127.54 24.29 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.348 2.032 . . . . 0.81999999999999995 112.324 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 104.69 -2.68 42.1 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.763 -0.732 . . . . 0.48999999999999999 112.549 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.6 m -95.68 -179.03 4.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.659 0.266 . . . . 1.23 110.99 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.475 ' HB1' HD12 ' A' ' 18' ' ' LEU . . . -65.69 -55.44 17.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.36 -0.382 . . . . 0.41999999999999998 111.189 179.937 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.72 -33.05 63.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.061 -0.518 . . . . 0.34999999999999998 111.413 -179.852 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.38 -50.47 31.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.259 -0.428 . . . . 0.44 111.442 -179.739 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.2 mt -61.4 -21.27 63.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.312 -0.404 . . . . 0.66000000000000003 111.123 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -60.66 -54.72 41.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.405 -0.361 . . . . 1.8600000000000001 110.977 -179.782 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.34 -46.85 1.79 Allowed Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.742 -0.742 . . . . 1.0600000000000001 112.927 179.458 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 66.9 mtp180 -56.45 -39.27 72.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.772 0.32 . . . . 2.5899999999999999 110.991 -179.772 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 64.6 mt -68.57 108.55 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.92000000000000004 110.883 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -107.29 137.41 19.6 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.038 -0.528 . . . . 1.98 110.715 -179.702 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -54.91 175.64 0.15 Allowed 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.571 2.181 . . . . 1.4399999999999999 112.278 179.855 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 59.32 44.48 15.28 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.031 0.443 . . . . 2.1499999999999999 110.285 -179.632 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -119.51 167.22 12.18 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.895 -0.593 . . . . 2.02 110.807 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -116.71 123.07 46.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.316 -0.402 . . . . 1.02 110.962 179.911 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.495 HD13 ' HB3' ' A' ' 100' ' ' LEU . 47.5 mm -81.16 139.11 18.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.159 -0.473 . . . . 0.28999999999999998 111.202 -179.729 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 79.2 mt -105.53 -68.75 0.85 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.906 -0.588 . . . . 0.40000000000000002 110.723 179.844 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.437 ' HG2' HD23 ' A' ' 99' ' ' LEU . 10.3 ptp180 -150.24 137.42 19.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 2.6099999999999999 111.21 -179.868 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.676 HG12 ' H ' ' A' ' 73' ' ' ASP . 2.6 t -87.19 175.29 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.712 -0.676 . . . . 0.28000000000000003 110.285 179.579 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.676 ' H ' HG12 ' A' ' 72' ' ' VAL . 17.7 t70 -50.49 112.7 0.73 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.773 0.321 . . . . 0.79000000000000004 111.465 179.432 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 56.69 23.23 7.61 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.079 -0.51 . . . . 2.0099999999999998 111.806 179.548 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.465 HG11 HG11 ' A' ' 88' ' ' VAL . 68.2 t -143.74 144.44 23.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.82 0.343 . . . . 0.79000000000000004 110.923 179.855 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -115.69 133.05 56.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.311 -0.404 . . . . 2.2400000000000002 110.504 179.668 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.543 HG11 HG13 ' A' ' 85' ' ' VAL . 31.2 m -121.15 35.49 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.849 0.357 . . . . 0.67000000000000004 111.722 -179.39 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -97.51 41.46 1.12 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.302 -0.408 . . . . 1.3899999999999999 111.051 179.948 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.19 36.18 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.449 -0.881 . . . . 0.55000000000000004 113.235 179.77 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 52.4 mtm -127.91 158.55 37.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.844 0.354 . . . . 0.52000000000000002 110.849 179.562 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.08 151.5 42.95 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.104 -0.498 . . . . 0.39000000000000001 111.149 -179.935 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -53.57 -55.0 29.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.334 -0.393 . . . . 1.52 111.308 -179.556 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 59.4 m -53.57 -37.37 62.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 1.48 111.445 -179.512 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -64.02 -42.35 97.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.478 -0.328 . . . . 2.1200000000000001 110.926 -179.826 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.543 HG13 HG11 ' A' ' 77' ' ' VAL . 48.0 t -61.08 -41.71 90.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.218 -0.447 . . . . 0.32000000000000001 111.05 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 47.8 t -63.3 -39.89 86.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.262 -0.426 . . . . 0.37 111.013 179.929 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.451 ' HG2' HH21 ' A' ' 90' ' ' ARG . 47.8 mt-10 -57.72 -48.05 80.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 1.51 111.072 -179.953 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.465 HG11 HG11 ' A' ' 75' ' ' VAL . 65.7 t -57.26 -55.86 18.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.27000000000000002 111.368 -179.889 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 91.4 mt -52.11 -32.64 36.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.028 -0.533 . . . . 0.40999999999999998 111.222 -179.445 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.6 ' HA ' HH22 ' A' ' 20' ' ' ARG . 80.0 mtm180 -81.04 -30.27 34.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.34 -0.391 . . . . 2.1000000000000001 111.291 -179.912 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -68.96 -22.26 64.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.443 -0.344 . . . . 1.1399999999999999 110.707 179.891 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.38 -84.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.093 -0.503 . . . . 0.55000000000000004 111.275 179.778 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.66 ' HA2' ' HD2' ' A' ' 20' ' ' ARG . . . 64.11 19.41 63.73 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.81 -0.709 . . . . 0.76000000000000001 112.555 -179.794 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -146.96 178.63 1.37 Allowed Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 110.263 -0.273 . . . . 2.52 110.263 -179.752 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.545 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 33.2 Cg_exo -60.46 102.79 0.2 Allowed 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.07 1.847 . . . . 0.64000000000000001 111.954 178.196 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 30.1 m -121.15 156.79 24.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.062 0.458 . . . . 0.64000000000000001 111.508 -179.552 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.625 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 76.3 ttt180 -101.58 142.51 32.83 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.826 -0.625 . . . . 2.3700000000000001 110.351 179.791 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 13.1 mt -118.21 111.63 19.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.191 -0.459 . . . . 0.37 111.024 -179.6 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.437 HD23 ' HG2' ' A' ' 71' ' ' ARG . 45.1 tp -101.65 103.82 14.64 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.834 0.349 . . . . 0.37 110.561 179.489 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.495 ' HB3' HD13 ' A' ' 69' ' ' ILE . 0.5 OUTLIER -132.38 155.14 48.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.125 -0.489 . . . . 0.31 111.102 -179.548 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 15.2 tt -103.13 136.92 33.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.45000000000000001 111.103 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.404 ' HB2' ' CD2' ' A' ' 14' ' ' TYR . 21.6 mmm180 -117.62 129.0 55.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.702 -0.681 . . . . 2.2599999999999998 110.518 179.809 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -87.75 118.76 27.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.239 -0.437 . . . . 3.9300000000000002 110.956 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 54.6 mt -84.55 148.13 51.24 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.074 -0.512 . . . . 2.0 110.611 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -82.75 162.08 16.37 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.577 2.185 . . . . 2.98 112.184 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.411 HD22 ' N ' ' A' ' 106' ' ' LEU . 3.8 mm? -108.49 111.49 23.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.165 -0.47 . . . . 3.6699999999999999 111.139 -179.815 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.441 HD22 ' N ' ' A' ' 107' ' ' LEU . 3.7 mm? -100.9 98.33 8.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.144 -0.48 . . . . 5.5899999999999999 110.793 179.872 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.206 -0.902 . . . . 6.0 110.898 179.99 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.166 0 N-CA-C 112.484 -0.247 . . . . 7.9199999999999999 112.484 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 63.6 m -109.31 172.8 6.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.912 0.387 . . . . 7.1799999999999997 110.914 -179.961 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 65.1 m-70 -131.64 125.16 31.47 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.974 -0.557 . . . . 5.9100000000000001 110.744 179.892 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -158.24 42.43 0.5 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.851 -0.69 . . . . 2.4500000000000002 112.262 179.879 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -101.55 84.36 2.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.94 0.4 . . . . 2.3300000000000001 110.971 -179.876 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.4 t -88.76 82.7 6.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.087 -0.506 . . . . 2.5899999999999999 110.718 179.779 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.1 t70 58.93 97.8 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.997 -0.547 . . . . 2.6699999999999999 111.013 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -128.32 88.7 2.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.106 -0.497 . . . . 1.5800000000000001 111.128 179.946 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 69.9 m 56.41 23.62 7.58 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.01 -0.541 . . . . 2.5499999999999998 111.056 179.957 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.423 ' HA3' ' HG3' ' A' ' 103' ' ' ARG . . . 101.98 -41.53 2.11 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.776 -0.726 . . . . 1.8200000000000001 112.624 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -58.88 123.52 16.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.795 0.331 . . . . 1.7 110.918 179.956 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.542 ' HB3' HD11 ' A' ' 104' ' ' LEU . 46.0 t -161.38 156.92 24.46 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.098 -0.501 . . . . 0.90000000000000002 111.276 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.544 HD23 ' HB ' ' A' ' 101' ' ' ILE . 17.8 mt -97.21 103.31 15.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.497 -0.774 . . . . 0.89000000000000001 110.1 179.599 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 36.5 p90 -124.5 151.91 44.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.858 0.361 . . . . 2.73 111.119 -179.344 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 48.4 t -120.68 155.81 33.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.024 0.44 . . . . 1.1899999999999999 111.383 -179.436 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.8 t -131.66 137.69 54.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.758 -0.656 . . . . 0.56000000000000005 110.416 179.801 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -88.51 114.43 25.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.947 0.403 . . . . 1.74 111.406 -179.491 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -124.95 117.67 24.57 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.892 -0.595 . . . . 0.81000000000000005 110.614 179.614 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.582 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 28.2 p90 -107.66 132.97 52.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.378 -0.374 . . . . 2.0800000000000001 111.053 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.65 ' HE ' ' HA2' ' A' ' 93' ' ' GLY . 20.7 ttp180 -107.78 102.89 12.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.853 0.359 . . . . 3.0600000000000001 110.861 179.56 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -128.08 -3.03 5.75 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.149 -0.478 . . . . 2.5800000000000001 111.113 -179.797 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.431 ' N ' ' HD2' ' A' ' 22' ' ' LYS . 0.9 OUTLIER -83.78 159.77 21.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.306 -0.407 . . . . 3.7200000000000002 110.792 179.825 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -83.32 34.65 0.47 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.468 . . . . 2.8700000000000001 110.978 -179.885 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 50.3 p -92.14 -23.22 19.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.283 -0.417 . . . . 1.3799999999999999 111.127 -179.872 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.7 m 56.91 24.67 9.62 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.879 -0.601 . . . . 2.4500000000000002 111.361 179.785 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 52.5 m -147.19 157.9 43.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.359 -0.382 . . . . 1.3999999999999999 111.053 -179.885 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.585 HD21 ' HB2' ' A' ' 20' ' ' ARG . 86.1 mt -114.98 1.1 13.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.175 -0.466 . . . . 0.45000000000000001 110.981 179.876 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 67.87 23.44 74.22 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.795 -0.717 . . . . 0.52000000000000002 112.735 179.898 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 62.5 mt -97.61 110.01 24.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.648 0.261 . . . . 0.83999999999999997 110.919 179.896 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 35.9 t -107.54 98.48 8.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.386 -0.37 . . . . 0.94999999999999996 111.01 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 40.6 pt -83.58 159.39 3.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.294 -0.412 . . . . 0.40999999999999998 111.142 -179.878 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 47.9 t -138.7 152.02 47.66 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.049 -0.523 . . . . 1.3200000000000001 110.989 -179.78 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -97.85 140.19 14.89 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.772 -0.727 . . . . 0.94999999999999996 112.471 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 59.8 ttp -89.16 120.26 30.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.789 0.328 . . . . 2.04 110.722 -179.919 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.14 89.22 4.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 5.46 110.965 -179.923 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -104.98 127.59 52.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.043 -0.526 . . . . 4.29 110.72 179.84 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -99.09 17.66 19.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 5.25 111.029 -179.826 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 61.2 m -156.25 130.58 8.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 4.8799999999999999 110.811 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 77.8 p -97.57 142.2 29.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.073 -0.512 . . . . 5.2699999999999996 111.107 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.6 t -164.76 9.52 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.241 -0.436 . . . . 6.9100000000000001 111.242 -179.991 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 156.8 -56.9 0.38 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.689 -0.767 . . . . 5.3600000000000003 112.551 179.905 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -103.0 125.86 49.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.768 0.318 . . . . 7.2199999999999998 110.954 -179.877 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -123.8 105.98 10.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.207 -0.451 . . . . 3.0499999999999998 111.128 -179.897 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 40.0 p 52.84 -171.92 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.037 -0.529 . . . . 2.5299999999999998 111.543 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 146.72 168.69 13.84 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.762 -0.732 . . . . 1.1399999999999999 112.64 -179.946 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 45.9 mm -106.39 127.25 61.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.752 0.31 . . . . 0.65000000000000002 111.032 -179.922 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -152.72 140.9 20.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.283 -0.417 . . . . 0.69999999999999996 110.825 179.796 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 97.0 t -74.48 116.29 16.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.078 -0.51 . . . . 0.39000000000000001 110.869 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -103.9 -25.08 13.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.22 -0.445 . . . . 2.3999999999999999 110.917 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 42.3 t -141.13 165.86 26.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 1.28 111.216 -179.926 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.463 HD11 HG22 ' A' ' 63' ' ' ILE . 95.6 mt -136.67 163.64 30.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.913 -0.585 . . . . 0.41999999999999998 110.792 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 50.1 mm -108.02 103.52 50.31 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.321 -0.399 . . . . 1.26 111.076 -179.853 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.93 132.1 47.99 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.426 2.084 . . . . 0.81999999999999995 112.297 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 99.68 -4.9 58.14 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.789 -0.72 . . . . 0.48999999999999999 112.408 -179.779 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.8 t -93.66 167.98 11.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.614 0.245 . . . . 1.23 110.944 -179.876 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -53.91 -57.84 9.5 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.283 -0.417 . . . . 0.41999999999999998 111.704 -179.75 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.35 -43.78 61.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.34999999999999998 111.468 -179.638 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.7 -34.57 77.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.44 111.719 -179.52 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 70.2 mt -62.94 -37.04 85.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.456 -0.338 . . . . 0.66000000000000003 111.444 -179.622 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.03 -44.88 95.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.469 -0.332 . . . . 1.8600000000000001 111.017 -179.878 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.76 -27.29 4.36 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.79 -0.719 . . . . 1.0600000000000001 112.652 179.892 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 78.4 mtp180 -62.51 -19.23 63.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.837 0.351 . . . . 2.5899999999999999 111.102 -179.955 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.509 ' N ' HD12 ' A' ' 63' ' ' ILE . 3.2 mp -82.5 104.55 11.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.115 -0.493 . . . . 0.92000000000000004 110.695 179.808 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -93.71 137.23 23.3 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.088 -0.506 . . . . 1.98 110.7 -179.764 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -51.47 160.8 2.24 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.38 2.053 . . . . 1.4399999999999999 112.316 179.693 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.1 m120 58.7 44.89 16.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.186 -0.461 . . . . 2.1499999999999999 110.787 -179.855 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -95.11 143.19 26.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.906 -0.588 . . . . 2.02 111.049 -179.88 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.675 ' HB3' HG23 ' A' ' 101' ' ' ILE . 25.9 tptp -91.85 101.49 14.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.108 -0.497 . . . . 1.02 111.152 -179.948 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.455 HG22 HG21 ' A' ' 77' ' ' VAL . 40.0 mm -74.33 134.39 29.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.494 -0.321 . . . . 0.28999999999999998 110.62 179.627 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 88.3 mt -108.91 -57.26 2.17 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.395 -0.366 . . . . 0.40000000000000002 111.139 -179.766 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -157.87 138.95 13.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.088 0.47 . . . . 2.6099999999999999 111.623 -179.738 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.631 HG12 ' H ' ' A' ' 73' ' ' ASP . 5.3 t -88.45 174.23 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.543 -0.753 . . . . 0.28000000000000003 109.855 179.242 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.67 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 14.9 t70 -46.6 111.0 0.33 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.866 0.365 . . . . 0.79000000000000004 111.957 179.845 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 54.1 29.02 9.64 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.021 -0.536 . . . . 2.0099999999999998 112.084 179.113 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 96.2 t -147.28 137.27 16.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.419 -0.355 . . . . 0.79000000000000004 110.771 179.729 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -103.51 132.19 49.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.42 -0.355 . . . . 2.2400000000000002 110.594 179.716 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.455 HG21 HG22 ' A' ' 69' ' ' ILE . 34.6 m -112.24 26.07 3.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-O 120.817 0.342 . . . . 0.67000000000000004 111.423 -179.588 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -95.26 31.03 2.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 1.3899999999999999 111.158 179.823 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 173.53 37.23 0.04 OUTLIER Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.575 -0.821 . . . . 0.55000000000000004 112.751 179.818 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 51.6 mtm -128.99 142.71 50.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.787 0.327 . . . . 0.52000000000000002 110.83 179.824 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.32 161.5 9.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.39000000000000001 111.254 -179.884 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.436 ' O ' HG23 ' A' ' 86' ' ' VAL . 35.6 tt0 -53.96 -60.97 2.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.256 -0.429 . . . . 1.52 110.949 -179.847 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 54.5 m -55.29 -26.74 42.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.244 -0.434 . . . . 1.48 111.386 -179.737 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -69.64 -54.21 14.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.771 0.319 . . . . 2.1200000000000001 110.894 -179.786 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.7 t -56.1 -39.08 56.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.298 -0.41 . . . . 0.32000000000000001 110.922 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.491 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 59.7 t -58.53 -55.86 20.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.232 -0.44 . . . . 0.37 110.628 179.586 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -47.6 -41.6 22.12 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.073 -0.512 . . . . 1.51 111.001 179.893 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 54.0 t -56.29 -51.84 58.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.164 -0.471 . . . . 0.27000000000000002 110.711 179.309 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 76.1 mt -56.28 -28.61 59.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.755 -0.657 . . . . 0.40999999999999998 110.792 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.491 ' HG2' ' O ' ' A' ' 86' ' ' VAL . 20.9 mmt180 -79.6 -30.3 41.44 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.082 -0.508 . . . . 2.1000000000000001 110.654 179.982 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -75.16 -18.41 60.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.052 -0.522 . . . . 1.1399999999999999 110.845 -179.824 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.53 -88.63 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.049 -0.523 . . . . 0.55000000000000004 111.636 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.65 ' HA2' ' HE ' ' A' ' 20' ' ' ARG . . . 60.97 16.97 49.98 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.746 -0.74 . . . . 0.76000000000000001 112.509 -179.741 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.435 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 5.7 p30 -146.99 172.9 4.66 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 110.657 -0.127 . . . . 2.52 110.657 -179.677 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.582 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 37.5 Cg_exo -62.39 97.45 0.17 Allowed 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 122.068 1.845 . . . . 0.64000000000000001 111.625 178.338 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 29.0 m -105.64 156.41 6.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.64000000000000001 111.717 -179.307 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.67 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 78.5 ttt180 -103.55 142.14 34.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.713 -0.676 . . . . 2.3700000000000001 110.029 179.366 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 21.3 mt -115.14 104.37 11.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 0.37 111.35 -179.214 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 34.3 tp -95.8 111.59 23.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.82 0.343 . . . . 0.37 110.172 179.173 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.09 166.84 23.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.086 0.469 . . . . 0.31 111.628 -179.105 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.675 HG23 ' HB3' ' A' ' 68' ' ' LYS . 4.1 tt -121.92 138.32 52.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.684 -0.689 . . . . 0.45000000000000001 110.478 179.71 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 33.0 tpt180 -166.29 145.78 5.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.322 -0.399 . . . . 2.2599999999999998 110.784 -179.831 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.423 ' HG3' ' HA3' ' A' ' 10' ' ' GLY . 19.4 ttm180 -62.53 144.95 55.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.932 -0.576 . . . . 3.9300000000000002 111.147 -179.672 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.542 HD11 ' HB3' ' A' ' 12' ' ' SER . 1.9 mt -111.34 150.52 42.19 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.778 -0.646 . . . . 2.0 110.774 -179.684 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -81.75 160.95 18.97 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.477 2.118 . . . . 2.98 112.07 179.67 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 98.5 mt -139.39 116.21 10.85 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.078 -0.51 . . . . 3.6699999999999999 110.764 -179.877 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 91.7 mt -70.33 108.19 4.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 5.5899999999999999 111.001 -179.874 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.132 -0.937 . . . . 6.0 110.963 179.871 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.186 0 N-CA-C 112.441 -0.264 . . . . 7.9199999999999999 112.441 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 53.4 m -151.39 -54.42 0.14 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.784 0.326 . . . . 7.1799999999999997 110.938 179.998 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 69.9 m80 -91.05 92.17 8.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.45 . . . . 5.9100000000000001 110.952 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -148.73 85.2 0.16 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.768 -0.73 . . . . 2.4500000000000002 112.562 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -111.56 163.87 13.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.746 0.308 . . . . 2.3300000000000001 110.709 179.867 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.5 m -147.84 87.15 1.61 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.253 -0.43 . . . . 2.5899999999999999 110.823 179.968 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 55.34 85.84 0.06 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.128 -0.487 . . . . 2.6699999999999999 111.015 -179.899 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -127.9 100.98 6.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.182 -0.463 . . . . 1.5800000000000001 111.147 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.2 t 58.0 28.41 16.21 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.985 -0.552 . . . . 2.5499999999999998 111.041 179.763 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.77 -49.53 1.59 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.742 -0.742 . . . . 1.8200000000000001 112.323 -179.855 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -56.27 106.46 0.28 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.789 0.328 . . . . 1.7 110.719 179.764 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 48.3 t -142.09 158.46 43.73 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 116.122 -0.49 . . . . 0.90000000000000002 111.383 -179.649 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.529 HD23 ' HB ' ' A' ' 101' ' ' ILE . 15.6 mt -93.88 101.86 13.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.468 -0.787 . . . . 0.89000000000000001 110.076 179.58 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.416 ' HE1' ' HB3' ' A' ' 102' ' ' ARG . 40.5 p90 -121.88 148.08 45.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.927 0.394 . . . . 2.73 111.117 -179.464 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 80.3 p -112.57 146.99 37.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.052 -0.522 . . . . 1.1899999999999999 111.143 -179.68 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 17.2 t -120.31 135.3 61.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.096 -0.502 . . . . 0.56000000000000005 110.644 179.751 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -92.09 111.53 23.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.323 -0.399 . . . . 1.74 111.614 -179.509 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.56 HD12 ' HB1' ' A' ' 56' ' ' ALA . 3.5 mm? -116.14 166.16 12.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.94 -0.573 . . . . 0.81000000000000005 110.184 179.112 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.576 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 42.2 p90 -153.61 136.93 15.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.796 0.332 . . . . 2.0800000000000001 111.433 -179.745 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.461 HH21 ' N ' ' A' ' 93' ' ' GLY . 21.5 ttp180 -121.31 140.32 52.25 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.175 -0.466 . . . . 3.0600000000000001 110.607 179.317 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -160.63 26.15 0.15 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.388 -0.369 . . . . 2.5800000000000001 111.317 -179.947 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -123.17 165.46 16.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.33 -0.395 . . . . 3.7200000000000002 110.712 179.602 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -88.96 72.58 8.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.243 -0.435 . . . . 2.8700000000000001 110.799 -179.951 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 48.3 p -124.07 -24.89 4.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.06 -0.518 . . . . 1.3799999999999999 110.987 179.935 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.0 t 58.35 23.82 10.93 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.775 -0.648 . . . . 2.4500000000000002 111.189 179.687 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 56.5 m -151.18 136.08 17.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.893 0.378 . . . . 1.3999999999999999 111.086 -179.918 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.456 HD21 ' HB2' ' A' ' 20' ' ' ARG . 46.7 mt -97.11 -12.29 23.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.017 -0.538 . . . . 0.45000000000000001 110.608 179.707 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.516 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 92.78 20.59 33.56 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.851 -0.69 . . . . 0.52000000000000002 112.509 179.91 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 75.9 mt -98.59 112.14 29.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.717 0.294 . . . . 0.83999999999999997 111.064 179.956 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 70.4 m -113.68 98.89 7.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.94999999999999996 110.834 179.921 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 36.9 pt -91.34 166.7 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.186 -0.461 . . . . 0.40999999999999998 111.376 -179.854 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 44.8 t -147.4 153.59 39.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.029 -0.532 . . . . 1.3200000000000001 110.654 -179.981 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.95 146.36 16.32 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.738 -0.744 . . . . 0.94999999999999996 112.529 -179.991 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 71.6 mtm -82.49 141.26 32.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.754 0.311 . . . . 2.04 110.737 179.919 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.404 ' HD3' ' N ' ' A' ' 35' ' ' ARG . 0.1 OUTLIER -96.92 84.45 3.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 5.46 110.966 -179.971 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -95.49 135.95 36.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 4.29 110.953 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -115.89 27.03 9.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.141 -0.482 . . . . 5.25 110.903 -179.928 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 46.8 t -156.08 112.9 3.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 4.8799999999999999 110.916 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 39.4 p -87.04 138.34 31.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.072 -0.513 . . . . 5.2699999999999996 111.14 179.909 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.2 t -146.05 -3.08 0.68 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 6.9100000000000001 111.059 179.864 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 162.7 -61.11 0.27 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.801 -0.714 . . . . 5.3600000000000003 112.352 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -95.76 166.15 11.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.76 0.314 . . . . 7.2199999999999998 110.886 -179.907 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -139.39 115.75 10.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.26 -0.427 . . . . 3.0499999999999998 111.203 -179.872 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 46.5 p 52.13 -171.92 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.917 -0.583 . . . . 2.5299999999999998 111.812 179.866 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -175.48 138.02 4.04 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.904 -0.665 . . . . 1.1399999999999999 112.395 -179.965 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 40.5 mm -84.74 124.11 39.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.723 0.297 . . . . 0.65000000000000002 111.164 -179.899 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -155.94 139.19 15.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.238 -0.437 . . . . 0.69999999999999996 110.715 179.862 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 57.5 t -76.74 127.11 37.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.222 -0.445 . . . . 0.39000000000000001 111.111 -179.84 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -116.71 -22.55 8.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.036 -0.529 . . . . 2.3999999999999999 111.165 -179.763 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 46.9 t -139.58 163.39 32.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.952 0.406 . . . . 1.28 111.304 -179.871 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 76.0 mt -134.78 163.17 30.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.888 -0.596 . . . . 0.41999999999999998 110.807 179.984 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.516 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 48.5 mm -110.32 98.92 38.15 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.29 -0.414 . . . . 1.26 110.96 179.67 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.07 126.88 22.92 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.404 2.069 . . . . 0.81999999999999995 112.28 -179.928 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.76 -4.54 32.41 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.905 -0.664 . . . . 0.48999999999999999 112.625 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.442 ' OG ' ' HA3' ' A' ' 28' ' ' GLY . 93.1 p -99.47 -172.54 2.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.903 0.383 . . . . 1.23 111.058 -179.814 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.56 ' HB1' HD12 ' A' ' 18' ' ' LEU . . . -67.8 -58.06 5.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.052 -0.522 . . . . 0.41999999999999998 111.333 -179.951 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.4 ' HA ' ' HA3' ' A' ' 61' ' ' GLY . . . -59.81 -22.91 62.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.079 -0.51 . . . . 0.34999999999999998 111.438 -179.782 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.15 -31.62 34.06 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.511 -0.313 . . . . 0.44 111.776 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.5 mt -83.45 -59.27 2.5 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.313 0.486 . . . . 0.66000000000000003 112.313 -179.038 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -103.98 -24.53 13.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.665 0.269 . . . . 1.8600000000000001 111.331 -178.781 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.469 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -64.53 87.15 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.516 -0.85 . . . . 1.0600000000000001 112.246 179.959 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 -61.31 0.75 0.24 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.603 0.24 . . . . 2.5899999999999999 111.234 179.751 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.469 ' H ' ' C ' ' A' ' 61' ' ' GLY . 59.2 mt -48.95 125.65 2.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.276 -0.42 . . . . 0.92000000000000004 111.194 179.582 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.425 ' C ' ' H ' ' A' ' 66' ' ' ASN . 11.5 mt-10 -78.93 159.85 72.66 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 1.98 110.93 179.86 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -73.61 28.06 0.31 Allowed 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.656 2.237 . . . . 1.4399999999999999 112.443 179.654 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.425 ' H ' ' C ' ' A' ' 64' ' ' GLU . 61.7 t30 -163.03 49.44 0.15 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.094 0.473 . . . . 2.1499999999999999 110.281 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -108.55 152.62 24.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.867 -0.606 . . . . 2.02 110.904 -179.716 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -107.09 111.21 23.56 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.41 -0.359 . . . . 1.02 110.981 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 34.7 mm -70.43 141.55 16.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.256 -0.429 . . . . 0.28999999999999998 110.768 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 82.8 mt -117.86 -66.11 1.11 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 0.40000000000000002 111.35 -179.724 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -137.69 135.62 36.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.972 0.415 . . . . 2.6099999999999999 111.431 -179.62 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.657 HG12 ' H ' ' A' ' 73' ' ' ASP . 3.1 t -94.41 174.49 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.899 -0.591 . . . . 0.28000000000000003 110.083 179.329 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.69 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 14.2 t70 -53.49 108.79 0.37 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.839 0.352 . . . . 0.79000000000000004 111.392 179.807 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.4 t70 61.48 15.91 7.1 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.008 -0.542 . . . . 2.0099999999999998 111.699 179.434 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.433 HG12 ' N ' ' A' ' 76' ' ' ASN . 26.0 t -138.42 157.18 30.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.559 -0.291 . . . . 0.79000000000000004 110.802 179.795 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.433 ' N ' HG12 ' A' ' 75' ' ' VAL . 65.6 m-20 -127.71 129.59 47.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.442 -0.345 . . . . 2.2400000000000002 110.907 -179.96 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.405 ' HA ' ' HE2' ' A' ' 80' ' ' MET . 34.7 m -106.41 21.02 4.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.337 -0.392 . . . . 0.67000000000000004 111.004 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -86.27 23.66 1.52 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.013 -0.54 . . . . 1.3899999999999999 110.918 -179.958 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -177.02 18.85 0.04 OUTLIER Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.706 -0.759 . . . . 0.55000000000000004 112.828 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.405 ' HE2' ' HA ' ' A' ' 77' ' ' VAL . 51.6 mtm -115.12 139.16 50.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.843 0.354 . . . . 0.52000000000000002 110.876 179.809 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.461 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -65.97 156.86 32.35 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.159 -0.473 . . . . 0.39000000000000001 111.025 -179.932 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -44.04 -55.03 4.97 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.199 -0.455 . . . . 1.52 111.546 -179.568 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 79.3 p -51.29 -46.78 62.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.312 -0.404 . . . . 1.48 111.256 -179.68 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -60.62 -40.74 93.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 2.1200000000000001 111.104 -179.915 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 81' ' ' ALA . 35.0 t -60.07 -39.69 81.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.295 -0.412 . . . . 0.32000000000000001 110.766 179.85 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.457 HG12 ' NE ' ' A' ' 90' ' ' ARG . 39.9 t -64.43 -37.06 79.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.168 -0.469 . . . . 0.37 110.658 179.711 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -58.92 -48.62 80.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.162 -0.472 . . . . 1.51 110.808 179.798 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 61.4 t -57.1 -55.15 22.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.205 -0.452 . . . . 0.27000000000000002 111.37 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 85.3 mt -56.33 -32.59 64.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.998 -0.546 . . . . 0.40999999999999998 111.385 -179.36 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.457 ' NE ' HG12 ' A' ' 86' ' ' VAL . 79.0 mtm180 -81.23 -20.07 41.81 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.458 -0.337 . . . . 2.1000000000000001 111.272 -179.687 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -86.05 -16.85 36.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.33 -0.395 . . . . 1.1399999999999999 111.077 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.2 -86.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.267 -0.424 . . . . 0.55000000000000004 111.424 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.461 ' N ' HH21 ' A' ' 20' ' ' ARG . . . 60.81 17.18 49.45 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.756 -0.735 . . . . 0.76000000000000001 112.578 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -147.38 175.56 2.66 Favored Pre-proline 0 CA--C 1.534 0.33 0 N-CA-C 110.377 -0.231 . . . . 2.52 110.377 -179.804 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.576 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 32.9 Cg_exo -61.47 99.38 0.17 Allowed 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 122.088 1.859 . . . . 0.64000000000000001 111.604 178.247 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.6 m -116.43 155.77 17.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.265 -0.425 . . . . 0.64000000000000001 111.837 -179.191 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.69 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 44.4 ttp180 -101.71 145.38 29.2 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.881 -0.6 . . . . 2.3700000000000001 110.484 179.788 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.6 mt -121.54 104.77 9.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.173 -0.467 . . . . 0.37 111.358 -179.228 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 61.6 tp -91.81 108.1 19.68 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.777 0.322 . . . . 0.37 110.381 179.421 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.467 HD21 HG12 ' A' ' 63' ' ' ILE . 0.5 OUTLIER -138.21 168.43 19.76 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.24 -0.436 . . . . 0.31 111.579 -179.212 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.529 ' HB ' HD23 ' A' ' 13' ' ' LEU . 9.8 tt -119.95 141.1 41.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.862 -0.608 . . . . 0.45000000000000001 111.048 179.873 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.416 ' HB3' ' HE1' ' A' ' 14' ' ' TYR . 27.2 tpt180 -166.44 138.41 3.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.101 -0.5 . . . . 2.2599999999999998 110.711 179.65 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -64.9 143.22 58.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.039 -0.528 . . . . 3.9300000000000002 110.93 -179.799 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.8 mt -94.97 148.42 34.67 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.872 -0.604 . . . . 2.0 111.091 -179.576 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -81.35 60.71 7.85 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.911 2.407 . . . . 2.98 112.355 179.821 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 71.1 mt -74.11 127.96 34.29 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.581 -0.736 . . . . 3.6699999999999999 110.92 -179.899 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.43 ' N ' HD22 ' A' ' 107' ' ' LEU . 3.7 mm? -74.08 114.12 12.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.03 -0.532 . . . . 5.5899999999999999 111.102 -179.878 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.236 -0.887 . . . . 6.0 111.086 179.876 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.219 0 N-CA-C 112.515 -0.234 . . . . 7.9199999999999999 112.515 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.7 m -123.82 143.7 50.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.806 0.336 . . . . 7.1799999999999997 111.105 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -165.12 88.48 0.45 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.16 -0.473 . . . . 5.9100000000000001 110.866 179.866 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 91.54 -30.13 6.72 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.673 -0.775 . . . . 2.4500000000000002 112.735 179.881 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -119.19 122.09 41.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.847 0.356 . . . . 2.3300000000000001 111.163 -179.848 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 46.2 t -157.51 98.98 1.72 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.078 -0.51 . . . . 2.5899999999999999 110.92 179.961 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 58.36 75.82 0.37 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.092 -0.504 . . . . 2.6699999999999999 110.961 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -133.25 113.56 12.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.479 . . . . 1.5800000000000001 111.194 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.2 m 53.56 34.53 18.72 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.111 -0.495 . . . . 2.5499999999999998 111.107 179.987 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.53 -55.61 3.48 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.736 -0.745 . . . . 1.8200000000000001 112.451 -179.962 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.519 ' HA ' ' HA ' ' A' ' 103' ' ' ARG . 47.2 m-85 -57.34 123.99 17.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.839 0.352 . . . . 1.7 110.88 179.96 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.5 t -151.42 155.01 37.73 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.191 -0.458 . . . . 0.90000000000000002 111.263 -179.878 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.539 HD23 ' HB ' ' A' ' 101' ' ' ILE . 23.8 mt -94.39 102.31 14.28 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.555 -0.748 . . . . 0.89000000000000001 110.209 179.53 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.43 ' CE1' ' HB3' ' A' ' 102' ' ' ARG . 39.5 p90 -123.46 151.17 42.99 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.887 0.375 . . . . 2.73 110.992 -179.602 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 80.2 p -122.39 161.28 23.74 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.279 -0.419 . . . . 1.1899999999999999 111.465 -179.472 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 12.4 t -131.22 149.88 33.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.86 -0.609 . . . . 0.56000000000000005 110.682 179.857 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.419 ' H ' ' NH2' ' A' ' 62' ' ' ARG . 14.8 mm-40 -103.46 110.05 21.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.441 -0.345 . . . . 1.74 111.526 -179.47 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.404 HD22 ' O ' ' A' ' 17' ' ' GLU . 3.4 mm? -126.49 123.84 38.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.179 -0.464 . . . . 0.81000000000000005 110.759 179.577 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.563 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 35.6 p90 -112.02 142.77 44.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.301 -0.409 . . . . 2.0800000000000001 110.747 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.583 ' HE ' ' HA2' ' A' ' 93' ' ' GLY . 47.5 ttp180 -125.97 160.85 28.91 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.859 -0.336 . . . . 3.0600000000000001 110.916 179.717 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -168.07 -33.06 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.139 -0.482 . . . . 2.5800000000000001 111.077 -179.891 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -59.07 160.93 5.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.949 -0.568 . . . . 3.7200000000000002 110.788 179.924 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -84.77 49.29 1.69 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.261 -0.427 . . . . 2.8700000000000001 111.069 -179.874 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 82.1 p -99.1 -24.59 14.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 1.3799999999999999 111.163 -179.977 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 36.4 t 56.41 18.04 3.25 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.797 -0.638 . . . . 2.4500000000000002 111.259 179.803 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 53.8 m -140.74 148.1 40.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.874 0.368 . . . . 1.3999999999999999 111.206 -179.882 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 61.5 mt -113.37 -23.58 9.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.991 -0.549 . . . . 0.45000000000000001 110.833 179.905 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.519 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 110.5 -23.64 19.69 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.804 -0.713 . . . . 0.52000000000000002 112.383 -179.791 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 76.5 mt -62.41 109.0 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.805 0.336 . . . . 0.83999999999999997 110.798 179.841 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 48.3 t -111.3 100.02 8.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.147 -0.479 . . . . 0.94999999999999996 110.853 -179.704 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.609 ' HA ' ' HA ' ' A' ' 48' ' ' VAL . 31.5 pt -85.19 172.75 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.825 -0.625 . . . . 0.40999999999999998 111.269 -179.928 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 43.9 t -139.67 132.12 28.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.485 . . . . 1.3200000000000001 110.838 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -65.62 155.2 50.17 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.806 -0.711 . . . . 0.94999999999999996 112.537 -179.905 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.469 ' HG2' ' HA ' ' A' ' 44' ' ' THR . 53.2 tpp -99.48 132.5 44.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.806 0.336 . . . . 2.04 110.891 -179.881 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.437 ' HD3' ' N ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -160.43 65.22 0.32 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.034 0.445 . . . . 5.46 111.06 179.936 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -66.99 -177.34 0.62 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.212 -0.449 . . . . 4.29 111.022 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -64.81 173.75 2.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.199 -0.455 . . . . 5.25 110.988 -179.967 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 59.9 p 51.18 -164.97 0.05 OUTLIER 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.094 -0.503 . . . . 4.8799999999999999 111.081 -179.95 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 68.6 p -56.22 139.43 47.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.935 0.398 . . . . 5.2699999999999996 111.091 179.792 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 67.2 p -82.19 15.45 2.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.111 -0.495 . . . . 6.9100000000000001 111.277 -179.876 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -78.92 -26.07 58.96 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.795 -0.716 . . . . 5.3600000000000003 112.445 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -106.68 149.48 27.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.784 0.326 . . . . 7.2199999999999998 110.915 -179.98 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 57.06 88.7 0.05 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.139 -0.482 . . . . 3.0499999999999998 111.178 -179.942 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.469 ' HA ' ' HG2' ' A' ' 34' ' ' MET . 59.8 p -135.34 151.8 50.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.106 -0.497 . . . . 2.5299999999999998 110.997 179.905 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 156.89 144.55 3.96 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.826 -0.702 . . . . 1.1399999999999999 112.399 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.407 HG12 HD12 ' A' ' 31' ' ' ILE . 5.1 tp -85.71 159.36 3.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.572 0.225 . . . . 0.65000000000000002 110.962 -179.891 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -163.31 139.49 6.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.749 0.309 . . . . 0.69999999999999996 111.336 -179.884 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.609 ' HA ' ' HA ' ' A' ' 31' ' ' ILE . 90.5 t -71.24 105.85 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.258 -0.428 . . . . 0.39000000000000001 110.761 179.483 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -66.89 -38.08 85.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.041 -0.527 . . . . 2.3999999999999999 111.013 -179.923 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 35.9 t -168.1 175.61 6.52 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.96 0.41 . . . . 1.28 111.252 -179.907 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 76.5 mt -115.13 155.7 26.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.842 -0.617 . . . . 0.41999999999999998 110.713 179.918 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.519 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 70.4 mt -98.93 108.51 49.53 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 1.26 111.388 -179.62 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.05 136.12 72.96 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.432 2.088 . . . . 0.81999999999999995 112.304 -179.919 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 103.99 -17.01 49.66 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.732 -0.747 . . . . 0.48999999999999999 112.645 179.92 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 95.6 p -88.54 -176.07 5.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.809 0.338 . . . . 1.23 111.118 -179.878 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.86 -54.84 13.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.41999999999999998 111.258 -179.853 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.64 -36.48 62.11 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.133 -0.485 . . . . 0.34999999999999998 111.522 -179.827 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.02 -46.38 62.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.44 111.316 -179.887 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 97.4 mt -66.16 -19.75 65.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.364 -0.38 . . . . 0.66000000000000003 110.834 179.73 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -61.24 -56.14 23.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 1.8600000000000001 110.826 179.981 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 97.3 -49.04 1.52 Allowed Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.805 -0.712 . . . . 1.0600000000000001 112.977 179.47 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.419 ' NH2' ' H ' ' A' ' 17' ' ' GLU . 83.1 mtm180 -56.0 -36.25 67.71 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.727 0.299 . . . . 2.5899999999999999 111.164 -179.583 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 62.5 mt -70.27 116.18 11.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.875 0.369 . . . . 0.92000000000000004 110.713 179.776 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -102.97 131.87 21.74 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.056 -0.52 . . . . 1.98 110.786 -179.684 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -60.91 171.88 3.39 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.443 2.096 . . . . 1.4399999999999999 112.03 179.897 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 57.5 52.85 8.0 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.303 -0.408 . . . . 2.1499999999999999 110.548 -179.469 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -123.52 174.19 7.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.124 -0.489 . . . . 2.02 111.017 -179.594 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -115.01 127.0 55.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.199 -0.455 . . . . 1.02 110.969 -179.964 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 47.9 mm -89.43 139.99 16.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.258 -0.428 . . . . 0.28999999999999998 111.014 -179.924 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 84.8 mt -110.83 -62.73 1.49 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.176 -0.465 . . . . 0.40000000000000002 111.109 -179.786 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -150.94 136.65 18.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.031 0.443 . . . . 2.6099999999999999 111.609 -179.402 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.651 HG12 ' H ' ' A' ' 73' ' ' ASP . 2.3 t -89.06 175.46 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.777 -0.647 . . . . 0.28000000000000003 110.186 179.437 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.655 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 14.5 t70 -49.15 108.66 0.2 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.725 0.298 . . . . 0.79000000000000004 111.493 179.558 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.7 t70 57.03 28.4 14.78 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.164 -0.471 . . . . 2.0099999999999998 111.544 179.306 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.7 t -145.88 144.27 20.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.334 -0.394 . . . . 0.79000000000000004 110.874 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -114.35 129.87 56.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.437 -0.347 . . . . 2.2400000000000002 110.585 179.62 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.2 m -112.29 26.12 3.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-N 116.548 -0.296 . . . . 0.67000000000000004 111.479 -179.441 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -94.25 31.64 1.67 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.92 0.39 . . . . 1.3899999999999999 110.724 179.739 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 177.37 34.87 0.05 OUTLIER Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.715 -0.755 . . . . 0.55000000000000004 112.704 -179.974 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 54.9 mtm -134.62 145.28 48.47 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.905 0.383 . . . . 0.52000000000000002 110.758 179.8 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.406 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -62.61 150.55 40.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.063 -0.517 . . . . 0.39000000000000001 111.028 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -46.05 -51.58 13.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.298 -0.41 . . . . 1.52 111.399 -179.638 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.1 m -50.49 -47.82 57.08 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.215 -0.448 . . . . 1.48 111.33 -179.676 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -59.4 -41.88 90.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.341 -0.39 . . . . 2.1200000000000001 111.065 -179.866 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 81' ' ' ALA . 18.6 t -58.96 -38.5 73.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.275 -0.421 . . . . 0.32000000000000001 110.947 179.909 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.4 t -66.95 -38.02 80.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.173 -0.467 . . . . 0.37 111.033 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -57.77 -46.1 85.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.305 -0.407 . . . . 1.51 110.674 179.734 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 54.8 t -59.27 -53.98 40.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.058 -0.519 . . . . 0.27000000000000002 111.073 179.747 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 78.5 mt -55.97 -26.77 49.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.996 -0.547 . . . . 0.40999999999999998 111.107 -179.612 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -89.41 -19.79 24.74 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.388 -0.369 . . . . 2.1000000000000001 111.308 179.978 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -89.68 -9.19 50.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.739 0.305 . . . . 1.1399999999999999 111.177 179.981 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.03 -87.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.439 . . . . 0.55000000000000004 111.404 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.583 ' HA2' ' HE ' ' A' ' 20' ' ' ARG . . . 60.74 20.07 56.14 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.66 -0.781 . . . . 0.76000000000000001 112.342 -179.838 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.607 ' HB3' ' HD2' ' A' ' 95' ' ' PRO . 73.8 m-20 -147.17 172.63 4.97 Favored Pre-proline 0 C--N 1.33 -0.263 0 C-N-CA 122.106 0.162 . . . . 2.52 110.775 -179.53 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.607 ' HD2' ' HB3' ' A' ' 94' ' ' ASN . 23.1 Cg_endo -62.86 89.53 0.12 Allowed 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 122.035 1.823 . . . . 0.64000000000000001 111.624 178.191 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.7 m -103.38 151.76 6.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.177 0.513 . . . . 0.64000000000000001 111.923 -179.216 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.655 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 79.4 ttt180 -101.2 143.95 30.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.566 -0.743 . . . . 2.3700000000000001 110.159 179.378 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.02 105.11 10.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.432 -0.349 . . . . 0.37 111.368 -179.525 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 51.4 tp -94.75 105.6 17.54 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.889 0.376 . . . . 0.37 110.309 179.215 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.32 168.18 19.06 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.051 -0.522 . . . . 0.31 111.41 -179.597 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.539 ' HB ' HD23 ' A' ' 13' ' ' LEU . 10.7 tt -122.63 142.1 40.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.916 -0.584 . . . . 0.45000000000000001 111.019 -179.962 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.43 ' HB3' ' CE1' ' A' ' 14' ' ' TYR . 31.5 tpt180 -166.06 136.28 3.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.986 -0.552 . . . . 2.2599999999999998 110.5 179.618 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.519 ' HA ' ' HA ' ' A' ' 11' ' ' PHE . 59.7 ttp180 -62.02 143.21 56.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.026 -0.534 . . . . 3.9300000000000002 111.251 -179.454 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.5 mt -103.44 153.05 38.81 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.659 -0.7 . . . . 2.0 110.652 -179.76 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -81.15 159.84 20.48 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.36 2.04 . . . . 2.98 112.045 179.921 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 91.5 mt -143.16 125.82 15.94 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.048 -0.524 . . . . 3.6699999999999999 110.791 -179.734 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.432 ' N ' HD22 ' A' ' 107' ' ' LEU . 3.7 mm? -67.05 101.39 0.86 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.479 . . . . 5.5899999999999999 110.828 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.356 -0.83 . . . . 6.0 111.143 -179.837 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.203 0 N-CA-C 112.495 -0.242 . . . . 7.9199999999999999 112.495 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 52.5 m -120.43 149.24 42.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.757 0.313 . . . . 7.1799999999999997 110.825 179.97 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -164.69 100.64 0.8 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 5.9100000000000001 110.813 179.928 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -140.35 -44.22 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.791 -0.719 . . . . 2.4500000000000002 112.711 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -80.61 84.05 6.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.815 0.34 . . . . 2.3300000000000001 110.824 -179.846 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 53.6 m -92.87 88.3 6.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 2.5899999999999999 110.92 -179.987 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 57.47 38.87 28.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.001 -0.545 . . . . 2.6699999999999999 111.071 179.94 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -90.1 120.99 31.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.087 -0.506 . . . . 1.5800000000000001 111.001 179.788 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.4 m 55.98 25.98 9.38 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.274 -0.421 . . . . 2.5499999999999998 110.753 -179.695 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.581 ' HA3' ' HG3' ' A' ' 103' ' ' ARG . . . 98.01 -39.21 2.83 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.835 -0.698 . . . . 1.8200000000000001 112.491 -179.945 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.4 ' HA ' ' HA ' ' A' ' 103' ' ' ARG . 62.5 m-85 -60.26 128.6 37.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.718 0.294 . . . . 1.7 110.73 179.855 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 46.9 t -149.48 147.02 27.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.90000000000000002 111.238 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.53 HD23 ' HB ' ' A' ' 101' ' ' ILE . 45.7 mt -90.42 102.32 15.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.777 -0.647 . . . . 0.89000000000000001 110.329 179.627 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -124.48 149.2 47.11 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.949 0.404 . . . . 2.73 111.229 -179.646 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.0 m -115.3 154.57 28.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.098 -0.501 . . . . 1.1899999999999999 110.883 -179.792 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.4 t -124.12 157.42 31.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 0.56000000000000005 110.529 179.827 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -116.18 107.69 15.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.864 0.364 . . . . 1.74 111.398 -179.672 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.455 HD11 ' HB2' ' A' ' 60' ' ' ASP . 4.3 mm? -116.98 144.76 44.21 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.079 -0.51 . . . . 0.81000000000000005 110.546 179.696 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.696 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 21.8 p90 -118.66 117.87 30.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.936 0.398 . . . . 2.0800000000000001 110.868 179.85 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.596 ' HG2' ' HA2' ' A' ' 93' ' ' GLY . 15.0 ttt180 -110.16 153.85 24.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.002 -0.545 . . . . 3.0600000000000001 110.585 179.924 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -113.51 -70.26 0.81 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.097 0.475 . . . . 2.5800000000000001 111.131 -179.862 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -136.22 -169.85 2.53 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.712 -0.676 . . . . 3.7200000000000002 110.969 -179.812 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -55.51 -27.26 47.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.338 -0.392 . . . . 2.8700000000000001 110.869 179.775 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.3 m -66.95 -36.99 83.47 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.16 -0.473 . . . . 1.3799999999999999 110.744 179.875 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.9 m -81.85 61.41 5.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.122 -0.49 . . . . 2.4500000000000002 110.931 179.869 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 51.0 m -57.88 138.34 55.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.479 . . . . 1.3999999999999999 110.833 179.773 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.518 HD21 ' HB2' ' A' ' 20' ' ' ARG . 75.0 mt -78.8 -35.3 44.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.033 -0.531 . . . . 0.45000000000000001 110.67 -179.845 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.428 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 93.75 -6.74 73.91 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.787 -0.72 . . . . 0.52000000000000002 113.219 179.212 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 74.5 mt -60.07 108.67 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.747 0.308 . . . . 0.83999999999999997 111.17 -179.851 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 39.6 t -112.31 97.91 6.95 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.21 -0.45 . . . . 0.94999999999999996 110.662 179.729 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.491 ' HA ' ' HA ' ' A' ' 48' ' ' VAL . 38.6 pt -89.72 166.66 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.051 -0.522 . . . . 0.40999999999999998 111.272 -179.838 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 54.7 m -143.71 138.94 29.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.095 -0.502 . . . . 1.3200000000000001 110.953 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -88.42 121.77 6.09 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.825 -0.702 . . . . 0.94999999999999996 112.48 179.966 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.409 ' HG2' ' H ' ' A' ' 36' ' ' ASP . 53.2 ttm -64.05 152.99 38.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.708 0.29 . . . . 2.04 110.847 -179.946 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.446 ' N ' ' HD2' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -144.04 42.12 1.42 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.249 -0.432 . . . . 5.46 110.888 179.982 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.409 ' H ' ' HG2' ' A' ' 34' ' ' MET . 20.1 t70 -57.61 141.85 46.73 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.223 -0.444 . . . . 4.29 110.85 179.934 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -119.36 -177.08 3.28 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.254 -0.43 . . . . 5.25 110.974 -179.772 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 52.6 m 60.33 -178.87 0.1 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.957 -0.565 . . . . 4.8799999999999999 111.067 -179.969 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 23.7 p 53.56 -172.74 0.04 OUTLIER 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.002 -0.545 . . . . 5.2699999999999996 111.614 179.77 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.1 t -133.83 29.72 3.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.985 -0.552 . . . . 6.9100000000000001 110.832 179.863 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -147.93 77.44 0.24 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.815 -0.707 . . . . 5.3600000000000003 112.57 -179.978 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -91.78 153.83 19.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.757 0.313 . . . . 7.2199999999999998 110.724 179.872 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -132.24 75.69 1.65 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.269 -0.423 . . . . 3.0499999999999998 111.302 -179.805 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 82.6 p -78.66 127.06 31.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 2.5299999999999998 110.901 179.728 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -146.39 176.86 25.08 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.619 -0.8 . . . . 1.1399999999999999 112.726 -179.803 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 37.5 mm -95.97 106.46 18.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.707 0.289 . . . . 0.65000000000000002 110.822 179.979 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -131.73 142.77 49.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.287 -0.415 . . . . 0.69999999999999996 111.189 -179.726 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.491 ' HA ' ' HA ' ' A' ' 31' ' ' ILE . 46.8 t -81.54 116.64 26.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.116 -0.493 . . . . 0.39000000000000001 111.004 179.847 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -84.79 -35.71 22.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.452 . . . . 2.3999999999999999 111.22 -179.705 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 54.6 m -149.66 172.68 14.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.125 0.488 . . . . 1.28 111.63 -179.527 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.467 HD11 HG22 ' A' ' 63' ' ' ILE . 63.0 mt -131.73 141.45 49.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.723 -0.671 . . . . 0.41999999999999998 110.538 179.835 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.428 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 43.2 mm -75.4 115.56 46.57 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.337 -0.392 . . . . 1.26 111.074 -179.89 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -58.07 126.26 21.07 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.387 2.058 . . . . 0.81999999999999995 112.391 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 98.53 -13.66 62.57 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.799 -0.715 . . . . 0.48999999999999999 112.785 179.659 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 92.8 p -72.02 -177.33 2.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.779 0.324 . . . . 1.23 110.914 -179.861 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.39 -55.29 12.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.41999999999999998 111.178 179.976 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.82 -33.88 67.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.108 -0.497 . . . . 0.34999999999999998 111.397 -179.804 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.78 -55.55 8.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.44 111.509 -179.649 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.0 mt -59.1 -20.23 51.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.66000000000000003 111.187 -179.835 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.455 ' HB2' HD11 ' A' ' 18' ' ' LEU . 17.4 t70 -59.05 -52.54 65.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.36 -0.382 . . . . 1.8600000000000001 110.642 -179.909 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.91 -31.7 7.36 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.707 -0.759 . . . . 1.0600000000000001 113.126 179.387 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 82.2 mtm180 -83.85 0.84 45.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.686 0.279 . . . . 2.5899999999999999 111.238 -179.571 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.467 HG22 HD11 ' A' ' 51' ' ' LEU . 53.6 mt -116.47 122.78 70.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.848 0.356 . . . . 0.92000000000000004 110.979 179.592 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -129.41 158.1 74.25 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.125 -0.489 . . . . 1.98 110.809 179.971 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -57.08 176.97 0.2 Allowed 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.587 2.191 . . . . 1.4399999999999999 112.308 179.674 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 56.38 50.08 13.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.013 -0.54 . . . . 2.1499999999999999 110.637 -179.805 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.429 ' HA ' ' HG2' ' A' ' 102' ' ' ARG . 8.3 t70 -120.81 151.85 39.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.815 -0.629 . . . . 2.02 110.83 -179.934 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -109.62 109.06 19.7 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.857 0.36 . . . . 1.02 110.912 179.979 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 49.2 mm -71.03 142.41 15.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.143 -0.48 . . . . 0.28999999999999998 110.982 179.896 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 73.3 mt -114.97 -71.77 0.73 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.097 -0.501 . . . . 0.40000000000000002 110.98 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.423 ' O ' ' HB3' ' A' ' 99' ' ' LEU . 75.9 mtp180 -135.95 135.33 39.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 2.6099999999999999 111.406 -179.611 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.564 HG12 ' H ' ' A' ' 73' ' ' ASP . 6.6 t -93.55 170.69 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.922 -0.581 . . . . 0.28000000000000003 109.842 179.166 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.606 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 16.8 t70 -46.7 108.7 0.15 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.917 0.389 . . . . 0.79000000000000004 111.841 179.928 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 53.41 14.52 0.57 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.817 -0.629 . . . . 2.0099999999999998 112.479 179.013 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 65.2 t -144.72 99.67 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.76 0.314 . . . . 0.79000000000000004 111.388 -179.887 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -68.07 155.58 39.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.386 -0.37 . . . . 2.2400000000000002 110.355 179.462 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.46 HG11 HG13 ' A' ' 85' ' ' VAL . 17.4 m -133.44 39.84 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.846 0.355 . . . . 0.67000000000000004 111.391 -179.814 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -109.8 35.84 3.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 1.3899999999999999 111.048 179.795 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -179.6 26.64 0.05 OUTLIER Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.481 -0.866 . . . . 0.55000000000000004 112.927 179.962 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 65.6 mtm -130.61 153.16 49.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.853 0.358 . . . . 0.52000000000000002 110.918 179.75 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.432 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -62.18 151.98 34.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.011 -0.54 . . . . 0.39000000000000001 111.333 -179.86 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -50.36 -55.75 14.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.238 -0.437 . . . . 1.52 111.249 -179.744 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.1 m -52.95 -41.03 64.12 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.07 -0.514 . . . . 1.48 111.171 -179.813 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -59.08 -43.56 91.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.288 -0.414 . . . . 2.1200000000000001 110.89 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.46 HG13 HG11 ' A' ' 77' ' ' VAL . 22.8 t -60.16 -36.46 68.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.143 -0.48 . . . . 0.32000000000000001 110.818 179.883 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.2 t -63.76 -40.89 90.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.036 -0.529 . . . . 0.37 111.015 179.92 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -59.1 -49.73 76.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.265 -0.425 . . . . 1.51 110.732 179.812 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 54.6 t -52.25 -53.83 17.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.95 -0.568 . . . . 0.27000000000000002 111.333 179.876 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 71.3 mt -56.71 -33.83 66.86 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.103 -0.499 . . . . 0.40999999999999998 111.329 -179.516 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 -82.2 -14.95 54.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.484 -0.325 . . . . 2.1000000000000001 111.226 -179.793 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -92.14 -15.4 27.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.365 -0.38 . . . . 1.1399999999999999 111.086 179.976 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.77 -83.51 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.287 -0.415 . . . . 0.55000000000000004 111.454 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.596 ' HA2' ' HG2' ' A' ' 20' ' ' ARG . . . 62.49 21.76 62.85 Favored Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.638 -0.791 . . . . 0.76000000000000001 112.431 -179.724 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -147.59 169.65 8.98 Favored Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 110.527 -0.175 . . . . 2.52 110.527 -179.823 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.696 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 48.8 Cg_exo -57.39 92.47 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.048 1.832 . . . . 0.64000000000000001 111.427 178.349 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.9 m -103.72 148.83 8.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.133 0.492 . . . . 0.64000000000000001 111.84 -179.051 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.606 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 71.6 ttt180 -99.7 144.11 29.15 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.618 -0.719 . . . . 2.3700000000000001 110.002 179.726 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 13.6 mt -118.38 103.79 10.12 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.386 -0.37 . . . . 0.37 111.525 -179.146 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.423 ' HB3' ' O ' ' A' ' 71' ' ' ARG . 65.3 tp -90.98 109.35 20.58 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.857 -0.423 . . . . 0.37 109.857 179.062 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -143.25 168.34 20.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.247 0.546 . . . . 0.31 111.963 -179.115 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.53 ' HB ' HD23 ' A' ' 13' ' ' LEU . 13.0 tt -119.49 143.1 31.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.572 -0.74 . . . . 0.45000000000000001 110.556 179.838 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.429 ' HG2' ' HA ' ' A' ' 67' ' ' ASP . 0.4 OUTLIER -166.1 133.63 2.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.34 -0.391 . . . . 2.2599999999999998 110.751 -179.955 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.581 ' HG3' ' HA3' ' A' ' 10' ' ' GLY . 70.4 ttt180 -61.41 146.91 46.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.072 -0.513 . . . . 3.9300000000000002 110.961 179.99 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.3 mt -90.47 144.23 30.44 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.734 -0.667 . . . . 2.0 110.917 -179.683 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -81.08 60.79 7.98 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.706 2.271 . . . . 2.98 112.232 179.865 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 96.4 mt -54.12 111.07 0.69 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.482 -0.781 . . . . 3.6699999999999999 111.13 179.959 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 81.4 mt -80.61 155.86 26.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.047 -0.524 . . . . 5.5899999999999999 111.014 -179.934 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.182 -0.913 . . . . 6.0 111.008 179.976 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.0 t . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.924 0.392 . . . . 0.9 110.908 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 85.0 mt -80.26 127.77 32.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.873 -0.603 . . . . 0.89 110.757 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -124.56 137.82 54.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.169 -0.468 . . . . 2.73 110.882 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 80.8 p -132.58 132.19 42.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.305 -0.407 . . . . 1.19 111.096 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.9 t -118.26 157.55 19.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 0.56 110.704 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -109.72 110.01 20.89 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.816 0.341 . . . . 1.74 111.282 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.478 HD11 ' HB2' ' A' ' 60' ' ' ASP . 4.6 mm? -118.6 166.48 12.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.154 -0.475 . . . . 0.81 110.318 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.608 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 35.0 p90 -144.14 132.33 21.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.906 0.384 . . . . 2.08 111.638 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.536 ' HE ' ' HG ' ' A' ' 27' ' ' LEU . 15.7 tpp85 -97.22 94.75 7.28 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.04 -0.527 . . . . 3.06 110.21 179.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -130.25 9.93 5.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.383 -0.371 . . . . 2.58 111.168 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -110.29 151.22 27.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.435 . . . . 3.72 110.836 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -80.68 17.16 1.19 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.068 -0.515 . . . . 2.87 110.998 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 63.0 p -69.0 -10.99 60.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 1.38 111.157 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.2 m 59.13 20.17 8.13 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.999 -0.546 . . . . 2.45 111.194 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 90.0 p -164.26 158.55 19.01 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.956 0.408 . . . . 1.4 111.077 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.536 ' HG ' ' HE ' ' A' ' 20' ' ' ARG . 87.4 mt -102.6 -12.09 17.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.064 -0.517 . . . . 0.45 110.614 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.531 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 100.15 24.86 9.31 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.831 -0.7 . . . . 0.52 112.373 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 75.6 mt -102.56 115.73 45.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.822 0.344 . . . . 0.84 110.927 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.7 t -110.67 102.44 11.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.95 110.666 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 25.3 pt -99.43 160.53 3.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.41 111.447 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 48.1 t -150.85 145.68 25.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.918 -0.583 . . . . 1.32 110.726 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 C-N-CA 120.72 -0.752 . . . . 0.95 112.609 -179.818 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 41.8 mm . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.667 0.27 . . . . 0.65 111.094 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 52.9 p90 -147.34 147.0 29.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.978 0.418 . . . . 0.7 111.086 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.1 t -84.27 136.64 22.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.969 -0.559 . . . . 0.39 111.223 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -125.96 -25.96 3.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.029 -0.532 . . . . 2.4 110.87 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 43.1 t -135.85 170.41 16.02 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.234 -0.439 . . . . 1.28 110.89 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 69.5 mt -141.66 160.28 40.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.211 -0.45 . . . . 0.42 110.963 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.531 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 51.0 mt -107.08 102.01 40.96 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.242 -0.435 . . . . 1.26 110.918 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.67 136.25 64.38 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.409 2.073 . . . . 0.82 112.31 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 99.91 -12.32 60.79 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.791 -0.718 . . . . 0.49 112.691 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 56.3 m -88.19 179.11 6.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.706 0.289 . . . . 1.23 111.023 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.406 ' HB1' HD12 ' A' ' 18' ' ' LEU . . . -63.48 -54.41 36.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.319 -0.401 . . . . 0.42 111.455 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.411 ' HB1' HG21 ' A' ' 63' ' ' ILE . . . -54.16 -48.02 71.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 0.35 111.744 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.53 -56.76 13.47 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.428 -0.351 . . . . 0.44 111.656 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 81.5 mt -59.86 -20.43 57.05 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.26 -0.427 . . . . 0.66 111.527 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.478 ' HB2' HD11 ' A' ' 18' ' ' LEU . 18.2 t70 -58.96 -48.37 81.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.875 0.369 . . . . 1.86 110.957 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.46 -48.49 1.11 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.782 -0.723 . . . . 1.06 112.689 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -65.24 -23.7 67.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.71 0.29 . . . . 2.59 110.921 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.411 HG21 ' HB1' ' A' ' 57' ' ' ALA . 39.8 mm -76.68 98.72 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.267 -0.424 . . . . 0.92 110.792 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -107.92 156.3 38.44 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 1.98 110.632 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.96 172.79 5.57 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.448 2.099 . . . . 1.44 112.271 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 57.88 74.54 0.42 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.187 -0.461 . . . . 2.15 111.243 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -149.6 151.33 33.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 2.02 110.433 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -109.88 114.67 28.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.816 0.341 . . . . 1.02 111.244 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 43.7 mm -70.31 140.03 19.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.069 -0.514 . . . . 0.29 110.597 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 90.5 mt -116.89 -65.1 1.22 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.298 -0.41 . . . . 0.4 111.274 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -141.2 134.91 30.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.955 0.407 . . . . 2.61 111.625 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.662 HG12 ' H ' ' A' ' 73' ' ' ASP . 6.6 t -90.4 175.09 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.861 -0.608 . . . . 0.28 109.596 178.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.668 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 18.6 t70 -47.55 108.97 0.18 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.693 0.283 . . . . 0.79 111.696 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 54.24 26.26 6.61 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.244 -0.434 . . . . 2.01 111.768 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 73' ' ' ASP . 58.2 t -143.02 152.04 17.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.296 -0.411 . . . . 0.79 110.696 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.507 ' ND2' ' H ' ' A' ' 78' ' ' GLN . 5.7 t30 -121.06 130.98 54.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.368 -0.378 . . . . 2.24 110.718 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.7 m -110.2 17.39 7.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.379 -0.373 . . . . 0.67 111.444 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.507 ' H ' ' ND2' ' A' ' 76' ' ' ASN . 14.5 mm100 -85.84 28.92 0.75 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.264 -0.426 . . . . 1.39 111.07 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -178.4 19.04 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.56 -0.829 . . . . 0.55 112.95 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 43.8 mtm -118.4 146.07 44.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.799 0.333 . . . . 0.52 110.711 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.437 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -62.11 155.79 23.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.1 -0.5 . . . . 0.39 111.068 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -51.73 -57.76 8.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.425 -0.352 . . . . 1.52 111.178 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.9 t -54.56 -37.88 65.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 1.48 111.306 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -60.94 -45.51 94.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.322 -0.399 . . . . 2.12 110.781 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 81' ' ' ALA . 45.6 t -60.09 -34.14 55.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.159 -0.473 . . . . 0.32 110.769 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.566 HG12 ' HE ' ' A' ' 90' ' ' ARG . 56.7 t -64.25 -43.93 97.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.111 -0.495 . . . . 0.37 110.533 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -58.1 -41.77 84.22 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.163 -0.471 . . . . 1.51 110.647 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 49.5 t -56.86 -52.52 54.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.954 -0.566 . . . . 0.27 111.049 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 71.2 mt -54.41 -36.07 63.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.026 -0.534 . . . . 0.41 110.923 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.566 ' HE ' HG12 ' A' ' 86' ' ' VAL . 74.7 mtt180 -75.14 -30.12 60.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 2.1 110.872 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -74.68 -18.01 60.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.123 -0.489 . . . . 1.14 111.019 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.21 -83.0 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.072 -0.513 . . . . 0.55 111.415 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.41 ' H ' ' HG2' ' A' ' 20' ' ' ARG . . . 65.64 11.76 54.53 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.477 -0.868 . . . . 0.76 112.315 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -146.7 166.33 16.87 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 110.557 -0.164 . . . . 2.52 110.557 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.608 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 46.2 Cg_exo -57.07 105.1 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.278 1.985 . . . . 0.64 111.366 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.7 m -107.29 154.46 8.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.224 0.535 . . . . 0.64 111.994 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.668 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 79.6 ttt180 -103.53 143.07 33.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.549 -0.75 . . . . 2.37 109.932 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 20.5 mt -114.83 131.01 56.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.249 -0.432 . . . . 0.37 110.972 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 62.2 tp -120.62 99.8 6.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 0.37 110.234 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.46 153.31 48.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.053 -0.522 . . . . 0.31 111.322 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.9 tt -100.91 138.68 24.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.069 -0.514 . . . . 0.45 110.708 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 24.8 tpt180 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.437 . . . . 2.26 110.885 -179.907 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 46.9 t . . . . . 0 C--O 1.233 0.192 0 CA-C-O 120.756 0.312 . . . . 0.9 110.818 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 89.6 mt -79.52 121.58 25.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.013 -0.54 . . . . 0.89 110.851 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -113.86 151.44 32.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.123 -0.49 . . . . 2.73 110.961 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 48.5 t -150.47 135.85 17.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.245 -0.434 . . . . 1.19 111.073 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.416 HG11 ' HB2' ' A' ' 62' ' ' ARG . 21.7 t -130.29 147.17 33.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.041 -0.527 . . . . 0.56 110.806 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -99.13 118.38 35.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.917 0.389 . . . . 1.74 111.076 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.53 HD11 ' HB2' ' A' ' 60' ' ' ASP . 4.2 mm? -116.97 166.91 11.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.937 -0.574 . . . . 0.81 110.788 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.595 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 30.4 p90 -160.49 130.5 5.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.247 -0.433 . . . . 2.08 111.151 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.652 ' HE ' ' HA2' ' A' ' 93' ' ' GLY . 57.2 ttp180 -112.68 97.43 6.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.399 -0.364 . . . . 3.06 110.919 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -95.65 -20.52 18.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.121 -0.491 . . . . 2.58 110.702 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -83.75 160.51 21.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.071 -0.513 . . . . 3.72 110.953 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -95.23 40.4 1.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.035 -0.53 . . . . 2.87 110.902 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 82.1 p -71.93 -13.96 61.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 1.38 111.127 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.2 m 57.76 19.1 5.32 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.921 -0.582 . . . . 2.45 111.256 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.8 m -154.9 154.93 33.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.435 -0.348 . . . . 1.4 111.005 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.468 HD21 ' HB2' ' A' ' 20' ' ' ARG . 52.0 mt -114.02 -24.43 9.04 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.097 -0.501 . . . . 0.45 111.141 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.18 -19.98 49.25 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.692 -0.766 . . . . 0.52 112.857 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 66.2 mt -61.64 110.27 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.676 0.274 . . . . 0.84 110.979 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.6 t -112.25 106.64 15.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.445 . . . . 0.95 110.964 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.557 ' HA ' ' HA ' ' A' ' 48' ' ' VAL . 46.3 pt -86.81 -177.88 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.015 -0.539 . . . . 0.41 111.144 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.2 t -156.14 146.24 21.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.358 -0.383 . . . . 1.32 111.137 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.378 0 C-N-CA 120.836 -0.697 . . . . 0.95 112.191 179.653 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.1 mm . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.68 0.276 . . . . 0.65 110.929 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -157.53 142.38 16.7 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.278 -0.419 . . . . 0.7 111.022 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.557 ' HA ' ' HA ' ' A' ' 31' ' ' ILE . 99.3 t -77.96 127.21 38.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.151 -0.477 . . . . 0.39 110.804 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -114.63 -23.22 9.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.031 -0.531 . . . . 2.4 111.139 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 78.1 p -146.09 161.76 39.45 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.134 0.492 . . . . 1.28 111.645 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 91.6 mt -133.55 154.35 50.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.662 -0.699 . . . . 0.42 110.572 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 49.0 mm -97.24 113.89 63.9 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.346 -0.388 . . . . 1.26 110.846 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -61.58 136.2 61.5 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.414 2.076 . . . . 0.82 112.122 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 97.9 -23.29 36.68 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.864 -0.684 . . . . 0.49 112.307 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.404 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 67.1 m -73.14 170.86 14.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.619 0.247 . . . . 1.23 111.079 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.64 -55.64 30.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.427 -0.351 . . . . 0.42 111.463 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.61 -39.33 57.8 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.203 -0.453 . . . . 0.35 111.333 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.69 -46.99 67.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 0.44 111.425 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 55' ' ' SER . 94.8 mt -63.15 -19.68 64.7 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.222 -0.444 . . . . 0.66 111.184 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.53 ' HB2' HD11 ' A' ' 18' ' ' LEU . 18.4 t70 -62.5 -50.81 69.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.294 -0.412 . . . . 1.86 110.808 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.49 -48.4 1.69 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.761 -0.733 . . . . 1.06 113.151 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.416 ' HB2' HG11 ' A' ' 16' ' ' VAL . 21.7 mmm180 -59.93 -29.25 68.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.638 0.256 . . . . 2.59 111.204 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 66.1 mt -77.19 111.73 14.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.896 0.379 . . . . 0.92 111.254 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -95.69 140.13 22.2 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.994 -0.548 . . . . 1.98 110.293 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -74.1 44.84 1.06 Allowed 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.495 2.13 . . . . 1.44 112.963 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -167.75 69.5 0.09 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.285 -0.416 . . . . 2.15 110.409 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -146.17 170.85 15.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.486 . . . . 2.02 110.835 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -115.0 104.47 11.94 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.288 -0.414 . . . . 1.02 110.986 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.5 HD13 ' HB3' ' A' ' 100' ' ' LEU . 49.5 mm -58.48 145.49 9.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.159 -0.473 . . . . 0.29 111.054 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.478 ' HA ' ' NE2' ' A' ' 78' ' ' GLN . 92.7 mt -124.35 -67.11 0.94 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.236 -0.438 . . . . 0.4 111.453 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 27.2 mtm180 -132.34 134.92 45.78 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.027 0.442 . . . . 2.61 111.695 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.607 HG12 ' H ' ' A' ' 73' ' ' ASP . 3.8 t -97.97 172.88 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.761 -0.654 . . . . 0.28 110.02 179.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.607 ' H ' HG12 ' A' ' 72' ' ' VAL . 28.1 t70 -51.07 108.81 0.27 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.784 0.326 . . . . 0.79 111.44 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 59.39 14.21 3.63 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.045 -0.525 . . . . 2.01 111.844 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.488 ' HB ' ' HB ' ' A' ' 72' ' ' VAL . 40.9 t -135.56 157.36 39.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.532 -0.304 . . . . 0.79 110.849 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.451 ' N ' HG12 ' A' ' 75' ' ' VAL . 3.2 p-10 -129.07 128.61 43.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.396 -0.366 . . . . 2.24 110.575 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.0 m -105.29 24.65 2.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.805 0.336 . . . . 0.67 111.399 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.478 ' NE2' ' HA ' ' A' ' 70' ' ' LEU . 29.1 mm-40 -90.72 33.6 0.92 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.277 -0.419 . . . . 1.39 110.763 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 170.15 23.55 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.77 -0.728 . . . . 0.55 112.815 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.433 ' HB2' ' HE2' ' A' ' 80' ' ' MET . 43.3 mtm -119.12 140.74 49.61 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.788 0.327 . . . . 0.52 110.668 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.419 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -58.77 156.62 10.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.165 -0.471 . . . . 0.39 111.484 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -50.49 -57.81 7.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 1.52 111.272 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 79.3 p -53.67 -38.85 64.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.022 -0.535 . . . . 1.48 111.369 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -61.18 -44.54 97.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.272 -0.422 . . . . 2.12 111.024 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 81' ' ' ALA . 47.4 t -59.42 -40.99 83.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.32 111.038 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.4 t -62.14 -39.14 82.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.199 -0.455 . . . . 0.37 110.926 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -59.91 -44.79 94.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 1.51 110.778 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 53.3 t -56.92 -54.16 33.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.173 -0.467 . . . . 0.27 111.124 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 92.9 mt -55.69 -34.29 64.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.887 -0.597 . . . . 0.41 111.364 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 79.3 mtm180 -80.46 -17.1 52.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.299 -0.41 . . . . 2.1 111.341 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.428 HD22 ' N ' ' A' ' 91' ' ' ASN . 0.9 OUTLIER -89.84 -15.47 32.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.42 -0.354 . . . . 1.14 111.142 179.858 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.62 -86.64 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.299 -0.41 . . . . 0.55 111.512 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.652 ' HA2' ' HE ' ' A' ' 20' ' ' ARG . . . 64.19 15.49 58.77 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.688 -0.768 . . . . 0.76 112.279 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.489 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -146.92 174.07 3.69 Favored Pre-proline 0 C--N 1.327 -0.37 0 N-CA-C 110.408 -0.219 . . . . 2.52 110.408 -179.727 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.595 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 46.2 Cg_exo -58.24 107.23 0.31 Allowed 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 121.897 1.731 . . . . 0.64 111.477 178.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.3 m -116.6 141.54 34.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.164 0.506 . . . . 0.64 112.173 -178.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.584 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 75.4 ttt180 -94.61 145.07 25.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.692 -0.685 . . . . 2.37 109.707 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 13.5 mt -121.75 136.12 54.94 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.845 0.355 . . . . 0.37 111.366 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 38.5 tp -123.88 104.1 8.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.004 -0.544 . . . . 0.37 110.495 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.5 ' HB3' HD13 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -128.87 147.03 50.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.276 -0.42 . . . . 0.31 111.118 -179.59 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.439 ' HB ' HD11 ' A' ' 70' ' ' LEU . 16.1 tt -98.52 143.84 12.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 0.45 111.029 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 13.7 mmm180 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 115.995 -0.548 . . . . 2.26 111.013 179.97 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.5 t . . . . . 0 C--O 1.232 0.183 0 CA-C-O 120.883 0.373 . . . . 0.9 111.021 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 62.5 mt -81.93 122.18 27.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.919 -0.582 . . . . 0.89 110.494 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -113.35 150.73 32.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 2.73 110.964 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 80.3 p -151.05 138.42 19.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 1.19 111.264 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.9 t -129.67 145.64 35.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.072 -0.513 . . . . 0.56 110.823 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -95.14 114.18 25.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.997 0.427 . . . . 1.74 111.376 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -117.26 166.66 12.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.861 -0.609 . . . . 0.81 110.591 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.508 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 30.4 p90 -157.94 134.39 9.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.81 0.338 . . . . 2.08 111.073 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.766 ' HE ' ' H ' ' A' ' 93' ' ' GLY . 12.2 ttp180 -121.75 160.27 24.92 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.344 -0.389 . . . . 3.06 110.847 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -165.87 -32.83 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.113 -0.494 . . . . 2.58 110.845 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -67.76 162.43 23.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.906 -0.588 . . . . 3.72 110.939 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -86.26 22.9 1.67 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.12 -0.491 . . . . 2.87 110.715 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 74.6 p -63.47 -23.11 67.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.119 -0.491 . . . . 1.38 111.095 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.474 ' HA ' ' NH1' ' A' ' 20' ' ' ARG . 52.5 m 56.73 26.19 11.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.822 -0.626 . . . . 2.45 111.299 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.7 m -152.24 153.68 34.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.916 0.388 . . . . 1.4 111.12 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.541 HD21 ' HB2' ' A' ' 20' ' ' ARG . 81.0 mt -119.77 -5.66 10.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.016 -0.538 . . . . 0.45 110.879 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.464 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 89.02 16.78 57.35 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.724 -0.751 . . . . 0.52 112.363 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.428 HG22 HG23 ' A' ' 31' ' ' ILE . 69.9 mt -97.19 115.65 37.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.7 0.286 . . . . 0.84 110.994 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.1 t -110.66 90.32 3.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.358 -0.383 . . . . 0.95 110.734 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.428 HG23 HG22 ' A' ' 29' ' ' ILE . 41.9 pt -87.18 167.52 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.034 -0.53 . . . . 0.41 111.197 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 47.5 t -150.6 134.42 16.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.088 -0.505 . . . . 1.32 110.792 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.267 0 C-N-CA 120.843 -0.694 . . . . 0.95 112.556 -179.863 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.8 mp . . . . . 0 CA--C 1.528 0.117 0 CA-C-O 120.735 0.302 . . . . 0.65 110.823 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -145.33 153.07 40.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.162 -0.472 . . . . 0.7 110.94 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 95.2 t -83.89 125.79 40.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.247 -0.433 . . . . 0.39 111.195 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -108.54 -27.34 9.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.95 -0.568 . . . . 2.4 111.001 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 59.2 m -147.71 172.1 14.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.045 0.45 . . . . 1.28 111.633 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 97.1 mt -132.14 165.72 23.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.669 -0.696 . . . . 0.42 110.741 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.464 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 43.0 mm -106.36 104.48 50.5 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.186 -0.461 . . . . 1.26 110.958 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.61 129.77 36.68 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.424 2.082 . . . . 0.82 112.407 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 98.01 0.44 58.7 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.768 -0.729 . . . . 0.49 112.76 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.424 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 27.9 t -100.41 170.88 8.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.637 0.256 . . . . 1.23 110.999 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -51.81 -58.54 6.12 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.226 -0.443 . . . . 0.42 111.659 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.3 -32.36 64.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.248 -0.433 . . . . 0.35 111.514 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.91 -24.47 55.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.349 -0.387 . . . . 0.44 111.344 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 55' ' ' SER . 90.8 mt -74.7 -37.65 62.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.277 -0.42 . . . . 0.66 111.033 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -57.18 -46.83 82.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.401 -0.363 . . . . 1.86 110.913 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.46 -34.93 2.65 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.905 -0.664 . . . . 1.06 112.709 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 78.0 mtm180 -65.11 -18.46 65.32 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.712 0.292 . . . . 2.59 111.096 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 67.8 mt -87.23 108.94 18.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.888 0.375 . . . . 0.92 110.919 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -82.67 138.25 44.05 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.011 -0.54 . . . . 1.98 110.5 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.54 53.41 3.98 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.45 2.1 . . . . 1.44 112.524 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -174.59 72.09 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.125 -0.489 . . . . 2.15 110.531 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -145.23 170.38 16.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.147 -0.479 . . . . 2.02 110.847 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -110.68 107.49 17.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.316 -0.402 . . . . 1.02 111.028 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 43.7 mm -63.0 142.69 16.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.146 -0.479 . . . . 0.29 110.732 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 94.4 mt -121.56 -59.22 1.71 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.286 -0.416 . . . . 0.4 111.281 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.467 ' HG2' HD22 ' A' ' 76' ' ' ASN . 77.3 mtp180 -142.02 140.92 32.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.025 0.44 . . . . 2.61 111.583 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.624 HG12 ' H ' ' A' ' 73' ' ' ASP . 3.9 t -103.41 173.99 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.86 -0.609 . . . . 0.28 109.646 178.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.644 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 15.3 t70 -47.28 108.62 0.16 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.736 0.303 . . . . 0.79 111.455 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 54.98 31.0 15.14 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.224 -0.444 . . . . 2.01 111.576 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.435 ' HB ' ' HB ' ' A' ' 72' ' ' VAL . 92.7 t -145.51 148.14 17.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.354 -0.385 . . . . 0.79 110.904 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.467 HD22 ' HG2' ' A' ' 71' ' ' ARG . 22.1 t-20 -120.2 118.33 30.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.148 -0.478 . . . . 2.24 110.552 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.8 m -102.21 25.24 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.871 0.367 . . . . 0.67 111.455 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -92.28 42.4 1.1 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.166 -0.47 . . . . 1.39 110.841 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 158.15 36.79 0.02 OUTLIER Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.661 -0.781 . . . . 0.55 112.901 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 57.6 mtm -131.36 146.88 52.47 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.826 0.345 . . . . 0.52 110.768 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.27 142.49 31.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.067 -0.515 . . . . 0.39 111.029 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -48.07 -54.3 13.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.804 0.335 . . . . 1.52 111.03 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 56.8 m -54.15 -42.93 70.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.987 -0.551 . . . . 1.48 110.98 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -58.1 -43.54 87.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 2.12 110.983 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 52.5 t -58.19 -41.63 81.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 0.32 110.702 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.3 t -61.61 -37.57 78.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.108 -0.496 . . . . 0.37 110.758 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.483 ' HG2' HH21 ' A' ' 90' ' ' ARG . 42.4 mt-10 -58.92 -48.46 81.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.193 -0.458 . . . . 1.51 110.595 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 55.5 t -54.17 -54.1 23.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.133 -0.485 . . . . 0.27 111.193 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.408 HD13 HD12 ' A' ' 29' ' ' ILE . 93.0 mt -59.26 -29.88 67.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.886 -0.597 . . . . 0.41 111.456 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.483 HH21 ' HG2' ' A' ' 87' ' ' GLU . 87.3 mtm180 -85.9 -11.46 53.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.414 -0.357 . . . . 2.1 111.154 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -100.02 -11.3 20.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.39 -0.368 . . . . 1.14 111.178 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.33 -85.03 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.343 -0.39 . . . . 0.55 111.571 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.766 ' H ' ' HE ' ' A' ' 20' ' ' ARG . . . 66.61 17.39 66.78 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.637 -0.792 . . . . 0.76 112.318 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.407 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 1.9 p-10 -146.9 169.62 9.13 Favored Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 110.295 -0.261 . . . . 2.52 110.295 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.508 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 34.6 Cg_exo -58.91 104.1 0.18 Allowed 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.025 1.817 . . . . 0.64 111.423 178.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 18.2 m -112.07 152.43 13.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.128 0.49 . . . . 0.64 112.209 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.644 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 79.5 ttt180 -104.01 145.01 30.78 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.606 -0.724 . . . . 2.37 109.825 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 17.9 mt -115.1 114.33 25.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.197 -0.456 . . . . 0.37 111.137 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 45.0 tp -105.63 102.21 11.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.407 -0.36 . . . . 0.37 110.448 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.4 162.0 31.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.31 111.388 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.2 tt -110.34 139.25 34.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.95 -0.568 . . . . 0.45 110.934 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 18.8 tpt180 . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.085 -0.507 . . . . 2.26 110.924 179.99 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 48.0 t . . . . . 0 C--O 1.233 0.203 0 CA-C-O 120.905 0.383 . . . . 0.9 110.787 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 70.9 mt -81.36 122.03 26.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.98 -0.555 . . . . 0.89 110.313 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -113.56 143.33 44.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.298 -0.41 . . . . 2.73 111.055 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 77.7 p -142.31 127.0 18.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.447 . . . . 1.19 111.09 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 19.5 t -118.36 143.86 28.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.078 -0.51 . . . . 0.56 110.699 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -96.74 114.55 26.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.946 0.403 . . . . 1.74 111.369 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.571 HD11 ' HB2' ' A' ' 60' ' ' ASP . 4.5 mm? -115.47 166.56 11.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.812 -0.631 . . . . 0.81 110.558 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.612 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 43.4 p90 -157.8 132.89 8.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.292 -0.413 . . . . 2.08 110.979 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.476 ' HB2' HD21 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -112.83 127.43 56.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.452 . . . . 3.06 110.599 179.718 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -125.29 -8.63 6.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 2.58 110.892 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -91.99 156.71 17.24 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.105 -0.498 . . . . 3.72 110.74 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -87.37 34.09 0.69 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 2.87 110.748 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 72.0 p -86.07 -21.41 27.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.964 -0.562 . . . . 1.38 111.091 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 55.7 m 58.32 17.62 4.86 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.893 -0.594 . . . . 2.45 111.398 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 54.5 m -127.84 142.42 51.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.853 0.359 . . . . 1.4 111.036 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.476 HD21 ' HB2' ' A' ' 20' ' ' ARG . 95.4 mt -113.4 -13.05 12.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.086 -0.507 . . . . 0.45 110.902 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.449 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 91.53 30.78 10.19 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.802 -0.714 . . . . 0.52 113.188 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.449 ' HB ' HD13 ' A' ' 89' ' ' LEU . 42.2 mm -101.6 113.31 37.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.676 0.274 . . . . 0.84 111.219 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 36.7 t -109.82 97.75 7.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.262 -0.426 . . . . 0.95 110.765 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 23.6 pt -86.23 154.0 3.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 0.41 111.18 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 48.3 t -131.27 139.17 49.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.091 -0.504 . . . . 1.32 110.873 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 C-N-CA 120.768 -0.73 . . . . 0.95 112.538 179.924 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.501 HG21 HG11 ' A' ' 85' ' ' VAL . 42.1 mm . . . . . 0 C--O 1.233 0.187 0 CA-C-O 120.893 0.378 . . . . 0.65 110.903 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -117.98 137.06 53.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.11 -0.496 . . . . 0.7 110.868 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.9 t -66.92 110.47 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.083 -0.508 . . . . 0.39 110.793 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -86.57 -28.87 23.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.0 -0.545 . . . . 2.4 110.876 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 75.9 p -153.62 168.19 27.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.003 0.43 . . . . 1.28 111.292 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.449 HD11 HG22 ' A' ' 63' ' ' ILE . 87.8 mt -123.76 165.03 17.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.849 -0.614 . . . . 0.42 110.865 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.449 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 43.8 mm -112.01 107.95 55.69 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.079 -0.51 . . . . 1.26 110.971 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -60.59 132.32 42.51 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.417 2.078 . . . . 0.82 112.276 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.73 -9.44 40.68 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.813 -0.708 . . . . 0.49 112.57 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.421 ' OG ' ' HA3' ' A' ' 28' ' ' GLY . 97.0 p -91.91 -173.2 3.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.778 0.323 . . . . 1.23 111.03 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.42 ' HB2' HH21 ' A' ' 20' ' ' ARG . . . -70.95 -52.41 20.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.282 -0.417 . . . . 0.42 111.251 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.423 ' HA ' HD11 ' A' ' 18' ' ' LEU . . . -57.53 -42.74 83.48 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.161 -0.472 . . . . 0.35 111.555 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.71 -52.93 47.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.278 -0.419 . . . . 0.44 111.729 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.3 mt -64.03 -19.69 65.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.398 -0.365 . . . . 0.66 111.424 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.571 ' HB2' HD11 ' A' ' 18' ' ' LEU . 14.3 t70 -57.27 -48.77 78.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.406 -0.361 . . . . 1.86 110.863 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.63 -42.15 2.26 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.8 -0.714 . . . . 1.06 112.86 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 67.9 mtp180 -70.38 -20.98 62.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.657 0.265 . . . . 2.59 111.18 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.449 HG22 HD11 ' A' ' 51' ' ' LEU . 41.3 mm -72.99 134.08 30.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.816 0.341 . . . . 0.92 110.833 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -129.77 136.71 29.5 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.105 -0.498 . . . . 1.98 110.707 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.18 168.27 16.26 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.394 2.063 . . . . 1.44 112.22 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 63.0 t30 61.89 56.45 2.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.023 -0.535 . . . . 2.15 110.614 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -131.92 149.93 52.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.971 -0.559 . . . . 2.02 110.683 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -96.58 117.38 30.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.342 -0.39 . . . . 1.02 111.218 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.606 HD13 ' HB3' ' A' ' 100' ' ' LEU . 46.5 mm -78.0 136.35 24.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 0.29 110.714 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.535 HD11 ' HB ' ' A' ' 101' ' ' ILE . 82.6 mt -107.34 -60.19 1.72 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.122 -0.49 . . . . 0.4 110.788 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -154.32 137.18 15.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.169 0.509 . . . . 2.61 111.377 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.672 HG12 ' H ' ' A' ' 73' ' ' ASP . 2.4 t -87.4 175.85 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.606 -0.724 . . . . 0.28 110.138 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.672 ' H ' HG12 ' A' ' 72' ' ' VAL . 24.2 t70 -49.91 110.09 0.35 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.874 0.369 . . . . 0.79 111.642 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 56.84 23.85 8.55 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.034 -0.53 . . . . 2.01 111.801 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.6 t -142.37 144.4 24.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.437 -0.347 . . . . 0.79 110.788 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -112.65 138.18 49.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.484 -0.325 . . . . 2.24 110.809 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.0 m -119.91 24.62 4.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.89 0.376 . . . . 0.67 111.212 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -95.41 44.85 1.09 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.093 -0.503 . . . . 1.39 110.908 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 164.66 24.95 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.612 -0.804 . . . . 0.55 112.672 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 38.9 mtm -124.01 142.23 51.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.714 0.292 . . . . 0.52 110.721 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.408 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -65.11 163.12 15.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.268 -0.423 . . . . 0.39 111.041 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.404 ' O ' HG23 ' A' ' 86' ' ' VAL . 34.8 tt0 -48.83 -52.54 23.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.205 -0.452 . . . . 1.52 111.343 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 80.1 p -54.13 -42.23 69.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.116 -0.493 . . . . 1.48 111.534 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -62.24 -43.91 97.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.47 -0.332 . . . . 2.12 111.471 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.501 HG11 HG21 ' A' ' 46' ' ' ILE . 21.7 t -61.48 -43.82 97.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.855 0.359 . . . . 0.32 111.175 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 82' ' ' GLN . 59.4 t -59.88 -41.02 84.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.069 -0.514 . . . . 0.37 111.154 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.51 ' HG2' HH21 ' A' ' 90' ' ' ARG . 44.0 mt-10 -59.46 -44.45 92.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 1.51 110.967 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 71.8 t -57.82 -57.39 10.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 0.27 111.574 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.449 HD13 ' HB ' ' A' ' 29' ' ' ILE . 86.8 mt -52.24 -34.93 48.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.049 -0.523 . . . . 0.41 111.376 -179.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.51 HH21 ' HG2' ' A' ' 87' ' ' GLU . 65.1 mtm180 -78.09 -29.12 48.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.39 -0.368 . . . . 2.1 111.011 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -71.03 -22.58 62.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 1.14 110.852 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.06 -86.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.115 -0.493 . . . . 0.55 111.279 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.462 ' HA2' ' HG2' ' A' ' 20' ' ' ARG . . . 60.76 17.04 48.61 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.676 -0.773 . . . . 0.76 112.472 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.487 ' HB3' ' HD2' ' A' ' 95' ' ' PRO . 2.4 m120 -147.52 175.13 2.88 Favored Pre-proline 0 CA--C 1.533 0.297 0 C-N-CA 122.001 0.121 . . . . 2.52 110.909 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.612 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 50.8 Cg_exo -56.28 104.93 0.15 Allowed 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 122.121 1.88 . . . . 0.64 111.762 178.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 30.5 m -125.45 150.31 30.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.027 0.441 . . . . 0.64 111.896 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.628 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 77.2 ttt180 -98.05 145.33 26.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.714 -0.675 . . . . 2.37 109.856 179.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 16.0 mt -119.89 125.33 48.21 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.329 -0.396 . . . . 0.37 111.247 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 50.8 tp -112.78 100.03 8.36 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.404 -0.362 . . . . 0.37 110.723 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.606 ' HB3' HD13 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -124.39 141.65 51.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.961 -0.563 . . . . 0.31 111.184 -179.897 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.535 ' HB ' HD11 ' A' ' 70' ' ' LEU . 15.0 tt -97.31 141.93 15.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.469 . . . . 0.45 111.126 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.031 -0.531 . . . . 2.26 110.839 179.933 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 46.8 t . . . . . 0 C--O 1.233 0.217 0 CA-C-O 120.749 0.309 . . . . 0.9 110.824 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 62.2 mt -78.87 121.25 24.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.113 -0.494 . . . . 0.89 110.772 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.401 ' CD1' ' HB2' ' A' ' 102' ' ' ARG . 57.7 m-85 -114.88 129.15 56.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.038 0.447 . . . . 2.73 111.194 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 48.4 t -101.36 137.17 40.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.843 -0.617 . . . . 1.19 111.084 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.1 t -131.28 158.38 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.047 -0.524 . . . . 0.56 110.526 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -136.35 112.93 10.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.827 0.346 . . . . 1.74 111.257 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.557 HD12 ' HB1' ' A' ' 56' ' ' ALA . 4.0 mm? -122.88 166.64 14.7 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.084 -0.507 . . . . 0.81 110.737 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.572 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 34.1 p90 -141.18 131.26 24.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.289 -0.414 . . . . 2.08 111.019 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.529 HH21 ' HG ' ' A' ' 27' ' ' LEU . 14.5 ttm180 -102.48 93.53 5.2 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.38 -0.373 . . . . 3.06 110.91 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -130.08 -0.08 4.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.35 -0.387 . . . . 2.58 110.824 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -88.25 161.09 17.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.067 -0.515 . . . . 3.72 110.881 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -84.46 39.72 0.74 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.14 -0.482 . . . . 2.87 110.865 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 71.5 p -98.06 -19.48 17.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.281 -0.418 . . . . 1.38 111.175 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 29.3 t 56.83 17.39 3.21 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.0 -0.545 . . . . 2.45 111.194 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.8 m -151.95 153.74 34.69 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.294 -0.412 . . . . 1.4 110.947 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.529 ' HG ' HH21 ' A' ' 20' ' ' ARG . 58.2 mt -102.88 -20.65 14.2 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.134 -0.485 . . . . 0.45 110.837 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.504 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 101.8 3.69 52.19 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.767 -0.73 . . . . 0.52 112.742 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 44.9 mm -76.27 109.01 9.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.729 0.299 . . . . 0.84 111.044 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 44.4 t -110.75 92.8 4.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.341 -0.391 . . . . 0.95 110.82 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 26.7 pt -91.01 167.8 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.968 -0.56 . . . . 0.41 111.22 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 77.8 p -137.95 142.26 40.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.02 -0.536 . . . . 1.32 110.853 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.247 0 C-N-CA 120.873 -0.679 . . . . 0.95 112.516 -179.998 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 44.3 mm . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.712 0.291 . . . . 0.65 110.804 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -148.48 144.99 27.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.337 -0.392 . . . . 0.7 111.117 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 97.1 t -83.37 126.17 40.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.029 -0.532 . . . . 0.39 110.649 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -107.32 -21.95 12.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 2.4 110.912 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 76.9 p -152.39 169.64 22.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 1.28 111.2 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 67.8 mt -134.59 165.5 25.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.941 -0.572 . . . . 0.42 110.771 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.504 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 47.5 mm -107.6 99.21 27.79 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 1.26 110.877 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -49.69 141.17 27.93 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.564 2.176 . . . . 0.82 112.652 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 95.66 -22.93 36.41 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.88 -0.676 . . . . 0.49 112.562 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 83.6 p -76.3 -178.19 4.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.733 0.301 . . . . 1.23 111.059 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.557 ' HB1' HD12 ' A' ' 18' ' ' LEU . . . -66.15 -56.87 9.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.316 -0.402 . . . . 0.42 111.229 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.11 -34.46 66.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.458 . . . . 0.35 111.314 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.14 -43.05 71.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.28 -0.418 . . . . 0.44 111.288 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.4 mt -67.93 -19.62 65.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.257 -0.428 . . . . 0.66 111.118 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -57.33 -46.88 82.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.444 -0.343 . . . . 1.86 110.891 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.61 -50.32 1.81 Allowed Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.77 -0.729 . . . . 1.06 112.87 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 66.4 mtm180 -64.08 -42.55 96.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.634 0.254 . . . . 2.59 111.017 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 61.5 mt -63.86 114.4 2.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.369 -0.378 . . . . 0.92 110.962 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -130.5 158.56 74.19 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 1.98 111.179 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -55.0 174.73 0.19 Allowed 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.734 2.29 . . . . 1.44 112.211 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 17.4 m120 61.66 35.58 17.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.195 -0.457 . . . . 2.15 111.122 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -112.96 152.71 29.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.152 -0.476 . . . . 2.02 110.649 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -116.02 105.81 13.06 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.83 0.347 . . . . 1.02 111.138 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 44.1 mm -63.7 131.82 29.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.195 -0.457 . . . . 0.29 110.983 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.609 ' HA ' HE21 ' A' ' 78' ' ' GLN . 66.9 mt -102.37 -65.69 0.97 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.134 -0.484 . . . . 0.4 110.802 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -146.84 135.31 21.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.988 -0.551 . . . . 2.61 111.296 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.657 HG12 ' H ' ' A' ' 73' ' ' ASP . 3.7 t -87.99 175.22 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.622 -0.717 . . . . 0.28 109.983 179.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.657 ' H ' HG12 ' A' ' 72' ' ' VAL . 21.3 t70 -48.63 109.28 0.23 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.803 0.335 . . . . 0.79 111.586 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 56.15 26.37 10.16 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.113 -0.494 . . . . 2.01 111.853 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.5 t -145.6 149.26 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.406 -0.361 . . . . 0.79 110.777 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -119.06 131.72 55.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.32 -0.4 . . . . 2.24 110.459 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.463 ' HA ' ' HE2' ' A' ' 80' ' ' MET . 30.0 m -105.25 26.43 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.879 0.371 . . . . 0.67 111.287 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.609 HE21 ' HA ' ' A' ' 70' ' ' LEU . 84.8 mm-40 -94.93 23.79 5.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.096 -0.502 . . . . 1.39 111.114 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -172.79 17.06 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.641 -0.79 . . . . 0.55 112.8 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.463 ' HE2' ' HA ' ' A' ' 77' ' ' VAL . 38.6 mtm -118.05 135.9 53.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.831 0.348 . . . . 0.52 110.849 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.91 160.08 18.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.436 . . . . 0.39 111.097 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -48.25 -54.21 14.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.374 -0.376 . . . . 1.52 111.249 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 46.1 t -53.88 -32.84 54.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.327 -0.397 . . . . 1.48 111.244 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.499 ' O ' HG23 ' A' ' 88' ' ' VAL . 10.4 t70 -73.35 -40.13 64.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.366 -0.379 . . . . 2.12 111.0 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 25.8 t -65.12 -30.32 49.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.961 0.41 . . . . 0.32 110.661 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 97.5 t -70.94 -49.27 51.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.985 -0.552 . . . . 0.37 111.187 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.433 ' HG2' ' O ' ' A' ' 84' ' ' ASP . 11.4 pt-20 -60.44 -30.01 69.37 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.722 0.296 . . . . 1.51 110.752 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 84' ' ' ASP . 50.2 t -65.27 -56.66 14.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.893 0.378 . . . . 0.27 110.825 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 93.5 mt -54.93 -35.19 63.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.957 -0.565 . . . . 0.41 111.378 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.466 ' HA ' ' NH1' ' A' ' 20' ' ' ARG . 86.9 mtm180 -76.96 -34.32 57.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.424 -0.353 . . . . 2.1 111.17 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.29 -18.36 63.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.436 -0.347 . . . . 1.14 110.682 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.43 -84.51 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.133 -0.485 . . . . 0.55 111.464 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.487 ' H ' ' HD2' ' A' ' 20' ' ' ARG . . . 63.63 22.2 65.75 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.692 -0.766 . . . . 0.76 112.186 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -147.17 169.81 8.77 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 110.39 -0.226 . . . . 2.52 110.39 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.572 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 33.3 Cg_exo -60.79 93.02 0.1 OUTLIER 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.055 1.837 . . . . 0.64 111.248 178.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.5 m -101.79 145.64 11.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.085 0.469 . . . . 0.64 111.918 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.629 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 60.4 ttp180 -91.88 136.44 33.16 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.694 -0.685 . . . . 2.37 110.157 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 65.5 mt -111.65 103.74 12.06 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.975 -0.557 . . . . 0.37 111.187 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 21.4 tp -97.51 106.77 19.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.889 0.376 . . . . 0.37 110.158 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.96 164.93 26.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.31 111.434 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 12.4 tt -110.34 133.75 54.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.031 -0.532 . . . . 0.45 111.033 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.401 ' HB2' ' CD1' ' A' ' 14' ' ' TYR . 18.2 mmm180 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 115.968 -0.56 . . . . 2.26 110.508 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.9 t . . . . . 0 CA--C 1.527 0.088 0 CA-C-O 120.669 0.271 . . . . 0.9 110.685 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 56.0 mt -81.65 122.56 27.77 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.293 -0.412 . . . . 0.89 111.166 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -121.15 130.58 53.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.066 -0.515 . . . . 2.73 110.84 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 47.6 t -125.57 132.9 52.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.31 -0.405 . . . . 1.19 111.214 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 18.3 t -131.13 151.29 35.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.968 -0.56 . . . . 0.56 110.606 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -101.2 118.71 37.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.958 0.408 . . . . 1.74 111.446 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.566 HD23 HD12 ' A' ' 98' ' ' LEU . 4.3 mm? -122.23 166.45 14.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.945 -0.57 . . . . 0.81 110.191 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.587 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 36.9 p90 -141.86 131.83 24.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.85 0.357 . . . . 2.08 111.078 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.432 ' HB2' HD21 ' A' ' 27' ' ' LEU . 3.2 tmm_? -100.83 104.82 16.06 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.21 -0.45 . . . . 3.06 110.712 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -146.43 8.88 1.05 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.311 -0.404 . . . . 2.58 110.953 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -89.75 162.75 15.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.253 -0.431 . . . . 3.72 110.958 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -84.05 34.13 0.5 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.108 -0.497 . . . . 2.87 110.958 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 51.6 p -98.1 -8.96 26.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.182 -0.463 . . . . 1.38 110.881 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.7 t 58.35 15.92 3.75 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.829 -0.623 . . . . 2.45 111.098 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 57.3 m -158.04 -176.96 6.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.262 -0.426 . . . . 1.4 110.902 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.432 HD21 ' HB2' ' A' ' 20' ' ' ARG . 37.4 mt -115.28 -5.1 12.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.042 -0.526 . . . . 0.45 110.794 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.491 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 94.82 6.27 60.71 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.779 -0.724 . . . . 0.52 112.171 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 25.0 mm -79.61 109.24 14.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.817 0.341 . . . . 0.84 110.958 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.7 m -113.33 93.35 4.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.176 -0.465 . . . . 0.95 110.796 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 44.6 pt -93.03 163.3 2.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.41 111.2 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 45.3 t -119.08 130.66 55.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.259 -0.428 . . . . 1.32 110.792 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.237 0 C-N-CA 120.849 -0.691 . . . . 0.95 112.623 -179.973 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 49.7 mm . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.719 0.295 . . . . 0.65 110.895 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -143.59 137.67 28.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.7 111.094 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 99.4 t -68.08 127.81 30.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.113 -0.494 . . . . 0.39 111.051 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -99.96 -30.58 11.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.912 -0.586 . . . . 2.4 110.999 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 80.1 p -157.17 171.62 20.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.894 0.378 . . . . 1.28 111.296 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.433 HD11 HG22 ' A' ' 63' ' ' ILE . 63.6 mt -129.26 140.55 51.4 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.921 -0.582 . . . . 0.42 110.88 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.491 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 49.5 mm -77.15 118.0 68.95 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 116.21 -0.45 . . . . 1.26 110.899 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -68.25 109.43 1.99 Allowed 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.268 1.979 . . . . 0.82 112.255 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 126.93 -5.46 7.39 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.849 -0.691 . . . . 0.49 112.448 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.8 m -94.07 -174.83 3.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.709 0.29 . . . . 1.23 111.086 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.51 ' HB1' HD12 ' A' ' 18' ' ' LEU . . . -72.48 -42.8 64.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.379 -0.373 . . . . 0.42 111.348 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.98 -42.57 99.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.298 -0.41 . . . . 0.35 111.451 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.03 -55.24 11.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.44 111.317 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.3 mt -59.25 -19.67 47.75 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.3 -0.409 . . . . 0.66 111.23 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.48 ' HB2' HD11 ' A' ' 18' ' ' LEU . 18.8 t70 -59.96 -49.74 76.5 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.837 0.351 . . . . 1.86 110.746 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 98.71 -49.73 1.27 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.905 -0.664 . . . . 1.06 112.987 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 51.3 mtp180 -60.33 -45.09 94.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.749 0.309 . . . . 2.59 111.134 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.433 HG22 HD11 ' A' ' 51' ' ' LEU . 71.9 mt -67.59 114.18 4.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.906 0.384 . . . . 0.92 111.111 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -117.29 139.75 26.41 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.025 -0.534 . . . . 1.98 110.568 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -47.62 167.18 0.09 OUTLIER 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.557 2.171 . . . . 1.44 112.73 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 63.97 60.78 0.99 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.094 -0.503 . . . . 2.15 110.554 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -134.28 156.66 48.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.788 -0.642 . . . . 2.02 110.579 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -109.47 113.29 25.96 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.867 0.365 . . . . 1.02 111.073 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 34.2 mm -74.05 143.36 13.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.076 -0.511 . . . . 0.29 110.857 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 74.7 mt -116.17 -66.51 1.08 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.312 -0.404 . . . . 0.4 111.392 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.494 ' HG2' HD22 ' A' ' 76' ' ' ASN . 76.8 mtp180 -140.22 142.45 35.83 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.041 0.448 . . . . 2.61 111.558 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.652 HG12 ' H ' ' A' ' 73' ' ' ASP . 3.6 t -100.83 174.48 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.871 -0.604 . . . . 0.28 109.788 179.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.689 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 12.7 t70 -49.76 108.66 0.22 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.727 0.299 . . . . 0.79 111.191 179.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 55.21 29.7 13.23 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.198 -0.455 . . . . 2.01 111.542 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.502 ' HB ' ' HB ' ' A' ' 72' ' ' VAL . 92.4 t -145.36 151.78 14.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.417 -0.356 . . . . 0.79 110.947 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.494 HD22 ' HG2' ' A' ' 71' ' ' ARG . 2.7 t-20 -120.66 126.1 49.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.32 -0.4 . . . . 2.24 110.565 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.9 m -107.56 19.84 5.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 111.708 0.262 . . . . 0.67 111.708 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.469 ' HG2' HD21 ' A' ' 76' ' ' ASN . 14.0 mm100 -94.26 21.72 6.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.92 0.39 . . . . 1.39 110.465 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -161.68 13.09 0.14 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.004 -0.617 . . . . 0.55 112.429 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 52.9 mtm -118.83 144.65 46.22 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.859 0.361 . . . . 0.52 110.825 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.4 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -71.87 168.02 18.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.12 -0.491 . . . . 0.39 111.086 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.448 ' O ' HG23 ' A' ' 86' ' ' VAL . 63.0 tt0 -49.5 -56.43 9.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.138 -0.483 . . . . 1.52 111.447 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 54.6 m -51.38 -43.31 61.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 1.48 111.837 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -60.68 -50.53 73.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.465 -0.334 . . . . 2.12 111.507 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 81' ' ' ALA . 25.7 t -57.86 -36.46 55.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.293 -0.412 . . . . 0.32 111.327 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 82' ' ' GLN . 90.6 t -62.54 -48.95 85.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.36 -0.382 . . . . 0.37 111.391 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -56.73 -41.46 77.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.339 -0.392 . . . . 1.51 111.143 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 75.1 t -57.33 -58.96 3.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.255 -0.43 . . . . 0.27 111.696 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 86.5 mt -54.22 -32.16 55.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 0.41 111.58 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 82.6 mtm180 -81.47 -23.47 37.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.503 -0.317 . . . . 2.1 111.276 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -84.14 -14.26 50.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.34 -0.391 . . . . 1.14 110.955 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.03 -81.61 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.162 -0.472 . . . . 0.55 111.49 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.409 ' H ' ' HE ' ' A' ' 20' ' ' ARG . . . 63.84 15.29 57.72 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 120.625 -0.797 . . . . 0.76 112.253 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -146.85 167.94 12.57 Favored Pre-proline 0 C--N 1.329 -0.303 0 N-CA-C 110.333 -0.247 . . . . 2.52 110.333 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.587 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 34.3 Cg_exo -61.94 98.38 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.051 1.834 . . . . 0.64 111.338 178.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.6 m -104.44 153.67 6.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.129 0.49 . . . . 0.64 112.108 -178.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.689 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 40.3 ttm180 -93.04 141.26 28.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.459 -0.791 . . . . 2.37 110.063 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.566 HD12 HD23 ' A' ' 18' ' ' LEU . 48.9 mt -117.37 103.58 10.28 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.149 -0.478 . . . . 0.37 110.848 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 58.5 tp -99.29 99.63 10.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.37 110.34 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.2 165.86 20.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.31 111.093 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.9 tt -114.33 130.23 68.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-O 121.096 0.474 . . . . 0.45 111.447 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 23.0 mmm180 . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 115.443 -0.799 . . . . 2.26 110.642 179.818 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 46.6 t . . . . . 0 C--O 1.233 0.205 0 CA-C-O 120.796 0.331 . . . . 0.9 110.788 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -84.77 126.09 33.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.89 111.211 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -121.16 136.09 55.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.897 -0.592 . . . . 2.73 110.586 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 49.4 m -136.75 127.57 27.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.284 -0.416 . . . . 1.19 111.205 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 28.3 t -129.86 145.98 34.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.986 -0.552 . . . . 0.56 110.61 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -107.92 117.51 34.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.949 0.404 . . . . 1.74 111.311 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.518 HD11 ' HB2' ' A' ' 60' ' ' ASP . 4.3 mm? -111.05 166.46 11.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.855 -0.611 . . . . 0.81 110.763 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.569 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 28.6 p90 -152.95 132.47 12.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.388 -0.369 . . . . 2.08 111.084 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.564 HH21 ' H ' ' A' ' 93' ' ' GLY . 24.2 ttp180 -122.37 156.2 34.46 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.271 -0.422 . . . . 3.06 110.637 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -169.39 26.45 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.311 -0.404 . . . . 2.58 110.84 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -116.78 164.7 14.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.176 -0.466 . . . . 3.72 110.91 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -87.58 25.99 1.36 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.999 -0.546 . . . . 2.87 111.007 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.4 p -78.26 -23.94 47.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.927 0.394 . . . . 1.38 110.902 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 59.2 m 56.59 21.75 6.05 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.683 -0.69 . . . . 2.45 111.339 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.7 m -140.03 144.69 37.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.287 -0.415 . . . . 1.4 111.058 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 41.4 mt -113.56 12.48 18.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.125 -0.489 . . . . 0.45 110.91 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.501 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 58.29 37.54 87.49 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.833 -0.699 . . . . 0.52 112.715 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 65.9 mt -109.51 109.48 28.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.791 0.329 . . . . 0.84 111.144 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 39.5 t -105.64 112.24 25.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.072 -0.513 . . . . 0.95 110.633 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.407 HD12 HG23 ' A' ' 46' ' ' ILE . 37.1 pt -107.84 167.13 3.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 0.41 111.509 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 56.8 m -141.56 134.89 29.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.965 -0.561 . . . . 1.32 110.623 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 C-N-CA 120.754 -0.736 . . . . 0.95 112.598 -179.897 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.407 HG23 HD12 ' A' ' 31' ' ' ILE . 48.3 mm . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.728 0.299 . . . . 0.65 110.648 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -128.48 142.36 51.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.258 -0.428 . . . . 0.7 111.22 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 86.3 t -76.9 113.02 15.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.11 -0.496 . . . . 0.39 110.47 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -88.35 -29.41 20.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.276 -0.42 . . . . 2.4 111.331 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 78.4 p -153.35 176.82 11.56 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.936 0.398 . . . . 1.28 111.377 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 69.8 mt -135.58 153.45 51.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.933 -0.576 . . . . 0.42 110.882 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.501 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 57.7 mt -90.33 109.71 35.54 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.312 -0.404 . . . . 1.26 110.947 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -57.73 124.95 17.23 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.426 2.084 . . . . 0.82 112.331 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.93 -3.86 31.92 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.774 -0.727 . . . . 0.49 112.498 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.9 t -100.09 177.86 4.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.743 0.306 . . . . 1.23 110.94 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.48 -58.34 8.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.263 -0.426 . . . . 0.42 111.755 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.46 -49.83 66.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.225 -0.443 . . . . 0.35 111.844 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.75 -39.45 80.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.385 -0.37 . . . . 0.44 111.876 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 81.1 mt -70.75 -23.0 62.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.503 -0.317 . . . . 0.66 111.319 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.518 ' HB2' HD11 ' A' ' 18' ' ' LEU . 15.2 t70 -60.51 -56.23 23.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.829 0.347 . . . . 1.86 110.862 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 98.35 -46.34 1.56 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.828 -0.701 . . . . 1.06 113.159 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 38.0 mtp180 -60.54 -26.88 67.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.63 0.252 . . . . 2.59 111.513 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 70.7 mt -73.06 102.24 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.946 0.403 . . . . 0.92 111.04 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -93.98 136.18 23.99 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.001 -0.545 . . . . 1.98 110.574 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.46 171.89 1.68 Allowed 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.41 2.074 . . . . 1.44 112.34 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 58.97 29.35 18.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.992 -0.549 . . . . 2.15 110.902 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.438 ' OD1' ' HB2' ' A' ' 100' ' ' LEU . 11.9 t0 -102.31 140.07 37.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.046 -0.524 . . . . 2.02 110.405 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -87.32 127.83 35.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.755 0.312 . . . . 1.02 111.202 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 39.9 mm -90.56 136.56 23.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.287 -0.415 . . . . 0.29 110.672 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 89.5 mt -107.29 -64.38 1.2 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.326 -0.397 . . . . 0.4 111.157 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -147.75 135.12 20.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.074 0.464 . . . . 2.61 111.704 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.675 HG12 ' H ' ' A' ' 73' ' ' ASP . 3.1 t -89.81 175.4 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.614 -0.721 . . . . 0.28 110.084 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.675 ' H ' HG12 ' A' ' 72' ' ' VAL . 16.6 t70 -47.24 109.21 0.19 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.721 0.296 . . . . 0.79 111.688 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 54.36 28.77 9.85 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.095 -0.502 . . . . 2.01 111.73 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.474 HG11 HG11 ' A' ' 88' ' ' VAL . 66.6 t -145.67 147.06 18.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.39 -0.368 . . . . 0.79 110.714 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -116.44 128.6 55.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.26 -0.427 . . . . 2.24 110.515 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.5 m -109.98 26.44 2.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.818 0.342 . . . . 0.67 111.353 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -97.05 24.48 6.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.451 . . . . 1.39 111.046 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -170.23 15.2 0.06 OUTLIER Glycine 0 C--N 1.329 0.194 0 C-N-CA 120.543 -0.837 . . . . 0.55 112.768 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 47.2 mtm -117.56 142.46 47.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.852 0.358 . . . . 0.52 110.98 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.41 ' HB3' ' OD2' ' A' ' 84' ' ' ASP . . . -66.29 165.13 14.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.091 -0.504 . . . . 0.39 110.99 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.401 ' O ' HG23 ' A' ' 86' ' ' VAL . 36.0 tt0 -50.01 -56.72 9.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.315 -0.402 . . . . 1.52 111.369 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.3 t -51.89 -39.92 59.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.251 -0.431 . . . . 1.48 111.456 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.41 ' OD2' ' HB3' ' A' ' 81' ' ' ALA . 11.6 m-20 -64.29 -47.07 80.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.487 -0.324 . . . . 2.12 111.129 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 54.3 t -58.06 -32.64 44.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.306 -0.406 . . . . 0.32 110.886 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.41 HG12 ' NE ' ' A' ' 90' ' ' ARG . 75.0 t -68.72 -42.28 82.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.14 -0.482 . . . . 0.37 110.957 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.436 ' HG2' HH21 ' A' ' 90' ' ' ARG . 44.7 mt-10 -56.74 -46.55 81.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.839 0.352 . . . . 1.51 110.801 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.474 HG11 HG11 ' A' ' 75' ' ' VAL . 53.0 t -59.09 -56.18 18.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.228 -0.442 . . . . 0.27 111.011 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 82.3 mt -58.73 -22.11 56.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.916 -0.584 . . . . 0.41 111.355 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.436 HH21 ' HG2' ' A' ' 87' ' ' GLU . 80.4 mtm180 -89.04 -21.96 23.19 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.596 -0.275 . . . . 2.1 111.177 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -86.5 -15.69 39.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.496 -0.32 . . . . 1.14 111.001 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.97 -87.73 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.256 -0.429 . . . . 0.55 111.377 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.564 ' H ' HH21 ' A' ' 20' ' ' ARG . . . 61.68 21.45 60.65 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.809 -0.71 . . . . 0.76 112.613 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.465 HD22 ' HA ' ' A' ' 94' ' ' ASN . 4.3 m120 -147.24 173.84 3.87 Favored Pre-proline 0 C--N 1.328 -0.345 0 C-N-CA 121.936 0.094 . . . . 2.52 110.846 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.569 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 37.1 Cg_exo -59.15 90.82 0.07 OUTLIER 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.141 1.894 . . . . 0.64 111.783 178.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 28.8 m -104.73 153.48 6.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.64 111.937 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.654 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 52.1 ttp180 -99.23 145.12 27.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.689 -0.687 . . . . 2.37 110.282 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.501 HD12 HD23 ' A' ' 18' ' ' LEU . 46.5 mt -120.78 106.21 11.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.261 -0.427 . . . . 0.37 111.26 -179.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 22.2 tp -99.3 107.45 19.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.389 -0.369 . . . . 0.37 110.116 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.438 ' HB2' ' OD1' ' A' ' 67' ' ' ASP . 0.4 OUTLIER -135.36 163.3 30.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.954 0.406 . . . . 0.31 111.539 -179.159 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 15.7 tt -120.9 141.03 43.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.927 -0.579 . . . . 0.45 110.965 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.402 ' HB2' ' OD2' ' A' ' 67' ' ' ASP . 25.7 tpt180 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.11 -0.495 . . . . 2.26 110.776 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.1 t . . . . . 0 C--O 1.233 0.186 0 CA-C-O 120.765 0.317 . . . . 0.9 110.549 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 70.7 mt -84.66 122.93 29.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.182 -0.463 . . . . 0.89 111.049 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -116.71 149.19 40.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.044 -0.525 . . . . 2.73 111.044 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 81.8 p -149.35 130.12 14.17 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.187 -0.461 . . . . 1.19 111.121 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 19.0 t -125.55 153.25 33.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 0.56 110.577 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -101.36 117.93 35.95 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.9 0.381 . . . . 1.74 111.692 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.412 HD11 ' HB2' ' A' ' 60' ' ' ASP . 4.5 mm? -114.14 166.27 11.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.874 -0.603 . . . . 0.81 110.375 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.58 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 42.3 p90 -156.93 137.03 12.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.714 0.292 . . . . 2.08 111.305 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.466 HH21 ' H ' ' A' ' 93' ' ' GLY . 21.3 ttp180 -129.96 153.22 48.58 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.313 -0.403 . . . . 3.06 111.1 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -155.69 -34.49 0.09 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.048 -0.523 . . . . 2.58 111.054 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -59.92 164.18 4.08 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.09 -0.505 . . . . 3.72 110.936 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -93.96 33.98 1.28 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 2.87 110.994 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 74.6 p -78.6 -13.34 59.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.277 -0.419 . . . . 1.38 111.136 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 97.2 p 50.22 24.09 1.37 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.615 -0.721 . . . . 2.45 111.605 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 47.7 t -141.84 135.37 29.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.841 0.353 . . . . 1.4 111.03 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 19.0 mt -103.45 -20.64 13.98 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.136 -0.483 . . . . 0.45 110.951 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.476 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 97.88 10.89 51.59 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.785 -0.721 . . . . 0.52 112.579 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 67.3 mt -94.03 110.69 23.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.721 0.296 . . . . 0.84 111.139 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 46.5 t -112.42 114.21 26.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.244 -0.434 . . . . 0.95 110.72 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 43.0 pt -100.55 177.84 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.241 -0.436 . . . . 0.41 111.287 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 62.8 m -158.0 132.38 8.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.882 -0.599 . . . . 1.32 110.636 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 C-N-CA 120.634 -0.793 . . . . 0.95 112.446 -179.889 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 43.9 mm . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.827 0.346 . . . . 0.65 110.982 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -139.02 138.57 37.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.164 -0.471 . . . . 0.7 111.072 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 85.5 t -74.01 120.44 23.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.297 -0.411 . . . . 0.39 110.822 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -99.77 -22.24 15.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 2.4 111.254 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 84.1 p -155.88 170.04 23.01 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.058 0.456 . . . . 1.28 111.557 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 90.6 mt -128.71 170.27 13.5 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.607 -0.724 . . . . 0.42 110.401 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.476 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 43.1 mm -109.74 98.53 33.8 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.36 -0.382 . . . . 1.26 111.084 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.79 111.54 0.76 Allowed 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.596 2.197 . . . . 0.82 112.312 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.15 1.9 7.85 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.794 -0.717 . . . . 0.49 112.49 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.0 t -112.01 -176.7 2.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.692 0.282 . . . . 1.23 110.89 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.15 -53.1 61.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.368 -0.378 . . . . 0.42 111.298 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.48 -46.55 70.03 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.169 -0.468 . . . . 0.35 111.275 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.95 -37.57 88.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.076 -0.511 . . . . 0.44 111.262 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 82.7 mt -73.87 -19.64 60.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.89 0.376 . . . . 0.66 110.894 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.412 ' HB2' HD11 ' A' ' 18' ' ' LEU . 26.5 t70 -66.7 -52.04 49.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.109 -0.496 . . . . 1.86 110.843 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 89.88 -44.49 3.0 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.846 -0.692 . . . . 1.06 113.22 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.406 ' HB2' ' OD2' ' A' ' 60' ' ' ASP . 22.2 mmm180 -59.66 -22.32 61.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.686 0.279 . . . . 2.59 111.126 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 52.6 mt -82.53 109.98 17.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.879 0.371 . . . . 0.92 111.003 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.401 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 39.9 tt0 -101.42 135.67 19.79 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 1.98 110.57 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 64' ' ' GLU . 40.7 Cg_exo -57.2 172.18 0.96 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.453 2.102 . . . . 1.44 112.44 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 59.33 26.89 15.84 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.918 -0.583 . . . . 2.15 111.275 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -94.5 158.87 15.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.341 -0.391 . . . . 2.02 110.645 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -107.76 124.24 49.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.77 0.319 . . . . 1.02 110.927 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.548 HD13 ' HB3' ' A' ' 100' ' ' LEU . 45.9 mm -87.33 140.31 15.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.191 -0.459 . . . . 0.29 110.983 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 71.6 mt -115.88 -60.58 1.85 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.206 -0.452 . . . . 0.4 110.946 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.466 ' O ' ' HB3' ' A' ' 99' ' ' LEU . 81.2 mtt180 -144.72 138.66 27.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 2.61 111.254 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.634 HG12 ' H ' ' A' ' 73' ' ' ASP . 4.4 t -94.13 173.82 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.963 -0.562 . . . . 0.28 109.941 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.645 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 19.1 t70 -47.67 108.81 0.17 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.703 0.287 . . . . 0.79 111.516 179.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 54.83 29.15 11.42 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.194 -0.457 . . . . 2.01 111.506 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.463 ' HB ' ' HB ' ' A' ' 72' ' ' VAL . 86.5 t -145.51 151.08 15.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.047 -0.524 . . . . 0.79 110.627 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -120.75 129.34 53.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.484 -0.325 . . . . 2.24 110.77 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.9 m -107.35 23.84 3.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-O 120.808 0.337 . . . . 0.67 111.366 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -96.71 38.31 1.23 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.293 -0.412 . . . . 1.39 110.692 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 175.94 28.43 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.721 -0.752 . . . . 0.55 112.76 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 60.3 mtm -132.39 141.81 49.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.93 0.395 . . . . 0.52 110.976 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.443 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -69.05 161.85 28.15 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.994 -0.548 . . . . 0.39 110.919 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -45.73 -57.1 4.52 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.195 -0.457 . . . . 1.52 111.638 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.4 m -50.62 -43.44 56.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.178 -0.465 . . . . 1.48 111.565 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -63.8 -42.9 97.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.359 -0.382 . . . . 2.12 111.471 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 81' ' ' ALA . 38.9 t -59.63 -38.73 77.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 120.857 0.361 . . . . 0.32 110.988 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 52.4 t -66.74 -36.58 77.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.11 -0.496 . . . . 0.37 110.968 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -60.1 -49.16 78.74 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.217 -0.447 . . . . 1.51 110.714 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.405 HG11 HG11 ' A' ' 75' ' ' VAL . 53.7 t -56.75 -53.52 40.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.082 -0.508 . . . . 0.27 111.27 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 79.2 mt -53.89 -32.62 53.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.077 -0.51 . . . . 0.41 111.277 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.465 ' HA ' HH22 ' A' ' 20' ' ' ARG . 85.0 mtm180 -81.64 -24.06 36.58 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.256 -0.429 . . . . 2.1 111.115 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -78.4 -17.96 55.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.276 -0.42 . . . . 1.14 110.835 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.68 -89.62 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.091 -0.504 . . . . 0.55 111.474 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.466 ' H ' HH21 ' A' ' 20' ' ' ARG . . . 60.48 21.86 58.12 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.702 -0.761 . . . . 0.76 112.429 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.13 174.79 3.11 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 110.461 -0.199 . . . . 2.52 110.461 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.58 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 38.2 Cg_exo -59.18 97.53 0.1 OUTLIER 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.021 1.814 . . . . 0.64 111.641 178.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 28.8 m -114.53 151.56 16.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.129 0.49 . . . . 0.64 111.893 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.645 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 75.2 ttt180 -102.1 145.24 29.62 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.673 -0.694 . . . . 2.37 110.082 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 18.3 mt -115.49 116.18 27.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.187 -0.46 . . . . 0.37 111.378 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.466 ' HB3' ' O ' ' A' ' 71' ' ' ARG . 63.6 tp -104.46 99.89 9.58 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.16 -0.473 . . . . 0.37 110.261 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.548 ' HB3' HD13 ' A' ' 69' ' ' ILE . 0.5 OUTLIER -129.82 158.25 39.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.197 -0.456 . . . . 0.31 111.394 -179.519 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.0 tt -110.37 140.39 29.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.45 110.949 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.081 -0.509 . . . . 2.26 110.942 -179.927 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.3 t . . . . . 0 C--O 1.233 0.23 0 CA-C-O 120.854 0.359 . . . . 0.9 110.891 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 79.8 mt -76.11 119.19 19.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.0 -0.545 . . . . 0.89 110.739 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -120.08 132.11 55.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 2.73 111.0 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 79.0 p -137.34 126.94 25.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.286 -0.416 . . . . 1.19 110.972 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.17 141.53 46.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.219 -0.446 . . . . 0.56 110.952 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -96.18 116.34 28.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 1.74 111.54 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.438 HD11 ' HB2' ' A' ' 60' ' ' ASP . 4.5 mm? -114.92 166.61 11.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.98 -0.555 . . . . 0.81 110.125 179.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.539 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 15.1 p90 -147.11 123.1 10.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.769 0.319 . . . . 2.08 111.149 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.578 ' HB2' HD21 ' A' ' 27' ' ' LEU . 14.9 ttp180 -95.61 96.84 9.3 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.325 -0.398 . . . . 3.06 110.687 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -107.69 -19.98 13.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.985 -0.552 . . . . 2.58 110.672 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -82.37 148.64 28.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.954 -0.566 . . . . 3.72 110.794 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -85.96 47.59 1.48 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.188 -0.46 . . . . 2.87 110.974 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 65.1 p -87.38 -10.04 53.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.484 . . . . 1.38 111.182 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.2 t 58.05 20.3 6.76 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.988 -0.551 . . . . 2.45 111.248 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 60.5 m -157.47 160.95 38.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.272 -0.422 . . . . 1.4 110.965 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.578 HD21 ' HB2' ' A' ' 20' ' ' ARG . 77.2 mt -113.61 -14.66 12.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.112 -0.494 . . . . 0.45 110.78 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.528 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 93.81 29.99 9.38 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.823 -0.703 . . . . 0.52 112.406 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.437 HD12 HD22 ' A' ' 89' ' ' LEU . 77.7 mt -109.79 109.25 27.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.737 0.303 . . . . 0.84 111.05 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 40.0 t -111.03 100.44 9.13 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.29 -0.414 . . . . 0.95 110.844 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 40.6 pt -92.71 179.66 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.087 -0.506 . . . . 0.41 111.175 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 82.0 p -135.42 136.83 41.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.053 -0.521 . . . . 1.32 110.929 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.254 0 C-N-CA 120.862 -0.685 . . . . 0.95 112.434 -179.943 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.3 mm . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.801 0.334 . . . . 0.65 110.787 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.414 ' HB2' ' O ' ' A' ' 67' ' ' ASP . 27.0 p90 -145.4 145.46 31.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.322 -0.399 . . . . 0.7 111.091 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 99.7 t -82.16 129.29 37.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.089 -0.505 . . . . 0.39 111.061 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.2 ttpp -102.02 -24.48 13.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.996 -0.547 . . . . 2.4 110.946 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 79.6 p -155.12 156.24 35.45 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.037 0.446 . . . . 1.28 111.36 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 77.1 mt -114.28 162.97 15.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.775 -0.648 . . . . 0.42 110.626 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.528 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 62.4 mt -109.7 101.97 48.43 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.367 -0.378 . . . . 1.26 111.248 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -52.11 146.44 30.44 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.586 2.191 . . . . 0.82 112.577 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.4 -22.37 30.38 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.827 -0.701 . . . . 0.49 112.581 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 67.4 m -80.93 -177.94 6.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.784 0.325 . . . . 1.23 111.071 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.65 -55.09 16.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.218 -0.447 . . . . 0.42 111.472 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.63 -39.86 65.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.103 -0.499 . . . . 0.35 111.843 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.35 -42.86 71.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.401 -0.363 . . . . 0.44 111.438 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.0 mt -70.95 -19.67 62.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.334 -0.394 . . . . 0.66 110.992 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.438 ' HB2' HD11 ' A' ' 18' ' ' LEU . 26.0 t70 -59.52 -56.13 25.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 1.86 110.945 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.2 -48.71 1.1 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.768 -0.73 . . . . 1.06 112.957 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -57.4 -32.05 66.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.761 0.315 . . . . 2.59 111.153 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 68.1 mt -76.83 127.91 37.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.304 -0.407 . . . . 0.92 111.095 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -125.49 138.16 31.29 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 116.139 -0.482 . . . . 1.98 110.81 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_exo -52.94 165.9 1.08 Allowed 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.59 2.193 . . . . 1.44 112.441 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 18.0 m120 60.18 45.65 11.38 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.046 -0.525 . . . . 2.15 110.755 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.414 ' O ' ' HB2' ' A' ' 47' ' ' TYR . 27.1 t70 -118.16 159.77 22.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.935 -0.575 . . . . 2.02 110.505 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.494 ' HB3' HG23 ' A' ' 101' ' ' ILE . 87.6 tttt -105.18 128.29 53.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.843 0.354 . . . . 1.02 111.181 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 41.6 mm -94.9 142.18 13.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.055 -0.52 . . . . 0.29 110.727 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 56.5 mt -111.31 -73.75 0.67 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 0.4 111.129 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.8 ptp180 -147.29 137.85 23.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.174 0.512 . . . . 2.61 111.779 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.678 HG12 ' H ' ' A' ' 73' ' ' ASP . 3.8 t -84.68 176.01 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.528 -0.76 . . . . 0.28 109.771 179.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.678 ' H ' HG12 ' A' ' 72' ' ' VAL . 6.6 t70 -44.25 109.0 0.13 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.17 0.434 . . . . 0.79 112.17 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 52.39 27.87 5.29 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.443 0.535 . . . . 2.01 112.443 178.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.406 ' O ' ' N ' ' A' ' 72' ' ' VAL . 88.1 t -148.66 140.11 17.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.725 0.298 . . . . 0.79 110.88 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 25.4 m-80 -100.23 141.86 32.49 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.922 -0.399 . . . . 2.24 109.922 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.8 m -122.59 -16.23 5.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 N-CA-C 112.104 0.409 . . . . 0.67 112.104 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -87.08 25.98 1.25 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.921 0.391 . . . . 1.39 110.886 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -141.3 1.72 1.94 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.869 -0.682 . . . . 0.55 112.557 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 51.4 mtm -123.99 172.14 9.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.748 0.309 . . . . 0.52 110.768 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.5 168.71 14.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.39 111.125 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.406 ' O ' HG23 ' A' ' 86' ' ' VAL . 63.4 tt0 -58.97 -47.3 85.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.44 -0.345 . . . . 1.52 110.902 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.9 m -55.46 -31.72 62.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 1.48 111.304 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -71.98 -39.27 69.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.355 -0.384 . . . . 2.12 111.042 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.2 t -67.75 -35.99 74.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.969 0.414 . . . . 0.32 111.021 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.485 HG12 ' NE ' ' A' ' 90' ' ' ARG . 56.5 t -70.32 -47.22 67.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.009 -0.541 . . . . 0.37 111.598 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -58.86 -40.75 85.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.714 -0.221 . . . . 1.51 111.085 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 52.4 t -60.04 -54.88 28.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 120.924 0.392 . . . . 0.27 111.115 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.437 HD22 HD12 ' A' ' 29' ' ' ILE . 66.8 mt -56.83 -27.89 60.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.993 -0.549 . . . . 0.41 111.006 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.485 ' NE ' HG12 ' A' ' 86' ' ' VAL . 76.1 mtm180 -89.24 -15.09 34.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.371 -0.377 . . . . 2.1 111.514 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -93.47 -10.04 36.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.417 -0.356 . . . . 1.14 111.114 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -48.9 -85.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.266 -0.425 . . . . 0.55 111.574 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.481 ' H ' ' HE ' ' A' ' 20' ' ' ARG . . . 62.25 14.59 48.23 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.695 -0.764 . . . . 0.76 112.556 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -146.97 169.85 8.74 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 110.54 -0.17 . . . . 2.52 110.54 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.539 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 24.4 Cg_exo -65.13 92.26 0.21 Allowed 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.223 1.948 . . . . 0.64 111.326 178.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 33.8 m -100.15 153.46 4.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.067 -0.515 . . . . 0.64 111.577 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.676 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 56.2 ttp180 -102.72 138.07 40.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.969 -0.559 . . . . 2.37 109.816 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 45.4 mt -107.7 109.42 21.01 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.262 -0.426 . . . . 0.37 111.137 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 31.7 tp -99.79 100.66 11.64 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.374 -0.375 . . . . 0.37 110.172 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -130.37 161.95 30.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.111 -0.495 . . . . 0.31 111.373 -179.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.494 HG23 ' HB3' ' A' ' 68' ' ' LYS . 14.2 tt -114.06 135.68 52.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.917 -0.583 . . . . 0.45 110.862 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.003 -0.544 . . . . 2.26 110.555 179.966 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 46.6 t . . . . . 0 C--O 1.233 0.228 0 CA-C-O 120.77 0.319 . . . . 0.9 110.78 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 62.3 mt -75.09 120.9 21.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.168 -0.469 . . . . 0.89 110.749 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -114.53 124.19 51.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.089 -0.505 . . . . 2.73 111.328 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 44.9 t -103.27 142.75 33.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 1.19 110.79 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.4 t -136.41 158.16 37.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.238 -0.437 . . . . 0.56 110.666 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -121.93 114.34 20.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.935 0.398 . . . . 1.74 111.353 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.558 HD11 ' HB2' ' A' ' 60' ' ' ASP . 4.4 mm? -119.58 166.82 12.65 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.033 -0.53 . . . . 0.81 110.787 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.605 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 30.1 p90 -148.8 129.45 14.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.282 -0.417 . . . . 2.08 110.964 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.508 ' HB2' HD21 ' A' ' 27' ' ' LEU . 15.1 ttp180 -106.5 107.66 18.78 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.794 0.33 . . . . 3.06 111.006 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -131.29 -5.67 3.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.299 -0.409 . . . . 2.58 111.036 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -81.69 170.2 16.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.396 -0.365 . . . . 3.72 110.874 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -93.47 30.04 1.83 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.136 -0.484 . . . . 2.87 110.959 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 71.6 p -84.25 -14.35 50.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.45 . . . . 1.38 110.863 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 35.2 t 59.17 20.63 8.65 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.849 -0.614 . . . . 2.45 111.18 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 83.0 p -160.56 175.27 12.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.941 0.4 . . . . 1.4 110.992 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.508 HD21 ' HB2' ' A' ' 20' ' ' ARG . 33.5 mt -115.0 -10.35 12.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.827 -0.624 . . . . 0.45 110.877 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.452 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 87.86 18.33 56.44 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.782 -0.723 . . . . 0.52 112.754 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 70.9 mt -91.36 108.5 19.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.822 0.344 . . . . 0.84 110.847 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 41.9 t -103.14 102.66 12.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.134 -0.485 . . . . 0.95 110.958 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.5 pt -100.34 165.68 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.82 -0.627 . . . . 0.41 111.291 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.6 m -149.04 145.19 27.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.917 -0.583 . . . . 1.32 110.474 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 C-N-CA 120.68 -0.771 . . . . 0.95 112.598 -179.846 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 37.2 mm . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.761 0.315 . . . . 0.65 110.703 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -131.38 143.31 50.38 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.218 -0.446 . . . . 0.7 111.201 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 84.1 t -84.54 128.6 38.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.051 -0.522 . . . . 0.39 110.837 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -107.89 -24.1 11.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.301 -0.408 . . . . 2.4 110.952 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.6 t -150.94 170.47 19.24 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.972 0.415 . . . . 1.28 111.44 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 91.3 mt -135.25 157.21 47.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.816 -0.629 . . . . 0.42 110.583 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.452 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 62.8 mt -101.46 104.05 31.3 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 1.26 111.01 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -55.16 132.5 52.67 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.429 2.086 . . . . 0.82 112.224 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 110.55 -24.13 18.34 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.801 -0.714 . . . . 0.49 112.544 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 63.2 m -80.91 -178.45 6.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.75 0.31 . . . . 1.23 110.921 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.74 -52.35 51.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.384 -0.371 . . . . 0.42 111.494 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.27 -34.61 64.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.25 -0.432 . . . . 0.35 111.616 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.79 -50.02 33.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.33 -0.395 . . . . 0.44 111.248 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 80.7 mt -64.02 -19.7 65.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.131 -0.486 . . . . 0.66 110.988 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.558 ' HB2' HD11 ' A' ' 18' ' ' LEU . 26.6 t70 -62.05 -56.13 22.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 1.86 110.91 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 97.42 -51.24 1.4 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.698 -0.763 . . . . 1.06 113.01 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 84.4 mtm180 -55.98 -28.07 55.51 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.743 0.306 . . . . 2.59 111.285 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 67.0 mt -81.05 106.25 11.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.292 -0.413 . . . . 0.92 110.746 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -108.11 137.53 19.88 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 1.98 110.546 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -53.41 175.52 0.1 Allowed 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.57 2.18 . . . . 1.44 112.725 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.7 m120 61.77 37.58 15.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.918 -0.583 . . . . 2.15 110.913 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -113.15 161.93 16.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.991 -0.55 . . . . 2.02 110.553 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.411 ' HB3' HG23 ' A' ' 101' ' ' ILE . 87.6 tttt -110.55 116.71 31.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.822 0.344 . . . . 1.02 111.087 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.443 HD13 ' HB3' ' A' ' 100' ' ' LEU . 42.0 mm -77.17 146.22 8.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.489 . . . . 0.29 110.834 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 55.3 mt -123.22 -61.59 1.4 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.241 -0.436 . . . . 0.4 111.257 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 66.8 mtp180 -144.47 142.73 30.47 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.096 0.474 . . . . 2.61 111.808 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.626 HG12 ' H ' ' A' ' 73' ' ' ASP . 9.9 t -99.89 173.92 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.611 -0.722 . . . . 0.28 109.582 179.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.626 ' H ' HG12 ' A' ' 72' ' ' VAL . 16.8 t70 -46.82 108.44 0.14 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.711 0.291 . . . . 0.79 111.418 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 53.32 33.84 16.54 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.18 -0.464 . . . . 2.01 111.716 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.411 ' HB ' ' HB ' ' A' ' 72' ' ' VAL . 87.9 t -147.96 147.81 16.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.409 -0.359 . . . . 0.79 110.842 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.551 HD21 ' HB2' ' A' ' 78' ' ' GLN . 7.1 t30 -115.44 124.89 52.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.346 -0.388 . . . . 2.24 110.405 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.6 m -106.96 24.46 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 CA-C-O 120.783 0.325 . . . . 0.67 111.52 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.551 ' HB2' HD21 ' A' ' 76' ' ' ASN . 19.2 mm-40 -96.23 34.12 1.64 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.272 -0.422 . . . . 1.39 110.734 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 175.0 22.65 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.757 -0.735 . . . . 0.55 112.811 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 54.6 mtm -117.98 144.42 45.54 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.873 0.368 . . . . 0.52 110.965 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.449 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -61.19 158.27 14.37 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.977 -0.556 . . . . 0.39 111.41 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -51.41 -62.14 1.81 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.141 -0.481 . . . . 1.52 111.33 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 81.6 p -52.78 -33.53 49.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.014 -0.539 . . . . 1.48 111.389 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -63.16 -43.46 98.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.512 -0.313 . . . . 2.12 110.925 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 81' ' ' ALA . 18.2 t -61.89 -38.94 81.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.297 -0.411 . . . . 0.32 110.605 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.1 t -63.22 -36.54 76.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.983 -0.553 . . . . 0.37 110.991 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -63.62 -47.74 80.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.15 -0.477 . . . . 1.51 110.977 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 54.4 t -53.86 -54.23 21.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.224 -0.443 . . . . 0.27 111.107 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 79.0 mt -57.58 -32.93 67.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.41 110.94 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 85.2 mtm180 -80.6 -13.5 59.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.312 -0.404 . . . . 2.1 111.212 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -95.62 -13.88 23.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 1.14 110.692 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.19 -83.53 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.998 -0.547 . . . . 0.55 111.588 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.478 ' H ' ' HE ' ' A' ' 20' ' ' ARG . . . 62.38 15.72 52.76 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.61 -0.805 . . . . 0.76 112.152 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -147.08 169.81 8.78 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 110.6 -0.148 . . . . 2.52 110.6 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.605 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 32.9 Cg_exo -61.59 98.27 0.16 Allowed 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.258 1.972 . . . . 0.64 111.429 177.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 23.6 m -106.42 150.46 9.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.082 0.467 . . . . 0.64 111.858 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.622 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 80.9 mtp180 -97.13 140.57 31.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.811 -0.632 . . . . 2.37 110.247 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 30.3 mt -115.03 111.89 21.8 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.041 -0.527 . . . . 0.37 110.951 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 43.3 tp -102.5 104.74 15.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 0.37 110.75 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.443 ' HB3' HD13 ' A' ' 69' ' ' ILE . 0.4 OUTLIER -134.13 156.43 48.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.212 -0.449 . . . . 0.31 111.045 -179.797 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.411 HG23 ' HB3' ' A' ' 68' ' ' LYS . 12.0 tt -104.61 136.17 39.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.23 -0.441 . . . . 0.45 111.046 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 25.4 mmm180 . . . . . 0 C--N 1.332 -0.185 0 CA-C-N 115.866 -0.606 . . . . 2.26 110.844 -179.986 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 46.1 t . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.887 0.375 . . . . 0.9 110.795 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 75.4 mt -79.03 121.46 24.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.89 110.924 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -117.31 154.53 31.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.111 -0.495 . . . . 2.73 110.877 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 84.4 p -151.2 134.82 16.33 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.344 -0.389 . . . . 1.19 111.302 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.1 t -132.23 144.96 35.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.149 -0.478 . . . . 0.56 110.675 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.439 ' C ' HD22 ' A' ' 18' ' ' LEU . 1.8 mp0 -94.89 115.22 27.19 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.842 0.353 . . . . 1.74 111.59 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.587 HD23 HD12 ' A' ' 98' ' ' LEU . 4.3 mm? -123.24 125.47 45.13 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.986 -0.552 . . . . 0.81 110.472 179.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.587 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 39.0 p90 -103.44 132.93 49.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.404 -0.362 . . . . 2.08 111.21 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.622 ' HE ' ' HA2' ' A' ' 93' ' ' GLY . 19.2 ttp180 -102.31 95.26 6.18 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.881 0.372 . . . . 3.06 110.882 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -103.01 -21.37 13.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.056 0.455 . . . . 2.58 110.425 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.432 ' HB3' HG23 ' A' ' 24' ' ' THR . 75.0 mmtt -85.16 140.8 30.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.704 -0.68 . . . . 3.72 110.659 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -83.37 37.4 0.56 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 2.87 111.077 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.432 HG23 ' HB3' ' A' ' 22' ' ' LYS . 57.4 p -73.0 -11.97 60.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 1.38 110.979 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 36.5 t 59.54 15.72 4.77 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.025 -0.534 . . . . 2.45 111.014 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 53.6 m -147.97 138.09 22.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.124 -0.489 . . . . 1.4 110.971 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.442 HD21 ' HB2' ' A' ' 20' ' ' ARG . 88.2 mt -97.55 -22.98 16.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.068 -0.514 . . . . 0.45 110.852 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.523 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 110.43 3.85 28.93 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.808 -0.71 . . . . 0.52 112.502 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.468 HD12 ' N ' ' A' ' 29' ' ' ILE . 3.0 mp -88.23 114.93 27.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.822 0.344 . . . . 0.84 111.012 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 45.0 t -111.89 93.32 4.4 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.103 -0.499 . . . . 0.95 110.522 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.499 ' HA ' ' HA ' ' A' ' 48' ' ' VAL . 44.6 pt -87.87 164.18 2.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.101 -0.499 . . . . 0.41 111.432 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 56.3 m -143.47 134.61 25.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.773 -0.649 . . . . 1.32 110.415 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.225 0 C-N-CA 120.614 -0.803 . . . . 0.95 112.816 -179.567 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 43.8 mm . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.779 0.323 . . . . 0.65 110.901 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -140.17 137.37 34.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.7 111.104 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.499 ' HA ' ' HA ' ' A' ' 31' ' ' ILE . 58.3 t -77.63 139.26 18.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.991 -0.55 . . . . 0.39 110.852 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -120.58 -28.46 4.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 2.4 111.116 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 56.3 m -143.82 173.28 11.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.15 0.5 . . . . 1.28 111.594 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 82.1 mt -137.42 161.94 34.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.603 -0.726 . . . . 0.42 110.55 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.523 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 71.6 mt -106.74 102.14 40.44 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.485 -0.325 . . . . 1.26 111.218 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.6 129.51 35.46 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.59 2.193 . . . . 0.82 112.42 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 110.93 -17.46 27.3 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.794 -0.717 . . . . 0.49 112.353 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 57.7 m -85.24 -176.67 6.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.719 0.295 . . . . 1.23 110.85 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.21 -52.55 32.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.916 0.388 . . . . 0.42 111.171 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.22 -37.9 75.75 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.045 -0.525 . . . . 0.35 111.659 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.99 -54.59 14.45 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.341 -0.391 . . . . 0.44 111.572 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.7 mt -60.34 -20.28 58.72 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.343 -0.39 . . . . 0.66 111.09 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.508 ' HB2' HD11 ' A' ' 18' ' ' LEU . 33.3 t70 -59.59 -49.34 78.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.252 -0.431 . . . . 1.86 110.927 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.11 -44.9 2.98 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.864 -0.684 . . . . 1.06 113.043 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 76.6 mtp180 -61.42 -22.13 64.73 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.688 0.28 . . . . 2.59 111.077 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.506 ' HA ' HH22 ' A' ' 102' ' ' ARG . 63.2 mt -89.92 116.13 30.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.353 -0.385 . . . . 0.92 111.119 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.421 ' H ' ' NH2' ' A' ' 102' ' ' ARG . 36.2 tt0 -117.59 140.02 26.98 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.041 -0.527 . . . . 1.98 110.532 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.34 -178.57 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.578 2.185 . . . . 1.44 112.295 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.525 HD22 ' N ' ' A' ' 66' ' ' ASN . 0.9 OUTLIER 60.97 44.88 9.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.444 . . . . 2.15 110.681 -179.689 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -126.54 177.33 6.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.084 -0.507 . . . . 2.02 110.734 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -130.72 122.48 27.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.427 -0.351 . . . . 1.02 111.118 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 39.8 mm -75.04 143.93 12.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.29 110.618 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.495 ' HA ' ' NE2' ' A' ' 78' ' ' GLN . 71.9 mt -122.54 -66.13 1.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.927 0.394 . . . . 0.4 111.428 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.553 ' HG2' HD22 ' A' ' 76' ' ' ASN . 21.5 mtp180 -134.4 138.11 44.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 2.61 111.609 -179.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.593 HG12 ' H ' ' A' ' 73' ' ' ASP . 7.6 t -105.32 172.34 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.773 -0.649 . . . . 0.28 109.624 178.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.607 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 13.1 t70 -46.81 107.98 0.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.872 0.367 . . . . 0.79 111.766 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 49.12 22.43 0.62 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.906 -0.588 . . . . 2.01 112.208 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 98.2 t -144.49 104.78 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.775 0.321 . . . . 0.79 111.589 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.553 HD22 ' HG2' ' A' ' 71' ' ' ARG . 12.7 m120 -70.67 144.49 51.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.314 -0.403 . . . . 2.24 110.371 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 18.3 m -127.89 32.88 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.841 0.353 . . . . 0.67 111.464 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.495 ' NE2' ' HA ' ' A' ' 70' ' ' LEU . 27.2 mm-40 -100.32 31.64 3.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.157 -0.474 . . . . 1.39 111.109 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -178.56 40.6 0.08 OUTLIER Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.478 -0.868 . . . . 0.55 112.848 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 68.2 mtm -138.29 145.05 40.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.852 0.358 . . . . 0.52 110.879 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.464 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -66.97 160.75 25.76 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.061 -0.518 . . . . 0.39 111.155 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -47.81 -53.49 15.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.185 -0.461 . . . . 1.52 111.515 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.7 t -52.51 -38.47 59.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.292 -0.413 . . . . 1.48 111.389 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -68.89 -38.5 79.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.312 -0.404 . . . . 2.12 111.32 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 81' ' ' ALA . 17.5 t -62.51 -42.38 95.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.468 -0.333 . . . . 0.32 110.933 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.0 t -65.63 -36.34 77.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.491 . . . . 0.37 111.025 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -58.93 -49.36 78.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.213 -0.449 . . . . 1.51 110.857 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 56.0 t -57.89 -53.16 48.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.295 -0.411 . . . . 0.27 111.369 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 83.6 mt -58.88 -31.51 68.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.41 111.385 -179.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.454 ' HA ' ' NH1' ' A' ' 20' ' ' ARG . 69.7 mtm180 -85.43 -12.16 52.65 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.546 -0.297 . . . . 2.1 111.269 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.436 HD22 ' N ' ' A' ' 91' ' ' ASN . 0.9 OUTLIER -97.61 -11.62 23.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.289 -0.414 . . . . 1.14 110.942 179.911 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.94 -85.62 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.213 -0.448 . . . . 0.55 111.52 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.622 ' HA2' ' HE ' ' A' ' 20' ' ' ARG . . . 63.09 19.82 61.94 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.685 -0.769 . . . . 0.76 112.548 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.651 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 1.9 p-10 -147.21 168.59 10.99 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 110.407 -0.22 . . . . 2.52 110.407 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.651 ' HD2' ' HB2' ' A' ' 94' ' ' ASN . 19.6 Cg_endo -60.47 89.91 0.08 OUTLIER 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.089 1.86 . . . . 0.64 111.325 178.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.422 ' HB ' ' HB2' ' A' ' 73' ' ' ASP . 17.3 m -100.13 151.98 4.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.998 -0.546 . . . . 0.64 112.087 -178.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.607 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 59.1 mtp180 -98.11 143.85 28.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.787 -0.642 . . . . 2.37 110.055 179.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.587 HD12 HD23 ' A' ' 18' ' ' LEU . 37.3 mt -118.09 104.1 10.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.04 -0.527 . . . . 0.37 111.069 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.4 HD23 ' HB2' ' A' ' 71' ' ' ARG . 58.5 tp -100.28 99.87 10.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.34 -0.391 . . . . 0.37 110.626 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.432 ' O ' HD12 ' A' ' 100' ' ' LEU . 0.5 OUTLIER -130.11 152.47 49.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 0.31 111.234 -179.782 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.3 tt -94.29 135.93 27.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 0.45 110.79 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.506 HH22 ' HA ' ' A' ' 63' ' ' ILE . 18.0 tpp85 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.066 -0.515 . . . . 2.26 110.993 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.3 m . . . . . 0 C--O 1.233 0.197 0 CA-C-O 120.772 0.32 . . . . 0.9 110.929 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 63.5 mt -79.57 122.21 26.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.988 -0.551 . . . . 0.89 110.857 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -113.71 125.53 54.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.466 . . . . 2.73 110.983 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 47.6 t -119.81 126.8 51.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.978 -0.556 . . . . 1.19 111.053 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.5 t -124.56 154.06 31.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.01 -0.541 . . . . 0.56 110.576 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -121.83 119.83 32.79 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.95 0.405 . . . . 1.74 111.585 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -114.56 166.62 11.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.87 -0.605 . . . . 0.81 110.318 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.541 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 89.3 m-85 -133.29 112.05 11.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.732 0.301 . . . . 2.08 111.497 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.472 ' HB2' HD21 ' A' ' 27' ' ' LEU . 50.8 tpt85 -97.34 102.81 14.67 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.272 -0.422 . . . . 3.06 110.571 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -160.33 20.72 0.15 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.461 . . . . 2.58 110.804 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.471 ' HD2' ' N ' ' A' ' 22' ' ' LYS . 11.5 mptt -106.8 161.52 14.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.113 -0.494 . . . . 3.72 110.952 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -83.07 50.17 1.68 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.028 -0.533 . . . . 2.87 111.038 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.4 p -117.05 -24.03 7.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.216 -0.447 . . . . 1.38 111.05 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.6 m 58.34 16.65 4.19 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.86 -0.609 . . . . 2.45 111.215 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 81.9 p -144.73 153.81 42.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.288 -0.415 . . . . 1.4 110.997 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.472 HD21 ' HB2' ' A' ' 20' ' ' ARG . 92.6 mt -114.31 -20.13 10.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 0.45 110.874 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.11 31.72 7.48 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.831 -0.7 . . . . 0.52 112.709 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 46.4 mt -110.02 116.13 51.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.868 0.366 . . . . 0.84 111.025 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 45.8 t -113.3 106.49 14.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.95 110.704 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 43.9 pt -97.36 148.08 5.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.036 -0.529 . . . . 0.41 111.245 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 45.0 t -111.46 139.45 46.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.105 -0.498 . . . . 1.32 110.878 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 C-N-CA 120.79 -0.719 . . . . 0.95 112.464 179.954 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 43.5 mm . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.827 0.346 . . . . 0.65 110.857 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -152.83 144.0 23.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.7 110.897 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 95.7 t -76.71 121.17 28.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.194 -0.457 . . . . 0.39 110.861 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -99.72 -23.31 15.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.109 -0.496 . . . . 2.4 110.918 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 46.7 t -154.28 165.09 37.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.966 0.412 . . . . 1.28 111.213 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 82.9 mt -131.88 154.79 48.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.957 -0.565 . . . . 0.42 110.671 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 42.3 mm -97.42 109.15 48.85 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.373 -0.376 . . . . 1.26 110.844 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.96 141.13 97.94 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.347 2.031 . . . . 0.82 112.422 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.92 -15.44 63.1 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.758 -0.734 . . . . 0.49 112.501 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 59.6 m -80.41 179.15 7.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.663 0.268 . . . . 1.23 110.966 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.49 -47.9 58.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.903 0.382 . . . . 0.42 111.096 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.21 -40.33 81.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.097 -0.501 . . . . 0.35 111.497 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.1 -54.16 12.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.21 -0.45 . . . . 0.44 111.331 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.2 mt -60.83 -19.56 60.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.271 -0.422 . . . . 0.66 111.212 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -52.7 -51.25 61.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.311 -0.404 . . . . 1.86 110.758 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 98.05 -32.31 7.02 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.881 -0.676 . . . . 1.06 113.145 179.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 23.2 mmm180 -71.57 -46.12 60.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.767 0.318 . . . . 2.59 111.284 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 49.5 mt -65.41 132.45 31.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.328 -0.396 . . . . 0.92 111.303 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -126.59 138.57 32.73 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.051 -0.522 . . . . 1.98 110.603 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -48.68 157.8 1.38 Allowed 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.443 2.096 . . . . 1.44 112.339 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 58.4 t30 58.99 67.27 0.94 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.471 . . . . 2.15 110.693 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -133.82 154.91 50.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.974 -0.557 . . . . 2.02 110.629 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -103.79 130.69 51.36 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.562 -0.29 . . . . 1.02 111.187 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 36.5 mm -92.54 145.43 7.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.19 -0.459 . . . . 0.29 111.022 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 70.2 mt -114.34 -66.9 1.04 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.242 -0.435 . . . . 0.4 111.038 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -152.0 141.32 21.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.086 0.47 . . . . 2.61 111.41 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.615 HG12 ' H ' ' A' ' 73' ' ' ASP . 2.2 t -90.36 175.26 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.627 -0.715 . . . . 0.28 110.033 179.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.615 ' H ' HG12 ' A' ' 72' ' ' VAL . 6.3 p-10 -55.53 114.24 1.76 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.874 0.369 . . . . 0.79 111.126 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 60.33 18.53 8.12 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.04 -0.527 . . . . 2.01 111.756 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 63.0 t -143.36 149.89 17.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.656 0.265 . . . . 0.79 111.139 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -120.01 138.58 53.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.459 -0.337 . . . . 2.24 110.587 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.2 m -117.24 28.53 2.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.822 0.344 . . . . 0.67 111.423 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -97.53 33.95 1.93 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 1.39 111.021 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 173.12 28.33 0.02 OUTLIER Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.565 -0.826 . . . . 0.55 112.865 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 36.0 mtm -126.25 145.64 50.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.739 0.304 . . . . 0.52 110.753 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.01 158.89 24.36 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.28 -0.418 . . . . 0.39 111.146 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -49.93 -58.07 6.19 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.215 -0.448 . . . . 1.52 111.531 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 46.5 t -52.65 -39.95 62.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.188 -0.46 . . . . 1.48 111.395 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -61.2 -47.9 84.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.832 0.349 . . . . 2.12 110.987 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 55.4 t -57.46 -40.79 76.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.108 -0.497 . . . . 0.32 111.121 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 90.9 t -63.27 -39.04 83.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 0.37 110.928 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.454 ' HG2' HH21 ' A' ' 90' ' ' ARG . 45.8 mt-10 -58.99 -40.83 86.03 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.264 -0.425 . . . . 1.51 110.386 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 52.1 t -60.36 -52.91 55.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.905 -0.589 . . . . 0.27 111.203 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 67.0 mt -53.93 -38.02 64.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.095 -0.502 . . . . 0.41 111.397 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.454 HH21 ' HG2' ' A' ' 87' ' ' GLU . 76.8 mtm180 -81.28 -21.12 39.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.244 -0.434 . . . . 2.1 111.246 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.468 HD22 ' N ' ' A' ' 91' ' ' ASN . 0.9 OUTLIER -90.82 -5.05 56.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.361 -0.381 . . . . 1.14 111.16 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.475 ' HB1' HG22 ' A' ' 96' ' ' VAL . . . -54.02 -71.66 0.07 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.329 -0.396 . . . . 0.55 111.133 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 63.14 10.55 34.58 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.697 -0.763 . . . . 0.76 112.522 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -147.51 173.57 4.09 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 110.077 -0.342 . . . . 2.52 110.077 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.541 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 86.8 Cg_exo -47.79 100.09 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.005 1.803 . . . . 0.64 111.379 178.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.475 HG22 ' HB1' ' A' ' 92' ' ' ALA . 2.3 t -80.84 113.72 20.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.106 -0.497 . . . . 0.64 111.755 -178.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.563 ' H ' ' HB3' ' A' ' 73' ' ' ASP . 80.0 ttt180 -91.38 126.51 36.49 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.532 -0.544 . . . . 2.37 109.532 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 27.7 mt -109.42 103.61 12.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.373 -0.376 . . . . 0.37 111.721 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 32.0 tp -96.34 99.75 11.41 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.324 -0.621 . . . . 0.37 109.324 178.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -130.14 168.19 17.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.119 -0.491 . . . . 0.31 111.862 -178.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 17.3 tt -118.44 143.95 27.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 115.668 -0.696 . . . . 0.45 110.782 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.39 0 CA-C-N 116.094 -0.503 . . . . 2.26 110.384 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.6 t . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.859 0.361 . . . . 0.9 110.671 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 58.2 mt -81.07 119.1 23.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.89 111.252 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -118.43 151.62 37.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.005 -0.543 . . . . 2.73 110.586 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 78.0 p -141.26 145.6 35.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.875 0.369 . . . . 1.19 111.341 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 46.6 t -135.07 139.46 47.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.009 -0.541 . . . . 0.56 110.788 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -100.2 113.09 25.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.321 -0.399 . . . . 1.74 110.848 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 33.8 mt -124.37 141.07 52.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.365 -0.379 . . . . 0.81 111.44 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.558 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 44.3 p90 -118.7 141.2 48.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.056 -0.52 . . . . 2.08 110.613 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.485 HH21 ' N ' ' A' ' 93' ' ' GLY . 13.0 ttp180 -118.49 80.76 1.58 Allowed 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.702 -0.399 . . . . 3.06 111.551 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -99.86 10.07 41.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.436 . . . . 2.58 110.779 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.468 ' HD2' ' N ' ' A' ' 22' ' ' LYS . 3.2 mptp? -108.88 156.05 20.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.988 -0.551 . . . . 3.72 110.819 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -86.25 73.56 10.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 2.87 110.926 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 52.4 p -113.43 -22.61 10.28 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.121 -0.49 . . . . 1.38 111.079 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 51.2 m 59.26 19.89 8.01 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.842 -0.617 . . . . 2.45 111.185 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 77.6 p -158.8 137.9 11.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.307 -0.406 . . . . 1.4 111.162 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.479 HD21 ' HB2' ' A' ' 20' ' ' ARG . 75.4 mt -97.26 -10.75 25.15 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.029 -0.532 . . . . 0.45 110.683 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.521 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 92.11 14.85 55.52 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.784 -0.722 . . . . 0.52 112.829 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 69.6 mt -98.61 110.57 26.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.778 0.323 . . . . 0.84 111.178 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 34.2 t -111.23 101.1 9.62 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.277 -0.419 . . . . 0.95 110.842 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 40.8 pt -92.4 166.67 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.996 -0.547 . . . . 0.41 111.43 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 46.0 t -131.94 134.94 46.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.03 -0.532 . . . . 1.32 110.795 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 0.294 0 C-N-CA 120.844 -0.693 . . . . 0.95 112.631 -179.977 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 49.8 mm . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.88 0.372 . . . . 0.65 111.114 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -119.77 138.28 53.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.466 . . . . 0.7 111.103 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.8 t -80.51 123.92 37.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.059 -0.519 . . . . 0.39 110.807 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -106.43 -29.26 9.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.033 -0.531 . . . . 2.4 111.053 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 53.3 m -137.6 167.27 22.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.031 0.443 . . . . 1.28 111.606 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 82.4 mt -137.68 163.59 30.9 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.807 -0.633 . . . . 0.42 110.752 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.521 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 67.6 mt -102.51 101.02 17.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 1.26 110.786 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.452 ' HD2' ' HA ' ' A' ' 52' ' ' ILE . 19.1 Cg_endo -57.56 94.81 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.475 2.116 . . . . 0.82 112.263 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 143.91 -8.09 1.95 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.838 -0.696 . . . . 0.49 112.388 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.423 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 53.0 m -96.47 178.66 5.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.757 0.313 . . . . 1.23 110.858 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.46 -53.34 59.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.301 -0.409 . . . . 0.42 111.706 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.86 -37.33 66.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.19 -0.459 . . . . 0.35 111.853 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -77.98 -32.67 51.41 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.963 0.357 . . . . 0.44 111.963 -179.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 55' ' ' SER . 55.1 mt -62.74 -55.47 26.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.727 0.299 . . . . 0.66 111.221 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -57.87 -41.78 83.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 1.86 111.1 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 79.6 -11.66 31.6 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.81 -0.709 . . . . 1.06 112.681 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 39.7 mtp180 -63.18 -16.83 61.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.807 0.337 . . . . 2.59 110.828 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 76.3 mt -104.04 115.56 46.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.081 -0.509 . . . . 0.92 110.932 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -86.85 155.46 55.74 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 1.98 111.156 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -78.3 38.19 0.68 Allowed 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.785 2.323 . . . . 1.44 112.473 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -164.93 64.14 0.13 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.861 0.362 . . . . 2.15 110.746 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -132.19 167.32 19.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.146 -0.479 . . . . 2.02 110.656 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -113.31 106.88 15.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.897 0.38 . . . . 1.02 111.171 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 46.5 mm -64.07 143.73 15.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.468 . . . . 0.29 110.833 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 57.9 mt -116.42 -58.13 2.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.28 -0.418 . . . . 0.4 111.212 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -159.94 136.09 8.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.031 0.443 . . . . 2.61 111.465 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.682 HG12 ' H ' ' A' ' 73' ' ' ASP . 2.6 t -88.88 175.87 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.634 -0.712 . . . . 0.28 109.909 179.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.682 ' H ' HG12 ' A' ' 72' ' ' VAL . 12.2 t70 -44.3 108.74 0.12 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.836 0.35 . . . . 0.79 111.802 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 53.13 33.91 16.18 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.115 -0.493 . . . . 2.01 112.11 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 92.1 t -147.56 126.39 4.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.535 -0.302 . . . . 0.79 111.047 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -96.83 122.98 40.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.401 -0.363 . . . . 2.24 110.423 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.49 HG11 HG13 ' A' ' 85' ' ' VAL . 29.7 m -108.42 26.44 2.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 CA-C-O 120.858 0.361 . . . . 0.67 111.586 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -94.4 24.82 4.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.269 -0.423 . . . . 1.39 110.779 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -169.88 16.42 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.663 -0.78 . . . . 0.55 112.746 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 60.4 mtm -118.35 143.51 46.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.864 0.364 . . . . 0.52 110.856 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.414 ' HB3' ' OD2' ' A' ' 84' ' ' ASP . . . -64.83 164.91 11.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.161 -0.472 . . . . 0.39 111.295 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.445 ' O ' HG23 ' A' ' 86' ' ' VAL . 35.3 tt0 -51.74 -55.4 19.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 1.52 111.351 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.2 m -50.44 -42.7 54.44 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.192 -0.458 . . . . 1.48 111.577 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.414 ' OD2' ' HB3' ' A' ' 81' ' ' ALA . 20.4 m-20 -61.05 -49.08 78.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.381 -0.372 . . . . 2.12 111.096 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.49 HG13 HG11 ' A' ' 77' ' ' VAL . 33.7 t -60.59 -33.44 54.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.486 . . . . 0.32 111.276 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 82' ' ' GLN . 89.7 t -67.59 -43.55 86.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.287 -0.415 . . . . 0.37 110.98 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.425 ' HG2' HH21 ' A' ' 90' ' ' ARG . 44.1 mt-10 -56.95 -45.78 82.57 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.363 -0.381 . . . . 1.51 110.633 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 55.3 t -56.15 -52.43 50.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.083 -0.508 . . . . 0.27 110.893 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 82.2 mt -61.38 -25.74 67.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.883 -0.599 . . . . 0.41 110.95 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.425 HH21 ' HG2' ' A' ' 87' ' ' GLU . 78.1 mtm180 -87.93 -11.68 46.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.196 -0.456 . . . . 2.1 111.12 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.449 HD22 ' N ' ' A' ' 91' ' ' ASN . 0.9 OUTLIER -99.41 -12.65 20.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.316 -0.402 . . . . 1.14 110.605 179.625 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.5 -86.22 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.998 -0.546 . . . . 0.55 111.445 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.485 ' N ' HH21 ' A' ' 20' ' ' ARG . . . 61.84 21.97 61.63 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.62 -0.8 . . . . 0.76 112.231 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.622 ' HB3' ' HD2' ' A' ' 95' ' ' PRO . 3.7 m120 -147.46 174.54 3.32 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 110.583 -0.155 . . . . 2.52 110.583 -179.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.622 ' HD2' ' HB3' ' A' ' 94' ' ' ASN . 36.2 Cg_endo -66.45 81.61 0.3 Allowed 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 122.106 1.871 . . . . 0.64 112.004 178.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 22.7 m -91.29 154.21 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.95 -0.568 . . . . 0.64 111.48 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.65 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 77.2 ttt180 -94.56 144.07 25.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.782 -0.645 . . . . 2.37 110.112 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 25.9 mt -118.53 103.89 10.16 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.221 -0.445 . . . . 0.37 110.986 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 24.8 tp -100.76 104.2 15.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.966 0.412 . . . . 0.37 110.781 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.85 168.03 20.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.995 -0.548 . . . . 0.31 110.866 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 19.4 tt -114.03 134.8 55.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-O 121.015 0.436 . . . . 0.45 111.289 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 115.584 -0.734 . . . . 2.26 110.689 179.997 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.0 t . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.79 0.329 . . . . 0.9 110.727 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.2 mt -79.62 120.6 24.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 0.89 111.276 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -115.0 157.29 23.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.075 -0.511 . . . . 2.73 110.656 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 41.1 t -148.91 132.24 16.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.916 0.389 . . . . 1.19 111.161 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 44.4 t -125.16 129.9 73.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.078 -0.51 . . . . 0.56 110.775 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -95.47 109.85 21.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.15 -0.477 . . . . 1.74 111.16 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.435 HD12 HD11 ' A' ' 98' ' ' LEU . 28.5 mt -115.76 166.19 12.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 0.81 110.874 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.66 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 39.3 p90 -149.91 133.75 16.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 2.08 111.046 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.6 tpp180 -109.49 122.24 46.97 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.001 0.429 . . . . 3.06 110.831 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -121.77 -25.69 5.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.893 -0.594 . . . . 2.58 110.637 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -71.65 169.71 15.0 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.841 -0.618 . . . . 3.72 110.682 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -95.63 51.91 1.32 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.269 -0.423 . . . . 2.87 110.788 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 79.7 p -103.36 -24.12 13.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.133 -0.485 . . . . 1.38 111.141 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.7 t 58.41 21.12 8.07 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.951 -0.568 . . . . 2.45 111.228 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 79.0 p -145.03 153.3 41.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.869 0.366 . . . . 1.4 111.122 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 81.7 mt -114.12 -8.5 12.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.008 -0.542 . . . . 0.45 110.799 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.438 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 97.78 -12.1 64.38 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.831 -0.699 . . . . 0.52 112.8 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 69.8 mt -63.51 108.69 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.727 0.299 . . . . 0.84 111.156 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 36.3 t -112.19 114.22 26.9 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.318 -0.401 . . . . 0.95 110.636 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.4 pt -96.22 -178.84 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.381 -0.372 . . . . 0.41 111.362 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 77.3 p -163.44 137.4 5.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.138 -0.483 . . . . 1.32 110.75 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.246 0 C-N-CA 120.796 -0.716 . . . . 0.95 112.561 -179.962 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 39.5 mm . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 120.699 0.285 . . . . 0.65 110.861 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 46.5 p90 -153.68 144.84 22.92 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.338 -0.392 . . . . 0.7 111.411 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 66.4 t -79.6 132.79 31.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.031 -0.532 . . . . 0.39 110.924 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -125.73 -26.19 3.54 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.102 -0.499 . . . . 2.4 111.022 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 56.6 m -130.16 161.96 29.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.025 0.441 . . . . 1.28 111.275 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 83.6 mt -141.65 129.09 21.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.814 -0.63 . . . . 0.42 110.728 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.438 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 63.1 mt -68.26 117.95 54.51 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.28 -0.418 . . . . 1.26 110.934 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.21 96.76 0.64 Allowed 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.191 1.927 . . . . 0.82 112.252 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 137.29 0.45 2.7 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.837 -0.697 . . . . 0.49 112.511 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 63.6 m -101.32 172.46 6.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.62 0.247 . . . . 1.23 110.902 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.36 -53.13 61.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.431 -0.35 . . . . 0.42 111.8 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -47.15 -40.78 16.41 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.243 -0.435 . . . . 0.35 112.019 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.37 -38.99 29.35 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.984 0.365 . . . . 0.44 111.984 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 60.1 mt -56.3 -56.22 23.77 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.47 -0.332 . . . . 0.66 111.634 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -56.54 -34.26 66.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.402 -0.363 . . . . 1.86 111.236 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 78.34 -12.74 18.71 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.784 -0.722 . . . . 1.06 112.504 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -59.72 -29.25 68.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.789 0.328 . . . . 2.59 110.792 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.507 ' N ' HD12 ' A' ' 63' ' ' ILE . 4.0 mp -93.49 115.1 31.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.479 . . . . 0.92 110.651 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.466 ' HB2' ' HD2' ' A' ' 65' ' ' PRO . 12.0 pt-20 -113.03 158.13 38.76 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.458 . . . . 1.98 110.696 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.466 ' HD2' ' HB2' ' A' ' 64' ' ' GLU . 21.2 Cg_endo -60.05 173.18 1.93 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.399 2.066 . . . . 1.44 112.095 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 54.09 58.86 4.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.044 0.45 . . . . 2.15 110.668 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -136.51 154.28 50.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.976 -0.556 . . . . 2.02 110.537 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -110.15 136.93 48.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.977 0.418 . . . . 1.02 111.49 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.471 HD13 ' HB3' ' A' ' 100' ' ' LEU . 45.3 mm -97.79 120.58 47.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.817 -0.629 . . . . 0.29 110.346 179.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 77.4 mt -93.25 -63.79 1.17 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.429 -0.35 . . . . 0.4 111.33 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.404 ' O ' ' HB3' ' A' ' 99' ' ' LEU . 62.6 mtp180 -141.7 142.09 33.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.098 0.475 . . . . 2.61 111.664 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.637 HG12 ' H ' ' A' ' 73' ' ' ASP . 4.4 t -100.47 174.04 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.724 -0.671 . . . . 0.28 109.944 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.653 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 18.8 t70 -50.43 110.6 0.42 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.657 0.265 . . . . 0.79 111.205 179.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.4 t70 56.04 26.05 9.58 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.254 -0.43 . . . . 2.01 111.248 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.52 ' HB ' ' HB ' ' A' ' 72' ' ' VAL . 86.9 t -144.56 153.93 14.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.79 110.631 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -129.59 126.56 38.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.743 0.306 . . . . 2.24 110.746 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.2 m -104.63 25.14 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.245 -0.434 . . . . 0.67 111.067 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -89.62 26.34 1.77 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.083 -0.508 . . . . 1.39 110.956 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 174.78 34.12 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.535 -0.84 . . . . 0.55 112.897 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 49.8 mtm -126.62 147.35 49.91 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.834 0.35 . . . . 0.52 110.858 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.03 156.23 18.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.1 -0.5 . . . . 0.39 111.301 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -51.44 -58.63 5.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.325 -0.398 . . . . 1.52 111.154 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.6 t -55.94 -36.94 68.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.099 -0.5 . . . . 1.48 111.179 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -60.15 -46.41 89.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.355 -0.384 . . . . 2.12 110.907 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 60.7 t -59.49 -38.3 74.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.454 . . . . 0.32 110.886 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 58.8 t -64.35 -41.57 92.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.157 -0.474 . . . . 0.37 111.077 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.546 ' HG2' HH21 ' A' ' 90' ' ' ARG . 48.3 mt-10 -57.85 -44.51 86.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.893 0.378 . . . . 1.51 110.547 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 54.0 t -56.18 -55.55 17.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.947 -0.57 . . . . 0.27 111.102 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 78.7 mt -57.22 -29.79 64.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.043 -0.526 . . . . 0.41 111.259 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.546 HH21 ' HG2' ' A' ' 87' ' ' GLU . 63.5 mtm180 -83.1 -20.76 34.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.462 -0.335 . . . . 2.1 111.097 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -86.44 -18.35 31.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 1.14 110.825 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.44 -85.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.289 -0.414 . . . . 0.55 110.988 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 60.48 23.01 59.88 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.739 -0.743 . . . . 0.76 112.583 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.483 ' HB3' ' HD2' ' A' ' 95' ' ' PRO . 2.2 m120 -147.34 175.91 2.48 Favored Pre-proline 0 C--N 1.329 -0.322 0 C-N-CA 121.928 0.091 . . . . 2.52 110.863 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.66 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 51.5 Cg_exo -56.76 103.54 0.12 Allowed 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 122.096 1.864 . . . . 0.64 111.715 178.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 31.3 m -123.51 149.46 27.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.111 0.482 . . . . 0.64 111.945 -179.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.653 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 42.5 ttp180 -94.34 142.96 26.81 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.61 -0.723 . . . . 2.37 109.983 179.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.435 HD11 HD12 ' A' ' 18' ' ' LEU . 52.8 mt -116.58 115.46 25.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.188 -0.46 . . . . 0.37 111.273 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.404 ' HB3' ' O ' ' A' ' 71' ' ' ARG . 59.3 tp -108.88 103.22 12.23 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.941 0.4 . . . . 0.37 110.32 179.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.471 ' HB3' HD13 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -132.4 166.27 22.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.089 -0.505 . . . . 0.31 111.329 -179.249 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 19.0 tt -120.6 140.38 44.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.121 -0.491 . . . . 0.45 110.986 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.056 -0.52 . . . . 2.26 110.396 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.2 t . . . . . 0 C--O 1.235 0.332 0 CA-C-O 121.031 0.443 . . . . 0.9 111.215 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.539 HD23 ' HB ' ' A' ' 101' ' ' ILE . 16.6 mt -96.02 106.99 19.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.614 -0.721 . . . . 0.89 110.242 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.432 ' HE1' ' HB3' ' A' ' 102' ' ' ARG . 32.7 p90 -127.97 150.47 49.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.855 0.36 . . . . 2.73 111.06 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 80.3 p -123.84 135.55 53.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.107 -0.497 . . . . 1.19 111.268 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.9 t -110.4 144.62 18.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.94 -0.573 . . . . 0.56 110.477 179.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -88.58 122.26 31.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.872 0.368 . . . . 1.74 111.252 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -127.13 166.25 18.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.964 -0.562 . . . . 0.81 110.787 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.558 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 27.9 p90 -152.77 130.52 11.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.25 -0.432 . . . . 2.08 111.04 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.465 ' HB2' HD21 ' A' ' 27' ' ' LEU . 2.0 tmm_? -108.17 107.03 17.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.312 -0.403 . . . . 3.06 110.659 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -133.06 -28.67 1.51 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.328 -0.396 . . . . 2.58 111.33 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -64.0 161.03 16.65 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.137 -0.483 . . . . 3.72 111.018 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -83.37 37.54 0.57 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.022 -0.535 . . . . 2.87 111.203 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 71.2 p -88.43 -16.18 33.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 1.38 111.028 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 51.6 m 57.54 20.5 6.22 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.903 -0.589 . . . . 2.45 111.082 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 88.5 p -159.32 -176.62 5.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.345 -0.389 . . . . 1.4 110.909 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.465 HD21 ' HB2' ' A' ' 20' ' ' ARG . 68.7 mt -128.83 -0.49 5.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.023 -0.535 . . . . 0.45 110.634 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.29 26.76 51.07 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.835 -0.698 . . . . 0.52 112.566 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.443 HG22 HG23 ' A' ' 31' ' ' ILE . 85.0 mt -100.94 114.52 40.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.905 0.383 . . . . 0.84 111.1 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.0 m -109.03 92.82 4.21 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.113 -0.494 . . . . 0.95 110.722 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.443 HG23 HG22 ' A' ' 29' ' ' ILE . 43.1 pt -90.46 164.99 2.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.0 -0.545 . . . . 0.41 111.236 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.2 t -145.4 134.49 22.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 1.32 110.788 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.266 0 C-N-CA 120.839 -0.696 . . . . 0.95 112.396 179.999 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 37.6 mm . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.704 0.288 . . . . 0.65 110.713 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -149.49 145.15 26.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.338 -0.392 . . . . 0.7 111.457 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 93.1 t -83.37 115.58 25.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.957 -0.565 . . . . 0.39 110.64 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -89.5 -31.34 17.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.073 -0.512 . . . . 2.4 111.351 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.0 t -151.29 169.0 23.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.96 0.409 . . . . 1.28 111.605 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 86.1 mt -124.94 169.73 11.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.731 -0.668 . . . . 0.42 110.514 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 50.4 mm -108.62 99.96 36.24 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.278 -0.419 . . . . 1.26 111.047 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -51.73 116.06 2.5 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.56 2.174 . . . . 0.82 112.397 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 111.31 3.49 27.54 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.802 -0.713 . . . . 0.49 112.33 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 55.1 m -99.78 174.15 6.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.65 0.262 . . . . 1.23 111.037 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.68 -56.65 19.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.304 -0.407 . . . . 0.42 111.353 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.46 -33.06 58.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.256 -0.429 . . . . 0.35 111.384 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.08 -26.06 39.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.289 -0.414 . . . . 0.44 111.529 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 31.2 mt -70.59 -37.65 73.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.473 -0.331 . . . . 0.66 111.241 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -61.74 -40.59 95.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.41 -0.359 . . . . 1.86 110.993 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 79.48 -13.99 19.45 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.797 -0.716 . . . . 1.06 112.632 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 69.6 mtp180 -74.99 -23.05 58.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.788 0.327 . . . . 2.59 110.935 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.488 ' N ' HD12 ' A' ' 63' ' ' ILE . 3.7 mp -84.19 118.9 32.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.436 . . . . 0.92 110.715 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -106.3 136.79 19.31 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.111 -0.495 . . . . 1.98 110.614 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -56.09 163.24 6.31 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.486 2.124 . . . . 1.44 112.316 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 62.95 45.78 5.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.065 -0.516 . . . . 2.15 111.046 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -109.55 165.45 11.66 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.098 -0.501 . . . . 2.02 110.602 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -113.61 107.05 15.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.819 0.342 . . . . 1.02 111.207 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.462 ' HA ' ' HB3' ' A' ' 100' ' ' LEU . 43.7 mm -66.53 136.73 26.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.12 -0.491 . . . . 0.29 110.692 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 96.6 mt -113.03 -72.17 0.72 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.45 -0.341 . . . . 0.4 111.318 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 -135.89 137.35 41.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.001 0.429 . . . . 2.61 111.61 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.515 HG12 ' H ' ' A' ' 73' ' ' ASP . 9.3 t -98.91 168.59 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.872 -0.604 . . . . 0.28 109.829 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.652 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 13.4 t70 -47.86 108.3 0.16 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.923 0.392 . . . . 0.79 111.95 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.8 t70 58.69 6.68 0.64 Allowed 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.592 0.589 . . . . 2.01 112.592 178.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 38.9 t -140.09 101.05 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.718 0.294 . . . . 0.79 111.59 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -73.83 153.78 39.78 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.454 -0.339 . . . . 2.24 110.427 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.402 HG11 HG13 ' A' ' 85' ' ' VAL . 34.9 m -125.62 28.55 2.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-O 120.853 0.359 . . . . 0.67 111.554 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -94.32 42.25 1.09 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.268 -0.424 . . . . 1.39 111.011 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 165.76 33.23 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.642 -0.79 . . . . 0.55 113.04 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 50.5 mtm -131.39 152.48 50.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.862 0.363 . . . . 0.52 111.01 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.402 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -64.55 152.98 40.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.011 -0.54 . . . . 0.39 111.179 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -52.69 -55.86 19.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.355 -0.384 . . . . 1.52 111.286 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 48.0 t -53.7 -40.06 65.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.137 -0.483 . . . . 1.48 111.413 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -62.34 -46.24 89.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.322 -0.399 . . . . 2.12 111.118 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.402 HG13 HG11 ' A' ' 77' ' ' VAL . 75.6 t -57.94 -36.64 56.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.122 -0.49 . . . . 0.32 111.128 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 64.9 t -65.99 -43.3 92.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 0.37 111.025 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -57.25 -39.41 75.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.183 -0.462 . . . . 1.51 110.612 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 52.9 t -62.3 -53.66 44.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.27 111.208 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 76.5 mt -53.29 -30.06 36.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.933 -0.576 . . . . 0.41 111.174 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -87.53 -26.64 23.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 2.1 111.295 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -78.22 -12.17 59.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.421 -0.354 . . . . 1.14 111.032 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -49.76 -80.26 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.272 -0.422 . . . . 0.55 111.29 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 65.87 10.84 52.54 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.591 -0.814 . . . . 0.76 112.379 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.548 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -146.88 168.56 11.15 Favored Pre-proline 0 C--N 1.328 -0.332 0 N-CA-C 110.44 -0.207 . . . . 2.52 110.44 -179.827 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.558 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 19.0 Cg_endo -61.24 102.42 0.22 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.003 1.802 . . . . 0.64 111.506 178.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 29.9 m -107.81 146.66 13.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.64 112.015 -178.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.652 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 20.7 ttm180 -92.18 142.76 27.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.818 -0.628 . . . . 2.37 109.847 179.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 71.8 mt -116.09 103.4 10.52 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.071 -0.513 . . . . 0.37 110.892 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 65.1 tp -98.99 114.26 26.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 0.37 110.382 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.462 ' HB3' ' HA ' ' A' ' 69' ' ' ILE . 0.5 OUTLIER -147.27 167.95 22.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.475 . . . . 0.31 111.487 -179.352 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.539 ' HB ' HD23 ' A' ' 13' ' ' LEU . 11.7 tt -116.23 139.16 44.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.828 -0.624 . . . . 0.45 110.807 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.432 ' HB3' ' HE1' ' A' ' 14' ' ' TYR . 32.7 tpt180 . . . . . 0 C--N 1.327 -0.413 0 CA-C-N 116.206 -0.452 . . . . 2.26 110.601 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 56.2 p . . . . . 0 C--O 1.233 0.197 0 CA-C-O 120.767 0.318 . . . . 0.9 110.655 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 76.5 mt -77.78 128.72 34.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.121 -0.491 . . . . 0.89 111.319 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -114.74 132.55 56.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.927 -0.579 . . . . 2.73 111.058 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 84.9 p -124.56 128.55 49.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.099 -0.501 . . . . 1.19 110.929 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 23.6 t -133.04 149.38 31.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.117 -0.492 . . . . 0.56 110.919 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -111.41 120.77 43.31 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.843 0.354 . . . . 1.74 110.986 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -121.18 166.45 13.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.034 -0.53 . . . . 0.81 111.119 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.6 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 33.8 p90 -147.86 129.19 14.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.997 -0.547 . . . . 2.08 110.82 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.472 ' HB2' HD21 ' A' ' 27' ' ' LEU . 3.0 tmm_? -108.71 115.31 29.84 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.935 0.398 . . . . 3.06 111.007 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -150.93 13.76 0.71 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.101 -0.5 . . . . 2.58 110.934 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -103.78 160.52 14.71 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.197 -0.456 . . . . 3.72 110.712 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -90.62 57.92 3.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 2.87 110.889 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 37.5 p -118.76 -10.49 9.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 1.38 111.103 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 90.7 p 49.71 26.84 1.98 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.76 -0.655 . . . . 2.45 111.413 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 53.4 m -152.69 137.48 17.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.38 -0.373 . . . . 1.4 111.059 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.472 HD21 ' HB2' ' A' ' 20' ' ' ARG . 85.1 mt -91.53 -34.58 14.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.081 -0.509 . . . . 0.45 110.778 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.459 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 127.26 -26.82 4.91 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.869 -0.682 . . . . 0.52 112.444 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 70.3 mt -63.93 113.67 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.792 0.329 . . . . 0.84 110.928 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.3 t -113.84 99.43 7.68 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.15 -0.477 . . . . 0.95 110.997 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.8 pt -96.47 159.2 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.073 -0.512 . . . . 0.41 111.071 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 47.4 t -115.2 146.69 41.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.237 -0.438 . . . . 1.32 110.949 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.246 0 C-N-CA 120.901 -0.666 . . . . 0.95 112.455 179.901 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 42.7 mm . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.796 0.331 . . . . 0.65 111.041 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -151.21 143.56 24.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.485 . . . . 0.7 111.109 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 79.3 t -76.81 134.89 27.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.215 -0.448 . . . . 0.39 110.757 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -113.39 -31.81 6.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.985 -0.552 . . . . 2.4 111.169 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 80.0 p -153.71 177.07 11.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.957 0.408 . . . . 1.28 111.395 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 97.6 mt -133.75 149.44 51.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.765 -0.652 . . . . 0.42 110.838 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.459 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 57.1 mt -81.16 121.35 80.41 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.289 -0.414 . . . . 1.26 111.121 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.16 114.23 3.7 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.441 2.094 . . . . 0.82 112.265 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.82 16.36 15.75 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.63 -0.795 . . . . 0.49 112.652 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 78.0 p -107.76 176.45 5.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.717 0.294 . . . . 1.23 110.906 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.57 -57.6 9.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.34 -0.391 . . . . 0.42 111.206 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.13 -29.58 13.94 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.118 -0.492 . . . . 0.35 111.591 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -77.74 -40.92 39.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.303 -0.408 . . . . 0.44 111.455 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.6 mt -61.78 -35.96 79.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.311 -0.404 . . . . 0.66 111.273 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -61.79 -47.32 85.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.287 -0.415 . . . . 1.86 111.101 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.06 -20.65 7.92 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.77 -0.728 . . . . 1.06 112.477 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 12.8 mmm180 -62.22 -22.39 65.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.827 0.346 . . . . 2.59 110.889 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.472 ' N ' HD12 ' A' ' 63' ' ' ILE . 4.1 mp -91.18 111.23 23.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.12 -0.491 . . . . 0.92 110.899 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -98.68 134.49 21.62 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.035 -0.529 . . . . 1.98 110.531 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.94 159.9 4.72 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.488 2.125 . . . . 1.44 112.279 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 61.13 82.98 0.15 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.992 -0.549 . . . . 2.15 110.861 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -156.51 170.77 21.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.072 -0.513 . . . . 2.02 110.707 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -114.42 126.06 54.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.405 -0.361 . . . . 1.02 111.096 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 41.4 mm -84.53 137.99 19.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.135 -0.484 . . . . 0.29 110.784 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.457 ' HA ' ' NE2' ' A' ' 78' ' ' GLN . 89.1 mt -101.36 -61.51 1.37 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.28 -0.418 . . . . 0.4 111.07 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -158.17 138.48 12.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.171 0.51 . . . . 2.61 111.676 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.671 HG12 ' H ' ' A' ' 73' ' ' ASP . 2.9 t -86.85 175.48 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.551 -0.749 . . . . 0.28 109.997 179.281 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.671 ' H ' HG12 ' A' ' 72' ' ' VAL . 14.7 t70 -49.54 110.25 0.36 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.795 0.331 . . . . 0.79 111.804 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.1 t70 60.69 9.91 2.39 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.044 -0.526 . . . . 2.01 111.978 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.558 HG11 HG21 ' A' ' 88' ' ' VAL . 57.7 t -128.51 141.85 45.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.674 0.273 . . . . 0.79 110.999 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -109.26 129.55 55.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.323 -0.399 . . . . 2.24 110.709 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.4 m -111.92 26.6 3.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-O 120.89 0.376 . . . . 0.67 111.319 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.457 ' NE2' ' HA ' ' A' ' 70' ' ' LEU . 27.0 mm-40 -86.77 31.62 0.69 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.14 -0.482 . . . . 1.39 111.306 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 162.38 43.3 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.466 -0.873 . . . . 0.55 112.974 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 47.7 mtm -129.68 138.34 51.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.874 0.368 . . . . 0.52 110.905 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.41 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -60.93 156.66 17.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.107 -0.497 . . . . 0.39 111.123 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -48.33 -49.16 35.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.331 -0.395 . . . . 1.52 111.363 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 81.0 p -53.31 -44.96 68.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.121 -0.491 . . . . 1.48 111.444 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -61.56 -45.32 94.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.294 -0.412 . . . . 2.12 111.426 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 81' ' ' ALA . 15.5 t -59.34 -41.38 84.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.331 -0.395 . . . . 0.32 111.003 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 92.2 t -64.14 -37.7 80.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.046 -0.525 . . . . 0.37 111.103 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -58.73 -47.5 84.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 1.51 110.655 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.558 HG21 HG11 ' A' ' 75' ' ' VAL . 65.1 t -56.75 -55.09 21.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.022 -0.535 . . . . 0.27 111.256 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.404 HD22 HD12 ' A' ' 27' ' ' LEU . 84.5 mt -53.07 -36.69 60.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.82 -0.627 . . . . 0.41 111.822 -179.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 81.7 mtm180 -84.48 -18.39 36.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.613 -0.267 . . . . 2.1 111.67 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -89.98 -8.03 52.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.703 0.287 . . . . 1.14 110.87 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -55.49 -83.74 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.251 -0.431 . . . . 0.55 111.263 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.463 ' HA2' ' NE ' ' A' ' 20' ' ' ARG . . . 62.11 14.5 46.8 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.717 -0.754 . . . . 0.76 112.37 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -146.9 168.51 11.25 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 110.45 -0.204 . . . . 2.52 110.45 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.6 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 36.1 Cg_exo -62.33 96.5 0.15 Allowed 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.211 1.941 . . . . 0.64 111.161 178.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.5 m -105.76 152.76 7.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.124 0.488 . . . . 0.64 111.988 -178.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.649 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 52.5 ttp180 -102.49 144.8 30.47 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.737 -0.665 . . . . 2.37 110.048 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.9 mt -117.23 107.5 14.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.106 -0.497 . . . . 0.37 110.838 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 53.4 tp -99.01 101.69 13.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.304 -0.407 . . . . 0.37 110.499 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.1 162.64 27.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.063 -0.517 . . . . 0.31 111.175 -179.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.5 tt -117.27 140.86 38.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.211 -0.45 . . . . 0.45 111.207 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 29.4 tpt180 . . . . . 0 C--N 1.331 -0.214 0 CA-C-N 116.016 -0.538 . . . . 2.26 110.766 179.82 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.1 t . . . . . 0 C--O 1.235 0.292 0 CA-C-O 120.825 0.345 . . . . 0.9 110.635 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 91.4 mt -84.34 121.65 27.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.89 110.945 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -115.6 150.24 36.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.064 -0.516 . . . . 2.73 110.921 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 80.9 p -146.43 138.18 24.74 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.385 -0.37 . . . . 1.19 111.274 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.479 HG11 ' HB2' ' A' ' 62' ' ' ARG . 42.0 t -136.99 138.64 45.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.131 -0.486 . . . . 0.56 110.935 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -89.92 112.49 23.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 1.74 111.042 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -115.7 114.05 24.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.011 -0.541 . . . . 0.81 110.735 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.618 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 44.2 p90 -95.8 134.42 38.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 2.08 111.037 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.59 ' HB2' HD21 ' A' ' 27' ' ' LEU . 14.0 ttp180 -110.94 88.35 2.76 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.416 -0.357 . . . . 3.06 111.101 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -157.75 64.19 0.47 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.977 0.418 . . . . 2.58 110.998 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -145.64 34.52 1.04 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.303 0.573 . . . . 3.72 110.774 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 17.7 t70 59.01 25.34 13.73 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.119 -0.946 . . . . 2.87 110.903 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 82.7 p -92.52 -28.24 16.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.338 -0.392 . . . . 1.38 111.213 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 99.0 p 49.62 24.84 1.27 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.811 -0.631 . . . . 2.45 111.505 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 80.9 p -160.0 144.98 15.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.938 0.399 . . . . 1.4 111.075 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.59 HD21 ' HB2' ' A' ' 20' ' ' ARG . 71.7 mt -101.33 -24.41 14.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.056 -0.52 . . . . 0.45 110.66 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.09 -9.32 75.23 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.802 -0.713 . . . . 0.52 112.648 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.5 mt -58.93 108.56 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.849 0.357 . . . . 0.84 110.877 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 44.4 t -111.79 109.88 19.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.141 -0.481 . . . . 0.95 110.79 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 38.3 pt -101.46 172.18 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.028 -0.533 . . . . 0.41 111.205 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 57.0 m -146.35 137.92 24.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.476 . . . . 1.32 110.933 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.268 0 C-N-CA 120.842 -0.694 . . . . 0.95 112.593 -179.931 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 47.4 mm . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.832 0.349 . . . . 0.65 110.942 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 48.3 p90 -156.97 142.28 17.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.124 -0.489 . . . . 0.7 110.969 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 89.0 t -85.78 135.03 25.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.39 111.006 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -123.65 -20.96 5.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.495 . . . . 2.4 111.081 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.7 t -140.31 161.22 38.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.988 0.423 . . . . 1.28 111.447 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 96.5 mt -136.6 127.16 26.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.748 -0.66 . . . . 0.42 110.569 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 50.8 mm -63.52 112.54 7.35 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.313 -0.403 . . . . 1.26 110.899 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.47 102.1 0.39 Allowed 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.398 2.066 . . . . 0.82 112.252 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 129.65 -0.58 5.88 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.794 -0.717 . . . . 0.49 112.489 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.9 m -98.2 174.19 6.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.678 0.275 . . . . 1.23 110.903 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -55.75 -58.59 7.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 0.42 111.648 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.407 ' HB1' HD12 ' A' ' 63' ' ' ILE . . . -50.72 -32.23 18.91 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.357 -0.383 . . . . 0.35 111.479 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.91 -32.79 40.2 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.308 -0.406 . . . . 0.44 111.627 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 79.9 mt -63.52 -55.94 19.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.377 -0.374 . . . . 0.66 111.114 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -55.13 -37.06 66.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.246 -0.433 . . . . 1.86 111.04 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 62.94 7.17 15.08 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.985 -0.626 . . . . 1.06 112.896 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.479 ' HB2' HG11 ' A' ' 16' ' ' VAL . 34.9 mtp180 -82.86 3.28 30.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.738 0.304 . . . . 2.59 110.926 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.407 HD12 ' HB1' ' A' ' 57' ' ' ALA . 61.7 mt -110.54 133.51 55.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.92 110.982 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.407 ' HA ' ' HD2' ' A' ' 65' ' ' PRO . 20.2 tp10 -108.08 125.39 32.14 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.475 . . . . 1.98 110.787 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 64' ' ' GLU . 11.2 Cg_endo -54.66 174.38 0.19 Allowed 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.628 2.219 . . . . 1.44 112.168 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.572 ' N ' HD22 ' A' ' 66' ' ' ASN . 0.8 OUTLIER 60.79 25.87 15.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.199 -0.455 . . . . 2.15 110.549 -179.66 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -95.7 155.58 16.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.926 -0.579 . . . . 2.02 110.578 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -104.95 109.32 21.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.407 -0.36 . . . . 1.02 110.984 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 41.1 mm -68.7 132.52 32.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.113 -0.494 . . . . 0.29 110.952 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 76.6 mt -104.12 -63.85 1.16 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.128 -0.487 . . . . 0.4 110.814 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -149.59 136.56 19.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.161 0.505 . . . . 2.61 111.518 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.573 HG12 ' H ' ' A' ' 73' ' ' ASP . 9.9 t -89.88 171.14 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.593 -0.73 . . . . 0.28 109.866 179.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.683 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 14.0 t70 -48.26 108.53 0.17 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.789 0.328 . . . . 0.79 111.817 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.5 t70 58.48 6.99 0.64 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.919 -0.582 . . . . 2.01 112.328 178.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.1 t -137.85 99.54 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.695 0.283 . . . . 0.79 111.435 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -72.57 152.08 42.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.214 -0.448 . . . . 2.24 110.769 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.452 HG13 HG23 ' A' ' 72' ' ' VAL . 34.4 m -119.92 26.11 3.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.36 -0.382 . . . . 0.67 111.269 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -91.22 27.58 1.86 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 1.39 111.13 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -175.18 19.91 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.532 -0.842 . . . . 0.55 112.905 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.411 ' HE2' ' HA ' ' A' ' 77' ' ' VAL . 45.7 mtm -120.95 139.46 53.22 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.858 0.361 . . . . 0.52 111.0 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.46 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -65.16 156.56 31.32 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.976 -0.556 . . . . 0.39 111.108 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -44.75 -44.14 9.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.369 -0.378 . . . . 1.52 111.386 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 48.2 t -58.71 -53.16 61.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.295 -0.411 . . . . 1.48 111.404 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -54.52 -39.14 67.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 2.12 111.429 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 81' ' ' ALA . 21.1 t -62.29 -41.44 91.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.426 -0.352 . . . . 0.32 111.221 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.568 HG13 HH21 ' A' ' 90' ' ' ARG . 85.8 t -63.23 -43.31 98.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.245 -0.434 . . . . 0.37 111.148 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -57.74 -46.63 84.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.301 -0.409 . . . . 1.51 111.207 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 71.9 t -56.37 -58.03 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.984 0.421 . . . . 0.27 111.345 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 75.8 mt -60.01 -23.98 64.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.971 -0.558 . . . . 0.41 111.297 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.568 HH21 HG13 ' A' ' 86' ' ' VAL . 2.1 tpp180 -89.28 -12.48 40.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.242 -0.436 . . . . 2.1 111.432 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -103.92 -9.64 18.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.612 -0.267 . . . . 1.14 111.143 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -50.18 -78.72 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.296 -0.411 . . . . 0.55 111.458 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.47 ' H ' ' HE ' ' A' ' 20' ' ' ARG . . . 61.02 19.39 56.68 Favored Glycine 0 C--N 1.331 0.25 0 C-N-CA 120.712 -0.756 . . . . 0.76 112.281 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -147.09 169.83 8.75 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 110.433 -0.21 . . . . 2.52 110.433 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.618 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 23.0 Cg_exo -65.9 93.23 0.27 Allowed 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.196 1.931 . . . . 0.64 111.644 178.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 29.8 m -101.96 153.4 5.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.043 0.449 . . . . 0.64 111.876 -179.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.683 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 80.0 ttt180 -98.55 144.6 27.69 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.605 -0.725 . . . . 2.37 110.182 179.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 18.2 mt -118.05 103.56 10.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.091 -0.504 . . . . 0.37 110.867 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 34.2 tp -97.96 104.59 16.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.879 0.371 . . . . 0.37 110.519 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -133.93 158.96 42.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.092 -0.503 . . . . 0.31 111.351 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 17.3 tt -105.32 135.33 43.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.102 -0.499 . . . . 0.45 110.273 179.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 32.4 tpt180 . . . . . 0 C--N 1.331 -0.231 0 CA-C-O 120.869 0.366 . . . . 2.26 111.379 -179.28 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 44.6 t . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.749 0.309 . . . . 0.9 110.547 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 88.3 mt -85.46 121.75 28.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.281 -0.418 . . . . 0.89 111.126 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -113.79 148.29 36.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.992 -0.549 . . . . 2.73 110.893 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.3 m -144.55 136.62 26.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 1.19 111.286 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 33.2 t -135.51 132.55 51.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.027 -0.533 . . . . 0.56 110.599 179.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -93.3 124.65 37.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.292 -0.413 . . . . 1.74 111.398 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -119.63 151.8 38.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.896 -0.593 . . . . 0.81 110.725 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.519 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 19.2 m-85 -123.14 106.52 10.84 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.108 -0.496 . . . . 2.08 110.462 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.487 ' HE ' ' HA2' ' A' ' 93' ' ' GLY . 5.0 ttp180 -97.56 126.16 42.69 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.56 -0.456 . . . . 3.06 110.813 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -141.61 -36.25 0.44 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.117 -0.492 . . . . 2.58 110.957 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -68.47 154.25 42.2 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.956 -0.566 . . . . 3.72 110.883 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -84.43 56.5 3.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 2.87 111.017 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 65.9 p -92.59 -21.16 20.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.306 -0.406 . . . . 1.38 110.994 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.1 t 58.0 18.56 5.2 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.759 -0.655 . . . . 2.45 111.461 179.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.2 t -154.59 141.48 19.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.835 0.35 . . . . 1.4 110.928 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.8 mt -107.95 -15.03 14.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.45 110.793 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.437 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 108.34 13.69 18.48 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.669 -0.776 . . . . 0.52 112.691 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.428 HG23 HG22 ' A' ' 48' ' ' VAL . 76.8 mt -97.56 113.38 31.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.816 0.341 . . . . 0.84 111.058 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.2 t -113.3 103.41 11.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.241 -0.436 . . . . 0.95 110.814 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 31.7 pt -101.54 147.48 8.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.247 -0.433 . . . . 0.41 111.256 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 71.5 m -114.25 130.73 56.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.479 . . . . 1.32 110.712 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 C-N-CA 120.813 -0.708 . . . . 0.95 112.467 -179.942 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 50.4 mm . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.719 0.295 . . . . 0.65 110.967 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 25.0 p90 -152.54 135.03 15.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.891 0.377 . . . . 0.7 111.214 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.428 HG22 HG23 ' A' ' 29' ' ' ILE . 85.3 t -70.72 112.99 6.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.123 -0.49 . . . . 0.39 110.834 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -88.52 -29.39 20.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.866 -0.606 . . . . 2.4 111.076 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 78.3 p -156.06 171.27 20.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.006 0.432 . . . . 1.28 111.212 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 71.0 mt -128.89 151.7 49.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.911 -0.586 . . . . 0.42 110.69 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.437 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 45.5 mm -84.02 113.41 47.71 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 1.26 110.921 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -58.5 132.11 46.53 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.576 2.184 . . . . 0.82 112.506 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.56 11.17 78.13 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.9 -0.667 . . . . 0.49 112.846 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.413 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 22.2 t -99.71 170.32 8.64 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.656 0.265 . . . . 1.23 111.055 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -56.52 -54.62 43.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.332 -0.395 . . . . 0.42 111.489 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -49.18 -44.07 42.65 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.04 -0.527 . . . . 0.35 111.533 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.79 -33.58 75.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.48 . . . . 0.44 111.477 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 55' ' ' SER . 90.9 mt -65.9 -33.42 75.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.378 -0.374 . . . . 0.66 111.187 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -58.8 -46.59 87.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.954 0.407 . . . . 1.86 110.764 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.95 -33.46 3.55 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.839 -0.696 . . . . 1.06 112.554 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 58.5 mtp180 -67.71 -22.14 65.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.805 0.336 . . . . 2.59 110.735 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 70.0 mt -93.84 115.41 32.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.485 . . . . 0.92 110.924 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.453 ' HB2' ' HD2' ' A' ' 65' ' ' PRO . 13.5 pt-20 -118.71 158.6 46.99 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.111 -0.495 . . . . 1.98 110.531 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.453 ' HD2' ' HB2' ' A' ' 64' ' ' GLU . 21.2 Cg_endo -59.27 178.05 0.33 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.38 2.053 . . . . 1.44 112.216 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 18.2 m120 55.5 34.94 24.09 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.166 -0.47 . . . . 2.15 110.809 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.507 ' HB2' ' HD3' ' A' ' 102' ' ' ARG . 5.3 t70 -100.42 153.05 19.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.021 -0.536 . . . . 2.02 110.886 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -110.89 95.67 5.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.861 0.363 . . . . 1.02 110.758 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.452 HD13 ' HB3' ' A' ' 100' ' ' LEU . 44.8 mm -60.42 132.58 25.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.059 -0.519 . . . . 0.29 110.971 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 73.1 mt -100.99 -65.44 0.97 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.036 -0.529 . . . . 0.4 110.866 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.425 ' CG ' HD23 ' A' ' 99' ' ' LEU . 7.7 ptp180 -150.54 135.18 17.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.16 0.505 . . . . 2.61 111.827 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.533 HG12 ' N ' ' A' ' 73' ' ' ASP . 15.7 t -87.96 170.31 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.46 -0.791 . . . . 0.28 109.822 179.025 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.654 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 11.8 t70 -46.51 117.95 1.8 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.723 0.297 . . . . 0.79 111.593 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.5 p30 47.32 19.4 0.12 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.755 -0.657 . . . . 2.01 112.696 179.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.5 t -147.87 100.1 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.655 0.264 . . . . 0.79 110.969 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -76.35 144.04 40.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.36 -0.382 . . . . 2.24 110.814 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.6 m -117.04 30.41 2.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.36 -0.382 . . . . 0.67 111.242 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -89.94 41.74 1.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 1.39 111.174 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 157.5 25.77 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.503 -0.856 . . . . 0.55 112.982 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 37.1 mtm -117.73 138.73 51.83 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.856 0.36 . . . . 0.52 110.742 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.412 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -59.66 160.95 6.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.019 -0.537 . . . . 0.39 111.234 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.446 ' O ' HG23 ' A' ' 86' ' ' VAL . 36.2 tt0 -54.12 -57.61 10.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.35 -0.386 . . . . 1.52 111.087 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 79.7 p -49.93 -32.9 15.9 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.209 -0.451 . . . . 1.48 111.271 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.477 ' O ' HG23 ' A' ' 88' ' ' VAL . 12.4 t70 -69.04 -46.75 67.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.379 -0.373 . . . . 2.12 110.969 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 81' ' ' ALA . 15.2 t -64.6 -29.16 46.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.99 0.424 . . . . 0.32 110.953 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 82' ' ' GLN . 95.9 t -66.18 -58.58 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.964 -0.562 . . . . 0.37 111.287 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 84' ' ' ASP . 13.6 pt-20 -54.16 -36.59 63.51 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.495 -0.32 . . . . 1.51 110.975 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 84' ' ' ASP . 51.7 t -57.11 -56.1 16.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.889 0.376 . . . . 0.27 111.041 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 65.4 mt -57.72 -27.25 62.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.001 -0.545 . . . . 0.41 111.192 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -86.83 -17.63 32.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.335 -0.393 . . . . 2.1 111.302 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -91.47 -13.24 32.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.459 -0.337 . . . . 1.14 110.923 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -50.48 -84.18 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.099 -0.5 . . . . 0.55 111.529 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.487 ' HA2' ' HE ' ' A' ' 20' ' ' ARG . . . 62.79 17.77 58.47 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.8 -0.714 . . . . 0.76 112.532 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.441 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -146.94 172.82 4.76 Favored Pre-proline 0 C--N 1.328 -0.354 0 C-N-CA 121.974 0.11 . . . . 2.52 110.922 -179.734 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.519 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 32.0 Cg_exo -61.43 92.22 0.11 Allowed 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 122.233 1.955 . . . . 0.64 111.497 178.086 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.438 HG13 HD22 ' A' ' 94' ' ' ASN . 16.0 m -97.0 144.97 9.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.93 0.395 . . . . 0.64 111.855 -179.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.654 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 75.2 ttt180 -101.64 143.2 31.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.766 -0.652 . . . . 2.37 109.711 179.121 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 36.6 mt -113.35 107.16 15.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.189 -0.46 . . . . 0.37 111.334 -179.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.425 HD23 ' CG ' ' A' ' 71' ' ' ARG . 33.6 tp -100.07 99.84 10.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.411 -0.358 . . . . 0.37 110.294 179.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.452 ' HB3' HD13 ' A' ' 69' ' ' ILE . 0.4 OUTLIER -127.99 164.42 22.38 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.224 -0.444 . . . . 0.31 111.379 -179.507 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.3 tt -118.02 139.25 45.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 116.087 -0.506 . . . . 0.45 111.133 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.507 ' HD3' ' HB2' ' A' ' 67' ' ' ASP . 15.5 mmm180 . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 115.738 -0.664 . . . . 2.26 110.867 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.6 t . . . . . 0 C--O 1.233 0.228 0 CA-C-O 120.996 0.427 . . . . 0.9 111.103 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.3 mt -77.33 119.44 20.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.816 -0.629 . . . . 0.89 110.883 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -119.09 163.68 16.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.127 -0.488 . . . . 2.73 110.859 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 84.4 p -151.63 146.88 26.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.878 0.371 . . . . 1.19 111.04 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 13.5 t -131.61 136.01 58.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.091 -0.504 . . . . 0.56 110.799 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -89.63 113.19 24.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.289 -0.414 . . . . 1.74 111.364 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -118.0 166.04 13.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.904 -0.589 . . . . 0.81 110.64 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.544 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 30.9 p90 -158.92 128.59 5.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.276 -0.42 . . . . 2.08 111.104 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.704 HH21 ' HG ' ' A' ' 27' ' ' LEU . 21.0 ttm180 -101.47 82.72 2.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.905 0.383 . . . . 3.06 110.835 179.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -97.99 -18.05 18.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.05 -0.523 . . . . 2.58 110.747 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -95.11 144.95 25.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.034 -0.53 . . . . 3.72 110.644 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -81.06 70.93 8.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.306 -0.406 . . . . 2.87 110.749 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 72.2 p -108.21 -9.85 15.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 1.38 111.138 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 83.3 p 51.99 22.51 1.85 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.788 -0.642 . . . . 2.45 111.211 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 56.3 m -157.09 131.78 8.73 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.306 -0.406 . . . . 1.4 110.962 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.704 ' HG ' HH21 ' A' ' 20' ' ' ARG . 49.7 mt -92.69 -25.24 18.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.45 110.619 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.568 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 99.6 31.76 5.96 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.819 -0.705 . . . . 0.52 112.759 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.438 HG22 HG23 ' A' ' 31' ' ' ILE . 45.4 mt -109.32 108.69 25.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.661 0.267 . . . . 0.84 110.926 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 46.5 m -104.14 90.22 3.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.345 -0.388 . . . . 0.95 110.884 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.438 HG23 HG22 ' A' ' 29' ' ' ILE . 28.7 pt -88.3 165.98 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.0 -0.545 . . . . 0.41 111.295 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 53.2 m -142.85 136.42 28.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.121 -0.49 . . . . 1.32 110.909 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 0.23 0 C-N-CA 120.87 -0.681 . . . . 0.95 112.769 -179.802 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 45.4 mm . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.765 0.317 . . . . 0.65 110.965 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 51.6 p90 -144.18 152.95 41.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.247 -0.433 . . . . 0.7 111.165 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.407 HG23 ' CG1' ' A' ' 69' ' ' ILE . 81.3 t -86.77 123.58 39.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.077 -0.51 . . . . 0.39 110.898 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -99.49 -26.91 13.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.072 -0.513 . . . . 2.4 110.941 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 64.0 m -151.85 170.64 19.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.308 -0.405 . . . . 1.28 111.122 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.5 mt -133.91 146.85 50.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.04 -0.527 . . . . 0.42 110.77 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.568 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 44.0 mm -90.06 108.64 27.43 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.239 -0.437 . . . . 1.26 110.892 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -60.94 138.09 76.54 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.351 2.034 . . . . 0.82 112.287 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 98.39 -11.12 63.4 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.75 -0.738 . . . . 0.49 112.499 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.1 m -89.44 -176.25 4.98 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.699 0.285 . . . . 1.23 110.963 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.73 -58.98 3.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.42 111.45 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.13 -32.13 45.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.13 -0.486 . . . . 0.35 111.649 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.81 -49.59 17.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.44 -0.345 . . . . 0.44 111.447 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.8 mt -63.24 -19.97 65.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.417 -0.356 . . . . 0.66 111.084 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -58.86 -55.27 37.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.357 -0.383 . . . . 1.86 110.852 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.3 -44.46 1.61 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.74 -0.743 . . . . 1.06 112.832 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 20.3 mtp180 -61.42 -29.28 69.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.635 0.255 . . . . 2.59 111.2 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 55.6 mt -85.49 109.18 18.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.914 0.388 . . . . 0.92 111.128 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.597 ' HB3' HH12 ' A' ' 102' ' ' ARG . 36.7 tt0 -111.23 139.28 21.74 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.947 -0.57 . . . . 1.98 110.296 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -47.27 165.64 0.1 Allowed 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.504 2.136 . . . . 1.44 112.643 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 64.04 54.17 1.73 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.002 -0.545 . . . . 2.15 110.831 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -128.42 160.99 30.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.846 -0.616 . . . . 2.02 110.269 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.486 ' HB3' HG23 ' A' ' 101' ' ' ILE . 88.0 tttt -110.35 122.56 47.99 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.828 0.347 . . . . 1.02 111.244 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.464 HD13 ' HB3' ' A' ' 100' ' ' LEU . 36.3 mm -90.17 145.85 6.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.173 -0.467 . . . . 0.29 110.699 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 87.2 mt -115.74 -65.8 1.15 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.257 -0.429 . . . . 0.4 111.274 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.535 ' HG2' HD23 ' A' ' 99' ' ' LEU . 15.8 ptm180 -149.88 137.15 19.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.252 0.549 . . . . 2.61 112.037 -179.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.648 HG12 ' H ' ' A' ' 73' ' ' ASP . 11.5 t -84.82 175.22 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.505 -0.771 . . . . 0.28 109.409 178.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.661 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 8.8 t70 -47.69 108.07 0.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.954 0.407 . . . . 0.79 111.684 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 52.3 19.03 1.01 Allowed 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.599 0.592 . . . . 2.01 112.599 179.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.9 t -146.38 102.14 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.63 0.252 . . . . 0.79 111.335 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -62.85 152.76 35.24 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.538 -0.301 . . . . 2.24 110.663 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.1 m -143.07 49.98 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 120.791 0.329 . . . . 0.67 111.862 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -143.3 21.33 1.89 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.069 0.461 . . . . 1.39 110.561 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -142.97 -4.21 0.85 Allowed Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.731 -0.668 . . . . 0.55 112.259 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 71.1 mtm -108.16 173.89 6.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.822 0.344 . . . . 0.52 110.719 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.413 ' HB3' ' OD1' ' A' ' 84' ' ' ASP . . . -69.17 166.28 18.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.212 -0.449 . . . . 0.39 111.104 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.418 ' NE2' HG13 ' A' ' 31' ' ' ILE . 7.8 tp60 -58.94 -58.39 8.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 1.52 110.948 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 45.0 t -51.75 -39.82 59.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.026 -0.534 . . . . 1.48 111.295 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.413 ' OD1' ' HB3' ' A' ' 81' ' ' ALA . 1.2 m-20 -57.28 -44.92 84.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.345 -0.389 . . . . 2.12 110.835 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 81' ' ' ALA . 55.6 t -61.24 -38.4 79.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.223 -0.444 . . . . 0.32 110.926 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 17.9 t -63.93 -39.62 86.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 0.37 110.995 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -58.62 -51.83 68.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.285 -0.416 . . . . 1.51 110.75 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 63.6 t -52.83 -53.58 20.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.27 111.431 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 80.0 mt -58.44 -30.92 67.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.049 -0.523 . . . . 0.41 111.366 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 73.2 mtm180 -85.81 -13.6 47.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.42 -0.354 . . . . 2.1 111.175 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -93.86 -13.76 26.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.405 -0.361 . . . . 1.14 110.917 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.15 -83.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.213 -0.449 . . . . 0.55 111.432 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.591 ' H ' ' HD2' ' A' ' 20' ' ' ARG . . . 63.76 13.2 50.89 Favored Glycine 0 CA--C 1.517 0.216 0 C-N-CA 120.664 -0.779 . . . . 0.76 112.419 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.421 HD22 ' C ' ' A' ' 94' ' ' ASN . 0.2 OUTLIER -146.78 170.4 7.87 Favored Pre-proline 0 C--N 1.329 -0.318 0 O-C-N 122.999 -0.118 . . . . 2.52 110.82 -179.725 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.544 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 31.8 Cg_exo -60.55 106.27 0.35 Allowed 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.241 1.961 . . . . 0.64 111.669 178.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 34.7 m -114.33 154.37 15.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.95 0.405 . . . . 0.64 111.699 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.661 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 73.7 ttt180 -101.9 142.2 33.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.833 -0.621 . . . . 2.37 109.932 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 21.8 mt -116.81 109.1 16.67 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.431 -0.35 . . . . 0.37 111.271 -179.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.535 HD23 ' HG2' ' A' ' 71' ' ' ARG . 52.4 tp -96.19 103.32 15.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.3 -0.409 . . . . 0.37 110.396 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.464 ' HB3' HD13 ' A' ' 69' ' ' ILE . 0.4 OUTLIER -129.8 154.11 47.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.454 . . . . 0.31 111.403 -179.557 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.486 HG23 ' HB3' ' A' ' 68' ' ' LYS . 13.9 tt -105.89 136.71 39.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-N 116.157 -0.474 . . . . 0.45 110.773 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.597 HH12 ' HB3' ' A' ' 64' ' ' GLU . 29.1 mmm-85 . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 115.741 -0.663 . . . . 2.26 110.429 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.0 t . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 120.732 0.301 . . . . 0.9 110.628 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 91.4 mt -76.71 121.51 23.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.244 -0.434 . . . . 0.89 110.824 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -113.38 155.18 25.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.978 -0.555 . . . . 2.73 110.862 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 48.3 t -151.35 132.69 14.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.271 -0.422 . . . . 1.19 111.154 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.4 t -131.56 128.77 61.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.11 -0.495 . . . . 0.56 110.676 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -92.7 119.15 31.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 1.74 111.525 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.439 HD12 HD11 ' A' ' 98' ' ' LEU . 19.6 mt -119.16 113.09 20.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.093 -0.503 . . . . 0.81 110.542 179.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.63 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 33.1 m-85 -79.58 114.21 18.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.092 -0.504 . . . . 2.08 111.022 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.515 ' HG2' ' HA2' ' A' ' 93' ' ' GLY . 20.3 ttt180 -100.16 104.9 16.46 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.836 0.35 . . . . 3.06 110.565 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -147.63 11.25 0.98 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.277 -0.42 . . . . 2.58 111.019 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -94.7 156.44 16.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 3.72 110.67 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -83.06 53.33 2.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.348 -0.387 . . . . 2.87 110.69 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.2 p -120.31 -29.27 4.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 1.38 110.95 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.441 ' HA ' ' NH2' ' A' ' 20' ' ' ARG . 41.2 t 59.61 14.88 4.24 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.691 -0.686 . . . . 2.45 111.153 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 47.6 t -125.05 132.81 53.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 1.4 110.699 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.428 HD21 ' HD2' ' A' ' 20' ' ' ARG . 95.2 mt -102.27 -11.8 18.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.45 110.697 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.513 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 87.02 6.67 78.83 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.812 -0.709 . . . . 0.52 112.584 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.42 HG23 HG22 ' A' ' 48' ' ' VAL . 67.7 mt -85.1 109.0 17.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.713 0.292 . . . . 0.84 111.026 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.5 m -113.84 99.81 7.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.37 -0.377 . . . . 0.95 110.822 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 36.7 pt -92.49 152.46 3.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.196 -0.456 . . . . 0.41 111.343 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.9 p -108.07 133.25 52.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.033 -0.531 . . . . 1.32 110.994 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 0.303 0 C-N-CA 120.904 -0.665 . . . . 0.95 112.529 179.964 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 50.5 mm . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.758 0.313 . . . . 0.65 110.913 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -153.67 137.23 15.96 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.362 -0.381 . . . . 0.7 111.203 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.42 HG22 HG23 ' A' ' 29' ' ' ILE . 91.1 t -63.41 119.11 6.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.15 -0.477 . . . . 0.39 110.888 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -98.1 -26.04 14.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.81 -0.632 . . . . 2.4 110.952 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 79.8 p -153.56 162.32 41.37 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.926 0.393 . . . . 1.28 111.31 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.2 mt -123.84 156.03 36.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.96 -0.564 . . . . 0.42 110.774 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.513 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 49.4 mm -99.28 114.02 65.23 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.312 -0.403 . . . . 1.26 110.871 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -62.15 119.73 6.97 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.446 2.097 . . . . 0.82 112.196 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.34 7.76 29.93 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.893 -0.67 . . . . 0.49 112.514 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.4 m -105.75 -174.48 2.54 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.626 0.251 . . . . 1.23 110.941 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.65 -47.38 66.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.888 0.375 . . . . 0.42 111.14 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.546 ' HB1' HG21 ' A' ' 63' ' ' ILE . . . -57.31 -41.15 79.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.939 -0.573 . . . . 0.35 111.533 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.49 -53.53 15.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.44 111.593 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 98.5 mt -60.55 -19.78 58.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.366 -0.379 . . . . 0.66 111.295 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -62.34 -55.41 28.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.811 0.338 . . . . 1.86 110.795 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 105.59 -49.75 0.87 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.826 -0.702 . . . . 1.06 112.752 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -68.26 -23.41 64.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.739 0.304 . . . . 2.59 111.126 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.546 HG21 ' HB1' ' A' ' 57' ' ' ALA . 39.5 mm -76.12 123.62 32.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.826 0.346 . . . . 0.92 110.937 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -111.9 155.05 43.85 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.138 -0.483 . . . . 1.98 111.028 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -78.81 36.95 0.63 Allowed 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.943 2.429 . . . . 1.44 112.259 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -169.29 75.93 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.296 -0.411 . . . . 2.15 110.872 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -143.28 150.01 38.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 2.02 110.877 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.462 ' HB3' HG23 ' A' ' 101' ' ' ILE . 87.7 tttt -90.62 114.68 27.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.828 0.346 . . . . 1.02 111.129 -179.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.516 HD13 ' HB3' ' A' ' 100' ' ' LEU . 41.0 mm -84.16 137.54 20.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.215 -0.448 . . . . 0.29 110.729 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 65.8 mt -117.08 -65.04 1.23 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.434 . . . . 0.4 111.17 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -131.07 163.7 27.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.097 -0.501 . . . . 2.61 111.703 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.551 HG12 ' N ' ' A' ' 73' ' ' ASP . 44.8 t -127.97 167.64 22.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.566 -0.743 . . . . 0.28 109.562 179.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.617 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 7.7 t70 -41.6 108.11 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.5 0.555 . . . . 0.79 112.5 -179.384 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 56.66 2.76 0.1 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.468 0.914 . . . . 2.01 113.468 178.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.454 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 84.7 t -143.57 112.79 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.679 0.276 . . . . 0.79 111.534 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -68.75 163.26 24.43 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.005 -0.368 . . . . 2.24 110.005 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.7 m -134.38 0.08 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.718 0.294 . . . . 0.67 111.651 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -91.5 109.32 20.61 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 120.883 0.373 . . . . 1.39 110.385 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 125.57 -12.94 7.38 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.843 -0.694 . . . . 0.55 112.516 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 74.4 mtm -105.44 158.66 16.5 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.839 0.352 . . . . 0.52 110.996 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.39 162.19 15.53 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.198 -0.455 . . . . 0.39 111.328 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -56.77 -46.38 81.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.329 -0.396 . . . . 1.52 111.136 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 85.4 p -53.42 -41.24 65.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.234 -0.439 . . . . 1.48 111.162 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -66.02 -44.04 85.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.296 -0.411 . . . . 2.12 111.13 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 57.7 t -58.34 -39.8 75.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.154 -0.476 . . . . 0.32 111.372 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 64.7 t -68.04 -43.52 85.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.496 -0.32 . . . . 0.37 111.145 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -57.35 -43.67 83.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.355 -0.384 . . . . 1.51 110.944 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 57.3 t -61.16 -55.47 24.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.46 . . . . 0.27 111.181 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 90.8 mt -52.62 -27.56 17.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.974 -0.557 . . . . 0.41 111.301 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 74.4 mtm180 -89.17 -28.25 20.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.286 -0.415 . . . . 2.1 111.271 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -74.07 -14.99 61.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.399 -0.364 . . . . 1.14 110.693 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.47 ' HB3' ' HD3' ' A' ' 20' ' ' ARG . . . -54.33 -81.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.994 -0.548 . . . . 0.55 111.364 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.515 ' HA2' ' HG2' ' A' ' 20' ' ' ARG . . . 61.1 17.42 51.93 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.655 -0.783 . . . . 0.76 112.139 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.443 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -147.13 170.88 7.05 Favored Pre-proline 0 CA--C 1.534 0.329 0 C-N-CA 122.06 0.144 . . . . 2.52 110.877 -179.824 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.63 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 47.4 Cg_exo -58.25 104.2 0.17 Allowed 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.081 1.854 . . . . 0.64 111.555 178.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 23.6 m -112.68 155.1 14.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.041 0.448 . . . . 0.64 112.011 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.617 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 35.3 ttp180 -111.46 145.25 39.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.695 -0.684 . . . . 2.37 109.949 179.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.439 HD11 HD12 ' A' ' 18' ' ' LEU . 25.9 mt -110.02 124.1 50.86 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.356 -0.383 . . . . 0.37 111.255 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 32.7 tp -109.88 101.08 9.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.332 -0.395 . . . . 0.37 110.245 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.516 ' HB3' HD13 ' A' ' 69' ' ' ILE . 0.4 OUTLIER -130.55 160.67 33.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.31 111.396 -179.467 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.462 HG23 ' HB3' ' A' ' 68' ' ' LYS . 12.6 tt -116.08 141.92 31.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.873 -0.603 . . . . 0.45 110.896 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 32.3 tpt180 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.043 -0.526 . . . . 2.26 110.979 -179.761 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 44.2 t . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.827 0.346 . . . . 0.9 110.869 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 62.6 mt -77.55 126.37 30.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.06 -0.518 . . . . 0.89 110.824 179.826 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.404 ' CD2' ' HB2' ' A' ' 102' ' ' ARG . 58.5 m-85 -123.65 130.42 52.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.12 -0.491 . . . . 2.73 111.023 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 80.8 p -120.42 139.26 53.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.285 -0.416 . . . . 1.19 111.091 -179.815 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.3 t -131.58 146.4 33.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.116 -0.493 . . . . 0.56 110.743 179.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -103.0 114.04 28.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.381 -0.372 . . . . 1.74 111.386 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.475 HD12 ' HB1' ' A' ' 56' ' ' ALA . 4.6 mm? -115.5 166.1 12.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.079 -0.509 . . . . 0.81 110.702 179.537 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.545 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 37.9 p90 -159.51 131.69 6.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.277 -0.42 . . . . 2.08 111.053 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.7 HH21 ' HG ' ' A' ' 27' ' ' LEU . 27.8 ttm180 -109.85 130.86 55.47 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.68 -0.408 . . . . 3.06 110.879 179.635 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -134.67 6.68 3.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.01 -0.541 . . . . 2.58 110.73 179.777 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -112.47 162.7 15.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.007 -0.542 . . . . 3.72 110.788 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -86.7 42.98 1.05 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.262 -0.426 . . . . 2.87 110.958 -179.911 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 69.3 p -86.98 -13.01 45.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 1.38 111.339 -179.924 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 94.8 p 50.56 24.56 1.67 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.778 -0.646 . . . . 2.45 111.504 179.89 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 80.5 p -158.7 153.32 24.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.297 -0.41 . . . . 1.4 110.904 -179.938 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.7 ' HG ' HH21 ' A' ' 20' ' ' ARG . 84.0 mt -107.76 -13.17 15.07 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.012 -0.54 . . . . 0.45 110.998 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.546 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 100.69 18.94 19.25 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.828 -0.701 . . . . 0.52 112.741 179.748 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 78.2 mt -97.52 112.46 29.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.702 0.287 . . . . 0.84 110.694 179.751 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.9 t -110.12 101.93 10.68 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.337 -0.392 . . . . 0.95 111.019 -179.713 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.436 ' HA ' ' HA ' ' A' ' 48' ' ' VAL . 33.2 pt -92.33 163.41 2.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.967 -0.56 . . . . 0.41 110.914 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 47.9 t -147.33 156.69 43.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.179 -0.464 . . . . 1.32 110.782 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.247 0 C-N-CA 120.722 -0.752 . . . . 0.95 112.558 -179.953 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 42.8 mm . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.784 0.326 . . . . 0.65 110.806 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -132.52 141.17 48.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 0.7 111.074 -179.888 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.436 ' HA ' ' HA ' ' A' ' 31' ' ' ILE . 97.8 t -80.19 111.86 17.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.147 -0.479 . . . . 0.39 110.51 179.444 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -84.39 -34.67 23.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.092 -0.503 . . . . 2.4 111.284 -179.607 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 83.0 p -151.06 179.07 8.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.064 0.459 . . . . 1.28 111.527 -179.718 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 66.6 mt -134.06 160.84 36.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.725 -0.67 . . . . 0.42 110.558 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.546 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 53.2 mt -96.54 108.55 43.1 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.257 -0.429 . . . . 1.26 111.12 179.954 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -59.34 127.54 24.29 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.348 2.032 . . . . 0.82 112.324 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 104.69 -2.68 42.1 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.763 -0.732 . . . . 0.49 112.549 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.6 m -95.68 -179.03 4.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.659 0.266 . . . . 1.23 110.99 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.475 ' HB1' HD12 ' A' ' 18' ' ' LEU . . . -65.69 -55.44 17.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.36 -0.382 . . . . 0.42 111.189 179.937 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.72 -33.05 63.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.061 -0.518 . . . . 0.35 111.413 -179.852 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.38 -50.47 31.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.259 -0.428 . . . . 0.44 111.442 -179.739 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.2 mt -61.4 -21.27 63.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.312 -0.404 . . . . 0.66 111.123 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -60.66 -54.72 41.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.405 -0.361 . . . . 1.86 110.977 -179.782 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.34 -46.85 1.79 Allowed Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.742 -0.742 . . . . 1.06 112.927 179.458 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 66.9 mtp180 -56.45 -39.27 72.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.772 0.32 . . . . 2.59 110.991 -179.772 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 64.6 mt -68.57 108.55 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.92 110.883 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -107.29 137.41 19.6 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.038 -0.528 . . . . 1.98 110.715 -179.702 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -54.91 175.64 0.15 Allowed 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.571 2.181 . . . . 1.44 112.278 179.855 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 59.32 44.48 15.28 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.031 0.443 . . . . 2.15 110.285 -179.632 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -119.51 167.22 12.18 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.895 -0.593 . . . . 2.02 110.807 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -116.71 123.07 46.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.316 -0.402 . . . . 1.02 110.962 179.911 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.495 HD13 ' HB3' ' A' ' 100' ' ' LEU . 47.5 mm -81.16 139.11 18.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.159 -0.473 . . . . 0.29 111.202 -179.729 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 79.2 mt -105.53 -68.75 0.85 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.906 -0.588 . . . . 0.4 110.723 179.844 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.437 ' HG2' HD23 ' A' ' 99' ' ' LEU . 10.3 ptp180 -150.24 137.42 19.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 2.61 111.21 -179.868 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.676 HG12 ' H ' ' A' ' 73' ' ' ASP . 2.6 t -87.19 175.29 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.712 -0.676 . . . . 0.28 110.285 179.579 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.676 ' H ' HG12 ' A' ' 72' ' ' VAL . 17.7 t70 -50.49 112.7 0.73 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.773 0.321 . . . . 0.79 111.465 179.432 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 56.69 23.23 7.61 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.079 -0.51 . . . . 2.01 111.806 179.548 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.465 HG11 HG11 ' A' ' 88' ' ' VAL . 68.2 t -143.74 144.44 23.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.82 0.343 . . . . 0.79 110.923 179.855 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -115.69 133.05 56.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.311 -0.404 . . . . 2.24 110.504 179.668 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.543 HG11 HG13 ' A' ' 85' ' ' VAL . 31.2 m -121.15 35.49 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.849 0.357 . . . . 0.67 111.722 -179.39 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -97.51 41.46 1.12 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.302 -0.408 . . . . 1.39 111.051 179.948 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.19 36.18 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.449 -0.881 . . . . 0.55 113.235 179.77 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 52.4 mtm -127.91 158.55 37.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.844 0.354 . . . . 0.52 110.849 179.562 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.08 151.5 42.95 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.104 -0.498 . . . . 0.39 111.149 -179.935 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -53.57 -55.0 29.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.334 -0.393 . . . . 1.52 111.308 -179.556 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 59.4 m -53.57 -37.37 62.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 1.48 111.445 -179.512 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -64.02 -42.35 97.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.478 -0.328 . . . . 2.12 110.926 -179.826 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.543 HG13 HG11 ' A' ' 77' ' ' VAL . 48.0 t -61.08 -41.71 90.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.218 -0.447 . . . . 0.32 111.05 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 47.8 t -63.3 -39.89 86.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.262 -0.426 . . . . 0.37 111.013 179.929 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.451 ' HG2' HH21 ' A' ' 90' ' ' ARG . 47.8 mt-10 -57.72 -48.05 80.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 1.51 111.072 -179.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.465 HG11 HG11 ' A' ' 75' ' ' VAL . 65.7 t -57.26 -55.86 18.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.27 111.368 -179.889 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 91.4 mt -52.11 -32.64 36.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.028 -0.533 . . . . 0.41 111.222 -179.445 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.6 ' HA ' HH22 ' A' ' 20' ' ' ARG . 80.0 mtm180 -81.04 -30.27 34.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.34 -0.391 . . . . 2.1 111.291 -179.912 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -68.96 -22.26 64.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.443 -0.344 . . . . 1.14 110.707 179.891 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.38 -84.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.093 -0.503 . . . . 0.55 111.275 179.778 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.66 ' HA2' ' HD2' ' A' ' 20' ' ' ARG . . . 64.11 19.41 63.73 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.81 -0.709 . . . . 0.76 112.555 -179.794 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -146.96 178.63 1.37 Allowed Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 110.263 -0.273 . . . . 2.52 110.263 -179.752 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.545 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 33.2 Cg_exo -60.46 102.79 0.2 Allowed 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.07 1.847 . . . . 0.64 111.954 178.196 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 30.1 m -121.15 156.79 24.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.062 0.458 . . . . 0.64 111.508 -179.552 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.625 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 76.3 ttt180 -101.58 142.51 32.83 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.826 -0.625 . . . . 2.37 110.351 179.791 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 13.1 mt -118.21 111.63 19.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.191 -0.459 . . . . 0.37 111.024 -179.6 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.437 HD23 ' HG2' ' A' ' 71' ' ' ARG . 45.1 tp -101.65 103.82 14.64 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.834 0.349 . . . . 0.37 110.561 179.489 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.495 ' HB3' HD13 ' A' ' 69' ' ' ILE . 0.5 OUTLIER -132.38 155.14 48.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.125 -0.489 . . . . 0.31 111.102 -179.548 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 15.2 tt -103.13 136.92 33.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.45 111.103 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.404 ' HB2' ' CD2' ' A' ' 14' ' ' TYR . 21.6 mmm180 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 115.702 -0.681 . . . . 2.26 110.518 179.809 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 46.0 t . . . . . 0 C--O 1.236 0.371 0 CA-C-O 121.015 0.436 . . . . 0.9 111.276 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.544 HD23 ' HB ' ' A' ' 101' ' ' ILE . 17.8 mt -97.21 103.31 15.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.497 -0.774 . . . . 0.89 110.1 179.599 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 36.5 p90 -124.5 151.91 44.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.858 0.361 . . . . 2.73 111.119 -179.344 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 48.4 t -120.68 155.81 33.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.024 0.44 . . . . 1.19 111.383 -179.436 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.8 t -131.66 137.69 54.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.758 -0.656 . . . . 0.56 110.416 179.801 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -88.51 114.43 25.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.947 0.403 . . . . 1.74 111.406 -179.491 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -124.95 117.67 24.57 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.892 -0.595 . . . . 0.81 110.614 179.614 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.582 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 28.2 p90 -107.66 132.97 52.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.378 -0.374 . . . . 2.08 111.053 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.65 ' HE ' ' HA2' ' A' ' 93' ' ' GLY . 20.7 ttp180 -107.78 102.89 12.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.853 0.359 . . . . 3.06 110.861 179.56 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -128.08 -3.03 5.75 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.149 -0.478 . . . . 2.58 111.113 -179.797 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.431 ' HD2' ' N ' ' A' ' 22' ' ' LYS . 0.9 OUTLIER -83.78 159.77 21.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.306 -0.407 . . . . 3.72 110.792 179.825 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -83.32 34.65 0.47 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.468 . . . . 2.87 110.978 -179.885 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 50.3 p -92.14 -23.22 19.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.283 -0.417 . . . . 1.38 111.127 -179.872 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.7 m 56.91 24.67 9.62 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.879 -0.601 . . . . 2.45 111.361 179.785 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 52.5 m -147.19 157.9 43.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.359 -0.382 . . . . 1.4 111.053 -179.885 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.585 HD21 ' HB2' ' A' ' 20' ' ' ARG . 86.1 mt -114.98 1.1 13.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.175 -0.466 . . . . 0.45 110.981 179.876 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 67.87 23.44 74.22 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.795 -0.717 . . . . 0.52 112.735 179.898 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 62.5 mt -97.61 110.01 24.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.648 0.261 . . . . 0.84 110.919 179.896 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 35.9 t -107.54 98.48 8.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.386 -0.37 . . . . 0.95 111.01 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 40.6 pt -83.58 159.39 3.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.294 -0.412 . . . . 0.41 111.142 -179.878 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 47.9 t -138.7 152.02 47.66 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.049 -0.523 . . . . 1.32 110.989 -179.78 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 C-N-CA 120.772 -0.727 . . . . 0.95 112.471 179.94 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 45.9 mm . . . . . 0 C--O 1.233 0.189 0 CA-C-O 120.752 0.31 . . . . 0.65 111.032 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -152.72 140.9 20.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.283 -0.417 . . . . 0.7 110.825 179.796 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 97.0 t -74.48 116.29 16.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.078 -0.51 . . . . 0.39 110.869 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -103.9 -25.08 13.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.22 -0.445 . . . . 2.4 110.917 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 42.3 t -141.13 165.86 26.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 1.28 111.216 -179.926 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.463 HD11 HG22 ' A' ' 63' ' ' ILE . 95.6 mt -136.67 163.64 30.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.913 -0.585 . . . . 0.42 110.792 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 50.1 mm -108.02 103.52 50.31 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.321 -0.399 . . . . 1.26 111.076 -179.853 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.93 132.1 47.99 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.426 2.084 . . . . 0.82 112.297 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 99.68 -4.9 58.14 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.789 -0.72 . . . . 0.49 112.408 -179.779 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.8 t -93.66 167.98 11.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.614 0.245 . . . . 1.23 110.944 -179.876 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -53.91 -57.84 9.5 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.283 -0.417 . . . . 0.42 111.704 -179.75 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.35 -43.78 61.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.35 111.468 -179.638 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.7 -34.57 77.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.44 111.719 -179.52 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 70.2 mt -62.94 -37.04 85.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.456 -0.338 . . . . 0.66 111.444 -179.622 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.03 -44.88 95.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.469 -0.332 . . . . 1.86 111.017 -179.878 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.76 -27.29 4.36 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.79 -0.719 . . . . 1.06 112.652 179.892 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 78.4 mtp180 -62.51 -19.23 63.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.837 0.351 . . . . 2.59 111.102 -179.955 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.509 ' N ' HD12 ' A' ' 63' ' ' ILE . 3.2 mp -82.5 104.55 11.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.115 -0.493 . . . . 0.92 110.695 179.808 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -93.71 137.23 23.3 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.088 -0.506 . . . . 1.98 110.7 -179.764 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -51.47 160.8 2.24 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.38 2.053 . . . . 1.44 112.316 179.693 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.1 m120 58.7 44.89 16.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.186 -0.461 . . . . 2.15 110.787 -179.855 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -95.11 143.19 26.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.906 -0.588 . . . . 2.02 111.049 -179.88 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.675 ' HB3' HG23 ' A' ' 101' ' ' ILE . 25.9 tptp -91.85 101.49 14.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.108 -0.497 . . . . 1.02 111.152 -179.948 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.455 HG22 HG21 ' A' ' 77' ' ' VAL . 40.0 mm -74.33 134.39 29.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.494 -0.321 . . . . 0.29 110.62 179.627 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.681 ' HA ' HE21 ' A' ' 78' ' ' GLN . 88.3 mt -108.91 -57.26 2.17 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.395 -0.366 . . . . 0.4 111.139 -179.766 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -157.87 138.95 13.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.088 0.47 . . . . 2.61 111.623 -179.738 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.631 HG12 ' H ' ' A' ' 73' ' ' ASP . 5.3 t -88.45 174.23 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.543 -0.753 . . . . 0.28 109.855 179.242 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.67 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 14.9 t70 -46.6 111.0 0.33 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.866 0.365 . . . . 0.79 111.957 179.845 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 54.1 29.02 9.64 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.021 -0.536 . . . . 2.01 112.084 179.113 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 96.2 t -147.28 137.27 16.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.419 -0.355 . . . . 0.79 110.771 179.729 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -103.51 132.19 49.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.42 -0.355 . . . . 2.24 110.594 179.716 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.455 HG21 HG22 ' A' ' 69' ' ' ILE . 34.6 m -112.24 26.07 3.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-O 120.817 0.342 . . . . 0.67 111.423 -179.588 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.681 HE21 ' HA ' ' A' ' 70' ' ' LEU . 72.5 mm-40 -95.26 31.03 2.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 1.39 111.158 179.823 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 173.53 37.23 0.04 OUTLIER Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.575 -0.821 . . . . 0.55 112.751 179.818 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 51.6 mtm -128.99 142.71 50.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.787 0.327 . . . . 0.52 110.83 179.824 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.32 161.5 9.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.39 111.254 -179.884 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.436 ' O ' HG23 ' A' ' 86' ' ' VAL . 35.6 tt0 -53.96 -60.97 2.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.256 -0.429 . . . . 1.52 110.949 -179.847 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 54.5 m -55.29 -26.74 42.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.244 -0.434 . . . . 1.48 111.386 -179.737 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -69.64 -54.21 14.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.771 0.319 . . . . 2.12 110.894 -179.786 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.7 t -56.1 -39.08 56.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.298 -0.41 . . . . 0.32 110.922 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.491 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 59.7 t -58.53 -55.86 20.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.232 -0.44 . . . . 0.37 110.628 179.586 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -47.6 -41.6 22.12 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.073 -0.512 . . . . 1.51 111.001 179.893 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 54.0 t -56.29 -51.84 58.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.164 -0.471 . . . . 0.27 110.711 179.309 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 76.1 mt -56.28 -28.61 59.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.755 -0.657 . . . . 0.41 110.792 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.491 ' HG2' ' O ' ' A' ' 86' ' ' VAL . 20.9 mmt180 -79.6 -30.3 41.44 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.082 -0.508 . . . . 2.1 110.654 179.982 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -75.16 -18.41 60.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.052 -0.522 . . . . 1.14 110.845 -179.824 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.53 -88.63 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.049 -0.523 . . . . 0.55 111.636 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.65 ' HA2' ' HE ' ' A' ' 20' ' ' ARG . . . 60.97 16.97 49.98 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.746 -0.74 . . . . 0.76 112.509 -179.741 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.442 HD22 HG13 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -146.99 172.9 4.66 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 110.657 -0.127 . . . . 2.52 110.657 -179.677 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.582 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 37.5 Cg_exo -62.39 97.45 0.17 Allowed 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 122.068 1.845 . . . . 0.64 111.625 178.338 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.442 HG13 HD22 ' A' ' 94' ' ' ASN . 29.0 m -105.64 156.41 6.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.64 111.717 -179.307 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.67 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 78.5 ttt180 -103.55 142.14 34.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.713 -0.676 . . . . 2.37 110.029 179.366 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 21.3 mt -115.14 104.37 11.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 0.37 111.35 -179.214 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 34.3 tp -95.8 111.59 23.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.82 0.343 . . . . 0.37 110.172 179.173 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.09 166.84 23.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.086 0.469 . . . . 0.31 111.628 -179.105 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.675 HG23 ' HB3' ' A' ' 68' ' ' LYS . 4.1 tt -121.92 138.32 52.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.684 -0.689 . . . . 0.45 110.478 179.71 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 33.0 tpt180 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.322 -0.399 . . . . 2.26 110.784 -179.831 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 48.3 t . . . . . 0 C--O 1.237 0.411 0 CA-C-O 121.033 0.444 . . . . 0.9 111.383 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.529 HD23 ' HB ' ' A' ' 101' ' ' ILE . 15.6 mt -93.88 101.86 13.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.468 -0.787 . . . . 0.89 110.076 179.58 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.416 ' HE1' ' HB3' ' A' ' 102' ' ' ARG . 40.5 p90 -121.88 148.08 45.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.927 0.394 . . . . 2.73 111.117 -179.464 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 80.3 p -112.57 146.99 37.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.052 -0.522 . . . . 1.19 111.143 -179.68 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 17.2 t -120.31 135.3 61.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.096 -0.502 . . . . 0.56 110.644 179.751 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -92.09 111.53 23.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.323 -0.399 . . . . 1.74 111.614 -179.509 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.56 HD12 ' HB1' ' A' ' 56' ' ' ALA . 3.5 mm? -116.14 166.16 12.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.94 -0.573 . . . . 0.81 110.184 179.112 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.576 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 42.2 p90 -153.61 136.93 15.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.796 0.332 . . . . 2.08 111.433 -179.745 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.461 HH21 ' N ' ' A' ' 93' ' ' GLY . 21.5 ttp180 -121.31 140.32 52.25 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.175 -0.466 . . . . 3.06 110.607 179.317 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -160.63 26.15 0.15 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.388 -0.369 . . . . 2.58 111.317 -179.947 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -123.17 165.46 16.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.33 -0.395 . . . . 3.72 110.712 179.602 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -88.96 72.58 8.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.243 -0.435 . . . . 2.87 110.799 -179.951 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 48.3 p -124.07 -24.89 4.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.06 -0.518 . . . . 1.38 110.987 179.935 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.0 t 58.35 23.82 10.93 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.775 -0.648 . . . . 2.45 111.189 179.687 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 56.5 m -151.18 136.08 17.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.893 0.378 . . . . 1.4 111.086 -179.918 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.456 HD21 ' HB2' ' A' ' 20' ' ' ARG . 46.7 mt -97.11 -12.29 23.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.017 -0.538 . . . . 0.45 110.608 179.707 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.516 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 92.78 20.59 33.56 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.851 -0.69 . . . . 0.52 112.509 179.91 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 75.9 mt -98.59 112.14 29.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.717 0.294 . . . . 0.84 111.064 179.956 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 70.4 m -113.68 98.89 7.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.95 110.834 179.921 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 36.9 pt -91.34 166.7 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.186 -0.461 . . . . 0.41 111.376 -179.854 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 44.8 t -147.4 153.59 39.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.029 -0.532 . . . . 1.32 110.654 -179.981 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 C-N-CA 120.738 -0.744 . . . . 0.95 112.529 -179.991 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 40.5 mm . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.723 0.297 . . . . 0.65 111.164 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -155.94 139.19 15.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.238 -0.437 . . . . 0.7 110.715 179.862 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 57.5 t -76.74 127.11 37.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.222 -0.445 . . . . 0.39 111.111 -179.84 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -116.71 -22.55 8.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.036 -0.529 . . . . 2.4 111.165 -179.763 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 46.9 t -139.58 163.39 32.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.952 0.406 . . . . 1.28 111.304 -179.871 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 76.0 mt -134.78 163.17 30.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.888 -0.596 . . . . 0.42 110.807 179.984 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.516 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 48.5 mm -110.32 98.92 38.15 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.29 -0.414 . . . . 1.26 110.96 179.67 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.07 126.88 22.92 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.404 2.069 . . . . 0.82 112.28 -179.928 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.76 -4.54 32.41 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.905 -0.664 . . . . 0.49 112.625 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.442 ' OG ' ' HA3' ' A' ' 28' ' ' GLY . 93.1 p -99.47 -172.54 2.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.903 0.383 . . . . 1.23 111.058 -179.814 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.56 ' HB1' HD12 ' A' ' 18' ' ' LEU . . . -67.8 -58.06 5.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.052 -0.522 . . . . 0.42 111.333 -179.951 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.4 ' HA ' ' HA3' ' A' ' 61' ' ' GLY . . . -59.81 -22.91 62.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.079 -0.51 . . . . 0.35 111.438 -179.782 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.15 -31.62 34.06 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.511 -0.313 . . . . 0.44 111.776 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.5 mt -83.45 -59.27 2.5 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.313 0.486 . . . . 0.66 112.313 -179.038 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -103.98 -24.53 13.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.665 0.269 . . . . 1.86 111.331 -178.781 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.469 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -64.53 87.15 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.516 -0.85 . . . . 1.06 112.246 179.959 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 -61.31 0.75 0.24 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.603 0.24 . . . . 2.59 111.234 179.751 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.469 ' H ' ' C ' ' A' ' 61' ' ' GLY . 59.2 mt -48.95 125.65 2.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.276 -0.42 . . . . 0.92 111.194 179.582 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.425 ' C ' ' H ' ' A' ' 66' ' ' ASN . 11.5 mt-10 -78.93 159.85 72.66 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 1.98 110.93 179.86 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -73.61 28.06 0.31 Allowed 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.656 2.237 . . . . 1.44 112.443 179.654 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.425 ' H ' ' C ' ' A' ' 64' ' ' GLU . 3.1 t-20 -163.03 49.44 0.15 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.094 0.473 . . . . 2.15 110.281 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -108.55 152.62 24.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.867 -0.606 . . . . 2.02 110.904 -179.716 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -107.09 111.21 23.56 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.41 -0.359 . . . . 1.02 110.981 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 34.7 mm -70.43 141.55 16.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.256 -0.429 . . . . 0.29 110.768 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 82.8 mt -117.86 -66.11 1.11 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 0.4 111.35 -179.724 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -137.69 135.62 36.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.972 0.415 . . . . 2.61 111.431 -179.62 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.657 HG12 ' H ' ' A' ' 73' ' ' ASP . 3.1 t -94.41 174.49 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.899 -0.591 . . . . 0.28 110.083 179.329 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.69 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 14.2 t70 -53.49 108.79 0.37 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.839 0.352 . . . . 0.79 111.392 179.807 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.4 t70 61.48 15.91 7.1 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.008 -0.542 . . . . 2.01 111.699 179.434 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.433 HG12 ' N ' ' A' ' 76' ' ' ASN . 26.0 t -138.42 157.18 30.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.559 -0.291 . . . . 0.79 110.802 179.795 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.433 ' N ' HG12 ' A' ' 75' ' ' VAL . 65.6 m-20 -127.71 129.59 47.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.442 -0.345 . . . . 2.24 110.907 -179.96 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.405 ' HA ' ' HE2' ' A' ' 80' ' ' MET . 34.7 m -106.41 21.02 4.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.337 -0.392 . . . . 0.67 111.004 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -86.27 23.66 1.52 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.013 -0.54 . . . . 1.39 110.918 -179.958 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -177.02 18.85 0.04 OUTLIER Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.706 -0.759 . . . . 0.55 112.828 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.405 ' HE2' ' HA ' ' A' ' 77' ' ' VAL . 51.6 mtm -115.12 139.16 50.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.843 0.354 . . . . 0.52 110.876 179.809 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.461 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -65.97 156.86 32.35 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.159 -0.473 . . . . 0.39 111.025 -179.932 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -44.04 -55.03 4.97 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.199 -0.455 . . . . 1.52 111.546 -179.568 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 79.3 p -51.29 -46.78 62.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.312 -0.404 . . . . 1.48 111.256 -179.68 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -60.62 -40.74 93.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 2.12 111.104 -179.915 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 81' ' ' ALA . 35.0 t -60.07 -39.69 81.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.295 -0.412 . . . . 0.32 110.766 179.85 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.457 HG12 ' NE ' ' A' ' 90' ' ' ARG . 39.9 t -64.43 -37.06 79.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.168 -0.469 . . . . 0.37 110.658 179.711 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -58.92 -48.62 80.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.162 -0.472 . . . . 1.51 110.808 179.798 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 61.4 t -57.1 -55.15 22.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.205 -0.452 . . . . 0.27 111.37 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 85.3 mt -56.33 -32.59 64.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.998 -0.546 . . . . 0.41 111.385 -179.36 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.457 ' NE ' HG12 ' A' ' 86' ' ' VAL . 79.0 mtm180 -81.23 -20.07 41.81 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.458 -0.337 . . . . 2.1 111.272 -179.687 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.435 HD22 ' N ' ' A' ' 91' ' ' ASN . 0.9 OUTLIER -86.05 -16.85 36.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.33 -0.395 . . . . 1.14 111.077 -179.953 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.2 -86.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.267 -0.424 . . . . 0.55 111.424 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.461 ' N ' HH21 ' A' ' 20' ' ' ARG . . . 60.81 17.18 49.45 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.756 -0.735 . . . . 0.76 112.578 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.41 HD22 ' HA ' ' A' ' 94' ' ' ASN . 0.1 OUTLIER -147.38 175.56 2.66 Favored Pre-proline 0 CA--C 1.534 0.33 0 N-CA-C 110.377 -0.231 . . . . 2.52 110.377 -179.804 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.576 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 32.9 Cg_exo -61.47 99.38 0.17 Allowed 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 122.088 1.859 . . . . 0.64 111.604 178.247 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.6 m -116.43 155.77 17.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.265 -0.425 . . . . 0.64 111.837 -179.191 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.69 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 44.4 ttp180 -101.71 145.38 29.2 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.881 -0.6 . . . . 2.37 110.484 179.788 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.6 mt -121.54 104.77 9.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.173 -0.467 . . . . 0.37 111.358 -179.228 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 61.6 tp -91.81 108.1 19.68 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.777 0.322 . . . . 0.37 110.381 179.421 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.467 HD21 HG12 ' A' ' 63' ' ' ILE . 0.5 OUTLIER -138.21 168.43 19.76 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.24 -0.436 . . . . 0.31 111.579 -179.212 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.529 ' HB ' HD23 ' A' ' 13' ' ' LEU . 9.8 tt -119.95 141.1 41.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.862 -0.608 . . . . 0.45 111.048 179.873 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.416 ' HB3' ' HE1' ' A' ' 14' ' ' TYR . 27.2 tpt180 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.101 -0.5 . . . . 2.26 110.711 179.65 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.5 t . . . . . 0 C--O 1.236 0.348 0 CA-C-O 121.049 0.452 . . . . 0.9 111.263 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.539 HD23 ' HB ' ' A' ' 101' ' ' ILE . 23.8 mt -94.39 102.31 14.28 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.555 -0.748 . . . . 0.89 110.209 179.53 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.43 ' CE1' ' HB3' ' A' ' 102' ' ' ARG . 39.5 p90 -123.46 151.17 42.99 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.887 0.375 . . . . 2.73 110.992 -179.602 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 80.2 p -122.39 161.28 23.74 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.279 -0.419 . . . . 1.19 111.465 -179.472 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 12.4 t -131.22 149.88 33.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.86 -0.609 . . . . 0.56 110.682 179.857 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.419 ' H ' ' NH2' ' A' ' 62' ' ' ARG . 14.8 mm-40 -103.46 110.05 21.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.441 -0.345 . . . . 1.74 111.526 -179.47 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.404 HD22 ' O ' ' A' ' 17' ' ' GLU . 3.4 mm? -126.49 123.84 38.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.179 -0.464 . . . . 0.81 110.759 179.577 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.563 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 35.6 p90 -112.02 142.77 44.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.301 -0.409 . . . . 2.08 110.747 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.583 ' HE ' ' HA2' ' A' ' 93' ' ' GLY . 47.5 ttp180 -125.97 160.85 28.91 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.859 -0.336 . . . . 3.06 110.916 179.717 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -168.07 -33.06 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.139 -0.482 . . . . 2.58 111.077 -179.891 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -59.07 160.93 5.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.949 -0.568 . . . . 3.72 110.788 179.924 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -84.77 49.29 1.69 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.261 -0.427 . . . . 2.87 111.069 -179.874 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 82.1 p -99.1 -24.59 14.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 1.38 111.163 -179.977 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 36.4 t 56.41 18.04 3.25 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.797 -0.638 . . . . 2.45 111.259 179.803 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 53.8 m -140.74 148.1 40.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.874 0.368 . . . . 1.4 111.206 -179.882 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 61.5 mt -113.37 -23.58 9.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.991 -0.549 . . . . 0.45 110.833 179.905 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.519 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 110.5 -23.64 19.69 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.804 -0.713 . . . . 0.52 112.383 -179.791 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 76.5 mt -62.41 109.0 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.805 0.336 . . . . 0.84 110.798 179.841 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 48.3 t -111.3 100.02 8.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.147 -0.479 . . . . 0.95 110.853 -179.704 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.609 ' HA ' ' HA ' ' A' ' 48' ' ' VAL . 31.5 pt -85.19 172.75 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.825 -0.625 . . . . 0.41 111.269 -179.928 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 43.9 t -139.67 132.12 28.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.485 . . . . 1.32 110.838 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 C-N-CA 120.806 -0.711 . . . . 0.95 112.537 -179.905 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.407 HG12 HD12 ' A' ' 31' ' ' ILE . 5.1 tp . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.572 0.225 . . . . 0.65 110.962 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -163.31 139.49 6.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.749 0.309 . . . . 0.7 111.336 -179.884 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.609 ' HA ' ' HA ' ' A' ' 31' ' ' ILE . 90.5 t -71.24 105.85 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.258 -0.428 . . . . 0.39 110.761 179.483 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -66.89 -38.08 85.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.041 -0.527 . . . . 2.4 111.013 -179.923 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 35.9 t -168.1 175.61 6.52 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.96 0.41 . . . . 1.28 111.252 -179.907 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 76.5 mt -115.13 155.7 26.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.842 -0.617 . . . . 0.42 110.713 179.918 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.519 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 70.4 mt -98.93 108.51 49.53 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 1.26 111.388 -179.62 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.05 136.12 72.96 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.432 2.088 . . . . 0.82 112.304 -179.919 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 103.99 -17.01 49.66 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.732 -0.747 . . . . 0.49 112.645 179.92 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 95.6 p -88.54 -176.07 5.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.809 0.338 . . . . 1.23 111.118 -179.878 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.86 -54.84 13.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.42 111.258 -179.853 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.64 -36.48 62.11 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.133 -0.485 . . . . 0.35 111.522 -179.827 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.02 -46.38 62.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.44 111.316 -179.887 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 97.4 mt -66.16 -19.75 65.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.364 -0.38 . . . . 0.66 110.834 179.73 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -61.24 -56.14 23.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 1.86 110.826 179.981 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 97.3 -49.04 1.52 Allowed Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.805 -0.712 . . . . 1.06 112.977 179.47 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.419 ' NH2' ' H ' ' A' ' 17' ' ' GLU . 83.1 mtm180 -56.0 -36.25 67.71 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.727 0.299 . . . . 2.59 111.164 -179.583 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 62.5 mt -70.27 116.18 11.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.875 0.369 . . . . 0.92 110.713 179.776 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -102.97 131.87 21.74 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.056 -0.52 . . . . 1.98 110.786 -179.684 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -60.91 171.88 3.39 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.443 2.096 . . . . 1.44 112.03 179.897 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 57.5 52.85 8.0 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.303 -0.408 . . . . 2.15 110.548 -179.469 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -123.52 174.19 7.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.124 -0.489 . . . . 2.02 111.017 -179.594 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -115.01 127.0 55.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.199 -0.455 . . . . 1.02 110.969 -179.964 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 47.9 mm -89.43 139.99 16.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.258 -0.428 . . . . 0.29 111.014 -179.924 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 84.8 mt -110.83 -62.73 1.49 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.176 -0.465 . . . . 0.4 111.109 -179.786 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -150.94 136.65 18.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.031 0.443 . . . . 2.61 111.609 -179.402 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.651 HG12 ' H ' ' A' ' 73' ' ' ASP . 2.3 t -89.06 175.46 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.777 -0.647 . . . . 0.28 110.186 179.437 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.655 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 14.5 t70 -49.15 108.66 0.2 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.725 0.298 . . . . 0.79 111.493 179.558 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.7 t70 57.03 28.4 14.78 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.164 -0.471 . . . . 2.01 111.544 179.306 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.7 t -145.88 144.27 20.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.334 -0.394 . . . . 0.79 110.874 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -114.35 129.87 56.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.437 -0.347 . . . . 2.24 110.585 179.62 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.2 m -112.29 26.12 3.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-N 116.548 -0.296 . . . . 0.67 111.479 -179.441 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -94.25 31.64 1.67 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.92 0.39 . . . . 1.39 110.724 179.739 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 177.37 34.87 0.05 OUTLIER Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.715 -0.755 . . . . 0.55 112.704 -179.974 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 54.9 mtm -134.62 145.28 48.47 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.905 0.383 . . . . 0.52 110.758 179.8 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.406 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -62.61 150.55 40.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.063 -0.517 . . . . 0.39 111.028 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -46.05 -51.58 13.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.298 -0.41 . . . . 1.52 111.399 -179.638 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.1 m -50.49 -47.82 57.08 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.215 -0.448 . . . . 1.48 111.33 -179.676 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -59.4 -41.88 90.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.341 -0.39 . . . . 2.12 111.065 -179.866 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 81' ' ' ALA . 18.6 t -58.96 -38.5 73.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.275 -0.421 . . . . 0.32 110.947 179.909 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.4 t -66.95 -38.02 80.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.173 -0.467 . . . . 0.37 111.033 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -57.77 -46.1 85.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.305 -0.407 . . . . 1.51 110.674 179.734 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 54.8 t -59.27 -53.98 40.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.058 -0.519 . . . . 0.27 111.073 179.747 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 78.5 mt -55.97 -26.77 49.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.996 -0.547 . . . . 0.41 111.107 -179.612 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -89.41 -19.79 24.74 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.388 -0.369 . . . . 2.1 111.308 179.978 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -89.68 -9.19 50.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.739 0.305 . . . . 1.14 111.177 179.981 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.03 -87.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.439 . . . . 0.55 111.404 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.583 ' HA2' ' HE ' ' A' ' 20' ' ' ARG . . . 60.74 20.07 56.14 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.66 -0.781 . . . . 0.76 112.342 -179.838 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.607 ' HB3' ' HD2' ' A' ' 95' ' ' PRO . 5.9 m120 -147.17 172.63 4.97 Favored Pre-proline 0 C--N 1.33 -0.263 0 C-N-CA 122.106 0.162 . . . . 2.52 110.775 -179.53 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.607 ' HD2' ' HB3' ' A' ' 94' ' ' ASN . 23.1 Cg_endo -62.86 89.53 0.12 Allowed 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 122.035 1.823 . . . . 0.64 111.624 178.191 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.7 m -103.38 151.76 6.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.177 0.513 . . . . 0.64 111.923 -179.216 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.655 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 79.4 ttt180 -101.2 143.95 30.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.566 -0.743 . . . . 2.37 110.159 179.378 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.02 105.11 10.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.432 -0.349 . . . . 0.37 111.368 -179.525 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 51.4 tp -94.75 105.6 17.54 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.889 0.376 . . . . 0.37 110.309 179.215 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.32 168.18 19.06 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.051 -0.522 . . . . 0.31 111.41 -179.597 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.539 ' HB ' HD23 ' A' ' 13' ' ' LEU . 10.7 tt -122.63 142.1 40.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.916 -0.584 . . . . 0.45 111.019 -179.962 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.43 ' HB3' ' CE1' ' A' ' 14' ' ' TYR . 31.5 tpt180 . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 115.986 -0.552 . . . . 2.26 110.5 179.618 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 46.9 t . . . . . 0 C--O 1.235 0.297 0 CA-C-O 120.88 0.372 . . . . 0.9 111.238 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.53 HD23 ' HB ' ' A' ' 101' ' ' ILE . 45.7 mt -90.42 102.32 15.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.777 -0.647 . . . . 0.89 110.329 179.627 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -124.48 149.2 47.11 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.949 0.404 . . . . 2.73 111.229 -179.646 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.0 m -115.3 154.57 28.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.098 -0.501 . . . . 1.19 110.883 -179.792 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.4 t -124.12 157.42 31.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 0.56 110.529 179.827 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -116.18 107.69 15.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.864 0.364 . . . . 1.74 111.398 -179.672 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.455 HD11 ' HB2' ' A' ' 60' ' ' ASP . 4.3 mm? -116.98 144.76 44.21 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.079 -0.51 . . . . 0.81 110.546 179.696 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.696 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 21.8 p90 -118.66 117.87 30.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.936 0.398 . . . . 2.08 110.868 179.85 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.596 ' HG2' ' HA2' ' A' ' 93' ' ' GLY . 15.0 ttt180 -110.16 153.85 24.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.002 -0.545 . . . . 3.06 110.585 179.924 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -113.51 -70.26 0.81 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.097 0.475 . . . . 2.58 111.131 -179.862 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -136.22 -169.85 2.53 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.712 -0.676 . . . . 3.72 110.969 -179.812 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -55.51 -27.26 47.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.338 -0.392 . . . . 2.87 110.869 179.775 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.3 m -66.95 -36.99 83.47 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.16 -0.473 . . . . 1.38 110.744 179.875 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.9 m -81.85 61.41 5.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.122 -0.49 . . . . 2.45 110.931 179.869 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 51.0 m -57.88 138.34 55.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.479 . . . . 1.4 110.833 179.773 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.518 HD21 ' HB2' ' A' ' 20' ' ' ARG . 75.0 mt -78.8 -35.3 44.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.033 -0.531 . . . . 0.45 110.67 -179.845 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.428 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 93.75 -6.74 73.91 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.787 -0.72 . . . . 0.52 113.219 179.212 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 74.5 mt -60.07 108.67 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.747 0.308 . . . . 0.84 111.17 -179.851 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 39.6 t -112.31 97.91 6.95 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.21 -0.45 . . . . 0.95 110.662 179.729 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.491 ' HA ' ' HA ' ' A' ' 48' ' ' VAL . 38.6 pt -89.72 166.66 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.051 -0.522 . . . . 0.41 111.272 -179.838 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 54.7 m -143.71 138.94 29.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.095 -0.502 . . . . 1.32 110.953 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 C-N-CA 120.825 -0.702 . . . . 0.95 112.48 179.966 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 37.5 mm . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.707 0.289 . . . . 0.65 110.822 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -131.73 142.77 49.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.287 -0.415 . . . . 0.7 111.189 -179.726 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.491 ' HA ' ' HA ' ' A' ' 31' ' ' ILE . 46.8 t -81.54 116.64 26.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.116 -0.493 . . . . 0.39 111.004 179.847 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -84.79 -35.71 22.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.452 . . . . 2.4 111.22 -179.705 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 54.6 m -149.66 172.68 14.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.125 0.488 . . . . 1.28 111.63 -179.527 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.467 HD11 HG22 ' A' ' 63' ' ' ILE . 63.0 mt -131.73 141.45 49.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.723 -0.671 . . . . 0.42 110.538 179.835 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.428 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 43.2 mm -75.4 115.56 46.57 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.337 -0.392 . . . . 1.26 111.074 -179.89 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -58.07 126.26 21.07 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.387 2.058 . . . . 0.82 112.391 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 98.53 -13.66 62.57 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.799 -0.715 . . . . 0.49 112.785 179.659 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 92.8 p -72.02 -177.33 2.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.779 0.324 . . . . 1.23 110.914 -179.861 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.39 -55.29 12.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.42 111.178 179.976 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.82 -33.88 67.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.108 -0.497 . . . . 0.35 111.397 -179.804 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.78 -55.55 8.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.44 111.509 -179.649 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.0 mt -59.1 -20.23 51.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.66 111.187 -179.835 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.455 ' HB2' HD11 ' A' ' 18' ' ' LEU . 17.4 t70 -59.05 -52.54 65.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.36 -0.382 . . . . 1.86 110.642 -179.909 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.91 -31.7 7.36 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.707 -0.759 . . . . 1.06 113.126 179.387 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 82.2 mtm180 -83.85 0.84 45.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.686 0.279 . . . . 2.59 111.238 -179.571 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.467 HG22 HD11 ' A' ' 51' ' ' LEU . 53.6 mt -116.47 122.78 70.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.848 0.356 . . . . 0.92 110.979 179.592 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -129.41 158.1 74.25 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.125 -0.489 . . . . 1.98 110.809 179.971 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -57.08 176.97 0.2 Allowed 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.587 2.191 . . . . 1.44 112.308 179.674 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 56.38 50.08 13.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.013 -0.54 . . . . 2.15 110.637 -179.805 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.429 ' HA ' ' HG2' ' A' ' 102' ' ' ARG . 8.3 t70 -120.81 151.85 39.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.815 -0.629 . . . . 2.02 110.83 -179.934 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -109.62 109.06 19.7 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.857 0.36 . . . . 1.02 110.912 179.979 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 49.2 mm -71.03 142.41 15.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.143 -0.48 . . . . 0.29 110.982 179.896 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 73.3 mt -114.97 -71.77 0.73 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.097 -0.501 . . . . 0.4 110.98 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.423 ' O ' ' HB3' ' A' ' 99' ' ' LEU . 75.9 mtp180 -135.95 135.33 39.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 2.61 111.406 -179.611 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.564 HG12 ' H ' ' A' ' 73' ' ' ASP . 6.6 t -93.55 170.69 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.922 -0.581 . . . . 0.28 109.842 179.166 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.606 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 16.8 t70 -46.7 108.7 0.15 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.917 0.389 . . . . 0.79 111.841 179.928 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 53.41 14.52 0.57 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.817 -0.629 . . . . 2.01 112.479 179.013 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 65.2 t -144.72 99.67 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.76 0.314 . . . . 0.79 111.388 -179.887 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -68.07 155.58 39.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.386 -0.37 . . . . 2.24 110.355 179.462 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.46 HG11 HG13 ' A' ' 85' ' ' VAL . 17.4 m -133.44 39.84 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.846 0.355 . . . . 0.67 111.391 -179.814 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -109.8 35.84 3.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 1.39 111.048 179.795 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -179.6 26.64 0.05 OUTLIER Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.481 -0.866 . . . . 0.55 112.927 179.962 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 65.6 mtm -130.61 153.16 49.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.853 0.358 . . . . 0.52 110.918 179.75 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.432 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -62.18 151.98 34.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.011 -0.54 . . . . 0.39 111.333 -179.86 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -50.36 -55.75 14.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.238 -0.437 . . . . 1.52 111.249 -179.744 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.1 m -52.95 -41.03 64.12 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.07 -0.514 . . . . 1.48 111.171 -179.813 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -59.08 -43.56 91.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.288 -0.414 . . . . 2.12 110.89 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.46 HG13 HG11 ' A' ' 77' ' ' VAL . 22.8 t -60.16 -36.46 68.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.143 -0.48 . . . . 0.32 110.818 179.883 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.2 t -63.76 -40.89 90.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.036 -0.529 . . . . 0.37 111.015 179.92 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -59.1 -49.73 76.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.265 -0.425 . . . . 1.51 110.732 179.812 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 54.6 t -52.25 -53.83 17.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.95 -0.568 . . . . 0.27 111.333 179.876 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 71.3 mt -56.71 -33.83 66.86 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.103 -0.499 . . . . 0.41 111.329 -179.516 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 -82.2 -14.95 54.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.484 -0.325 . . . . 2.1 111.226 -179.793 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -92.14 -15.4 27.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.365 -0.38 . . . . 1.14 111.086 179.976 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.77 -83.51 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.287 -0.415 . . . . 0.55 111.454 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.596 ' HA2' ' HG2' ' A' ' 20' ' ' ARG . . . 62.49 21.76 62.85 Favored Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.638 -0.791 . . . . 0.76 112.431 -179.724 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.59 169.65 8.98 Favored Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 110.527 -0.175 . . . . 2.52 110.527 -179.823 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.696 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 48.8 Cg_exo -57.39 92.47 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.048 1.832 . . . . 0.64 111.427 178.349 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.9 m -103.72 148.83 8.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.133 0.492 . . . . 0.64 111.84 -179.051 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.606 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 71.6 ttt180 -99.7 144.11 29.15 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.618 -0.719 . . . . 2.37 110.002 179.726 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 13.6 mt -118.38 103.79 10.12 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.386 -0.37 . . . . 0.37 111.525 -179.146 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.423 ' HB3' ' O ' ' A' ' 71' ' ' ARG . 65.3 tp -90.98 109.35 20.58 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.857 -0.423 . . . . 0.37 109.857 179.062 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -143.25 168.34 20.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.247 0.546 . . . . 0.31 111.963 -179.115 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.53 ' HB ' HD23 ' A' ' 13' ' ' LEU . 13.0 tt -119.49 143.1 31.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.572 -0.74 . . . . 0.45 110.556 179.838 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.429 ' HG2' ' HA ' ' A' ' 67' ' ' ASP . 0.4 OUTLIER . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.34 -0.391 . . . . 2.26 110.751 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.188 0 N-CA-C 112.498 -0.241 . . . . 7.92 112.498 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.0 m -106.39 -12.5 15.64 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.732 0.301 . . . . 7.18 111.062 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 45.5 m80 -61.88 121.41 12.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 5.91 111.015 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -134.88 -60.14 0.07 OUTLIER Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.714 -0.755 . . . . 2.45 112.619 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 56.07 46.53 21.5 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.835 0.35 . . . . 2.33 111.021 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 58.0 m -73.61 102.01 3.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 2.59 110.845 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 58.14 86.42 0.08 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.246 -0.434 . . . . 2.67 110.992 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -145.25 102.42 3.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.143 -0.48 . . . . 1.58 111.103 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 69.0 m 58.29 20.83 7.59 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.049 -0.523 . . . . 2.55 111.119 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.58 40.24 8.44 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.785 -0.721 . . . . 1.82 112.751 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -143.6 119.38 10.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.844 0.355 . . . . 1.7 110.742 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.0 t -143.38 144.36 32.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.9 110.908 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 85.0 mt -80.26 127.77 32.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.873 -0.603 . . . . 0.89 110.757 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -124.56 137.82 54.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.169 -0.468 . . . . 2.73 110.882 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 80.8 p -132.58 132.19 42.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.305 -0.407 . . . . 1.19 111.096 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.9 t -118.26 157.55 19.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 0.56 110.704 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -109.72 110.01 20.89 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.816 0.341 . . . . 1.74 111.282 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.478 HD11 ' HB2' ' A' ' 60' ' ' ASP . 4.6 mm? -118.6 166.48 12.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.154 -0.475 . . . . 0.81 110.318 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.608 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 35.0 p90 -144.14 132.33 21.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.906 0.384 . . . . 2.08 111.638 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.536 ' HE ' ' HG ' ' A' ' 27' ' ' LEU . 15.7 tpp85 -97.22 94.75 7.28 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.04 -0.527 . . . . 3.06 110.21 179.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -130.25 9.93 5.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.383 -0.371 . . . . 2.58 111.168 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -110.29 151.22 27.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.435 . . . . 3.72 110.836 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -80.68 17.16 1.19 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.068 -0.515 . . . . 2.87 110.998 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 63.0 p -69.0 -10.99 60.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 1.38 111.157 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.2 m 59.13 20.17 8.13 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.999 -0.546 . . . . 2.45 111.194 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 90.0 p -164.26 158.55 19.01 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.956 0.408 . . . . 1.4 111.077 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.536 ' HG ' ' HE ' ' A' ' 20' ' ' ARG . 87.4 mt -102.6 -12.09 17.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.064 -0.517 . . . . 0.45 110.614 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.531 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 100.15 24.86 9.31 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.831 -0.7 . . . . 0.52 112.373 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 75.6 mt -102.56 115.73 45.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.822 0.344 . . . . 0.84 110.927 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.7 t -110.67 102.44 11.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.95 110.666 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 25.3 pt -99.43 160.53 3.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.41 111.447 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 48.1 t -150.85 145.68 25.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.918 -0.583 . . . . 1.32 110.726 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -86.1 149.13 22.79 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.72 -0.752 . . . . 0.95 112.609 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 56.7 ttm -92.89 151.41 19.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.791 0.329 . . . . 2.04 110.864 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.435 ' HD2' ' N ' ' A' ' 35' ' ' ARG . 7.7 mpt_? -106.19 94.82 5.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 5.46 110.932 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -100.45 132.04 46.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 4.29 110.682 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -121.12 11.28 10.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.237 -0.438 . . . . 5.25 111.138 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 75.3 m -155.44 143.13 19.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.233 -0.44 . . . . 4.88 111.012 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 50.5 p -85.91 134.31 33.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 5.27 111.13 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.3 t -154.84 23.42 0.45 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.129 -0.487 . . . . 6.91 110.972 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 110.71 -48.33 0.95 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.956 -0.64 . . . . 5.36 112.471 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -108.55 151.59 25.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.779 0.323 . . . . 7.22 110.881 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -163.78 133.78 4.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.253 -0.43 . . . . 3.05 111.006 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 63.6 p 51.39 -169.66 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.88 -0.6 . . . . 2.53 111.479 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 128.24 144.69 5.9 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.823 -0.703 . . . . 1.14 112.456 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 41.8 mm -87.33 123.9 40.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.667 0.27 . . . . 0.65 111.094 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 52.9 p90 -147.34 147.0 29.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.978 0.418 . . . . 0.7 111.086 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.1 t -84.27 136.64 22.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.969 -0.559 . . . . 0.39 111.223 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -125.96 -25.96 3.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.029 -0.532 . . . . 2.4 110.87 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 43.1 t -135.85 170.41 16.02 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.234 -0.439 . . . . 1.28 110.89 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 69.5 mt -141.66 160.28 40.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.211 -0.45 . . . . 0.42 110.963 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.531 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 51.0 mt -107.08 102.01 40.96 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.242 -0.435 . . . . 1.26 110.918 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.67 136.25 64.38 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.409 2.073 . . . . 0.82 112.31 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 99.91 -12.32 60.79 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.791 -0.718 . . . . 0.49 112.691 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 56.3 m -88.19 179.11 6.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.706 0.289 . . . . 1.23 111.023 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.406 ' HB1' HD12 ' A' ' 18' ' ' LEU . . . -63.48 -54.41 36.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.319 -0.401 . . . . 0.42 111.455 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.411 ' HB1' HG21 ' A' ' 63' ' ' ILE . . . -54.16 -48.02 71.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 0.35 111.744 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.53 -56.76 13.47 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.428 -0.351 . . . . 0.44 111.656 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 81.5 mt -59.86 -20.43 57.05 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.26 -0.427 . . . . 0.66 111.527 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.478 ' HB2' HD11 ' A' ' 18' ' ' LEU . 18.2 t70 -58.96 -48.37 81.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.875 0.369 . . . . 1.86 110.957 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.46 -48.49 1.11 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.782 -0.723 . . . . 1.06 112.689 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -65.24 -23.7 67.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.71 0.29 . . . . 2.59 110.921 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.411 HG21 ' HB1' ' A' ' 57' ' ' ALA . 39.8 mm -76.68 98.72 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.267 -0.424 . . . . 0.92 110.792 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -107.92 156.3 38.44 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 1.98 110.632 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.96 172.79 5.57 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.448 2.099 . . . . 1.44 112.271 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 57.88 74.54 0.42 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.187 -0.461 . . . . 2.15 111.243 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -149.6 151.33 33.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 2.02 110.433 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -109.88 114.67 28.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.816 0.341 . . . . 1.02 111.244 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 43.7 mm -70.31 140.03 19.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.069 -0.514 . . . . 0.29 110.597 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 90.5 mt -116.89 -65.1 1.22 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.298 -0.41 . . . . 0.4 111.274 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -141.2 134.91 30.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.955 0.407 . . . . 2.61 111.625 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.662 HG12 ' H ' ' A' ' 73' ' ' ASP . 6.6 t -90.4 175.09 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.861 -0.608 . . . . 0.28 109.596 178.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.668 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 18.6 t70 -47.55 108.97 0.18 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.693 0.283 . . . . 0.79 111.696 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 54.24 26.26 6.61 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.244 -0.434 . . . . 2.01 111.768 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 73' ' ' ASP . 58.2 t -143.02 152.04 17.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.296 -0.411 . . . . 0.79 110.696 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.507 ' ND2' ' H ' ' A' ' 78' ' ' GLN . 5.7 t30 -121.06 130.98 54.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.368 -0.378 . . . . 2.24 110.718 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.7 m -110.2 17.39 7.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.379 -0.373 . . . . 0.67 111.444 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.507 ' H ' ' ND2' ' A' ' 76' ' ' ASN . 14.5 mm100 -85.84 28.92 0.75 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.264 -0.426 . . . . 1.39 111.07 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -178.4 19.04 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.56 -0.829 . . . . 0.55 112.95 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 43.8 mtm -118.4 146.07 44.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.799 0.333 . . . . 0.52 110.711 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.437 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -62.11 155.79 23.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.1 -0.5 . . . . 0.39 111.068 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -51.73 -57.76 8.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.425 -0.352 . . . . 1.52 111.178 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.9 t -54.56 -37.88 65.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 1.48 111.306 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -60.94 -45.51 94.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.322 -0.399 . . . . 2.12 110.781 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 81' ' ' ALA . 45.6 t -60.09 -34.14 55.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.159 -0.473 . . . . 0.32 110.769 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.566 HG12 ' HE ' ' A' ' 90' ' ' ARG . 56.7 t -64.25 -43.93 97.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.111 -0.495 . . . . 0.37 110.533 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -58.1 -41.77 84.22 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.163 -0.471 . . . . 1.51 110.647 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 49.5 t -56.86 -52.52 54.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.954 -0.566 . . . . 0.27 111.049 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 71.2 mt -54.41 -36.07 63.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.026 -0.534 . . . . 0.41 110.923 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.566 ' HE ' HG12 ' A' ' 86' ' ' VAL . 74.7 mtt180 -75.14 -30.12 60.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 2.1 110.872 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -74.68 -18.01 60.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.123 -0.489 . . . . 1.14 111.019 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.21 -83.0 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.072 -0.513 . . . . 0.55 111.415 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.41 ' H ' ' HG2' ' A' ' 20' ' ' ARG . . . 65.64 11.76 54.53 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.477 -0.868 . . . . 0.76 112.315 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -146.7 166.33 16.87 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 110.557 -0.164 . . . . 2.52 110.557 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.608 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 46.2 Cg_exo -57.07 105.1 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.278 1.985 . . . . 0.64 111.366 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.7 m -107.29 154.46 8.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.224 0.535 . . . . 0.64 111.994 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.668 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 79.6 ttt180 -103.53 143.07 33.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.549 -0.75 . . . . 2.37 109.932 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 20.5 mt -114.83 131.01 56.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.249 -0.432 . . . . 0.37 110.972 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 62.2 tp -120.62 99.8 6.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 0.37 110.234 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.46 153.31 48.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.053 -0.522 . . . . 0.31 111.322 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.9 tt -100.91 138.68 24.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.069 -0.514 . . . . 0.45 110.708 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 24.8 tpt180 -130.26 133.42 46.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.437 . . . . 2.26 110.885 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 75.6 mtp180 -83.42 132.34 34.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.019 -0.537 . . . . 3.93 110.969 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 59.7 mt -99.68 148.48 34.81 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.022 -0.536 . . . . 2.0 110.624 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -80.71 163.01 21.33 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.576 2.184 . . . . 2.98 112.456 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 78.2 mt -130.57 93.55 3.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.863 -0.608 . . . . 3.67 110.669 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 72.2 mt -93.01 124.54 37.05 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.108 -0.496 . . . . 5.59 111.261 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.139 -0.934 . . . . 6.0 111.061 -179.987 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.204 0 N-CA-C 112.514 -0.234 . . . . 7.92 112.514 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.6 p -103.86 -65.81 0.99 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.824 0.345 . . . . 7.18 110.936 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -60.14 130.86 48.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 5.91 110.955 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 134.17 133.72 3.35 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.874 -0.679 . . . . 2.45 112.374 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -104.69 164.51 11.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.942 0.401 . . . . 2.33 111.144 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.1 m -134.98 83.22 2.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.911 -0.586 . . . . 2.59 110.483 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.9 t70 57.72 76.49 0.32 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.976 -0.556 . . . . 2.67 110.73 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -113.06 104.38 12.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.073 -0.512 . . . . 1.58 111.297 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.8 t 57.96 22.18 8.51 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.057 -0.52 . . . . 2.55 111.186 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.48 32.31 10.49 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.706 -0.759 . . . . 1.82 112.685 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -138.85 136.67 35.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.848 0.356 . . . . 1.7 110.762 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 46.9 t -153.77 140.38 18.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.088 -0.506 . . . . 0.9 110.818 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 89.6 mt -79.52 121.58 25.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.013 -0.54 . . . . 0.89 110.851 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.444 ' OH ' HD21 ' A' ' 104' ' ' LEU . 43.1 m-85 -113.86 151.44 32.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.123 -0.49 . . . . 2.73 110.961 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 48.5 t -150.47 135.85 17.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.245 -0.434 . . . . 1.19 111.073 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.416 HG11 ' HB2' ' A' ' 62' ' ' ARG . 21.7 t -130.29 147.17 33.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.041 -0.527 . . . . 0.56 110.806 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -99.13 118.38 35.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.917 0.389 . . . . 1.74 111.076 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.53 HD11 ' HB2' ' A' ' 60' ' ' ASP . 4.2 mm? -116.97 166.91 11.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.937 -0.574 . . . . 0.81 110.788 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.595 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 30.4 p90 -160.49 130.5 5.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.247 -0.433 . . . . 2.08 111.151 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.652 ' HE ' ' HA2' ' A' ' 93' ' ' GLY . 57.2 ttp180 -112.68 97.43 6.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.399 -0.364 . . . . 3.06 110.919 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -95.65 -20.52 18.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.121 -0.491 . . . . 2.58 110.702 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -83.75 160.51 21.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.071 -0.513 . . . . 3.72 110.953 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -95.23 40.4 1.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.035 -0.53 . . . . 2.87 110.902 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 82.1 p -71.93 -13.96 61.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 1.38 111.127 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.2 m 57.76 19.1 5.32 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.921 -0.582 . . . . 2.45 111.256 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.8 m -154.9 154.93 33.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.435 -0.348 . . . . 1.4 111.005 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.468 HD21 ' HB2' ' A' ' 20' ' ' ARG . 52.0 mt -114.02 -24.43 9.04 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.097 -0.501 . . . . 0.45 111.141 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.18 -19.98 49.25 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.692 -0.766 . . . . 0.52 112.857 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 66.2 mt -61.64 110.27 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.676 0.274 . . . . 0.84 110.979 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.6 t -112.25 106.64 15.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.445 . . . . 0.95 110.964 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.557 ' HA ' ' HA ' ' A' ' 48' ' ' VAL . 46.3 pt -86.81 -177.88 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.015 -0.539 . . . . 0.41 111.144 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.2 t -156.14 146.24 21.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.358 -0.383 . . . . 1.32 111.137 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -81.53 132.13 10.94 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.836 -0.697 . . . . 0.95 112.191 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 27.2 ttt -58.12 150.72 20.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.774 0.321 . . . . 2.04 111.084 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -151.79 157.27 41.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.231 -0.441 . . . . 5.46 111.167 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -158.07 161.87 38.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.013 -0.539 . . . . 4.29 110.59 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -93.72 24.89 3.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.392 -0.367 . . . . 5.25 111.442 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 93.1 p -165.72 102.44 0.69 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.916 0.389 . . . . 4.88 111.051 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 69.6 p -106.41 135.64 47.55 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.001 -0.545 . . . . 5.27 111.095 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.7 t -159.24 19.41 0.18 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.146 -0.479 . . . . 6.91 110.991 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.417 ' H ' ' H ' ' A' ' 42' ' ' GLU . . . -170.69 -6.47 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.849 -0.691 . . . . 5.36 112.448 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.417 ' H ' ' H ' ' A' ' 41' ' ' GLY . 44.8 mt-10 57.17 90.38 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.878 0.37 . . . . 7.22 111.156 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -130.29 91.77 3.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.121 -0.491 . . . . 3.05 111.015 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 81.0 p -119.73 155.29 32.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 2.53 111.015 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -146.8 173.08 27.13 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.635 -0.793 . . . . 1.14 112.792 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.1 mm -100.2 129.55 50.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.68 0.276 . . . . 0.65 110.929 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -157.53 142.38 16.7 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.278 -0.419 . . . . 0.7 111.022 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.557 ' HA ' ' HA ' ' A' ' 31' ' ' ILE . 99.3 t -77.96 127.21 38.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.151 -0.477 . . . . 0.39 110.804 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -114.63 -23.22 9.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.031 -0.531 . . . . 2.4 111.139 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 78.1 p -146.09 161.76 39.45 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.134 0.492 . . . . 1.28 111.645 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 91.6 mt -133.55 154.35 50.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.662 -0.699 . . . . 0.42 110.572 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 49.0 mm -97.24 113.89 63.9 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.346 -0.388 . . . . 1.26 110.846 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -61.58 136.2 61.5 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.414 2.076 . . . . 0.82 112.122 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 97.9 -23.29 36.68 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.864 -0.684 . . . . 0.49 112.307 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.404 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 67.1 m -73.14 170.86 14.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.619 0.247 . . . . 1.23 111.079 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.64 -55.64 30.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.427 -0.351 . . . . 0.42 111.463 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.61 -39.33 57.8 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.203 -0.453 . . . . 0.35 111.333 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.69 -46.99 67.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 0.44 111.425 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 55' ' ' SER . 94.8 mt -63.15 -19.68 64.7 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.222 -0.444 . . . . 0.66 111.184 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.53 ' HB2' HD11 ' A' ' 18' ' ' LEU . 18.4 t70 -62.5 -50.81 69.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.294 -0.412 . . . . 1.86 110.808 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.49 -48.4 1.69 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.761 -0.733 . . . . 1.06 113.151 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.416 ' HB2' HG11 ' A' ' 16' ' ' VAL . 21.7 mmm180 -59.93 -29.25 68.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.638 0.256 . . . . 2.59 111.204 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 66.1 mt -77.19 111.73 14.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.896 0.379 . . . . 0.92 111.254 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -95.69 140.13 22.2 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.994 -0.548 . . . . 1.98 110.293 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -74.1 44.84 1.06 Allowed 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.495 2.13 . . . . 1.44 112.963 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -167.75 69.5 0.09 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.285 -0.416 . . . . 2.15 110.409 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -146.17 170.85 15.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.486 . . . . 2.02 110.835 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -115.0 104.47 11.94 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.288 -0.414 . . . . 1.02 110.986 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.5 HD13 ' HB3' ' A' ' 100' ' ' LEU . 49.5 mm -58.48 145.49 9.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.159 -0.473 . . . . 0.29 111.054 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.478 ' HA ' ' NE2' ' A' ' 78' ' ' GLN . 92.7 mt -124.35 -67.11 0.94 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.236 -0.438 . . . . 0.4 111.453 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 27.2 mtm180 -132.34 134.92 45.78 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.027 0.442 . . . . 2.61 111.695 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.607 HG12 ' H ' ' A' ' 73' ' ' ASP . 3.8 t -97.97 172.88 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.761 -0.654 . . . . 0.28 110.02 179.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.607 ' H ' HG12 ' A' ' 72' ' ' VAL . 28.1 t70 -51.07 108.81 0.27 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.784 0.326 . . . . 0.79 111.44 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 59.39 14.21 3.63 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.045 -0.525 . . . . 2.01 111.844 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.488 ' HB ' ' HB ' ' A' ' 72' ' ' VAL . 40.9 t -135.56 157.36 39.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.532 -0.304 . . . . 0.79 110.849 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.451 ' N ' HG12 ' A' ' 75' ' ' VAL . 3.2 p-10 -129.07 128.61 43.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.396 -0.366 . . . . 2.24 110.575 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.0 m -105.29 24.65 2.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.805 0.336 . . . . 0.67 111.399 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.478 ' NE2' ' HA ' ' A' ' 70' ' ' LEU . 29.1 mm-40 -90.72 33.6 0.92 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.277 -0.419 . . . . 1.39 110.763 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 170.15 23.55 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.77 -0.728 . . . . 0.55 112.815 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.433 ' HB2' ' HE2' ' A' ' 80' ' ' MET . 43.3 mtm -119.12 140.74 49.61 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.788 0.327 . . . . 0.52 110.668 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.419 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -58.77 156.62 10.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.165 -0.471 . . . . 0.39 111.484 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -50.49 -57.81 7.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 1.52 111.272 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 79.3 p -53.67 -38.85 64.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.022 -0.535 . . . . 1.48 111.369 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -61.18 -44.54 97.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.272 -0.422 . . . . 2.12 111.024 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 81' ' ' ALA . 47.4 t -59.42 -40.99 83.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.32 111.038 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.4 t -62.14 -39.14 82.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.199 -0.455 . . . . 0.37 110.926 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -59.91 -44.79 94.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 1.51 110.778 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 53.3 t -56.92 -54.16 33.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.173 -0.467 . . . . 0.27 111.124 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 92.9 mt -55.69 -34.29 64.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.887 -0.597 . . . . 0.41 111.364 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 79.3 mtm180 -80.46 -17.1 52.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.299 -0.41 . . . . 2.1 111.341 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.428 HD22 ' N ' ' A' ' 91' ' ' ASN . 0.9 OUTLIER -89.84 -15.47 32.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.42 -0.354 . . . . 1.14 111.142 179.858 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.62 -86.64 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.299 -0.41 . . . . 0.55 111.512 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.652 ' HA2' ' HE ' ' A' ' 20' ' ' ARG . . . 64.19 15.49 58.77 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.688 -0.768 . . . . 0.76 112.279 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.489 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -146.92 174.07 3.69 Favored Pre-proline 0 C--N 1.327 -0.37 0 N-CA-C 110.408 -0.219 . . . . 2.52 110.408 -179.727 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.595 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 46.2 Cg_exo -58.24 107.23 0.31 Allowed 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 121.897 1.731 . . . . 0.64 111.477 178.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.3 m -116.6 141.54 34.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.164 0.506 . . . . 0.64 112.173 -178.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.584 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 75.4 ttt180 -94.61 145.07 25.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.692 -0.685 . . . . 2.37 109.707 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 13.5 mt -121.75 136.12 54.94 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.845 0.355 . . . . 0.37 111.366 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 38.5 tp -123.88 104.1 8.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.004 -0.544 . . . . 0.37 110.495 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.5 ' HB3' HD13 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -128.87 147.03 50.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.276 -0.42 . . . . 0.31 111.118 -179.59 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.439 ' HB ' HD11 ' A' ' 70' ' ' LEU . 16.1 tt -98.52 143.84 12.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 0.45 111.029 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 13.7 mmm180 -132.56 139.02 47.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.995 -0.548 . . . . 2.26 111.013 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -90.18 131.41 36.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.134 -0.484 . . . . 3.93 110.931 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.444 HD21 ' OH ' ' A' ' 14' ' ' TYR . 62.2 mt -98.49 134.37 21.87 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.25 -0.432 . . . . 2.0 110.938 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -81.89 162.4 18.47 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.473 2.115 . . . . 2.98 112.285 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 96.7 mt -128.19 98.78 5.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.484 . . . . 3.67 110.921 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 90.2 mt -73.48 114.22 11.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.122 -0.49 . . . . 5.59 111.043 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.257 -0.878 . . . . 6.0 110.892 -179.968 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.167 0 N-CA-C 112.576 -0.209 . . . . 7.92 112.576 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.7 m -147.54 -53.35 0.21 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.732 0.301 . . . . 7.18 110.89 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 69.1 t60 -83.5 130.83 35.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 5.91 110.88 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 173.07 -150.03 11.89 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.81 -0.709 . . . . 2.45 112.359 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 56.55 48.66 16.2 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.707 0.289 . . . . 2.33 111.112 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.2 m -82.65 113.13 20.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.431 -0.35 . . . . 2.59 110.818 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 57.0 82.87 0.11 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.174 -0.466 . . . . 2.67 110.656 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -129.14 90.95 3.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.247 -0.433 . . . . 1.58 111.61 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 52.2 m 55.76 27.78 11.29 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.035 -0.53 . . . . 2.55 111.512 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.06 35.4 6.73 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.684 -0.769 . . . . 1.82 112.682 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -139.24 119.72 13.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.848 0.356 . . . . 1.7 110.703 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.5 t -139.38 145.69 39.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.096 -0.502 . . . . 0.9 111.021 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 62.5 mt -81.93 122.18 27.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.919 -0.582 . . . . 0.89 110.494 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -113.35 150.73 32.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 2.73 110.964 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 80.3 p -151.05 138.42 19.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 1.19 111.264 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.9 t -129.67 145.64 35.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.072 -0.513 . . . . 0.56 110.823 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -95.14 114.18 25.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.997 0.427 . . . . 1.74 111.376 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -117.26 166.66 12.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.861 -0.609 . . . . 0.81 110.591 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.508 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 30.4 p90 -157.94 134.39 9.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.81 0.338 . . . . 2.08 111.073 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.766 ' HE ' ' H ' ' A' ' 93' ' ' GLY . 12.2 ttp180 -121.75 160.27 24.92 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.344 -0.389 . . . . 3.06 110.847 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -165.87 -32.83 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.113 -0.494 . . . . 2.58 110.845 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -67.76 162.43 23.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.906 -0.588 . . . . 3.72 110.939 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -86.26 22.9 1.67 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.12 -0.491 . . . . 2.87 110.715 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 74.6 p -63.47 -23.11 67.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.119 -0.491 . . . . 1.38 111.095 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.474 ' HA ' ' NH1' ' A' ' 20' ' ' ARG . 52.5 m 56.73 26.19 11.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.822 -0.626 . . . . 2.45 111.299 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.7 m -152.24 153.68 34.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.916 0.388 . . . . 1.4 111.12 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.541 HD21 ' HB2' ' A' ' 20' ' ' ARG . 81.0 mt -119.77 -5.66 10.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.016 -0.538 . . . . 0.45 110.879 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.464 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 89.02 16.78 57.35 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.724 -0.751 . . . . 0.52 112.363 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.428 HG22 HG23 ' A' ' 31' ' ' ILE . 69.9 mt -97.19 115.65 37.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.7 0.286 . . . . 0.84 110.994 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.1 t -110.66 90.32 3.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.358 -0.383 . . . . 0.95 110.734 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.428 HG23 HG22 ' A' ' 29' ' ' ILE . 41.9 pt -87.18 167.52 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.034 -0.53 . . . . 0.41 111.197 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 47.5 t -150.6 134.42 16.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.088 -0.505 . . . . 1.32 110.792 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.92 132.02 43.18 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.843 -0.694 . . . . 0.95 112.556 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 15.9 tpt -65.1 129.42 39.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.872 0.367 . . . . 2.04 110.751 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -62.36 162.88 9.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.003 -0.544 . . . . 5.46 111.06 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -87.8 124.49 33.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.055 -0.52 . . . . 4.29 111.125 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -109.58 169.58 8.61 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.161 -0.472 . . . . 5.25 110.826 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.8 m -91.31 27.45 1.93 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.122 -0.49 . . . . 4.88 111.063 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 60.8 p -114.25 135.37 54.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 5.27 111.079 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 80.4 p -85.97 -0.57 55.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.169 -0.468 . . . . 6.91 111.241 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.42 -52.97 5.31 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.803 -0.713 . . . . 5.36 112.445 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -117.45 144.93 44.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.699 0.285 . . . . 7.22 110.574 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -146.88 122.16 10.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.441 -0.345 . . . . 3.05 111.483 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 44.1 p 51.55 -172.08 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.798 -0.637 . . . . 2.53 111.739 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 141.76 146.62 4.72 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.705 -0.76 . . . . 1.14 112.681 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.8 mp -100.64 122.31 52.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.735 0.302 . . . . 0.65 110.823 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -145.33 153.07 40.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.162 -0.472 . . . . 0.7 110.94 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 95.2 t -83.89 125.79 40.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.247 -0.433 . . . . 0.39 111.195 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -108.54 -27.34 9.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.95 -0.568 . . . . 2.4 111.001 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 59.2 m -147.71 172.1 14.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.045 0.45 . . . . 1.28 111.633 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 97.1 mt -132.14 165.72 23.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.669 -0.696 . . . . 0.42 110.741 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.464 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 43.0 mm -106.36 104.48 50.5 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.186 -0.461 . . . . 1.26 110.958 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.61 129.77 36.68 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.424 2.082 . . . . 0.82 112.407 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 98.01 0.44 58.7 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.768 -0.729 . . . . 0.49 112.76 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.424 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 27.9 t -100.41 170.88 8.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.637 0.256 . . . . 1.23 110.999 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -51.81 -58.54 6.12 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.226 -0.443 . . . . 0.42 111.659 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.3 -32.36 64.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.248 -0.433 . . . . 0.35 111.514 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.91 -24.47 55.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.349 -0.387 . . . . 0.44 111.344 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 55' ' ' SER . 90.8 mt -74.7 -37.65 62.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.277 -0.42 . . . . 0.66 111.033 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -57.18 -46.83 82.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.401 -0.363 . . . . 1.86 110.913 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.46 -34.93 2.65 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.905 -0.664 . . . . 1.06 112.709 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 78.0 mtm180 -65.11 -18.46 65.32 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.712 0.292 . . . . 2.59 111.096 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 67.8 mt -87.23 108.94 18.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.888 0.375 . . . . 0.92 110.919 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -82.67 138.25 44.05 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.011 -0.54 . . . . 1.98 110.5 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.54 53.41 3.98 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.45 2.1 . . . . 1.44 112.524 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -174.59 72.09 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.125 -0.489 . . . . 2.15 110.531 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -145.23 170.38 16.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.147 -0.479 . . . . 2.02 110.847 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -110.68 107.49 17.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.316 -0.402 . . . . 1.02 111.028 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 43.7 mm -63.0 142.69 16.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.146 -0.479 . . . . 0.29 110.732 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 94.4 mt -121.56 -59.22 1.71 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.286 -0.416 . . . . 0.4 111.281 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.467 ' HG2' HD22 ' A' ' 76' ' ' ASN . 77.3 mtp180 -142.02 140.92 32.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.025 0.44 . . . . 2.61 111.583 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.624 HG12 ' H ' ' A' ' 73' ' ' ASP . 3.9 t -103.41 173.99 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.86 -0.609 . . . . 0.28 109.646 178.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.644 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 15.3 t70 -47.28 108.62 0.16 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.736 0.303 . . . . 0.79 111.455 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 54.98 31.0 15.14 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.224 -0.444 . . . . 2.01 111.576 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.435 ' HB ' ' HB ' ' A' ' 72' ' ' VAL . 92.7 t -145.51 148.14 17.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.354 -0.385 . . . . 0.79 110.904 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.467 HD22 ' HG2' ' A' ' 71' ' ' ARG . 22.1 t-20 -120.2 118.33 30.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.148 -0.478 . . . . 2.24 110.552 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.8 m -102.21 25.24 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.871 0.367 . . . . 0.67 111.455 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -92.28 42.4 1.1 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.166 -0.47 . . . . 1.39 110.841 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 158.15 36.79 0.02 OUTLIER Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.661 -0.781 . . . . 0.55 112.901 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 57.6 mtm -131.36 146.88 52.47 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.826 0.345 . . . . 0.52 110.768 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.27 142.49 31.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.067 -0.515 . . . . 0.39 111.029 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -48.07 -54.3 13.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.804 0.335 . . . . 1.52 111.03 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 56.8 m -54.15 -42.93 70.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.987 -0.551 . . . . 1.48 110.98 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -58.1 -43.54 87.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 2.12 110.983 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 52.5 t -58.19 -41.63 81.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 0.32 110.702 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.3 t -61.61 -37.57 78.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.108 -0.496 . . . . 0.37 110.758 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.483 ' HG2' HH21 ' A' ' 90' ' ' ARG . 42.4 mt-10 -58.92 -48.46 81.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.193 -0.458 . . . . 1.51 110.595 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 55.5 t -54.17 -54.1 23.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.133 -0.485 . . . . 0.27 111.193 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.408 HD13 HD12 ' A' ' 29' ' ' ILE . 93.0 mt -59.26 -29.88 67.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.886 -0.597 . . . . 0.41 111.456 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.483 HH21 ' HG2' ' A' ' 87' ' ' GLU . 87.3 mtm180 -85.9 -11.46 53.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.414 -0.357 . . . . 2.1 111.154 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -100.02 -11.3 20.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.39 -0.368 . . . . 1.14 111.178 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.33 -85.03 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.343 -0.39 . . . . 0.55 111.571 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.766 ' H ' ' HE ' ' A' ' 20' ' ' ARG . . . 66.61 17.39 66.78 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.637 -0.792 . . . . 0.76 112.318 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.407 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 1.9 p-10 -146.9 169.62 9.13 Favored Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 110.295 -0.261 . . . . 2.52 110.295 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.508 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 34.6 Cg_exo -58.91 104.1 0.18 Allowed 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.025 1.817 . . . . 0.64 111.423 178.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 18.2 m -112.07 152.43 13.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.128 0.49 . . . . 0.64 112.209 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.644 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 79.5 ttt180 -104.01 145.01 30.78 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.606 -0.724 . . . . 2.37 109.825 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 17.9 mt -115.1 114.33 25.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.197 -0.456 . . . . 0.37 111.137 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 45.0 tp -105.63 102.21 11.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.407 -0.36 . . . . 0.37 110.448 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.4 162.0 31.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.31 111.388 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.2 tt -110.34 139.25 34.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.95 -0.568 . . . . 0.45 110.934 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 18.8 tpt180 -133.99 139.1 45.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.085 -0.507 . . . . 2.26 110.924 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -85.26 125.2 32.7 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.136 -0.483 . . . . 3.93 110.964 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 68.9 mt -64.37 150.4 93.14 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.068 -0.515 . . . . 2.0 110.991 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -81.55 61.84 8.13 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.799 2.333 . . . . 2.98 112.61 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 93.0 mt -85.14 119.04 25.08 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.769 -0.65 . . . . 3.67 110.842 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -87.48 165.54 15.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.202 -0.454 . . . . 5.59 110.871 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.199 -0.905 . . . . 6.0 110.866 179.926 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 112.594 -0.203 . . . . 7.92 112.594 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.8 m -88.28 145.93 25.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.844 0.354 . . . . 7.18 111.142 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -148.89 -24.91 0.31 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.034 -0.53 . . . . 5.91 110.564 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -164.02 -104.95 0.19 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.837 -0.697 . . . . 2.45 112.475 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -92.9 127.32 38.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.801 0.334 . . . . 2.33 111.071 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 72.6 p -112.38 95.07 5.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.458 . . . . 2.59 110.785 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 20.3 t70 54.29 78.74 0.15 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.025 -0.534 . . . . 2.67 110.894 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -123.18 107.55 11.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 1.58 111.246 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 64.3 m 55.57 25.87 8.47 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.094 -0.503 . . . . 2.55 111.199 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.65 42.76 9.7 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.753 -0.737 . . . . 1.82 112.654 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -143.52 112.88 6.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.944 0.402 . . . . 1.7 110.685 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 48.0 t -126.19 140.62 52.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.964 -0.562 . . . . 0.9 110.787 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 70.9 mt -81.36 122.03 26.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.98 -0.555 . . . . 0.89 110.313 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -113.56 143.33 44.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.298 -0.41 . . . . 2.73 111.055 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 77.7 p -142.31 127.0 18.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.447 . . . . 1.19 111.09 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 19.5 t -118.36 143.86 28.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.078 -0.51 . . . . 0.56 110.699 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -96.74 114.55 26.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.946 0.403 . . . . 1.74 111.369 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.571 HD11 ' HB2' ' A' ' 60' ' ' ASP . 4.5 mm? -115.47 166.56 11.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.812 -0.631 . . . . 0.81 110.558 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.612 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 43.4 p90 -157.8 132.89 8.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.292 -0.413 . . . . 2.08 110.979 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.476 ' HB2' HD21 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -112.83 127.43 56.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.452 . . . . 3.06 110.599 179.718 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -125.29 -8.63 6.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 2.58 110.892 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -91.99 156.71 17.24 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.105 -0.498 . . . . 3.72 110.74 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -87.37 34.09 0.69 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 2.87 110.748 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 72.0 p -86.07 -21.41 27.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.964 -0.562 . . . . 1.38 111.091 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 55.7 m 58.32 17.62 4.86 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.893 -0.594 . . . . 2.45 111.398 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 54.5 m -127.84 142.42 51.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.853 0.359 . . . . 1.4 111.036 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.476 HD21 ' HB2' ' A' ' 20' ' ' ARG . 95.4 mt -113.4 -13.05 12.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.086 -0.507 . . . . 0.45 110.902 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.449 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 91.53 30.78 10.19 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.802 -0.714 . . . . 0.52 113.188 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.449 ' HB ' HD13 ' A' ' 89' ' ' LEU . 42.2 mm -101.6 113.31 37.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.676 0.274 . . . . 0.84 111.219 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 36.7 t -109.82 97.75 7.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.262 -0.426 . . . . 0.95 110.765 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 23.6 pt -86.23 154.0 3.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 0.41 111.18 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 48.3 t -131.27 139.17 49.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.091 -0.504 . . . . 1.32 110.873 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -73.27 143.11 32.53 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.768 -0.73 . . . . 0.95 112.538 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 27.2 ttt -98.74 107.31 19.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.818 0.342 . . . . 2.04 110.817 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.45 ' HD2' ' N ' ' A' ' 35' ' ' ARG . 6.8 mpt_? -97.23 124.52 41.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.168 -0.469 . . . . 5.46 110.899 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -92.63 155.51 17.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 4.29 110.817 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -77.93 16.07 0.78 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.936 -0.575 . . . . 5.25 111.249 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 44.3 t -165.11 163.74 20.43 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.41 -0.359 . . . . 4.88 110.893 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 68.0 p -122.7 139.12 54.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.163 -0.471 . . . . 5.27 111.049 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.9 t -161.16 8.97 0.08 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.082 -0.508 . . . . 6.91 111.067 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 143.89 -109.64 0.55 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.752 -0.737 . . . . 5.36 112.413 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -105.25 135.17 47.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.82 0.343 . . . . 7.22 110.816 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -161.8 61.57 0.25 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.025 -0.534 . . . . 3.05 111.102 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 82.4 p -131.4 138.9 49.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.149 -0.478 . . . . 2.53 111.007 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -132.7 126.28 4.42 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.674 -0.774 . . . . 1.14 112.686 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.501 HG21 HG11 ' A' ' 85' ' ' VAL . 42.1 mm -88.32 83.98 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.893 0.378 . . . . 0.65 110.903 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -117.98 137.06 53.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.11 -0.496 . . . . 0.7 110.868 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.9 t -66.92 110.47 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.083 -0.508 . . . . 0.39 110.793 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -86.57 -28.87 23.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.0 -0.545 . . . . 2.4 110.876 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 75.9 p -153.62 168.19 27.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.003 0.43 . . . . 1.28 111.292 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.449 HD11 HG22 ' A' ' 63' ' ' ILE . 87.8 mt -123.76 165.03 17.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.849 -0.614 . . . . 0.42 110.865 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.449 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 43.8 mm -112.01 107.95 55.69 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.079 -0.51 . . . . 1.26 110.971 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -60.59 132.32 42.51 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.417 2.078 . . . . 0.82 112.276 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.73 -9.44 40.68 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.813 -0.708 . . . . 0.49 112.57 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.421 ' OG ' ' HA3' ' A' ' 28' ' ' GLY . 97.0 p -91.91 -173.2 3.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.778 0.323 . . . . 1.23 111.03 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.42 ' HB2' HH21 ' A' ' 20' ' ' ARG . . . -70.95 -52.41 20.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.282 -0.417 . . . . 0.42 111.251 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.423 ' HA ' HD11 ' A' ' 18' ' ' LEU . . . -57.53 -42.74 83.48 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.161 -0.472 . . . . 0.35 111.555 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.71 -52.93 47.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.278 -0.419 . . . . 0.44 111.729 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.3 mt -64.03 -19.69 65.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.398 -0.365 . . . . 0.66 111.424 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.571 ' HB2' HD11 ' A' ' 18' ' ' LEU . 14.3 t70 -57.27 -48.77 78.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.406 -0.361 . . . . 1.86 110.863 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.63 -42.15 2.26 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.8 -0.714 . . . . 1.06 112.86 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 67.9 mtp180 -70.38 -20.98 62.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.657 0.265 . . . . 2.59 111.18 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.449 HG22 HD11 ' A' ' 51' ' ' LEU . 41.3 mm -72.99 134.08 30.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.816 0.341 . . . . 0.92 110.833 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -129.77 136.71 29.5 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.105 -0.498 . . . . 1.98 110.707 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.18 168.27 16.26 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.394 2.063 . . . . 1.44 112.22 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 63.0 t30 61.89 56.45 2.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.023 -0.535 . . . . 2.15 110.614 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -131.92 149.93 52.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.971 -0.559 . . . . 2.02 110.683 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -96.58 117.38 30.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.342 -0.39 . . . . 1.02 111.218 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.606 HD13 ' HB3' ' A' ' 100' ' ' LEU . 46.5 mm -78.0 136.35 24.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 0.29 110.714 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.535 HD11 ' HB ' ' A' ' 101' ' ' ILE . 82.6 mt -107.34 -60.19 1.72 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.122 -0.49 . . . . 0.4 110.788 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -154.32 137.18 15.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.169 0.509 . . . . 2.61 111.377 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.672 HG12 ' H ' ' A' ' 73' ' ' ASP . 2.4 t -87.4 175.85 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.606 -0.724 . . . . 0.28 110.138 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.672 ' H ' HG12 ' A' ' 72' ' ' VAL . 24.2 t70 -49.91 110.09 0.35 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.874 0.369 . . . . 0.79 111.642 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 56.84 23.85 8.55 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.034 -0.53 . . . . 2.01 111.801 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.6 t -142.37 144.4 24.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.437 -0.347 . . . . 0.79 110.788 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -112.65 138.18 49.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.484 -0.325 . . . . 2.24 110.809 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.0 m -119.91 24.62 4.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.89 0.376 . . . . 0.67 111.212 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -95.41 44.85 1.09 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.093 -0.503 . . . . 1.39 110.908 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 164.66 24.95 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.612 -0.804 . . . . 0.55 112.672 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 38.9 mtm -124.01 142.23 51.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.714 0.292 . . . . 0.52 110.721 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.408 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -65.11 163.12 15.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.268 -0.423 . . . . 0.39 111.041 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.404 ' O ' HG23 ' A' ' 86' ' ' VAL . 34.8 tt0 -48.83 -52.54 23.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.205 -0.452 . . . . 1.52 111.343 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 80.1 p -54.13 -42.23 69.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.116 -0.493 . . . . 1.48 111.534 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -62.24 -43.91 97.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.47 -0.332 . . . . 2.12 111.471 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.501 HG11 HG21 ' A' ' 46' ' ' ILE . 21.7 t -61.48 -43.82 97.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.855 0.359 . . . . 0.32 111.175 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 82' ' ' GLN . 59.4 t -59.88 -41.02 84.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.069 -0.514 . . . . 0.37 111.154 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.51 ' HG2' HH21 ' A' ' 90' ' ' ARG . 44.0 mt-10 -59.46 -44.45 92.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 1.51 110.967 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 71.8 t -57.82 -57.39 10.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 0.27 111.574 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.449 HD13 ' HB ' ' A' ' 29' ' ' ILE . 86.8 mt -52.24 -34.93 48.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.049 -0.523 . . . . 0.41 111.376 -179.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.51 HH21 ' HG2' ' A' ' 87' ' ' GLU . 65.1 mtm180 -78.09 -29.12 48.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.39 -0.368 . . . . 2.1 111.011 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -71.03 -22.58 62.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 1.14 110.852 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.06 -86.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.115 -0.493 . . . . 0.55 111.279 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.462 ' HA2' ' HG2' ' A' ' 20' ' ' ARG . . . 60.76 17.04 48.61 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.676 -0.773 . . . . 0.76 112.472 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.487 ' HB3' ' HD2' ' A' ' 95' ' ' PRO . 2.4 m120 -147.52 175.13 2.88 Favored Pre-proline 0 CA--C 1.533 0.297 0 C-N-CA 122.001 0.121 . . . . 2.52 110.909 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.612 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 50.8 Cg_exo -56.28 104.93 0.15 Allowed 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 122.121 1.88 . . . . 0.64 111.762 178.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 30.5 m -125.45 150.31 30.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.027 0.441 . . . . 0.64 111.896 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.628 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 77.2 ttt180 -98.05 145.33 26.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.714 -0.675 . . . . 2.37 109.856 179.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 16.0 mt -119.89 125.33 48.21 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.329 -0.396 . . . . 0.37 111.247 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 50.8 tp -112.78 100.03 8.36 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.404 -0.362 . . . . 0.37 110.723 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.606 ' HB3' HD13 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -124.39 141.65 51.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.961 -0.563 . . . . 0.31 111.184 -179.897 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.535 ' HB ' HD11 ' A' ' 70' ' ' LEU . 15.0 tt -97.31 141.93 15.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.469 . . . . 0.45 111.126 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -138.06 131.58 30.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.031 -0.531 . . . . 2.26 110.839 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -85.96 141.95 29.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 3.93 111.053 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 75.6 mt -84.44 147.55 50.07 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.984 -0.553 . . . . 2.0 110.914 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -81.37 60.55 7.77 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.82 2.346 . . . . 2.98 112.043 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 50.9 mt -84.97 111.72 19.95 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.449 -0.796 . . . . 3.67 110.985 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -90.56 96.51 10.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 5.59 110.794 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.266 -0.873 . . . . 6.0 110.899 -179.787 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.213 0 N-CA-C 112.561 -0.215 . . . . 7.92 112.561 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 56.8 m -91.72 163.07 14.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.82 0.343 . . . . 7.18 110.966 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 54.8 m80 -137.33 26.72 2.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.168 -0.469 . . . . 5.91 110.887 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.24 -103.92 0.18 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.725 -0.75 . . . . 2.45 112.564 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -108.18 157.76 18.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.803 0.335 . . . . 2.33 111.017 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.8 m -119.0 94.9 4.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.495 . . . . 2.59 110.83 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 55.71 46.82 21.79 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.136 -0.484 . . . . 2.67 111.102 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -95.21 113.74 25.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.195 -0.457 . . . . 1.58 111.158 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 54.5 m 56.51 25.73 10.11 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.129 -0.487 . . . . 2.55 111.173 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.71 -35.23 4.04 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.758 -0.734 . . . . 1.82 112.657 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.419 ' HB3' HD11 ' A' ' 101' ' ' ILE . 94.0 m-85 -65.56 112.86 3.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.9 0.381 . . . . 1.7 110.961 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 46.8 t -136.01 140.83 44.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.032 -0.531 . . . . 0.9 110.824 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 62.2 mt -78.87 121.25 24.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.113 -0.494 . . . . 0.89 110.772 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.401 ' CD1' ' HB2' ' A' ' 102' ' ' ARG . 57.7 m-85 -114.88 129.15 56.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.038 0.447 . . . . 2.73 111.194 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 48.4 t -101.36 137.17 40.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.843 -0.617 . . . . 1.19 111.084 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.1 t -131.28 158.38 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.047 -0.524 . . . . 0.56 110.526 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -136.35 112.93 10.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.827 0.346 . . . . 1.74 111.257 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.557 HD12 ' HB1' ' A' ' 56' ' ' ALA . 4.0 mm? -122.88 166.64 14.7 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.084 -0.507 . . . . 0.81 110.737 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.572 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 34.1 p90 -141.18 131.26 24.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.289 -0.414 . . . . 2.08 111.019 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.529 HH21 ' HG ' ' A' ' 27' ' ' LEU . 14.5 ttm180 -102.48 93.53 5.2 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.38 -0.373 . . . . 3.06 110.91 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -130.08 -0.08 4.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.35 -0.387 . . . . 2.58 110.824 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -88.25 161.09 17.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.067 -0.515 . . . . 3.72 110.881 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -84.46 39.72 0.74 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.14 -0.482 . . . . 2.87 110.865 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 71.5 p -98.06 -19.48 17.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.281 -0.418 . . . . 1.38 111.175 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 29.3 t 56.83 17.39 3.21 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.0 -0.545 . . . . 2.45 111.194 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.8 m -151.95 153.74 34.69 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.294 -0.412 . . . . 1.4 110.947 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.529 ' HG ' HH21 ' A' ' 20' ' ' ARG . 58.2 mt -102.88 -20.65 14.2 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.134 -0.485 . . . . 0.45 110.837 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.504 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 101.8 3.69 52.19 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.767 -0.73 . . . . 0.52 112.742 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 44.9 mm -76.27 109.01 9.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.729 0.299 . . . . 0.84 111.044 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 44.4 t -110.75 92.8 4.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.341 -0.391 . . . . 0.95 110.82 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 26.7 pt -91.01 167.8 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.968 -0.56 . . . . 0.41 111.22 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 77.8 p -137.95 142.26 40.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.02 -0.536 . . . . 1.32 110.853 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.04 128.78 37.44 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.873 -0.679 . . . . 0.95 112.516 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 17.3 tpt -65.23 142.2 58.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.806 0.336 . . . . 2.04 110.943 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 -109.6 119.11 38.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.197 -0.456 . . . . 5.46 110.629 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -103.53 -65.91 0.98 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.063 -0.517 . . . . 4.29 111.3 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 60.44 77.87 0.3 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.242 -0.435 . . . . 5.25 110.762 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 52.4 m 58.18 86.49 0.08 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.088 -0.505 . . . . 4.88 111.098 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 75.3 p -135.5 136.71 41.46 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.132 -0.485 . . . . 5.27 111.207 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.7 t -109.66 19.2 19.46 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.177 -0.465 . . . . 6.91 110.76 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -120.05 -74.48 0.41 Allowed Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.897 -0.668 . . . . 5.36 112.476 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -96.23 168.2 10.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.879 0.371 . . . . 7.22 110.883 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -145.58 104.87 3.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.104 -0.498 . . . . 3.05 110.945 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 56.4 p 50.85 -167.25 0.03 OUTLIER 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.066 -0.516 . . . . 2.53 111.487 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 146.88 128.16 1.86 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.767 -0.73 . . . . 1.14 112.554 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 44.3 mm -86.44 124.57 40.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.712 0.291 . . . . 0.65 110.804 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -148.48 144.99 27.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.337 -0.392 . . . . 0.7 111.117 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 97.1 t -83.37 126.17 40.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.029 -0.532 . . . . 0.39 110.649 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -107.32 -21.95 12.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 2.4 110.912 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 76.9 p -152.39 169.64 22.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 1.28 111.2 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 67.8 mt -134.59 165.5 25.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.941 -0.572 . . . . 0.42 110.771 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.504 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 47.5 mm -107.6 99.21 27.79 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 1.26 110.877 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -49.69 141.17 27.93 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.564 2.176 . . . . 0.82 112.652 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 95.66 -22.93 36.41 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.88 -0.676 . . . . 0.49 112.562 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 83.6 p -76.3 -178.19 4.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.733 0.301 . . . . 1.23 111.059 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.557 ' HB1' HD12 ' A' ' 18' ' ' LEU . . . -66.15 -56.87 9.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.316 -0.402 . . . . 0.42 111.229 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.11 -34.46 66.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.458 . . . . 0.35 111.314 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.14 -43.05 71.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.28 -0.418 . . . . 0.44 111.288 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.4 mt -67.93 -19.62 65.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.257 -0.428 . . . . 0.66 111.118 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -57.33 -46.88 82.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.444 -0.343 . . . . 1.86 110.891 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.61 -50.32 1.81 Allowed Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.77 -0.729 . . . . 1.06 112.87 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 66.4 mtm180 -64.08 -42.55 96.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.634 0.254 . . . . 2.59 111.017 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 61.5 mt -63.86 114.4 2.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.369 -0.378 . . . . 0.92 110.962 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -130.5 158.56 74.19 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 1.98 111.179 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -55.0 174.73 0.19 Allowed 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.734 2.29 . . . . 1.44 112.211 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 17.4 m120 61.66 35.58 17.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.195 -0.457 . . . . 2.15 111.122 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -112.96 152.71 29.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.152 -0.476 . . . . 2.02 110.649 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -116.02 105.81 13.06 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.83 0.347 . . . . 1.02 111.138 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 44.1 mm -63.7 131.82 29.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.195 -0.457 . . . . 0.29 110.983 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.609 ' HA ' HE21 ' A' ' 78' ' ' GLN . 66.9 mt -102.37 -65.69 0.97 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.134 -0.484 . . . . 0.4 110.802 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -146.84 135.31 21.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.988 -0.551 . . . . 2.61 111.296 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.657 HG12 ' H ' ' A' ' 73' ' ' ASP . 3.7 t -87.99 175.22 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.622 -0.717 . . . . 0.28 109.983 179.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.657 ' H ' HG12 ' A' ' 72' ' ' VAL . 21.3 t70 -48.63 109.28 0.23 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.803 0.335 . . . . 0.79 111.586 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 56.15 26.37 10.16 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.113 -0.494 . . . . 2.01 111.853 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.5 t -145.6 149.26 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.406 -0.361 . . . . 0.79 110.777 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -119.06 131.72 55.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.32 -0.4 . . . . 2.24 110.459 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.463 ' HA ' ' HE2' ' A' ' 80' ' ' MET . 30.0 m -105.25 26.43 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.879 0.371 . . . . 0.67 111.287 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.609 HE21 ' HA ' ' A' ' 70' ' ' LEU . 84.8 mm-40 -94.93 23.79 5.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.096 -0.502 . . . . 1.39 111.114 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -172.79 17.06 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.641 -0.79 . . . . 0.55 112.8 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.463 ' HE2' ' HA ' ' A' ' 77' ' ' VAL . 38.6 mtm -118.05 135.9 53.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.831 0.348 . . . . 0.52 110.849 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.91 160.08 18.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.436 . . . . 0.39 111.097 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -48.25 -54.21 14.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.374 -0.376 . . . . 1.52 111.249 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 46.1 t -53.88 -32.84 54.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.327 -0.397 . . . . 1.48 111.244 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.499 ' O ' HG23 ' A' ' 88' ' ' VAL . 10.4 t70 -73.35 -40.13 64.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.366 -0.379 . . . . 2.12 111.0 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 25.8 t -65.12 -30.32 49.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.961 0.41 . . . . 0.32 110.661 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 97.5 t -70.94 -49.27 51.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.985 -0.552 . . . . 0.37 111.187 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.433 ' HG2' ' O ' ' A' ' 84' ' ' ASP . 11.4 pt-20 -60.44 -30.01 69.37 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.722 0.296 . . . . 1.51 110.752 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 84' ' ' ASP . 50.2 t -65.27 -56.66 14.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.893 0.378 . . . . 0.27 110.825 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 93.5 mt -54.93 -35.19 63.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.957 -0.565 . . . . 0.41 111.378 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.466 ' HA ' ' NH1' ' A' ' 20' ' ' ARG . 86.9 mtm180 -76.96 -34.32 57.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.424 -0.353 . . . . 2.1 111.17 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.29 -18.36 63.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.436 -0.347 . . . . 1.14 110.682 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.43 -84.51 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.133 -0.485 . . . . 0.55 111.464 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.487 ' H ' ' HD2' ' A' ' 20' ' ' ARG . . . 63.63 22.2 65.75 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.692 -0.766 . . . . 0.76 112.186 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -147.17 169.81 8.77 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 110.39 -0.226 . . . . 2.52 110.39 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.572 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 33.3 Cg_exo -60.79 93.02 0.1 OUTLIER 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.055 1.837 . . . . 0.64 111.248 178.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.5 m -101.79 145.64 11.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.085 0.469 . . . . 0.64 111.918 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.629 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 60.4 ttp180 -91.88 136.44 33.16 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.694 -0.685 . . . . 2.37 110.157 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 65.5 mt -111.65 103.74 12.06 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.975 -0.557 . . . . 0.37 111.187 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 21.4 tp -97.51 106.77 19.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.889 0.376 . . . . 0.37 110.158 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.96 164.93 26.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.31 111.434 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.419 HD11 ' HB3' ' A' ' 11' ' ' PHE . 12.4 tt -110.34 133.75 54.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.031 -0.532 . . . . 0.45 111.033 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.401 ' HB2' ' CD1' ' A' ' 14' ' ' TYR . 18.2 mmm180 -111.87 130.47 55.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.968 -0.56 . . . . 2.26 110.508 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 41.3 ttp180 -89.68 108.28 19.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.311 -0.404 . . . . 3.93 110.933 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 79.1 mt -63.91 133.99 95.76 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 2.0 110.786 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -79.98 60.04 7.67 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.64 2.227 . . . . 2.98 112.218 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 78.3 mt -89.58 115.55 27.06 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.533 -0.758 . . . . 3.67 110.912 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -76.13 150.95 37.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 5.59 110.677 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.303 -0.856 . . . . 6.0 110.909 -179.979 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.07 0 N-CA-C 112.508 -0.237 . . . . 7.92 112.508 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 52.0 m -139.65 140.04 36.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.705 0.288 . . . . 7.18 110.933 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 28.3 t60 -168.59 99.56 0.41 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 5.91 110.879 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 144.63 -106.99 0.42 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.786 -0.721 . . . . 2.45 112.462 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -70.49 145.87 50.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.773 0.32 . . . . 2.33 110.83 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 77.7 p -138.87 96.94 3.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.189 -0.459 . . . . 2.59 111.067 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 55.16 35.88 25.78 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.113 -0.494 . . . . 2.67 110.988 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -94.29 113.03 24.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.093 -0.503 . . . . 1.58 111.144 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.5 t 56.02 22.95 6.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.182 -0.463 . . . . 2.55 110.996 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.66 -29.07 5.53 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.835 -0.698 . . . . 1.82 112.688 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.413 ' HB3' HD11 ' A' ' 101' ' ' ILE . 74.5 m-85 -60.64 109.61 1.08 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.878 0.37 . . . . 1.7 111.131 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.9 t -132.16 146.67 52.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.007 -0.542 . . . . 0.9 110.685 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 56.0 mt -81.65 122.56 27.77 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.293 -0.412 . . . . 0.89 111.166 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -121.15 130.58 53.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.066 -0.515 . . . . 2.73 110.84 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 47.6 t -125.57 132.9 52.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.31 -0.405 . . . . 1.19 111.214 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 18.3 t -131.13 151.29 35.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.968 -0.56 . . . . 0.56 110.606 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -101.2 118.71 37.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.958 0.408 . . . . 1.74 111.446 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.566 HD23 HD12 ' A' ' 98' ' ' LEU . 4.3 mm? -122.23 166.45 14.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.945 -0.57 . . . . 0.81 110.191 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.587 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 36.9 p90 -141.86 131.83 24.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.85 0.357 . . . . 2.08 111.078 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.432 ' HB2' HD21 ' A' ' 27' ' ' LEU . 3.2 tmm_? -100.83 104.82 16.06 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.21 -0.45 . . . . 3.06 110.712 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -146.43 8.88 1.05 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.311 -0.404 . . . . 2.58 110.953 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -89.75 162.75 15.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.253 -0.431 . . . . 3.72 110.958 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -84.05 34.13 0.5 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.108 -0.497 . . . . 2.87 110.958 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 51.6 p -98.1 -8.96 26.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.182 -0.463 . . . . 1.38 110.881 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.7 t 58.35 15.92 3.75 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.829 -0.623 . . . . 2.45 111.098 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 57.3 m -158.04 -176.96 6.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.262 -0.426 . . . . 1.4 110.902 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.432 HD21 ' HB2' ' A' ' 20' ' ' ARG . 37.4 mt -115.28 -5.1 12.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.042 -0.526 . . . . 0.45 110.794 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.491 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 94.82 6.27 60.71 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.779 -0.724 . . . . 0.52 112.171 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 25.0 mm -79.61 109.24 14.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.817 0.341 . . . . 0.84 110.958 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.7 m -113.33 93.35 4.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.176 -0.465 . . . . 0.95 110.796 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 44.6 pt -93.03 163.3 2.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.41 111.2 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 45.3 t -119.08 130.66 55.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.259 -0.428 . . . . 1.32 110.792 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -67.14 115.84 7.54 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.849 -0.691 . . . . 0.95 112.623 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 26.0 ttt -78.22 114.92 17.55 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.873 0.368 . . . . 2.04 110.854 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.73 155.86 5.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.045 -0.525 . . . . 5.46 111.113 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -107.07 -18.21 13.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.045 -0.525 . . . . 4.29 110.984 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 62.74 -175.46 0.15 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.891 -0.595 . . . . 5.25 110.864 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 80.1 p -87.49 22.76 2.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.168 -0.469 . . . . 4.88 110.914 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 59.1 p -80.43 138.29 36.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.127 -0.488 . . . . 5.27 111.178 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.8 t -71.57 -4.87 29.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.067 -0.515 . . . . 6.91 111.14 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -114.73 114.49 3.25 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.818 -0.706 . . . . 5.36 112.468 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -69.87 138.98 52.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.753 0.311 . . . . 7.22 110.917 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -150.62 38.53 0.69 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.96 0.409 . . . . 3.05 111.206 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 64.7 p -64.27 149.18 48.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.934 -0.575 . . . . 2.53 110.995 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -149.29 135.07 5.2 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.708 -0.758 . . . . 1.14 112.617 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 49.7 mm -98.05 114.94 36.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.719 0.295 . . . . 0.65 110.895 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -143.59 137.67 28.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.7 111.094 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 99.4 t -68.08 127.81 30.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.113 -0.494 . . . . 0.39 111.051 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -99.96 -30.58 11.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.912 -0.586 . . . . 2.4 110.999 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 80.1 p -157.17 171.62 20.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.894 0.378 . . . . 1.28 111.296 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.433 HD11 HG22 ' A' ' 63' ' ' ILE . 63.6 mt -129.26 140.55 51.4 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.921 -0.582 . . . . 0.42 110.88 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.491 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 49.5 mm -77.15 118.0 68.95 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 116.21 -0.45 . . . . 1.26 110.899 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -68.25 109.43 1.99 Allowed 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.268 1.979 . . . . 0.82 112.255 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 126.93 -5.46 7.39 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.849 -0.691 . . . . 0.49 112.448 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.8 m -94.07 -174.83 3.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.709 0.29 . . . . 1.23 111.086 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.51 ' HB1' HD12 ' A' ' 18' ' ' LEU . . . -72.48 -42.8 64.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.379 -0.373 . . . . 0.42 111.348 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.98 -42.57 99.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.298 -0.41 . . . . 0.35 111.451 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.03 -55.24 11.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.44 111.317 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.3 mt -59.25 -19.67 47.75 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.3 -0.409 . . . . 0.66 111.23 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.48 ' HB2' HD11 ' A' ' 18' ' ' LEU . 18.8 t70 -59.96 -49.74 76.5 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.837 0.351 . . . . 1.86 110.746 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 98.71 -49.73 1.27 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.905 -0.664 . . . . 1.06 112.987 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 51.3 mtp180 -60.33 -45.09 94.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.749 0.309 . . . . 2.59 111.134 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.433 HG22 HD11 ' A' ' 51' ' ' LEU . 71.9 mt -67.59 114.18 4.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.906 0.384 . . . . 0.92 111.111 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -117.29 139.75 26.41 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.025 -0.534 . . . . 1.98 110.568 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -47.62 167.18 0.09 OUTLIER 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.557 2.171 . . . . 1.44 112.73 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 63.97 60.78 0.99 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.094 -0.503 . . . . 2.15 110.554 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -134.28 156.66 48.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.788 -0.642 . . . . 2.02 110.579 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -109.47 113.29 25.96 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.867 0.365 . . . . 1.02 111.073 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 34.2 mm -74.05 143.36 13.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.076 -0.511 . . . . 0.29 110.857 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 74.7 mt -116.17 -66.51 1.08 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.312 -0.404 . . . . 0.4 111.392 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.494 ' HG2' HD22 ' A' ' 76' ' ' ASN . 76.8 mtp180 -140.22 142.45 35.83 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.041 0.448 . . . . 2.61 111.558 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.652 HG12 ' H ' ' A' ' 73' ' ' ASP . 3.6 t -100.83 174.48 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.871 -0.604 . . . . 0.28 109.788 179.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.689 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 12.7 t70 -49.76 108.66 0.22 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.727 0.299 . . . . 0.79 111.191 179.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 55.21 29.7 13.23 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.198 -0.455 . . . . 2.01 111.542 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.502 ' HB ' ' HB ' ' A' ' 72' ' ' VAL . 92.4 t -145.36 151.78 14.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.417 -0.356 . . . . 0.79 110.947 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.494 HD22 ' HG2' ' A' ' 71' ' ' ARG . 2.7 t-20 -120.66 126.1 49.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.32 -0.4 . . . . 2.24 110.565 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.9 m -107.56 19.84 5.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 111.708 0.262 . . . . 0.67 111.708 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.469 ' HG2' HD21 ' A' ' 76' ' ' ASN . 14.0 mm100 -94.26 21.72 6.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.92 0.39 . . . . 1.39 110.465 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -161.68 13.09 0.14 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.004 -0.617 . . . . 0.55 112.429 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 52.9 mtm -118.83 144.65 46.22 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.859 0.361 . . . . 0.52 110.825 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.4 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -71.87 168.02 18.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.12 -0.491 . . . . 0.39 111.086 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.448 ' O ' HG23 ' A' ' 86' ' ' VAL . 63.0 tt0 -49.5 -56.43 9.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.138 -0.483 . . . . 1.52 111.447 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 54.6 m -51.38 -43.31 61.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 1.48 111.837 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -60.68 -50.53 73.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.465 -0.334 . . . . 2.12 111.507 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 81' ' ' ALA . 25.7 t -57.86 -36.46 55.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.293 -0.412 . . . . 0.32 111.327 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 82' ' ' GLN . 90.6 t -62.54 -48.95 85.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.36 -0.382 . . . . 0.37 111.391 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -56.73 -41.46 77.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.339 -0.392 . . . . 1.51 111.143 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 75.1 t -57.33 -58.96 3.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.255 -0.43 . . . . 0.27 111.696 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 86.5 mt -54.22 -32.16 55.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 0.41 111.58 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 82.6 mtm180 -81.47 -23.47 37.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.503 -0.317 . . . . 2.1 111.276 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -84.14 -14.26 50.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.34 -0.391 . . . . 1.14 110.955 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.03 -81.61 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.162 -0.472 . . . . 0.55 111.49 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.409 ' H ' ' HE ' ' A' ' 20' ' ' ARG . . . 63.84 15.29 57.72 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 120.625 -0.797 . . . . 0.76 112.253 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -146.85 167.94 12.57 Favored Pre-proline 0 C--N 1.329 -0.303 0 N-CA-C 110.333 -0.247 . . . . 2.52 110.333 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.587 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 34.3 Cg_exo -61.94 98.38 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.051 1.834 . . . . 0.64 111.338 178.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.6 m -104.44 153.67 6.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.129 0.49 . . . . 0.64 112.108 -178.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.689 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 40.3 ttm180 -93.04 141.26 28.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.459 -0.791 . . . . 2.37 110.063 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.566 HD12 HD23 ' A' ' 18' ' ' LEU . 48.9 mt -117.37 103.58 10.28 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.149 -0.478 . . . . 0.37 110.848 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 58.5 tp -99.29 99.63 10.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.37 110.34 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.2 165.86 20.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.31 111.093 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.413 HD11 ' HB3' ' A' ' 11' ' ' PHE . 14.9 tt -114.33 130.23 68.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-O 121.096 0.474 . . . . 0.45 111.447 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 23.0 mmm180 -108.98 146.33 34.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.443 -0.799 . . . . 2.26 110.642 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 31.2 ttp180 -101.54 124.04 46.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.948 0.404 . . . . 3.93 110.744 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.9 mt -94.74 139.78 22.34 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.004 -0.544 . . . . 2.0 110.814 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -82.12 167.77 15.71 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.53 2.153 . . . . 2.98 112.395 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 88.1 mt -132.25 135.31 46.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.271 -0.422 . . . . 3.67 110.903 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 95.3 mt -107.11 138.99 42.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.111 -0.495 . . . . 5.59 111.063 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.266 -0.873 . . . . 6.0 110.981 179.979 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.152 0 N-CA-C 112.473 -0.251 . . . . 7.92 112.473 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.6 m -151.96 152.65 32.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.731 0.3 . . . . 7.18 110.971 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -133.84 71.43 1.46 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.272 -0.422 . . . . 5.91 110.883 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -176.66 112.56 0.39 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.858 -0.687 . . . . 2.45 112.411 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -113.9 93.46 4.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.817 0.342 . . . . 2.33 111.136 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.6 p -79.47 82.36 5.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.25 -0.432 . . . . 2.59 110.677 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 23.2 t70 57.23 85.15 0.09 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.075 -0.511 . . . . 2.67 110.88 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -136.69 115.85 12.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.068 -0.515 . . . . 1.58 111.018 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.3 t 58.37 25.94 13.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.086 -0.506 . . . . 2.55 111.017 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.84 -39.99 2.67 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.843 -0.694 . . . . 1.82 112.759 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -58.12 102.54 0.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.903 0.383 . . . . 1.7 111.083 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 46.6 t -113.78 148.88 35.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.016 -0.538 . . . . 0.9 110.788 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -84.77 126.09 33.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.89 111.211 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -121.16 136.09 55.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.897 -0.592 . . . . 2.73 110.586 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 49.4 m -136.75 127.57 27.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.284 -0.416 . . . . 1.19 111.205 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 28.3 t -129.86 145.98 34.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.986 -0.552 . . . . 0.56 110.61 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -107.92 117.51 34.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.949 0.404 . . . . 1.74 111.311 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.518 HD11 ' HB2' ' A' ' 60' ' ' ASP . 4.3 mm? -111.05 166.46 11.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.855 -0.611 . . . . 0.81 110.763 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.569 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 28.6 p90 -152.95 132.47 12.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.388 -0.369 . . . . 2.08 111.084 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.564 HH21 ' H ' ' A' ' 93' ' ' GLY . 24.2 ttp180 -122.37 156.2 34.46 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.271 -0.422 . . . . 3.06 110.637 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -169.39 26.45 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.311 -0.404 . . . . 2.58 110.84 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -116.78 164.7 14.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.176 -0.466 . . . . 3.72 110.91 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -87.58 25.99 1.36 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.999 -0.546 . . . . 2.87 111.007 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.4 p -78.26 -23.94 47.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.927 0.394 . . . . 1.38 110.902 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 59.2 m 56.59 21.75 6.05 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.683 -0.69 . . . . 2.45 111.339 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.7 m -140.03 144.69 37.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.287 -0.415 . . . . 1.4 111.058 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 41.4 mt -113.56 12.48 18.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.125 -0.489 . . . . 0.45 110.91 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.501 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 58.29 37.54 87.49 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.833 -0.699 . . . . 0.52 112.715 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 65.9 mt -109.51 109.48 28.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.791 0.329 . . . . 0.84 111.144 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 39.5 t -105.64 112.24 25.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.072 -0.513 . . . . 0.95 110.633 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.407 HD12 HG23 ' A' ' 46' ' ' ILE . 37.1 pt -107.84 167.13 3.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 0.41 111.509 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 56.8 m -141.56 134.89 29.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.965 -0.561 . . . . 1.32 110.623 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -91.49 78.19 1.35 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.754 -0.736 . . . . 0.95 112.598 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 10.7 tmm? -103.04 113.26 26.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.804 0.335 . . . . 2.04 110.479 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 28.4 mmm180 -100.72 152.47 20.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 5.46 110.966 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -117.16 139.41 50.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.101 -0.499 . . . . 4.29 110.726 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -97.42 158.46 15.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 5.25 110.968 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 52.2 m 56.46 59.89 3.39 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.081 -0.509 . . . . 4.88 110.853 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 41.5 p -71.62 152.16 43.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.915 -0.584 . . . . 5.27 111.294 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.8 t -150.99 2.05 0.43 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.052 -0.522 . . . . 6.91 111.082 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.81 -46.85 0.15 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.934 -0.65 . . . . 5.36 112.448 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -89.44 158.42 17.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.804 0.335 . . . . 7.22 110.925 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -155.37 121.05 5.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.211 -0.45 . . . . 3.05 111.192 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.2 p -107.79 127.5 53.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.036 -0.529 . . . . 2.53 111.266 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -134.05 -115.43 1.57 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.87 -0.681 . . . . 1.14 112.236 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.407 HG23 HD12 ' A' ' 31' ' ' ILE . 48.3 mm -82.93 99.86 6.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.728 0.299 . . . . 0.65 110.648 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -128.48 142.36 51.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.258 -0.428 . . . . 0.7 111.22 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 86.3 t -76.9 113.02 15.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.11 -0.496 . . . . 0.39 110.47 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -88.35 -29.41 20.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.276 -0.42 . . . . 2.4 111.331 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 78.4 p -153.35 176.82 11.56 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.936 0.398 . . . . 1.28 111.377 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 69.8 mt -135.58 153.45 51.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.933 -0.576 . . . . 0.42 110.882 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.501 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 57.7 mt -90.33 109.71 35.54 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.312 -0.404 . . . . 1.26 110.947 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -57.73 124.95 17.23 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.426 2.084 . . . . 0.82 112.331 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.93 -3.86 31.92 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.774 -0.727 . . . . 0.49 112.498 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.9 t -100.09 177.86 4.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.743 0.306 . . . . 1.23 110.94 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.48 -58.34 8.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.263 -0.426 . . . . 0.42 111.755 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.46 -49.83 66.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.225 -0.443 . . . . 0.35 111.844 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.75 -39.45 80.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.385 -0.37 . . . . 0.44 111.876 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 81.1 mt -70.75 -23.0 62.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.503 -0.317 . . . . 0.66 111.319 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.518 ' HB2' HD11 ' A' ' 18' ' ' LEU . 15.2 t70 -60.51 -56.23 23.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.829 0.347 . . . . 1.86 110.862 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 98.35 -46.34 1.56 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.828 -0.701 . . . . 1.06 113.159 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 38.0 mtp180 -60.54 -26.88 67.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.63 0.252 . . . . 2.59 111.513 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 70.7 mt -73.06 102.24 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.946 0.403 . . . . 0.92 111.04 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -93.98 136.18 23.99 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.001 -0.545 . . . . 1.98 110.574 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.46 171.89 1.68 Allowed 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.41 2.074 . . . . 1.44 112.34 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 58.97 29.35 18.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.992 -0.549 . . . . 2.15 110.902 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.438 ' OD1' ' HB2' ' A' ' 100' ' ' LEU . 11.9 t0 -102.31 140.07 37.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.046 -0.524 . . . . 2.02 110.405 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -87.32 127.83 35.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.755 0.312 . . . . 1.02 111.202 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 39.9 mm -90.56 136.56 23.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.287 -0.415 . . . . 0.29 110.672 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 89.5 mt -107.29 -64.38 1.2 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.326 -0.397 . . . . 0.4 111.157 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -147.75 135.12 20.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.074 0.464 . . . . 2.61 111.704 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.675 HG12 ' H ' ' A' ' 73' ' ' ASP . 3.1 t -89.81 175.4 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.614 -0.721 . . . . 0.28 110.084 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.675 ' H ' HG12 ' A' ' 72' ' ' VAL . 16.6 t70 -47.24 109.21 0.19 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.721 0.296 . . . . 0.79 111.688 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 54.36 28.77 9.85 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.095 -0.502 . . . . 2.01 111.73 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.474 HG11 HG11 ' A' ' 88' ' ' VAL . 66.6 t -145.67 147.06 18.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.39 -0.368 . . . . 0.79 110.714 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -116.44 128.6 55.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.26 -0.427 . . . . 2.24 110.515 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.5 m -109.98 26.44 2.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.818 0.342 . . . . 0.67 111.353 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -97.05 24.48 6.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.451 . . . . 1.39 111.046 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -170.23 15.2 0.06 OUTLIER Glycine 0 C--N 1.329 0.194 0 C-N-CA 120.543 -0.837 . . . . 0.55 112.768 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 47.2 mtm -117.56 142.46 47.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.852 0.358 . . . . 0.52 110.98 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.41 ' HB3' ' OD2' ' A' ' 84' ' ' ASP . . . -66.29 165.13 14.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.091 -0.504 . . . . 0.39 110.99 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.401 ' O ' HG23 ' A' ' 86' ' ' VAL . 36.0 tt0 -50.01 -56.72 9.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.315 -0.402 . . . . 1.52 111.369 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.3 t -51.89 -39.92 59.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.251 -0.431 . . . . 1.48 111.456 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.41 ' OD2' ' HB3' ' A' ' 81' ' ' ALA . 11.6 m-20 -64.29 -47.07 80.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.487 -0.324 . . . . 2.12 111.129 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 54.3 t -58.06 -32.64 44.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.306 -0.406 . . . . 0.32 110.886 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.41 HG12 ' NE ' ' A' ' 90' ' ' ARG . 75.0 t -68.72 -42.28 82.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.14 -0.482 . . . . 0.37 110.957 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.436 ' HG2' HH21 ' A' ' 90' ' ' ARG . 44.7 mt-10 -56.74 -46.55 81.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.839 0.352 . . . . 1.51 110.801 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.474 HG11 HG11 ' A' ' 75' ' ' VAL . 53.0 t -59.09 -56.18 18.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.228 -0.442 . . . . 0.27 111.011 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 82.3 mt -58.73 -22.11 56.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.916 -0.584 . . . . 0.41 111.355 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.436 HH21 ' HG2' ' A' ' 87' ' ' GLU . 80.4 mtm180 -89.04 -21.96 23.19 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.596 -0.275 . . . . 2.1 111.177 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -86.5 -15.69 39.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.496 -0.32 . . . . 1.14 111.001 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.97 -87.73 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.256 -0.429 . . . . 0.55 111.377 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.564 ' H ' HH21 ' A' ' 20' ' ' ARG . . . 61.68 21.45 60.65 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.809 -0.71 . . . . 0.76 112.613 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.465 HD22 ' HA ' ' A' ' 94' ' ' ASN . 4.3 m120 -147.24 173.84 3.87 Favored Pre-proline 0 C--N 1.328 -0.345 0 C-N-CA 121.936 0.094 . . . . 2.52 110.846 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.569 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 37.1 Cg_exo -59.15 90.82 0.07 OUTLIER 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.141 1.894 . . . . 0.64 111.783 178.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 28.8 m -104.73 153.48 6.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.64 111.937 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.654 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 52.1 ttp180 -99.23 145.12 27.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.689 -0.687 . . . . 2.37 110.282 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.501 HD12 HD23 ' A' ' 18' ' ' LEU . 46.5 mt -120.78 106.21 11.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.261 -0.427 . . . . 0.37 111.26 -179.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 22.2 tp -99.3 107.45 19.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.389 -0.369 . . . . 0.37 110.116 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.438 ' HB2' ' OD1' ' A' ' 67' ' ' ASP . 0.4 OUTLIER -135.36 163.3 30.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.954 0.406 . . . . 0.31 111.539 -179.159 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 15.7 tt -120.9 141.03 43.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.927 -0.579 . . . . 0.45 110.965 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.402 ' HB2' ' OD2' ' A' ' 67' ' ' ASP . 25.7 tpt180 -137.07 135.97 37.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.11 -0.495 . . . . 2.26 110.776 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 37.2 ttp180 -87.75 141.71 28.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 3.93 110.714 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 49.7 mt -82.7 147.28 54.95 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 2.0 110.78 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -79.39 60.63 7.89 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.793 2.329 . . . . 2.98 112.353 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 80.3 mt -92.05 120.47 32.71 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.508 -0.769 . . . . 3.67 111.011 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.412 HD22 ' N ' ' A' ' 107' ' ' LEU . 3.8 mm? -84.54 143.25 29.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.103 -0.499 . . . . 5.59 110.845 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.181 -0.914 . . . . 6.0 110.856 179.957 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.282 0 N-CA-C 112.467 -0.253 . . . . 7.92 112.467 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 60.9 m -141.89 177.04 8.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.693 0.282 . . . . 7.18 110.996 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 53.9 m80 55.3 94.13 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.009 -0.542 . . . . 5.91 111.281 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -178.79 40.25 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.695 -0.765 . . . . 2.45 112.544 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -99.45 55.88 0.99 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.846 0.355 . . . . 2.33 111.037 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.1 t -68.84 95.11 0.66 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.242 -0.435 . . . . 2.59 110.843 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.7 t70 56.65 85.59 0.08 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.197 -0.456 . . . . 2.67 110.862 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -132.26 100.5 5.04 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.34 -0.391 . . . . 1.58 111.3 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.2 t 58.25 20.55 7.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.968 -0.56 . . . . 2.55 111.422 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.455 ' O ' ' HG ' ' A' ' 104' ' ' LEU . . . 107.07 -29.74 10.29 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.598 -0.811 . . . . 1.82 112.717 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -77.85 96.47 4.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.857 0.36 . . . . 1.7 111.081 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.1 t -116.83 145.88 43.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.964 -0.562 . . . . 0.9 110.549 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 70.7 mt -84.66 122.93 29.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.182 -0.463 . . . . 0.89 111.049 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -116.71 149.19 40.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.044 -0.525 . . . . 2.73 111.044 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 81.8 p -149.35 130.12 14.17 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.187 -0.461 . . . . 1.19 111.121 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 19.0 t -125.55 153.25 33.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 0.56 110.577 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -101.36 117.93 35.95 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.9 0.381 . . . . 1.74 111.692 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.412 HD11 ' HB2' ' A' ' 60' ' ' ASP . 4.5 mm? -114.14 166.27 11.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.874 -0.603 . . . . 0.81 110.375 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.58 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 42.3 p90 -156.93 137.03 12.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.714 0.292 . . . . 2.08 111.305 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.466 HH21 ' H ' ' A' ' 93' ' ' GLY . 21.3 ttp180 -129.96 153.22 48.58 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.313 -0.403 . . . . 3.06 111.1 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -155.69 -34.49 0.09 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.048 -0.523 . . . . 2.58 111.054 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -59.92 164.18 4.08 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.09 -0.505 . . . . 3.72 110.936 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -93.96 33.98 1.28 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 2.87 110.994 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 74.6 p -78.6 -13.34 59.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.277 -0.419 . . . . 1.38 111.136 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 97.2 p 50.22 24.09 1.37 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.615 -0.721 . . . . 2.45 111.605 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 47.7 t -141.84 135.37 29.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.841 0.353 . . . . 1.4 111.03 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 19.0 mt -103.45 -20.64 13.98 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.136 -0.483 . . . . 0.45 110.951 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.476 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 97.88 10.89 51.59 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.785 -0.721 . . . . 0.52 112.579 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 67.3 mt -94.03 110.69 23.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.721 0.296 . . . . 0.84 111.139 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 46.5 t -112.42 114.21 26.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.244 -0.434 . . . . 0.95 110.72 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 43.0 pt -100.55 177.84 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.241 -0.436 . . . . 0.41 111.287 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 62.8 m -158.0 132.38 8.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.882 -0.599 . . . . 1.32 110.636 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -85.38 121.0 5.5 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.634 -0.793 . . . . 0.95 112.446 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 58.1 ttp -69.97 137.98 51.9 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.681 0.277 . . . . 2.04 110.549 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.434 ' N ' ' HD3' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -89.93 139.07 30.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.843 0.354 . . . . 5.46 110.965 -179.854 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -143.74 110.05 5.43 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.048 -0.524 . . . . 4.29 110.909 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -100.71 14.49 31.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 5.25 110.692 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 51.2 m -135.78 126.82 27.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.975 -0.557 . . . . 4.88 110.815 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 67.3 p -96.28 136.5 36.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.276 -0.42 . . . . 5.27 111.134 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.0 t -161.94 7.43 0.06 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.22 -0.446 . . . . 6.91 111.175 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 138.24 -82.97 0.25 Allowed Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.755 -0.736 . . . . 5.36 112.527 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -63.82 163.13 12.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.83 0.348 . . . . 7.22 110.96 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -136.75 -158.88 0.9 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.125 -0.489 . . . . 3.05 110.724 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 67.3 p -59.61 175.79 0.32 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.075 -0.511 . . . . 2.53 111.365 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -162.22 159.34 31.48 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.84 -0.695 . . . . 1.14 112.46 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 43.9 mm -98.85 107.43 20.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.827 0.346 . . . . 0.65 110.982 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -139.02 138.57 37.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.164 -0.471 . . . . 0.7 111.072 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 85.5 t -74.01 120.44 23.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.297 -0.411 . . . . 0.39 110.822 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -99.77 -22.24 15.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 2.4 111.254 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 84.1 p -155.88 170.04 23.01 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.058 0.456 . . . . 1.28 111.557 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 90.6 mt -128.71 170.27 13.5 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.607 -0.724 . . . . 0.42 110.401 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.476 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 43.1 mm -109.74 98.53 33.8 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.36 -0.382 . . . . 1.26 111.084 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.79 111.54 0.76 Allowed 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.596 2.197 . . . . 0.82 112.312 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.15 1.9 7.85 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.794 -0.717 . . . . 0.49 112.49 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.0 t -112.01 -176.7 2.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.692 0.282 . . . . 1.23 110.89 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.15 -53.1 61.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.368 -0.378 . . . . 0.42 111.298 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.48 -46.55 70.03 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.169 -0.468 . . . . 0.35 111.275 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.95 -37.57 88.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.076 -0.511 . . . . 0.44 111.262 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 82.7 mt -73.87 -19.64 60.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.89 0.376 . . . . 0.66 110.894 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.412 ' HB2' HD11 ' A' ' 18' ' ' LEU . 26.5 t70 -66.7 -52.04 49.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.109 -0.496 . . . . 1.86 110.843 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 89.88 -44.49 3.0 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.846 -0.692 . . . . 1.06 113.22 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.406 ' HB2' ' OD2' ' A' ' 60' ' ' ASP . 22.2 mmm180 -59.66 -22.32 61.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.686 0.279 . . . . 2.59 111.126 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 52.6 mt -82.53 109.98 17.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.879 0.371 . . . . 0.92 111.003 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.401 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 39.9 tt0 -101.42 135.67 19.79 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 1.98 110.57 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 64' ' ' GLU . 40.7 Cg_exo -57.2 172.18 0.96 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.453 2.102 . . . . 1.44 112.44 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 59.33 26.89 15.84 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.918 -0.583 . . . . 2.15 111.275 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -94.5 158.87 15.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.341 -0.391 . . . . 2.02 110.645 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -107.76 124.24 49.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.77 0.319 . . . . 1.02 110.927 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.548 HD13 ' HB3' ' A' ' 100' ' ' LEU . 45.9 mm -87.33 140.31 15.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.191 -0.459 . . . . 0.29 110.983 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 71.6 mt -115.88 -60.58 1.85 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.206 -0.452 . . . . 0.4 110.946 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.466 ' O ' ' HB3' ' A' ' 99' ' ' LEU . 81.2 mtt180 -144.72 138.66 27.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 2.61 111.254 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.634 HG12 ' H ' ' A' ' 73' ' ' ASP . 4.4 t -94.13 173.82 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.963 -0.562 . . . . 0.28 109.941 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.645 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 19.1 t70 -47.67 108.81 0.17 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.703 0.287 . . . . 0.79 111.516 179.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 54.83 29.15 11.42 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.194 -0.457 . . . . 2.01 111.506 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.463 ' HB ' ' HB ' ' A' ' 72' ' ' VAL . 86.5 t -145.51 151.08 15.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.047 -0.524 . . . . 0.79 110.627 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -120.75 129.34 53.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.484 -0.325 . . . . 2.24 110.77 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.9 m -107.35 23.84 3.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-O 120.808 0.337 . . . . 0.67 111.366 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -96.71 38.31 1.23 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.293 -0.412 . . . . 1.39 110.692 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 175.94 28.43 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.721 -0.752 . . . . 0.55 112.76 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 60.3 mtm -132.39 141.81 49.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.93 0.395 . . . . 0.52 110.976 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.443 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -69.05 161.85 28.15 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.994 -0.548 . . . . 0.39 110.919 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -45.73 -57.1 4.52 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.195 -0.457 . . . . 1.52 111.638 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.4 m -50.62 -43.44 56.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.178 -0.465 . . . . 1.48 111.565 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -63.8 -42.9 97.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.359 -0.382 . . . . 2.12 111.471 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 81' ' ' ALA . 38.9 t -59.63 -38.73 77.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 120.857 0.361 . . . . 0.32 110.988 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 52.4 t -66.74 -36.58 77.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.11 -0.496 . . . . 0.37 110.968 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -60.1 -49.16 78.74 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.217 -0.447 . . . . 1.51 110.714 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.405 HG11 HG11 ' A' ' 75' ' ' VAL . 53.7 t -56.75 -53.52 40.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.082 -0.508 . . . . 0.27 111.27 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 79.2 mt -53.89 -32.62 53.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.077 -0.51 . . . . 0.41 111.277 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.465 ' HA ' HH22 ' A' ' 20' ' ' ARG . 85.0 mtm180 -81.64 -24.06 36.58 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.256 -0.429 . . . . 2.1 111.115 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -78.4 -17.96 55.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.276 -0.42 . . . . 1.14 110.835 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.68 -89.62 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.091 -0.504 . . . . 0.55 111.474 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.466 ' H ' HH21 ' A' ' 20' ' ' ARG . . . 60.48 21.86 58.12 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.702 -0.761 . . . . 0.76 112.429 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.13 174.79 3.11 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 110.461 -0.199 . . . . 2.52 110.461 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.58 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 38.2 Cg_exo -59.18 97.53 0.1 OUTLIER 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.021 1.814 . . . . 0.64 111.641 178.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 28.8 m -114.53 151.56 16.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.129 0.49 . . . . 0.64 111.893 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.645 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 75.2 ttt180 -102.1 145.24 29.62 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.673 -0.694 . . . . 2.37 110.082 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 18.3 mt -115.49 116.18 27.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.187 -0.46 . . . . 0.37 111.378 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.466 ' HB3' ' O ' ' A' ' 71' ' ' ARG . 63.6 tp -104.46 99.89 9.58 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.16 -0.473 . . . . 0.37 110.261 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.548 ' HB3' HD13 ' A' ' 69' ' ' ILE . 0.5 OUTLIER -129.82 158.25 39.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.197 -0.456 . . . . 0.31 111.394 -179.519 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.0 tt -110.37 140.39 29.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.45 110.949 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -128.08 145.11 51.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.081 -0.509 . . . . 2.26 110.942 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -102.49 141.89 34.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.08 -0.509 . . . . 3.93 110.785 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 10' ' ' GLY . 52.4 mt -92.58 148.66 36.67 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.107 -0.497 . . . . 2.0 110.895 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -79.83 62.74 8.61 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.83 2.353 . . . . 2.98 112.437 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 89.5 mt -101.36 103.05 13.99 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.672 -0.694 . . . . 3.67 110.95 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -82.49 102.55 11.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 5.59 110.818 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.306 -0.854 . . . . 6.0 110.888 179.997 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.181 0 N-CA-C 112.337 -0.305 . . . . 7.92 112.337 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.7 p -147.13 -178.27 6.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.822 0.344 . . . . 7.18 110.967 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 55.0 m80 56.02 83.57 0.09 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.994 -0.548 . . . . 5.91 111.008 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -160.54 68.23 0.25 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.743 -0.742 . . . . 2.45 112.65 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -70.39 141.75 52.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.834 0.35 . . . . 2.33 110.907 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.9 t -154.38 108.91 3.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.464 . . . . 2.59 110.897 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 55.91 36.26 26.99 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.175 -0.466 . . . . 2.67 110.912 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -102.75 119.44 38.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.1 -0.5 . . . . 1.58 111.182 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.9 m 57.08 21.85 6.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.06 -0.518 . . . . 2.55 111.169 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.1 33.4 23.62 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.731 -0.747 . . . . 1.82 112.544 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.427 ' HB3' HD11 ' A' ' 101' ' ' ILE . 81.9 m-85 -136.81 131.65 33.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.82 0.343 . . . . 1.7 110.65 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.3 t -136.44 135.33 38.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.087 -0.506 . . . . 0.9 110.891 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 79.8 mt -76.11 119.19 19.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.0 -0.545 . . . . 0.89 110.739 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -120.08 132.11 55.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 2.73 111.0 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 79.0 p -137.34 126.94 25.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.286 -0.416 . . . . 1.19 110.972 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.17 141.53 46.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.219 -0.446 . . . . 0.56 110.952 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -96.18 116.34 28.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 1.74 111.54 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.438 HD11 ' HB2' ' A' ' 60' ' ' ASP . 4.5 mm? -114.92 166.61 11.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.98 -0.555 . . . . 0.81 110.125 179.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.539 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 15.1 p90 -147.11 123.1 10.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.769 0.319 . . . . 2.08 111.149 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.578 ' HB2' HD21 ' A' ' 27' ' ' LEU . 14.9 ttp180 -95.61 96.84 9.3 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.325 -0.398 . . . . 3.06 110.687 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -107.69 -19.98 13.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.985 -0.552 . . . . 2.58 110.672 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -82.37 148.64 28.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.954 -0.566 . . . . 3.72 110.794 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -85.96 47.59 1.48 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.188 -0.46 . . . . 2.87 110.974 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 65.1 p -87.38 -10.04 53.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.484 . . . . 1.38 111.182 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.2 t 58.05 20.3 6.76 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.988 -0.551 . . . . 2.45 111.248 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 60.5 m -157.47 160.95 38.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.272 -0.422 . . . . 1.4 110.965 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.578 HD21 ' HB2' ' A' ' 20' ' ' ARG . 77.2 mt -113.61 -14.66 12.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.112 -0.494 . . . . 0.45 110.78 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.528 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 93.81 29.99 9.38 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.823 -0.703 . . . . 0.52 112.406 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.437 HD12 HD22 ' A' ' 89' ' ' LEU . 77.7 mt -109.79 109.25 27.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.737 0.303 . . . . 0.84 111.05 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 40.0 t -111.03 100.44 9.13 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.29 -0.414 . . . . 0.95 110.844 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 40.6 pt -92.71 179.66 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.087 -0.506 . . . . 0.41 111.175 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 82.0 p -135.42 136.83 41.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.053 -0.521 . . . . 1.32 110.929 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -66.47 99.99 0.5 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.862 -0.685 . . . . 0.95 112.434 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 26.7 ttt -66.78 148.18 52.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.78 0.324 . . . . 2.04 110.811 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.31 162.99 36.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.269 -0.423 . . . . 5.46 110.962 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -136.87 131.27 32.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.017 -0.538 . . . . 4.29 110.82 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -123.36 107.31 11.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 5.25 110.92 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 55.6 m 55.64 41.89 30.05 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.072 -0.513 . . . . 4.88 110.918 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 82.5 p -92.13 139.73 30.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.063 -0.517 . . . . 5.27 111.317 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.8 t -89.24 16.05 7.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 6.91 110.988 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -145.19 89.77 0.16 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.811 -0.709 . . . . 5.36 112.472 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -68.47 92.27 0.44 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.761 0.315 . . . . 7.22 110.912 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -136.62 60.68 1.66 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.234 -0.439 . . . . 3.05 111.082 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 65.9 p -77.89 153.53 32.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.271 -0.422 . . . . 2.53 111.396 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -171.66 -163.32 25.41 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.851 -0.69 . . . . 1.14 112.389 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.3 mm -124.61 131.04 73.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.801 0.334 . . . . 0.65 110.787 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.414 ' HB2' ' O ' ' A' ' 67' ' ' ASP . 27.0 p90 -145.4 145.46 31.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.322 -0.399 . . . . 0.7 111.091 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 99.7 t -82.16 129.29 37.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.089 -0.505 . . . . 0.39 111.061 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.2 ttpp -102.02 -24.48 13.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.996 -0.547 . . . . 2.4 110.946 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 79.6 p -155.12 156.24 35.45 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.037 0.446 . . . . 1.28 111.36 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 77.1 mt -114.28 162.97 15.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.775 -0.648 . . . . 0.42 110.626 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.528 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 62.4 mt -109.7 101.97 48.43 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.367 -0.378 . . . . 1.26 111.248 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -52.11 146.44 30.44 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.586 2.191 . . . . 0.82 112.577 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.4 -22.37 30.38 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.827 -0.701 . . . . 0.49 112.581 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 67.4 m -80.93 -177.94 6.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.784 0.325 . . . . 1.23 111.071 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.65 -55.09 16.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.218 -0.447 . . . . 0.42 111.472 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.63 -39.86 65.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.103 -0.499 . . . . 0.35 111.843 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.35 -42.86 71.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.401 -0.363 . . . . 0.44 111.438 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.0 mt -70.95 -19.67 62.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.334 -0.394 . . . . 0.66 110.992 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.438 ' HB2' HD11 ' A' ' 18' ' ' LEU . 26.0 t70 -59.52 -56.13 25.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 1.86 110.945 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.2 -48.71 1.1 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.768 -0.73 . . . . 1.06 112.957 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -57.4 -32.05 66.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.761 0.315 . . . . 2.59 111.153 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 68.1 mt -76.83 127.91 37.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.304 -0.407 . . . . 0.92 111.095 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -125.49 138.16 31.29 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 116.139 -0.482 . . . . 1.98 110.81 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_exo -52.94 165.9 1.08 Allowed 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.59 2.193 . . . . 1.44 112.441 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 18.0 m120 60.18 45.65 11.38 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.046 -0.525 . . . . 2.15 110.755 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.414 ' O ' ' HB2' ' A' ' 47' ' ' TYR . 27.1 t70 -118.16 159.77 22.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.935 -0.575 . . . . 2.02 110.505 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.494 ' HB3' HG23 ' A' ' 101' ' ' ILE . 87.6 tttt -105.18 128.29 53.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.843 0.354 . . . . 1.02 111.181 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 41.6 mm -94.9 142.18 13.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.055 -0.52 . . . . 0.29 110.727 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 56.5 mt -111.31 -73.75 0.67 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 0.4 111.129 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.8 ptp180 -147.29 137.85 23.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.174 0.512 . . . . 2.61 111.779 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.678 HG12 ' H ' ' A' ' 73' ' ' ASP . 3.8 t -84.68 176.01 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.528 -0.76 . . . . 0.28 109.771 179.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.678 ' H ' HG12 ' A' ' 72' ' ' VAL . 6.6 t70 -44.25 109.0 0.13 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.17 0.434 . . . . 0.79 112.17 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 52.39 27.87 5.29 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.443 0.535 . . . . 2.01 112.443 178.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.406 ' O ' ' N ' ' A' ' 72' ' ' VAL . 88.1 t -148.66 140.11 17.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.725 0.298 . . . . 0.79 110.88 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 25.4 m-80 -100.23 141.86 32.49 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.922 -0.399 . . . . 2.24 109.922 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.8 m -122.59 -16.23 5.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 N-CA-C 112.104 0.409 . . . . 0.67 112.104 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -87.08 25.98 1.25 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.921 0.391 . . . . 1.39 110.886 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -141.3 1.72 1.94 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.869 -0.682 . . . . 0.55 112.557 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 51.4 mtm -123.99 172.14 9.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.748 0.309 . . . . 0.52 110.768 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.5 168.71 14.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.39 111.125 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.406 ' O ' HG23 ' A' ' 86' ' ' VAL . 63.4 tt0 -58.97 -47.3 85.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.44 -0.345 . . . . 1.52 110.902 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.9 m -55.46 -31.72 62.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 1.48 111.304 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -71.98 -39.27 69.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.355 -0.384 . . . . 2.12 111.042 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.2 t -67.75 -35.99 74.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.969 0.414 . . . . 0.32 111.021 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.485 HG12 ' NE ' ' A' ' 90' ' ' ARG . 56.5 t -70.32 -47.22 67.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.009 -0.541 . . . . 0.37 111.598 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -58.86 -40.75 85.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.714 -0.221 . . . . 1.51 111.085 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 52.4 t -60.04 -54.88 28.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 120.924 0.392 . . . . 0.27 111.115 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.437 HD22 HD12 ' A' ' 29' ' ' ILE . 66.8 mt -56.83 -27.89 60.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.993 -0.549 . . . . 0.41 111.006 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.485 ' NE ' HG12 ' A' ' 86' ' ' VAL . 76.1 mtm180 -89.24 -15.09 34.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.371 -0.377 . . . . 2.1 111.514 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -93.47 -10.04 36.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.417 -0.356 . . . . 1.14 111.114 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -48.9 -85.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.266 -0.425 . . . . 0.55 111.574 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.481 ' H ' ' HE ' ' A' ' 20' ' ' ARG . . . 62.25 14.59 48.23 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.695 -0.764 . . . . 0.76 112.556 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -146.97 169.85 8.74 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 110.54 -0.17 . . . . 2.52 110.54 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.539 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 24.4 Cg_exo -65.13 92.26 0.21 Allowed 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.223 1.948 . . . . 0.64 111.326 178.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 33.8 m -100.15 153.46 4.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.067 -0.515 . . . . 0.64 111.577 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.676 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 56.2 ttp180 -102.72 138.07 40.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.969 -0.559 . . . . 2.37 109.816 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 45.4 mt -107.7 109.42 21.01 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.262 -0.426 . . . . 0.37 111.137 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 31.7 tp -99.79 100.66 11.64 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.374 -0.375 . . . . 0.37 110.172 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -130.37 161.95 30.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.111 -0.495 . . . . 0.31 111.373 -179.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.494 HG23 ' HB3' ' A' ' 68' ' ' LYS . 14.2 tt -114.06 135.68 52.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.917 -0.583 . . . . 0.45 110.862 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -122.4 133.91 54.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.003 -0.544 . . . . 2.26 110.555 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 31.4 ptt180 -89.94 134.84 33.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.143 -0.48 . . . . 3.93 111.127 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 51.9 mt -102.55 150.79 37.97 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.015 -0.539 . . . . 2.0 110.596 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -80.87 161.63 21.15 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.467 2.111 . . . . 2.98 112.131 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -104.98 140.19 38.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.026 -0.533 . . . . 3.67 111.222 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 89.2 mt -105.01 95.47 5.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.953 -0.567 . . . . 5.59 110.879 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.31 -0.853 . . . . 6.0 111.071 -179.901 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.168 0 N-CA-C 112.456 -0.258 . . . . 7.92 112.456 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 52.5 m -85.65 -59.42 2.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.798 0.333 . . . . 7.18 110.92 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -85.19 106.39 16.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.208 -0.451 . . . . 5.91 110.948 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -91.85 -85.36 1.48 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.738 -0.744 . . . . 2.45 112.408 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 55.7 30.24 15.19 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.825 0.345 . . . . 2.33 111.197 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 43.5 t -70.44 98.86 1.5 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 2.59 110.716 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 57.94 71.52 0.57 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.116 -0.493 . . . . 2.67 110.916 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -119.87 108.78 14.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 1.58 111.242 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 61.9 m 57.04 20.01 5.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.045 -0.525 . . . . 2.55 111.329 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.7 30.91 31.18 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.766 -0.731 . . . . 1.82 112.788 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.4 ' HB3' HD11 ' A' ' 101' ' ' ILE . 92.0 m-85 -141.19 115.02 9.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.83 0.348 . . . . 1.7 110.825 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 46.6 t -140.18 136.04 33.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.9 110.78 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 62.3 mt -75.09 120.9 21.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.168 -0.469 . . . . 0.89 110.749 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -114.53 124.19 51.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.089 -0.505 . . . . 2.73 111.328 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 44.9 t -103.27 142.75 33.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 1.19 110.79 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.4 t -136.41 158.16 37.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.238 -0.437 . . . . 0.56 110.666 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -121.93 114.34 20.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.935 0.398 . . . . 1.74 111.353 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.558 HD11 ' HB2' ' A' ' 60' ' ' ASP . 4.4 mm? -119.58 166.82 12.65 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.033 -0.53 . . . . 0.81 110.787 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.605 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 30.1 p90 -148.8 129.45 14.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.282 -0.417 . . . . 2.08 110.964 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.508 ' HB2' HD21 ' A' ' 27' ' ' LEU . 15.1 ttp180 -106.5 107.66 18.78 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.794 0.33 . . . . 3.06 111.006 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -131.29 -5.67 3.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.299 -0.409 . . . . 2.58 111.036 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -81.69 170.2 16.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.396 -0.365 . . . . 3.72 110.874 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -93.47 30.04 1.83 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.136 -0.484 . . . . 2.87 110.959 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 71.6 p -84.25 -14.35 50.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.45 . . . . 1.38 110.863 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 35.2 t 59.17 20.63 8.65 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.849 -0.614 . . . . 2.45 111.18 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 83.0 p -160.56 175.27 12.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.941 0.4 . . . . 1.4 110.992 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.508 HD21 ' HB2' ' A' ' 20' ' ' ARG . 33.5 mt -115.0 -10.35 12.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.827 -0.624 . . . . 0.45 110.877 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.452 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 87.86 18.33 56.44 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.782 -0.723 . . . . 0.52 112.754 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 70.9 mt -91.36 108.5 19.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.822 0.344 . . . . 0.84 110.847 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 41.9 t -103.14 102.66 12.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.134 -0.485 . . . . 0.95 110.958 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.5 pt -100.34 165.68 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.82 -0.627 . . . . 0.41 111.291 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.6 m -149.04 145.19 27.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.917 -0.583 . . . . 1.32 110.474 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -97.72 125.49 8.53 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.68 -0.771 . . . . 0.95 112.598 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 52.8 ttp -85.5 112.57 21.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.754 0.312 . . . . 2.04 110.711 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -108.24 139.34 43.08 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.225 -0.443 . . . . 5.46 110.74 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -131.89 161.3 33.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.272 -0.422 . . . . 4.29 110.819 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -100.21 69.53 1.49 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.978 0.418 . . . . 5.25 111.109 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 75.2 m -137.2 129.34 29.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 4.88 110.986 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 77.3 p -89.75 155.54 19.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 5.27 111.142 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 15.0 t 42.3 33.19 0.39 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.776 -0.647 . . . . 6.91 111.372 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -168.8 47.58 0.22 Allowed Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.598 -0.728 . . . . 5.36 112.255 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -84.83 159.47 20.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.844 0.354 . . . . 7.22 111.012 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -149.72 89.91 1.66 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.187 -0.46 . . . . 3.05 111.239 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 73.0 p -92.75 152.86 19.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.243 -0.435 . . . . 2.53 110.907 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -169.65 146.07 9.78 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.656 -0.783 . . . . 1.14 112.54 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 37.2 mm -94.11 108.44 20.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.761 0.315 . . . . 0.65 110.703 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -131.38 143.31 50.38 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.218 -0.446 . . . . 0.7 111.201 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 84.1 t -84.54 128.6 38.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.051 -0.522 . . . . 0.39 110.837 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -107.89 -24.1 11.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.301 -0.408 . . . . 2.4 110.952 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.6 t -150.94 170.47 19.24 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.972 0.415 . . . . 1.28 111.44 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 91.3 mt -135.25 157.21 47.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.816 -0.629 . . . . 0.42 110.583 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.452 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 62.8 mt -101.46 104.05 31.3 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 1.26 111.01 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -55.16 132.5 52.67 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.429 2.086 . . . . 0.82 112.224 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 110.55 -24.13 18.34 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.801 -0.714 . . . . 0.49 112.544 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 63.2 m -80.91 -178.45 6.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.75 0.31 . . . . 1.23 110.921 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.74 -52.35 51.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.384 -0.371 . . . . 0.42 111.494 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.27 -34.61 64.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.25 -0.432 . . . . 0.35 111.616 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.79 -50.02 33.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.33 -0.395 . . . . 0.44 111.248 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 80.7 mt -64.02 -19.7 65.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.131 -0.486 . . . . 0.66 110.988 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.558 ' HB2' HD11 ' A' ' 18' ' ' LEU . 26.6 t70 -62.05 -56.13 22.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 1.86 110.91 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 97.42 -51.24 1.4 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.698 -0.763 . . . . 1.06 113.01 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 84.4 mtm180 -55.98 -28.07 55.51 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.743 0.306 . . . . 2.59 111.285 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 67.0 mt -81.05 106.25 11.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.292 -0.413 . . . . 0.92 110.746 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -108.11 137.53 19.88 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 1.98 110.546 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -53.41 175.52 0.1 Allowed 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.57 2.18 . . . . 1.44 112.725 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.7 m120 61.77 37.58 15.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.918 -0.583 . . . . 2.15 110.913 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -113.15 161.93 16.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.991 -0.55 . . . . 2.02 110.553 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.411 ' HB3' HG23 ' A' ' 101' ' ' ILE . 87.6 tttt -110.55 116.71 31.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.822 0.344 . . . . 1.02 111.087 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.443 HD13 ' HB3' ' A' ' 100' ' ' LEU . 42.0 mm -77.17 146.22 8.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.489 . . . . 0.29 110.834 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 55.3 mt -123.22 -61.59 1.4 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.241 -0.436 . . . . 0.4 111.257 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 66.8 mtp180 -144.47 142.73 30.47 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.096 0.474 . . . . 2.61 111.808 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.626 HG12 ' H ' ' A' ' 73' ' ' ASP . 9.9 t -99.89 173.92 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.611 -0.722 . . . . 0.28 109.582 179.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.626 ' H ' HG12 ' A' ' 72' ' ' VAL . 16.8 t70 -46.82 108.44 0.14 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.711 0.291 . . . . 0.79 111.418 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 53.32 33.84 16.54 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.18 -0.464 . . . . 2.01 111.716 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.411 ' HB ' ' HB ' ' A' ' 72' ' ' VAL . 87.9 t -147.96 147.81 16.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.409 -0.359 . . . . 0.79 110.842 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.551 HD21 ' HB2' ' A' ' 78' ' ' GLN . 7.1 t30 -115.44 124.89 52.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.346 -0.388 . . . . 2.24 110.405 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.6 m -106.96 24.46 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 CA-C-O 120.783 0.325 . . . . 0.67 111.52 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.551 ' HB2' HD21 ' A' ' 76' ' ' ASN . 19.2 mm-40 -96.23 34.12 1.64 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.272 -0.422 . . . . 1.39 110.734 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 175.0 22.65 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.757 -0.735 . . . . 0.55 112.811 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 54.6 mtm -117.98 144.42 45.54 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.873 0.368 . . . . 0.52 110.965 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.449 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -61.19 158.27 14.37 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.977 -0.556 . . . . 0.39 111.41 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -51.41 -62.14 1.81 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.141 -0.481 . . . . 1.52 111.33 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 81.6 p -52.78 -33.53 49.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.014 -0.539 . . . . 1.48 111.389 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -63.16 -43.46 98.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.512 -0.313 . . . . 2.12 110.925 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 81' ' ' ALA . 18.2 t -61.89 -38.94 81.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.297 -0.411 . . . . 0.32 110.605 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.1 t -63.22 -36.54 76.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.983 -0.553 . . . . 0.37 110.991 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -63.62 -47.74 80.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.15 -0.477 . . . . 1.51 110.977 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 54.4 t -53.86 -54.23 21.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.224 -0.443 . . . . 0.27 111.107 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 79.0 mt -57.58 -32.93 67.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.41 110.94 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 85.2 mtm180 -80.6 -13.5 59.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.312 -0.404 . . . . 2.1 111.212 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -95.62 -13.88 23.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 1.14 110.692 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.19 -83.53 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.998 -0.547 . . . . 0.55 111.588 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.478 ' H ' ' HE ' ' A' ' 20' ' ' ARG . . . 62.38 15.72 52.76 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.61 -0.805 . . . . 0.76 112.152 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -147.08 169.81 8.78 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 110.6 -0.148 . . . . 2.52 110.6 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.605 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 32.9 Cg_exo -61.59 98.27 0.16 Allowed 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.258 1.972 . . . . 0.64 111.429 177.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 23.6 m -106.42 150.46 9.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.082 0.467 . . . . 0.64 111.858 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.622 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 80.9 mtp180 -97.13 140.57 31.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.811 -0.632 . . . . 2.37 110.247 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 30.3 mt -115.03 111.89 21.8 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.041 -0.527 . . . . 0.37 110.951 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 43.3 tp -102.5 104.74 15.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 0.37 110.75 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.443 ' HB3' HD13 ' A' ' 69' ' ' ILE . 0.4 OUTLIER -134.13 156.43 48.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.212 -0.449 . . . . 0.31 111.045 -179.797 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.411 HG23 ' HB3' ' A' ' 68' ' ' LYS . 12.0 tt -104.61 136.17 39.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.23 -0.441 . . . . 0.45 111.046 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 25.4 mmm180 -115.74 141.89 47.48 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.866 -0.606 . . . . 2.26 110.844 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 53.7 mtm180 -89.99 126.46 35.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.223 -0.444 . . . . 3.93 110.978 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 44.5 mt -102.17 103.85 32.92 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.074 -0.512 . . . . 2.0 110.872 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -63.76 176.54 2.27 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.304 2.003 . . . . 2.98 112.326 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 95.8 mt -139.02 146.77 41.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.088 -0.506 . . . . 3.67 110.99 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.404 ' N ' HD22 ' A' ' 107' ' ' LEU . 3.8 mm? -81.02 103.22 10.69 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.15 -0.477 . . . . 5.59 110.797 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.451 -0.785 . . . . 6.0 111.048 179.852 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.117 0 N-CA-C 112.626 -0.19 . . . . 7.92 112.626 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.6 m -94.31 -58.15 2.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.836 0.351 . . . . 7.18 110.919 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 51.0 m80 -70.97 -51.05 27.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 5.91 110.868 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 137.42 -105.54 0.51 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.835 -0.698 . . . . 2.45 112.419 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -88.53 132.75 34.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.917 0.389 . . . . 2.33 110.911 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 78.1 p -153.45 110.6 3.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.13 -0.486 . . . . 2.59 110.686 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 57.66 67.1 1.01 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.154 -0.475 . . . . 2.67 110.718 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -146.76 110.57 4.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.276 -0.42 . . . . 1.58 111.393 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.0 t 56.02 25.66 9.09 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.081 -0.509 . . . . 2.55 111.219 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.98 36.87 34.56 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.66 -0.781 . . . . 1.82 112.558 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -137.57 112.48 9.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.758 0.314 . . . . 1.7 110.825 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 46.1 t -135.99 140.84 44.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.134 -0.485 . . . . 0.9 110.795 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 75.4 mt -79.03 121.46 24.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.89 110.924 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -117.31 154.53 31.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.111 -0.495 . . . . 2.73 110.877 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 84.4 p -151.2 134.82 16.33 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.344 -0.389 . . . . 1.19 111.302 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.1 t -132.23 144.96 35.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.149 -0.478 . . . . 0.56 110.675 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.439 ' C ' HD22 ' A' ' 18' ' ' LEU . 1.8 mp0 -94.89 115.22 27.19 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.842 0.353 . . . . 1.74 111.59 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.587 HD23 HD12 ' A' ' 98' ' ' LEU . 4.3 mm? -123.24 125.47 45.13 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.986 -0.552 . . . . 0.81 110.472 179.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.587 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 39.0 p90 -103.44 132.93 49.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.404 -0.362 . . . . 2.08 111.21 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.622 ' HE ' ' HA2' ' A' ' 93' ' ' GLY . 19.2 ttp180 -102.31 95.26 6.18 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.881 0.372 . . . . 3.06 110.882 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -103.01 -21.37 13.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.056 0.455 . . . . 2.58 110.425 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.432 ' HB3' HG23 ' A' ' 24' ' ' THR . 75.0 mmtt -85.16 140.8 30.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.704 -0.68 . . . . 3.72 110.659 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -83.37 37.4 0.56 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 2.87 111.077 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.432 HG23 ' HB3' ' A' ' 22' ' ' LYS . 57.4 p -73.0 -11.97 60.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 1.38 110.979 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 36.5 t 59.54 15.72 4.77 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.025 -0.534 . . . . 2.45 111.014 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 53.6 m -147.97 138.09 22.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.124 -0.489 . . . . 1.4 110.971 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.442 HD21 ' HB2' ' A' ' 20' ' ' ARG . 88.2 mt -97.55 -22.98 16.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.068 -0.514 . . . . 0.45 110.852 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.523 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 110.43 3.85 28.93 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.808 -0.71 . . . . 0.52 112.502 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.468 HD12 ' N ' ' A' ' 29' ' ' ILE . 3.0 mp -88.23 114.93 27.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.822 0.344 . . . . 0.84 111.012 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 45.0 t -111.89 93.32 4.4 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.103 -0.499 . . . . 0.95 110.522 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.499 ' HA ' ' HA ' ' A' ' 48' ' ' VAL . 44.6 pt -87.87 164.18 2.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.101 -0.499 . . . . 0.41 111.432 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 56.3 m -143.47 134.61 25.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.773 -0.649 . . . . 1.32 110.415 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -89.23 125.82 7.96 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.614 -0.803 . . . . 0.95 112.816 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 58.5 ttp -78.5 90.11 4.48 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.816 0.341 . . . . 2.04 110.498 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 19.1 mmm180 -85.4 164.71 17.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 5.46 110.867 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -146.99 11.87 1.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.481 . . . . 4.29 110.762 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 57.23 28.75 15.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.1 -0.5 . . . . 5.25 110.847 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 10.0 t -127.88 -158.85 0.9 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.112 -0.495 . . . . 4.88 110.457 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 57.7 p -50.54 139.05 16.55 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.782 0.325 . . . . 5.27 111.169 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.5 t -93.53 -2.64 54.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.183 -0.462 . . . . 6.91 111.285 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -70.01 -53.57 14.42 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.798 -0.715 . . . . 5.36 112.526 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -110.92 -179.32 3.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.808 0.337 . . . . 7.22 110.923 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 57.32 41.47 26.53 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.076 -0.511 . . . . 3.05 111.108 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 44.7 p -134.11 127.13 31.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.087 -0.506 . . . . 2.53 111.11 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -150.21 172.02 30.08 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.833 -0.698 . . . . 1.14 112.606 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 43.8 mm -118.27 116.03 50.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.779 0.323 . . . . 0.65 110.901 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -140.17 137.37 34.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.7 111.104 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.499 ' HA ' ' HA ' ' A' ' 31' ' ' ILE . 58.3 t -77.63 139.26 18.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.991 -0.55 . . . . 0.39 110.852 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -120.58 -28.46 4.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 2.4 111.116 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 56.3 m -143.82 173.28 11.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.15 0.5 . . . . 1.28 111.594 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 82.1 mt -137.42 161.94 34.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.603 -0.726 . . . . 0.42 110.55 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.523 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 71.6 mt -106.74 102.14 40.44 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.485 -0.325 . . . . 1.26 111.218 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.6 129.51 35.46 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.59 2.193 . . . . 0.82 112.42 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 110.93 -17.46 27.3 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.794 -0.717 . . . . 0.49 112.353 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 57.7 m -85.24 -176.67 6.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.719 0.295 . . . . 1.23 110.85 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.21 -52.55 32.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.916 0.388 . . . . 0.42 111.171 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.22 -37.9 75.75 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.045 -0.525 . . . . 0.35 111.659 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.99 -54.59 14.45 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.341 -0.391 . . . . 0.44 111.572 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.7 mt -60.34 -20.28 58.72 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.343 -0.39 . . . . 0.66 111.09 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.508 ' HB2' HD11 ' A' ' 18' ' ' LEU . 33.3 t70 -59.59 -49.34 78.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.252 -0.431 . . . . 1.86 110.927 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.11 -44.9 2.98 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.864 -0.684 . . . . 1.06 113.043 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 76.6 mtp180 -61.42 -22.13 64.73 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.688 0.28 . . . . 2.59 111.077 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.506 ' HA ' HH22 ' A' ' 102' ' ' ARG . 63.2 mt -89.92 116.13 30.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.353 -0.385 . . . . 0.92 111.119 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.421 ' H ' ' NH2' ' A' ' 102' ' ' ARG . 36.2 tt0 -117.59 140.02 26.98 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.041 -0.527 . . . . 1.98 110.532 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.34 -178.57 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.578 2.185 . . . . 1.44 112.295 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.525 HD22 ' N ' ' A' ' 66' ' ' ASN . 0.9 OUTLIER 60.97 44.88 9.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.444 . . . . 2.15 110.681 -179.689 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -126.54 177.33 6.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.084 -0.507 . . . . 2.02 110.734 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -130.72 122.48 27.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.427 -0.351 . . . . 1.02 111.118 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 39.8 mm -75.04 143.93 12.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.29 110.618 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.495 ' HA ' ' NE2' ' A' ' 78' ' ' GLN . 71.9 mt -122.54 -66.13 1.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.927 0.394 . . . . 0.4 111.428 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.553 ' HG2' HD22 ' A' ' 76' ' ' ASN . 21.5 mtp180 -134.4 138.11 44.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 2.61 111.609 -179.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.593 HG12 ' H ' ' A' ' 73' ' ' ASP . 7.6 t -105.32 172.34 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.773 -0.649 . . . . 0.28 109.624 178.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.607 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 13.1 t70 -46.81 107.98 0.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.872 0.367 . . . . 0.79 111.766 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 49.12 22.43 0.62 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.906 -0.588 . . . . 2.01 112.208 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 98.2 t -144.49 104.78 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.775 0.321 . . . . 0.79 111.589 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.553 HD22 ' HG2' ' A' ' 71' ' ' ARG . 12.7 m120 -70.67 144.49 51.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.314 -0.403 . . . . 2.24 110.371 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 18.3 m -127.89 32.88 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.841 0.353 . . . . 0.67 111.464 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.495 ' NE2' ' HA ' ' A' ' 70' ' ' LEU . 27.2 mm-40 -100.32 31.64 3.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.157 -0.474 . . . . 1.39 111.109 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -178.56 40.6 0.08 OUTLIER Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.478 -0.868 . . . . 0.55 112.848 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 68.2 mtm -138.29 145.05 40.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.852 0.358 . . . . 0.52 110.879 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.464 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -66.97 160.75 25.76 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.061 -0.518 . . . . 0.39 111.155 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -47.81 -53.49 15.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.185 -0.461 . . . . 1.52 111.515 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.7 t -52.51 -38.47 59.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.292 -0.413 . . . . 1.48 111.389 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -68.89 -38.5 79.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.312 -0.404 . . . . 2.12 111.32 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 81' ' ' ALA . 17.5 t -62.51 -42.38 95.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.468 -0.333 . . . . 0.32 110.933 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.0 t -65.63 -36.34 77.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.491 . . . . 0.37 111.025 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -58.93 -49.36 78.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.213 -0.449 . . . . 1.51 110.857 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 56.0 t -57.89 -53.16 48.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.295 -0.411 . . . . 0.27 111.369 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 83.6 mt -58.88 -31.51 68.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.41 111.385 -179.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.454 ' HA ' ' NH1' ' A' ' 20' ' ' ARG . 69.7 mtm180 -85.43 -12.16 52.65 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.546 -0.297 . . . . 2.1 111.269 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.436 HD22 ' N ' ' A' ' 91' ' ' ASN . 0.9 OUTLIER -97.61 -11.62 23.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.289 -0.414 . . . . 1.14 110.942 179.911 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.94 -85.62 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.213 -0.448 . . . . 0.55 111.52 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.622 ' HA2' ' HE ' ' A' ' 20' ' ' ARG . . . 63.09 19.82 61.94 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.685 -0.769 . . . . 0.76 112.548 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.651 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 1.9 p-10 -147.21 168.59 10.99 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 110.407 -0.22 . . . . 2.52 110.407 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.651 ' HD2' ' HB2' ' A' ' 94' ' ' ASN . 19.6 Cg_endo -60.47 89.91 0.08 OUTLIER 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.089 1.86 . . . . 0.64 111.325 178.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.422 ' HB ' ' HB2' ' A' ' 73' ' ' ASP . 17.3 m -100.13 151.98 4.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.998 -0.546 . . . . 0.64 112.087 -178.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.607 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 59.1 mtp180 -98.11 143.85 28.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.787 -0.642 . . . . 2.37 110.055 179.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.587 HD12 HD23 ' A' ' 18' ' ' LEU . 37.3 mt -118.09 104.1 10.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.04 -0.527 . . . . 0.37 111.069 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.4 HD23 ' HB2' ' A' ' 71' ' ' ARG . 58.5 tp -100.28 99.87 10.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.34 -0.391 . . . . 0.37 110.626 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.432 ' O ' HD12 ' A' ' 100' ' ' LEU . 0.5 OUTLIER -130.11 152.47 49.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 0.31 111.234 -179.782 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.3 tt -94.29 135.93 27.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 0.45 110.79 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.506 HH22 ' HA ' ' A' ' 63' ' ' ILE . 18.0 tpp85 -120.74 145.09 47.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.066 -0.515 . . . . 2.26 110.993 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -96.69 129.86 44.02 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.067 -0.515 . . . . 3.93 110.874 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 86.2 mt -71.05 145.63 91.66 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.088 -0.505 . . . . 2.0 110.766 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -80.99 61.2 8.16 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.807 2.338 . . . . 2.98 112.388 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 99.0 mt -94.25 100.18 12.28 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.51 -0.768 . . . . 3.67 110.914 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.44 HD22 ' N ' ' A' ' 107' ' ' LEU . 3.6 mm? -88.05 102.46 14.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.484 . . . . 5.59 110.815 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.336 -0.84 . . . . 6.0 110.914 179.972 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.24 0 N-CA-C 112.591 -0.203 . . . . 7.92 112.591 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.9 p -90.32 -67.02 0.87 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.778 0.323 . . . . 7.18 111.09 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 60.2 m80 -62.49 128.45 36.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 5.91 111.023 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -179.57 43.95 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.707 -0.759 . . . . 2.45 112.639 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -101.98 71.69 1.29 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.946 0.403 . . . . 2.33 110.805 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.4 t -70.48 85.49 0.61 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.937 -0.574 . . . . 2.59 110.979 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 20.7 t70 55.83 85.8 0.07 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.163 -0.471 . . . . 2.67 110.804 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -129.53 115.37 17.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 1.58 111.445 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 27.0 t 55.94 32.62 20.12 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.957 -0.565 . . . . 2.55 111.026 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.97 -38.09 3.21 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.659 -0.782 . . . . 1.82 112.533 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.408 ' HB3' HD11 ' A' ' 101' ' ' ILE . 98.7 m-85 -61.93 95.28 0.06 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.837 0.351 . . . . 1.7 110.857 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.3 m -111.18 141.67 44.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.155 -0.475 . . . . 0.9 110.929 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 63.5 mt -79.57 122.21 26.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.988 -0.551 . . . . 0.89 110.857 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -113.71 125.53 54.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.466 . . . . 2.73 110.983 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 47.6 t -119.81 126.8 51.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.978 -0.556 . . . . 1.19 111.053 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.5 t -124.56 154.06 31.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.01 -0.541 . . . . 0.56 110.576 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -121.83 119.83 32.79 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.95 0.405 . . . . 1.74 111.585 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -114.56 166.62 11.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.87 -0.605 . . . . 0.81 110.318 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.541 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 89.3 m-85 -133.29 112.05 11.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.732 0.301 . . . . 2.08 111.497 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.472 ' HB2' HD21 ' A' ' 27' ' ' LEU . 50.8 tpt85 -97.34 102.81 14.67 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.272 -0.422 . . . . 3.06 110.571 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -160.33 20.72 0.15 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.461 . . . . 2.58 110.804 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.471 ' HD2' ' N ' ' A' ' 22' ' ' LYS . 11.5 mptt -106.8 161.52 14.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.113 -0.494 . . . . 3.72 110.952 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -83.07 50.17 1.68 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.028 -0.533 . . . . 2.87 111.038 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.4 p -117.05 -24.03 7.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.216 -0.447 . . . . 1.38 111.05 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.6 m 58.34 16.65 4.19 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.86 -0.609 . . . . 2.45 111.215 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 81.9 p -144.73 153.81 42.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.288 -0.415 . . . . 1.4 110.997 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.472 HD21 ' HB2' ' A' ' 20' ' ' ARG . 92.6 mt -114.31 -20.13 10.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 0.45 110.874 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.11 31.72 7.48 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.831 -0.7 . . . . 0.52 112.709 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 46.4 mt -110.02 116.13 51.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.868 0.366 . . . . 0.84 111.025 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 45.8 t -113.3 106.49 14.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.95 110.704 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 43.9 pt -97.36 148.08 5.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.036 -0.529 . . . . 0.41 111.245 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 45.0 t -111.46 139.45 46.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.105 -0.498 . . . . 1.32 110.878 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -89.2 113.25 4.1 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.79 -0.719 . . . . 0.95 112.464 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.405 ' HB2' ' HE1' ' A' ' 47' ' ' TYR . 56.7 ttp -94.39 116.54 28.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.686 0.279 . . . . 2.04 110.926 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.428 ' N ' ' HD3' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -110.61 138.16 47.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.302 -0.408 . . . . 5.46 110.881 179.916 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -137.07 122.47 19.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.949 -0.569 . . . . 4.29 110.655 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -123.78 18.88 9.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.278 -0.419 . . . . 5.25 111.167 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.7 p -108.33 173.57 6.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.244 -0.435 . . . . 4.88 110.974 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 63.0 p 49.31 -165.25 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.939 -0.573 . . . . 5.27 111.427 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 70.3 p -135.33 36.45 2.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 6.91 111.267 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -162.07 35.2 0.36 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.611 -0.804 . . . . 5.36 112.779 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -79.47 165.06 23.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.756 0.312 . . . . 7.22 110.891 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -146.68 120.39 9.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 3.05 111.218 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 70.7 p -86.06 154.73 21.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.154 -0.475 . . . . 2.53 110.984 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -167.73 154.67 24.96 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.626 -0.797 . . . . 1.14 112.719 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 43.5 mm -90.31 134.22 29.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.827 0.346 . . . . 0.65 110.857 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.405 ' HE1' ' HB2' ' A' ' 34' ' ' MET . 31.6 p90 -152.83 144.0 23.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.7 110.897 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 95.7 t -76.71 121.17 28.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.194 -0.457 . . . . 0.39 110.861 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -99.72 -23.31 15.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.109 -0.496 . . . . 2.4 110.918 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 46.7 t -154.28 165.09 37.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.966 0.412 . . . . 1.28 111.213 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 82.9 mt -131.88 154.79 48.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.957 -0.565 . . . . 0.42 110.671 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 42.3 mm -97.42 109.15 48.85 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.373 -0.376 . . . . 1.26 110.844 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.96 141.13 97.94 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.347 2.031 . . . . 0.82 112.422 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.92 -15.44 63.1 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.758 -0.734 . . . . 0.49 112.501 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 59.6 m -80.41 179.15 7.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.663 0.268 . . . . 1.23 110.966 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.49 -47.9 58.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.903 0.382 . . . . 0.42 111.096 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.21 -40.33 81.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.097 -0.501 . . . . 0.35 111.497 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.1 -54.16 12.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.21 -0.45 . . . . 0.44 111.331 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.2 mt -60.83 -19.56 60.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.271 -0.422 . . . . 0.66 111.212 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -52.7 -51.25 61.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.311 -0.404 . . . . 1.86 110.758 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 98.05 -32.31 7.02 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.881 -0.676 . . . . 1.06 113.145 179.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 23.2 mmm180 -71.57 -46.12 60.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.767 0.318 . . . . 2.59 111.284 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 49.5 mt -65.41 132.45 31.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.328 -0.396 . . . . 0.92 111.303 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -126.59 138.57 32.73 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.051 -0.522 . . . . 1.98 110.603 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -48.68 157.8 1.38 Allowed 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.443 2.096 . . . . 1.44 112.339 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 58.4 t30 58.99 67.27 0.94 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.471 . . . . 2.15 110.693 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -133.82 154.91 50.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.974 -0.557 . . . . 2.02 110.629 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -103.79 130.69 51.36 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.562 -0.29 . . . . 1.02 111.187 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 36.5 mm -92.54 145.43 7.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.19 -0.459 . . . . 0.29 111.022 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 70.2 mt -114.34 -66.9 1.04 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.242 -0.435 . . . . 0.4 111.038 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -152.0 141.32 21.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.086 0.47 . . . . 2.61 111.41 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.615 HG12 ' H ' ' A' ' 73' ' ' ASP . 2.2 t -90.36 175.26 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.627 -0.715 . . . . 0.28 110.033 179.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.615 ' H ' HG12 ' A' ' 72' ' ' VAL . 6.3 p-10 -55.53 114.24 1.76 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.874 0.369 . . . . 0.79 111.126 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 60.33 18.53 8.12 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.04 -0.527 . . . . 2.01 111.756 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 63.0 t -143.36 149.89 17.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.656 0.265 . . . . 0.79 111.139 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -120.01 138.58 53.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.459 -0.337 . . . . 2.24 110.587 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.2 m -117.24 28.53 2.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.822 0.344 . . . . 0.67 111.423 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -97.53 33.95 1.93 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 1.39 111.021 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 173.12 28.33 0.02 OUTLIER Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.565 -0.826 . . . . 0.55 112.865 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 36.0 mtm -126.25 145.64 50.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.739 0.304 . . . . 0.52 110.753 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.01 158.89 24.36 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.28 -0.418 . . . . 0.39 111.146 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -49.93 -58.07 6.19 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.215 -0.448 . . . . 1.52 111.531 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 46.5 t -52.65 -39.95 62.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.188 -0.46 . . . . 1.48 111.395 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -61.2 -47.9 84.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.832 0.349 . . . . 2.12 110.987 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 55.4 t -57.46 -40.79 76.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.108 -0.497 . . . . 0.32 111.121 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 90.9 t -63.27 -39.04 83.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 0.37 110.928 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.454 ' HG2' HH21 ' A' ' 90' ' ' ARG . 45.8 mt-10 -58.99 -40.83 86.03 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.264 -0.425 . . . . 1.51 110.386 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 52.1 t -60.36 -52.91 55.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.905 -0.589 . . . . 0.27 111.203 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 67.0 mt -53.93 -38.02 64.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.095 -0.502 . . . . 0.41 111.397 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.454 HH21 ' HG2' ' A' ' 87' ' ' GLU . 76.8 mtm180 -81.28 -21.12 39.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.244 -0.434 . . . . 2.1 111.246 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.468 HD22 ' N ' ' A' ' 91' ' ' ASN . 0.9 OUTLIER -90.82 -5.05 56.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.361 -0.381 . . . . 1.14 111.16 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.475 ' HB1' HG22 ' A' ' 96' ' ' VAL . . . -54.02 -71.66 0.07 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.329 -0.396 . . . . 0.55 111.133 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 63.14 10.55 34.58 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.697 -0.763 . . . . 0.76 112.522 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -147.51 173.57 4.09 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 110.077 -0.342 . . . . 2.52 110.077 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.541 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 86.8 Cg_exo -47.79 100.09 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.005 1.803 . . . . 0.64 111.379 178.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.475 HG22 ' HB1' ' A' ' 92' ' ' ALA . 2.3 t -80.84 113.72 20.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.106 -0.497 . . . . 0.64 111.755 -178.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.563 ' H ' ' HB3' ' A' ' 73' ' ' ASP . 80.0 ttt180 -91.38 126.51 36.49 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.532 -0.544 . . . . 2.37 109.532 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 27.7 mt -109.42 103.61 12.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.373 -0.376 . . . . 0.37 111.721 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 32.0 tp -96.34 99.75 11.41 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.324 -0.621 . . . . 0.37 109.324 178.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -130.14 168.19 17.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.119 -0.491 . . . . 0.31 111.862 -178.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.408 HD11 ' HB3' ' A' ' 11' ' ' PHE . 17.3 tt -118.44 143.95 27.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 115.668 -0.696 . . . . 0.45 110.782 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.69 123.21 27.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.094 -0.503 . . . . 2.26 110.384 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 43.8 ttp180 -79.76 135.99 36.64 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.95 0.405 . . . . 3.93 111.3 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 16.2 mt -107.11 152.88 41.23 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.99 -0.55 . . . . 2.0 110.725 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -82.4 162.0 17.24 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.472 2.114 . . . . 2.98 112.279 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 90.7 mt -139.87 73.74 1.44 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.168 -0.469 . . . . 3.67 110.794 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 86.6 mt -70.73 167.31 19.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.484 . . . . 5.59 111.089 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.238 -0.887 . . . . 6.0 111.022 -179.87 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.141 0 N-CA-C 112.492 -0.243 . . . . 7.92 112.492 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 55.3 m -92.92 -32.79 14.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.814 0.34 . . . . 7.18 110.949 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -89.32 -10.15 47.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.19 -0.459 . . . . 5.91 110.885 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 95.52 -156.91 21.71 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.849 -0.691 . . . . 2.45 112.509 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 55.19 73.14 0.43 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.804 0.335 . . . . 2.33 111.033 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.5 t -99.99 108.58 20.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 2.59 110.794 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 40.95 49.55 2.99 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.119 -0.492 . . . . 2.67 111.31 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.58 101.74 5.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.996 -0.547 . . . . 1.58 111.267 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.8 m 56.91 27.0 12.4 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.133 -0.485 . . . . 2.55 111.094 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.25 35.88 16.42 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.732 -0.747 . . . . 1.82 112.378 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -139.0 126.96 22.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.97 0.414 . . . . 1.7 111.0 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.6 t -147.67 141.44 25.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.938 -0.574 . . . . 0.9 110.671 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 58.2 mt -81.07 119.1 23.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.89 111.252 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -118.43 151.62 37.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.005 -0.543 . . . . 2.73 110.586 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 78.0 p -141.26 145.6 35.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.875 0.369 . . . . 1.19 111.341 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 46.6 t -135.07 139.46 47.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.009 -0.541 . . . . 0.56 110.788 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -100.2 113.09 25.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.321 -0.399 . . . . 1.74 110.848 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 33.8 mt -124.37 141.07 52.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.365 -0.379 . . . . 0.81 111.44 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.558 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 44.3 p90 -118.7 141.2 48.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.056 -0.52 . . . . 2.08 110.613 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.485 HH21 ' N ' ' A' ' 93' ' ' GLY . 13.0 ttp180 -118.49 80.76 1.58 Allowed 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.702 -0.399 . . . . 3.06 111.551 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -99.86 10.07 41.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.436 . . . . 2.58 110.779 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.468 ' HD2' ' N ' ' A' ' 22' ' ' LYS . 3.2 mptp? -108.88 156.05 20.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.988 -0.551 . . . . 3.72 110.819 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -86.25 73.56 10.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 2.87 110.926 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 52.4 p -113.43 -22.61 10.28 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.121 -0.49 . . . . 1.38 111.079 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 51.2 m 59.26 19.89 8.01 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.842 -0.617 . . . . 2.45 111.185 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 77.6 p -158.8 137.9 11.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.307 -0.406 . . . . 1.4 111.162 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.479 HD21 ' HB2' ' A' ' 20' ' ' ARG . 75.4 mt -97.26 -10.75 25.15 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.029 -0.532 . . . . 0.45 110.683 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.521 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 92.11 14.85 55.52 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.784 -0.722 . . . . 0.52 112.829 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 69.6 mt -98.61 110.57 26.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.778 0.323 . . . . 0.84 111.178 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 34.2 t -111.23 101.1 9.62 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.277 -0.419 . . . . 0.95 110.842 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 40.8 pt -92.4 166.67 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.996 -0.547 . . . . 0.41 111.43 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 46.0 t -131.94 134.94 46.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.03 -0.532 . . . . 1.32 110.795 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.19 127.99 46.38 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.844 -0.693 . . . . 0.95 112.631 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 27.1 ttt -87.22 102.52 14.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.817 0.341 . . . . 2.04 110.873 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.9 ppt_? -106.07 39.76 1.73 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.482 . . . . 5.46 111.016 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -115.2 158.45 22.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.111 -0.495 . . . . 4.29 110.856 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 57.63 88.31 0.06 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.052 -0.522 . . . . 5.25 110.999 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 51.8 m -68.68 85.96 0.31 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 4.88 110.919 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 72.0 p -134.78 142.81 46.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.11 -0.495 . . . . 5.27 111.019 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 74.2 p -106.66 29.96 6.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 6.91 111.218 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.26 -48.74 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.861 -0.685 . . . . 5.36 112.43 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -138.88 95.06 2.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.87 0.367 . . . . 7.22 110.842 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -143.73 -160.15 1.08 Allowed 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.125 -0.488 . . . . 3.05 110.526 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 80.7 p 49.51 -167.18 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.901 -0.59 . . . . 2.53 111.53 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 159.17 -24.26 0.32 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.611 -0.805 . . . . 1.14 112.558 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 49.8 mm 58.97 95.61 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.88 0.372 . . . . 0.65 111.114 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -119.77 138.28 53.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.466 . . . . 0.7 111.103 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.8 t -80.51 123.92 37.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.059 -0.519 . . . . 0.39 110.807 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -106.43 -29.26 9.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.033 -0.531 . . . . 2.4 111.053 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 53.3 m -137.6 167.27 22.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.031 0.443 . . . . 1.28 111.606 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 82.4 mt -137.68 163.59 30.9 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.807 -0.633 . . . . 0.42 110.752 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.521 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 67.6 mt -102.51 101.02 17.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 1.26 110.786 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.452 ' HD2' ' HA ' ' A' ' 52' ' ' ILE . 19.1 Cg_endo -57.56 94.81 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.475 2.116 . . . . 0.82 112.263 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 143.91 -8.09 1.95 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.838 -0.696 . . . . 0.49 112.388 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.423 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 53.0 m -96.47 178.66 5.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.757 0.313 . . . . 1.23 110.858 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.46 -53.34 59.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.301 -0.409 . . . . 0.42 111.706 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.86 -37.33 66.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.19 -0.459 . . . . 0.35 111.853 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -77.98 -32.67 51.41 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.963 0.357 . . . . 0.44 111.963 -179.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 55' ' ' SER . 55.1 mt -62.74 -55.47 26.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.727 0.299 . . . . 0.66 111.221 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -57.87 -41.78 83.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 1.86 111.1 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 79.6 -11.66 31.6 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.81 -0.709 . . . . 1.06 112.681 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 39.7 mtp180 -63.18 -16.83 61.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.807 0.337 . . . . 2.59 110.828 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 76.3 mt -104.04 115.56 46.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.081 -0.509 . . . . 0.92 110.932 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -86.85 155.46 55.74 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 1.98 111.156 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -78.3 38.19 0.68 Allowed 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.785 2.323 . . . . 1.44 112.473 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -164.93 64.14 0.13 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.861 0.362 . . . . 2.15 110.746 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -132.19 167.32 19.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.146 -0.479 . . . . 2.02 110.656 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -113.31 106.88 15.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.897 0.38 . . . . 1.02 111.171 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 46.5 mm -64.07 143.73 15.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.468 . . . . 0.29 110.833 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 57.9 mt -116.42 -58.13 2.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.28 -0.418 . . . . 0.4 111.212 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -159.94 136.09 8.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.031 0.443 . . . . 2.61 111.465 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.682 HG12 ' H ' ' A' ' 73' ' ' ASP . 2.6 t -88.88 175.87 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.634 -0.712 . . . . 0.28 109.909 179.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.682 ' H ' HG12 ' A' ' 72' ' ' VAL . 12.2 t70 -44.3 108.74 0.12 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.836 0.35 . . . . 0.79 111.802 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 53.13 33.91 16.18 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.115 -0.493 . . . . 2.01 112.11 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 92.1 t -147.56 126.39 4.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.535 -0.302 . . . . 0.79 111.047 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -96.83 122.98 40.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.401 -0.363 . . . . 2.24 110.423 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.49 HG11 HG13 ' A' ' 85' ' ' VAL . 29.7 m -108.42 26.44 2.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 CA-C-O 120.858 0.361 . . . . 0.67 111.586 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -94.4 24.82 4.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.269 -0.423 . . . . 1.39 110.779 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -169.88 16.42 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.663 -0.78 . . . . 0.55 112.746 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 60.4 mtm -118.35 143.51 46.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.864 0.364 . . . . 0.52 110.856 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.414 ' HB3' ' OD2' ' A' ' 84' ' ' ASP . . . -64.83 164.91 11.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.161 -0.472 . . . . 0.39 111.295 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.445 ' O ' HG23 ' A' ' 86' ' ' VAL . 35.3 tt0 -51.74 -55.4 19.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 1.52 111.351 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.2 m -50.44 -42.7 54.44 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.192 -0.458 . . . . 1.48 111.577 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.414 ' OD2' ' HB3' ' A' ' 81' ' ' ALA . 20.4 m-20 -61.05 -49.08 78.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.381 -0.372 . . . . 2.12 111.096 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.49 HG13 HG11 ' A' ' 77' ' ' VAL . 33.7 t -60.59 -33.44 54.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.486 . . . . 0.32 111.276 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 82' ' ' GLN . 89.7 t -67.59 -43.55 86.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.287 -0.415 . . . . 0.37 110.98 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.425 ' HG2' HH21 ' A' ' 90' ' ' ARG . 44.1 mt-10 -56.95 -45.78 82.57 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.363 -0.381 . . . . 1.51 110.633 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 55.3 t -56.15 -52.43 50.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.083 -0.508 . . . . 0.27 110.893 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 82.2 mt -61.38 -25.74 67.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.883 -0.599 . . . . 0.41 110.95 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.425 HH21 ' HG2' ' A' ' 87' ' ' GLU . 78.1 mtm180 -87.93 -11.68 46.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.196 -0.456 . . . . 2.1 111.12 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.449 HD22 ' N ' ' A' ' 91' ' ' ASN . 0.9 OUTLIER -99.41 -12.65 20.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.316 -0.402 . . . . 1.14 110.605 179.625 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.5 -86.22 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.998 -0.546 . . . . 0.55 111.445 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.485 ' N ' HH21 ' A' ' 20' ' ' ARG . . . 61.84 21.97 61.63 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.62 -0.8 . . . . 0.76 112.231 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.622 ' HB3' ' HD2' ' A' ' 95' ' ' PRO . 3.7 m120 -147.46 174.54 3.32 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 110.583 -0.155 . . . . 2.52 110.583 -179.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.622 ' HD2' ' HB3' ' A' ' 94' ' ' ASN . 36.2 Cg_endo -66.45 81.61 0.3 Allowed 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 122.106 1.871 . . . . 0.64 112.004 178.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 22.7 m -91.29 154.21 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.95 -0.568 . . . . 0.64 111.48 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.65 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 77.2 ttt180 -94.56 144.07 25.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.782 -0.645 . . . . 2.37 110.112 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 25.9 mt -118.53 103.89 10.16 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.221 -0.445 . . . . 0.37 110.986 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 24.8 tp -100.76 104.2 15.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.966 0.412 . . . . 0.37 110.781 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.85 168.03 20.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.995 -0.548 . . . . 0.31 110.866 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 19.4 tt -114.03 134.8 55.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-O 121.015 0.436 . . . . 0.45 111.289 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -115.28 146.43 41.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.584 -0.734 . . . . 2.26 110.689 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -97.62 124.1 41.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.36 -0.382 . . . . 3.93 111.125 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 66.4 mt -95.02 142.48 24.67 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.122 -0.49 . . . . 2.0 110.74 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -82.34 165.86 16.35 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.526 2.15 . . . . 2.98 112.549 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 89.4 mt -134.53 154.26 51.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 3.67 110.833 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -99.55 138.19 36.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.117 -0.492 . . . . 5.59 111.001 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.282 -0.866 . . . . 6.0 110.779 -179.951 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.185 0 N-CA-C 112.538 -0.225 . . . . 7.92 112.538 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 53.4 m -91.71 -55.73 3.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.84 0.352 . . . . 7.18 111.081 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -96.4 -64.46 1.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 5.91 110.973 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -143.45 -98.98 0.29 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.676 -0.774 . . . . 2.45 112.409 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.551 ' H ' HD11 ' A' ' 13' ' ' LEU . 41.3 m-85 -94.39 123.83 38.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.896 0.379 . . . . 2.33 111.12 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.3 t -106.13 -169.32 1.56 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.024 -0.535 . . . . 2.59 110.543 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -54.17 103.53 0.08 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.857 0.361 . . . . 2.67 110.839 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -145.76 112.34 5.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.489 . . . . 1.58 111.051 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 61.4 m 56.86 19.11 4.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.137 -0.483 . . . . 2.55 111.095 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.91 -45.8 1.26 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.737 -0.744 . . . . 1.82 112.652 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -51.44 110.98 0.51 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.927 0.394 . . . . 1.7 111.357 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.0 t -130.29 141.28 50.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.863 -0.608 . . . . 0.9 110.727 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.551 HD11 ' H ' ' A' ' 5' ' ' TYR . 95.2 mt -79.62 120.6 24.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 0.89 111.276 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -115.0 157.29 23.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.075 -0.511 . . . . 2.73 110.656 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 41.1 t -148.91 132.24 16.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.916 0.389 . . . . 1.19 111.161 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 44.4 t -125.16 129.9 73.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.078 -0.51 . . . . 0.56 110.775 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -95.47 109.85 21.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.15 -0.477 . . . . 1.74 111.16 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.435 HD12 HD11 ' A' ' 98' ' ' LEU . 28.5 mt -115.76 166.19 12.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 0.81 110.874 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.66 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 39.3 p90 -149.91 133.75 16.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 2.08 111.046 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.6 tpp180 -109.49 122.24 46.97 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.001 0.429 . . . . 3.06 110.831 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -121.77 -25.69 5.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.893 -0.594 . . . . 2.58 110.637 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -71.65 169.71 15.0 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.841 -0.618 . . . . 3.72 110.682 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -95.63 51.91 1.32 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.269 -0.423 . . . . 2.87 110.788 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 79.7 p -103.36 -24.12 13.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.133 -0.485 . . . . 1.38 111.141 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.7 t 58.41 21.12 8.07 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.951 -0.568 . . . . 2.45 111.228 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 79.0 p -145.03 153.3 41.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.869 0.366 . . . . 1.4 111.122 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 81.7 mt -114.12 -8.5 12.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.008 -0.542 . . . . 0.45 110.799 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.438 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 97.78 -12.1 64.38 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.831 -0.699 . . . . 0.52 112.8 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 69.8 mt -63.51 108.69 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.727 0.299 . . . . 0.84 111.156 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 36.3 t -112.19 114.22 26.9 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.318 -0.401 . . . . 0.95 110.636 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.4 pt -96.22 -178.84 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.381 -0.372 . . . . 0.41 111.362 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 77.3 p -163.44 137.4 5.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.138 -0.483 . . . . 1.32 110.75 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -88.73 120.93 5.82 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.796 -0.716 . . . . 0.95 112.561 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 57.1 ttp -71.35 147.19 48.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.762 0.315 . . . . 2.04 110.944 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.446 ' N ' ' HD3' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -147.79 140.14 24.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.196 -0.456 . . . . 5.46 110.848 -179.907 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -111.65 171.53 7.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 4.29 110.939 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.467 ' CD ' ' H ' ' A' ' 37' ' ' GLN . 5.4 pm0 -87.92 28.2 1.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.062 -0.517 . . . . 5.25 110.837 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.4 m -154.77 78.83 1.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 4.88 110.723 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 77.6 p -61.0 134.29 56.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.109 -0.496 . . . . 5.27 111.201 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.7 t -168.88 14.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.095 -0.502 . . . . 6.91 111.01 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.8 171.21 41.83 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.812 -0.709 . . . . 5.36 112.548 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 58.36 -177.56 0.07 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.832 0.348 . . . . 7.22 111.202 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 58.27 49.71 10.74 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.099 -0.5 . . . . 3.05 111.07 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 50.8 p -141.24 127.05 19.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.1 -0.5 . . . . 2.53 111.079 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -149.74 160.64 28.57 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.734 -0.746 . . . . 1.14 112.632 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 39.5 mm -90.92 131.53 37.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.699 0.285 . . . . 0.65 110.861 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 46.5 p90 -153.68 144.84 22.92 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.338 -0.392 . . . . 0.7 111.411 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 66.4 t -79.6 132.79 31.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.031 -0.532 . . . . 0.39 110.924 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -125.73 -26.19 3.54 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.102 -0.499 . . . . 2.4 111.022 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 56.6 m -130.16 161.96 29.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.025 0.441 . . . . 1.28 111.275 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 83.6 mt -141.65 129.09 21.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.814 -0.63 . . . . 0.42 110.728 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.438 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 63.1 mt -68.26 117.95 54.51 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.28 -0.418 . . . . 1.26 110.934 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.21 96.76 0.64 Allowed 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.191 1.927 . . . . 0.82 112.252 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 137.29 0.45 2.7 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.837 -0.697 . . . . 0.49 112.511 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 63.6 m -101.32 172.46 6.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.62 0.247 . . . . 1.23 110.902 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.36 -53.13 61.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.431 -0.35 . . . . 0.42 111.8 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -47.15 -40.78 16.41 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.243 -0.435 . . . . 0.35 112.019 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.37 -38.99 29.35 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.984 0.365 . . . . 0.44 111.984 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 60.1 mt -56.3 -56.22 23.77 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.47 -0.332 . . . . 0.66 111.634 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -56.54 -34.26 66.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.402 -0.363 . . . . 1.86 111.236 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 78.34 -12.74 18.71 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.784 -0.722 . . . . 1.06 112.504 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -59.72 -29.25 68.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.789 0.328 . . . . 2.59 110.792 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.507 ' N ' HD12 ' A' ' 63' ' ' ILE . 4.0 mp -93.49 115.1 31.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.479 . . . . 0.92 110.651 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.466 ' HB2' ' HD2' ' A' ' 65' ' ' PRO . 12.0 pt-20 -113.03 158.13 38.76 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.458 . . . . 1.98 110.696 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.466 ' HD2' ' HB2' ' A' ' 64' ' ' GLU . 21.2 Cg_endo -60.05 173.18 1.93 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.399 2.066 . . . . 1.44 112.095 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 54.09 58.86 4.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.044 0.45 . . . . 2.15 110.668 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -136.51 154.28 50.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.976 -0.556 . . . . 2.02 110.537 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -110.15 136.93 48.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.977 0.418 . . . . 1.02 111.49 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.471 HD13 ' HB3' ' A' ' 100' ' ' LEU . 45.3 mm -97.79 120.58 47.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.817 -0.629 . . . . 0.29 110.346 179.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 77.4 mt -93.25 -63.79 1.17 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.429 -0.35 . . . . 0.4 111.33 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.404 ' O ' ' HB3' ' A' ' 99' ' ' LEU . 62.6 mtp180 -141.7 142.09 33.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.098 0.475 . . . . 2.61 111.664 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.637 HG12 ' H ' ' A' ' 73' ' ' ASP . 4.4 t -100.47 174.04 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.724 -0.671 . . . . 0.28 109.944 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.653 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 18.8 t70 -50.43 110.6 0.42 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.657 0.265 . . . . 0.79 111.205 179.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.4 t70 56.04 26.05 9.58 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.254 -0.43 . . . . 2.01 111.248 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.52 ' HB ' ' HB ' ' A' ' 72' ' ' VAL . 86.9 t -144.56 153.93 14.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.79 110.631 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -129.59 126.56 38.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.743 0.306 . . . . 2.24 110.746 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.2 m -104.63 25.14 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.245 -0.434 . . . . 0.67 111.067 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -89.62 26.34 1.77 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.083 -0.508 . . . . 1.39 110.956 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 174.78 34.12 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.535 -0.84 . . . . 0.55 112.897 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 49.8 mtm -126.62 147.35 49.91 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.834 0.35 . . . . 0.52 110.858 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.03 156.23 18.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.1 -0.5 . . . . 0.39 111.301 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -51.44 -58.63 5.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.325 -0.398 . . . . 1.52 111.154 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.6 t -55.94 -36.94 68.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.099 -0.5 . . . . 1.48 111.179 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -60.15 -46.41 89.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.355 -0.384 . . . . 2.12 110.907 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 60.7 t -59.49 -38.3 74.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.454 . . . . 0.32 110.886 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 58.8 t -64.35 -41.57 92.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.157 -0.474 . . . . 0.37 111.077 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.546 ' HG2' HH21 ' A' ' 90' ' ' ARG . 48.3 mt-10 -57.85 -44.51 86.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.893 0.378 . . . . 1.51 110.547 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 54.0 t -56.18 -55.55 17.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.947 -0.57 . . . . 0.27 111.102 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 78.7 mt -57.22 -29.79 64.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.043 -0.526 . . . . 0.41 111.259 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.546 HH21 ' HG2' ' A' ' 87' ' ' GLU . 63.5 mtm180 -83.1 -20.76 34.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.462 -0.335 . . . . 2.1 111.097 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -86.44 -18.35 31.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 1.14 110.825 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.44 -85.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.289 -0.414 . . . . 0.55 110.988 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 60.48 23.01 59.88 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.739 -0.743 . . . . 0.76 112.583 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.483 ' HB3' ' HD2' ' A' ' 95' ' ' PRO . 2.2 m120 -147.34 175.91 2.48 Favored Pre-proline 0 C--N 1.329 -0.322 0 C-N-CA 121.928 0.091 . . . . 2.52 110.863 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.66 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 51.5 Cg_exo -56.76 103.54 0.12 Allowed 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 122.096 1.864 . . . . 0.64 111.715 178.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 31.3 m -123.51 149.46 27.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.111 0.482 . . . . 0.64 111.945 -179.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.653 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 42.5 ttp180 -94.34 142.96 26.81 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.61 -0.723 . . . . 2.37 109.983 179.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.435 HD11 HD12 ' A' ' 18' ' ' LEU . 52.8 mt -116.58 115.46 25.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.188 -0.46 . . . . 0.37 111.273 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.404 ' HB3' ' O ' ' A' ' 71' ' ' ARG . 59.3 tp -108.88 103.22 12.23 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.941 0.4 . . . . 0.37 110.32 179.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.471 ' HB3' HD13 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -132.4 166.27 22.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.089 -0.505 . . . . 0.31 111.329 -179.249 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 19.0 tt -120.6 140.38 44.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.121 -0.491 . . . . 0.45 110.986 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -130.58 126.21 36.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.056 -0.52 . . . . 2.26 110.396 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -82.85 138.93 33.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.904 0.383 . . . . 3.93 111.216 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.1 mt -101.16 145.23 30.07 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.098 -0.501 . . . . 2.0 110.626 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -81.1 163.22 20.22 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.406 2.071 . . . . 2.98 112.5 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 85.1 mt -137.45 109.97 7.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.95 -0.568 . . . . 3.67 110.854 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -74.19 147.38 42.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.133 -0.485 . . . . 5.59 110.93 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.249 -0.881 . . . . 6.0 110.877 -179.972 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 112.436 -0.266 . . . . 7.92 112.436 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.6 m -111.29 -31.9 6.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.813 0.34 . . . . 7.18 110.843 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 28.3 t60 -88.31 95.06 10.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 5.91 110.747 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -149.94 54.43 0.49 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.805 -0.712 . . . . 2.45 112.412 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -139.3 157.03 46.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.908 0.385 . . . . 2.33 111.111 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 93.7 p -144.37 -167.99 2.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.991 -0.549 . . . . 2.59 110.459 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -55.49 97.63 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.837 0.351 . . . . 2.67 110.978 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -134.85 100.05 4.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.062 -0.517 . . . . 1.58 110.788 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.2 t 56.86 22.74 7.38 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.126 -0.488 . . . . 2.55 110.887 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.83 -36.36 4.3 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.81 -0.709 . . . . 1.82 112.643 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.42 ' HA ' ' HA ' ' A' ' 103' ' ' ARG . 25.1 m-85 -55.99 118.86 5.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.907 0.384 . . . . 1.7 110.961 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.2 t -154.75 159.66 40.8 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.071 -0.513 . . . . 0.9 111.215 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.539 HD23 ' HB ' ' A' ' 101' ' ' ILE . 16.6 mt -96.02 106.99 19.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.614 -0.721 . . . . 0.89 110.242 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.432 ' HE1' ' HB3' ' A' ' 102' ' ' ARG . 32.7 p90 -127.97 150.47 49.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.855 0.36 . . . . 2.73 111.06 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 80.3 p -123.84 135.55 53.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.107 -0.497 . . . . 1.19 111.268 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.9 t -110.4 144.62 18.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.94 -0.573 . . . . 0.56 110.477 179.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -88.58 122.26 31.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.872 0.368 . . . . 1.74 111.252 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -127.13 166.25 18.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.964 -0.562 . . . . 0.81 110.787 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.558 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 27.9 p90 -152.77 130.52 11.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.25 -0.432 . . . . 2.08 111.04 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.465 ' HB2' HD21 ' A' ' 27' ' ' LEU . 2.0 tmm_? -108.17 107.03 17.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.312 -0.403 . . . . 3.06 110.659 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -133.06 -28.67 1.51 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.328 -0.396 . . . . 2.58 111.33 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -64.0 161.03 16.65 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.137 -0.483 . . . . 3.72 111.018 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -83.37 37.54 0.57 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.022 -0.535 . . . . 2.87 111.203 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 71.2 p -88.43 -16.18 33.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 1.38 111.028 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 51.6 m 57.54 20.5 6.22 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.903 -0.589 . . . . 2.45 111.082 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 88.5 p -159.32 -176.62 5.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.345 -0.389 . . . . 1.4 110.909 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.465 HD21 ' HB2' ' A' ' 20' ' ' ARG . 68.7 mt -128.83 -0.49 5.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.023 -0.535 . . . . 0.45 110.634 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.29 26.76 51.07 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.835 -0.698 . . . . 0.52 112.566 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.443 HG22 HG23 ' A' ' 31' ' ' ILE . 85.0 mt -100.94 114.52 40.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.905 0.383 . . . . 0.84 111.1 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.0 m -109.03 92.82 4.21 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.113 -0.494 . . . . 0.95 110.722 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.443 HG23 HG22 ' A' ' 29' ' ' ILE . 43.1 pt -90.46 164.99 2.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.0 -0.545 . . . . 0.41 111.236 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.2 t -145.4 134.49 22.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 1.32 110.788 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -66.73 131.83 31.64 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.839 -0.696 . . . . 0.95 112.396 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 53.0 ttm -60.52 146.16 45.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.762 0.315 . . . . 2.04 110.97 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -118.9 130.75 55.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 5.46 110.935 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -134.97 154.84 51.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.047 -0.524 . . . . 4.29 110.857 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.425 ' CD ' ' H ' ' A' ' 37' ' ' GLN . 5.1 pm0 -110.24 134.68 51.99 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.133 -0.485 . . . . 5.25 110.804 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.2 m 53.94 71.46 0.51 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.14 -0.482 . . . . 4.88 110.787 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 61.1 p -81.45 147.64 29.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.061 -0.518 . . . . 5.27 111.321 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 72.4 p -99.53 9.07 43.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.051 -0.522 . . . . 6.91 110.919 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 155.76 -82.9 0.15 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.915 -0.659 . . . . 5.36 112.482 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -125.23 133.83 52.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.872 0.368 . . . . 7.22 110.936 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -166.55 56.2 0.09 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.154 -0.475 . . . . 3.05 111.163 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 68.2 p -118.44 152.88 35.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 2.53 111.106 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -152.09 142.93 9.83 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.644 -0.789 . . . . 1.14 112.598 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 37.6 mm -94.88 126.02 47.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.704 0.288 . . . . 0.65 110.713 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -149.49 145.15 26.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.338 -0.392 . . . . 0.7 111.457 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 93.1 t -83.37 115.58 25.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.957 -0.565 . . . . 0.39 110.64 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -89.5 -31.34 17.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.073 -0.512 . . . . 2.4 111.351 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.0 t -151.29 169.0 23.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.96 0.409 . . . . 1.28 111.605 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 86.1 mt -124.94 169.73 11.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.731 -0.668 . . . . 0.42 110.514 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 50.4 mm -108.62 99.96 36.24 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.278 -0.419 . . . . 1.26 111.047 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -51.73 116.06 2.5 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.56 2.174 . . . . 0.82 112.397 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 111.31 3.49 27.54 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.802 -0.713 . . . . 0.49 112.33 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 55.1 m -99.78 174.15 6.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.65 0.262 . . . . 1.23 111.037 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.68 -56.65 19.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.304 -0.407 . . . . 0.42 111.353 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.46 -33.06 58.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.256 -0.429 . . . . 0.35 111.384 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.08 -26.06 39.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.289 -0.414 . . . . 0.44 111.529 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 31.2 mt -70.59 -37.65 73.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.473 -0.331 . . . . 0.66 111.241 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -61.74 -40.59 95.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.41 -0.359 . . . . 1.86 110.993 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 79.48 -13.99 19.45 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.797 -0.716 . . . . 1.06 112.632 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 69.6 mtp180 -74.99 -23.05 58.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.788 0.327 . . . . 2.59 110.935 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.488 ' N ' HD12 ' A' ' 63' ' ' ILE . 3.7 mp -84.19 118.9 32.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.436 . . . . 0.92 110.715 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -106.3 136.79 19.31 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.111 -0.495 . . . . 1.98 110.614 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -56.09 163.24 6.31 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.486 2.124 . . . . 1.44 112.316 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 62.95 45.78 5.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.065 -0.516 . . . . 2.15 111.046 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -109.55 165.45 11.66 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.098 -0.501 . . . . 2.02 110.602 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -113.61 107.05 15.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.819 0.342 . . . . 1.02 111.207 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.462 ' HA ' ' HB3' ' A' ' 100' ' ' LEU . 43.7 mm -66.53 136.73 26.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.12 -0.491 . . . . 0.29 110.692 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 96.6 mt -113.03 -72.17 0.72 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.45 -0.341 . . . . 0.4 111.318 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 -135.89 137.35 41.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.001 0.429 . . . . 2.61 111.61 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.515 HG12 ' H ' ' A' ' 73' ' ' ASP . 9.3 t -98.91 168.59 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.872 -0.604 . . . . 0.28 109.829 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.652 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 13.4 t70 -47.86 108.3 0.16 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.923 0.392 . . . . 0.79 111.95 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.8 t70 58.69 6.68 0.64 Allowed 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.592 0.589 . . . . 2.01 112.592 178.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 38.9 t -140.09 101.05 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.718 0.294 . . . . 0.79 111.59 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -73.83 153.78 39.78 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.454 -0.339 . . . . 2.24 110.427 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.402 HG11 HG13 ' A' ' 85' ' ' VAL . 34.9 m -125.62 28.55 2.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-O 120.853 0.359 . . . . 0.67 111.554 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -94.32 42.25 1.09 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.268 -0.424 . . . . 1.39 111.011 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 165.76 33.23 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.642 -0.79 . . . . 0.55 113.04 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 50.5 mtm -131.39 152.48 50.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.862 0.363 . . . . 0.52 111.01 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.402 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -64.55 152.98 40.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.011 -0.54 . . . . 0.39 111.179 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -52.69 -55.86 19.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.355 -0.384 . . . . 1.52 111.286 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 48.0 t -53.7 -40.06 65.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.137 -0.483 . . . . 1.48 111.413 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -62.34 -46.24 89.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.322 -0.399 . . . . 2.12 111.118 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.402 HG13 HG11 ' A' ' 77' ' ' VAL . 75.6 t -57.94 -36.64 56.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.122 -0.49 . . . . 0.32 111.128 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 64.9 t -65.99 -43.3 92.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 0.37 111.025 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -57.25 -39.41 75.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.183 -0.462 . . . . 1.51 110.612 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 52.9 t -62.3 -53.66 44.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.27 111.208 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 76.5 mt -53.29 -30.06 36.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.933 -0.576 . . . . 0.41 111.174 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -87.53 -26.64 23.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 2.1 111.295 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -78.22 -12.17 59.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.421 -0.354 . . . . 1.14 111.032 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -49.76 -80.26 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.272 -0.422 . . . . 0.55 111.29 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 65.87 10.84 52.54 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.591 -0.814 . . . . 0.76 112.379 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.548 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -146.88 168.56 11.15 Favored Pre-proline 0 C--N 1.328 -0.332 0 N-CA-C 110.44 -0.207 . . . . 2.52 110.44 -179.827 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.558 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 19.0 Cg_endo -61.24 102.42 0.22 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.003 1.802 . . . . 0.64 111.506 178.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 29.9 m -107.81 146.66 13.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.64 112.015 -178.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.652 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 20.7 ttm180 -92.18 142.76 27.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.818 -0.628 . . . . 2.37 109.847 179.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 71.8 mt -116.09 103.4 10.52 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.071 -0.513 . . . . 0.37 110.892 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 65.1 tp -98.99 114.26 26.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 0.37 110.382 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.462 ' HB3' ' HA ' ' A' ' 69' ' ' ILE . 0.5 OUTLIER -147.27 167.95 22.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.475 . . . . 0.31 111.487 -179.352 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.539 ' HB ' HD23 ' A' ' 13' ' ' LEU . 11.7 tt -116.23 139.16 44.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.828 -0.624 . . . . 0.45 110.807 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.432 ' HB3' ' HE1' ' A' ' 14' ' ' TYR . 32.7 tpt180 -166.22 138.89 3.94 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.206 -0.452 . . . . 2.26 110.601 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.42 ' HA ' ' HA ' ' A' ' 11' ' ' PHE . 16.7 ptm180 -62.85 145.5 54.92 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.02 -0.536 . . . . 3.93 111.288 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.3 mt -106.19 154.78 39.44 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.657 -0.701 . . . . 2.0 110.791 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.81 171.38 9.88 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.407 2.072 . . . . 2.98 112.275 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 90.5 mt -145.31 127.43 15.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.948 -0.569 . . . . 3.67 110.831 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.476 HD22 ' N ' ' A' ' 107' ' ' LEU . 3.3 mm? -93.28 165.65 12.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 5.59 110.661 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.276 -0.869 . . . . 6.0 110.778 179.747 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.111 0 N-CA-C 112.528 -0.229 . . . . 7.92 112.528 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.2 t -154.59 -72.85 0.12 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.74 0.305 . . . . 7.18 110.839 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 59.6 m80 55.53 82.68 0.1 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.148 -0.478 . . . . 5.91 110.88 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 151.0 89.38 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.753 -0.737 . . . . 2.45 112.464 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -107.22 93.85 4.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.785 0.326 . . . . 2.33 110.865 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 45.1 t -89.18 99.58 12.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 2.59 110.781 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 20.4 t70 56.4 81.64 0.12 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.128 -0.487 . . . . 2.67 110.787 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -143.91 111.3 5.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.27 -0.423 . . . . 1.58 111.353 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 63.0 m 56.49 25.62 9.93 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.957 -0.565 . . . . 2.55 111.515 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.68 -52.47 1.15 Allowed Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.62 -0.8 . . . . 1.82 112.594 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -50.65 103.98 0.07 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.928 0.394 . . . . 1.7 111.068 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 56.2 p -123.16 143.19 50.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.891 -0.595 . . . . 0.9 110.655 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 76.5 mt -77.78 128.72 34.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.121 -0.491 . . . . 0.89 111.319 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -114.74 132.55 56.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.927 -0.579 . . . . 2.73 111.058 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 84.9 p -124.56 128.55 49.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.099 -0.501 . . . . 1.19 110.929 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 23.6 t -133.04 149.38 31.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.117 -0.492 . . . . 0.56 110.919 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -111.41 120.77 43.31 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.843 0.354 . . . . 1.74 110.986 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -121.18 166.45 13.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.034 -0.53 . . . . 0.81 111.119 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.6 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 33.8 p90 -147.86 129.19 14.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.997 -0.547 . . . . 2.08 110.82 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.472 ' HB2' HD21 ' A' ' 27' ' ' LEU . 3.0 tmm_? -108.71 115.31 29.84 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.935 0.398 . . . . 3.06 111.007 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -150.93 13.76 0.71 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.101 -0.5 . . . . 2.58 110.934 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -103.78 160.52 14.71 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.197 -0.456 . . . . 3.72 110.712 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -90.62 57.92 3.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 2.87 110.889 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 37.5 p -118.76 -10.49 9.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 1.38 111.103 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 90.7 p 49.71 26.84 1.98 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.76 -0.655 . . . . 2.45 111.413 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 53.4 m -152.69 137.48 17.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.38 -0.373 . . . . 1.4 111.059 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.472 HD21 ' HB2' ' A' ' 20' ' ' ARG . 85.1 mt -91.53 -34.58 14.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.081 -0.509 . . . . 0.45 110.778 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.459 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 127.26 -26.82 4.91 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.869 -0.682 . . . . 0.52 112.444 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 70.3 mt -63.93 113.67 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.792 0.329 . . . . 0.84 110.928 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.3 t -113.84 99.43 7.68 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.15 -0.477 . . . . 0.95 110.997 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.8 pt -96.47 159.2 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.073 -0.512 . . . . 0.41 111.071 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 47.4 t -115.2 146.69 41.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.237 -0.438 . . . . 1.32 110.949 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.98 157.54 35.16 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.901 -0.666 . . . . 0.95 112.455 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 16.7 tpt -117.97 145.46 44.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.894 0.378 . . . . 2.04 111.04 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.41 ' HD2' ' N ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -130.23 72.63 1.49 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.028 -0.533 . . . . 5.46 110.69 179.787 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -99.45 152.43 20.0 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.007 -0.542 . . . . 4.29 111.071 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -94.45 147.64 23.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.004 -0.544 . . . . 5.25 110.847 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 53.0 m -59.94 103.23 0.2 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.113 -0.494 . . . . 4.88 110.983 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 71.6 p -128.77 163.12 25.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.015 -0.538 . . . . 5.27 110.93 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.4 t -74.06 0.44 13.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.013 -0.539 . . . . 6.91 111.246 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -119.83 104.41 1.03 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.742 -0.742 . . . . 5.36 112.554 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 58.98 -178.73 0.08 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.822 0.344 . . . . 7.22 111.209 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -163.95 117.26 1.45 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.488 . . . . 3.05 111.205 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 79.8 p 50.2 -167.41 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.075 -0.512 . . . . 2.53 111.701 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 159.56 140.34 2.88 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.825 -0.703 . . . . 1.14 112.337 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 42.7 mm -100.01 138.13 25.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.796 0.331 . . . . 0.65 111.041 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -151.21 143.56 24.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.485 . . . . 0.7 111.109 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 79.3 t -76.81 134.89 27.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.215 -0.448 . . . . 0.39 110.757 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -113.39 -31.81 6.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.985 -0.552 . . . . 2.4 111.169 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 80.0 p -153.71 177.07 11.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.957 0.408 . . . . 1.28 111.395 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 97.6 mt -133.75 149.44 51.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.765 -0.652 . . . . 0.42 110.838 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.459 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 57.1 mt -81.16 121.35 80.41 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.289 -0.414 . . . . 1.26 111.121 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.16 114.23 3.7 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.441 2.094 . . . . 0.82 112.265 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.82 16.36 15.75 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.63 -0.795 . . . . 0.49 112.652 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 78.0 p -107.76 176.45 5.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.717 0.294 . . . . 1.23 110.906 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.57 -57.6 9.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.34 -0.391 . . . . 0.42 111.206 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.13 -29.58 13.94 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.118 -0.492 . . . . 0.35 111.591 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -77.74 -40.92 39.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.303 -0.408 . . . . 0.44 111.455 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.6 mt -61.78 -35.96 79.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.311 -0.404 . . . . 0.66 111.273 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -61.79 -47.32 85.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.287 -0.415 . . . . 1.86 111.101 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.06 -20.65 7.92 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.77 -0.728 . . . . 1.06 112.477 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 12.8 mmm180 -62.22 -22.39 65.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.827 0.346 . . . . 2.59 110.889 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.472 ' N ' HD12 ' A' ' 63' ' ' ILE . 4.1 mp -91.18 111.23 23.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.12 -0.491 . . . . 0.92 110.899 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -98.68 134.49 21.62 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.035 -0.529 . . . . 1.98 110.531 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.94 159.9 4.72 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.488 2.125 . . . . 1.44 112.279 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 61.13 82.98 0.15 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.992 -0.549 . . . . 2.15 110.861 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -156.51 170.77 21.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.072 -0.513 . . . . 2.02 110.707 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -114.42 126.06 54.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.405 -0.361 . . . . 1.02 111.096 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 41.4 mm -84.53 137.99 19.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.135 -0.484 . . . . 0.29 110.784 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.457 ' HA ' ' NE2' ' A' ' 78' ' ' GLN . 89.1 mt -101.36 -61.51 1.37 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.28 -0.418 . . . . 0.4 111.07 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -158.17 138.48 12.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.171 0.51 . . . . 2.61 111.676 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.671 HG12 ' H ' ' A' ' 73' ' ' ASP . 2.9 t -86.85 175.48 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.551 -0.749 . . . . 0.28 109.997 179.281 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.671 ' H ' HG12 ' A' ' 72' ' ' VAL . 14.7 t70 -49.54 110.25 0.36 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.795 0.331 . . . . 0.79 111.804 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.1 t70 60.69 9.91 2.39 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.044 -0.526 . . . . 2.01 111.978 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.558 HG11 HG21 ' A' ' 88' ' ' VAL . 57.7 t -128.51 141.85 45.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.674 0.273 . . . . 0.79 110.999 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -109.26 129.55 55.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.323 -0.399 . . . . 2.24 110.709 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.4 m -111.92 26.6 3.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-O 120.89 0.376 . . . . 0.67 111.319 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.457 ' NE2' ' HA ' ' A' ' 70' ' ' LEU . 27.0 mm-40 -86.77 31.62 0.69 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.14 -0.482 . . . . 1.39 111.306 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 162.38 43.3 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.466 -0.873 . . . . 0.55 112.974 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 47.7 mtm -129.68 138.34 51.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.874 0.368 . . . . 0.52 110.905 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.41 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -60.93 156.66 17.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.107 -0.497 . . . . 0.39 111.123 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -48.33 -49.16 35.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.331 -0.395 . . . . 1.52 111.363 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 81.0 p -53.31 -44.96 68.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.121 -0.491 . . . . 1.48 111.444 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -61.56 -45.32 94.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.294 -0.412 . . . . 2.12 111.426 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 81' ' ' ALA . 15.5 t -59.34 -41.38 84.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.331 -0.395 . . . . 0.32 111.003 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 92.2 t -64.14 -37.7 80.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.046 -0.525 . . . . 0.37 111.103 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -58.73 -47.5 84.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 1.51 110.655 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.558 HG21 HG11 ' A' ' 75' ' ' VAL . 65.1 t -56.75 -55.09 21.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.022 -0.535 . . . . 0.27 111.256 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.404 HD22 HD12 ' A' ' 27' ' ' LEU . 84.5 mt -53.07 -36.69 60.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.82 -0.627 . . . . 0.41 111.822 -179.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 81.7 mtm180 -84.48 -18.39 36.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.613 -0.267 . . . . 2.1 111.67 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -89.98 -8.03 52.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.703 0.287 . . . . 1.14 110.87 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -55.49 -83.74 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.251 -0.431 . . . . 0.55 111.263 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.463 ' HA2' ' NE ' ' A' ' 20' ' ' ARG . . . 62.11 14.5 46.8 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.717 -0.754 . . . . 0.76 112.37 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -146.9 168.51 11.25 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 110.45 -0.204 . . . . 2.52 110.45 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.6 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 36.1 Cg_exo -62.33 96.5 0.15 Allowed 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.211 1.941 . . . . 0.64 111.161 178.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.5 m -105.76 152.76 7.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.124 0.488 . . . . 0.64 111.988 -178.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.649 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 52.5 ttp180 -102.49 144.8 30.47 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.737 -0.665 . . . . 2.37 110.048 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.9 mt -117.23 107.5 14.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.106 -0.497 . . . . 0.37 110.838 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 53.4 tp -99.01 101.69 13.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.304 -0.407 . . . . 0.37 110.499 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.1 162.64 27.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.063 -0.517 . . . . 0.31 111.175 -179.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.5 tt -117.27 140.86 38.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.211 -0.45 . . . . 0.45 111.207 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 29.4 tpt180 -136.56 130.3 32.19 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.016 -0.538 . . . . 2.26 110.766 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -79.19 139.99 37.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.102 -0.499 . . . . 3.93 110.941 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 24.9 mt -86.34 137.71 34.53 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.963 -0.562 . . . . 2.0 110.507 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -81.27 58.76 7.08 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.61 2.207 . . . . 2.98 112.111 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 91.2 mt -88.61 145.85 25.45 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.367 -0.833 . . . . 3.67 111.013 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -105.45 141.07 37.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.981 -0.554 . . . . 5.59 110.781 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.239 -0.886 . . . . 6.0 110.831 179.941 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.197 0 N-CA-C 112.517 -0.233 . . . . 7.92 112.517 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.7 t -79.07 -67.33 0.76 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.96 0.41 . . . . 7.18 110.865 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 51.8 m80 -68.11 -23.93 64.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.889 -0.596 . . . . 5.91 110.866 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 97.98 -59.86 1.0 Allowed Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.849 -0.691 . . . . 2.45 112.372 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -98.29 80.13 2.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.754 0.311 . . . . 2.33 111.008 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.5 m -129.65 21.7 5.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.997 0.427 . . . . 2.59 110.815 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -179.53 89.51 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.422 -0.808 . . . . 2.67 110.692 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -160.23 102.58 1.42 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.286 -0.415 . . . . 1.58 111.091 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 70.7 m 60.62 21.71 11.56 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.119 -0.491 . . . . 2.55 110.867 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.407 ' HA2' HD12 ' A' ' 104' ' ' LEU . . . 88.5 10.49 67.75 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.842 -0.694 . . . . 1.82 112.75 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.419 ' HB3' HD11 ' A' ' 101' ' ' ILE . 84.1 m-85 -104.85 91.24 3.75 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.944 0.402 . . . . 1.7 111.041 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.1 t -110.72 143.2 41.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.907 -0.588 . . . . 0.9 110.635 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 91.4 mt -84.34 121.65 27.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.89 110.945 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -115.6 150.24 36.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.064 -0.516 . . . . 2.73 110.921 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 80.9 p -146.43 138.18 24.74 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.385 -0.37 . . . . 1.19 111.274 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.479 HG11 ' HB2' ' A' ' 62' ' ' ARG . 42.0 t -136.99 138.64 45.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.131 -0.486 . . . . 0.56 110.935 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -89.92 112.49 23.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 1.74 111.042 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -115.7 114.05 24.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.011 -0.541 . . . . 0.81 110.735 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.618 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 44.2 p90 -95.8 134.42 38.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 2.08 111.037 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.59 ' HB2' HD21 ' A' ' 27' ' ' LEU . 14.0 ttp180 -110.94 88.35 2.76 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.416 -0.357 . . . . 3.06 111.101 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -157.75 64.19 0.47 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.977 0.418 . . . . 2.58 110.998 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -145.64 34.52 1.04 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.303 0.573 . . . . 3.72 110.774 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 17.7 t70 59.01 25.34 13.73 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.119 -0.946 . . . . 2.87 110.903 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 82.7 p -92.52 -28.24 16.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.338 -0.392 . . . . 1.38 111.213 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 99.0 p 49.62 24.84 1.27 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.811 -0.631 . . . . 2.45 111.505 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 80.9 p -160.0 144.98 15.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.938 0.399 . . . . 1.4 111.075 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.59 HD21 ' HB2' ' A' ' 20' ' ' ARG . 71.7 mt -101.33 -24.41 14.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.056 -0.52 . . . . 0.45 110.66 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.09 -9.32 75.23 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.802 -0.713 . . . . 0.52 112.648 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.5 mt -58.93 108.56 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.849 0.357 . . . . 0.84 110.877 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 44.4 t -111.79 109.88 19.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.141 -0.481 . . . . 0.95 110.79 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 38.3 pt -101.46 172.18 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.028 -0.533 . . . . 0.41 111.205 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 57.0 m -146.35 137.92 24.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.476 . . . . 1.32 110.933 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -75.82 161.72 52.53 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.842 -0.694 . . . . 0.95 112.593 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 54.0 ttm -108.88 139.74 43.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.84 0.352 . . . . 2.04 110.925 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.471 ' HD3' ' N ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -164.8 132.5 3.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 5.46 110.747 179.76 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -149.67 -68.03 0.21 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.15 -0.477 . . . . 4.29 110.896 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -126.13 145.22 50.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.086 -0.506 . . . . 5.25 111.035 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 52.3 m -65.52 95.62 0.22 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.041 -0.527 . . . . 4.88 110.795 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 67.9 p -86.6 146.22 26.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 5.27 111.17 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.8 t -80.97 3.61 22.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.081 -0.509 . . . . 6.91 111.144 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -135.05 -121.08 2.09 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.845 -0.693 . . . . 5.36 112.311 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -114.98 147.52 39.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.84 0.352 . . . . 7.22 110.956 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -168.53 39.03 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.056 -0.52 . . . . 3.05 111.228 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 70.6 p -139.67 137.97 35.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 2.53 111.05 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -146.92 158.24 27.67 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.751 -0.738 . . . . 1.14 112.598 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 47.4 mm -91.46 128.24 43.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.832 0.349 . . . . 0.65 110.942 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 48.3 p90 -156.97 142.28 17.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.124 -0.489 . . . . 0.7 110.969 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 89.0 t -85.78 135.03 25.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.39 111.006 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -123.65 -20.96 5.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.495 . . . . 2.4 111.081 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.7 t -140.31 161.22 38.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.988 0.423 . . . . 1.28 111.447 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 96.5 mt -136.6 127.16 26.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.748 -0.66 . . . . 0.42 110.569 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 50.8 mm -63.52 112.54 7.35 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.313 -0.403 . . . . 1.26 110.899 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.47 102.1 0.39 Allowed 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.398 2.066 . . . . 0.82 112.252 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 129.65 -0.58 5.88 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.794 -0.717 . . . . 0.49 112.489 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.9 m -98.2 174.19 6.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.678 0.275 . . . . 1.23 110.903 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -55.75 -58.59 7.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 0.42 111.648 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.407 ' HB1' HD12 ' A' ' 63' ' ' ILE . . . -50.72 -32.23 18.91 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.357 -0.383 . . . . 0.35 111.479 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.91 -32.79 40.2 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.308 -0.406 . . . . 0.44 111.627 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 79.9 mt -63.52 -55.94 19.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.377 -0.374 . . . . 0.66 111.114 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -55.13 -37.06 66.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.246 -0.433 . . . . 1.86 111.04 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 62.94 7.17 15.08 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.985 -0.626 . . . . 1.06 112.896 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.479 ' HB2' HG11 ' A' ' 16' ' ' VAL . 34.9 mtp180 -82.86 3.28 30.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.738 0.304 . . . . 2.59 110.926 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.407 HD12 ' HB1' ' A' ' 57' ' ' ALA . 61.7 mt -110.54 133.51 55.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.92 110.982 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.407 ' HA ' ' HD2' ' A' ' 65' ' ' PRO . 20.2 tp10 -108.08 125.39 32.14 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.475 . . . . 1.98 110.787 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 64' ' ' GLU . 11.2 Cg_endo -54.66 174.38 0.19 Allowed 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.628 2.219 . . . . 1.44 112.168 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.572 HD22 ' N ' ' A' ' 66' ' ' ASN . 0.8 OUTLIER 60.79 25.87 15.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.199 -0.455 . . . . 2.15 110.549 -179.66 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -95.7 155.58 16.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.926 -0.579 . . . . 2.02 110.578 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -104.95 109.32 21.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.407 -0.36 . . . . 1.02 110.984 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 41.1 mm -68.7 132.52 32.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.113 -0.494 . . . . 0.29 110.952 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 76.6 mt -104.12 -63.85 1.16 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.128 -0.487 . . . . 0.4 110.814 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -149.59 136.56 19.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.161 0.505 . . . . 2.61 111.518 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.573 HG12 ' H ' ' A' ' 73' ' ' ASP . 9.9 t -89.88 171.14 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.593 -0.73 . . . . 0.28 109.866 179.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.683 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 14.0 t70 -48.26 108.53 0.17 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.789 0.328 . . . . 0.79 111.817 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.5 t70 58.48 6.99 0.64 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.919 -0.582 . . . . 2.01 112.328 178.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.1 t -137.85 99.54 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.695 0.283 . . . . 0.79 111.435 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -72.57 152.08 42.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.214 -0.448 . . . . 2.24 110.769 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.452 HG13 HG23 ' A' ' 72' ' ' VAL . 34.4 m -119.92 26.11 3.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.36 -0.382 . . . . 0.67 111.269 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -91.22 27.58 1.86 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 1.39 111.13 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -175.18 19.91 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.532 -0.842 . . . . 0.55 112.905 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.411 ' HE2' ' HA ' ' A' ' 77' ' ' VAL . 45.7 mtm -120.95 139.46 53.22 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.858 0.361 . . . . 0.52 111.0 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.46 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -65.16 156.56 31.32 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.976 -0.556 . . . . 0.39 111.108 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -44.75 -44.14 9.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.369 -0.378 . . . . 1.52 111.386 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 48.2 t -58.71 -53.16 61.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.295 -0.411 . . . . 1.48 111.404 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -54.52 -39.14 67.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 2.12 111.429 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 81' ' ' ALA . 21.1 t -62.29 -41.44 91.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.426 -0.352 . . . . 0.32 111.221 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.568 HG13 HH21 ' A' ' 90' ' ' ARG . 85.8 t -63.23 -43.31 98.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.245 -0.434 . . . . 0.37 111.148 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -57.74 -46.63 84.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.301 -0.409 . . . . 1.51 111.207 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 71.9 t -56.37 -58.03 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.984 0.421 . . . . 0.27 111.345 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 75.8 mt -60.01 -23.98 64.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.971 -0.558 . . . . 0.41 111.297 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.568 HH21 HG13 ' A' ' 86' ' ' VAL . 2.1 tpp180 -89.28 -12.48 40.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.242 -0.436 . . . . 2.1 111.432 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -103.92 -9.64 18.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.612 -0.267 . . . . 1.14 111.143 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -50.18 -78.72 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.296 -0.411 . . . . 0.55 111.458 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.47 ' H ' ' HE ' ' A' ' 20' ' ' ARG . . . 61.02 19.39 56.68 Favored Glycine 0 C--N 1.331 0.25 0 C-N-CA 120.712 -0.756 . . . . 0.76 112.281 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -147.09 169.83 8.75 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 110.433 -0.21 . . . . 2.52 110.433 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.618 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 23.0 Cg_exo -65.9 93.23 0.27 Allowed 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.196 1.931 . . . . 0.64 111.644 178.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 29.8 m -101.96 153.4 5.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.043 0.449 . . . . 0.64 111.876 -179.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.683 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 80.0 ttt180 -98.55 144.6 27.69 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.605 -0.725 . . . . 2.37 110.182 179.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 18.2 mt -118.05 103.56 10.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.091 -0.504 . . . . 0.37 110.867 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 34.2 tp -97.96 104.59 16.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.879 0.371 . . . . 0.37 110.519 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -133.93 158.96 42.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.092 -0.503 . . . . 0.31 111.351 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.419 HD11 ' HB3' ' A' ' 11' ' ' PHE . 17.3 tt -105.32 135.33 43.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.102 -0.499 . . . . 0.45 110.273 179.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 32.4 tpt180 -128.47 132.96 48.4 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.869 0.366 . . . . 2.26 111.379 -179.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 22.6 ttp180 -85.32 142.26 29.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.004 -0.544 . . . . 3.93 110.696 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.407 HD12 ' HA2' ' A' ' 10' ' ' GLY . 41.0 mt -85.69 151.92 56.21 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.114 -0.494 . . . . 2.0 110.708 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -78.38 60.89 7.68 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.674 2.249 . . . . 2.98 112.095 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 87.2 mt -59.66 110.7 1.2 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.393 -0.822 . . . . 3.67 111.146 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 82.8 mt -102.41 98.09 8.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.471 . . . . 5.59 110.786 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.28 -0.867 . . . . 6.0 110.935 -179.86 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.154 0 N-CA-C 112.459 -0.256 . . . . 7.92 112.459 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.9 m -104.46 -14.96 15.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.796 0.332 . . . . 7.18 110.903 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -75.14 132.99 41.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 5.91 111.044 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 74.01 -124.9 8.68 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.801 -0.714 . . . . 2.45 112.674 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -81.37 139.58 35.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.857 0.36 . . . . 2.33 110.966 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.5 t -141.1 90.35 2.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.196 -0.457 . . . . 2.59 111.025 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 20.5 t70 55.04 88.07 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.108 -0.497 . . . . 2.67 111.028 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -139.49 114.52 9.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.081 -0.509 . . . . 1.58 110.653 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.0 p 53.8 32.11 14.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.048 -0.524 . . . . 2.55 110.995 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.437 ' O ' ' HG ' ' A' ' 104' ' ' LEU . . . 92.57 -46.58 2.55 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.797 -0.716 . . . . 1.82 112.478 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -62.0 98.16 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.868 0.366 . . . . 1.7 111.074 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 44.6 t -120.51 147.11 45.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.985 -0.552 . . . . 0.9 110.547 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 88.3 mt -85.46 121.75 28.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.281 -0.418 . . . . 0.89 111.126 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -113.79 148.29 36.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.992 -0.549 . . . . 2.73 110.893 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.3 m -144.55 136.62 26.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 1.19 111.286 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 33.2 t -135.51 132.55 51.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.027 -0.533 . . . . 0.56 110.599 179.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -93.3 124.65 37.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.292 -0.413 . . . . 1.74 111.398 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -119.63 151.8 38.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.896 -0.593 . . . . 0.81 110.725 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.519 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 19.2 m-85 -123.14 106.52 10.84 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.108 -0.496 . . . . 2.08 110.462 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.487 ' HE ' ' HA2' ' A' ' 93' ' ' GLY . 5.0 ttp180 -97.56 126.16 42.69 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.56 -0.456 . . . . 3.06 110.813 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -141.61 -36.25 0.44 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.117 -0.492 . . . . 2.58 110.957 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -68.47 154.25 42.2 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.956 -0.566 . . . . 3.72 110.883 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -84.43 56.5 3.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 2.87 111.017 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 65.9 p -92.59 -21.16 20.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.306 -0.406 . . . . 1.38 110.994 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.1 t 58.0 18.56 5.2 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.759 -0.655 . . . . 2.45 111.461 179.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.2 t -154.59 141.48 19.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.835 0.35 . . . . 1.4 110.928 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.8 mt -107.95 -15.03 14.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.45 110.793 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.437 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 108.34 13.69 18.48 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.669 -0.776 . . . . 0.52 112.691 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.428 HG23 HG22 ' A' ' 48' ' ' VAL . 76.8 mt -97.56 113.38 31.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.816 0.341 . . . . 0.84 111.058 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.2 t -113.3 103.41 11.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.241 -0.436 . . . . 0.95 110.814 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 31.7 pt -101.54 147.48 8.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.247 -0.433 . . . . 0.41 111.256 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 71.5 m -114.25 130.73 56.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.479 . . . . 1.32 110.712 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -63.82 132.35 40.44 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.813 -0.708 . . . . 0.95 112.467 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.416 ' HB2' ' HE1' ' A' ' 47' ' ' TYR . 16.0 tpt -112.06 88.06 2.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.758 0.313 . . . . 2.04 111.081 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -150.48 77.49 1.3 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.077 0.465 . . . . 5.46 110.947 179.831 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -59.54 153.54 19.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.09 -0.505 . . . . 4.29 111.064 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.467 ' CD ' ' H ' ' A' ' 37' ' ' GLN . 0.1 OUTLIER -91.71 14.98 13.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.154 -0.476 . . . . 5.25 111.008 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 79.2 p -139.44 27.04 2.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 4.88 110.783 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 74.3 p -64.84 138.5 58.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 5.27 111.016 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.8 t -95.9 -5.24 41.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.074 -0.512 . . . . 6.91 110.956 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -165.99 -131.52 1.26 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.868 -0.682 . . . . 5.36 112.421 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -106.88 127.27 53.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.761 0.315 . . . . 7.22 110.839 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -163.71 80.43 0.43 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 3.05 111.137 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 50.4 p -139.27 156.07 47.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.36 -0.382 . . . . 2.53 111.406 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.18 153.62 8.04 Favored Glycine 0 C--N 1.329 0.194 0 C-N-CA 120.808 -0.71 . . . . 1.14 112.488 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 50.4 mm -90.85 131.23 38.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.719 0.295 . . . . 0.65 110.967 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.416 ' HE1' ' HB2' ' A' ' 34' ' ' MET . 25.0 p90 -152.54 135.03 15.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.891 0.377 . . . . 0.7 111.214 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.428 HG22 HG23 ' A' ' 29' ' ' ILE . 85.3 t -70.72 112.99 6.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.123 -0.49 . . . . 0.39 110.834 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -88.52 -29.39 20.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.866 -0.606 . . . . 2.4 111.076 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 78.3 p -156.06 171.27 20.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.006 0.432 . . . . 1.28 111.212 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 71.0 mt -128.89 151.7 49.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.911 -0.586 . . . . 0.42 110.69 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.437 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 45.5 mm -84.02 113.41 47.71 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 1.26 110.921 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -58.5 132.11 46.53 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.576 2.184 . . . . 0.82 112.506 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.56 11.17 78.13 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.9 -0.667 . . . . 0.49 112.846 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.413 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 22.2 t -99.71 170.32 8.64 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.656 0.265 . . . . 1.23 111.055 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -56.52 -54.62 43.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.332 -0.395 . . . . 0.42 111.489 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -49.18 -44.07 42.65 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.04 -0.527 . . . . 0.35 111.533 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.79 -33.58 75.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.48 . . . . 0.44 111.477 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 55' ' ' SER . 90.9 mt -65.9 -33.42 75.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.378 -0.374 . . . . 0.66 111.187 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -58.8 -46.59 87.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.954 0.407 . . . . 1.86 110.764 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.95 -33.46 3.55 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.839 -0.696 . . . . 1.06 112.554 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 58.5 mtp180 -67.71 -22.14 65.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.805 0.336 . . . . 2.59 110.735 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 70.0 mt -93.84 115.41 32.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.485 . . . . 0.92 110.924 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.453 ' HB2' ' HD2' ' A' ' 65' ' ' PRO . 13.5 pt-20 -118.71 158.6 46.99 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.111 -0.495 . . . . 1.98 110.531 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.453 ' HD2' ' HB2' ' A' ' 64' ' ' GLU . 21.2 Cg_endo -59.27 178.05 0.33 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.38 2.053 . . . . 1.44 112.216 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 18.2 m120 55.5 34.94 24.09 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.166 -0.47 . . . . 2.15 110.809 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.507 ' HB2' ' HD3' ' A' ' 102' ' ' ARG . 5.3 t70 -100.42 153.05 19.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.021 -0.536 . . . . 2.02 110.886 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -110.89 95.67 5.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.861 0.363 . . . . 1.02 110.758 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.452 HD13 ' HB3' ' A' ' 100' ' ' LEU . 44.8 mm -60.42 132.58 25.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.059 -0.519 . . . . 0.29 110.971 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 73.1 mt -100.99 -65.44 0.97 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.036 -0.529 . . . . 0.4 110.866 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.425 ' CG ' HD23 ' A' ' 99' ' ' LEU . 7.7 ptp180 -150.54 135.18 17.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.16 0.505 . . . . 2.61 111.827 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.533 HG12 ' N ' ' A' ' 73' ' ' ASP . 15.7 t -87.96 170.31 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.46 -0.791 . . . . 0.28 109.822 179.025 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.654 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 11.8 t70 -46.51 117.95 1.8 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.723 0.297 . . . . 0.79 111.593 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.5 p30 47.32 19.4 0.12 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.755 -0.657 . . . . 2.01 112.696 179.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.5 t -147.87 100.1 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.655 0.264 . . . . 0.79 110.969 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -76.35 144.04 40.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.36 -0.382 . . . . 2.24 110.814 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.6 m -117.04 30.41 2.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.36 -0.382 . . . . 0.67 111.242 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -89.94 41.74 1.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 1.39 111.174 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 157.5 25.77 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.503 -0.856 . . . . 0.55 112.982 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 37.1 mtm -117.73 138.73 51.83 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.856 0.36 . . . . 0.52 110.742 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.412 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -59.66 160.95 6.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.019 -0.537 . . . . 0.39 111.234 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.446 ' O ' HG23 ' A' ' 86' ' ' VAL . 36.2 tt0 -54.12 -57.61 10.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.35 -0.386 . . . . 1.52 111.087 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 79.7 p -49.93 -32.9 15.9 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.209 -0.451 . . . . 1.48 111.271 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.477 ' O ' HG23 ' A' ' 88' ' ' VAL . 12.4 t70 -69.04 -46.75 67.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.379 -0.373 . . . . 2.12 110.969 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 81' ' ' ALA . 15.2 t -64.6 -29.16 46.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.99 0.424 . . . . 0.32 110.953 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 82' ' ' GLN . 95.9 t -66.18 -58.58 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.964 -0.562 . . . . 0.37 111.287 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 84' ' ' ASP . 13.6 pt-20 -54.16 -36.59 63.51 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.495 -0.32 . . . . 1.51 110.975 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 84' ' ' ASP . 51.7 t -57.11 -56.1 16.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.889 0.376 . . . . 0.27 111.041 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 65.4 mt -57.72 -27.25 62.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.001 -0.545 . . . . 0.41 111.192 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -86.83 -17.63 32.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.335 -0.393 . . . . 2.1 111.302 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -91.47 -13.24 32.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.459 -0.337 . . . . 1.14 110.923 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -50.48 -84.18 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.099 -0.5 . . . . 0.55 111.529 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.487 ' HA2' ' HE ' ' A' ' 20' ' ' ARG . . . 62.79 17.77 58.47 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.8 -0.714 . . . . 0.76 112.532 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.441 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -146.94 172.82 4.76 Favored Pre-proline 0 C--N 1.328 -0.354 0 C-N-CA 121.974 0.11 . . . . 2.52 110.922 -179.734 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.519 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 32.0 Cg_exo -61.43 92.22 0.11 Allowed 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 122.233 1.955 . . . . 0.64 111.497 178.086 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.438 HG13 HD22 ' A' ' 94' ' ' ASN . 16.0 m -97.0 144.97 9.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.93 0.395 . . . . 0.64 111.855 -179.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.654 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 75.2 ttt180 -101.64 143.2 31.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.766 -0.652 . . . . 2.37 109.711 179.121 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 36.6 mt -113.35 107.16 15.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.189 -0.46 . . . . 0.37 111.334 -179.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.425 HD23 ' CG ' ' A' ' 71' ' ' ARG . 33.6 tp -100.07 99.84 10.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.411 -0.358 . . . . 0.37 110.294 179.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.452 ' HB3' HD13 ' A' ' 69' ' ' ILE . 0.4 OUTLIER -127.99 164.42 22.38 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.224 -0.444 . . . . 0.31 111.379 -179.507 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.3 tt -118.02 139.25 45.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 116.087 -0.506 . . . . 0.45 111.133 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.507 ' HD3' ' HB2' ' A' ' 67' ' ' ASP . 15.5 mmm180 -130.91 135.05 47.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.738 -0.664 . . . . 2.26 110.867 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 34.8 ptt180 -97.12 136.29 37.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.123 -0.49 . . . . 3.93 110.806 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 10' ' ' GLY . 28.3 mt -87.14 148.47 45.1 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.049 -0.523 . . . . 2.0 110.697 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -80.37 59.41 7.43 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.639 2.226 . . . . 2.98 112.171 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 92.0 mt -90.17 97.49 11.22 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.436 -0.802 . . . . 3.67 111.007 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -100.67 175.78 5.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.142 -0.481 . . . . 5.59 110.819 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.297 -0.859 . . . . 6.0 110.93 -179.948 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.557 -0.217 . . . . 7.92 112.557 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 61.3 p -78.01 -177.93 5.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.702 0.287 . . . . 7.18 110.962 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 54.6 m-70 57.5 45.57 19.36 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.144 -0.48 . . . . 5.91 110.979 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -142.25 64.57 0.5 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.764 -0.731 . . . . 2.45 112.497 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -119.79 62.53 0.82 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.914 0.388 . . . . 2.33 110.782 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 51.4 m -88.11 100.42 12.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.975 -0.557 . . . . 2.59 111.02 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 54.29 74.19 0.35 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.078 -0.51 . . . . 2.67 110.809 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -106.1 -34.35 7.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.139 -0.482 . . . . 1.58 111.316 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 93.0 p -178.11 32.01 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.111 -0.495 . . . . 2.55 110.563 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.68 19.19 5.79 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 121.004 -0.617 . . . . 1.82 112.479 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -134.33 131.9 38.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.683 0.278 . . . . 1.7 110.709 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.6 t -151.9 138.63 18.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.439 . . . . 0.9 111.103 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.3 mt -77.33 119.44 20.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.816 -0.629 . . . . 0.89 110.883 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -119.09 163.68 16.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.127 -0.488 . . . . 2.73 110.859 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 84.4 p -151.63 146.88 26.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.878 0.371 . . . . 1.19 111.04 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 13.5 t -131.61 136.01 58.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.091 -0.504 . . . . 0.56 110.799 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -89.63 113.19 24.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.289 -0.414 . . . . 1.74 111.364 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -118.0 166.04 13.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.904 -0.589 . . . . 0.81 110.64 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.544 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 30.9 p90 -158.92 128.59 5.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.276 -0.42 . . . . 2.08 111.104 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.704 HH21 ' HG ' ' A' ' 27' ' ' LEU . 21.0 ttm180 -101.47 82.72 2.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.905 0.383 . . . . 3.06 110.835 179.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -97.99 -18.05 18.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.05 -0.523 . . . . 2.58 110.747 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -95.11 144.95 25.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.034 -0.53 . . . . 3.72 110.644 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -81.06 70.93 8.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.306 -0.406 . . . . 2.87 110.749 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 72.2 p -108.21 -9.85 15.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 1.38 111.138 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 83.3 p 51.99 22.51 1.85 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.788 -0.642 . . . . 2.45 111.211 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 56.3 m -157.09 131.78 8.73 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.306 -0.406 . . . . 1.4 110.962 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.704 ' HG ' HH21 ' A' ' 20' ' ' ARG . 49.7 mt -92.69 -25.24 18.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.45 110.619 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.568 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 99.6 31.76 5.96 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.819 -0.705 . . . . 0.52 112.759 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.438 HG22 HG23 ' A' ' 31' ' ' ILE . 45.4 mt -109.32 108.69 25.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.661 0.267 . . . . 0.84 110.926 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 46.5 m -104.14 90.22 3.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.345 -0.388 . . . . 0.95 110.884 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.438 HG23 HG22 ' A' ' 29' ' ' ILE . 28.7 pt -88.3 165.98 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.0 -0.545 . . . . 0.41 111.295 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 53.2 m -142.85 136.42 28.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.121 -0.49 . . . . 1.32 110.909 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.96 160.29 42.38 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.87 -0.681 . . . . 0.95 112.769 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 28.1 ttt -114.56 113.74 24.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.766 0.317 . . . . 2.04 110.896 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.425 ' HD2' ' N ' ' A' ' 35' ' ' ARG . 4.2 mpt_? -111.65 98.81 7.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 5.46 110.695 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -147.46 152.23 37.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.336 -0.393 . . . . 4.29 111.023 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -99.61 127.2 45.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 5.25 111.051 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 61.7 m -144.3 128.72 17.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 4.88 110.592 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 69.6 p -94.16 171.81 8.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 5.27 111.523 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 15.3 t 42.25 33.08 0.37 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.627 -0.715 . . . . 6.91 111.58 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 159.7 168.05 21.16 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.849 -0.691 . . . . 5.36 112.437 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -94.92 177.11 6.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.665 0.269 . . . . 7.22 110.7 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -161.82 40.51 0.13 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.274 -0.421 . . . . 3.05 111.123 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.9 p -103.67 142.88 33.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 2.53 111.021 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -170.23 150.26 14.27 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.828 -0.701 . . . . 1.14 112.479 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 45.4 mm -101.76 131.82 48.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.765 0.317 . . . . 0.65 110.965 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 51.6 p90 -144.18 152.95 41.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.247 -0.433 . . . . 0.7 111.165 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.407 HG23 ' CG1' ' A' ' 69' ' ' ILE . 81.3 t -86.77 123.58 39.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.077 -0.51 . . . . 0.39 110.898 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -99.49 -26.91 13.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.072 -0.513 . . . . 2.4 110.941 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 64.0 m -151.85 170.64 19.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.308 -0.405 . . . . 1.28 111.122 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.5 mt -133.91 146.85 50.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.04 -0.527 . . . . 0.42 110.77 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.568 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 44.0 mm -90.06 108.64 27.43 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.239 -0.437 . . . . 1.26 110.892 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -60.94 138.09 76.54 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.351 2.034 . . . . 0.82 112.287 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 98.39 -11.12 63.4 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.75 -0.738 . . . . 0.49 112.499 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.1 m -89.44 -176.25 4.98 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.699 0.285 . . . . 1.23 110.963 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.73 -58.98 3.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.42 111.45 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.13 -32.13 45.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.13 -0.486 . . . . 0.35 111.649 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.81 -49.59 17.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.44 -0.345 . . . . 0.44 111.447 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.8 mt -63.24 -19.97 65.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.417 -0.356 . . . . 0.66 111.084 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -58.86 -55.27 37.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.357 -0.383 . . . . 1.86 110.852 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.3 -44.46 1.61 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.74 -0.743 . . . . 1.06 112.832 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 20.3 mtp180 -61.42 -29.28 69.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.635 0.255 . . . . 2.59 111.2 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 55.6 mt -85.49 109.18 18.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.914 0.388 . . . . 0.92 111.128 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.597 ' HB3' HH12 ' A' ' 102' ' ' ARG . 36.7 tt0 -111.23 139.28 21.74 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.947 -0.57 . . . . 1.98 110.296 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -47.27 165.64 0.1 Allowed 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.504 2.136 . . . . 1.44 112.643 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 64.04 54.17 1.73 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.002 -0.545 . . . . 2.15 110.831 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -128.42 160.99 30.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.846 -0.616 . . . . 2.02 110.269 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.486 ' HB3' HG23 ' A' ' 101' ' ' ILE . 88.0 tttt -110.35 122.56 47.99 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.828 0.347 . . . . 1.02 111.244 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.464 HD13 ' HB3' ' A' ' 100' ' ' LEU . 36.3 mm -90.17 145.85 6.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.173 -0.467 . . . . 0.29 110.699 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 87.2 mt -115.74 -65.8 1.15 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.257 -0.429 . . . . 0.4 111.274 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.535 ' HG2' HD23 ' A' ' 99' ' ' LEU . 15.8 ptm180 -149.88 137.15 19.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.252 0.549 . . . . 2.61 112.037 -179.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.648 HG12 ' H ' ' A' ' 73' ' ' ASP . 11.5 t -84.82 175.22 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.505 -0.771 . . . . 0.28 109.409 178.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.661 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 8.8 t70 -47.69 108.07 0.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.954 0.407 . . . . 0.79 111.684 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 52.3 19.03 1.01 Allowed 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.599 0.592 . . . . 2.01 112.599 179.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.9 t -146.38 102.14 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.63 0.252 . . . . 0.79 111.335 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -62.85 152.76 35.24 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.538 -0.301 . . . . 2.24 110.663 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.1 m -143.07 49.98 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 120.791 0.329 . . . . 0.67 111.862 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -143.3 21.33 1.89 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.069 0.461 . . . . 1.39 110.561 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -142.97 -4.21 0.85 Allowed Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.731 -0.668 . . . . 0.55 112.259 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 71.1 mtm -108.16 173.89 6.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.822 0.344 . . . . 0.52 110.719 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.413 ' HB3' ' OD1' ' A' ' 84' ' ' ASP . . . -69.17 166.28 18.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.212 -0.449 . . . . 0.39 111.104 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.418 ' NE2' HG13 ' A' ' 31' ' ' ILE . 7.8 tp60 -58.94 -58.39 8.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 1.52 110.948 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 45.0 t -51.75 -39.82 59.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.026 -0.534 . . . . 1.48 111.295 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.413 ' OD1' ' HB3' ' A' ' 81' ' ' ALA . 1.2 m-20 -57.28 -44.92 84.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.345 -0.389 . . . . 2.12 110.835 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 81' ' ' ALA . 55.6 t -61.24 -38.4 79.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.223 -0.444 . . . . 0.32 110.926 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 17.9 t -63.93 -39.62 86.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 0.37 110.995 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -58.62 -51.83 68.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.285 -0.416 . . . . 1.51 110.75 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 63.6 t -52.83 -53.58 20.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.27 111.431 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 80.0 mt -58.44 -30.92 67.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.049 -0.523 . . . . 0.41 111.366 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 73.2 mtm180 -85.81 -13.6 47.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.42 -0.354 . . . . 2.1 111.175 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -93.86 -13.76 26.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.405 -0.361 . . . . 1.14 110.917 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.15 -83.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.213 -0.449 . . . . 0.55 111.432 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.591 ' H ' ' HD2' ' A' ' 20' ' ' ARG . . . 63.76 13.2 50.89 Favored Glycine 0 CA--C 1.517 0.216 0 C-N-CA 120.664 -0.779 . . . . 0.76 112.419 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.421 HD22 ' C ' ' A' ' 94' ' ' ASN . 0.2 OUTLIER -146.78 170.4 7.87 Favored Pre-proline 0 C--N 1.329 -0.318 0 O-C-N 122.999 -0.118 . . . . 2.52 110.82 -179.725 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.544 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 31.8 Cg_exo -60.55 106.27 0.35 Allowed 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.241 1.961 . . . . 0.64 111.669 178.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 34.7 m -114.33 154.37 15.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.95 0.405 . . . . 0.64 111.699 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.661 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 73.7 ttt180 -101.9 142.2 33.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.833 -0.621 . . . . 2.37 109.932 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 21.8 mt -116.81 109.1 16.67 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.431 -0.35 . . . . 0.37 111.271 -179.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.535 HD23 ' HG2' ' A' ' 71' ' ' ARG . 52.4 tp -96.19 103.32 15.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.3 -0.409 . . . . 0.37 110.396 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.464 ' HB3' HD13 ' A' ' 69' ' ' ILE . 0.4 OUTLIER -129.8 154.11 47.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.454 . . . . 0.31 111.403 -179.557 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.486 HG23 ' HB3' ' A' ' 68' ' ' LYS . 13.9 tt -105.89 136.71 39.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-N 116.157 -0.474 . . . . 0.45 110.773 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.597 HH12 ' HB3' ' A' ' 64' ' ' GLU . 29.1 mmm-85 -116.92 146.05 43.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.741 -0.663 . . . . 2.26 110.429 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -93.33 112.83 24.86 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.915 0.388 . . . . 3.93 111.088 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 82.6 mt -83.89 141.63 41.16 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.938 -0.574 . . . . 2.0 110.767 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -83.44 160.35 14.84 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.502 2.135 . . . . 2.98 112.027 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 96.4 mt -137.91 115.86 11.58 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.19 -0.459 . . . . 3.67 110.712 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -63.7 120.63 12.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.485 . . . . 5.59 110.974 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.276 -0.869 . . . . 6.0 110.883 179.939 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.161 0 N-CA-C 112.456 -0.258 . . . . 7.92 112.456 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.2 m 60.08 -178.99 0.09 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.832 0.348 . . . . 7.18 111.132 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -134.72 79.16 1.78 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 5.91 110.926 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 99.41 174.04 31.18 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.83 -0.7 . . . . 2.45 112.443 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -68.02 91.35 0.34 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.86 0.362 . . . . 2.33 111.015 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 79.6 p -95.31 109.64 21.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.026 -0.534 . . . . 2.59 110.965 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 57.79 49.12 12.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.055 -0.52 . . . . 2.67 110.999 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -108.64 111.29 23.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.027 -0.533 . . . . 1.58 111.098 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.0 m 57.42 27.9 14.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.051 -0.522 . . . . 2.55 110.957 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.67 -37.68 3.47 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.85 -0.69 . . . . 1.82 112.498 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.442 ' HB3' HD11 ' A' ' 101' ' ' ILE . 90.7 m-85 -62.6 107.37 0.93 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.87 0.367 . . . . 1.7 111.031 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.0 t -120.0 134.04 55.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.935 -0.575 . . . . 0.9 110.628 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 91.4 mt -76.71 121.51 23.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.244 -0.434 . . . . 0.89 110.824 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -113.38 155.18 25.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.978 -0.555 . . . . 2.73 110.862 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 48.3 t -151.35 132.69 14.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.271 -0.422 . . . . 1.19 111.154 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.4 t -131.56 128.77 61.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.11 -0.495 . . . . 0.56 110.676 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -92.7 119.15 31.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 1.74 111.525 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.439 HD12 HD11 ' A' ' 98' ' ' LEU . 19.6 mt -119.16 113.09 20.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.093 -0.503 . . . . 0.81 110.542 179.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.63 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 33.1 m-85 -79.58 114.21 18.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.092 -0.504 . . . . 2.08 111.022 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.515 ' HG2' ' HA2' ' A' ' 93' ' ' GLY . 20.3 ttt180 -100.16 104.9 16.46 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.836 0.35 . . . . 3.06 110.565 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -147.63 11.25 0.98 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.277 -0.42 . . . . 2.58 111.019 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -94.7 156.44 16.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 3.72 110.67 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -83.06 53.33 2.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.348 -0.387 . . . . 2.87 110.69 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.2 p -120.31 -29.27 4.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 1.38 110.95 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.441 ' HA ' ' NH2' ' A' ' 20' ' ' ARG . 41.2 t 59.61 14.88 4.24 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.691 -0.686 . . . . 2.45 111.153 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 47.6 t -125.05 132.81 53.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 1.4 110.699 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.428 HD21 ' HD2' ' A' ' 20' ' ' ARG . 95.2 mt -102.27 -11.8 18.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.45 110.697 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.513 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 87.02 6.67 78.83 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.812 -0.709 . . . . 0.52 112.584 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.42 HG23 HG22 ' A' ' 48' ' ' VAL . 67.7 mt -85.1 109.0 17.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.713 0.292 . . . . 0.84 111.026 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.5 m -113.84 99.81 7.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.37 -0.377 . . . . 0.95 110.822 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 36.7 pt -92.49 152.46 3.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.196 -0.456 . . . . 0.41 111.343 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.9 p -108.07 133.25 52.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.033 -0.531 . . . . 1.32 110.994 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.85 108.87 2.2 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.904 -0.665 . . . . 0.95 112.529 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 27.9 ttt -81.87 102.55 10.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.762 0.315 . . . . 2.04 110.977 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.27 160.55 15.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 5.46 110.913 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -100.64 142.64 31.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.064 -0.516 . . . . 4.29 110.695 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -95.54 48.29 1.14 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.278 -0.419 . . . . 5.25 111.13 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 52.4 m 54.21 77.73 0.18 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.471 . . . . 4.88 110.993 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 50.9 p -134.09 137.52 44.65 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.249 -0.432 . . . . 5.27 111.084 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.9 t -88.26 11.4 16.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 6.91 110.847 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -118.21 4.31 15.91 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.829 -0.7 . . . . 5.36 112.388 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 57.3 88.53 0.05 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.863 0.363 . . . . 7.22 111.031 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -101.68 38.57 1.59 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.121 -0.49 . . . . 3.05 110.834 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 67.0 p -85.3 153.95 22.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.003 -0.544 . . . . 2.53 111.105 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.17 148.6 18.14 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.706 -0.759 . . . . 1.14 112.599 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 50.5 mm -108.71 131.1 60.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.758 0.313 . . . . 0.65 110.913 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -153.67 137.23 15.96 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.362 -0.381 . . . . 0.7 111.203 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.42 HG22 HG23 ' A' ' 29' ' ' ILE . 91.1 t -63.41 119.11 6.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.15 -0.477 . . . . 0.39 110.888 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -98.1 -26.04 14.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.81 -0.632 . . . . 2.4 110.952 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 79.8 p -153.56 162.32 41.37 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.926 0.393 . . . . 1.28 111.31 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.2 mt -123.84 156.03 36.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.96 -0.564 . . . . 0.42 110.774 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.513 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 49.4 mm -99.28 114.02 65.23 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.312 -0.403 . . . . 1.26 110.871 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -62.15 119.73 6.97 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.446 2.097 . . . . 0.82 112.196 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.34 7.76 29.93 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.893 -0.67 . . . . 0.49 112.514 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.4 m -105.75 -174.48 2.54 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.626 0.251 . . . . 1.23 110.941 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.65 -47.38 66.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.888 0.375 . . . . 0.42 111.14 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.546 ' HB1' HG21 ' A' ' 63' ' ' ILE . . . -57.31 -41.15 79.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.939 -0.573 . . . . 0.35 111.533 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.49 -53.53 15.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.44 111.593 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 98.5 mt -60.55 -19.78 58.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.366 -0.379 . . . . 0.66 111.295 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -62.34 -55.41 28.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.811 0.338 . . . . 1.86 110.795 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 105.59 -49.75 0.87 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.826 -0.702 . . . . 1.06 112.752 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -68.26 -23.41 64.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.739 0.304 . . . . 2.59 111.126 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.546 HG21 ' HB1' ' A' ' 57' ' ' ALA . 39.5 mm -76.12 123.62 32.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.826 0.346 . . . . 0.92 110.937 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -111.9 155.05 43.85 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.138 -0.483 . . . . 1.98 111.028 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -78.81 36.95 0.63 Allowed 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.943 2.429 . . . . 1.44 112.259 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -169.29 75.93 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.296 -0.411 . . . . 2.15 110.872 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -143.28 150.01 38.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 2.02 110.877 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.462 ' HB3' HG23 ' A' ' 101' ' ' ILE . 87.7 tttt -90.62 114.68 27.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.828 0.346 . . . . 1.02 111.129 -179.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.516 HD13 ' HB3' ' A' ' 100' ' ' LEU . 41.0 mm -84.16 137.54 20.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.215 -0.448 . . . . 0.29 110.729 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 65.8 mt -117.08 -65.04 1.23 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.434 . . . . 0.4 111.17 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -131.07 163.7 27.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.097 -0.501 . . . . 2.61 111.703 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.551 HG12 ' N ' ' A' ' 73' ' ' ASP . 44.8 t -127.97 167.64 22.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.566 -0.743 . . . . 0.28 109.562 179.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.617 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 7.7 t70 -41.6 108.11 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.5 0.555 . . . . 0.79 112.5 -179.384 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 56.66 2.76 0.1 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.468 0.914 . . . . 2.01 113.468 178.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.454 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 84.7 t -143.57 112.79 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.679 0.276 . . . . 0.79 111.534 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -68.75 163.26 24.43 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.005 -0.368 . . . . 2.24 110.005 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.7 m -134.38 0.08 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.718 0.294 . . . . 0.67 111.651 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -91.5 109.32 20.61 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 120.883 0.373 . . . . 1.39 110.385 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 125.57 -12.94 7.38 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.843 -0.694 . . . . 0.55 112.516 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 74.4 mtm -105.44 158.66 16.5 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.839 0.352 . . . . 0.52 110.996 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.39 162.19 15.53 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.198 -0.455 . . . . 0.39 111.328 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -56.77 -46.38 81.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.329 -0.396 . . . . 1.52 111.136 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 85.4 p -53.42 -41.24 65.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.234 -0.439 . . . . 1.48 111.162 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -66.02 -44.04 85.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.296 -0.411 . . . . 2.12 111.13 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 57.7 t -58.34 -39.8 75.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.154 -0.476 . . . . 0.32 111.372 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 64.7 t -68.04 -43.52 85.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.496 -0.32 . . . . 0.37 111.145 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -57.35 -43.67 83.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.355 -0.384 . . . . 1.51 110.944 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 57.3 t -61.16 -55.47 24.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.46 . . . . 0.27 111.181 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 90.8 mt -52.62 -27.56 17.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.974 -0.557 . . . . 0.41 111.301 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 74.4 mtm180 -89.17 -28.25 20.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.286 -0.415 . . . . 2.1 111.271 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -74.07 -14.99 61.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.399 -0.364 . . . . 1.14 110.693 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.47 ' HB3' ' HD3' ' A' ' 20' ' ' ARG . . . -54.33 -81.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.994 -0.548 . . . . 0.55 111.364 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.515 ' HA2' ' HG2' ' A' ' 20' ' ' ARG . . . 61.1 17.42 51.93 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.655 -0.783 . . . . 0.76 112.139 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.443 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 0.2 OUTLIER -147.13 170.88 7.05 Favored Pre-proline 0 CA--C 1.534 0.329 0 C-N-CA 122.06 0.144 . . . . 2.52 110.877 -179.824 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.63 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 47.4 Cg_exo -58.25 104.2 0.17 Allowed 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.081 1.854 . . . . 0.64 111.555 178.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 23.6 m -112.68 155.1 14.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.041 0.448 . . . . 0.64 112.011 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.617 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 35.3 ttp180 -111.46 145.25 39.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.695 -0.684 . . . . 2.37 109.949 179.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.439 HD11 HD12 ' A' ' 18' ' ' LEU . 25.9 mt -110.02 124.1 50.86 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.356 -0.383 . . . . 0.37 111.255 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 32.7 tp -109.88 101.08 9.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.332 -0.395 . . . . 0.37 110.245 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.516 ' HB3' HD13 ' A' ' 69' ' ' ILE . 0.4 OUTLIER -130.55 160.67 33.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.31 111.396 -179.467 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.462 HG23 ' HB3' ' A' ' 68' ' ' LYS . 12.6 tt -116.08 141.92 31.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.873 -0.603 . . . . 0.45 110.896 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 32.3 tpt180 -141.49 132.29 25.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.043 -0.526 . . . . 2.26 110.979 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 22.5 ttm180 -74.09 143.85 45.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.116 -0.493 . . . . 3.93 110.623 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 59.9 mt -87.2 140.91 32.52 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.299 -0.41 . . . . 2.0 110.897 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -81.96 62.09 8.03 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.805 2.337 . . . . 2.98 112.363 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 91.5 mt -61.19 112.35 2.09 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.602 -0.726 . . . . 3.67 110.887 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 80.4 mt -69.8 130.01 41.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 5.59 111.085 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 . . . . . 0 C--O 1.251 1.155 0 CA-C-O 118.344 -0.836 . . . . 6.0 111.054 179.919 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.128 0 N-CA-C 112.5 -0.24 . . . . 7.92 112.5 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.1 p -119.72 155.05 33.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.871 0.367 . . . . 7.18 111.266 179.972 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -145.75 -4.42 0.66 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.951 -0.568 . . . . 5.91 110.871 179.548 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 132.78 -62.26 0.64 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.822 -0.704 . . . . 2.45 112.352 -179.881 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -106.16 125.85 51.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.771 0.32 . . . . 2.33 110.729 179.762 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 45.0 t -128.33 95.16 4.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 2.59 111.076 -179.688 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.7 t70 56.54 79.88 0.17 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.053 -0.521 . . . . 2.67 111.144 179.872 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -133.88 113.45 12.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.043 -0.526 . . . . 1.58 110.751 179.825 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.6 t 57.52 20.09 5.84 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.16 -0.473 . . . . 2.55 110.864 -179.948 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.7 37.58 11.66 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.847 -0.692 . . . . 1.82 112.634 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -135.83 137.33 41.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.878 0.37 . . . . 1.7 110.917 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 44.2 t -156.86 139.65 15.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.072 -0.513 . . . . 0.9 110.869 -179.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 62.6 mt -77.55 126.37 30.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.06 -0.518 . . . . 0.89 110.824 179.826 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.404 ' CD2' ' HB2' ' A' ' 102' ' ' ARG . 58.5 m-85 -123.65 130.42 52.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.12 -0.491 . . . . 2.73 111.023 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 80.8 p -120.42 139.26 53.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.285 -0.416 . . . . 1.19 111.091 -179.815 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.3 t -131.58 146.4 33.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.116 -0.493 . . . . 0.56 110.743 179.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -103.0 114.04 28.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.381 -0.372 . . . . 1.74 111.386 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.475 HD12 ' HB1' ' A' ' 56' ' ' ALA . 4.6 mm? -115.5 166.1 12.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.079 -0.509 . . . . 0.81 110.702 179.537 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.545 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 37.9 p90 -159.51 131.69 6.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.277 -0.42 . . . . 2.08 111.053 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.7 HH21 ' HG ' ' A' ' 27' ' ' LEU . 27.8 ttm180 -109.85 130.86 55.47 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.68 -0.408 . . . . 3.06 110.879 179.635 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -134.67 6.68 3.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.01 -0.541 . . . . 2.58 110.73 179.777 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -112.47 162.7 15.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.007 -0.542 . . . . 3.72 110.788 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -86.7 42.98 1.05 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.262 -0.426 . . . . 2.87 110.958 -179.911 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 69.3 p -86.98 -13.01 45.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 1.38 111.339 -179.924 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 94.8 p 50.56 24.56 1.67 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.778 -0.646 . . . . 2.45 111.504 179.89 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 80.5 p -158.7 153.32 24.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.297 -0.41 . . . . 1.4 110.904 -179.938 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.7 ' HG ' HH21 ' A' ' 20' ' ' ARG . 84.0 mt -107.76 -13.17 15.07 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.012 -0.54 . . . . 0.45 110.998 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.546 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 100.69 18.94 19.25 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.828 -0.701 . . . . 0.52 112.741 179.748 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 78.2 mt -97.52 112.46 29.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.702 0.287 . . . . 0.84 110.694 179.751 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.9 t -110.12 101.93 10.68 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.337 -0.392 . . . . 0.95 111.019 -179.713 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.436 ' HA ' ' HA ' ' A' ' 48' ' ' VAL . 33.2 pt -92.33 163.41 2.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.967 -0.56 . . . . 0.41 110.914 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 47.9 t -147.33 156.69 43.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.179 -0.464 . . . . 1.32 110.782 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -114.79 103.62 1.28 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.722 -0.752 . . . . 0.95 112.558 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.431 ' H ' ' HE1' ' A' ' 47' ' ' TYR . 48.6 ttm -64.55 138.7 58.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.841 0.353 . . . . 2.04 110.788 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 24.8 mmm180 -127.58 43.92 3.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.208 -0.451 . . . . 5.46 110.953 -179.872 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -114.1 140.62 48.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.103 -0.499 . . . . 4.29 110.974 -180.0 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -97.75 110.61 23.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 5.25 110.946 179.843 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.3 t -113.29 132.77 55.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.469 . . . . 4.88 110.901 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 67.7 p -68.73 133.98 49.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.084 -0.507 . . . . 5.27 111.055 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 14.6 t 41.96 33.52 0.37 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.791 -0.641 . . . . 6.91 111.424 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -125.0 170.22 16.95 Favored Glycine 0 N--CA 1.451 -0.301 0 CA-C-N 115.632 -0.713 . . . . 5.36 112.518 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -90.24 153.14 20.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.805 0.336 . . . . 7.22 110.94 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -163.93 -168.92 1.72 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 116.154 -0.475 . . . . 3.05 110.357 179.872 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 58.9 p 48.31 -163.0 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.768 -0.651 . . . . 2.53 111.491 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.09 155.66 9.34 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.785 -0.722 . . . . 1.14 112.551 179.836 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 42.8 mm -83.92 114.09 23.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.784 0.326 . . . . 0.65 110.806 179.87 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.431 ' HE1' ' H ' ' A' ' 34' ' ' MET . 54.2 p90 -132.52 141.17 48.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 0.7 111.074 -179.888 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.436 ' HA ' ' HA ' ' A' ' 31' ' ' ILE . 97.8 t -80.19 111.86 17.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.147 -0.479 . . . . 0.39 110.51 179.444 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -84.39 -34.67 23.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.092 -0.503 . . . . 2.4 111.284 -179.607 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 83.0 p -151.06 179.07 8.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.064 0.459 . . . . 1.28 111.527 -179.718 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 66.6 mt -134.06 160.84 36.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.725 -0.67 . . . . 0.42 110.558 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.546 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 53.2 mt -96.54 108.55 43.1 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.257 -0.429 . . . . 1.26 111.12 179.954 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -59.34 127.54 24.29 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.348 2.032 . . . . 0.82 112.324 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 104.69 -2.68 42.1 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.763 -0.732 . . . . 0.49 112.549 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.6 m -95.68 -179.03 4.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.659 0.266 . . . . 1.23 110.99 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.475 ' HB1' HD12 ' A' ' 18' ' ' LEU . . . -65.69 -55.44 17.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.36 -0.382 . . . . 0.42 111.189 179.937 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.72 -33.05 63.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.061 -0.518 . . . . 0.35 111.413 -179.852 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.38 -50.47 31.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.259 -0.428 . . . . 0.44 111.442 -179.739 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.2 mt -61.4 -21.27 63.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.312 -0.404 . . . . 0.66 111.123 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -60.66 -54.72 41.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.405 -0.361 . . . . 1.86 110.977 -179.782 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.34 -46.85 1.79 Allowed Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.742 -0.742 . . . . 1.06 112.927 179.458 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 66.9 mtp180 -56.45 -39.27 72.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.772 0.32 . . . . 2.59 110.991 -179.772 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 64.6 mt -68.57 108.55 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.92 110.883 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -107.29 137.41 19.6 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.038 -0.528 . . . . 1.98 110.715 -179.702 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -54.91 175.64 0.15 Allowed 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.571 2.181 . . . . 1.44 112.278 179.855 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 59.32 44.48 15.28 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.031 0.443 . . . . 2.15 110.285 -179.632 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -119.51 167.22 12.18 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.895 -0.593 . . . . 2.02 110.807 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -116.71 123.07 46.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.316 -0.402 . . . . 1.02 110.962 179.911 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.495 HD13 ' HB3' ' A' ' 100' ' ' LEU . 47.5 mm -81.16 139.11 18.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.159 -0.473 . . . . 0.29 111.202 -179.729 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 79.2 mt -105.53 -68.75 0.85 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.906 -0.588 . . . . 0.4 110.723 179.844 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.437 ' HG2' HD23 ' A' ' 99' ' ' LEU . 10.3 ptp180 -150.24 137.42 19.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 2.61 111.21 -179.868 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.676 HG12 ' H ' ' A' ' 73' ' ' ASP . 2.6 t -87.19 175.29 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.712 -0.676 . . . . 0.28 110.285 179.579 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.676 ' H ' HG12 ' A' ' 72' ' ' VAL . 17.7 t70 -50.49 112.7 0.73 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.773 0.321 . . . . 0.79 111.465 179.432 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 56.69 23.23 7.61 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.079 -0.51 . . . . 2.01 111.806 179.548 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.465 HG11 HG11 ' A' ' 88' ' ' VAL . 68.2 t -143.74 144.44 23.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.82 0.343 . . . . 0.79 110.923 179.855 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -115.69 133.05 56.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.311 -0.404 . . . . 2.24 110.504 179.668 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.543 HG11 HG13 ' A' ' 85' ' ' VAL . 31.2 m -121.15 35.49 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.849 0.357 . . . . 0.67 111.722 -179.39 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -97.51 41.46 1.12 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.302 -0.408 . . . . 1.39 111.051 179.948 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.19 36.18 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.449 -0.881 . . . . 0.55 113.235 179.77 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 52.4 mtm -127.91 158.55 37.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.844 0.354 . . . . 0.52 110.849 179.562 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.08 151.5 42.95 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.104 -0.498 . . . . 0.39 111.149 -179.935 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -53.57 -55.0 29.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.334 -0.393 . . . . 1.52 111.308 -179.556 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 59.4 m -53.57 -37.37 62.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 1.48 111.445 -179.512 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -64.02 -42.35 97.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.478 -0.328 . . . . 2.12 110.926 -179.826 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.543 HG13 HG11 ' A' ' 77' ' ' VAL . 48.0 t -61.08 -41.71 90.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.218 -0.447 . . . . 0.32 111.05 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 47.8 t -63.3 -39.89 86.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.262 -0.426 . . . . 0.37 111.013 179.929 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.451 ' HG2' HH21 ' A' ' 90' ' ' ARG . 47.8 mt-10 -57.72 -48.05 80.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 1.51 111.072 -179.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.465 HG11 HG11 ' A' ' 75' ' ' VAL . 65.7 t -57.26 -55.86 18.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.27 111.368 -179.889 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 91.4 mt -52.11 -32.64 36.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.028 -0.533 . . . . 0.41 111.222 -179.445 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.6 ' HA ' HH22 ' A' ' 20' ' ' ARG . 80.0 mtm180 -81.04 -30.27 34.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.34 -0.391 . . . . 2.1 111.291 -179.912 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -68.96 -22.26 64.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.443 -0.344 . . . . 1.14 110.707 179.891 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.38 -84.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.093 -0.503 . . . . 0.55 111.275 179.778 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.66 ' HA2' ' HD2' ' A' ' 20' ' ' ARG . . . 64.11 19.41 63.73 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.81 -0.709 . . . . 0.76 112.555 -179.794 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -146.96 178.63 1.37 Allowed Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 110.263 -0.273 . . . . 2.52 110.263 -179.752 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.545 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 33.2 Cg_exo -60.46 102.79 0.2 Allowed 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.07 1.847 . . . . 0.64 111.954 178.196 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 30.1 m -121.15 156.79 24.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.062 0.458 . . . . 0.64 111.508 -179.552 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.625 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 76.3 ttt180 -101.58 142.51 32.83 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.826 -0.625 . . . . 2.37 110.351 179.791 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 13.1 mt -118.21 111.63 19.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.191 -0.459 . . . . 0.37 111.024 -179.6 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.437 HD23 ' HG2' ' A' ' 71' ' ' ARG . 45.1 tp -101.65 103.82 14.64 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.834 0.349 . . . . 0.37 110.561 179.489 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.495 ' HB3' HD13 ' A' ' 69' ' ' ILE . 0.5 OUTLIER -132.38 155.14 48.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.125 -0.489 . . . . 0.31 111.102 -179.548 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 15.2 tt -103.13 136.92 33.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.45 111.103 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.404 ' HB2' ' CD2' ' A' ' 14' ' ' TYR . 21.6 mmm180 -117.62 129.0 55.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.702 -0.681 . . . . 2.26 110.518 179.809 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -87.75 118.76 27.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.239 -0.437 . . . . 3.93 110.956 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 54.6 mt -84.55 148.13 51.24 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.074 -0.512 . . . . 2.0 110.611 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -82.75 162.08 16.37 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.577 2.185 . . . . 2.98 112.184 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.411 HD22 ' N ' ' A' ' 106' ' ' LEU . 3.8 mm? -108.49 111.49 23.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.165 -0.47 . . . . 3.67 111.139 -179.815 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.441 HD22 ' N ' ' A' ' 107' ' ' LEU . 3.7 mm? -100.9 98.33 8.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.144 -0.48 . . . . 5.59 110.793 179.872 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.206 -0.902 . . . . 6.0 110.898 179.99 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.166 0 N-CA-C 112.484 -0.247 . . . . 7.92 112.484 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 63.6 m -109.31 172.8 6.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.912 0.387 . . . . 7.18 110.914 -179.961 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 65.1 m-70 -131.64 125.16 31.47 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.974 -0.557 . . . . 5.91 110.744 179.892 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -158.24 42.43 0.5 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.851 -0.69 . . . . 2.45 112.262 179.879 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -101.55 84.36 2.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.94 0.4 . . . . 2.33 110.971 -179.876 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.4 t -88.76 82.7 6.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.087 -0.506 . . . . 2.59 110.718 179.779 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.1 t70 58.93 97.8 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.997 -0.547 . . . . 2.67 111.013 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -128.32 88.7 2.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.106 -0.497 . . . . 1.58 111.128 179.946 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 69.9 m 56.41 23.62 7.58 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.01 -0.541 . . . . 2.55 111.056 179.957 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.423 ' HA3' ' HG3' ' A' ' 103' ' ' ARG . . . 101.98 -41.53 2.11 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.776 -0.726 . . . . 1.82 112.624 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -58.88 123.52 16.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.795 0.331 . . . . 1.7 110.918 179.956 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.542 ' HB3' HD11 ' A' ' 104' ' ' LEU . 46.0 t -161.38 156.92 24.46 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.098 -0.501 . . . . 0.9 111.276 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.544 HD23 ' HB ' ' A' ' 101' ' ' ILE . 17.8 mt -97.21 103.31 15.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.497 -0.774 . . . . 0.89 110.1 179.599 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 36.5 p90 -124.5 151.91 44.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.858 0.361 . . . . 2.73 111.119 -179.344 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 48.4 t -120.68 155.81 33.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.024 0.44 . . . . 1.19 111.383 -179.436 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.8 t -131.66 137.69 54.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.758 -0.656 . . . . 0.56 110.416 179.801 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -88.51 114.43 25.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.947 0.403 . . . . 1.74 111.406 -179.491 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -124.95 117.67 24.57 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.892 -0.595 . . . . 0.81 110.614 179.614 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.582 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 28.2 p90 -107.66 132.97 52.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.378 -0.374 . . . . 2.08 111.053 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.65 ' HE ' ' HA2' ' A' ' 93' ' ' GLY . 20.7 ttp180 -107.78 102.89 12.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.853 0.359 . . . . 3.06 110.861 179.56 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -128.08 -3.03 5.75 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.149 -0.478 . . . . 2.58 111.113 -179.797 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.431 ' N ' ' HD2' ' A' ' 22' ' ' LYS . 0.9 OUTLIER -83.78 159.77 21.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.306 -0.407 . . . . 3.72 110.792 179.825 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -83.32 34.65 0.47 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.468 . . . . 2.87 110.978 -179.885 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 50.3 p -92.14 -23.22 19.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.283 -0.417 . . . . 1.38 111.127 -179.872 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.7 m 56.91 24.67 9.62 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.879 -0.601 . . . . 2.45 111.361 179.785 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 52.5 m -147.19 157.9 43.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.359 -0.382 . . . . 1.4 111.053 -179.885 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.585 HD21 ' HB2' ' A' ' 20' ' ' ARG . 86.1 mt -114.98 1.1 13.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.175 -0.466 . . . . 0.45 110.981 179.876 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 67.87 23.44 74.22 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.795 -0.717 . . . . 0.52 112.735 179.898 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 62.5 mt -97.61 110.01 24.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.648 0.261 . . . . 0.84 110.919 179.896 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 35.9 t -107.54 98.48 8.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.386 -0.37 . . . . 0.95 111.01 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 40.6 pt -83.58 159.39 3.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.294 -0.412 . . . . 0.41 111.142 -179.878 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 47.9 t -138.7 152.02 47.66 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.049 -0.523 . . . . 1.32 110.989 -179.78 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -97.85 140.19 14.89 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.772 -0.727 . . . . 0.95 112.471 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 59.8 ttp -89.16 120.26 30.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.789 0.328 . . . . 2.04 110.722 -179.919 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.14 89.22 4.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 5.46 110.965 -179.923 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -104.98 127.59 52.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.043 -0.526 . . . . 4.29 110.72 179.84 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -99.09 17.66 19.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 5.25 111.029 -179.826 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 61.2 m -156.25 130.58 8.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 4.88 110.811 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 77.8 p -97.57 142.2 29.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.073 -0.512 . . . . 5.27 111.107 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.6 t -164.76 9.52 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.241 -0.436 . . . . 6.91 111.242 -179.991 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 156.8 -56.9 0.38 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.689 -0.767 . . . . 5.36 112.551 179.905 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -103.0 125.86 49.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.768 0.318 . . . . 7.22 110.954 -179.877 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -123.8 105.98 10.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.207 -0.451 . . . . 3.05 111.128 -179.897 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 40.0 p 52.84 -171.92 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.037 -0.529 . . . . 2.53 111.543 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 146.72 168.69 13.84 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.762 -0.732 . . . . 1.14 112.64 -179.946 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 45.9 mm -106.39 127.25 61.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.752 0.31 . . . . 0.65 111.032 -179.922 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -152.72 140.9 20.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.283 -0.417 . . . . 0.7 110.825 179.796 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 97.0 t -74.48 116.29 16.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.078 -0.51 . . . . 0.39 110.869 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -103.9 -25.08 13.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.22 -0.445 . . . . 2.4 110.917 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 42.3 t -141.13 165.86 26.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 1.28 111.216 -179.926 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.463 HD11 HG22 ' A' ' 63' ' ' ILE . 95.6 mt -136.67 163.64 30.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.913 -0.585 . . . . 0.42 110.792 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 50.1 mm -108.02 103.52 50.31 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.321 -0.399 . . . . 1.26 111.076 -179.853 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.93 132.1 47.99 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.426 2.084 . . . . 0.82 112.297 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 99.68 -4.9 58.14 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.789 -0.72 . . . . 0.49 112.408 -179.779 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.8 t -93.66 167.98 11.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.614 0.245 . . . . 1.23 110.944 -179.876 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -53.91 -57.84 9.5 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.283 -0.417 . . . . 0.42 111.704 -179.75 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.35 -43.78 61.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.35 111.468 -179.638 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.7 -34.57 77.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.44 111.719 -179.52 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 70.2 mt -62.94 -37.04 85.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.456 -0.338 . . . . 0.66 111.444 -179.622 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.03 -44.88 95.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.469 -0.332 . . . . 1.86 111.017 -179.878 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.76 -27.29 4.36 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.79 -0.719 . . . . 1.06 112.652 179.892 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 78.4 mtp180 -62.51 -19.23 63.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.837 0.351 . . . . 2.59 111.102 -179.955 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.509 HD12 ' N ' ' A' ' 63' ' ' ILE . 3.2 mp -82.5 104.55 11.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.115 -0.493 . . . . 0.92 110.695 179.808 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -93.71 137.23 23.3 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.088 -0.506 . . . . 1.98 110.7 -179.764 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -51.47 160.8 2.24 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.38 2.053 . . . . 1.44 112.316 179.693 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.1 m120 58.7 44.89 16.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.186 -0.461 . . . . 2.15 110.787 -179.855 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -95.11 143.19 26.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.906 -0.588 . . . . 2.02 111.049 -179.88 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.675 ' HB3' HG23 ' A' ' 101' ' ' ILE . 25.9 tptp -91.85 101.49 14.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.108 -0.497 . . . . 1.02 111.152 -179.948 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.455 HG22 HG21 ' A' ' 77' ' ' VAL . 40.0 mm -74.33 134.39 29.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.494 -0.321 . . . . 0.29 110.62 179.627 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.681 ' HA ' HE21 ' A' ' 78' ' ' GLN . 88.3 mt -108.91 -57.26 2.17 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.395 -0.366 . . . . 0.4 111.139 -179.766 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -157.87 138.95 13.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.088 0.47 . . . . 2.61 111.623 -179.738 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.631 HG12 ' H ' ' A' ' 73' ' ' ASP . 5.3 t -88.45 174.23 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.543 -0.753 . . . . 0.28 109.855 179.242 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.67 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 14.9 t70 -46.6 111.0 0.33 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.866 0.365 . . . . 0.79 111.957 179.845 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 54.1 29.02 9.64 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.021 -0.536 . . . . 2.01 112.084 179.113 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 96.2 t -147.28 137.27 16.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.419 -0.355 . . . . 0.79 110.771 179.729 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -103.51 132.19 49.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.42 -0.355 . . . . 2.24 110.594 179.716 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.455 HG21 HG22 ' A' ' 69' ' ' ILE . 34.6 m -112.24 26.07 3.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-O 120.817 0.342 . . . . 0.67 111.423 -179.588 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.681 HE21 ' HA ' ' A' ' 70' ' ' LEU . 72.5 mm-40 -95.26 31.03 2.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 1.39 111.158 179.823 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 173.53 37.23 0.04 OUTLIER Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.575 -0.821 . . . . 0.55 112.751 179.818 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 51.6 mtm -128.99 142.71 50.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.787 0.327 . . . . 0.52 110.83 179.824 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.32 161.5 9.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.39 111.254 -179.884 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.436 ' O ' HG23 ' A' ' 86' ' ' VAL . 35.6 tt0 -53.96 -60.97 2.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.256 -0.429 . . . . 1.52 110.949 -179.847 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 54.5 m -55.29 -26.74 42.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.244 -0.434 . . . . 1.48 111.386 -179.737 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -69.64 -54.21 14.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.771 0.319 . . . . 2.12 110.894 -179.786 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.7 t -56.1 -39.08 56.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.298 -0.41 . . . . 0.32 110.922 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.491 ' O ' ' HG2' ' A' ' 90' ' ' ARG . 59.7 t -58.53 -55.86 20.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.232 -0.44 . . . . 0.37 110.628 179.586 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -47.6 -41.6 22.12 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.073 -0.512 . . . . 1.51 111.001 179.893 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 54.0 t -56.29 -51.84 58.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.164 -0.471 . . . . 0.27 110.711 179.309 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 76.1 mt -56.28 -28.61 59.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.755 -0.657 . . . . 0.41 110.792 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.491 ' HG2' ' O ' ' A' ' 86' ' ' VAL . 20.9 mmt180 -79.6 -30.3 41.44 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.082 -0.508 . . . . 2.1 110.654 179.982 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -75.16 -18.41 60.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.052 -0.522 . . . . 1.14 110.845 -179.824 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.53 -88.63 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.049 -0.523 . . . . 0.55 111.636 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.65 ' HA2' ' HE ' ' A' ' 20' ' ' ARG . . . 60.97 16.97 49.98 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.746 -0.74 . . . . 0.76 112.509 -179.741 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.442 HD22 HG13 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -146.99 172.9 4.66 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 110.657 -0.127 . . . . 2.52 110.657 -179.677 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.582 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 37.5 Cg_exo -62.39 97.45 0.17 Allowed 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 122.068 1.845 . . . . 0.64 111.625 178.338 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.442 HG13 HD22 ' A' ' 94' ' ' ASN . 29.0 m -105.64 156.41 6.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.64 111.717 -179.307 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.67 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 78.5 ttt180 -103.55 142.14 34.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.713 -0.676 . . . . 2.37 110.029 179.366 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 21.3 mt -115.14 104.37 11.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 0.37 111.35 -179.214 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 34.3 tp -95.8 111.59 23.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.82 0.343 . . . . 0.37 110.172 179.173 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.09 166.84 23.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.086 0.469 . . . . 0.31 111.628 -179.105 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.675 HG23 ' HB3' ' A' ' 68' ' ' LYS . 4.1 tt -121.92 138.32 52.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.684 -0.689 . . . . 0.45 110.478 179.71 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 33.0 tpt180 -166.29 145.78 5.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.322 -0.399 . . . . 2.26 110.784 -179.831 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.423 ' HG3' ' HA3' ' A' ' 10' ' ' GLY . 19.4 ttm180 -62.53 144.95 55.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.932 -0.576 . . . . 3.93 111.147 -179.672 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.542 HD11 ' HB3' ' A' ' 12' ' ' SER . 1.9 mt -111.34 150.52 42.19 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.778 -0.646 . . . . 2.0 110.774 -179.684 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -81.75 160.95 18.97 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.477 2.118 . . . . 2.98 112.07 179.67 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 98.5 mt -139.39 116.21 10.85 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.078 -0.51 . . . . 3.67 110.764 -179.877 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 91.7 mt -70.33 108.19 4.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 5.59 111.001 -179.874 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.132 -0.937 . . . . 6.0 110.963 179.871 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.186 0 N-CA-C 112.441 -0.264 . . . . 7.92 112.441 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 53.4 m -151.39 -54.42 0.14 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.784 0.326 . . . . 7.18 110.938 179.998 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 69.9 m80 -91.05 92.17 8.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.45 . . . . 5.91 110.952 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -148.73 85.2 0.16 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.768 -0.73 . . . . 2.45 112.562 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -111.56 163.87 13.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.746 0.308 . . . . 2.33 110.709 179.867 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.5 m -147.84 87.15 1.61 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.253 -0.43 . . . . 2.59 110.823 179.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 55.34 85.84 0.06 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.128 -0.487 . . . . 2.67 111.015 -179.899 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -127.9 100.98 6.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.182 -0.463 . . . . 1.58 111.147 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.2 t 58.0 28.41 16.21 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.985 -0.552 . . . . 2.55 111.041 179.763 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.77 -49.53 1.59 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.742 -0.742 . . . . 1.82 112.323 -179.855 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -56.27 106.46 0.28 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.789 0.328 . . . . 1.7 110.719 179.764 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 48.3 t -142.09 158.46 43.73 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 116.122 -0.49 . . . . 0.9 111.383 -179.649 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.529 HD23 ' HB ' ' A' ' 101' ' ' ILE . 15.6 mt -93.88 101.86 13.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.468 -0.787 . . . . 0.89 110.076 179.58 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.416 ' HE1' ' HB3' ' A' ' 102' ' ' ARG . 40.5 p90 -121.88 148.08 45.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.927 0.394 . . . . 2.73 111.117 -179.464 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 80.3 p -112.57 146.99 37.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.052 -0.522 . . . . 1.19 111.143 -179.68 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 17.2 t -120.31 135.3 61.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.096 -0.502 . . . . 0.56 110.644 179.751 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -92.09 111.53 23.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.323 -0.399 . . . . 1.74 111.614 -179.509 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.56 HD12 ' HB1' ' A' ' 56' ' ' ALA . 3.5 mm? -116.14 166.16 12.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.94 -0.573 . . . . 0.81 110.184 179.112 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.576 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 42.2 p90 -153.61 136.93 15.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.796 0.332 . . . . 2.08 111.433 -179.745 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.461 HH21 ' N ' ' A' ' 93' ' ' GLY . 21.5 ttp180 -121.31 140.32 52.25 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.175 -0.466 . . . . 3.06 110.607 179.317 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -160.63 26.15 0.15 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.388 -0.369 . . . . 2.58 111.317 -179.947 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -123.17 165.46 16.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.33 -0.395 . . . . 3.72 110.712 179.602 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -88.96 72.58 8.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.243 -0.435 . . . . 2.87 110.799 -179.951 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 48.3 p -124.07 -24.89 4.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.06 -0.518 . . . . 1.38 110.987 179.935 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.0 t 58.35 23.82 10.93 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.775 -0.648 . . . . 2.45 111.189 179.687 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 56.5 m -151.18 136.08 17.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.893 0.378 . . . . 1.4 111.086 -179.918 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.456 HD21 ' HB2' ' A' ' 20' ' ' ARG . 46.7 mt -97.11 -12.29 23.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.017 -0.538 . . . . 0.45 110.608 179.707 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.516 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 92.78 20.59 33.56 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.851 -0.69 . . . . 0.52 112.509 179.91 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 75.9 mt -98.59 112.14 29.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.717 0.294 . . . . 0.84 111.064 179.956 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 70.4 m -113.68 98.89 7.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.95 110.834 179.921 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 36.9 pt -91.34 166.7 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.186 -0.461 . . . . 0.41 111.376 -179.854 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 44.8 t -147.4 153.59 39.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.029 -0.532 . . . . 1.32 110.654 -179.981 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.95 146.36 16.32 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.738 -0.744 . . . . 0.95 112.529 -179.991 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 71.6 mtm -82.49 141.26 32.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.754 0.311 . . . . 2.04 110.737 179.919 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.404 ' HD3' ' N ' ' A' ' 35' ' ' ARG . 0.1 OUTLIER -96.92 84.45 3.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 5.46 110.966 -179.971 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -95.49 135.95 36.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 4.29 110.953 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -115.89 27.03 9.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.141 -0.482 . . . . 5.25 110.903 -179.928 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 46.8 t -156.08 112.9 3.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 4.88 110.916 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 39.4 p -87.04 138.34 31.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.072 -0.513 . . . . 5.27 111.14 179.909 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.2 t -146.05 -3.08 0.68 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 6.91 111.059 179.864 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 162.7 -61.11 0.27 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.801 -0.714 . . . . 5.36 112.352 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -95.76 166.15 11.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.76 0.314 . . . . 7.22 110.886 -179.907 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -139.39 115.75 10.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.26 -0.427 . . . . 3.05 111.203 -179.872 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 46.5 p 52.13 -171.92 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.917 -0.583 . . . . 2.53 111.812 179.866 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -175.48 138.02 4.04 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.904 -0.665 . . . . 1.14 112.395 -179.965 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 40.5 mm -84.74 124.11 39.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.723 0.297 . . . . 0.65 111.164 -179.899 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -155.94 139.19 15.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.238 -0.437 . . . . 0.7 110.715 179.862 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 57.5 t -76.74 127.11 37.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.222 -0.445 . . . . 0.39 111.111 -179.84 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -116.71 -22.55 8.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.036 -0.529 . . . . 2.4 111.165 -179.763 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 46.9 t -139.58 163.39 32.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.952 0.406 . . . . 1.28 111.304 -179.871 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 76.0 mt -134.78 163.17 30.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.888 -0.596 . . . . 0.42 110.807 179.984 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.516 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 48.5 mm -110.32 98.92 38.15 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.29 -0.414 . . . . 1.26 110.96 179.67 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.07 126.88 22.92 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.404 2.069 . . . . 0.82 112.28 -179.928 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.76 -4.54 32.41 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.905 -0.664 . . . . 0.49 112.625 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.442 ' OG ' ' HA3' ' A' ' 28' ' ' GLY . 93.1 p -99.47 -172.54 2.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.903 0.383 . . . . 1.23 111.058 -179.814 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.56 ' HB1' HD12 ' A' ' 18' ' ' LEU . . . -67.8 -58.06 5.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.052 -0.522 . . . . 0.42 111.333 -179.951 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.4 ' HA ' ' HA3' ' A' ' 61' ' ' GLY . . . -59.81 -22.91 62.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.079 -0.51 . . . . 0.35 111.438 -179.782 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.15 -31.62 34.06 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.511 -0.313 . . . . 0.44 111.776 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.5 mt -83.45 -59.27 2.5 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.313 0.486 . . . . 0.66 112.313 -179.038 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -103.98 -24.53 13.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.665 0.269 . . . . 1.86 111.331 -178.781 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.469 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -64.53 87.15 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.516 -0.85 . . . . 1.06 112.246 179.959 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 -61.31 0.75 0.24 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.603 0.24 . . . . 2.59 111.234 179.751 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.469 ' H ' ' C ' ' A' ' 61' ' ' GLY . 59.2 mt -48.95 125.65 2.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.276 -0.42 . . . . 0.92 111.194 179.582 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.425 ' C ' ' H ' ' A' ' 66' ' ' ASN . 11.5 mt-10 -78.93 159.85 72.66 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 1.98 110.93 179.86 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -73.61 28.06 0.31 Allowed 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.656 2.237 . . . . 1.44 112.443 179.654 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.425 ' H ' ' C ' ' A' ' 64' ' ' GLU . 3.1 t-20 -163.03 49.44 0.15 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.094 0.473 . . . . 2.15 110.281 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -108.55 152.62 24.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.867 -0.606 . . . . 2.02 110.904 -179.716 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -107.09 111.21 23.56 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.41 -0.359 . . . . 1.02 110.981 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 34.7 mm -70.43 141.55 16.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.256 -0.429 . . . . 0.29 110.768 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 82.8 mt -117.86 -66.11 1.11 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 0.4 111.35 -179.724 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -137.69 135.62 36.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.972 0.415 . . . . 2.61 111.431 -179.62 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.657 HG12 ' H ' ' A' ' 73' ' ' ASP . 3.1 t -94.41 174.49 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.899 -0.591 . . . . 0.28 110.083 179.329 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.69 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 14.2 t70 -53.49 108.79 0.37 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.839 0.352 . . . . 0.79 111.392 179.807 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.4 t70 61.48 15.91 7.1 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.008 -0.542 . . . . 2.01 111.699 179.434 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.433 HG12 ' N ' ' A' ' 76' ' ' ASN . 26.0 t -138.42 157.18 30.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.559 -0.291 . . . . 0.79 110.802 179.795 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.433 ' N ' HG12 ' A' ' 75' ' ' VAL . 65.6 m-20 -127.71 129.59 47.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.442 -0.345 . . . . 2.24 110.907 -179.96 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.405 ' HA ' ' HE2' ' A' ' 80' ' ' MET . 34.7 m -106.41 21.02 4.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.337 -0.392 . . . . 0.67 111.004 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -86.27 23.66 1.52 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.013 -0.54 . . . . 1.39 110.918 -179.958 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -177.02 18.85 0.04 OUTLIER Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.706 -0.759 . . . . 0.55 112.828 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.405 ' HE2' ' HA ' ' A' ' 77' ' ' VAL . 51.6 mtm -115.12 139.16 50.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.843 0.354 . . . . 0.52 110.876 179.809 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.461 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -65.97 156.86 32.35 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.159 -0.473 . . . . 0.39 111.025 -179.932 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -44.04 -55.03 4.97 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.199 -0.455 . . . . 1.52 111.546 -179.568 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 79.3 p -51.29 -46.78 62.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.312 -0.404 . . . . 1.48 111.256 -179.68 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -60.62 -40.74 93.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 2.12 111.104 -179.915 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 81' ' ' ALA . 35.0 t -60.07 -39.69 81.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.295 -0.412 . . . . 0.32 110.766 179.85 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.457 HG12 ' NE ' ' A' ' 90' ' ' ARG . 39.9 t -64.43 -37.06 79.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.168 -0.469 . . . . 0.37 110.658 179.711 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -58.92 -48.62 80.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.162 -0.472 . . . . 1.51 110.808 179.798 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 61.4 t -57.1 -55.15 22.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.205 -0.452 . . . . 0.27 111.37 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 85.3 mt -56.33 -32.59 64.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.998 -0.546 . . . . 0.41 111.385 -179.36 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.457 ' NE ' HG12 ' A' ' 86' ' ' VAL . 79.0 mtm180 -81.23 -20.07 41.81 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.458 -0.337 . . . . 2.1 111.272 -179.687 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.435 HD22 ' N ' ' A' ' 91' ' ' ASN . 0.9 OUTLIER -86.05 -16.85 36.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.33 -0.395 . . . . 1.14 111.077 -179.953 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.2 -86.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.267 -0.424 . . . . 0.55 111.424 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.461 ' N ' HH21 ' A' ' 20' ' ' ARG . . . 60.81 17.18 49.45 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.756 -0.735 . . . . 0.76 112.578 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.41 HD22 ' HA ' ' A' ' 94' ' ' ASN . 0.1 OUTLIER -147.38 175.56 2.66 Favored Pre-proline 0 CA--C 1.534 0.33 0 N-CA-C 110.377 -0.231 . . . . 2.52 110.377 -179.804 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.576 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 32.9 Cg_exo -61.47 99.38 0.17 Allowed 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 122.088 1.859 . . . . 0.64 111.604 178.247 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.6 m -116.43 155.77 17.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.265 -0.425 . . . . 0.64 111.837 -179.191 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.69 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 44.4 ttp180 -101.71 145.38 29.2 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.881 -0.6 . . . . 2.37 110.484 179.788 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.6 mt -121.54 104.77 9.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.173 -0.467 . . . . 0.37 111.358 -179.228 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 61.6 tp -91.81 108.1 19.68 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.777 0.322 . . . . 0.37 110.381 179.421 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.467 HD21 HG12 ' A' ' 63' ' ' ILE . 0.5 OUTLIER -138.21 168.43 19.76 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.24 -0.436 . . . . 0.31 111.579 -179.212 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.529 ' HB ' HD23 ' A' ' 13' ' ' LEU . 9.8 tt -119.95 141.1 41.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.862 -0.608 . . . . 0.45 111.048 179.873 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.416 ' HB3' ' HE1' ' A' ' 14' ' ' TYR . 27.2 tpt180 -166.44 138.41 3.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.101 -0.5 . . . . 2.26 110.711 179.65 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -64.9 143.22 58.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.039 -0.528 . . . . 3.93 110.93 -179.799 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.8 mt -94.97 148.42 34.67 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.872 -0.604 . . . . 2.0 111.091 -179.576 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -81.35 60.71 7.85 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.911 2.407 . . . . 2.98 112.355 179.821 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 71.1 mt -74.11 127.96 34.29 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.581 -0.736 . . . . 3.67 110.92 -179.899 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.43 HD22 ' N ' ' A' ' 107' ' ' LEU . 3.7 mm? -74.08 114.12 12.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.03 -0.532 . . . . 5.59 111.102 -179.878 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.236 -0.887 . . . . 6.0 111.086 179.876 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.219 0 N-CA-C 112.515 -0.234 . . . . 7.92 112.515 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.7 m -123.82 143.7 50.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.806 0.336 . . . . 7.18 111.105 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -165.12 88.48 0.45 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.16 -0.473 . . . . 5.91 110.866 179.866 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 91.54 -30.13 6.72 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.673 -0.775 . . . . 2.45 112.735 179.881 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -119.19 122.09 41.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.847 0.356 . . . . 2.33 111.163 -179.848 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 46.2 t -157.51 98.98 1.72 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.078 -0.51 . . . . 2.59 110.92 179.961 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 58.36 75.82 0.37 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.092 -0.504 . . . . 2.67 110.961 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -133.25 113.56 12.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.479 . . . . 1.58 111.194 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.2 m 53.56 34.53 18.72 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.111 -0.495 . . . . 2.55 111.107 179.987 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.53 -55.61 3.48 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.736 -0.745 . . . . 1.82 112.451 -179.962 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.519 ' HA ' ' HA ' ' A' ' 103' ' ' ARG . 47.2 m-85 -57.34 123.99 17.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.839 0.352 . . . . 1.7 110.88 179.96 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.5 t -151.42 155.01 37.73 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.191 -0.458 . . . . 0.9 111.263 -179.878 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.539 HD23 ' HB ' ' A' ' 101' ' ' ILE . 23.8 mt -94.39 102.31 14.28 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.555 -0.748 . . . . 0.89 110.209 179.53 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.43 ' CE1' ' HB3' ' A' ' 102' ' ' ARG . 39.5 p90 -123.46 151.17 42.99 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.887 0.375 . . . . 2.73 110.992 -179.602 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 80.2 p -122.39 161.28 23.74 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.279 -0.419 . . . . 1.19 111.465 -179.472 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 12.4 t -131.22 149.88 33.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.86 -0.609 . . . . 0.56 110.682 179.857 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.419 ' H ' ' NH2' ' A' ' 62' ' ' ARG . 14.8 mm-40 -103.46 110.05 21.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.441 -0.345 . . . . 1.74 111.526 -179.47 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.404 HD22 ' O ' ' A' ' 17' ' ' GLU . 3.4 mm? -126.49 123.84 38.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.179 -0.464 . . . . 0.81 110.759 179.577 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.563 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 35.6 p90 -112.02 142.77 44.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.301 -0.409 . . . . 2.08 110.747 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.583 ' HE ' ' HA2' ' A' ' 93' ' ' GLY . 47.5 ttp180 -125.97 160.85 28.91 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.859 -0.336 . . . . 3.06 110.916 179.717 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -168.07 -33.06 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.139 -0.482 . . . . 2.58 111.077 -179.891 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -59.07 160.93 5.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.949 -0.568 . . . . 3.72 110.788 179.924 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -84.77 49.29 1.69 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.261 -0.427 . . . . 2.87 111.069 -179.874 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 82.1 p -99.1 -24.59 14.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 1.38 111.163 -179.977 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 36.4 t 56.41 18.04 3.25 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.797 -0.638 . . . . 2.45 111.259 179.803 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 53.8 m -140.74 148.1 40.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.874 0.368 . . . . 1.4 111.206 -179.882 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 61.5 mt -113.37 -23.58 9.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.991 -0.549 . . . . 0.45 110.833 179.905 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.519 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 110.5 -23.64 19.69 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.804 -0.713 . . . . 0.52 112.383 -179.791 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 76.5 mt -62.41 109.0 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.805 0.336 . . . . 0.84 110.798 179.841 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 48.3 t -111.3 100.02 8.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.147 -0.479 . . . . 0.95 110.853 -179.704 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.609 ' HA ' ' HA ' ' A' ' 48' ' ' VAL . 31.5 pt -85.19 172.75 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.825 -0.625 . . . . 0.41 111.269 -179.928 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 43.9 t -139.67 132.12 28.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.485 . . . . 1.32 110.838 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -65.62 155.2 50.17 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.806 -0.711 . . . . 0.95 112.537 -179.905 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.469 ' HG2' ' HA ' ' A' ' 44' ' ' THR . 53.2 tpp -99.48 132.5 44.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.806 0.336 . . . . 2.04 110.891 -179.881 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.437 ' HD3' ' N ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -160.43 65.22 0.32 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.034 0.445 . . . . 5.46 111.06 179.936 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -66.99 -177.34 0.62 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.212 -0.449 . . . . 4.29 111.022 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -64.81 173.75 2.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.199 -0.455 . . . . 5.25 110.988 -179.967 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 59.9 p 51.18 -164.97 0.05 OUTLIER 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.094 -0.503 . . . . 4.88 111.081 -179.95 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 68.6 p -56.22 139.43 47.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.935 0.398 . . . . 5.27 111.091 179.792 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 67.2 p -82.19 15.45 2.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.111 -0.495 . . . . 6.91 111.277 -179.876 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -78.92 -26.07 58.96 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.795 -0.716 . . . . 5.36 112.445 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -106.68 149.48 27.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.784 0.326 . . . . 7.22 110.915 -179.98 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 57.06 88.7 0.05 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.139 -0.482 . . . . 3.05 111.178 -179.942 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.469 ' HA ' ' HG2' ' A' ' 34' ' ' MET . 59.8 p -135.34 151.8 50.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.106 -0.497 . . . . 2.53 110.997 179.905 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 156.89 144.55 3.96 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.826 -0.702 . . . . 1.14 112.399 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.407 HG12 HD12 ' A' ' 31' ' ' ILE . 5.1 tp -85.71 159.36 3.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.572 0.225 . . . . 0.65 110.962 -179.891 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -163.31 139.49 6.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.749 0.309 . . . . 0.7 111.336 -179.884 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.609 ' HA ' ' HA ' ' A' ' 31' ' ' ILE . 90.5 t -71.24 105.85 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.258 -0.428 . . . . 0.39 110.761 179.483 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -66.89 -38.08 85.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.041 -0.527 . . . . 2.4 111.013 -179.923 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 35.9 t -168.1 175.61 6.52 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.96 0.41 . . . . 1.28 111.252 -179.907 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 76.5 mt -115.13 155.7 26.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.842 -0.617 . . . . 0.42 110.713 179.918 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.519 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 70.4 mt -98.93 108.51 49.53 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 1.26 111.388 -179.62 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.05 136.12 72.96 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.432 2.088 . . . . 0.82 112.304 -179.919 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 103.99 -17.01 49.66 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.732 -0.747 . . . . 0.49 112.645 179.92 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 95.6 p -88.54 -176.07 5.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.809 0.338 . . . . 1.23 111.118 -179.878 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.86 -54.84 13.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.42 111.258 -179.853 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.64 -36.48 62.11 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.133 -0.485 . . . . 0.35 111.522 -179.827 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.02 -46.38 62.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.44 111.316 -179.887 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 97.4 mt -66.16 -19.75 65.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.364 -0.38 . . . . 0.66 110.834 179.73 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -61.24 -56.14 23.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 1.86 110.826 179.981 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 97.3 -49.04 1.52 Allowed Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.805 -0.712 . . . . 1.06 112.977 179.47 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.419 ' NH2' ' H ' ' A' ' 17' ' ' GLU . 83.1 mtm180 -56.0 -36.25 67.71 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.727 0.299 . . . . 2.59 111.164 -179.583 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 62.5 mt -70.27 116.18 11.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.875 0.369 . . . . 0.92 110.713 179.776 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -102.97 131.87 21.74 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.056 -0.52 . . . . 1.98 110.786 -179.684 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -60.91 171.88 3.39 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.443 2.096 . . . . 1.44 112.03 179.897 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 57.5 52.85 8.0 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.303 -0.408 . . . . 2.15 110.548 -179.469 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -123.52 174.19 7.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.124 -0.489 . . . . 2.02 111.017 -179.594 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -115.01 127.0 55.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.199 -0.455 . . . . 1.02 110.969 -179.964 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 47.9 mm -89.43 139.99 16.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.258 -0.428 . . . . 0.29 111.014 -179.924 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 84.8 mt -110.83 -62.73 1.49 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.176 -0.465 . . . . 0.4 111.109 -179.786 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -150.94 136.65 18.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.031 0.443 . . . . 2.61 111.609 -179.402 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.651 HG12 ' H ' ' A' ' 73' ' ' ASP . 2.3 t -89.06 175.46 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.777 -0.647 . . . . 0.28 110.186 179.437 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.655 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 14.5 t70 -49.15 108.66 0.2 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.725 0.298 . . . . 0.79 111.493 179.558 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.7 t70 57.03 28.4 14.78 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.164 -0.471 . . . . 2.01 111.544 179.306 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.7 t -145.88 144.27 20.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.334 -0.394 . . . . 0.79 110.874 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -114.35 129.87 56.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.437 -0.347 . . . . 2.24 110.585 179.62 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.2 m -112.29 26.12 3.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-N 116.548 -0.296 . . . . 0.67 111.479 -179.441 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -94.25 31.64 1.67 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.92 0.39 . . . . 1.39 110.724 179.739 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 177.37 34.87 0.05 OUTLIER Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.715 -0.755 . . . . 0.55 112.704 -179.974 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 54.9 mtm -134.62 145.28 48.47 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.905 0.383 . . . . 0.52 110.758 179.8 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.406 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -62.61 150.55 40.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.063 -0.517 . . . . 0.39 111.028 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -46.05 -51.58 13.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.298 -0.41 . . . . 1.52 111.399 -179.638 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.1 m -50.49 -47.82 57.08 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.215 -0.448 . . . . 1.48 111.33 -179.676 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -59.4 -41.88 90.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.341 -0.39 . . . . 2.12 111.065 -179.866 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 81' ' ' ALA . 18.6 t -58.96 -38.5 73.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.275 -0.421 . . . . 0.32 110.947 179.909 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.4 t -66.95 -38.02 80.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.173 -0.467 . . . . 0.37 111.033 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -57.77 -46.1 85.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.305 -0.407 . . . . 1.51 110.674 179.734 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 54.8 t -59.27 -53.98 40.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.058 -0.519 . . . . 0.27 111.073 179.747 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 78.5 mt -55.97 -26.77 49.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.996 -0.547 . . . . 0.41 111.107 -179.612 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -89.41 -19.79 24.74 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.388 -0.369 . . . . 2.1 111.308 179.978 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -89.68 -9.19 50.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.739 0.305 . . . . 1.14 111.177 179.981 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.03 -87.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.439 . . . . 0.55 111.404 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.583 ' HA2' ' HE ' ' A' ' 20' ' ' ARG . . . 60.74 20.07 56.14 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.66 -0.781 . . . . 0.76 112.342 -179.838 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.607 ' HB3' ' HD2' ' A' ' 95' ' ' PRO . 5.9 m120 -147.17 172.63 4.97 Favored Pre-proline 0 C--N 1.33 -0.263 0 C-N-CA 122.106 0.162 . . . . 2.52 110.775 -179.53 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.607 ' HD2' ' HB3' ' A' ' 94' ' ' ASN . 23.1 Cg_endo -62.86 89.53 0.12 Allowed 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 122.035 1.823 . . . . 0.64 111.624 178.191 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.7 m -103.38 151.76 6.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.177 0.513 . . . . 0.64 111.923 -179.216 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.655 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 79.4 ttt180 -101.2 143.95 30.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.566 -0.743 . . . . 2.37 110.159 179.378 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.02 105.11 10.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.432 -0.349 . . . . 0.37 111.368 -179.525 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 51.4 tp -94.75 105.6 17.54 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.889 0.376 . . . . 0.37 110.309 179.215 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.32 168.18 19.06 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.051 -0.522 . . . . 0.31 111.41 -179.597 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.539 ' HB ' HD23 ' A' ' 13' ' ' LEU . 10.7 tt -122.63 142.1 40.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.916 -0.584 . . . . 0.45 111.019 -179.962 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.43 ' HB3' ' CE1' ' A' ' 14' ' ' TYR . 31.5 tpt180 -166.06 136.28 3.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.986 -0.552 . . . . 2.26 110.5 179.618 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.519 ' HA ' ' HA ' ' A' ' 11' ' ' PHE . 59.7 ttp180 -62.02 143.21 56.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.026 -0.534 . . . . 3.93 111.251 -179.454 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.5 mt -103.44 153.05 38.81 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.659 -0.7 . . . . 2.0 110.652 -179.76 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -81.15 159.84 20.48 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.36 2.04 . . . . 2.98 112.045 179.921 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 91.5 mt -143.16 125.82 15.94 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.048 -0.524 . . . . 3.67 110.791 -179.734 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.432 HD22 ' N ' ' A' ' 107' ' ' LEU . 3.7 mm? -67.05 101.39 0.86 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.479 . . . . 5.59 110.828 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.356 -0.83 . . . . 6.0 111.143 -179.837 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.203 0 N-CA-C 112.495 -0.242 . . . . 7.92 112.495 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 52.5 m -120.43 149.24 42.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.757 0.313 . . . . 7.18 110.825 179.97 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -164.69 100.64 0.8 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 5.91 110.813 179.928 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -140.35 -44.22 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.791 -0.719 . . . . 2.45 112.711 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -80.61 84.05 6.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.815 0.34 . . . . 2.33 110.824 -179.846 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 53.6 m -92.87 88.3 6.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 2.59 110.92 -179.987 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 57.47 38.87 28.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.001 -0.545 . . . . 2.67 111.071 179.94 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -90.1 120.99 31.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.087 -0.506 . . . . 1.58 111.001 179.788 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.4 m 55.98 25.98 9.38 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.274 -0.421 . . . . 2.55 110.753 -179.695 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.581 ' HA3' ' HG3' ' A' ' 103' ' ' ARG . . . 98.01 -39.21 2.83 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.835 -0.698 . . . . 1.82 112.491 -179.945 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.4 ' HA ' ' HA ' ' A' ' 103' ' ' ARG . 62.5 m-85 -60.26 128.6 37.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.718 0.294 . . . . 1.7 110.73 179.855 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 46.9 t -149.48 147.02 27.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.9 111.238 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.53 HD23 ' HB ' ' A' ' 101' ' ' ILE . 45.7 mt -90.42 102.32 15.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.777 -0.647 . . . . 0.89 110.329 179.627 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -124.48 149.2 47.11 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.949 0.404 . . . . 2.73 111.229 -179.646 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.0 m -115.3 154.57 28.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.098 -0.501 . . . . 1.19 110.883 -179.792 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.4 t -124.12 157.42 31.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 0.56 110.529 179.827 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -116.18 107.69 15.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.864 0.364 . . . . 1.74 111.398 -179.672 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.455 HD11 ' HB2' ' A' ' 60' ' ' ASP . 4.3 mm? -116.98 144.76 44.21 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.079 -0.51 . . . . 0.81 110.546 179.696 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.696 ' HA ' ' HA ' ' A' ' 95' ' ' PRO . 21.8 p90 -118.66 117.87 30.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.936 0.398 . . . . 2.08 110.868 179.85 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.596 ' HG2' ' HA2' ' A' ' 93' ' ' GLY . 15.0 ttt180 -110.16 153.85 24.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.002 -0.545 . . . . 3.06 110.585 179.924 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -113.51 -70.26 0.81 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.097 0.475 . . . . 2.58 111.131 -179.862 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -136.22 -169.85 2.53 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.712 -0.676 . . . . 3.72 110.969 -179.812 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -55.51 -27.26 47.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.338 -0.392 . . . . 2.87 110.869 179.775 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.3 m -66.95 -36.99 83.47 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.16 -0.473 . . . . 1.38 110.744 179.875 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.9 m -81.85 61.41 5.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.122 -0.49 . . . . 2.45 110.931 179.869 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 51.0 m -57.88 138.34 55.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.479 . . . . 1.4 110.833 179.773 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.518 HD21 ' HB2' ' A' ' 20' ' ' ARG . 75.0 mt -78.8 -35.3 44.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.033 -0.531 . . . . 0.45 110.67 -179.845 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.428 ' HA2' ' HB ' ' A' ' 52' ' ' ILE . . . 93.75 -6.74 73.91 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.787 -0.72 . . . . 0.52 113.219 179.212 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 74.5 mt -60.07 108.67 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.747 0.308 . . . . 0.84 111.17 -179.851 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 39.6 t -112.31 97.91 6.95 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.21 -0.45 . . . . 0.95 110.662 179.729 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.491 ' HA ' ' HA ' ' A' ' 48' ' ' VAL . 38.6 pt -89.72 166.66 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.051 -0.522 . . . . 0.41 111.272 -179.838 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 54.7 m -143.71 138.94 29.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.095 -0.502 . . . . 1.32 110.953 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -88.42 121.77 6.09 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.825 -0.702 . . . . 0.95 112.48 179.966 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.409 ' HG2' ' H ' ' A' ' 36' ' ' ASP . 53.2 ttm -64.05 152.99 38.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.708 0.29 . . . . 2.04 110.847 -179.946 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.446 ' HD2' ' N ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -144.04 42.12 1.42 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.249 -0.432 . . . . 5.46 110.888 179.982 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.409 ' H ' ' HG2' ' A' ' 34' ' ' MET . 20.1 t70 -57.61 141.85 46.73 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.223 -0.444 . . . . 4.29 110.85 179.934 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -119.36 -177.08 3.28 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.254 -0.43 . . . . 5.25 110.974 -179.772 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 52.6 m 60.33 -178.87 0.1 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.957 -0.565 . . . . 4.88 111.067 -179.969 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 23.7 p 53.56 -172.74 0.04 OUTLIER 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.002 -0.545 . . . . 5.27 111.614 179.77 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.1 t -133.83 29.72 3.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.985 -0.552 . . . . 6.91 110.832 179.863 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -147.93 77.44 0.24 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.815 -0.707 . . . . 5.36 112.57 -179.978 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -91.78 153.83 19.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.757 0.313 . . . . 7.22 110.724 179.872 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -132.24 75.69 1.65 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.269 -0.423 . . . . 3.05 111.302 -179.805 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 82.6 p -78.66 127.06 31.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 2.53 110.901 179.728 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -146.39 176.86 25.08 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.619 -0.8 . . . . 1.14 112.726 -179.803 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 37.5 mm -95.97 106.46 18.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.707 0.289 . . . . 0.65 110.822 179.979 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -131.73 142.77 49.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.287 -0.415 . . . . 0.7 111.189 -179.726 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.491 ' HA ' ' HA ' ' A' ' 31' ' ' ILE . 46.8 t -81.54 116.64 26.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.116 -0.493 . . . . 0.39 111.004 179.847 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -84.79 -35.71 22.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.452 . . . . 2.4 111.22 -179.705 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 54.6 m -149.66 172.68 14.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.125 0.488 . . . . 1.28 111.63 -179.527 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.467 HD11 HG22 ' A' ' 63' ' ' ILE . 63.0 mt -131.73 141.45 49.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.723 -0.671 . . . . 0.42 110.538 179.835 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.428 ' HB ' ' HA2' ' A' ' 28' ' ' GLY . 43.2 mm -75.4 115.56 46.57 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.337 -0.392 . . . . 1.26 111.074 -179.89 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -58.07 126.26 21.07 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.387 2.058 . . . . 0.82 112.391 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 98.53 -13.66 62.57 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.799 -0.715 . . . . 0.49 112.785 179.659 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 92.8 p -72.02 -177.33 2.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.779 0.324 . . . . 1.23 110.914 -179.861 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.39 -55.29 12.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.42 111.178 179.976 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.82 -33.88 67.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.108 -0.497 . . . . 0.35 111.397 -179.804 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.78 -55.55 8.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.44 111.509 -179.649 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.0 mt -59.1 -20.23 51.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.66 111.187 -179.835 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.455 ' HB2' HD11 ' A' ' 18' ' ' LEU . 17.4 t70 -59.05 -52.54 65.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.36 -0.382 . . . . 1.86 110.642 -179.909 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.91 -31.7 7.36 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.707 -0.759 . . . . 1.06 113.126 179.387 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 82.2 mtm180 -83.85 0.84 45.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.686 0.279 . . . . 2.59 111.238 -179.571 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.467 HG22 HD11 ' A' ' 51' ' ' LEU . 53.6 mt -116.47 122.78 70.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.848 0.356 . . . . 0.92 110.979 179.592 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -129.41 158.1 74.25 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.125 -0.489 . . . . 1.98 110.809 179.971 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -57.08 176.97 0.2 Allowed 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.587 2.191 . . . . 1.44 112.308 179.674 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 56.38 50.08 13.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.013 -0.54 . . . . 2.15 110.637 -179.805 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.429 ' HA ' ' HG2' ' A' ' 102' ' ' ARG . 8.3 t70 -120.81 151.85 39.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.815 -0.629 . . . . 2.02 110.83 -179.934 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -109.62 109.06 19.7 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.857 0.36 . . . . 1.02 110.912 179.979 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 49.2 mm -71.03 142.41 15.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.143 -0.48 . . . . 0.29 110.982 179.896 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 73.3 mt -114.97 -71.77 0.73 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.097 -0.501 . . . . 0.4 110.98 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.423 ' O ' ' HB3' ' A' ' 99' ' ' LEU . 75.9 mtp180 -135.95 135.33 39.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 2.61 111.406 -179.611 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.564 HG12 ' H ' ' A' ' 73' ' ' ASP . 6.6 t -93.55 170.69 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.922 -0.581 . . . . 0.28 109.842 179.166 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.606 ' HB2' ' H ' ' A' ' 97' ' ' ARG . 16.8 t70 -46.7 108.7 0.15 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.917 0.389 . . . . 0.79 111.841 179.928 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 53.41 14.52 0.57 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.817 -0.629 . . . . 2.01 112.479 179.013 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 65.2 t -144.72 99.67 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.76 0.314 . . . . 0.79 111.388 -179.887 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -68.07 155.58 39.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.386 -0.37 . . . . 2.24 110.355 179.462 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.46 HG11 HG13 ' A' ' 85' ' ' VAL . 17.4 m -133.44 39.84 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.846 0.355 . . . . 0.67 111.391 -179.814 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -109.8 35.84 3.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 1.39 111.048 179.795 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -179.6 26.64 0.05 OUTLIER Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.481 -0.866 . . . . 0.55 112.927 179.962 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 65.6 mtm -130.61 153.16 49.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.853 0.358 . . . . 0.52 110.918 179.75 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.432 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -62.18 151.98 34.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.011 -0.54 . . . . 0.39 111.333 -179.86 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -50.36 -55.75 14.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.238 -0.437 . . . . 1.52 111.249 -179.744 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.1 m -52.95 -41.03 64.12 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.07 -0.514 . . . . 1.48 111.171 -179.813 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -59.08 -43.56 91.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.288 -0.414 . . . . 2.12 110.89 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.46 HG13 HG11 ' A' ' 77' ' ' VAL . 22.8 t -60.16 -36.46 68.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.143 -0.48 . . . . 0.32 110.818 179.883 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.2 t -63.76 -40.89 90.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.036 -0.529 . . . . 0.37 111.015 179.92 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -59.1 -49.73 76.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.265 -0.425 . . . . 1.51 110.732 179.812 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 54.6 t -52.25 -53.83 17.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.95 -0.568 . . . . 0.27 111.333 179.876 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 71.3 mt -56.71 -33.83 66.86 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.103 -0.499 . . . . 0.41 111.329 -179.516 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 -82.2 -14.95 54.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.484 -0.325 . . . . 2.1 111.226 -179.793 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -92.14 -15.4 27.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.365 -0.38 . . . . 1.14 111.086 179.976 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.77 -83.51 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.287 -0.415 . . . . 0.55 111.454 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.596 ' HA2' ' HG2' ' A' ' 20' ' ' ARG . . . 62.49 21.76 62.85 Favored Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.638 -0.791 . . . . 0.76 112.431 -179.724 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.59 169.65 8.98 Favored Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 110.527 -0.175 . . . . 2.52 110.527 -179.823 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.696 ' HA ' ' HA ' ' A' ' 19' ' ' PHE . 48.8 Cg_exo -57.39 92.47 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.048 1.832 . . . . 0.64 111.427 178.349 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.9 m -103.72 148.83 8.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.133 0.492 . . . . 0.64 111.84 -179.051 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.606 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 71.6 ttt180 -99.7 144.11 29.15 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.618 -0.719 . . . . 2.37 110.002 179.726 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 13.6 mt -118.38 103.79 10.12 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.386 -0.37 . . . . 0.37 111.525 -179.146 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.423 ' HB3' ' O ' ' A' ' 71' ' ' ARG . 65.3 tp -90.98 109.35 20.58 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.857 -0.423 . . . . 0.37 109.857 179.062 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -143.25 168.34 20.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.247 0.546 . . . . 0.31 111.963 -179.115 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.53 ' HB ' HD23 ' A' ' 13' ' ' LEU . 13.0 tt -119.49 143.1 31.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.572 -0.74 . . . . 0.45 110.556 179.838 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.429 ' HG2' ' HA ' ' A' ' 67' ' ' ASP . 0.4 OUTLIER -166.1 133.63 2.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.34 -0.391 . . . . 2.26 110.751 -179.955 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.581 ' HG3' ' HA3' ' A' ' 10' ' ' GLY . 70.4 ttt180 -61.41 146.91 46.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.072 -0.513 . . . . 3.93 110.961 179.99 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.3 mt -90.47 144.23 30.44 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.734 -0.667 . . . . 2.0 110.917 -179.683 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -81.08 60.79 7.98 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.706 2.271 . . . . 2.98 112.232 179.865 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 96.4 mt -54.12 111.07 0.69 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.482 -0.781 . . . . 3.67 111.13 179.959 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 81.4 mt -80.61 155.86 26.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.047 -0.524 . . . . 5.59 111.014 -179.934 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.182 -0.913 . . . . 6.0 111.008 179.976 . . . . . . . . 0 0 . 1 stop_ save_